Citrus Sinensis ID: 006168
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 658 | 2.2.26 [Sep-21-2011] | |||||||
| Q9CAL2 | 646 | Cysteine-rich receptor-li | yes | no | 0.788 | 0.803 | 0.387 | 1e-103 | |
| Q9FNE1 | 651 | Cysteine-rich receptor-li | no | no | 0.806 | 0.815 | 0.388 | 1e-103 | |
| Q9CAL3 | 649 | Cysteine-rich receptor-li | no | no | 0.857 | 0.869 | 0.366 | 1e-101 | |
| Q9LMB9 | 615 | Cysteine-rich receptor-li | no | no | 0.776 | 0.830 | 0.375 | 7e-89 | |
| Q8S9L6 | 679 | Cysteine-rich receptor-li | no | no | 0.826 | 0.801 | 0.353 | 5e-88 | |
| Q9M0G5 | 625 | Putative cysteine-rich re | no | no | 0.803 | 0.846 | 0.345 | 1e-87 | |
| Q9M0X5 | 675 | Cysteine-rich receptor-li | no | no | 0.796 | 0.776 | 0.357 | 1e-85 | |
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.873 | 0.859 | 0.355 | 1e-84 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.518 | 0.330 | 0.463 | 9e-84 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.518 | 0.330 | 0.458 | 1e-83 |
| >sp|Q9CAL2|CRK3_ARATH Cysteine-rich receptor-like protein kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 377 bits (967), Expect = e-103, Method: Compositional matrix adjust.
Identities = 215/555 (38%), Positives = 312/555 (56%), Gaps = 36/555 (6%)
Query: 67 VYTMVQCRRYVSTADCAACFTSAESLIRNC----SAANGARVIYLACSLRYESSSFYDQS 122
VY +C + + DC CF ++ + C G +V C +RY+ +FY+++
Sbjct: 76 VYAYGECIKDLDKKDCDLCFAQIKAKVPRCLPFQKGTRGGQVFSDGCYIRYDDYNFYNET 135
Query: 123 TQEGRFGFCGNR--TALQADAFKTAAQELLENLEVATPKINGFFAASKNNIIGSRAGAND 180
C + T + F+ A EL++N+ V + GF+A
Sbjct: 136 LSLQDRTVCAPKEITGVNRTVFRDNAAELVKNMSVEAVRNGGFYAGFV------------ 183
Query: 181 DDDKNSTAVYGIAQCVETISETGCQNCLSGAFDNIQRCLGSAFGWAVDAGCFLRYSDTPF 240
D+++ V+G+AQC ET++ +GC CLS A I CL + G + AGC++R+S F
Sbjct: 184 --DRHNVTVHGLAQCWETLNRSGCVECLSKASVRIGSCLVNEEGRVLSAGCYMRFSTQKF 241
Query: 241 F--ADNQTTDITPFLKNGSSNKEAIIGGVVGGGTGLILFALLIWLVISRKSKKIQR--GN 296
+ + N T+D NG N +I V +L ++ ++ K QR
Sbjct: 242 YNNSGNSTSD-----GNGGHNHLGVILAVTSSVVAFVLLVSAAGFLLKKRHAKKQREKKQ 296
Query: 297 ISEATELQGPVN--YRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIG 354
+ L N + ++L AT FS++NKLG+GG G +YKG L NGK VAVK+L
Sbjct: 297 LGSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRLFFN 356
Query: 355 ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKR-G 413
+++ + F NEV LIS V H+NL++LLGC GPE +LVYEY+AN SL +LF K
Sbjct: 357 -TKQWVDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLFVRKDVQ 415
Query: 414 SLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473
LNW +RF IILGTA G+AYLHE+ ++RIIHRDIK SN+LL+DD P+IADFGLARL PE
Sbjct: 416 PLNWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGLARLFPE 475
Query: 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLL 533
+++H+ST AGTLGY APEY + G+L+EK D YSFGVL++E+I+G +++ + G +L
Sbjct: 476 DKTHISTAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQDAGS-IL 534
Query: 534 KRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK- 592
+ W LY E +D L N K A ++++I L+C Q+A + RP MS VV ++K
Sbjct: 535 QSVWSLYRTSNVEEAVDPILGDN-FNKIEASRLLQIGLLCVQAAFDQRPAMSVVVKMMKG 593
Query: 593 STSSSLLGNKPLLKP 607
S P L P
Sbjct: 594 SLEIHTPTQPPFLNP 608
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9FNE1|CRK42_ARATH Cysteine-rich receptor-like protein kinase 42 OS=Arabidopsis thaliana GN=CRK42 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 375 bits (962), Expect = e-103, Method: Compositional matrix adjust.
Identities = 222/572 (38%), Positives = 316/572 (55%), Gaps = 41/572 (7%)
Query: 53 KKFATAQRTRGPDQVYTMVQCRRYVSTADCAACFTSAESLIRNCSAANGARVIYLACSLR 112
++FAT + +Y ++QC +S +DC C+ A + I C ++ AR+ C LR
Sbjct: 71 RRFAT-ESLNSTTSIYALIQCHDDLSPSDCQLCYAIARTRIPRCLPSSSARIFLDGCFLR 129
Query: 113 YESSSFYDQSTQEGRFGF-CGNRTALQADAFKTAAQELLENLEVATPKINGFFAASKNNI 171
YE+ FYD+S + F C N T L F E + V + GF A +N
Sbjct: 130 YETYEFYDESVSDASDSFSCSNDTVLDP-RFGFQVSETAARVAV---RKGGFGVAGEN-- 183
Query: 172 IGSRAGANDDDDKNSTAVYGIAQCVETISETGCQNCLSGAFDNIQRCLGSAFGWAVDAGC 231
V+ +AQC E++ + C+ CL A ++RC+ G A++ GC
Sbjct: 184 ----------------GVHALAQCWESLGKEDCRVCLEKAVKEVKRCVSRREGRAMNTGC 227
Query: 232 FLRYSDTPFFADNQTTDITPFLKNGSSNKEAIIGGVVGGGTGLILFALLIWLVISRKSK- 290
+LRYSD F+ + NK I+ V+ ++L L ++++++ SK
Sbjct: 228 YLRYSDHKFYNGDGHHKFHVLF-----NKGVIVAIVLTTSAFVMLILLATYVIMTKVSKT 282
Query: 291 KIQRGNISEATEL--QGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAV 348
K ++ N+ + ++ + L AT FS + LG+GG G ++ G L NGK VAV
Sbjct: 283 KQEKRNLGLVSRKFNNSKTKFKYETLEKATDYFSHKKMLGQGGNGTVFLGILPNGKNVAV 342
Query: 349 KKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLF 408
K+L +R + +F NEV LIS + H+NL++LLGC +GPE +LVYEY+ N SLD+FLF
Sbjct: 343 KRLVFN-TRDWVEEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNKSLDQFLF 401
Query: 409 GEKRGS-LNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL 467
E + LNW QR +IILGTA GLAYLH VRIIHRDIK SNVLLDD L PKIADFGL
Sbjct: 402 DESQSKVLNWSQRLNIILGTAEGLAYLHGGSPVRIIHRDIKTSNVLLDDQLNPKIADFGL 461
Query: 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE 527
AR +++HLST AGTLGY APEY + GQL+EK D YSFGVLVLEI GT+ + E
Sbjct: 462 ARCFGLDKTHLSTGIAGTLGYMAPEYVVRGQLTEKADVYSFGVLVLEIACGTRINAFVPE 521
Query: 528 EGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAE----KVVEIALMCTQSAANSRPT 583
G +LL+R W LY E +D L + +E KV+ + L+CTQ++ + RP+
Sbjct: 522 TG-HLLQRVWNLYTLNRLVEALDPCLKDEFLQVQGSEAEACKVLRVGLLCTQASPSLRPS 580
Query: 584 MSEVVALLKSTSSSLLG--NKPLLKPTFVETD 613
M EV+ +L + + P L+ + + TD
Sbjct: 581 MEEVIRMLTERDYPIPSPTSPPFLRVSSLTTD 612
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9CAL3|CRK2_ARATH Cysteine-rich receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 370 bits (951), Expect = e-101, Method: Compositional matrix adjust.
Identities = 223/609 (36%), Positives = 330/609 (54%), Gaps = 45/609 (7%)
Query: 23 CSQYNVTNFSEFNSNLNATFKELREQLNGGKKFATAQRTRGPDQVYTMVQCRRYVSTADC 82
CS N + + N AT +++ Q+ F A GPD Y + QC + DC
Sbjct: 40 CSPLLEHNETAYVPNFVATMEKISTQVQT-SGFGVALTGTGPDANYGLAQCYGDLPLNDC 98
Query: 83 AACFTSAESLIRNCSAANGARVIYLACSLRYESSSFYDQSTQEGRFGFCGNRTALQADAF 142
C+ A +++ C NG R+ C +R E+ SFY++ CGN T + F
Sbjct: 99 VLCYAEARTMLPQCYPQNGGRIFLDGCFMRAENYSFYNEYKGPEDSIVCGN-TTRKNKTF 157
Query: 143 KTAAQELLENLEVATPKINGFFAASKNNIIGSRAGANDDDDKNSTAVYGIAQCVETISET 202
A ++ L N G+ AS ++AG ++ S + + +A C T+S
Sbjct: 158 GDAVRQGLRNAVTEASGTGGYARAS------AKAGESE-----SESAFVLANCWRTLSPD 206
Query: 203 GCQNCLSGAFDNIQR-CLGSAFGWAVDAGCFLRYSDTPFFADNQTTDITPFLKNGSSNKE 261
C+ CL A ++ + CL + G A+ GCFLRYSD F + +NG S
Sbjct: 207 SCKQCLENASASVVKGCLPWSEGRALHTGCFLRYSDQDF--------LNKIPRNGRSRGS 258
Query: 262 AIIGG----------VVGGGTGLILFALLIWLVISRKSKKIQRGNISEATELQGPVNYRL 311
++ ++G + + R SK +++ T +N++
Sbjct: 259 VVVIVVSVLSSVVVFMIGVAVSVYICKRRTIKRKRRGSKDVEK---MAKTLKDSSLNFKY 315
Query: 312 KDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLIS 371
L AT F NKLG+GGFG +YKG L +G+ +AVK+L +R +DF NEV +IS
Sbjct: 316 STLEKATGSFDNANKLGQGGFGTVYKGVLPDGRDIAVKRLFFN-NRHRATDFYNEVNMIS 374
Query: 372 NVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRG-SLNWKQRFDIILGTARG 430
V H+NL+RLLGC GPE +LVYEY+ N SLD+F+F RG +L+W++R+ II+GTA G
Sbjct: 375 TVEHKNLVRLLGCSCSGPESLLVYEYLQNKSLDRFIFDVNRGKTLDWQRRYTIIVGTAEG 434
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
L YLHE V+IIHRDIK SN+LLD LQ KIADFGLAR +++SH+ST AGTLGY A
Sbjct: 435 LVYLHEQSSVKIIHRDIKASNILLDSKLQAKIADFGLARSFQDDKSHISTAIAGTLGYMA 494
Query: 491 PEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETK-GEEGEYLLKRAWRLYENGTHWELM 549
PEY HGQL+E VD YSFGVLVLEI++G +++++K + + L+ AW+ +++G ++
Sbjct: 495 PEYLAHGQLTEMVDVYSFGVLVLEIVTGKQNTKSKMSDYSDSLITEAWKHFQSGELEKIY 554
Query: 550 DESLD-----PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSS--SLLGNK 602
D +LD + K+ +VV+I L+CTQ + RP MS+++ +LK+ L N
Sbjct: 555 DPNLDWKSQYDSHIIKKEIARVVQIGLLCTQEIPSLRPPMSKLLHMLKNKEEVLPLPSNP 614
Query: 603 PLLKPTFVE 611
P + +E
Sbjct: 615 PFMDERVME 623
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMB9|CRK1_ARATH Cysteine-rich receptor-like protein kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 328 bits (841), Expect = 7e-89, Method: Compositional matrix adjust.
Identities = 213/567 (37%), Positives = 301/567 (53%), Gaps = 56/567 (9%)
Query: 67 VYTMVQCRRYVSTADCAACFTSAE-SLIRNCSAANGARVIYLACSLRYESSSFYDQSTQE 125
+Y +QCR +S +DC CF + L R CS + G R+ C LR++ F ++
Sbjct: 80 IYVFLQCREDLSVSDCRHCFNESRLELERKCSGS-GGRIHSDRCFLRFDDRDFSEEFVDP 138
Query: 126 GRFGFCGNRTALQADAFKTAAQELLENLEVATPKINGFFAASKNNIIGSRAGANDDDDKN 185
T F E L N+ + K GF AAS +I
Sbjct: 139 TFDKANCEETGTGFGEFWRFLDEALVNVTLKAVKNGGFGAAS---VI------------K 183
Query: 186 STAVYGIAQCVETISETGCQNCLSGAFDNIQRCLGSAFGWAVDAGCFLRYSDTPFFADNQ 245
+ AVY +AQC +T+ E C+ CL A +++ C G A GC+L+YS FF D
Sbjct: 184 TEAVYALAQCWQTLDENTCRECLVNARSSLRACDGHE-ARAFFTGCYLKYSTHKFFDDAA 242
Query: 246 T------------TDITPFLKNGSSNKEAIIGGVVGGGTGLILFALLIWLVISRKSKKIQ 293
+ P L + + AI + T L A + + +SRK K
Sbjct: 243 EHKPDADQRNFIRSSFFPHLSDRDVTRLAIAAISLSILTSL--GAFISYRRVSRKRK--- 297
Query: 294 RGNISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAI 353
++ VN++ + L AT F + KLG+GG G +YKG L +G+IVAVKKL
Sbjct: 298 -------AQVPSCVNFKYEMLEKATESFHDSMKLGQGGAGSVYKGILPDGRIVAVKKLFF 350
Query: 354 GISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRG 413
+R F NEV LIS V H+NL+RLLGC +GP+ +LVYEY+ N SLD+ LF +
Sbjct: 351 N-TREWADQFFNEVNLISGVQHKNLVRLLGCSIEGPKSLLVYEYVHNRSLDQILFMKNTV 409
Query: 414 S-LNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472
L+WKQRF+II+G + GL YLH V+IIHRDIK SN+LLD +L PKIADFGL R +
Sbjct: 410 HILSWKQRFNIIIGISEGLEYLHRGSEVKIIHRDIKTSNILLDRNLSPKIADFGLIRSMG 469
Query: 473 ENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSE-TKGEEGEY 531
+++ +T AGTLGY APEY I GQL+EK D Y+FGVL++EI++G K++ T+G
Sbjct: 470 TDKTQTNTGIAGTLGYLAPEYLIKGQLTEKADVYAFGVLIIEIVTGKKNNAFTQGTSS-- 527
Query: 532 LLKRAWRLYENGTHWELMDESLDPN---ECTKEAAEKVVEIALMCTQSAANSRPTMSEVV 588
+L W ++ T +D S+DP +E A KV++I L+C QS+ RP+MSE+V
Sbjct: 528 VLYSVWEHFKANT----LDRSIDPRLKGSFVEEEALKVLQIGLLCVQSSVELRPSMSEIV 583
Query: 589 ALLKSTSSSLLGNK--PLLKPTFVETD 613
+L++ S K P L + + D
Sbjct: 584 FMLQNKDSKFEYPKQPPFLSASVLMPD 610
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S9L6|CRK29_ARATH Cysteine-rich receptor-like protein kinase 29 OS=Arabidopsis thaliana GN=CRK29 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 325 bits (834), Expect = 5e-88, Method: Compositional matrix adjust.
Identities = 212/599 (35%), Positives = 308/599 (51%), Gaps = 55/599 (9%)
Query: 65 DQVYTMVQCRRYVSTADCAACF-TSAESLIRNCSAANGARVIYLACSLRYESSSFYD-QS 122
++ Y + CRR V DC +C T+A +L + C A V Y C RY + + Y +
Sbjct: 80 ERAYAIGLCRREVKRDDCVSCIQTAARNLTKQCPLTKQAVVWYTHCMFRYSNRTIYGRKE 139
Query: 123 TQEGRFGFCGNRTALQADAFKTAAQELLENLEVATPKINGFFAASKNNIIGSRAGANDDD 182
T + G + D F+ + LL+ L+ G AA N A N
Sbjct: 140 TNPTKAFIAGEEISANRDDFERLQRGLLDRLK-------GIAAAGGPN--RKYAQGNGSA 190
Query: 183 DKNSTAVYGIAQCVETISETGCQNCLSGAFDNIQRCLGSAFG--WAVDAGCFLRYSDTPF 240
YG QC +SE C +CL F+NI C + G W C R+ F
Sbjct: 191 SAGYRRFYGTVQCTPDLSEQDCNDCLVFGFENIPSCCDAEIGLRW-FSPSCNFRFETWRF 249
Query: 241 FA-DNQTTDITPFLKNGSSNKEAIIGGVVGGGTG--------------LILFALLIWLVI 285
+ D P ++ S + A G G G + L A+ + LV+
Sbjct: 250 YEFDADLEPDPPAIQPADSPQSAARTERTGKGKGGSKVIIAIVIPILLVALLAICLCLVL 309
Query: 286 S-RKSKKIQRGNISEATELQGPVN-----------YRLKDLVSATRKFSEENKLGEGGFG 333
RK+K + + + L G + + L +AT FS EN+LG GGFG
Sbjct: 310 KWRKNKSGYKNKVLGKSPLSGSIAEDEFSNTESLLVHFETLKTATDNFSSENELGRGGFG 369
Query: 334 DIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393
+YKG G+ +AVK+L+ G S + ++F+NE+ L++ + HRNL+RL+G C QG E +L
Sbjct: 370 SVYKGVFPQGQEIAVKRLS-GNSGQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLL 428
Query: 394 VYEYMANSSLDKFLFG-EKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNV 452
VYE++ N+SLD+F+F EKR L+W R+ +I G ARGL YLHED RIIHRD+K SN+
Sbjct: 429 VYEFIKNASLDQFIFDTEKRQLLDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNI 488
Query: 453 LLDDDLQPKIADFGLARLLPENQS---HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFG 509
LLD ++ PKIADFGLA+L Q+ +++ AGT GY APEYA+HGQ S K D +SFG
Sbjct: 489 LLDQEMNPKIADFGLAKLFDSGQTMTHRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFG 548
Query: 510 VLVLEIISGTKSS---ETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKV 566
VLV+EII+G +++ E+ E LL WR + T ++D SL ++ +
Sbjct: 549 VLVIEIITGKRNNNGGSNGDEDAEDLLSWVWRSWREDTILSVIDPSLTAG--SRNEILRC 606
Query: 567 VEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNKPLLKPTFVETDYRKTPADTSTST 625
+ I L+C Q +A +RPTM+ V +L S S +L L+P FV + P++ S+ST
Sbjct: 607 IHIGLLCVQESAATRPTMATVSLMLNSYSFTL---PTPLRPAFV-LESVVIPSNVSSST 661
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M0G5|CRK43_ARATH Putative cysteine-rich receptor-like protein kinase 43 OS=Arabidopsis thaliana GN=CRK43 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 324 bits (831), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 204/590 (34%), Positives = 317/590 (53%), Gaps = 61/590 (10%)
Query: 34 FNSNLNATFKELREQLNGGKKFATAQRTRGPDQVYTMVQCRRYVSTADCAACFTSAESLI 93
+ NL+A ++R KF T + P+++Y + QC +S+ +C+ C++ A L+
Sbjct: 51 YQINLDAIRGDMRHV-----KFGTHEHGDPPERMYVLSQCVSDLSSDECSLCWSRATDLL 105
Query: 94 RNCSAANGARVIYLACSLRYESSSFYDQSTQEGRFGFCGNRTALQADAFKTAAQELLENL 153
C A G C +R ++ SFY + C + A+ FK +E+ +++
Sbjct: 106 SQCFPATGGWFHLDGCFVRADNYSFYQEPVSHQDTKICASDKEKSAE-FKGLVKEVTKSI 164
Query: 154 EVATPKINGFFAASKNNIIGSRAGANDDDDKNSTAVYGIAQCVETISETGCQNCLSGAFD 213
A P GF A + G D VYG+ C T+++ C+ CL+
Sbjct: 165 VEAAPYSRGFSVA--------KMGIRD------LTVYGLGVCWRTLNDELCKLCLADGAL 210
Query: 214 NIQRCLGSAFGWAVDAGCFLRYSDTPFFADNQTTDITPFLKNGSSNKEAIIGGVVGGGTG 273
++ CL S G+A++AGC+LRYS+ F+ + L S KE + V G
Sbjct: 211 SVTSCLPSKEGFALNAGCYLRYSNYTFYNERG-------LLAMSFTKENLTYIFVISMVG 263
Query: 274 LILFALLIWL---VISRKSK------------------KIQRGNISEATELQGPVNYRLK 312
++ A W R S +I++ + S TE +++
Sbjct: 264 VLAIAAGFWCGKCFYMRTSPKKKIKGTKTKKFHLFGHLRIEKESESICTE-SHLMSFEYS 322
Query: 313 DLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISN 372
L AT F+E KLG GG+G+++KGTL +G+ +A+K+L + ++ + NE+ +IS
Sbjct: 323 TLKKATNNFNESCKLGVGGYGEVFKGTLSDGREIAIKRLHVS-GKKPRDEIHNEIDVISR 381
Query: 373 VHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFG-EKRGSLNWKQRFDIILGTARGL 431
H+NL+RLLGCC +VYE++AN+SLD LF EK+ L+WK+R IILGTA GL
Sbjct: 382 CQHKNLVRLLGCCFTNMNSFIVYEFLANTSLDHILFNPEKKKELDWKKRRTIILGTAEGL 441
Query: 432 AYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN-----QSHLS-TKFAGT 485
YLHE +IIHRDIK SN+LLD +PKI+DFGLA+ PE S LS + AGT
Sbjct: 442 EYLHET--CKIIHRDIKASNILLDLKYKPKISDFGLAKFYPEGGKDIPASSLSPSSIAGT 499
Query: 486 LGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEG-EYLLKRAWRLYENGT 544
LGY APEY G+LS K+DAYSFGVLVLEI SG ++++ + + E L+ + W+ + +
Sbjct: 500 LGYMAPEYISKGRLSNKIDAYSFGVLVLEITSGFRNNKFRSDNSLETLVTQVWKCFASNK 559
Query: 545 HWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594
E++D+ + + K+ ++V++I L+CTQ + RPTMS+V+ ++ ST
Sbjct: 560 MEEMIDKDMG-EDTDKQEMKRVMQIGLLCTQESPQLRPTMSKVIQMVSST 608
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (814), Expect = 1e-85, Method: Compositional matrix adjust.
Identities = 205/574 (35%), Positives = 302/574 (52%), Gaps = 50/574 (8%)
Query: 56 ATAQRTRGPDQVYTMVQCRRYVSTADCAAC--FTSAESLIRNCSAANGARVIYLACSLRY 113
A A ++VY + CR VS C C F + E+L R C A + Y C +RY
Sbjct: 71 AAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQR-CPREKVAVIWYDECMVRY 129
Query: 114 ESSSFYDQ-STQEGRF-GFCGNRTALQADAFKTAAQELLENLEVATPKINGFFAASKNNI 171
+ S Q + G F N T Q F + LL ++ V + FA K N
Sbjct: 130 SNQSIVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSRKFATEKANF 189
Query: 172 IGSRAGANDDDDKNSTAVYGIAQCVETISETGCQNCLSGAFDNIQRCLGSAFGWAVDA-G 230
+ +Y + QC ++ C++CL + + RC + G V A
Sbjct: 190 TVFQT------------IYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPS 237
Query: 231 CFLRYSDTPFFADN----------QTTDITPFL-----KNGSSNKEAIIGGV-VGGGTGL 274
C RY PF+ + +T P L K N I+ + V +
Sbjct: 238 CSFRYELYPFYNETIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCV 297
Query: 275 ILFALLIWLVISRKSKKI-------QRGNISEATELQGPVNYRLKDLVSATRKFSEENKL 327
+L + WL+ R++ K+ I+ LQ ++ + +AT KFSE NKL
Sbjct: 298 LLLGAMCWLLARRRNNKLSAETEDLDEDGITSTETLQ----FQFSAIEAATNKFSESNKL 353
Query: 328 GEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ 387
G GGFG++YKG L G+ VA+K+L+ G S + +F+NEV +++ + HRNL +LLG C
Sbjct: 354 GHGGFGEVYKGQLITGETVAIKRLSQG-STQGAEEFKNEVDVVAKLQHRNLAKLLGYCLD 412
Query: 388 GPELILVYEYMANSSLDKFLF-GEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRD 446
G E ILVYE++ N SLD FLF EKR L+W++R+ II G ARG+ YLH D + IIHRD
Sbjct: 413 GEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRD 472
Query: 447 IKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK-FAGTLGYTAPEYAIHGQLSEKVDA 505
+K SN+LLD D+ PKI+DFG+AR+ +Q+ +TK GT GY +PEYAIHG+ S K D
Sbjct: 473 LKASNILLDADMHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDV 532
Query: 506 YSFGVLVLEIISGTKSSETKGEEG-EYLLKRAWRLYENGTHWELMDESLDPNECTKEAAE 564
YSFGVLVLE+I+G K+S E+G L+ W+L+ + EL+DE++ N T E
Sbjct: 533 YSFGVLVLELITGKKNSSFYEEDGLGDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVI- 591
Query: 565 KVVEIALMCTQSAANSRPTMSEVVALLKSTSSSL 598
+ + IAL+C Q ++ RP+M +++ ++ S + +L
Sbjct: 592 RCIHIALLCVQEDSSERPSMDDILVMMNSFTVTL 625
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 315 bits (806), Expect = 1e-84, Method: Compositional matrix adjust.
Identities = 226/635 (35%), Positives = 326/635 (51%), Gaps = 60/635 (9%)
Query: 27 NVTNFSEFNSNLNATFKELREQ-LNGGKKFATAQRTRGPDQVYTMVQCRRYVSTADCAAC 85
N T+ S +N+NL L + + F A + PD+V + CR VST C C
Sbjct: 49 NYTSNSTYNNNLKTLLASLSSRNASYSTGFQNATVGQAPDRVTGLFNCRGDVSTEVCRRC 108
Query: 86 --FTSAESLIRNCSAANGARVIYLACSLRYESSSFYDQSTQEGRFGFCGNRTALQADAFK 143
F ++L R C A + Y C LRY + + G R
Sbjct: 109 VSFAVNDTLTR-CPNQKEATLYYDECVLRYSNQNILSTLITTGGVILVNTRNV------- 160
Query: 144 TAAQ-ELLENLEVATPKINGFFAASKNNIIGSRAGANDDDDKNSTAV---YGIAQCVETI 199
T+ Q +LL +L + T A + + G+R N TA+ YG+ QC +
Sbjct: 161 TSNQLDLLSDLVLPTLNQAATVALNSSKKFGTRK-------NNFTALQSFYGLVQCTPDL 213
Query: 200 SETGCQNCLSGAFDNIQRCLGSAFGWAVDAGCFLRYSDTPFFADNQTTDITPFL------ 253
+ C CL + I A ++ C RY F+ ++ P
Sbjct: 214 TRQDCSRCLQLVINQIPTDRIGA--RIINPSCTSRYEIYAFYTESAVPPPPPPPSISTPP 271
Query: 254 --------KNGSSNKEAIIGGVVGGGTGLILFALLIWLVISRKSKK-------IQRGNIS 298
K+G+S I V L+ A +L +R+++K +I+
Sbjct: 272 VSAPPRSGKDGNSKVLVIAIVVPIIVAVLLFIAGYCFL--TRRARKSYYTPSAFAGDDIT 329
Query: 299 EATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRR 358
A LQ ++YR + +AT F E NK+G+GGFG++YKGTL +G VAVK+L+ S +
Sbjct: 330 TADSLQ--LDYRT--IQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKS-SGQ 384
Query: 359 TLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGE-KRGSLNW 417
+F+NEV L++ + HRNL+RLLG C G E +LVYEY+ N SLD FLF K+G L+W
Sbjct: 385 GEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDW 444
Query: 418 KQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477
+R+ II G ARG+ YLH+D + IIHRD+K SN+LLD D+ PKIADFG+AR+ +Q+
Sbjct: 445 TRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTE 504
Query: 478 LST-KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEY-LLKR 535
+T + GT GY +PEYA+HGQ S K D YSFGVLVLEIISG K+S +G + L+
Sbjct: 505 ENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSY 564
Query: 536 AWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595
AW L+ NG EL+D ++ N C + + V I L+C Q RPT+S +V +L S +
Sbjct: 565 AWGLWSNGRPLELVDPAIVEN-CQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNT 623
Query: 596 SSL-LGNKPLLKPTFVETDYRKTPADTSTSTALLL 629
+L + +P L F ++ K P DT T++ LL
Sbjct: 624 VTLPVPRQPGL---FFQSRIGKDPLDTDTTSKSLL 655
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 311 bits (798), Expect = 9e-84, Method: Compositional matrix adjust.
Identities = 163/352 (46%), Positives = 225/352 (63%), Gaps = 11/352 (3%)
Query: 246 TTDITPFLKN-----GSSNKEAIIGGVVGGGTGLILFALLIWLVISRKSKKIQRGNISEA 300
T D TP + N G S I+G +VG G I+ ++I+++ R+ + I
Sbjct: 615 TPDFTPTVGNRPPSKGKSMTGTIVGVIVGVGLLSIISGVVIFIIRKRRKRYTDDEEILSM 674
Query: 301 TELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTL 360
P + +L SAT+ F NKLGEGGFG +YKG L +G+ VAVK L++G SR+
Sbjct: 675 D--VKPYTFTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVG-SRQGK 731
Query: 361 SDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQR 420
F E+ IS V HRNL++L GCC +G +LVYEY+ N SLD+ LFGEK L+W R
Sbjct: 732 GQFVAEIVAISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGEKTLHLDWSTR 791
Query: 421 FDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480
++I LG ARGL YLHE+ +RI+HRD+K SN+LLD L PK++DFGLA+L + ++H+ST
Sbjct: 792 YEICLGVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHIST 851
Query: 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG-TKSSETKGEEGEYLLKRAWRL 539
+ AGT+GY APEYA+ G L+EK D Y+FGV+ LE++SG S E +E YLL+ AW L
Sbjct: 852 RVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAWNL 911
Query: 540 YENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
+E G EL+D L E E ++++ IAL+CTQ++ RP MS VVA+L
Sbjct: 912 HEKGREVELIDHQL--TEFNMEEGKRMIGIALLCTQTSHALRPPMSRVVAML 961
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 311 bits (796), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 165/360 (45%), Positives = 234/360 (65%), Gaps = 19/360 (5%)
Query: 242 ADNQTTDITPFLKN-----GSSNKEAIIGGVVGGGTGLILFALLIWLVISRKSKKIQRGN 296
A + T D TP + N G + I+G +VG G IL ++++ + R+ +
Sbjct: 612 AVSATPDFTPTVANKPPSKGKNRTGTIVGVIVGVGLLSILAGVVMFTIRKRRKR------ 665
Query: 297 ISEATELQG----PVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLA 352
++ EL G P + +L SAT+ F NKLGEGGFG +YKG L +G++VAVK L+
Sbjct: 666 YTDDEELLGMDVKPYIFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLS 725
Query: 353 IGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKR 412
+G SR+ F E+ IS+V HRNL++L GCC +G +LVYEY+ N SLD+ LFG+K
Sbjct: 726 VG-SRQGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKT 784
Query: 413 GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472
L+W R++I LG ARGL YLHE+ VRI+HRD+K SN+LLD L P+I+DFGLA+L
Sbjct: 785 LHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYD 844
Query: 473 ENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG-TKSSETKGEEGEY 531
+ ++H+ST+ AGT+GY APEYA+ G L+EK D Y+FGV+ LE++SG S E EE +Y
Sbjct: 845 DKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKY 904
Query: 532 LLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
LL+ AW L+E EL+D+ L + E A++++ IAL+CTQ++ RP MS VVA+L
Sbjct: 905 LLEWAWNLHEKSRDIELIDDKL--TDFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAML 962
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 658 | ||||||
| 225466204 | 645 | PREDICTED: cysteine-rich receptor-like p | 0.916 | 0.934 | 0.644 | 0.0 | |
| 255570477 | 650 | serine-threonine protein kinase, plant-t | 0.905 | 0.916 | 0.631 | 0.0 | |
| 147858923 | 671 | hypothetical protein VITISV_005057 [Viti | 0.916 | 0.898 | 0.617 | 0.0 | |
| 225466206 | 647 | PREDICTED: cysteine-rich receptor-like p | 0.904 | 0.919 | 0.632 | 0.0 | |
| 225466208 | 682 | PREDICTED: cysteine-rich receptor-like p | 0.916 | 0.884 | 0.636 | 0.0 | |
| 297738128 | 765 | unnamed protein product [Vitis vinifera] | 0.898 | 0.772 | 0.632 | 0.0 | |
| 356537750 | 652 | PREDICTED: cysteine-rich receptor-like p | 0.899 | 0.907 | 0.631 | 0.0 | |
| 356537748 | 652 | PREDICTED: cysteine-rich receptor-like p | 0.899 | 0.907 | 0.623 | 0.0 | |
| 357460631 | 682 | Cysteine-rich receptor-like protein kina | 0.902 | 0.870 | 0.578 | 0.0 | |
| 357460633 | 646 | Cysteine-rich receptor-like protein kina | 0.889 | 0.905 | 0.602 | 0.0 |
| >gi|225466204|ref|XP_002265619.1| PREDICTED: cysteine-rich receptor-like protein kinase 2 [Vitis vinifera] gi|296085798|emb|CBI31122.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2041), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/619 (64%), Positives = 475/619 (76%), Gaps = 16/619 (2%)
Query: 10 AVAEPEMELINSGCSQYNVTNFSEFNSNLNATFKELREQLNGGKKFATAQRTRGPDQVYT 69
AV++P+ L+N GCS YN ++ S F SNLNAT +L+ QLN FATA+RTR D VY
Sbjct: 23 AVSDPQTNLLNEGCSTYNASSVSNFYSNLNATLSDLKTQLNDNNHFATAERTRTGDSVYA 82
Query: 70 MVQCRRYVSTADCAACFTSAESLIRNCSAANGARVIYLACSLRYESSSFYDQSTQEGRFG 129
MVQCR Y+ST DC ACFT+A+SLIRNCSAANGARVIY C LRYESSSFYDQ+T G
Sbjct: 83 MVQCRNYMSTKDCVACFTAAQSLIRNCSAANGARVIYDGCFLRYESSSFYDQATLPGNAA 142
Query: 130 FCGNRTALQADAFKTAAQELLENLEVATPKINGFFAASKNNIIGSRAGANDDDDKNSTAV 189
CGN+TA Q AF+ A + LL +LEVATP+ + F+ A K ++G GA V
Sbjct: 143 ICGNQTASQVTAFQAAVEGLLADLEVATPRTDDFYVAYKKEVVGG-GGAT---------V 192
Query: 190 YGIAQCVETISETGCQNCLSGAFDNIQRCLGSAFGWAVDAGCFLRYSDTPFFADNQTTDI 249
YG+AQC ET+S + CQ CL A NI CL S +G AVDAGCFLRYS+TPFFADNQTT+I
Sbjct: 193 YGMAQCAETVSPSACQECLKVANGNINSCLPSTYGRAVDAGCFLRYSNTPFFADNQTTNI 252
Query: 250 TPFLKNGSSNKE--AIIGGVVGGGTGLILFALLIWLVISRKSKKIQRGNISEATELQGPV 307
TPFL+ G S+K+ I G G G L++ L +W SRK+K RG+I ATEL+GPV
Sbjct: 253 TPFLEKGGSSKKKAIIGGVAGGVGLLLLISVLFLWYQQSRKAKAAPRGDILGATELRGPV 312
Query: 308 NYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEV 367
NY +DL +AT+ FSEENKLGEGGFGD+YKGTLKNGK+VAVK+L IG R +DFE+EV
Sbjct: 313 NYSYRDLKAATKNFSEENKLGEGGFGDVYKGTLKNGKMVAVKRLFIGQPNRAKADFESEV 372
Query: 368 RLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGT 427
+LISN+HHRNLIRLLGCC + EL+LVYEYMANSSLDKFLFGE+RG+LNWKQR DII GT
Sbjct: 373 KLISNIHHRNLIRLLGCCGKRSELLLVYEYMANSSLDKFLFGERRGALNWKQRLDIIAGT 432
Query: 428 ARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG 487
ARGLAYLHE+FHV IIHRDIK SN+LLD+D QPKIADFGLARLLPE++SHLSTKFAGTLG
Sbjct: 433 ARGLAYLHEEFHVCIIHRDIKSSNILLDNDFQPKIADFGLARLLPEDKSHLSTKFAGTLG 492
Query: 488 YTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE-GEYLLKRAWRLYENGTHW 546
YT+PEYAIHGQLSEKVD YS+G++VLEIISG K +E K E GEYLL+RAW+LYE+ H
Sbjct: 493 YTSPEYAIHGQLSEKVDTYSYGIVVLEIISGRKCNEMKAEPVGEYLLERAWKLYEDDKHL 552
Query: 547 ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNKPLLK 606
EL+DESLDP E E +K++EIALMC QS+ + RPTMSEVV LL+S S L + P +
Sbjct: 553 ELVDESLDPEEYKAEEVKKIIEIALMCAQSSVSMRPTMSEVVVLLRSKGS--LEHGPPTR 610
Query: 607 PTFVETDYRKTPADTSTST 625
PTFVE+ ++ P DTS ST
Sbjct: 611 PTFVESS-KRNPGDTSIST 628
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255570477|ref|XP_002526197.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223534501|gb|EEF36201.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 789 bits (2038), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/613 (63%), Positives = 476/613 (77%), Gaps = 17/613 (2%)
Query: 7 TKWAVAEPEMELINSGCSQYNVTNFSEFNSNLNATFKELREQLNGGKKFATAQRTRGPDQ 66
K AV++P L+N GCS YNV++ S FN+NLNA+F++LR QL+ GK+FAT ++ G D
Sbjct: 23 VKVAVSDPGTNLLNQGCSTYNVSSVSNFNTNLNASFRDLRTQLDSGKRFATTEQLTGADG 82
Query: 67 VYTMVQCRRYVSTADCAACFTSAESLIRNCSAANGARVIYLACSLRYESSSFYDQSTQEG 126
VY M+QCR Y+S+ADC +CF +A + IRNCSAANG RV+Y C LRYE S FY ++T++
Sbjct: 83 VYAMIQCRDYMSSADCISCFAAASNQIRNCSAANGGRVVYDGCFLRYERSDFYGETTRDA 142
Query: 127 RFGFCGNRTALQ-ADAFKTAAQELLENLEVATPKINGFFAASKNNIIGSRAGANDDDDKN 185
+CGNRTA A F+TA + LL +LE+ATP+INGFFAASK ++G+ +
Sbjct: 143 NREYCGNRTASSPATDFQTAVERLLGDLEIATPRINGFFAASKREVVGT----------S 192
Query: 186 STAVYGIAQCVETISETGCQNCLSGAFDNIQRCLGSAFGWAVDAGCFLRYSDTPFFADNQ 245
+ +VY +AQCV+TI GC C+ A+ N+QRC +A G AVD+GCF+RYSD PFFADNQ
Sbjct: 193 NASVYAVAQCVQTIDMAGCLACMQAAYRNLQRCPPNADGRAVDSGCFMRYSDRPFFADNQ 252
Query: 246 TTDITPFLKNGSSNKEAIIGGVVGGGTGLILF--ALLIWLVISRKSKKIQRGNISEATEL 303
T ++ PFLK GSS+ +A I G V GG G IL L IW +SR+ KK RGNI ATEL
Sbjct: 253 TINLEPFLKTGSSSAKAPIIGGVAGGVGFILLLTVLFIWFKLSRR-KKAPRGNILGATEL 311
Query: 304 QGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDF 363
+GPVNY KDL SATR F EENKLGEGGFGD+YKGTLKNGKIVAVKKLA+ SRR +DF
Sbjct: 312 RGPVNYSYKDLKSATRNFKEENKLGEGGFGDVYKGTLKNGKIVAVKKLALSQSRRAQADF 371
Query: 364 ENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDI 423
+EV LISNVHHRNL+RLLGCCS+GPEL+LVYEYMANSSLD+ LFG ++GSL WKQRFD+
Sbjct: 372 VSEVTLISNVHHRNLVRLLGCCSKGPELLLVYEYMANSSLDRLLFGNRQGSLTWKQRFDV 431
Query: 424 ILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFA 483
I+GTA+GLAYLHE +HV IIHRDIKPSN+LLDDD QPKIADFGL RLLP+NQ+HLSTKFA
Sbjct: 432 IIGTAQGLAYLHEQYHVCIIHRDIKPSNILLDDDFQPKIADFGLVRLLPDNQTHLSTKFA 491
Query: 484 GTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEG-EYLLKRAWRLYEN 542
GTLGYTAPEYAIHGQLSEKVD YS+G++VLE ISG K+SE + G +YLLKRAW+LYEN
Sbjct: 492 GTLGYTAPEYAIHGQLSEKVDTYSYGIVVLETISGKKNSEMLADPGSDYLLKRAWKLYEN 551
Query: 543 GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNK 602
G H EL+D++L+PNE E ++++EIALMCTQS+ RPTMSEV+ LLKS S L ++
Sbjct: 552 GMHLELVDKNLEPNEYEAEEVKRIIEIALMCTQSSPALRPTMSEVIVLLKSKGS--LEHR 609
Query: 603 PLLKPTFVETDYR 615
P +P F+E D R
Sbjct: 610 PPTRPPFIEPDER 622
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147858923|emb|CAN82890.1| hypothetical protein VITISV_005057 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 773 bits (1996), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/645 (61%), Positives = 475/645 (73%), Gaps = 42/645 (6%)
Query: 10 AVAEPEMELINSGCSQYNVTNFSEFNSNLNATFKELREQLNGGKKFATAQRTRGPDQVYT 69
AV++P+ L+N GCS YN ++ S F SNLNAT +L+ QLN FATA+RTR D VY
Sbjct: 23 AVSDPQTNLLNEGCSTYNASSVSNFYSNLNATLSDLKTQLNDNNHFATAERTRTGDSVYA 82
Query: 70 MVQCRRYVSTADCAACFTSAESLIRNCSAANGARVIYLACSLRYESSSFYDQSTQEGRFG 129
MVQCR Y+ST DC ACFT+A+SLIRNCSAANGARVIY C LRYESSSFYDQ+T G
Sbjct: 83 MVQCRNYMSTKDCVACFTAAQSLIRNCSAANGARVIYDGCFLRYESSSFYDQATLPGNAA 142
Query: 130 FCGNRTALQADAFKTAAQELLENLEVATPKINGFFAASKNNIIGSRAGANDDDDKNSTAV 189
CGN+TA Q AF+ A + LL +LEVATP+ + F+ A K ++G GA V
Sbjct: 143 ICGNQTASQVTAFQAAVEGLLADLEVATPRTDDFYVAYKKEVVGG-GGAT---------V 192
Query: 190 YGIAQCVETISETGCQNCLSGAFDNIQRCLGSAFGWAVDAGCFLRYSDTPFFADNQTTDI 249
YG+AQC ET+S + CQ CL A NI CL S +G AVDAGCFLRYS+TPFFADNQTT+I
Sbjct: 193 YGMAQCAETVSPSACQECLKVANGNINSCLPSTYGRAVDAGCFLRYSNTPFFADNQTTNI 252
Query: 250 TPFLKNGSSNKE--AIIGGVVGGGTGLILFALLIWLVISRKSKKIQRGNISEATELQGPV 307
TPFL+ G S+K+ I G G G L++ L +W SRK+K RG+I ATEL+GPV
Sbjct: 253 TPFLEKGGSSKKKAIIGGVAGGVGLLLLISVLFLWYQQSRKAKAAPRGDILGATELRGPV 312
Query: 308 NYRLKDLVSATRKFSEENKLGEGGFGDIYK--------------------------GTLK 341
NY +DL +AT+ FSEENKLGEGGFGD+YK GTLK
Sbjct: 313 NYSYRDLKAATKNFSEENKLGEGGFGDVYKAKFNTYLCDWIDVYCFGQVFIGYLEQGTLK 372
Query: 342 NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANS 401
NGK+VAVK+L IG R +DF++EV+LISN+HHRNLIRLLGCC + EL+LVYEYMANS
Sbjct: 373 NGKMVAVKRLFIGQPNRAKADFKSEVKLISNIHHRNLIRLLGCCGKRSELLLVYEYMANS 432
Query: 402 SLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPK 461
SLDKFLFGE+RG+LNWKQR DII GTARGLAYLHE+FHV IIHRDIK SN+LLD+D QPK
Sbjct: 433 SLDKFLFGERRGALNWKQRLDIIAGTARGLAYLHEEFHVCIIHRDIKSSNILLDNDFQPK 492
Query: 462 IADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKS 521
IADFGLARLLPE++SHLSTKFAGTLGYT+PEYAIHGQLSEKVD YS+G++VLEIISG K
Sbjct: 493 IADFGLARLLPEDKSHLSTKFAGTLGYTSPEYAIHGQLSEKVDTYSYGIVVLEIISGXKC 552
Query: 522 SETKGEE-GEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANS 580
+E K E GEYLL+RAW+LYE+ H EL+DESLDP E E +K++EIALMC QS+ +
Sbjct: 553 NEMKAEPVGEYLLERAWKLYEDDKHLELVDESLDPEEYKAEEVKKIIEIALMCAQSSVSM 612
Query: 581 RPTMSEVVALLKSTSSSLLGNKPLLKPTFVETDYRKTPADTSTST 625
RPTMSEVV LL+S S L + P +PTFVE+ ++ P DTS ST
Sbjct: 613 RPTMSEVVVLLRSKGS--LEHGPPTRPTFVESS-KRNPGDTSIST 654
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225466206|ref|XP_002265819.1| PREDICTED: cysteine-rich receptor-like protein kinase 2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 768 bits (1983), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/609 (63%), Positives = 460/609 (75%), Gaps = 14/609 (2%)
Query: 10 AVAEPEMELINSGCSQYNVTNFSEFNSNLNATFKELREQLNGGKKFATAQRTRGPDQVYT 69
AV++P+ L+ GCS Y+ N S+F SNLN T +L+ QL+ K+FATAQRTR VY
Sbjct: 24 AVSDPQTNLLIQGCSTYSPPNLSDFYSNLNDTLSDLKTQLSDNKRFATAQRTRSTGTVYG 83
Query: 70 MVQCRRYVSTADCAACFTSAESLIRNCSAANGARVIYLACSLRYESSSFYDQSTQEGRFG 129
+ QCR Y+ST DC ACF +A+S IRNCS+ANGARVIY C LRYESSSFYD++T G
Sbjct: 84 LAQCRNYMSTEDCVACFNTAQSDIRNCSSANGARVIYDGCFLRYESSSFYDETTGSGNTA 143
Query: 130 FCGNRTALQADAFKTAAQELLENLEVATPKINGFFAASKNNIIGSRAGANDDDDKNSTAV 189
CGN+TA QA AF+ A LL +LE ATP+ N +AA K ++G GA V
Sbjct: 144 ICGNQTAAQATAFQEAVNGLLSDLETATPRTNDSYAAYKKEVVGG-GGAT---------V 193
Query: 190 YGIAQCVETISETGCQNCLSGAFDNIQRCLGSAFGWAVDAGCFLRYSDTPFFADNQTTDI 249
YG+AQCVE S + C+ CL A NI+ CL S G AVDAGCFLRYS+TPFFADNQTTDI
Sbjct: 194 YGVAQCVERASASACKECLKVADGNIKSCLPSTDGRAVDAGCFLRYSNTPFFADNQTTDI 253
Query: 250 TPFL-KNGSSNKEAIIGGVVGG-GTGLILFALLIWLVISRKSKKIQRGNISEATELQGPV 307
PFL K GS+ K+AIIGGVVGG L+L L +W SR++K RG++ ELQGPV
Sbjct: 254 LPFLEKGGSTKKKAIIGGVVGGVCLFLLLIMLFVWHQHSRRAKAAPRGDMLGVPELQGPV 313
Query: 308 NYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEV 367
NY +DL SAT+ F E KLG+GGFGD+YKG LKNG VAVKKL IG R +DFE+EV
Sbjct: 314 NYSHRDLKSATKNFRAEYKLGKGGFGDVYKGYLKNGTTVAVKKLIIGQPNRAKADFESEV 373
Query: 368 RLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGT 427
++ISNVHHRNL+RLLGCC +G EL+LVYEYM NSSLDKFLFGE+RG+LNW+QRFDII+GT
Sbjct: 374 KIISNVHHRNLLRLLGCCKKGSELLLVYEYMVNSSLDKFLFGERRGALNWRQRFDIIVGT 433
Query: 428 ARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG 487
ARGLAYLHE+FHV IIHRDIK SN+LLD+D QP+IADFGLARLLPE+Q+HLSTK AGTLG
Sbjct: 434 ARGLAYLHEEFHVCIIHRDIKSSNILLDNDFQPRIADFGLARLLPEDQTHLSTKVAGTLG 493
Query: 488 YTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE-GEYLLKRAWRLYENGTHW 546
YTAPEYAI GQLSEKVD YS+GV+VLEIISG K +E K E+ EYLL+RAW LYEN H
Sbjct: 494 YTAPEYAILGQLSEKVDTYSYGVVVLEIISGRKCNEMKAEDVTEYLLERAWTLYENDKHL 553
Query: 547 ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNKPLLK 606
EL+DESLDP E E +K++EIALMCTQS+ + RPTMSEVV LL+S SS L + P +
Sbjct: 554 ELVDESLDPEEYKAEEVKKIIEIALMCTQSSVSMRPTMSEVVFLLRSKISS-LEHGPPTR 612
Query: 607 PTFVETDYR 615
P F+++DYR
Sbjct: 613 PAFIDSDYR 621
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225466208|ref|XP_002265938.1| PREDICTED: cysteine-rich receptor-like protein kinase 3-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 763 bits (1971), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/622 (63%), Positives = 467/622 (75%), Gaps = 19/622 (3%)
Query: 10 AVAEPEMELINSGCSQYNVTNFSEFNSNLNATFKELREQLNGGKKFATAQRTRGPDQVYT 69
AV++P+ L+N GCS YNVTN S+F +NLNATF +L QLN K F TA+RTR D VY
Sbjct: 57 AVSDPQTNLLNQGCSTYNVTNLSDFYTNLNATFSDLETQLNNNKLFDTAERTRSGDSVYA 116
Query: 70 MVQCRRYVSTADCAACFTSAESLIRNCSAANGARVIYLACSLRYESSSFYDQSTQEGRFG 129
MVQCR Y+S DC ACF A+SLIR C AANGARVIY C LRYESSSFYDQ+T G
Sbjct: 117 MVQCRNYMSAEDCLACFADAQSLIRRCGAANGARVIYDGCFLRYESSSFYDQTTLAGNAP 176
Query: 130 FCGNRTALQADAFKTAAQELLENLEVATPKINGFFAASKNNIIGSRAGANDDDDKNSTAV 189
CGN TA Q AF++A + L+ +LEVATP+IN F+AA K ++G GA V
Sbjct: 177 ICGNDTASQVTAFQSAVEGLIADLEVATPRINRFYAAYKMEVVGG-GGA---------TV 226
Query: 190 YGIAQCVETISETGCQNCLSGAFDNIQRCLGSAFGWAVDAGCFLRYSDTPFFADNQTTDI 249
YG+AQC ET S+T CQ CL A NI CL S G A+DAGCFLRYSD FFADNQTT+I
Sbjct: 227 YGVAQCAETASQTACQECLQVAKSNINSCLPSKNGRAIDAGCFLRYSDVAFFADNQTTNI 286
Query: 250 TPFLKNGSSNKE--AIIGGVVGGGTGLILFALLIWLVI---SRKSKKIQRGNISEATELQ 304
TPFL+ G SNK+ I G V G G LI+ LL+W SRK+K G++ TELQ
Sbjct: 287 TPFLQKGGSNKKKAIIGGVVGGVGIVLIIVVLLLWYRTYRSSRKAKLASTGDLLGVTELQ 346
Query: 305 GPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFE 364
GPVNY DL +ATR FSEENKLGEGGFGD+YKG LKNGKIVAVKKL IG + ++FE
Sbjct: 347 GPVNYSYNDLKTATRMFSEENKLGEGGFGDVYKGHLKNGKIVAVKKLFIGQTDGAKANFE 406
Query: 365 NEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDII 424
+EV+LISNVHHRNLIRLLGCCS+ EL+LVYEYMANSSLDKFLFGEKRG+LNWKQR +II
Sbjct: 407 SEVKLISNVHHRNLIRLLGCCSKKSELLLVYEYMANSSLDKFLFGEKRGALNWKQRLNII 466
Query: 425 LGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAG 484
+G ARGLAYLHE+FHV IIHRDIKP+NVLLDDD QP+IADFGLARLLPE+Q+H+STKFAG
Sbjct: 467 VGIARGLAYLHEEFHVCIIHRDIKPNNVLLDDDFQPRIADFGLARLLPEDQTHVSTKFAG 526
Query: 485 TLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE-GEYLLKRAWRLYENG 543
TLGYTAPEYAIHGQLS K D YS+GV+VLEIISG + +E K E E+LL+RAW+LYEN
Sbjct: 527 TLGYTAPEYAIHGQLSAKADTYSYGVVVLEIISGQRCNEMKVEPVTEFLLERAWKLYEND 586
Query: 544 THWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNKP 603
H EL+DESLDP E E +K++EIAL+CTQS+A+ RPTMSE+V +L S + L + P
Sbjct: 587 NHLELVDESLDPEEYDAEEVKKIIEIALLCTQSSASMRPTMSEIVVMLYSKDA--LQHGP 644
Query: 604 LLKPTFVETDYRKTPADTSTST 625
+PTF+ ++ R DTS ST
Sbjct: 645 PTRPTFISSNNR-AGGDTSAST 665
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297738128|emb|CBI27329.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 763 bits (1970), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/609 (63%), Positives = 458/609 (75%), Gaps = 18/609 (2%)
Query: 10 AVAEPEMELINSGCSQYNVTNFSEFNSNLNATFKELREQLNGGKKFATAQRTRGPDQVYT 69
AV++P+ L+ GCS Y+ N S+F SNLN T +L+ QL+ K+FATAQRTR VY
Sbjct: 103 AVSDPQTNLLIQGCSTYSPPNLSDFYSNLNDTLSDLKTQLSDNKRFATAQRTRSTGTVYG 162
Query: 70 MVQCRRYVSTADCAACFTSAESLIRNCSAANGARVIYLACSLRYESSSFYDQSTQEGRFG 129
+ QCR Y+ST DC ACF +A+S IRNCS+ANGARVIY C LRYESSSFYD++T G
Sbjct: 163 LAQCRNYMSTEDCVACFNTAQSDIRNCSSANGARVIYDGCFLRYESSSFYDETTGSGNTA 222
Query: 130 FCGNRTALQADAFKTAAQELLENLEVATPKINGFFAASKNNIIGSRAGANDDDDKNSTAV 189
CGN+TA QA AF+ A LL +LE ATP+ N +AA K ++G GA V
Sbjct: 223 ICGNQTAAQATAFQEAVNGLLSDLETATPRTNDSYAAYKKEVVGG-GGA---------TV 272
Query: 190 YGIAQCVETISETGCQNCLSGAFDNIQRCLGSAFGWAVDAGCFLRYSDTPFFADNQTTDI 249
YG+AQCVE S + C+ CL A NI+ CL S G AVDAGCFLRYS+TPFFADNQTTDI
Sbjct: 273 YGVAQCVERASASACKECLKVADGNIKSCLPSTDGRAVDAGCFLRYSNTPFFADNQTTDI 332
Query: 250 TPFL-KNGSSNKEAIIGGVVGG-GTGLILFALLIWLVISRKSKKIQRGNISEATELQGPV 307
PFL K GS+ K+AIIGGVVGG L+L L +W SR++K RG ELQGPV
Sbjct: 333 LPFLEKGGSTKKKAIIGGVVGGVCLFLLLIMLFVWHQHSRRAKAAPRG----VPELQGPV 388
Query: 308 NYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEV 367
NY +DL SAT+ F E KLG+GGFGD+YKG LKNG VAVKKL IG R +DFE+EV
Sbjct: 389 NYSHRDLKSATKNFRAEYKLGKGGFGDVYKGYLKNGTTVAVKKLIIGQPNRAKADFESEV 448
Query: 368 RLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGT 427
++ISNVHHRNL+RLLGCC +G EL+LVYEYM NSSLDKFLFGE+RG+LNW+QRFDII+GT
Sbjct: 449 KIISNVHHRNLLRLLGCCKKGSELLLVYEYMVNSSLDKFLFGERRGALNWRQRFDIIVGT 508
Query: 428 ARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG 487
ARGLAYLHE+FHV IIHRDIK SN+LLD+D QP+IADFGLARLLPE+Q+HLSTK AGTLG
Sbjct: 509 ARGLAYLHEEFHVCIIHRDIKSSNILLDNDFQPRIADFGLARLLPEDQTHLSTKVAGTLG 568
Query: 488 YTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE-GEYLLKRAWRLYENGTHW 546
YTAPEYAI GQLSEKVD YS+GV+VLEIISG K +E K E+ EYLL+RAW LYEN H
Sbjct: 569 YTAPEYAILGQLSEKVDTYSYGVVVLEIISGRKCNEMKAEDVTEYLLERAWTLYENDKHL 628
Query: 547 ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNKPLLK 606
EL+DESLDP E E +K++EIALMCTQS+ + RPTMSEVV LL+S SS L + P +
Sbjct: 629 ELVDESLDPEEYKAEEVKKIIEIALMCTQSSVSMRPTMSEVVFLLRSKISS-LEHGPPTR 687
Query: 607 PTFVETDYR 615
P F+++DYR
Sbjct: 688 PAFIDSDYR 696
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537750|ref|XP_003537388.1| PREDICTED: cysteine-rich receptor-like protein kinase 3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 756 bits (1953), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/613 (63%), Positives = 470/613 (76%), Gaps = 21/613 (3%)
Query: 10 AVAEPEMELINSGCSQYNVTNFSEFNSNLNATFKELREQL-NGGKKFATAQRTRGPDQVY 68
A+ +P+ LIN GCSQYN T+ S FN NLNAT +LR Q+ N K FATAQ RG D VY
Sbjct: 28 ALGDPQTHLINKGCSQYNATDLSNFNQNLNATLDDLRAQVSNQSKHFATAQEARGADPVY 87
Query: 69 TMVQCRRYVSTADCAACFTSAESLIRNCSA-ANGARVIYLACSLRYESSSFYDQSTQEGR 127
M QCR Y+STADCAACF A + IRNCSA ANGARVIY C LRYES+ F+DQ+T G
Sbjct: 88 AMFQCRNYLSTADCAACFVVATAQIRNCSAGANGARVIYDGCFLRYESNGFFDQTTLAGN 147
Query: 128 FGFCGNRTALQAD-AFKTAAQELLENLEVATPKINGFFAASKNNIIGSRAGANDDDDKNS 186
CGN+TA+ A +F T AQ++L L++ATPKI GFFAA+K + G
Sbjct: 148 SMICGNQTAVGATTSFNTTAQQVLMELQIATPKITGFFAATKTQLAGG------------ 195
Query: 187 TAVYGIAQCVETISETGCQNCLSGAFDNIQRCLGSAFGWAVDAGCFLRYSDTPFFADNQT 246
A+Y IAQC ET +E+ C +CL+ ++NI CL + G A DAGCF+RYS+T FFADNQT
Sbjct: 196 GAIYAIAQCAETATESACLDCLTVGYNNIHICLPNTDGRAFDAGCFMRYSETAFFADNQT 255
Query: 247 TDITPFLKNGSSNKEAIIGGVVGGGTGLILFALLIWLVISR--KSKKIQRGNISEATELQ 304
DITPFLK GSSNK+ I G V GG GL++ L ++ ++ R K K++ RG+I ATEL+
Sbjct: 256 IDITPFLKQGSSNKKGAIIGGVVGGVGLVVILLALFGLLRRYKKPKRVPRGDILGATELK 315
Query: 305 GPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFE 364
GPV YR KDL +AT+ FS+ENKLGEGGFGD+YKGTLKNGKIVAVKKL +G S + FE
Sbjct: 316 GPVPYRYKDLKTATKNFSDENKLGEGGFGDVYKGTLKNGKIVAVKKLILGQSGKMDEQFE 375
Query: 365 NEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDII 424
+EV+LISNVHH+NL+RLLGCCS+G E ILVYEYMAN SLD+FLFGE +GSLNWKQR+DII
Sbjct: 376 SEVKLISNVHHKNLVRLLGCCSKGQERILVYEYMANKSLDRFLFGENKGSLNWKQRYDII 435
Query: 425 LGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAG 484
LGTA+GLAYLHEDFHV IIHRDIK SN+LLDD++QP+IADFGLARLLPE+QSHLST+FAG
Sbjct: 436 LGTAKGLAYLHEDFHVCIIHRDIKTSNILLDDEMQPRIADFGLARLLPEDQSHLSTRFAG 495
Query: 485 TLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE-EGEYLLKRAWRLYENG 543
TLGYTAPEYAIHGQLSEK DAYSFGV+VLEIISG KSSE + + +GE+LL+RAW+LY
Sbjct: 496 TLGYTAPEYAIHGQLSEKADAYSFGVVVLEIISGQKSSELRTDTDGEFLLQRAWKLYVQD 555
Query: 544 THWELMDES-LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNK 602
H EL+D++ LDP + E +K++EIAL+CTQ++A +RPTMSE+VA LKS +S LG
Sbjct: 556 MHLELVDKTLLDPEDYDAEEVKKIIEIALLCTQASAAARPTMSEIVAFLKSKNS--LGQI 613
Query: 603 PLLKPTFVETDYR 615
P FVET+ R
Sbjct: 614 RPSMPVFVETNLR 626
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537748|ref|XP_003537387.1| PREDICTED: cysteine-rich receptor-like protein kinase 3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 752 bits (1941), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/613 (62%), Positives = 470/613 (76%), Gaps = 21/613 (3%)
Query: 10 AVAEPEMELINSGCSQYNVTNFSEFNSNLNATFKELREQL-NGGKKFATAQRTRGPDQVY 68
A+ +P+ LIN GCSQYN T+ S FN NLNAT +LR Q+ N K FATAQ RG D VY
Sbjct: 28 ALGDPQTHLINKGCSQYNATDLSNFNQNLNATLDDLRAQVSNQSKHFATAQEARGADPVY 87
Query: 69 TMVQCRRYVSTADCAACFTSAESLIRNCSA-ANGARVIYLACSLRYESSSFYDQSTQEGR 127
M QCR Y+STADCAACF A + IRNCSA ANGARVIY C LRYES+ F+DQ+T G
Sbjct: 88 AMFQCRNYLSTADCAACFVVATAQIRNCSAGANGARVIYDGCFLRYESNGFFDQTTLAGN 147
Query: 128 FGFCGNRTALQAD-AFKTAAQELLENLEVATPKINGFFAASKNNIIGSRAGANDDDDKNS 186
CGN+TA+ A +F T AQ++L L++ATPKI GFFAA+K + G
Sbjct: 148 SMICGNQTAVGATTSFNTTAQQVLMELQIATPKITGFFAATKTQLAGG------------ 195
Query: 187 TAVYGIAQCVETISETGCQNCLSGAFDNIQRCLGSAFGWAVDAGCFLRYSDTPFFADNQT 246
A+Y IAQC ET +E+ C +CL+ ++NI CL + G A DAGCF+RYS+T FFADNQT
Sbjct: 196 GAIYAIAQCAETATESACLDCLTVGYNNIHICLPNTDGRAFDAGCFMRYSETAFFADNQT 255
Query: 247 TDITPFLKNGSSNKEAIIGGVVGGGTGLILFALLIWLVISR--KSKKIQRGNISEATELQ 304
DITPFLK GSSNK+ I G V GG GL++ L ++ ++ R K K++ RG+I ATEL+
Sbjct: 256 IDITPFLKQGSSNKKGAIIGGVVGGVGLVVILLALFGLLRRYKKPKRVPRGDILGATELK 315
Query: 305 GPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFE 364
GPV YR KDL +AT+ FS+ENKLGEGGFGD+YKGTLKNGKIVAVKKL +G S + FE
Sbjct: 316 GPVPYRYKDLKTATKNFSDENKLGEGGFGDVYKGTLKNGKIVAVKKLILGQSGKMDEQFE 375
Query: 365 NEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDII 424
+EV+LISNVHH+NL+RLLGCCS+G E ILVYEYMAN SLD+FLFGE +GSLNWKQR+DII
Sbjct: 376 SEVKLISNVHHKNLVRLLGCCSKGQERILVYEYMANKSLDRFLFGENKGSLNWKQRYDII 435
Query: 425 LGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAG 484
LGTA+GLAYLHEDFHV IIHRDIK SN+LLDD++QP+IADFGLARLLPE+QSHLST+FAG
Sbjct: 436 LGTAKGLAYLHEDFHVCIIHRDIKTSNILLDDEMQPRIADFGLARLLPEDQSHLSTRFAG 495
Query: 485 TLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE-EGEYLLKRAWRLYENG 543
TLGYTAPEYAIHGQLSEK DAYSFGV+VLEI+SG KSSE + + +GE+LL+RAW+L+
Sbjct: 496 TLGYTAPEYAIHGQLSEKADAYSFGVVVLEIVSGQKSSELRADADGEFLLQRAWKLHVQD 555
Query: 544 THWELMDES-LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNK 602
H +L+D++ LDP + E +K++EIAL+CTQ++A +RPTMSE+VA LK +S LG
Sbjct: 556 MHLDLVDKTLLDPEDYDAEEVKKIIEIALLCTQASAAARPTMSEIVAFLKCKNS--LGQI 613
Query: 603 PLLKPTFVETDYR 615
P FVE+++R
Sbjct: 614 RPSMPVFVESNFR 626
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357460631|ref|XP_003600597.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355489645|gb|AES70848.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 721 bits (1861), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/652 (57%), Positives = 465/652 (71%), Gaps = 58/652 (8%)
Query: 9 WAV--AEPEMELINSGCSQYNVTNFSEFNSNLNATFKELREQL-NGGKKFATAQRTRGPD 65
W++ A+P+ LIN GCSQYN TN S F NLNAT +L+ Q+ N K FATAQ RG +
Sbjct: 18 WSLTKADPQTSLINKGCSQYNATNLSNFYQNLNATLLDLKSQVRNDSKHFATAQSARGAN 77
Query: 66 QVYTMVQCRRYVSTADCAACFTSAESLIRNCSA-ANGARVIYLACSLR------------ 112
VY + QCR Y+S +DCAAC A++ IRNCSA +NGARVIY C LR
Sbjct: 78 PVYALFQCRNYLSNSDCAACLAVADAQIRNCSAGSNGARVIYDGCFLRCGQPAGSRRIYI 137
Query: 113 --------------------------YESSSFYDQSTQEGRFGFCGNRTALQADAFKTAA 146
YES+ F+DQ+TQ G CG++ A A AF AA
Sbjct: 138 LPPSLIIRAVKTGGPALNGPALAGFGYESNGFFDQTTQPGNSMICGSQAANGATAFNAAA 197
Query: 147 QELLENLEVATPKINGFFAASKNNIIGSRAGANDDDDKNSTAVYGIAQCVETISETGCQN 206
Q++LE+L+ ATPKI GFFAA+K ++G+ A+Y IAQC ET++++GC +
Sbjct: 198 QQVLEDLQTATPKIPGFFAATKTQVVGT-----------GNAIYAIAQCAETVTQSGCLD 246
Query: 207 CLSGAFDNIQRCLGSAFGWAVDAGCFLRYSDTPFFADNQTTDITPFLKNGSSNKE--AII 264
CL+ F NIQ C + G A DAGCF+RYS+ FFADNQT DI PFLK G S+K+ I
Sbjct: 247 CLTVGFTNIQSCFPNTDGRAFDAGCFMRYSEKSFFADNQTIDIAPFLKQGGSSKKRAIIG 306
Query: 265 GGVVGGGTGLILFALLIWLVISRKSKKIQRGNISEATELQGPVNYRLKDLVSATRKFSEE 324
G V G +IL AL W + +K KK+ RG+I ATEL+GPV YR KDL SAT+ F++E
Sbjct: 307 GVVGGVALVVILLALFAWFRLKKKPKKLPRGDILGATELKGPVTYRYKDLKSATKNFNDE 366
Query: 325 NKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGC 384
NKLGEGGFGD+YKGTLKNGK+VAVKKL +G S + FE+EV+LISNVHHRNL+RLLGC
Sbjct: 367 NKLGEGGFGDVYKGTLKNGKVVAVKKLILGSSGKMDEQFESEVKLISNVHHRNLVRLLGC 426
Query: 385 CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIH 444
CS+G E ILVYEYMANSSLD+FLFGE +GSLNW QR+DIILGTARGL+YLHEDFHV IIH
Sbjct: 427 CSKGQERILVYEYMANSSLDRFLFGENKGSLNWIQRYDIILGTARGLSYLHEDFHVCIIH 486
Query: 445 RDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVD 504
RDIK +N+LLDDDLQP+IADFGLARLLPE+QSH+STKFAGTLGYTAPEYAIHGQLS K D
Sbjct: 487 RDIKTNNILLDDDLQPRIADFGLARLLPEDQSHVSTKFAGTLGYTAPEYAIHGQLSVKAD 546
Query: 505 AYSFGVLVLEIISGTKSSETKGE-EGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAA 563
YSFGV+VLEIISG KS E + + +GE+LL+RAW+LYE G H EL+D++L+P + E
Sbjct: 547 TYSFGVVVLEIISGQKSGELRDDVDGEFLLQRAWKLYEEGRHLELVDKTLNPGDYDAEEV 606
Query: 564 EKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNKPLLKPTFVETDYR 615
+KV+EIAL+CTQ+ A +RPTMSE+V LLKS + + KP + P FV ++ R
Sbjct: 607 KKVIEIALLCTQATAATRPTMSEIVVLLKS-KNFMEHMKPTM-PVFVNSNLR 656
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357460633|ref|XP_003600598.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355489646|gb|AES70849.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 711 bits (1836), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/602 (60%), Positives = 458/602 (76%), Gaps = 17/602 (2%)
Query: 18 LINSGCSQYNVTNFSEFNSNLNATFKELREQL-NGGKKFATAQRTRGPDQVYTMVQCRRY 76
++NS CS +N +N F +N+N TF +L+ Q+ N K FAT+Q+ G V++M QCR Y
Sbjct: 33 VLNSSCSTFNASNLRSFYANINGTFLDLKNQISNESKHFATSQQAIGEVIVFSMFQCRNY 92
Query: 77 VSTADCAACFTSAESLIRNCSAANGARVIYLACSLRYESSSFYDQSTQEGRFGFCGNRTA 136
+S DC CF A + IR+CSAANGARVIY C LRYES FYDQ+TQ+G CGN+TA
Sbjct: 93 LSKNDCVGCFNIASTKIRSCSAANGARVIYDGCFLRYESERFYDQTTQQGNGVICGNKTA 152
Query: 137 LQADAFKTAAQELLENLEVATPKINGFFAASKNNIIGSRAGANDDDDKNSTAVYGIAQCV 196
+ AF T ++L ++++ATPKI GFFAA+K + G N ++VY +AQC
Sbjct: 153 KEGTAFGTIGHKVLMDIQLATPKIKGFFAATKTQVT---PGGN-------SSVYAVAQCA 202
Query: 197 ETISETGCQNCLSGAFDNIQRCLGSAFGWAVDAGCFLRYSDTPFFADNQTTDITPFLKNG 256
ET++E+GC CL+ + N+Q CL ++ G A DAGCF+RYS+TPFFADNQT DIT +LK G
Sbjct: 203 ETVTESGCLACLAVGYSNLQTCLPNSDGRAYDAGCFMRYSETPFFADNQTIDITAYLKGG 262
Query: 257 SSNKEAIIGGVVGGGTGLILF--ALLIWLVISRKSKKIQRGNISEATELQGPVNYRLKDL 314
SSNK AIIGGVVGG GL++ A+L W RK K+ RGNI AT+L+GPVNY+ DL
Sbjct: 263 SSNKWAIIGGVVGGVVGLVVIILAILGWRQY-RKPKRAPRGNILGATDLKGPVNYKYSDL 321
Query: 315 VSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVH 374
+AT+ F++ENKLGEGGFGD+YKGTLKNG +VAVKKL +G S + +DFE+EV+LISNVH
Sbjct: 322 KAATKNFNDENKLGEGGFGDVYKGTLKNGNVVAVKKLVLGKSSKIDNDFESEVKLISNVH 381
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYL 434
HRNL+RLLGCCS+ E ILVYEYMANSSLDKFLFG K+GSLNWKQR +IILGTARGLAYL
Sbjct: 382 HRNLVRLLGCCSKSQERILVYEYMANSSLDKFLFGNKQGSLNWKQRCNIILGTARGLAYL 441
Query: 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYA 494
HE+FH+ IIHRDIK SN+LLDD+L PKIADFGLARLLP ++SHLST AGTLGYTAPEYA
Sbjct: 442 HEEFHISIIHRDIKSSNILLDDNLHPKIADFGLARLLPGDRSHLSTGVAGTLGYTAPEYA 501
Query: 495 IHGQLSEKVDAYSFGVLVLEIISGTKSSETK-GEEGEYLLKRAWRLYENGTHWELMDESL 553
IHGQLSEK D YS+G++VLEIISG KS+E K ++GE+LL++ W+L+E G H EL+D+ L
Sbjct: 502 IHGQLSEKADTYSYGIVVLEIISGQKSTEMKVDDDGEFLLQKTWKLHERGMHLELVDKVL 561
Query: 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNKPLLKPTFVETD 613
DPN+ E +K++EIAL+CTQ++A RPTMSEVV LL+ + SL+ + P FVET+
Sbjct: 562 DPNDYDGEEVKKMIEIALLCTQASAGMRPTMSEVVVLLQ--TRSLVEHLQPTMPVFVETN 619
Query: 614 YR 615
R
Sbjct: 620 LR 621
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 658 | ||||||
| TAIR|locus:2026821 | 649 | CRK2 "cysteine-rich RLK (RECEP | 0.861 | 0.873 | 0.374 | 4.1e-97 | |
| TAIR|locus:2026785 | 646 | CRK3 "cysteine-rich RLK (RECEP | 0.811 | 0.826 | 0.381 | 3e-94 | |
| TAIR|locus:2141201 | 679 | CRK29 "cysteine-rich RLK (RECE | 0.463 | 0.449 | 0.467 | 2.7e-86 | |
| TAIR|locus:2123116 | 700 | CRK30 "cysteine-rich RLK (RECE | 0.662 | 0.622 | 0.384 | 1e-84 | |
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.480 | 0.468 | 0.444 | 2.8e-82 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.904 | 0.889 | 0.337 | 7.4e-82 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.484 | 0.476 | 0.443 | 4.1e-79 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.893 | 0.869 | 0.342 | 1.1e-78 | |
| TAIR|locus:2127323 | 642 | CRK27 "cysteine-rich RLK (RECE | 0.851 | 0.872 | 0.344 | 1.4e-78 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.594 | 0.373 | 0.430 | 3e-78 |
| TAIR|locus:2026821 CRK2 "cysteine-rich RLK (RECEPTOR-like protein kinase) 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 965 (344.8 bits), Expect = 4.1e-97, P = 4.1e-97
Identities = 227/606 (37%), Positives = 335/606 (55%)
Query: 23 CSQYNVTNFSEFNSNLNATFKELREQLNGGKKFATAQRTRGPDQVYTMVQCRRYVSTADC 82
CS N + + N AT +++ Q+ F A GPD Y + QC + DC
Sbjct: 40 CSPLLEHNETAYVPNFVATMEKISTQVQTSG-FGVALTGTGPDANYGLAQCYGDLPLNDC 98
Query: 83 AACFTSAESLIRNCSAANGARVIYLACSLRYESSSFYDQSTQEGRFGFCGNRTALQADAF 142
C+ A +++ C NG R+ C +R E+ SFY++ CGN T + F
Sbjct: 99 VLCYAEARTMLPQCYPQNGGRIFLDGCFMRAENYSFYNEYKGPEDSIVCGNTTR-KNKTF 157
Query: 143 KTAAQELLENLEVATPKINGFFAASKNNIIGSRAGANDDDDKNSTAVYGIAQCVETISET 202
A ++ L N G+ AS ++AG ++ S + + +A C T+S
Sbjct: 158 GDAVRQGLRNAVTEASGTGGYARAS------AKAGESE-----SESAFVLANCWRTLSPD 206
Query: 203 GCQNCLSGAFDNIQR-CLGSAFGWAVDAGCFLRYSDTPFFADNQTTDITPFLKNGSSNKE 261
C+ CL A ++ + CL + G A+ GCFLRYSD F N+ P +NG S
Sbjct: 207 SCKQCLENASASVVKGCLPWSEGRALHTGCFLRYSDQDFL--NKI----P--RNGRSRGS 258
Query: 262 AXXXXXXXXXXXXXXF---ALLIWLVISRKSKKIQRGN--ISE-ATELQ-GPVNYRLKDL 314
A+ +++ R K+ +RG+ + + A L+ +N++ L
Sbjct: 259 VVVIVVSVLSSVVVFMIGVAVSVYICKRRTIKRKRRGSKDVEKMAKTLKDSSLNFKYSTL 318
Query: 315 VSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVH 374
AT F NKLG+GGFG +YKG L +G+ +AVK+L +R +DF NEV +IS V
Sbjct: 319 EKATGSFDNANKLGQGGFGTVYKGVLPDGRDIAVKRLFFN-NRHRATDFYNEVNMISTVE 377
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRG-SLNWKQRFDIILGTARGLAY 433
H+NL+RLLGC GPE +LVYEY+ N SLD+F+F RG +L+W++R+ II+GTA GL Y
Sbjct: 378 HKNLVRLLGCSCSGPESLLVYEYLQNKSLDRFIFDVNRGKTLDWQRRYTIIVGTAEGLVY 437
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEY 493
LHE V+IIHRDIK SN+LLD LQ KIADFGLAR +++SH+ST AGTLGY APEY
Sbjct: 438 LHEQSSVKIIHRDIKASNILLDSKLQAKIADFGLARSFQDDKSHISTAIAGTLGYMAPEY 497
Query: 494 AIHGQLSEKVDAYSFGVLVLEIISGTKSSETK-GEEGEYLLKRAWRLYENGTHWELMDES 552
HGQL+E VD YSFGVLVLEI++G +++++K + + L+ AW+ +++G ++ D +
Sbjct: 498 LAHGQLTEMVDVYSFGVLVLEIVTGKQNTKSKMSDYSDSLITEAWKHFQSGELEKIYDPN 557
Query: 553 LD-----PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSS--SLLGNKPLL 605
LD + K+ +VV+I L+CTQ + RP MS+++ +LK+ L N P +
Sbjct: 558 LDWKSQYDSHIIKKEIARVVQIGLLCTQEIPSLRPPMSKLLHMLKNKEEVLPLPSNPPFM 617
Query: 606 KPTFVE 611
+E
Sbjct: 618 DERVME 623
|
|
| TAIR|locus:2026785 CRK3 "cysteine-rich RLK (RECEPTOR-like protein kinase) 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 938 (335.3 bits), Expect = 3.0e-94, P = 3.0e-94
Identities = 221/580 (38%), Positives = 323/580 (55%)
Query: 67 VYTMVQCRRYVSTADCAACFTSAESLIRNC----SAANGARVIYLACSLRYESSSFYDQS 122
VY +C + + DC CF ++ + C G +V C +RY+ +FY+++
Sbjct: 76 VYAYGECIKDLDKKDCDLCFAQIKAKVPRCLPFQKGTRGGQVFSDGCYIRYDDYNFYNET 135
Query: 123 TQEGRFGFCGNR--TALQADAFKTAAQELLENLEVATPKINGFFAASKNNIIGSRAGAND 180
C + T + F+ A EL++N+ V + GF+A
Sbjct: 136 LSLQDRTVCAPKEITGVNRTVFRDNAAELVKNMSVEAVRNGGFYAGFV------------ 183
Query: 181 DDDKNSTAVYGIAQCVETISETGCQNCLSGAFDNIQRCLGSAFGWAVDAGCFLRYSDTPF 240
D+++ V+G+AQC ET++ +GC CLS A I CL + G + AGC++R+S F
Sbjct: 184 --DRHNVTVHGLAQCWETLNRSGCVECLSKASVRIGSCLVNEEGRVLSAGCYMRFSTQKF 241
Query: 241 F--ADNQTTDITPFLKNGSSNKEAXXXXXXXXXXXXXXFALLI----WLVISRKSKKI-Q 293
+ + N T+D NG N F LL+ +L+ R +KK +
Sbjct: 242 YNNSGNSTSD-----GNGGHNH---LGVILAVTSSVVAFVLLVSAAGFLLKKRHAKKQRE 293
Query: 294 RGNISEATELQGPVN--YRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKL 351
+ + L N + ++L AT FS++NKLG+GG G +YKG L NGK VAVK+L
Sbjct: 294 KKQLGSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRL 353
Query: 352 AIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEK 411
+++ + F NEV LIS V H+NL++LLGC GPE +LVYEY+AN SL +LF K
Sbjct: 354 FFN-TKQWVDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLFVRK 412
Query: 412 RGS-LNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470
LNW +RF IILGTA G+AYLHE+ ++RIIHRDIK SN+LL+DD P+IADFGLARL
Sbjct: 413 DVQPLNWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGLARL 472
Query: 471 LPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE 530
PE+++H+ST AGTLGY APEY + G+L+EK D YSFGVL++E+I+G +++ + G
Sbjct: 473 FPEDKTHISTAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQDAGS 532
Query: 531 YLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590
+L+ W LY E +D L N K A ++++I L+C Q+A + RP MS VV +
Sbjct: 533 -ILQSVWSLYRTSNVEEAVDPILGDN-FNKIEASRLLQIGLLCVQAAFDQRPAMSVVVKM 590
Query: 591 LK-STSSSLLGNKPLLKPTFVETDYRK---TPADTSTSTA 626
+K S P L P V + RK TP ++++
Sbjct: 591 MKGSLEIHTPTQPPFLNPGSV-VEMRKMMMTPTTNQSNSS 629
|
|
| TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 687 (246.9 bits), Expect = 2.7e-86, Sum P(2) = 2.7e-86
Identities = 149/319 (46%), Positives = 211/319 (66%)
Query: 314 LVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV 373
L +AT FS EN+LG GGFG +YKG G+ +AVK+L+ G S + ++F+NE+ L++ +
Sbjct: 350 LKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLS-GNSGQGDNEFKNEILLLAKL 408
Query: 374 HHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFG-EKRGSLNWKQRFDIILGTARGLA 432
HRNL+RL+G C QG E +LVYE++ N+SLD+F+F EKR L+W R+ +I G ARGL
Sbjct: 409 QHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLLDWVVRYKMIGGIARGLL 468
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS--H-LSTKFAGTLGYT 489
YLHED RIIHRD+K SN+LLD ++ PKIADFGLA+L Q+ H +++ AGT GY
Sbjct: 469 YLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFTSRIAGTYGYM 528
Query: 490 APEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSE--TKGEE-GEYLLKRAWRLYENGTHW 546
APEYA+HGQ S K D +SFGVLV+EII+G +++ + G+E E LL WR + T
Sbjct: 529 APEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDLLSWVWRSWREDTIL 588
Query: 547 ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNKPLLK 606
++D SL ++ + + I L+C Q +A +RPTM+ V +L S S +L PL +
Sbjct: 589 SVIDPSLTAG--SRNEILRCIHIGLLCVQESAATRPTMATVSLMLNSYSFTL--PTPL-R 643
Query: 607 PTFVETDYRKTPADTSTST 625
P FV + P++ S+ST
Sbjct: 644 PAFV-LESVVIPSNVSSST 661
|
|
| TAIR|locus:2123116 CRK30 "cysteine-rich RLK (RECEPTOR-like protein kinase) 30" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 743 (266.6 bits), Expect = 1.0e-84, Sum P(2) = 1.0e-84
Identities = 180/468 (38%), Positives = 257/468 (54%)
Query: 178 ANDDDDKNSTAVYGIAQCVETISETGCQNCLSGAFDN-IQRCLGSAFGWAVDAGCFLRYS 236
A++ + NS VY + QC +S + C CL + D+ + C G G+ C R+
Sbjct: 187 ADETNLTNSQMVYALMQCTPDVSPSNCNTCLKQSVDDYVGCCHGKQGGYVYRPSCIFRWD 246
Query: 237 DTPFFA--DNQTTDITPFLKNGS----SNKEAXXXXXXXXXXXXXXFALLIWLV------ 284
PF D T P + S +NK+ A++I +
Sbjct: 247 LYPFNGAFDLLTLAPPPSSQLQSPPPVTNKDEKTIHTGTIIGIVIVVAMVIIMALLALGV 306
Query: 285 -ISRKSKKIQRGNISEATELQ--GPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK 341
+ R KK Q A ++ G + + +KD+ +AT F NK+G+GGFG++YKGTL
Sbjct: 307 SVCRSRKKYQAFASETADDITTVGYLQFDIKDIEAATSNFLASNKIGQGGFGEVYKGTLS 366
Query: 342 NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANS 401
NG VAVK+L+ + L +F+NEV L++ + HRNL+RLLG QG E ILV+E++ N
Sbjct: 367 NGTEVAVKRLSRTSDQGEL-EFKNEVLLVAKLQHRNLVRLLGFALQGEEKILVFEFVPNK 425
Query: 402 SLDKFLFGE----KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD 457
SLD FLFG K+G L+W +R++II G RGL YLH+D + IIHRDIK SN+LLD D
Sbjct: 426 SLDYFLFGSTNPTKKGQLDWTRRYNIIGGITRGLLYLHQDSRLTIIHRDIKASNILLDAD 485
Query: 458 LQPKIADFGLARLLPENQSHLST-KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEII 516
+ PKIADFG+AR ++Q+ ST + GT GY PEY HGQ S K D YSFGVL+LEI+
Sbjct: 486 MNPKIADFGMARNFRDHQTEDSTGRVVGTFGYMPPEYVAHGQFSTKSDVYSFGVLILEIV 545
Query: 517 SGTKSSETKGEEGEY--LLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCT 574
SG K+S +G L+ WRL+ + EL+D ++ K+ + + I L+C
Sbjct: 546 SGRKNSSFYQMDGSVCNLVTYVWRLWNTDSSLELVDPAIS-GSYEKDEVTRCIHIGLLCV 604
Query: 575 QSAANSRPTMSEVVALLKSTSSSLLGNKPLLKPTFVETDYRKTP-ADT 621
Q +RP +S + +L T+SS+ N P P F +R P +DT
Sbjct: 605 QENPVNRPALSTIFQML--TNSSITLNVPQ-PPGFF---FRNRPESDT 646
|
|
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 705 (253.2 bits), Expect = 2.8e-82, Sum P(2) = 2.8e-82
Identities = 145/326 (44%), Positives = 216/326 (66%)
Query: 280 LIWLVISRKSKKI--QRGNISE--ATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDI 335
+ WL+ R++ K+ + ++ E T + + ++ + +AT KFSE NKLG GGFG++
Sbjct: 303 MCWLLARRRNNKLSAETEDLDEDGITSTE-TLQFQFSAIEAATNKFSESNKLGHGGFGEV 361
Query: 336 YKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395
YKG L G+ VA+K+L+ G S + +F+NEV +++ + HRNL +LLG C G E ILVY
Sbjct: 362 YKGQLITGETVAIKRLSQG-STQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVY 420
Query: 396 EYMANSSLDKFLF-GEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL 454
E++ N SLD FLF EKR L+W++R+ II G ARG+ YLH D + IIHRD+K SN+LL
Sbjct: 421 EFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILL 480
Query: 455 DDDLQPKIADFGLARLLPENQSHLSTK-FAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVL 513
D D+ PKI+DFG+AR+ +Q+ +TK GT GY +PEYAIHG+ S K D YSFGVLVL
Sbjct: 481 DADMHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVL 540
Query: 514 EIISGTKSSETKGEEG-EYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALM 572
E+I+G K+S E+G L+ W+L+ + EL+DE++ N T E + + IAL+
Sbjct: 541 ELITGKKNSSFYEEDGLGDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVI-RCIHIALL 599
Query: 573 CTQSAANSRPTMSEVVALLKSTSSSL 598
C Q ++ RP+M +++ ++ S + +L
Sbjct: 600 CVQEDSSERPSMDDILVMMNSFTVTL 625
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 821 (294.1 bits), Expect = 7.4e-82, P = 7.4e-82
Identities = 219/648 (33%), Positives = 333/648 (51%)
Query: 7 TKWAVAEPEMELINSGCSQY-NVTNFSEFNSNLNATFKELREQ-LNGGKKFATAQRTRGP 64
T + V+ + + C N T+ S +N+NL L + + F A + P
Sbjct: 28 TSFRVSAQDPTYVYHTCQNTANYTSNSTYNNNLKTLLASLSSRNASYSTGFQNATVGQAP 87
Query: 65 DQVYTMVQCRRYVSTADCAACFTSA--ESLIRNCSAANGARVIYLACSLRYESSSFYDQS 122
D+V + CR VST C C + A ++L R C A + Y C LRY + +
Sbjct: 88 DRVTGLFNCRGDVSTEVCRRCVSFAVNDTLTR-CPNQKEATLYYDECVLRYSNQNILSTL 146
Query: 123 TQEGRFGFCGNRTALQADAFKTAAQ-ELLENLEVATPKINGFFAASKNNIIGSRAGANDD 181
G R T+ Q +LL +L + P +N + N+ + G +
Sbjct: 147 ITTGGVILVNTRNV-------TSNQLDLLSDLVL--PTLNQAATVALNS--SKKFGTRKN 195
Query: 182 DDKNSTAVYGIAQCVETISETGCQNCLSGAFDNIQRC-LGSAFGWAVDAGCFLRYSDTPF 240
+ + YG+ QC ++ C CL + I +G+ ++ C RY F
Sbjct: 196 NFTALQSFYGLVQCTPDLTRQDCSRCLQLVINQIPTDRIGARI---INPSCTSRYEIYAF 252
Query: 241 FADNQ--------TTDITPFLKNGSSNKEAXXXXXXXXXXXXXXFALLIWLV----ISRK 288
+ ++ + P S K+ A+L+++ ++R+
Sbjct: 253 YTESAVPPPPPPPSISTPPVSAPPRSGKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRR 312
Query: 289 SKK-------IQRGNISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK 341
++K +I+ A LQ ++YR + +AT F E NK+G+GGFG++YKGTL
Sbjct: 313 ARKSYYTPSAFAGDDITTADSLQ--LDYRT--IQTATDDFVESNKIGQGGFGEVYKGTLS 368
Query: 342 NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANS 401
+G VAVK+L+ + + +F+NEV L++ + HRNL+RLLG C G E +LVYEY+ N
Sbjct: 369 DGTEVAVKRLSKSSGQGEV-EFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNK 427
Query: 402 SLDKFLFGE-KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP 460
SLD FLF K+G L+W +R+ II G ARG+ YLH+D + IIHRD+K SN+LLD D+ P
Sbjct: 428 SLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNP 487
Query: 461 KIADFGLARLLPENQSHLST-KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGT 519
KIADFG+AR+ +Q+ +T + GT GY +PEYA+HGQ S K D YSFGVLVLEIISG
Sbjct: 488 KIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGK 547
Query: 520 KSSETKGEEGEY-LLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAA 578
K+S +G + L+ AW L+ NG EL+D ++ N C + + V I L+C Q
Sbjct: 548 KNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIVEN-CQRNEVVRCVHIGLLCVQEDP 606
Query: 579 NSRPTMSEVVALLKSTSSSL-LGNKPLLKPTFVETDYRKTPADTSTST 625
RPT+S +V +L S + +L + +P L F ++ K P DT T++
Sbjct: 607 AERPTLSTIVLMLTSNTVTLPVPRQPGL---FFQSRIGKDPLDTDTTS 651
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 713 (256.0 bits), Expect = 4.1e-79, Sum P(2) = 4.1e-79
Identities = 145/327 (44%), Positives = 214/327 (65%)
Query: 278 ALLIWLVISRKSKKIQRGNISEATELQGP--VNYRLKDLVSATRKFSEENKLGEGGFGDI 335
+L++ LV+ R+ K + + E+ + + K + +AT KFS+ N +G GGFG++
Sbjct: 300 SLVVLLVVCRRKKSYKTTEVQATDEITTTHSLQFSFKTIEAATDKFSDSNMIGRGGFGEV 359
Query: 336 YKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395
Y+G L +G VAVK+L+ S + +F+NE L+S + H+NL+RLLG C +G E ILVY
Sbjct: 360 YRGKLSSGPEVAVKRLS-KTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVY 418
Query: 396 EYMANSSLDKFLFGE-KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL 454
E++ N SLD FLF K+G L+W +R++II G ARG+ YLH+D + IIHRD+K SN+LL
Sbjct: 419 EFVPNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILL 478
Query: 455 DDDLQPKIADFGLARLLPENQSHLSTK-FAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVL 513
D D+ PKIADFG+AR+ +QS +T+ AGT GY +PEYA+ G S K D YSFGVLVL
Sbjct: 479 DADMNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVL 538
Query: 514 EIISGTKSSETKG--EEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIAL 571
EIISG K+S + G L+ AWRL+ NG+ EL+D ++ + + EA + + IAL
Sbjct: 539 EIISGKKNSSFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEAT-RCIHIAL 597
Query: 572 MCTQSAANSRPTMSEVVALLKSTSSSL 598
+C Q RP + ++ +L S++++L
Sbjct: 598 LCVQEDPADRPLLPAIIMMLTSSTTTL 624
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 791 (283.5 bits), Expect = 1.1e-78, P = 1.1e-78
Identities = 218/636 (34%), Positives = 324/636 (50%)
Query: 19 INSGCSQYNVTNFSEFNSNLNATFKELREQL-NGGKKFATA-QRTRG---PDQVYTMVQC 73
+N C N T +S NS + K L + ++T Q R PD+V + C
Sbjct: 40 LNHDCP--NRTTYSS-NSTYSTNLKTLLSSFASRNASYSTGFQNIRAGQTPDRVTGLFLC 96
Query: 74 RRYVSTADCAAC--FTSAESLIRNCSAANGARVIYLACSLRYESSSFYDQSTQEGRFGFC 131
R +S C+ C F+ ESL R C A Y C LRY +F T EG
Sbjct: 97 RGDLSPEVCSNCVAFSVNESLTR-CPNQREAVFYYEECILRYSHKNFLSTVTYEGELIM- 154
Query: 132 GNRTALQADAFKTAAQELLENLEVATPKINGFFAASKNNIIGSRAGANDDDDKNSTAVYG 191
R + + + ++ ++ +N AA++ + + + +YG
Sbjct: 155 --RNPNNISSIQNQRDQFIDLVQ---SNMNQ--AANEAANSSRKFSTIKTELTSLQTLYG 207
Query: 192 IAQCVETISETGCQNCLSGAFDNIQRC--LGSAFGW-AVDAG--CFLRYSDT-------- 238
+ QC ++ C +CL+ + + + +G+ W + ++ + Y++T
Sbjct: 208 LVQCTPDLARQDCFSCLTSSINRMMPLFRIGARQFWPSCNSRYELYAFYNETAIGTPSPP 267
Query: 239 PFFADNQTTDITPFLKNGSSNKEAXXXXXXXXXXXXXXFALLIWLVISRKSKK-IQRGNI 297
P F + +P + G S AL+ + +++++KK +
Sbjct: 268 PLFPGSTPPLTSPSIP-GKSGNSTVLVVAIVVLAVLLFIALVGYCFLAQRTKKTFDTASA 326
Query: 298 SE-----ATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLA 352
SE AT ++YR + +AT F+E NK+G GGFG++YKGT NGK VAVK+L+
Sbjct: 327 SEVGDDMATADSLQLDYRT--IQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLS 384
Query: 353 IGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGE-K 411
SR+ ++F+ EV +++ + HRNL+RLLG QG E ILVYEYM N SLD LF K
Sbjct: 385 KN-SRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTK 443
Query: 412 RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471
+ L+W QR++II G ARG+ YLH+D + IIHRD+K SN+LLD D+ PKIADFG+AR+
Sbjct: 444 QTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIF 503
Query: 472 PENQSHLST-KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEG- 529
+Q+ +T + GT GY APEYA+HGQ S K D YSFGVLVLEIISG K+S +G
Sbjct: 504 GLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGA 563
Query: 530 EYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589
+ LL WRL+ N T +L+D L N C + + I L+C Q RPT+S V
Sbjct: 564 QDLLTHTWRLWTNRTALDLVDP-LIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFM 622
Query: 590 LLKSTSSSLLGNKPLLKPTFVETDYRKTPADTSTST 625
+L S + +L P F+++ K P D+ ST
Sbjct: 623 MLTSNTVTL--PVPRQPGFFIQSSPVKDPTDSDQST 656
|
|
| TAIR|locus:2127323 CRK27 "cysteine-rich RLK (RECEPTOR-like protein kinase) 27" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 790 (283.2 bits), Expect = 1.4e-78, P = 1.4e-78
Identities = 208/604 (34%), Positives = 317/604 (52%)
Query: 27 NVTNFSEFNSNLN---ATFKELREQLNGGKKFATAQRTRGPDQVYTMVQCRRYVS-TADC 82
N T+ + ++ NLN ++ +L +NG + G +V + CR V DC
Sbjct: 40 NFTSNTSYSLNLNRLISSLPDLTPTINGFYNISI----NG--EVNAIALCRGDVKPNQDC 93
Query: 83 AACFTSA-ESLIRNCSAANGARVIYLACSLRYESSSFYDQSTQEGRFGFCGNRTAL-QAD 140
+C T+A + L+ +C A + C RY S Q + F + + ++ +
Sbjct: 94 ISCITTAAKQLVESCPNIIEANIWLEKCMFRYTSRIILGQM-EPVPFSYTSSNVSVTDKE 152
Query: 141 AFKTAAQELLENLEVATPKINGFFAASKNNIIGSRAGANDDDDKNSTAVYGIAQCVETIS 200
F +LL++L KI+ AA++ + AG +Y +AQC +S
Sbjct: 153 GFSKGLGDLLDSLGA---KID---AANETKEVKFAAGVKG-------TIYALAQCTPDLS 199
Query: 201 ETGCQNCLSGAFDNIQRCL-GSAFGWAVDAGCFLRYSDTPFFADNQTTDITPFLKNGSSN 259
E+ C+ CL+ F + C G GW + C+ R+ PFF + T++ L + ++N
Sbjct: 200 ESDCRICLAQIFAGVPTCCDGKTGGWWTNPSCYFRFEVYPFFDLSVTSEQKQPLSSHNNN 259
Query: 260 KEAXXXXXXXXXXXXXXFAL---------LIWLVI---SRKSKKIQRGNISEATELQGPV 307
FA+ L++L I R+ KK + N E +
Sbjct: 260 TRRSDQGKSKDRSKTLIFAVVPIVAIILGLVFLFIYLKRRRKKKTLKENAENEFESTDSL 319
Query: 308 NYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEV 367
++ + + AT FS NK+GEGGFG +YKG L +G +AVK+L+I S + ++F+ EV
Sbjct: 320 HFDFETIRVATDDFSLTNKIGEGGFGVVYKGHLPDGLEIAVKRLSIH-SGQGNAEFKTEV 378
Query: 368 RLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGE-KRGSLNWKQRFDIILG 426
L++ + H+NL++L G + E +LVYE++ N+SLD+FLF K+ L+W++R++II+G
Sbjct: 379 LLMTKLQHKNLVKLFGFSIKESERLLVYEFIPNTSLDRFLFDPIKQKQLDWEKRYNIIVG 438
Query: 427 TARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP-ENQSHLSTKFAGT 485
+RGL YLHE IIHRD+K SNVLLD+ + PKI+DFG+AR +N ++ + GT
Sbjct: 439 VSRGLLYLHEGSEFPIIHRDLKSSNVLLDEQMLPKISDFGMARQFDFDNTQAVTRRVVGT 498
Query: 486 LGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTH 545
GY APEYA+HG+ S K D YSFGVLVLEII+G ++S EG L AW+ + GT
Sbjct: 499 YGYMAPEYAMHGRFSVKTDVYSFGVLVLEIITGKRNSGLGLGEGTDLPTFAWQNWIEGTS 558
Query: 546 WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNKPLL 605
EL+D L KE+ + +EIAL C Q RPTM VV++L S S S KP
Sbjct: 559 MELIDPVLLQTHDKKESMQ-CLEIALSCVQENPTKRPTMDSVVSMLSSDSESRQLPKPS- 616
Query: 606 KPTF 609
+P F
Sbjct: 617 QPGF 620
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 787 (282.1 bits), Expect = 3.0e-78, P = 3.0e-78
Identities = 176/409 (43%), Positives = 250/409 (61%)
Query: 225 WAVDAGCFLRYSDT--PFFAD-NQTTDITPFLKNGSSNKEAXXXXXXXXXXXX----XXF 277
WA C + P A + T D TP + N +K F
Sbjct: 608 WAGKGTCCIPIQGAYGPLIAAVSATPDFTPTVANRPPSKGKSRTGTIVGVIVGVGLLSIF 667
Query: 278 ALLIWLVISRKSKKIQRGNISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYK 337
A ++ LVI ++ K + +++ P + +L +AT+ F NKLGEGGFG +YK
Sbjct: 668 AGVVILVIRKRRKPYTDDEEILSMDVK-PYTFTYSELKNATQDFDLSNKLGEGGFGAVYK 726
Query: 338 GTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397
G L +G+ VAVK+L+IG SR+ F E+ IS+V HRNL++L GCC +G +LVYEY
Sbjct: 727 GNLNDGREVAVKQLSIG-SRQGKGQFVAEIIAISSVLHRNLVKLYGCCFEGDHRLLVYEY 785
Query: 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD 457
+ N SLD+ LFG+K L+W R++I LG ARGL YLHE+ VRIIHRD+K SN+LLD +
Sbjct: 786 LPNGSLDQALFGDKSLHLDWSTRYEICLGVARGLVYLHEEASVRIIHRDVKASNILLDSE 845
Query: 458 LQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS 517
L PK++DFGLA+L + ++H+ST+ AGT+GY APEYA+ G L+EK D Y+FGV+ LE++S
Sbjct: 846 LVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVS 905
Query: 518 GTKSSETKGEEGE-YLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQS 576
G K+S+ EEG+ YLL+ AW L+E EL+D+ L +E E ++++ IAL+CTQS
Sbjct: 906 GRKNSDENLEEGKKYLLEWAWNLHEKNRDVELIDDEL--SEYNMEEVKRMIGIALLCTQS 963
Query: 577 AANSRPTMSEVVALLKSTSSSLLGNKPLLKPTFVETDYRKTPADTSTST 625
+ RP MS VVA+L + N KP ++ TD T DT++S+
Sbjct: 964 SYALRPPMSRVVAMLSGDAEV---NDATSKPGYL-TDC--TFDDTTSSS 1006
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00023428001 | SubName- Full=Chromosome undetermined scaffold_30, whole genome shotgun sequence; (626 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 658 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-61 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-60 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-58 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-56 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-54 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-42 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-41 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-39 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-38 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-36 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-36 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-35 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-32 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-31 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-31 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-31 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-31 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-31 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-30 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-30 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-29 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-29 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-28 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-28 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-28 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-28 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-28 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-27 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-27 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-27 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-27 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-25 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-25 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-25 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-24 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-23 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-23 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-22 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-22 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-21 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-21 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-20 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-20 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 4e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-19 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-19 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-19 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-19 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-19 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-18 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-18 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-17 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-16 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-16 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-16 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-14 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-14 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-14 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-10 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 9e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 9e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 5e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 8e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 3e-61
Identities = 88/275 (32%), Positives = 130/275 (47%), Gaps = 28/275 (10%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKI-----VAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
KLGEG FG++YKG LK VAVK L S + + +F E R++ + H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
++LLG C++ L +V EYM L +L + R L+ L ARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLES-- 120
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ 498
IHRD+ N L+ ++L KI+DFGL+R L ++ + + + APE G+
Sbjct: 121 -KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 499 LSEKVDAYSFGVLVLEIISGTKS--SETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556
+ K D +SFGVL+ EI + + EE LK +RL + P
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQ-------------PP 226
Query: 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
C E + ++ L C RPT SE+V +L
Sbjct: 227 NCPPE----LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 2e-60
Identities = 88/277 (31%), Positives = 131/277 (47%), Gaps = 31/277 (11%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKI-----VAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
KLGEG FG++YKGTLK VAVK L S + + +F E R++ + H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
++LLG C++ L++V EYM L +L + L+ L ARG+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES-- 121
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIH 496
IHRD+ N L+ ++L KI+DFGL+R L ++ K + + APE
Sbjct: 122 -KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKE 178
Query: 497 GQLSEKVDAYSFGVLVLEIISGTKS--SETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554
G+ + K D +SFGVL+ EI + + E LK+ +RL +
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPK------------- 225
Query: 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
P C E + ++ L C RPT SE+V +L
Sbjct: 226 PPNCPPE----LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 2e-58
Identities = 93/276 (33%), Positives = 129/276 (46%), Gaps = 33/276 (11%)
Query: 326 KLGEGGFGDIYKGTLK-----NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIR 380
KLGEG FG++YKGTLK VAVK L G S +F E ++ + H N++R
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 381 LLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
LLG C+QG L +V EYM L FL + L K + L A+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLES---K 121
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG---YTAPEYAIHG 497
+HRD+ N L+ ++L KI+DFGL+R + E+ + G + APE G
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESLKDG 179
Query: 498 QLSEKVDAYSFGVLVLEIISGTKS--SETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555
+ + K D +SFGVL+ EI + + EE LL+ +RL P
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR-------------P 226
Query: 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
C E + E+ L C RPT SE+V L
Sbjct: 227 ENCPDE----LYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 8e-56
Identities = 89/286 (31%), Positives = 126/286 (44%), Gaps = 42/286 (14%)
Query: 325 NKLGEGGFGDIYKGTLKNGK----IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIR 380
KLGEG FG++YKG LK VAVK L S DF E R++ + H N++R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 381 LLGCCSQGPELILVYEYMANSSLDKFL-------FGEKRGSLNWKQRFDIILGTARGLAY 433
LLG C++ L LV EYM L +L ++ +L+ K + A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG-----Y 488
L + +HRD+ N L+ +DL KI+DFGL+R + ++ + T G +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRW 173
Query: 489 TAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE--GEYLLKRAWRLYENGTHW 546
APE G + K D +SFGVL+ EI T G + G
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIF-------TLGATPYPGLSNEEVLEYLRKGYRL 226
Query: 547 ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
P C E + E+ L C Q RPT SE+V L+
Sbjct: 227 P------KPEYCPDE----LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 1e-54
Identities = 77/193 (39%), Positives = 107/193 (55%), Gaps = 10/193 (5%)
Query: 327 LGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCC 385
LGEGGFG +Y K GK VA+K + S L + E+ ++ ++H N+++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 386 SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHR 445
L LV EY SL L E G L+ + I+L GL YLH IIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHS---NGIIHR 116
Query: 446 DIKPSNVLLD-DDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ--LSEK 502
D+KP N+LLD D+ + K+ADFGL++LL ++S L T GT Y APE + G+ SEK
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPE-VLLGKGYYSEK 174
Query: 503 VDAYSFGVLVLEI 515
D +S GV++ E+
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 2e-52
Identities = 81/199 (40%), Positives = 110/199 (55%), Gaps = 15/199 (7%)
Query: 326 KLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFE----NEVRLISNVHHRNLIR 380
KLG G FG +YK K GKIVAVK L R S + E+R++ + H N++R
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKK---RSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 381 LLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
L+ L LV EY L +L + G L+ + I L RGL YLH +
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL- 499
IIHRD+KP N+LLD++ KIADFGLA+ L ++ S L+T F GT Y APE + G
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGY 176
Query: 500 SEKVDAYSFGVLVLEIISG 518
KVD +S GV++ E+++G
Sbjct: 177 GPKVDVWSLGVILYELLTG 195
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-48
Identities = 69/199 (34%), Positives = 102/199 (51%), Gaps = 8/199 (4%)
Query: 321 FSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+ KLGEG FG +Y K GK+VA+K + ++ E++++ + H N++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
RL +L LV EY L L +KRG L+ + + L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHS--- 115
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL 499
I+HRD+KP N+LLD+D K+ADFGLAR L + T F GT Y APE +
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE--KLTTFVGTPEYMAPEVLLGKGY 173
Query: 500 SEKVDAYSFGVLVLEIISG 518
+ VD +S GV++ E+++G
Sbjct: 174 GKAVDIWSLGVILYELLTG 192
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 81/284 (28%), Positives = 128/284 (45%), Gaps = 49/284 (17%)
Query: 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAI-GISRRTLSDFENEVRLISNVHHRNLIRLL 382
LG G FG +Y K G+++AVK + + G S L E E+R++S++ H N++R
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 383 GCC-SQGPELILVY-EYMANSSLDKFLFGEKRGSLNWK--QRF--DIILGTARGLAYLHE 436
G + + ++ EY++ SL L +K G L +++ I+ GLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQIL----EGLAYLHS 119
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK-FAGTLGYTAPEYAI 495
+ I+HRDIK +N+L+D D K+ADFG A+ L + ++ T GT + APE
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 496 HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM------ 549
+ D +S G V+E+ +G K W E G +
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATG---------------KPPW--SELGNPMAALYKIGSS 219
Query: 550 DESLD-PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
E + P ++EA + C + RPT E LL+
Sbjct: 220 GEPPEIPEHLSEEA----KDFLRKCLRRDPKKRPTADE---LLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 87/272 (31%), Positives = 135/272 (49%), Gaps = 44/272 (16%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLS--DFENEVRLISNVHHRNLIRL 381
E KLG G FG+++ GT VAVK L G T+S F E +++ + H L++L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG----TMSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 382 LGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVR 441
CS+ + +V EYM+ SL FL + L Q D+ A G+AYL
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---N 123
Query: 442 IIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHGQL 499
IHRD+ N+L+ ++L KIADFGLARL+ +++ + KF + +TAPE A +G+
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRF 181
Query: 500 SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRL-YENGTHWELMDESLD---- 554
+ K D +SFG+L+ EI+ T G R+ Y T+ E++++ ++
Sbjct: 182 TIKSDVWSFGILLTEIV-------TYG-----------RVPYPGMTNREVLEQ-VERGYR 222
Query: 555 ---PNECTKEAAEKVVEIALMCTQSAANSRPT 583
P C +E + ++ L C RPT
Sbjct: 223 MPRPPNCPEE----LYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 6e-39
Identities = 88/280 (31%), Positives = 144/280 (51%), Gaps = 38/280 (13%)
Query: 324 ENKLGEGGFGDIYKGTLK-NGK---IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
E +G G FG++ +G LK GK VA+K L G S + DF E ++ H N+I
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
RL G ++ ++++ EYM N SLDKFL E G Q ++ G A G+ YL E +
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAG--TLGYTAPEYAIHG 497
V HRD+ N+L++ +L K++DFGL+R L ++++ +TK G + +TAPE +
Sbjct: 128 V---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKIPIRWTAPEAIAYR 183
Query: 498 QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD--- 554
+ + D +SFG+++ E++S GE R Y + ++ +++ D
Sbjct: 184 KFTSASDVWSFGIVMWEVMS-------YGE----------RPYWDMSNQDVIKAVEDGYR 226
Query: 555 ---PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
P +C + ++ L C Q N RPT S++V+ L
Sbjct: 227 LPPPMDC----PSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 74/198 (37%), Positives = 105/198 (53%), Gaps = 7/198 (3%)
Query: 321 FSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIR 380
F+ E KLG G FG++++G KN VA+K L DF+ EV+ + + H++LI
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD-DLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 381 LLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
L CS G + ++ E M SL FL + L D+ A G+AYL E
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN-QSHLSTKFAGTLGYTAPEYAIHGQL 499
IHRD+ N+L+ +DL K+ADFGLARL+ E+ K +TAPE A HG
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAPEAASHGTF 181
Query: 500 SEKVDAYSFGVLVLEIIS 517
S K D +SFG+L+ E+ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 90/336 (26%), Positives = 144/336 (42%), Gaps = 24/336 (7%)
Query: 326 KLGEGGFGDIYKGTLKNGKIVAVKKLAIG--ISRRTLSDFENEVRLISNV-HHRNLIRLL 382
KLGEG FG++Y ++ K+VA+K LA + + F E+++++++ H N+++L
Sbjct: 7 KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 383 GCCSQGPELILVYEYMANSSLDKFL-FGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVR 441
L LV EY+ SL+ L ++G L+ + I+ L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121
Query: 442 IIHRDIKPSNVLLDDDL-QPKIADFGLARLLPENQSH-----LSTKFAGTLGYTAPEYAI 495
IIHRDIKP N+LLD D K+ DFGLA+LLP+ S L + GT GY APE +
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 496 HGQL---SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWR-LYENGTHWELMDE 551
L S D +S G+ + E+++G E GE+ + + + E T
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFE--GEKNSSATSQTLKIILELPTPSLASPL 239
Query: 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNKPLLKPTFVE 611
S E +AA +++ L +R + S ++ L + +
Sbjct: 240 SPSNPELISKAASDLLKKLL---AKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDD 296
Query: 612 TDYRKTPADTSTSTALLLLMLQPPSHKSQVDSPFNF 647
+ + S + L S NF
Sbjct: 297 SAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNF 332
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 5e-36
Identities = 69/191 (36%), Positives = 99/191 (51%), Gaps = 10/191 (5%)
Query: 327 LGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCS 386
+G+G FGD+ G + K VAVK L + F E +++ + H NL++LLG
Sbjct: 14 IGKGEFGDVMLGDYRGQK-VAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 387 QGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRD 446
QG L +V EYMA SL +L R + Q+ L G+ YL E +HRD
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 447 IKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAY 506
+ NVL+ +DL K++DFGLA+ +Q S K + +TAPE + S K D +
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFSTKSDVW 183
Query: 507 SFGVLVLEIIS 517
SFG+L+ EI S
Sbjct: 184 SFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 6e-36
Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
F K+G+GGFG++YK + GK VA+K + + + NE++++ H N+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK-KEKIINEIQILKKCKHPNI 59
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFD------IILGTARGLA 432
++ G + EL +V E+ + SL L + Q + +GL
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLL-------KSTNQTLTESQIAYVCKELLKGLE 112
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLA-RLLPENQSHLSTKFAGTLGYTAP 491
YLH + IIHRDIK +N+LL D + K+ DFGL+ +L + GT + AP
Sbjct: 113 YLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAP 166
Query: 492 EYAIHGQLSEKVDAYSFGVLVLEIISG 518
E K D +S G+ +E+ G
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEG 193
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 70/196 (35%), Positives = 109/196 (55%), Gaps = 13/196 (6%)
Query: 326 KLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLS--DFENEVRLISNVHHRNLIRLLG 383
KLG G FG++++G N VAVK L G T+ DF E +++ + H LI+L
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPG----TMDPKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
C+ + +V E M SL ++L G +L Q D+ A G+AYL + I
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY---I 125
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPEN--QSHLSTKFAGTLGYTAPEYAIHGQLSE 501
HRD+ NVL+ ++ K+ADFGLAR++ E+ ++ KF + +TAPE A++ + S
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP--IKWTAPEAALYNRFSI 183
Query: 502 KVDAYSFGVLVLEIIS 517
K D +SFG+L+ EI++
Sbjct: 184 KSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 82/273 (30%), Positives = 136/273 (49%), Gaps = 29/273 (10%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSD--FENEVRLISNVHHRNLIRL 381
E KLG+G FG+++ GT VA+K L G T+S F E +++ + H L++L
Sbjct: 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG----TMSPEAFLQEAQVMKKLRHEKLVQL 66
Query: 382 LGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVR 441
S+ P + +V EYM+ SL FL GE L Q D+ A G+AY+ +
Sbjct: 67 YAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MN 122
Query: 442 IIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSE 501
+HRD++ +N+L+ ++L K+ADFGLARL+ +N+ + +TAPE A++G+ +
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 502 KVDAYSFGVLVLEIISGTKSSETKGEEGEYL--LKRAWRLYENGTHWELMDESLDPNECT 559
K D +SFG+L+ E+ + + E L ++R +R+ C
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-----------------PCP 225
Query: 560 KEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
E E + ++ C + RPT + A L+
Sbjct: 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 80/283 (28%), Positives = 131/283 (46%), Gaps = 34/283 (12%)
Query: 325 NKLGEGGFGDIYKGTLKN-----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+LGEG FG + G+ VAVK L + SDFE E+ ++ + H N++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 380 RLLGCC--SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
+ G C G L L+ EY+ + SL +L R +N K+ +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG--YTAPEYAI 495
R IHRD+ N+L++ + KI+DFGLA++LPE++ + K G + APE
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 496 HGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGE--------EGEYLLKRAWRLYENGTHW 546
+ S D +SFGV + E+ + G S E +G+ ++ R L + G
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG--- 242
Query: 547 ELMDESLD-PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVV 588
E L P C E V ++ +C ++ RP+ ++++
Sbjct: 243 ----ERLPRPPSCPDE----VYDLMKLCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 78/275 (28%), Positives = 122/275 (44%), Gaps = 44/275 (16%)
Query: 326 KLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGC 384
LG+G G +YK K GKI A+KK+ + E++ + + +++ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 385 CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTA-----RGLAYLHEDFH 439
+ E+ +V EYM SL L +K G + + +L +GL YLH H
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL--KKVGKIP-----EPVLAYIARQILKGLDYLHTKRH 120
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL 499
IIHRDIKPSN+L++ + KIADFG++++L +T F GT+ Y +PE I G+
Sbjct: 121 --IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT-FVGTVTYMSPE-RIQGES 176
Query: 500 -SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE------- 551
S D +S G+ +LE G++ + +ELM
Sbjct: 177 YSYAADIWSLGLTLLECAL-----------GKFPFLPP----GQPSFFELMQAICDGPPP 221
Query: 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSE 586
SL E + E + + C Q RP+ +E
Sbjct: 222 SLPAEEFSPEFRDFIS----ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 77/267 (28%), Positives = 127/267 (47%), Gaps = 25/267 (9%)
Query: 324 ENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
++KLG G +G++Y+G K VAVK L + +F E ++ + H NL++LL
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLL 68
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
G C++ P ++ E+M +L +L R +N + + + YL +
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 125
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPEN--QSHLSTKFAGTLGYTAPEYAIHGQLS 500
IHRD+ N L+ ++ K+ADFGL+RL+ + +H KF + +TAPE + + S
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYNKFS 183
Query: 501 EKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTK 560
K D ++FGVL+ EI + S + L + + L E G E P C
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEKGYRME------RPEGC-- 230
Query: 561 EAAEKVVEIALMCTQSAANSRPTMSEV 587
KV E+ C Q + RP+ +E+
Sbjct: 231 --PPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 76/216 (35%), Positives = 108/216 (50%), Gaps = 37/216 (17%)
Query: 321 FSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAI-----GISRRTLSDFENEVRLISNVH 374
+ + KLGEG +G +YK K G+IVA+KK+ + GI L E+ L+ +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELK 56
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRG---SLNWKQRFDI-ILGTARG 430
H N+++LL +L LV+EY L K+L +KR S N + +L RG
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDMD-LKKYL--DKRPGPLSPNLIKSIMYQLL---RG 110
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
LAY H RI+HRD+KP N+L++ D K+ADFGLAR + + TL Y A
Sbjct: 111 LAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRA 166
Query: 491 PE-------YAIHGQLSEKVDAYSFGVLVLEIISGT 519
PE Y S VD +S G + E+I+G
Sbjct: 167 PEILLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 79/291 (27%), Positives = 124/291 (42%), Gaps = 49/291 (16%)
Query: 327 LGEGGFGDIYKGTLKNGK------IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIR 380
LGEG FG ++ G + + +VAVK L S DFE E L++N H N+++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 381 LLGCCSQGPELILVYEYMANSSLDKFL------------FGEKRGSLNWKQRFDIILGTA 428
G C++G I+V+EYM + L+KFL G L Q I + A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 429 RGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT--- 485
G+ YL +HRD+ N L+ DL KI DFG++R + + + G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY---RVGGHTML 186
Query: 486 -LGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGT 544
+ + PE ++ + + + D +SFGV++ EI T G K+ W N
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIF-------TYG-------KQPWYGLSNEE 232
Query: 545 HWELMDESL---DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
E + + P C E V +I L C + R + ++ L+
Sbjct: 233 VIECITQGRLLQRPRTCPSE----VYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 65/197 (32%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 325 NKLGEGGFGDIYKG-TLKNGKIVAVKKLAI-GISRRTLSDFENEVRLISNVHHRNLIRLL 382
+ +G G FG +YKG L+ G VA+K++++ I L E+ L+ N+ H N+++ +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
G L ++ EY N SL + + +K G + +GLAYLHE +
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVLQGLAYLHEQ---GV 120
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ-LSE 501
IHRDIK +N+L D K+ADFG+A L + S GT + APE I S
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDV-SKDDASVVGTPYWMAPE-VIEMSGAST 178
Query: 502 KVDAYSFGVLVLEIISG 518
D +S G V+E+++G
Sbjct: 179 ASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-31
Identities = 81/270 (30%), Positives = 130/270 (48%), Gaps = 28/270 (10%)
Query: 326 KLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCC 385
KLG G FG+++ G N VAVK L G ++ F E L+ + H L+RL
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 386 SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHR 445
++ + ++ EYMA SL FL ++ G + + D A G+AY+ + IHR
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY---IHR 127
Query: 446 DIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHGQLSEKV 503
D++ +NVL+ + L KIADFGLAR++ +N+ + KF + +TAPE G + K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP--IKWTAPEAINFGSFTIKS 185
Query: 504 DAYSFGVLVLEIISGTKSSETKGEEGEYL--LKRAWRLYENGTHWELMDESLDPNECTKE 561
D +SFG+L+ EI++ K + + L+R +R+ C E
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR-------------MENCPDE 232
Query: 562 AAEKVVEIALMCTQSAANSRPTMSEVVALL 591
+ +I C + A RPT + ++L
Sbjct: 233 ----LYDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 5e-31
Identities = 80/282 (28%), Positives = 143/282 (50%), Gaps = 37/282 (13%)
Query: 322 SEENKLGEGGFGDIYKGTLK-NGK---IVAVKKLAIGISRRTLSDFENEVRLISNVHHRN 377
+++ +G G FG++++G LK G+ VA+K L G + + DF +E ++ H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
+IRL G ++ +++ EYM N +LDK+L + G + Q ++ G A G+ YL +
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYL-RDHDGEFSSYQLVGMLRGIAAGMKYLSD- 125
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG--YTAPEYAI 495
+ +HRD+ N+L++ +L+ K++DFGL+R+L ++ T G + +TAPE
Sbjct: 126 --MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 496 HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD- 554
+ + + D +SFG+++ E++S GE R Y + ++ E+M D
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMS-------FGE----------RPYWDMSNHEVMKAINDG 226
Query: 555 -----PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
P +C V ++ L C Q RP ++V LL
Sbjct: 227 FRLPAPMDC----PSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 68/196 (34%), Positives = 104/196 (53%), Gaps = 10/196 (5%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
KLG G FG+++ G VA+K L G + F E L+ + H L+RL
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG--SMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
+Q P I + EYM N SL FL + L + D+ A G+A++ + I
Sbjct: 69 VVTQEPIYI-ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---I 124
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHGQLSE 501
HRD++ +N+L+ + L KIADFGLARL+ +N+ + KF + +TAPE +G +
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTI 182
Query: 502 KVDAYSFGVLVLEIIS 517
K D +SFG+L+ EI++
Sbjct: 183 KSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 79/272 (29%), Positives = 125/272 (45%), Gaps = 35/272 (12%)
Query: 327 LGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLS--DFENEVRLISNVHHRNLIRLLGC 384
LG G FG ++ G + VA+K + G +S DF E +++ + H NL++L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREG----AMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 385 CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIH 444
C++ + +V EYMAN L +L E++G L + D+ + YL + IH
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIH 123
Query: 445 RDIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHGQLSEK 502
RD+ N L+ +D K++DFGLAR + ++Q S TKF + + PE + + S K
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSRFSSK 181
Query: 503 VDAYSFGVLVLEIISGTK---SSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECT 559
D +SFGVL+ E+ S K + E E + +RLY
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYR-----------------P 223
Query: 560 KEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
K A +V I C RP ++++ L
Sbjct: 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 8/200 (4%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
F+ +G+G FG++YK + ++VA+K + + + + D + E++ +S +
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYI 61
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
+ G +G +L ++ EY S L K G L+ I+ GL YLHE+
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ 498
IHRDIK +N+LL ++ K+ADFG++ L S +T F GT + APE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPEVIKQSG 174
Query: 499 LSEKVDAYSFGVLVLEIISG 518
EK D +S G+ +E+ G
Sbjct: 175 YDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAI-GISRRTLSDFENEVRLISNVHHRN 377
K+ ++G+G FG +Y +GK+ +K++ + +S + D NEV+++ ++H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRF------DIILGTARGL 431
+I+ + +L +V EY L + + +K+ + F D + L
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKI--KKQKKEG--KPFPEEQILDWFVQLCLAL 116
Query: 432 AYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAP 491
YLH +I+HRDIKP N+ L + K+ DFG++++L T GT Y +P
Sbjct: 117 KYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYLSP 172
Query: 492 EYAIHGQ-LSEKVDAYSFGVLVLE 514
E + + K D +S G ++ E
Sbjct: 173 E-LCQNKPYNYKSDIWSLGCVLYE 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 82/287 (28%), Positives = 134/287 (46%), Gaps = 22/287 (7%)
Query: 319 RKFSEENKLGEGGFGDI--YKGTLKN---GKIVAVKKLAIGISRRTLSDFENEVRLISNV 373
R + LGEG FG + Y N G++VAVK L ++ S ++ E+ ++ +
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 374 HHRNLIRLLGCCSQGPE--LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGL 431
+H N+++ GCCS+ L L+ EY+ SL +L + LN Q G+
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGM 120
Query: 432 AYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT--LGYT 489
AYLH IHRD+ NVLLD+D KI DFGLA+ +PE + + G + +
Sbjct: 121 AYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 177
Query: 490 APEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549
A E + S D +SFGV + E+++ S ++ ++ E ++ EL+
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237
Query: 550 DESLD---PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
+ + P C +E V + C ++ A RPT ++ +LK
Sbjct: 238 ERGMRLPCPKNCPQE----VYILMKNCWETEAKFRPTFRSLIPILKE 280
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 86/276 (31%), Positives = 139/276 (50%), Gaps = 35/276 (12%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLS--DFENEVRLISNVHHRNLIRL 381
KLG G FG+++ GT VAVK L G T+S F E +++ + H L++L
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPG----TMSPESFLEEAQIMKKLRHDKLVQL 66
Query: 382 LGCCSQGPELILVYEYMANSSLDKFLF-GEKRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
S+ P + +V EYM+ SL FL GE R +L D+ A G+AY+ +
Sbjct: 67 YAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIER---M 121
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHGQ 498
IHRD++ +N+L+ D L KIADFGLARL+ +N+ + KF + +TAPE A++G+
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGR 179
Query: 499 LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYL--LKRAWRLYENGTHWELMDESLDPN 556
+ K D +SFG+L+ E+++ + E L ++R +R+
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM----------------- 222
Query: 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
C ++ + E+ L C + RPT + + L+
Sbjct: 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 70/214 (32%), Positives = 107/214 (50%), Gaps = 13/214 (6%)
Query: 310 RLKDLVSA---TRKFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFEN 365
LKD+VS + K+GEG G++YK T + GK VA+KK + + ++ N
Sbjct: 7 ALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKK--MRLRKQNKELIIN 64
Query: 366 EVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL 425
E+ ++ + H N++ G EL +V EYM SL + + +N Q +
Sbjct: 65 EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT-QNFVRMNEPQIAYVCR 123
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT 485
+GL YLH +IHRDIK N+LL D K+ADFG A L + +S ++ GT
Sbjct: 124 EVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGT 179
Query: 486 LGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISG 518
+ APE I + KVD +S G++ +E+ G
Sbjct: 180 PYWMAPE-VIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 71/200 (35%), Positives = 104/200 (52%), Gaps = 19/200 (9%)
Query: 327 LGEGGFGDIYKGTLKN-GKIVAVKKL--AIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
LG+G FG + K+ GK+ A+K L I R+ + E ++S ++H +++L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 384 CCSQGPE-LILVYEYMANSSLDKFLFGEKRGSLNWKQ-RF---DIILGTARGLAYLHEDF 438
Q E L LV EY L L K G + ++ RF +I+L L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLA----LEYLHS-- 111
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ 498
+ II+RD+KP N+LLD D K+ DFGLA+ L S +T F GT Y APE +
Sbjct: 112 -LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKG 169
Query: 499 LSEKVDAYSFGVLVLEIISG 518
+ VD +S GVL+ E+++G
Sbjct: 170 YGKAVDWWSLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 76/271 (28%), Positives = 129/271 (47%), Gaps = 30/271 (11%)
Query: 327 LGEGGFGDIYKGT----LKNGKI-VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRL 381
LG G FG +YKG + KI VA+K L S + + +E ++++V H +++RL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 382 LGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVR 441
LG C ++ L+ + M L ++ + ++ + + + A+G++YL E R
Sbjct: 75 LGIC-LSSQVQLITQLMPLGCLLDYV-RNHKDNIGSQYLLNWCVQIAKGMSYLEE---KR 129
Query: 442 IIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT-LGYTAPEYAIHGQLS 500
++HRD+ NVL+ KI DFGLA+LL ++ + + + A E +H +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYT 189
Query: 501 EKVDAYSFGVLVLEIIS-GTKSSETK-GEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558
K D +S+GV V E+++ G K E E LL++ RL + P C
Sbjct: 190 HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ-------------PPIC 236
Query: 559 TKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589
T + V + + C A SRPT E++
Sbjct: 237 TID----VYMVLVKCWMIDAESRPTFKELIN 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 63/185 (34%), Positives = 98/185 (52%), Gaps = 25/185 (13%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAI--------GISRRTLSDFENEVRLI 370
++ + KLGEG + +YK K G+IVA+KK+ + GI+ L E++L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL----REIKLL 56
Query: 371 SNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSL---NWKQRFDIILGT 427
+ H N+I LL + LV+E+M + L+K + +K L + K +L T
Sbjct: 57 QELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEK-VIKDKSIVLTPADIKS---YMLMT 111
Query: 428 ARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG 487
RGL YLH ++ I+HRD+KP+N+L+ D K+ADFGLAR ++ + T
Sbjct: 112 LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRW 167
Query: 488 YTAPE 492
Y APE
Sbjct: 168 YRAPE 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 88/276 (31%), Positives = 129/276 (46%), Gaps = 31/276 (11%)
Query: 325 NKLGEGGFGDIYKGT--LKNGKI--VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIR 380
+LG G FG + KG +K+GK VAVK L +F E +++ + H ++R
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 381 LLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
L+G C +G L+LV E L K+L +KR + ++ A G+AYL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYLES---K 114
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT--LGYTAPEYAIHGQ 498
+HRD+ NVLL + Q KI+DFG++R L + AG L + APE +G+
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 499 LSEKVDAYSFGVLVLEIIS-GTKS-SETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556
S K D +S+GV + E S G K E KG E +L+ RL P
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPR-------------PE 221
Query: 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
EC +E + I L C + RPT SE+ + +
Sbjct: 222 ECPQE----IYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 66/200 (33%), Positives = 103/200 (51%), Gaps = 17/200 (8%)
Query: 326 KLGEGGFGDIYKG-TLKNGKIVAVKKLAIGISRRTLSDFEN-----EVRLISNVHHRNLI 379
K+GEG +G +YK G+IVA+KK I R S+ E++L+ ++H N+I
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKK----IKLRFESEGIPKTALREIKLLKELNHPNII 61
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
+LL +L LV+E+M ++ L K + +RG L + +GLA+ H
Sbjct: 62 KLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHSH-- 117
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH-GQ 498
I+HRD+KP N+L++ + K+ADFGLAR + T + T Y APE +
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 499 LSEKVDAYSFGVLVLEIISG 518
S VD +S G + E++S
Sbjct: 176 YSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 79/273 (28%), Positives = 134/273 (49%), Gaps = 29/273 (10%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSD--FENEVRLISNVHHRNLIRL 381
+ KLG+G FG+++ GT VA+K L G T+ F E +++ + H L+ L
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG----TMMPEAFLQEAQIMKKLRHDKLVPL 66
Query: 382 LGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVR 441
S+ P + +V E+M SL FL L Q D+ A G+AY+ +
Sbjct: 67 YAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MN 122
Query: 442 IIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSE 501
IHRD++ +N+L+ D+L KIADFGLARL+ +N+ + +TAPE A++G+ +
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 502 KVDAYSFGVLVLEIISGTKSSETKGEEGEYL--LKRAWRLYENGTHWELMDESLDPNECT 559
K D +SFG+L+ E+++ + E L ++R +R+ C
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM-----------------PCP 225
Query: 560 KEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
+ E + E+ +C + + RPT + + L+
Sbjct: 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 76/279 (27%), Positives = 125/279 (44%), Gaps = 40/279 (14%)
Query: 326 KLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSD-----FENEVRLISNVHHRNLIR 380
K+G+G FGD+YKG LK VAVK R TL F E ++ H N+++
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKT-----CRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 381 LLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
L+G C Q + +V E + SL FL +K L K+ + L A G+ YL
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESK--- 112
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT----LGYTAPEYAIH 496
IHRD+ N L+ ++ KI+DFG++R E + + T G + +TAPE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 497 GQLSEKVDAYSFGVLVLEIISG--TKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554
G+ + + D +S+G+L+ E S T ++ ++ +R+
Sbjct: 170 GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM--------------- 214
Query: 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
+ E++ + L C +RP+ SE+ L+
Sbjct: 215 --PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 321 FSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
F KLGEG +G +YK + G++VA+K + + L + E+ ++ ++
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE---EDLQEIIKEISILKQCDSPYIV 61
Query: 380 RLLGCCSQGPELILVYEYM-ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
+ G + +L +V EY A S D K +L ++ I+ T +GL YLH
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHS-- 117
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ 498
+ IHRDIK N+LL+++ Q K+ADFG++ L + + +T GT + APE
Sbjct: 118 -NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIG 175
Query: 499 LSEKVDAYSFGVLVLEIISG 518
+ K D +S G+ +E+ G
Sbjct: 176 YNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 326 KLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFEN----EVRLISNVHHRNLIR 380
++GEG G ++K + G+ VA+KK+A+ RR N E++ + H +++
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVAL---RRLEGGIPNQALREIKALQACQHPYVVK 63
Query: 381 LLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
LL G +LV EYM S L + L ++ L Q + +G+AY+H +
Sbjct: 64 LLDVFPHGSGFVLVMEYMP-SDLSEVL-RDEERPLPEAQVKSYMRMLLKGVAYMHAN--- 118
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ-- 498
I+HRD+KP+N+L+ D KIADFGLARL E + L + T Y APE ++G
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL-LYGARK 177
Query: 499 LSEKVDAYSFGVLVLEIISG 518
VD ++ G + E+++G
Sbjct: 178 YDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 88/292 (30%), Positives = 126/292 (43%), Gaps = 56/292 (19%)
Query: 327 LGEGGFGDIYKGTLK-----NGKI-VAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLI 379
LGEG FG + K N VAVK L + + LSD +E+ ++ + H+N+I
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFL-----FGEK---------RGSLNWKQRFDIIL 425
LLG C+Q L +V EY A+ +L FL GE +L K
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN-------QSHL 478
ARG+ +L + IHRD+ NVL+ +D KIADFGLAR + L
Sbjct: 140 QVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS--GTKSSETKGEEGEYLLKRA 536
K + APE + + D +SFGVL+ EI + G+ EE LLK
Sbjct: 197 PVK------WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 250
Query: 537 WRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVV 588
+R M++ P CT+E + + C + RPT ++V
Sbjct: 251 YR----------MEK---PQNCTQE----LYHLMRDCWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 65/233 (27%), Positives = 112/233 (48%), Gaps = 30/233 (12%)
Query: 325 NKLGEGGFGDIYKG-TLKNGKIVAVKKLAIGISRR-TLSDFENEVRLISNVHHRNLIRLL 382
NK+G G FG +Y L G+++AVK++ I + T+ + +E++++ + H NL++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
G ++ + EY + +L++ L + + + + + L GLAYLH I
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSH---GI 120
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG---YTAPEYAIHGQL 499
+HRDIKP+N+ LD + K+ DFG A L N + + + G Y APE G+
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 500 SEK---VDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549
D +S G +VLE+ +G KR W +N +++M
Sbjct: 181 KGHGRAADIWSLGCVVLEMATG---------------KRPWSELDN--EFQIM 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 20/264 (7%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+E +G G FG ++ G + VA+K + G DF E +++ + H L+
Sbjct: 7 TLVQE--IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE--EDFIEEAQVMMKLSHPKLV 62
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
+L G C++ + LV+E+M + L +L +RG + + + L G+AYL
Sbjct: 63 QLYGVCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEGMAYLESS-- 119
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL 499
+IHRD+ N L+ ++ K++DFG+ R + ++Q ST + +++PE +
Sbjct: 120 -NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 500 SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYL--LKRAWRLYE----NGTHWELMDESL 553
S K D +SFGVL+ E+ S K+ E + + +RLY+ + + +ELM
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELM---- 234
Query: 554 DPNECTKEAAEKVVEIALMCTQSA 577
C KE E +L+ Q A
Sbjct: 235 --QHCWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 63/204 (30%), Positives = 111/204 (54%), Gaps = 16/204 (7%)
Query: 324 ENKLGEGGFGDIYKGTLKN-GK---IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
E +G G FG++ +G LK GK VA+K L G + + DF +E ++ H N+I
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
L G ++ ++++ E+M N +LD FL + G Q ++ G A G+ YL E
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYLSE--- 124
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG------YTAPEY 493
+ +HRD+ N+L++ +L K++DFGL+R L ++ S + +LG +TAPE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS--DPTYTSSLGGKIPIRWTAPEA 182
Query: 494 AIHGQLSEKVDAYSFGVLVLEIIS 517
+ + + D +S+G+++ E++S
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 67/195 (34%), Positives = 102/195 (52%), Gaps = 18/195 (9%)
Query: 326 KLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCC 385
+GEG FG + +G G+ VAVK + + T F E +++ +HH+NL+RLLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 386 -SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIH 444
G L +V E M+ +L FL R ++ Q L A G+ YL +++H
Sbjct: 69 LHNG--LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 445 RDIKPSNVLLDDDLQPKIADFGLARLLPE--NQSHLSTKFAGTLGYTAPEYAIHGQLSEK 502
RD+ N+L+ +D K++DFGLAR+ + S L K +TAPE H + S K
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSK 177
Query: 503 VDAYSFGVLVLEIIS 517
D +S+GVL+ E+ S
Sbjct: 178 SDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 78/285 (27%), Positives = 135/285 (47%), Gaps = 47/285 (16%)
Query: 324 ENKLGEGGFGDIYKGTLK-NGK---IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
E +G G FG++ G LK GK VA+K L G + + DF +E ++ H N+I
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
L G ++ +++V EYM N SLD FL + G Q ++ G A G+ YL + +
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFL-RKHDGQFTVIQLVGMLRGIASGMKYLSDMGY 127
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG--YTAPEYAIHG 497
V HRD+ N+L++ +L K++DFGL+R+L ++ T G + +TAPE +
Sbjct: 128 V---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 498 QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL---- 553
+ + D +S+G+++ E++S Y +WE+ ++ +
Sbjct: 185 KFTSASDVWSYGIVMWEVMS----------------------YGERPYWEMSNQDVIKAI 222
Query: 554 -------DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
P +C + ++ L C Q N RP ++V++L
Sbjct: 223 EEGYRLPAPMDC----PAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 79/273 (28%), Positives = 128/273 (46%), Gaps = 36/273 (13%)
Query: 327 LGEGGFGDIYKG-TLKNGKIVAVKKLAI----GISRRTLSDFENEVRLISNVHHRNLIRL 381
LG G FG +Y+G L +G AVK++++ + + E E+ L+S + H N+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 382 LGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTAR---GLAYLHEDF 438
LG + L + E + SL K L +K GS I L T + GL YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLL--KKYGSFPEPV---IRLYTRQILLGLEYLHDR- 121
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEY-AIHG 497
+HRDIK +N+L+D + K+ADFG+A+ + E S F G+ + APE A G
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQG 177
Query: 498 QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRA-WRLYENGTHWELMDESLDPN 556
D +S G VLE+ +G K + A +++ + + P+
Sbjct: 178 GYGLAADIWSLGCTVLEMATG------KPPWSQLEGVAAVFKIGRSKELPPI------PD 225
Query: 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589
+ EA + + L C Q + RPT +E++
Sbjct: 226 HLSDEAKDFI----LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHH---RNLIRLL 382
+G G +G +Y+G + G++VA+K + + +SD + EV L+S + N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
G +GP L ++ EY S+ + K G + K II L Y+H V +
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM---KAGPIAEKYISVIIREVLVALKYIH---KVGV 122
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSE- 501
IHRDIK +N+L+ + K+ DFG+A LL +N S ST F GT + APE G+ +
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITEGKYYDT 181
Query: 502 KVDAYSFGVLVLEIISGT 519
K D +S G+ + E+ +G
Sbjct: 182 KADIWSLGITIYEMATGN 199
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 74/268 (27%), Positives = 126/268 (47%), Gaps = 29/268 (10%)
Query: 326 KLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCC 385
+LG G FG + G + VA+K + G + +F E +++ + H L++L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 386 SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHR 445
++ + +V EYM+N L +L E Q ++ G+AYL + IHR
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 446 DIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHGQLSEKV 503
D+ N L+DD K++DFGL+R + +++ S + +KF + ++ PE ++ + S K
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLYSKFSSKS 182
Query: 504 DAYSFGVLVLEIISGTKSSETKGEEGEYLLK--RAWRLYENGTHWELMDESLDPNECTKE 561
D ++FGVL+ E+ S K + E + K + RLY
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR-----------------PHL 225
Query: 562 AAEKVVEIALMCTQSAANSRPTMSEVVA 589
A+EKV I C A RPT ++++
Sbjct: 226 ASEKVYAIMYSCWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 73/273 (26%), Positives = 131/273 (47%), Gaps = 29/273 (10%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
E KLG G FG+++ T VAVK + G ++ F E ++ + H L++L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHA 68
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
++ P + ++ E+MA SL FL ++ + D A G+A++ + + I
Sbjct: 69 VVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---I 124
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHGQLSE 501
HRD++ +N+L+ L KIADFGLAR++ +N+ + KF + +TAPE G +
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP--IKWTAPEAINFGSFTI 182
Query: 502 KVDAYSFGVLVLEIISGTKSSETKGEEGEYL--LKRAWRLYENGTHWELMDESLDPNECT 559
K D +SFG+L++EI++ + E + L+R +R+
Sbjct: 183 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-----------------P 225
Query: 560 KEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
+ E++ I + C ++ RPT + ++L
Sbjct: 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 34/211 (16%)
Query: 325 NKLGEGGFGDIYKG-TLKNGKIVAVKKLAI-----GISRRTLSDFENEVRLISNVHHRNL 378
++GEG +G +YK K G++VA+KK+ + G + E++L+ + H N+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAI----REIKLLQKLRHPNI 60
Query: 379 IRLLG-CCSQGP-ELILVYEYM-------ANSSLDKFLFGEKRGSLNWKQRFDIILGTAR 429
+RL S+G + +V+EYM +S KF + + + KQ
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM--KQLL-------E 111
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL-PENQSHLSTKFAGTLGY 488
GL YLH I+HRDIK SN+L+++D K+ADFGLAR N + + + TL Y
Sbjct: 112 GLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWY 167
Query: 489 TAPEYAIHG-QLSEKVDAYSFGVLVLEIISG 518
PE + + +VD +S G ++ E+ G
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 67/225 (29%), Positives = 97/225 (43%), Gaps = 46/225 (20%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISN--------VHHRN 377
+GEG F + K K A+K L +R L E +V+ + H
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKIL----DKRQLIK-EKKVKYVKIEKEVLTRLNGHPG 63
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQ-RF---DIILGTARGLAY 433
+I+L L V EY N L +++ K GSL+ K RF +I+L L Y
Sbjct: 64 IIKLYYTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLA----LEY 117
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK------------ 481
LH IIHRD+KP N+LLD D+ KI DFG A++L N S S K
Sbjct: 118 LHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 482 -------FAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGT 519
F GT Y +PE + D ++ G ++ ++++G
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 66/228 (28%), Positives = 110/228 (48%), Gaps = 38/228 (16%)
Query: 317 ATRKFSEENKLGEGGFGDIYKGTL------KNGKIVAVKKLAIGISRRTLSDFENEVRLI 370
+ +F EE LGEG FG +YKG L + VA+K L + +F E L+
Sbjct: 5 SAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELM 62
Query: 371 SNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLF--------------GEKRGSLN 416
S++ H N++ LLG C++ +++EY+A+ L +FL + SL+
Sbjct: 63 SDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLD 122
Query: 417 WKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL----- 471
I + A G+ YL +HRD+ N L+ + L KI+DFGL+R +
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY 179
Query: 472 --PENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS 517
+++S L + + PE ++G+ + + D +SFGV++ EI S
Sbjct: 180 YRVQSKSLLPVR------WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 85/282 (30%), Positives = 116/282 (41%), Gaps = 44/282 (15%)
Query: 326 KLGEGGFGDIYKGTLKN--GKI--VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRL 381
KLG+G FG + +G GK+ VAVK L + DF E ++ ++ H NLIRL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 382 LGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVR 441
G P L++V E SL L + G D + A G+ YL R
Sbjct: 62 YGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---R 117
Query: 442 IIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN------QSHLSTKFAGTLGYTAPEYAI 495
IHRD+ N+LL D + KI DFGL R LP+N + HL FA + APE
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA----WCAPESLR 173
Query: 496 HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE------GEYLLKRAWRLYENGTHWELM 549
S D + FGV + E+ T GEE G +LK+ + E
Sbjct: 174 TRTFSHASDVWMFGVTLWEMF-------TYGEEPWAGLSGSQILKKIDKEGERLER---- 222
Query: 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
P C + + + L C RPT + + L
Sbjct: 223 -----PEAC----PQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 6/200 (3%)
Query: 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAI-GISRRTLSDFENEVRLISNVHHRNL 378
F NK+G+G FG ++K K + ++ A+K++ + ++RR + +E R+++ + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
IR +L +V EY N L K L ++ L Q + + GLA+LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK- 120
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ 498
+I+HRDIK N+ LD KI D G+A+LL +N ++ + GT Y +PE
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN-TNFANTIVGTPYYLSPELCEDKP 177
Query: 499 LSEKVDAYSFGVLVLEIISG 518
+EK D ++ GV++ E +G
Sbjct: 178 YNEKSDVWALGVVLYECCTG 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 79/282 (28%), Positives = 126/282 (44%), Gaps = 33/282 (11%)
Query: 327 LGEGGFGDIYKGTLKN------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIR 380
LG+G FG +Y+G K VA+K + S R +F NE ++ + +++R
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 381 LLGCCSQGPELILVYEYMANSSLDKFL--------FGEKRGSLNWKQRFDIILGTARGLA 432
LLG S G ++V E MA L +L G ++ + A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAP 491
YL + +HRD+ N ++ +DL KI DFG+ R + E + K + + AP
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 492 EYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551
E G + K D +SFGV++ E+ + +G E +L + +G H +L
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT-LAEQPYQGLSNEEVL----KFVIDGGHLDL--- 242
Query: 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
P C +K++E+ MC Q RPT E+V+ LK
Sbjct: 243 ---PENC----PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 62/195 (31%), Positives = 98/195 (50%), Gaps = 7/195 (3%)
Query: 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
+LG G G + K + GKI+AVK + + I+ E+ ++ + ++ G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
++ + EYM SLDK L E +G + + I + +GL YLHE II
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKIL-KEVQGRIPERILGKIAVAVLKGLTYLHEKHK--II 123
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKV 503
HRD+KPSN+L++ Q K+ DFG++ L + L+ F GT Y APE S K
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTSSYMAPERIQGNDYSVKS 180
Query: 504 DAYSFGVLVLEIISG 518
D +S G+ ++E+ +G
Sbjct: 181 DIWSLGLSLIELATG 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 81/295 (27%), Positives = 132/295 (44%), Gaps = 64/295 (21%)
Query: 327 LGEGGFGDI----YKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRL 381
LG+G FG + Y N G++VAVKKL + L DFE E+ ++ ++ H N+++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 382 LGCC-SQG-PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFD---IILGTA---RGLAY 433
G C S G L LV EY+ SL +L ++R D ++L + +G+ Y
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYL-------QKHRERLDHRKLLLYASQICKGMEY 123
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT--LGYTAP 491
L R +HRD+ N+L++ + + KI DFGL ++LP+++ + + G + + AP
Sbjct: 124 LGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180
Query: 492 EYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEY-------------------L 532
E + S D +SFGV++ E+ T S ++ E+ L
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELF--TYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238
Query: 533 LKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
LK RL P C E + I C + + RP+ SE+
Sbjct: 239 LKNNGRLPA-------------PPGCPAE----IYAIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 81/290 (27%), Positives = 127/290 (43%), Gaps = 47/290 (16%)
Query: 327 LGEGGFGDIYKGTLKNGK------IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIR 380
LGEG FG + K T K VAVK L S L D +E L+ V+H ++I+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 381 LLGCCSQGPELILVYEYMANSSLDKFL----------------------FGEKRGSLNWK 418
L G CSQ L+L+ EY SL FL +L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 419 QRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478
+RG+ YL E ++++HRD+ NVL+ + + KI+DFGL+R + E S++
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 479 S-TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAW 537
+K + + A E + + D +SFGVL+ EI++ + G E R +
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-LGGNPYPGIAPE----RLF 239
Query: 538 RLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
L + G E P C+ E++ + L C + + RPT +++
Sbjct: 240 NLLKTGYRME------RPENCS----EEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 68/224 (30%), Positives = 112/224 (50%), Gaps = 27/224 (12%)
Query: 315 VSATRKFSEENKLGEGGFGDIYKGTL-----KNGKIVAVKKLAIGISRRTLSDFENEVRL 369
+SA R F EE LGE FG IYKG L + ++VA+K L + + +F+ E L
Sbjct: 4 LSAVR-FMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 370 ISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLF---------------GEKRGS 414
++ +HH N++ LLG +Q + +++EY+ L +FL G + S
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 415 LNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR-LLPE 473
L+ I + A G+ YL F +H+D+ N+L+ + L KI+D GL+R +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS 517
+ + K + + PE ++G+ S D +SFGV++ EI S
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 326 KLGEGGFGDIYKGTLKN-GKIVAVKKLAIG----ISRRTLSDFENEVRLISNVHHRNLIR 380
+GEG +G + K K G+IVA+KK ++T EV+++ + H N++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL---REVKVLRQLRHENIVN 64
Query: 381 LLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
L + L LV+EY+ + L+ L G L I + +AY H
Sbjct: 65 LKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIAYCHSH--- 119
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI-HGQL 499
IIHRDIKP N+L+ + K+ DFG AR L + T + T Y APE +
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179
Query: 500 SEKVDAYSFGVLVLEIISG 518
+ VD ++ G ++ E++ G
Sbjct: 180 GKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 320 KFSEENKLGEGGFGDIYKG-TLKNGKIVAVK--KLAIGISRRTLSDFENEVRLISNVHHR 376
+ ++G G +GD+YK + G++VA+K KL G + E+ ++ H
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHP 60
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE 436
N++ G + +L +V EY SL ++ RG L+ Q + T +GLAYLHE
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYA-- 494
IHRDIK +N+LL +D K+ADFG++ L + + F GT + APE A
Sbjct: 120 ---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS-FIGTPYWMAPEVAAV 175
Query: 495 -IHGQLSEKVDAYSFGVLVLE 514
G K D ++ G+ +E
Sbjct: 176 ERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 71/268 (26%), Positives = 125/268 (46%), Gaps = 33/268 (12%)
Query: 327 LGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCS 386
LG+G FG+++KGTLK+ VAVK + + F +E R++ H N+++L+G C+
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 387 QGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRD 446
Q + +V E + FL +K+ L KQ L A G+AYL IHRD
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRD 118
Query: 447 IKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAY 506
+ N L+ ++ KI+DFG++R + S + +TAPE +G+ S + D +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178
Query: 507 SFGVLVLEIIS-------GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECT 559
S+G+L+ E S G + + + + +++ +R+ C
Sbjct: 179 SYGILLWETFSLGVCPYPGMTNQQAREQ-----VEKGYRM-----------------SCP 216
Query: 560 KEAAEKVVEIALMCTQSAANSRPTMSEV 587
++ + V ++ C +RP SE+
Sbjct: 217 QKCPDDVYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 77/278 (27%), Positives = 123/278 (44%), Gaps = 35/278 (12%)
Query: 329 EGGFGDIYKGTLKNGKI-----VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
EG FG I+ G L + K V VK + S ++ E L+ + H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 384 CCSQGPELILV-YEYMANSSLDKFL----FGEKRG--SLNWKQRFDIILGTARGLAYLHE 436
C + E V Y YM +L FL GE +L+ +Q + + A G++YLH+
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR-LLPENQSHLSTKFAGTLGYTAPEYAI 495
+IH+DI N ++D++LQ KI D L+R L P + L + + A E +
Sbjct: 136 ---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192
Query: 496 HGQLSEKVDAYSFGVLVLEIIS--GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553
+ + S D +SFGVL+ E+++ T E E LK +RL +
Sbjct: 193 NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ------------ 240
Query: 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
P C E + + C RP+ S++V L
Sbjct: 241 -PINCPDE----LFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 325 NKLGEGGFGDIYKG-TLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
+G G +Y L N + VA+K++ + + ++ + EV+ +S +H N+++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 384 CCSQGPELILVYEYMANSS-LDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
G EL LV Y++ S LD RG L+ ++ +GL YLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPEN---QSHLSTKFAGTLGYTAPE--YAIHG 497
IHRDIK N+LL +D KIADFG++ L + + F GT + APE +HG
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 498 QLSEKVDAYSFGVLVLEIISGT 519
K D +SFG+ +E+ +G
Sbjct: 184 -YDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 30/221 (13%)
Query: 324 ENKLGEGGFGDIYKGTL------KNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN 377
+G+G FG +++ + +VAVK L S +DF+ E L++ H N
Sbjct: 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFL--------------------FGEKRGSLNW 417
+++LLG C+ G + L++EYMA L++FL G L+
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 418 KQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR-LLPENQS 476
++ I A G+AYL E + +HRD+ N L+ +++ KIADFGL+R + +
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS 517
S A + + PE + + + + D +++GV++ EI S
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 82/296 (27%), Positives = 133/296 (44%), Gaps = 54/296 (18%)
Query: 324 ENKLGEGGFGDIYKGT------LKNGKIVAVKKLA-IGISRRTLSDFENEVRLISNVHHR 376
+ +LGEG FG ++ K+ +VAVK L ++ R DF+ E L++N+ H
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHE 67
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSLDKFLFG--------------EKRGSLNWKQRFD 422
++++ G C G LI+V+EYM + L+KFL + +G L Q
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 423 IILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKF 482
I A G+ YL +HRD+ N L+ +L KI DFG++R + ST +
Sbjct: 128 IASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDV------YSTDY 178
Query: 483 AGTLGYT-------APEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKR 535
G+T PE ++ + + + D +SFGV++ EI T G++ + L
Sbjct: 179 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF-------TYGKQPWFQLSN 231
Query: 536 AWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
+ E T +++ P C KE V +I L C Q R + E+ +L
Sbjct: 232 T-EVIECITQGRVLER---PRVCPKE----VYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 3e-23
Identities = 69/207 (33%), Positives = 113/207 (54%), Gaps = 20/207 (9%)
Query: 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
F + KLGEG + +YKG + G+IVA+K++ + T S E+ L+ + H N++
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFL--FGEKRGSLNWKQRFDIILGTARGLAYLHED 437
RL +L+LV+EYM L K++ G RG+L+ +G+A+ HE+
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKD-LKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL--LPENQSHLSTKFAG---TLGYTAPE 492
R++HRD+KP N+L++ + K+ADFGLAR +P N F+ TL Y AP+
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN------TFSNEVVTLWYRAPD 170
Query: 493 YAIHGQL-SEKVDAYSFGVLVLEIISG 518
+ + S +D +S G ++ E+I+G
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 4e-23
Identities = 73/271 (26%), Positives = 124/271 (45%), Gaps = 31/271 (11%)
Query: 326 KLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCC 385
+LG G FG ++ G + VA+K AI + DF E +++ + H L++L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIK--AINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 386 SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHR 445
+Q L +V E+M N L +L +++G L+ + G+ YL + IHR
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHR 124
Query: 446 DIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHGQLSEKV 503
D+ N L+ K++DFG+ R + +++ S KF + ++ PE + S K
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFP--VKWSPPEVFNFSKYSSKS 182
Query: 504 DAYSFGVLVLEIISGTK---SSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTK 560
D +SFGVL+ E+ + K ++ E E ++ R +RLY K
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEVVE-MISRGFRLYR-----------------PK 224
Query: 561 EAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
A+ V E+ C RPT +E++ +
Sbjct: 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 5e-23
Identities = 66/278 (23%), Positives = 114/278 (41%), Gaps = 30/278 (10%)
Query: 327 LGEGGFGDIYKGTLKNG------KIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIR 380
LG G FG+++ K +V VK L S+F E+ + + H+N++R
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 381 LLGCCSQGPELILVYEYMANSSLDKFLFGEKRGS-------LNWKQRFDIILGTARGLAY 433
LLG C + ++ EY L +FL K L+ KQ+ + A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEY 493
L + R +HRD+ N L+ + K++ L++ + ++ + L + APE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 494 AIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553
S K D +SFGVL+ E+ + + + E L RL +
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN----RLQAGKLELPV----- 240
Query: 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
P C ++ ++ C RP+ SE+V+ L
Sbjct: 241 -PEGC----PSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 73/213 (34%), Positives = 108/213 (50%), Gaps = 32/213 (15%)
Query: 321 FSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAI-----GISRRTLSDFENEVRL---IS 371
+ E ++GEG +G +YK L G+ VA+KK+ + GI TL E+ L +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL----REIALLKQLE 56
Query: 372 NVHHRNLIRLLGCCSQGPE------LILVYEYMANSSLDKFLFGEK---RGSLNWKQRFD 422
+ H N++RLL C GP L LV+E++ + L +L K G + D
Sbjct: 57 SFEHPNIVRLLDVC-HGPRTDRELKLTLVFEHV-DQDLATYL--SKCPKPGLPPETIK-D 111
Query: 423 IILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKF 482
++ RG+ +LH RI+HRD+KP N+L+ D Q KIADFGLAR+ + L T
Sbjct: 112 LMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEMAL-TSV 166
Query: 483 AGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEI 515
TL Y APE + + VD +S G + E+
Sbjct: 167 VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 17/212 (8%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFE-----NEVRLISNV 373
+ +G+G FG + K K+ GKI+ K+ I +++ E +EV ++ +
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKE----IDYGNMTEKEKQQLVSEVNILREL 56
Query: 374 HHRNLIRLLG--CCSQGPELILVYEYMANSSLDKFL--FGEKRGSLNWKQRFDIILGTAR 429
H N++R L +V EY L + + ++R + + + I+
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 430 GLAYLH--EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG 487
L H D ++HRD+KP+N+ LD + K+ DFGLA++L + S T + GT
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPY 175
Query: 488 YTAPEYAIHGQLSEKVDAYSFGVLVLEIISGT 519
Y +PE H EK D +S G L+ E+ + +
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 9e-23
Identities = 68/201 (33%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 321 FSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRN 377
F++ ++G G FG +Y ++ ++VA+KK++ S D EVR + + H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
I GC + LV EY S+ D + + L + I G +GLAYLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQEVEIAAICHGALQGLAYLHS- 133
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI-- 495
H RI HRDIK N+LL + K+ADFG A L+ S F GT + APE +
Sbjct: 134 -HERI-HRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTPYWMAPEVILAM 186
Query: 496 -HGQLSEKVDAYSFGVLVLEI 515
GQ KVD +S G+ +E+
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 9e-23
Identities = 76/269 (28%), Positives = 132/269 (49%), Gaps = 30/269 (11%)
Query: 327 LGEGGFGDIYKGT-LKNG---KI-VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRL 381
LG G FG ++KG + G KI VA+K + R+T + + + + ++ H ++RL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 382 LGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVR 441
LG C G L LV + SL + + R SL+ ++ + + A+G+ YL E R
Sbjct: 75 LGICP-GASLQLVTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQIAKGMYYLEEH---R 129
Query: 442 IIHRDIKPSNVLLDDDLQPKIADFGLARLL-PENQSHLSTKFAGTLGYTAPEYAIHGQLS 500
++HR++ N+LL D +IADFG+A LL P+++ + ++ + + A E + G+ +
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189
Query: 501 EKVDAYSFGVLVLEIIS--GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558
+ D +S+GV V E++S + + E LL++ RL + P C
Sbjct: 190 HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ-------------PQIC 236
Query: 559 TKEAAEKVVEIALMCTQSAANSRPTMSEV 587
T + V + + C N RPT E+
Sbjct: 237 TID----VYMVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 327 LGEGGFGDIYKG-TLKNGKIVAVKKL---AIGIS-----RRTLSDFENEVRLISNVHHRN 377
+G G FG +Y G +G+++AVK++ ++ S R L E+ L+ + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
+++ LG L + EY+ S+ L G+ + + +GL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK-------FAGTLGYTA 490
IIHRDIK +N+L+D+ KI+DFG+++ L N LSTK G++ + A
Sbjct: 126 ---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANS--LSTKTNGARPSLQGSVFWMA 180
Query: 491 PEYAIHGQLSEKVDAYSFGVLVLEIISGT 519
PE + K D +S G LV+E+++G
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 72/210 (34%), Positives = 106/210 (50%), Gaps = 23/210 (10%)
Query: 327 LGEGGFGDIYKGTLKN------GKI-VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
LG G FG++Y+GT + G I VAVK L G + + +F E L+SN +H N++
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGS-----LNWKQRFDIILGTARGLAYL 434
+LLG C ++ E M L +L + L K+ DI L A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 435 HEDFHVRIIHRDIKPSNVLL-----DDDLQPKIADFGLARLLPENQSHLSTKFAGTLG-- 487
E H IHRD+ N L+ D D KI DFGLAR + ++ + + G L
Sbjct: 123 -EQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS-DYYRKEGEGLLPVR 178
Query: 488 YTAPEYAIHGQLSEKVDAYSFGVLVLEIIS 517
+ APE + G+ + + D +SFGVL+ EI++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 8/201 (3%)
Query: 319 RKFSEENKLGEGGFGDIYKGTLKNGK-IVAVKKLAIGISRRTLSDFENEVRLISNVHHRN 377
F++ ++G+G FG++YKG K +VA+K + + + + D + E+ ++S
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
+ R G +G +L ++ EY+ S L K G L I+ +GL YLH +
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSE 120
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG 497
R IHRDIK +NVLL + K+ADFG+A L + Q +T F GT + APE
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQS 176
Query: 498 QLSEKVDAYSFGVLVLEIISG 518
K D +S G+ +E+ G
Sbjct: 177 AYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 326 KLGEGGFGDIYKG-TLKNGKIVAVKKLAIGISRRTLSDFEN-------EVRLISNVHHRN 377
K+GEG +G +YK G+IVA+KK+ R ++ E E+ L+ ++H N
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKI------RLETEDEGVPSTAIREISLLKELNHPN 59
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
++RLL +L LV+E++ + L K++ L+ + +G+AY H
Sbjct: 60 IVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL--LPENQSHLSTKFAGTLGYTAPEYAI 495
R++HRD+KP N+L+D + K+ADFGLAR +P T TL Y APE +
Sbjct: 119 ---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT---YTHEVVTLWYRAPEILL 172
Query: 496 HG-QLSEKVDAYSFGVLVLEII 516
Q S VD +S G + E++
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 78/299 (26%), Positives = 131/299 (43%), Gaps = 45/299 (15%)
Query: 326 KLGEGGFGDIY------------KGTLKNGK-----IVAVKKLAIGISRRTLSDFENEVR 368
KLGEG FG+++ K +N +VAVK L S DF EV+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 369 LISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFL----FGEKRGSLNWKQ----- 419
++S + N+ RLLG C+ P L ++ EYM N L++FL + N K
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 420 RFDIILGTARGLAYLHE-DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478
+ A G+ YL +F +HRD+ N L+ + KIADFG++R L + +
Sbjct: 132 LLYMATQIASGMRYLESLNF----VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY- 186
Query: 479 STKFAGT----LGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLK 534
+ G + + A E + G+ + K D ++FGV + EI++ + + + +++
Sbjct: 187 --RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIE 244
Query: 535 RAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
A + + + P C K+ + E+ L C + RPT E+ L+
Sbjct: 245 NAGHFFRDDGRQIYLPR---PPNCPKD----IYELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 67/237 (28%), Positives = 101/237 (42%), Gaps = 28/237 (11%)
Query: 328 GEGGFGDIYKGTLK-NGKIVAVK---KLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
G+G FG + + K+ A+K K + + ++ + NE R++ ++H L+ L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFD------IILGTARGLAYLHED 437
+ LV + + L G+ R L+ K +F I L YLH
Sbjct: 68 SFQDEENMYLVVDLL--------LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG 497
IIHRDIKP N+LLD+ I DF +A + + L+T +GT GY APE
Sbjct: 120 ---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQ 174
Query: 498 QLSEKVDAYSFGVLVLEIISGT----KSSETKGEEGEYLLKRAWRLYENGTHWELMD 550
S VD +S GV E + G S T ++ + A LY E +D
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAID 231
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-22
Identities = 87/293 (29%), Positives = 128/293 (43%), Gaps = 48/293 (16%)
Query: 327 LGEGGFGDIYKGTL--------KNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRN 377
LGEG FG + + VAVK L + + L+D +E+ L+ + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEK--------------RGSLNWKQRFDI 423
+I LLG C+Q L ++ EY A +L +FL + L++K
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 424 ILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFA 483
ARG+ YL R IHRD+ NVL+ +D KIADFGLAR + + + T
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS-N 195
Query: 484 GTL--GYTAPEYAIHGQLSEKVDAYSFGVLVLEI--ISGTKSSETKGEEGEYLLKRAWRL 539
G L + APE + + D +SFG+L+ EI + G+ EE LL+ R
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR- 254
Query: 540 YENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
MD+ P+ CT E + E C + RPT ++V L
Sbjct: 255 ---------MDK---PSNCTHELYMLMRE----CWHAVPTQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 3e-22
Identities = 80/297 (26%), Positives = 132/297 (44%), Gaps = 47/297 (15%)
Query: 324 ENKLGEGGFGDIYKGTLKN-----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
+ +LGEG FG ++ N KI+ K S DF E L++N+ H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLF-----------GEKRGSLNWKQRFDIILGT 427
++ G C +G LI+V+EYM + L+KFL G + L Q I
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 428 ARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG 487
A G+ YL +HRD+ N L+ ++L KI DFG++R + ST + G
Sbjct: 130 AAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDV------YSTDYYRVGG 180
Query: 488 YT-------APEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLY 540
+T PE ++ + + + D +S GV++ EI T G++ Y L +
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF-------TYGKQPWYQLSNN-EVI 232
Query: 541 ENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSS 597
E T ++ P C KE V ++ L C Q + R + E+ +LL++ + +
Sbjct: 233 ECITQGRVLQR---PRTCPKE----VYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 72/218 (33%), Positives = 108/218 (49%), Gaps = 41/218 (18%)
Query: 321 FSEENKLGEGGFGDIYKG-TLKNGKIVAVKKLAI-----GISRRTLSDFENEVRLISNVH 374
F + N++GEG +G +Y+ +G+IVA+KK+ + GI +L E+ L+ N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL----REITLLLNLR 64
Query: 375 HRNLIRLLGCC--SQGPELILVYEY----MANSSLDKFLFGEKRGSLNWKQRFD------ 422
H N++ L + LV EY +A S LD N F
Sbjct: 65 HPNIVELKEVVVGKHLDSIFLVMEYCEQDLA-SLLD-----------NMPTPFSESQVKC 112
Query: 423 IILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKF 482
++L RGL YLHE+F IIHRD+K SN+LL D KIADFGLAR ++ K
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169
Query: 483 AGTLGYTAPEYAIHGQL--SEKVDAYSFGVLVLEIISG 518
TL Y APE + G + +D ++ G ++ E+++
Sbjct: 170 V-TLWYRAPELLL-GCTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 8e-22
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFEN----EVRLISNVHH 375
K E ++LGEG G + K LKN ++ K I+ D + E+ + +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKT---ITTDPNPDLQKQILRELEINKSCKS 58
Query: 376 RNLIRLLGCC--SQGPELILVYEYMANSSLDKFLFGEKR---GSLNWKQRFDIILGTARG 430
+++ G + + EY SLD ++ + + G + K I +G
Sbjct: 59 PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
L+YLH +IIHRDIKPSN+LL Q K+ DFG++ E + L+ F GT Y A
Sbjct: 118 LSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSLAGTFTGTSFYMA 171
Query: 491 PEYAIHGQLSEKVDAYSFGVLVLEIISG 518
PE S D +S G+ +LE+
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 9e-22
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 36/218 (16%)
Query: 326 KLGEGGFGDIYKGTLKN------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+LGEG FG ++ N +VAVK L S DF+ E L++ + H++++
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTVLQHQHIV 70
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLF-------------GEKRGSLNWKQRFDIILG 426
R G C++G L++V+EYM + L++FL G L Q I
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 427 TARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTL 486
A G+ YL + +HRD+ N L+ L KI DFG++R + ST +
Sbjct: 131 IASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI------YSTDYYRVG 181
Query: 487 GYT-------APEYAIHGQLSEKVDAYSFGVLVLEIIS 517
G T PE ++ + + + D +SFGV++ EI +
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 1e-21
Identities = 65/201 (32%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 324 ENKLGEGGFGDIYKGTLK-NGK---IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
E LG G FG++ +G LK K VA+ L G S + F E + H N++
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
RL G ++G +++V EYM+N +LD FL + G L Q ++ G A G+ YL E
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMGMLPGLASGMKYLSE--- 125
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH-LSTKFAG--TLGYTAPEYAIH 496
+ +H+ + VL++ DL KI+ F R L E++S + T +G + + APE +
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 497 GQLSEKVDAYSFGVLVLEIIS 517
S D +SFG+++ E++S
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 23/202 (11%)
Query: 326 KLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFE-----NEVR-LISNVHHRNL 378
+LG+G FG +Y + G++VA+KK+ ++ +E EV+ L H N+
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-----KKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED- 437
++L + EL V+EYM +L + + K + II +GLA++H+
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 438 -FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH 496
FH RD+KP N+L+ KIADFGLAR + ++ T + T Y APE +
Sbjct: 120 FFH-----RDLKPENLLVSGPEVVKIADFGLAREI-RSRPPY-TDYVSTRWYRAPEILLR 172
Query: 497 GQL-SEKVDAYSFGVLVLEIIS 517
S VD ++ G ++ E+ +
Sbjct: 173 STSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 1e-21
Identities = 88/308 (28%), Positives = 138/308 (44%), Gaps = 51/308 (16%)
Query: 326 KLGEGGFGDIYKGTLKN---GKI---VAVKKLAIGISRRTLSDFENEVRLIS--NVHHRN 377
+LG+G FG +Y+G ++ G+ VAVK + S R +F NE ++ HH
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH-- 70
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLN--------WKQRFDIILGTAR 429
++RLLG S+G ++V E MA+ L +L + + N ++ + A
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS-TKFAGTLGY 488
G+AYL+ + +HRD+ N ++ D KI DFG+ R + E + K + +
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 489 TAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWEL 548
APE G + D +SFGV++ E I+ +G E +LK +
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVLKF------------V 234
Query: 549 MD-ESLD-PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNKPLLK 606
MD LD P+ C E+V ++ MC Q RPT E+V LLK L
Sbjct: 235 MDGGYLDQPDNC----PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD----------LH 280
Query: 607 PTFVETDY 614
P+F E +
Sbjct: 281 PSFPEVSF 288
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAI--GISRRTLSDFENEVRLISNVH 374
F E K+G+G F +YK L +G++VA+KK+ I + + D E+ L+ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFL--FGEKRGSLNWKQRFDIILGTARGLA 432
H N+I+ L + EL +V E L + + F +++ + + + + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPE 492
++H RI+HRDIKP+NV + K+ D GL R + + GT Y +PE
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPE 176
Query: 493 YAIHGQ-LSEKVDAYSFGVLVLEI 515
IH + K D +S G L+ E+
Sbjct: 177 -RIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 57/195 (29%), Positives = 89/195 (45%), Gaps = 12/195 (6%)
Query: 327 LGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCS 386
LG+G FG +YK K + A K+ S L DF E+ ++S H N++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 387 QGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRD 446
+L ++ E+ +LD + +RG L Q + L +LH +IHRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSHK---VIHRD 128
Query: 447 IKPSNVLLDDDLQPKIADFGL-ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSE---- 501
+K N+LL D K+ADFG+ A+ Q + F GT + APE +
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPYD 186
Query: 502 -KVDAYSFGVLVLEI 515
K D +S G+ ++E+
Sbjct: 187 YKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 73/223 (32%), Positives = 97/223 (43%), Gaps = 48/223 (21%)
Query: 325 NKLGEGGFGDIYKGTLKNGKI------VAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
LG G FG++Y+G + VAVK L S + SDF E ++S +H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 379 IRLLGCCSQG-PELILVYEYMANSSLDKFLFGEKR------GSLNWKQRFDIILGTARGL 431
+RL+G + P IL+ E MA L FL E R SL K A+G
Sbjct: 72 VRLIGVSFERLPRFILL-ELMAGGDLKSFL-RENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 432 AYLHEDFHVRIIHRDIKPSNVLLDD---DLQPKIADFGLAR--------------LLPEN 474
YL E+ IHRDI N LL KIADFG+AR +LP
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP-- 184
Query: 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS 517
+ + PE + G + K D +SFGVL+ EI S
Sbjct: 185 -----------IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 2e-21
Identities = 73/292 (25%), Positives = 143/292 (48%), Gaps = 27/292 (9%)
Query: 311 LKDLVSATRKFSEENKLGEGGFGDIYKG-TLKNGKIVAVKKLAIGISRRTLSDFENEVRL 369
+ D++S+ + EEN + G G YKG ++KNG VK++ S +E+
Sbjct: 685 INDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEI-----NDVNSIPSSEIAD 736
Query: 370 ISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTAR 429
+ + H N+++L+G C L++EY+ +L + L L+W++R I +G A+
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAK 791
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYT 489
L +LH ++ ++ P +++D +P L LP + F + Y
Sbjct: 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH-----LRLSLPGLLCTDTKCFISS-AYV 845
Query: 490 APEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWEL- 548
APE ++EK D Y FG++++E+++G ++ + +++ A Y + H ++
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD-CHLDMW 904
Query: 549 MDESLDPNECTKEAAEKVVEI---ALMCTQSAANSRPTMSEVVALLKSTSSS 597
+D S+ + + ++VE+ AL CT + +RP ++V+ L+S S S
Sbjct: 905 IDPSIRGDVSVNQ--NEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954
|
Length = 968 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 87/289 (30%), Positives = 125/289 (43%), Gaps = 48/289 (16%)
Query: 327 LGEGGFGD--------IYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRN 377
LGEG FG I K VAVK L + + LSD +E+ ++ + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEK--------------RGSLNWKQRFDI 423
+I LLG C+Q L ++ EY + +L ++L + L +K
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 424 ILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFA 483
ARG+ YL + IHRD+ NVL+ +D KIADFGLAR + N +
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDV-HNIDYYKKTTN 195
Query: 484 GTL--GYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS--GTKSSETKGEEGEYLLKRAWRL 539
G L + APE + + D +SFGVL+ EI + G+ EE LLK R
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR- 254
Query: 540 YENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVV 588
MD+ P CT E + I C + + RPT ++V
Sbjct: 255 ---------MDK---PANCTHE----LYMIMRECWHAVPSQRPTFKQLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 86/291 (29%), Positives = 127/291 (43%), Gaps = 52/291 (17%)
Query: 327 LGEGGFGDIY--------KGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRN 377
LGEG FG + K K VAVK L + + LSD +E+ ++ + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDI-------------- 423
+I LLG C+Q L ++ EY + +L ++L R + +DI
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYL--RARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 424 --ILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK 481
ARG+ YL + IHRD+ NVL+ ++ KIADFGLAR + N +
Sbjct: 141 SCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDV-NNIDYYKKT 196
Query: 482 FAGTL--GYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS--GTKSSETKGEEGEYLLKRAW 537
G L + APE + + D +SFGVL+ EI + G+ EE LLK
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH 256
Query: 538 RLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVV 588
R MD+ P CT E + + C + + RPT ++V
Sbjct: 257 R----------MDK---PANCTNELYMMMRD----CWHAIPSHRPTFKQLV 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 12/202 (5%)
Query: 321 FSEENKLGEGGFGDIYKG-TLKNGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNL 378
F + K+GEG +G +YK G++VA+KK+ + + S E+ L+ ++H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
++LL +L LV+E++ + L KF+ + + +GLA+ H
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS-- 118
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARL--LPENQSHLSTKFAGTLGYTAPEYAIH 496
H R++HRD+KP N+L++ + K+ADFGLAR +P T TL Y APE +
Sbjct: 119 H-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPEILLG 174
Query: 497 GQL-SEKVDAYSFGVLVLEIIS 517
+ S VD +S G + E+++
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-21
Identities = 58/199 (29%), Positives = 103/199 (51%), Gaps = 8/199 (4%)
Query: 321 FSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
F++ ++G+G FG+++KG + ++VA+K + + + + D + E+ ++S +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
+ G +G +L ++ EY+ S L + G + Q ++ +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLL---RAGPFDEFQIATMLKEILKGLDYLHSE-- 120
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL 499
+ IHRDIK +NVLL + K+ADFG+A L + Q +T F GT + APE
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIQQSAY 178
Query: 500 SEKVDAYSFGVLVLEIISG 518
K D +S G+ +E+ G
Sbjct: 179 DSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 8/199 (4%)
Query: 321 FSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
F++ K+G+G FG+++KG + K+VA+K + + + + D + E+ ++S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
+ G + +L ++ EY+ S L + G L+ Q I+ +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSE-- 120
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL 499
+ IHRDIK +NVLL + + K+ADFG+A L + Q F GT + APE
Sbjct: 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQSAY 178
Query: 500 SEKVDAYSFGVLVLEIISG 518
K D +S G+ +E+ G
Sbjct: 179 DSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 85/300 (28%), Positives = 130/300 (43%), Gaps = 54/300 (18%)
Query: 327 LGEGGFGDIYKGTL------KNGKI--VAVKKLAIGISRRTLSDFENEVRLISNV-HHRN 377
LGEG FG + K ++ VAVK L + + LSD +E+ ++ + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNW--------------KQRFDI 423
+I LLG C+Q L ++ EY + +L ++L + + + K
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 424 ILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFA 483
ARG+ YL + IHRD+ NVL+ +D KIADFGLAR + H+
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 198
Query: 484 GTLG-----YTAPEYAIHGQLSEKVDAYSFGVLVLEI--ISGTKSSETKGEEGEYLLKRA 536
T G + APE + + D +SFGVL+ EI + G+ EE LLK
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 258
Query: 537 WRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSS 596
R MD+ P+ CT E + + C + + RPT ++V L +
Sbjct: 259 HR----------MDK---PSNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDLDRILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 311 LKDLVSATR---KFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENE 366
L+ +V K+GEG G + T K+ G+ VAVKK+ + +R F NE
Sbjct: 8 LQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-NE 66
Query: 367 VRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILG 426
V ++ + H N++ + G EL +V E++ +L + +N +Q + L
Sbjct: 67 VVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLA 123
Query: 427 TARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFG----LARLLPENQSHLSTKF 482
+ L++LH +IHRDIK ++LL D + K++DFG +++ +P +S
Sbjct: 124 VLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS-----L 175
Query: 483 AGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
GT + APE +VD +S G++V+E++ G
Sbjct: 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-20
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 321 FSEENK---LGEGGFGDIYKG-TLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHR 376
+ E + LG+G +G +Y L +A+K++ SR E E+ L S + HR
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE-EIALHSYLKHR 65
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTAR---GLAY 433
N+++ LG S+ + E + SL L K G L ++ II T + GL Y
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSA-LLRSKWGPLKDNEQ-TIIFYTKQILEGLKY 123
Query: 434 LHEDFHVRIIHRDIKPSNVLLDD-DLQPKIADFG----LARLLPENQSHLSTKFAGTLGY 488
LH++ +I+HRDIK NVL++ KI+DFG LA + P ++ F GTL Y
Sbjct: 124 LHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-----FTGTLQY 175
Query: 489 TAPEYAIHGQ--LSEKVDAYSFGVLVLEIISG 518
APE G D +S G ++E+ +G
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATG 207
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 57/184 (30%), Positives = 87/184 (47%), Gaps = 32/184 (17%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-----HHRNLIR 380
+GEG +G +YK K G++VA+K + I + D E E++ N+ +H N+
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDI------IEDEEEEIKEEYNILRKYSNHPNIAT 67
Query: 381 LLGC------CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFD------IILGTA 428
G +L LV E S+ + +G +R I+ T
Sbjct: 68 FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV----KGLRKKGKRLKEEWIAYILRETL 123
Query: 429 RGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGY 488
RGLAYLHE+ ++IHRDIK N+LL + + K+ DFG++ L +T F GT +
Sbjct: 124 RGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT-FIGTPYW 179
Query: 489 TAPE 492
APE
Sbjct: 180 MAPE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 68/215 (31%), Positives = 107/215 (49%), Gaps = 35/215 (16%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFEN-------EVRLIS 371
+++ K+GEG +G +YKG K G+IVA+KK+ R S+ E E+ L+
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI------RLESEEEGVPSTAIREISLLK 54
Query: 372 NVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTA--- 428
+ H N++ L Q L L++E+++ L K+L SL Q D L +
Sbjct: 55 ELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYL-----DSLPKGQYMDAELVKSYLY 108
Query: 429 ---RGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL--LPENQSHLSTKFA 483
+G+ + H R++HRD+KP N+L+D+ K+ADFGLAR +P + T
Sbjct: 109 QILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---VRVYTHEV 162
Query: 484 GTLGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIIS 517
TL Y APE + S VD +S G + E+ +
Sbjct: 163 VTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 30/222 (13%)
Query: 306 PVNYRLKDLVSATRKFSEENKLGEGGFGDIYKG-TLKNGKIVAVKKLAIGIS----RRTL 360
P N+R L LG+G FG +Y + G+ +AVK++ ++ +
Sbjct: 1 PTNWRRGKL------------LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEV 48
Query: 361 SDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFL--FGEKRGSLNWK 418
+ E E++L+ N+ H +++ GC L + EYM S+ L +G ++ K
Sbjct: 49 NALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK 108
Query: 419 QRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478
I+ G+ YLH + I+HRDIK +N+L D K+ DFG ++ L S
Sbjct: 109 YTRQIL----EGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161
Query: 479 S--TKFAGTLGYTAPEYAIHGQ-LSEKVDAYSFGVLVLEIIS 517
+ GT + +PE I G+ K D +S G V+E+++
Sbjct: 162 TGMKSVTGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 66/208 (31%), Positives = 109/208 (52%), Gaps = 20/208 (9%)
Query: 321 FSEENKLGEGGFGDIYK-GTLKNGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNL 378
F KLG+G +G +YK L + + A+K++ +G +S++ D NE+R++++V+H N+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 379 IR-----LLGCCSQGPELILVYEYMANSSLDKFLF-GEKRGSLNWKQR-FDIILGTARGL 431
I L G +L +V EY L K + +K+ L +Q + I + RGL
Sbjct: 62 ISYKEAFLDGN-----KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 432 AYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAP 491
LHE +I+HRD+K +N+LL + KI D G++++L +N + GT Y AP
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAP 170
Query: 492 EYAIHGQLSEKVDAYSFGVLVLEIISGT 519
E S K D +S G L+ E+ +
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-20
Identities = 40/106 (37%), Positives = 49/106 (46%), Gaps = 7/106 (6%)
Query: 20 NSGCSQYNVTNF----SEFNSNLNATFKELREQL--NGGKKFATAQRTRGPDQVYTMVQC 73
CS N+ S F SNLNA L + GK FA PD VY + QC
Sbjct: 1 FHLCSSNTSGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQC 60
Query: 74 RRYVSTADCAACFTSA-ESLIRNCSAANGARVIYLACSLRYESSSF 118
R +S +DC +C +A L R C G R+ Y +C LRYES F
Sbjct: 61 RGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIG--------ISRRTLSDFENEVRLI 370
K+ +GEG +G + K K G+IVA+KK I+ R E+R++
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-------EIRML 54
Query: 371 SNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKR-GSLNWKQRFDIILGTAR 429
+ H NL+ L+ + L LV+E++ ++ LD EK L+ + + R
Sbjct: 55 KQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILR 111
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYT 489
G+ + H IIHRDIKP N+L+ K+ DFG AR L + T + T Y
Sbjct: 112 GIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYTDYVATRWYR 167
Query: 490 APEYAI-HGQLSEKVDAYSFGVLVLEIISG 518
APE + + VD ++ G LV E+++G
Sbjct: 168 APELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 74/221 (33%), Positives = 109/221 (49%), Gaps = 33/221 (14%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSD---FEN---EVRLISNVHHRNLI 379
LG+GGFG++ ++ GK+ A KKL +++ L +E E R+++ VH R ++
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKL----NKKRLKKRKGYEGAMVEKRILAKVHSRFIV 56
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFL---------FGEKRGSLNWKQRFDIILGTARG 430
L +L LV M L + F E R Q II G
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ---IISG---- 109
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK-FAGTLGYT 489
L +LH+ RII+RD+KP NVLLD+D +I+D GLA L + QS TK +AGT G+
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFM 164
Query: 490 APEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE 530
APE + VD ++ GV + E+I+ +GE+ E
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 7e-20
Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 13/205 (6%)
Query: 327 LGEGGFGDI----YKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRL 381
LGEG FG + Y N G+ VAVK L ++D + E+ ++ N++H N+++
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 382 LGCCSQ--GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
G C++ G + L+ E++ + SL ++L + +N KQ+ + +G+ YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGSRQY 130
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK--FAGTLGYTAPEYAIHG 497
V HRD+ NVL++ + Q KI DFGL + + ++ + + K + + APE I
Sbjct: 131 V---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 498 QLSEKVDAYSFGVLVLEIISGTKSS 522
+ D +SFGV + E+++ S
Sbjct: 188 KFYIASDVWSFGVTLYELLTYCDSE 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 8e-20
Identities = 66/201 (32%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 321 FSEENKLGEGGFGDIY-KGTLKNGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRN 377
F++ ++G G FG +Y ++ ++VA+KK++ S D EV+ + + H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
I GC + LV EY S+ D L + L + I G +GLAYLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI-- 495
+IHRDIK N+LL + Q K+ADFG A + S F GT + APE +
Sbjct: 145 ---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTPYWMAPEVILAM 196
Query: 496 -HGQLSEKVDAYSFGVLVLEI 515
GQ KVD +S G+ +E+
Sbjct: 197 DEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 63/194 (32%), Positives = 92/194 (47%), Gaps = 16/194 (8%)
Query: 327 LGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGC-C 385
+G+G FGD+ G + G VAVK + + T F E +++ + H NL++LLG
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 386 SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHR 445
+ L +V EYMA SL +L R L L + YL + +HR
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHR 126
Query: 446 DIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHGQLSEKV 503
D+ NVL+ +D K++DFGL + Q L K +TAPE + S K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKS 180
Query: 504 DAYSFGVLVLEIIS 517
D +SFG+L+ EI S
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 1e-19
Identities = 66/220 (30%), Positives = 105/220 (47%), Gaps = 35/220 (15%)
Query: 316 SATRKFSE---ENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLIS 371
SA + SE N++G G G +YK + G++ A+K + E+ ++
Sbjct: 68 SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILR 127
Query: 372 NVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRF--DIILGTAR 429
+V+H N+++ E+ ++ E+M SL+ G+ ++F D+
Sbjct: 128 DVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE--------GTHIADEQFLADVARQILS 179
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL-----PENQSHLSTKFAG 484
G+AYLH I+HRDIKPSN+L++ KIADFG++R+L P N S G
Sbjct: 180 GIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS------VG 230
Query: 485 TLGYTAPEYAIHGQLSE-KVDAY-----SFGVLVLEIISG 518
T+ Y +PE I+ L+ D Y S GV +LE G
Sbjct: 231 TIAYMSPE-RINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269
|
Length = 353 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 24/211 (11%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLA-----IGISRRTLSDFENEVRLISNV 373
++ +G G +G + ++GK VA+KK+ +++RTL E++++ +
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL----RELKILRHF 61
Query: 374 HHRNLIRLLGCC-SQGPELILVYEYM--ANSSLDKFLFGEKRGSLNWKQRFDIILGTARG 430
H N+I + G + VY M S L + ++ + + F L RG
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQL--LRG 119
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL---PENQSHLSTKFAGTLG 487
L Y+H +IHRD+KPSN+L+++D + +I DFG+AR L P + T++ T
Sbjct: 120 LKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 488 YTAPE--YAIHGQLSEKVDAYSFGVLVLEII 516
Y APE ++ + + +D +S G + E++
Sbjct: 177 YRAPELLLSLP-EYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 64/201 (31%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 321 FSEENKLGEGGFGDIYKG-TLKNGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRN 377
FS+ ++G G FG +Y ++N ++VA+KK++ S D EVR + + H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
I+ GC + LV EY S+ D L + L + + G +GLAYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI-- 495
+IHRD+K N+LL + K+ DFG A ++ F GT + APE +
Sbjct: 135 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVILAM 186
Query: 496 -HGQLSEKVDAYSFGVLVLEI 515
GQ KVD +S G+ +E+
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 17/206 (8%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAI-----GISRRTLSDFENEVRLISNV 373
K+ + K+GEG +G ++K + +IVA+K++ + G+ L E+ L+ +
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKEL 56
Query: 374 HHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAY 433
H+N++RL +L LV+EY + L K+ F G ++ + + +GLA+
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEY-CDQDLKKY-FDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEY 493
H ++HRD+KP N+L++ + + K+ADFGLAR S + TL Y P+
Sbjct: 115 CHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDV 170
Query: 494 AIHGQL-SEKVDAYSFGVLVLEIISG 518
+L S +D +S G + E+ +
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 1e-19
Identities = 64/214 (29%), Positives = 109/214 (50%), Gaps = 25/214 (11%)
Query: 319 RKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKL--AIGIS---RRTLSDFENEVRLISN 372
RK+ KLG+G +G ++K + ++VA+KK+ A + +RT E+ +
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF----REIMFLQE 62
Query: 373 V-HHRNLIRLLGC--CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTAR 429
+ H N+++LL ++ LV+EYM + L + + L + I+ +
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVI---RANILEDVHKRYIMYQLLK 118
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS----TKFAGT 485
L Y+H +IHRD+KPSN+LL+ D + K+ADFGLAR L E + + T + T
Sbjct: 119 ALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 486 LGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISG 518
Y APE + ++ VD +S G ++ E++ G
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 73/277 (26%), Positives = 124/277 (44%), Gaps = 37/277 (13%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFEN-------EVRLISNVHHRNL 378
LG G F Y+ +K G ++AVK+ + R T S+ E E+RL++ ++H ++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQ--VTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
IR+LG + L E+MA S+ L K G+ + RGL+YLHE+
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLL--SKYGAFKEAVIINYTEQLLRGLSYLHEN- 122
Query: 439 HVRIIHRDIKPSNVLLDDDLQP-KIADFGLARLLPENQS---HLSTKFAGTLGYTAPEYA 494
+IIHRD+K +N+L+D Q +IADFG A L + + GT+ + APE
Sbjct: 123 --QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 495 IHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE--- 551
Q D +S G +++E+ + K W ++ H L+ +
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATA---------------KPPWNAEKHSNHLALIFKIAS 225
Query: 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVV 588
+ + + + ++ L C + RP E++
Sbjct: 226 ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 67/292 (22%), Positives = 127/292 (43%), Gaps = 50/292 (17%)
Query: 327 LGEGGFGDIYKGTLKN-----GKIVAVKKLAI-GISRRTLSDFENEVRLISNVHHRNLIR 380
LGEG FG + +G L K VAVK + + + + +F +E + + H N+++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLK-VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 381 LLGCCSQG------PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL----GTARG 430
L+G C + P+ +++ +M + L FL + G L K +L A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT-LGYT 489
+ YL IHRD+ N +L +D+ +ADFGL++ + + + A + +
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 490 APEYAIHGQLSEKVDAYSFGVLVLEIIS-------GTKSSETKGEEGEYLLKRAWRLYEN 542
A E + K D ++FGV + EI + G ++ E +YL +
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY----DYLR--------H 230
Query: 543 GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594
G + P +C +++ ++ C ++ RPT +++ +L++
Sbjct: 231 GNRLK------QPEDCL----DELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 75/276 (27%), Positives = 127/276 (46%), Gaps = 31/276 (11%)
Query: 326 KLGEGGFGDIYKG---TLKNGKIVAVKKLAIGISRRTLSD-FENEVRLISNVHHRNLIRL 381
+LG G FG + KG K+ K VAVK L + L D E ++ + + ++R+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 382 LGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVR 441
+G C + +LV E L+KFL +K + K +++ + G+ YL E
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKYLEET---N 115
Query: 442 IIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT--LGYTAPEYAIHGQL 499
+HRD+ NVLL KI+DFGL++ L ++++ K G + + APE + +
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 500 SEKVDAYSFGVLVLEIIS-GTKSSE-TKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557
S K D +SFGVL+ E S G K + KG E +++ R+ E
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM-----------------E 218
Query: 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
C + ++ ++ +C + RP + V L++
Sbjct: 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 64/198 (32%), Positives = 105/198 (53%), Gaps = 17/198 (8%)
Query: 326 KLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGC 384
K+GEG G + T K+ GK VAVKK+ + +R F NEV ++ + HH N++ +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHENVVDMYNS 87
Query: 385 CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIH 444
G EL +V E++ +L + + +N +Q + L R L+YLH +IH
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQ---GVIH 141
Query: 445 RDIKPSNVLLDDDLQPKIADFG----LARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLS 500
RDIK ++LL D + K++DFG +++ +P+ +S GT + APE
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS-----LVGTPYWMAPEVISRLPYG 196
Query: 501 EKVDAYSFGVLVLEIISG 518
+VD +S G++V+E+I G
Sbjct: 197 TEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 77/270 (28%), Positives = 125/270 (46%), Gaps = 30/270 (11%)
Query: 327 LGEGGFGDIYKGTL----KNGKI-VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRL 381
LG G FG +YKG +N KI VA+K L S + + +E +++ V + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 382 LGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVR 441
LG C + LV + M L ++ E + + + + + A+G++YL E VR
Sbjct: 75 LGICLTS-TVQLVTQLMPYGCLLDYV-RENKDRIGSQDLLNWCVQIAKGMSYLEE---VR 129
Query: 442 IIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT-LGYTAPEYAIHGQLS 500
++HRD+ NVL+ KI DFGLARLL +++ + + A E +H + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 501 EKVDAYSFGVLVLEIIS-GTKSSET-KGEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558
+ D +S+GV V E+++ G K + E LL++ RL + P C
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ-------------PPIC 236
Query: 559 TKEAAEKVVEIALMCTQSAANSRPTMSEVV 588
T + V I + C + RP E+V
Sbjct: 237 TID----VYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 70/289 (24%), Positives = 127/289 (43%), Gaps = 38/289 (13%)
Query: 326 KLGEGGFGDIY----KGTLK-----------NGKIVAVKKLAIGISRRTLSDFENEVRLI 370
KLGEG FG+++ +G + +VAVK L +++ +DF E++++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 371 SNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFL----------FGEKRGSLNWKQR 420
S + + N+IRLLG C L ++ EYM N L++FL S++
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 421 FDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR-LLPENQSHLS 479
+ + A G+ YL + +HRD+ N L+ + KIADFG++R L + +
Sbjct: 132 LYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 480 TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRL 539
+ + + A E + G+ + D ++FGV + E+ + K E +++
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEF 248
Query: 540 YEN-GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
+ N G L L P+ V ++ + C RPT +++
Sbjct: 249 FRNQGRQIYLSQTPLCPS--------PVFKLMMRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 70/269 (26%), Positives = 120/269 (44%), Gaps = 29/269 (10%)
Query: 326 KLGEGGFGDIYKGTLKNGKI---VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
+LG G FG + KG K K VA+K L + + E ++ + + ++R++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
G C + L+LV E + L+KFL G K+ + +++ + G+ YL
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGK---NF 116
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT--LGYTAPEYAIHGQLS 500
+HRD+ NVLL + KI+DFGL++ L + S+ + AG L + APE + S
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 501 EKVDAYSFGVLVLEIIS-GTKS-SETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558
+ D +S+G+ + E S G K + KG E +++ RL +C
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL-----------------DC 219
Query: 559 TKEAAEKVVEIALMCTQSAANSRPTMSEV 587
E ++ + C RP ++V
Sbjct: 220 PAECPPEMYALMKDCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 2e-19
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 42/216 (19%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLAIGIS-----RRTLSDFENEVRLISNVHHRNLIR 380
+G G +G + + G+ VA+KK++ +R L E++L+ ++ H N+I
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL----REIKLLRHLRHENIIG 63
Query: 381 LLGCCSQGP-------ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDI-ILGTARGLA 432
LL P ++ +V E M + L K + + + + Q F IL RGL
Sbjct: 64 LLDI--LRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQIL---RGLK 117
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS--TKFAGTLGYTA 490
YLH +IHRD+KPSN+L++ + KI DFGLAR + ++ T++ T Y A
Sbjct: 118 YLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174
Query: 491 PE-------YAIHGQLSEKVDAYSFGVLVLEIISGT 519
PE Y ++ +D +S G + E+++
Sbjct: 175 PELLLSSSRY------TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 80/277 (28%), Positives = 129/277 (46%), Gaps = 42/277 (15%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLS-----DFENEVRLISNVHHRNLIR 380
LG G FG +YKG + G+ V + +AI I T +F +E +++++ H +L+R
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIP-VAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 381 LLGCCSQGPELILVYEYMANSSLDKFLFGEKR--GS---LNWKQRFDIILGTARGLAYLH 435
LLG C P + LV + M + L ++ K GS LNW + A+G+ YL
Sbjct: 74 LLGVC-LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT-LGYTAPEYA 494
E R++HRD+ NVL+ KI DFGLARLL ++ + + + A E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 495 IHGQLSEKVDAYSFGVLVLEIIS--GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552
+ + + + D +S+GV + E+++ G E LL++ RL +
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ----------- 232
Query: 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589
P CT + V + + C A+SRP E+ A
Sbjct: 233 --PPICTID----VYMVMVKCWMIDADSRPKFKELAA 263
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 75/303 (24%), Positives = 132/303 (43%), Gaps = 45/303 (14%)
Query: 326 KLGEGGFGDIYKGTLKNGK-----------------IVAVKKLAIGISRRTLSDFENEVR 368
KLGEG FG+++ + N + +VAVK L ++ +DF EV+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 369 LISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFL----FGEKRG----------- 413
++S + N+IRLLG C L ++ EYM N L++FL +K
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 414 --SLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR-L 470
++++ + L A G+ YL + +HRD+ N L+ ++L KIADFG++R L
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 471 LPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE 530
+ + + + + A E + G+ + D ++FGV + EI+ K E
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248
Query: 531 YLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590
+++ A + + + P C + + E+ L C RP+ S++ A
Sbjct: 249 QVIENAGEFFRDQGRQVYLFR---PPPC----PQGLYELMLQCWSRDCRERPSFSDIHAF 301
Query: 591 LKS 593
L
Sbjct: 302 LTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 327 LGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFE------NEVRLISNVHHRNLI 379
LG+GGFG++ +K GK+ A KKL ++ L + NE +++ V R ++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKL----DKKRLKKRKGEQMALNEKKILEKVSSRFIV 56
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTAR---GLAYLHE 436
L +L LV M L ++ I A+ GL +LH+
Sbjct: 57 SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGF---PEARAIFYAAQIICGLEHLHQ 113
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH 496
RI++RD+KP NVLLDD +I+D GLA L + AGT GY APE
Sbjct: 114 R---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQG 168
Query: 497 GQLSEKVDAYSFGVLVLEIISG 518
VD ++ G + E+I+G
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 8/203 (3%)
Query: 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+ + KLGEG + +YKG K NGK+VA+K + + T E L+ + H N++
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
L L LV+EY+ ++ L +++ + G L+ + + RGL+Y+H+ +
Sbjct: 67 LLHDIIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKLFLFQLLRGLSYIHQRY- 123
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG-Q 498
I+HRD+KP N+L+ D + K+ADFGLAR SH + TL Y P+ + +
Sbjct: 124 --ILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 499 LSEKVDAYSFGVLVLEIISGTKS 521
S +D + G + +E+I G +
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 19/202 (9%)
Query: 326 KLGEGGFGDIYKG-TLKNG-KIVAVKKLAI-----GISRRTLSDFENEVRLISNVHHRNL 378
++GEG +G ++K LKNG + VA+K++ + G+ T+ + +R + H N+
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRHLETFEHPNV 66
Query: 379 IRLLGCCS-----QGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAY 433
+RL C+ + +L LV+E++ + L +L + + D++ RGL +
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEY 493
LH R++HRD+KP N+L+ Q K+ADFGLAR+ + T TL Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEV 180
Query: 494 AIHGQLSEKVDAYSFGVLVLEI 515
+ + VD +S G + E+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 61/195 (31%), Positives = 102/195 (52%), Gaps = 11/195 (5%)
Query: 326 KLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGC 384
K+GEG G + T+K+ GK+VAVKK+ + +R F NEV ++ + H N++ +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEMYNS 85
Query: 385 CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIH 444
G EL +V E++ +L + + +N +Q + L + L+ LH +IH
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLHAQ---GVIH 139
Query: 445 RDIKPSNVLLDDDLQPKIADFGL-ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKV 503
RDIK ++LL D + K++DFG A++ E S GT + APE +V
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPEV 197
Query: 504 DAYSFGVLVLEIISG 518
D +S G++V+E++ G
Sbjct: 198 DIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 84/290 (28%), Positives = 122/290 (42%), Gaps = 46/290 (15%)
Query: 324 ENKLGEGGFGDIYKGTLK---NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLI 379
E+ +GEG FG + + +K A+K L S DF E+ ++ + HH N+I
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFL-----------FGEKRGS---LNWKQRFDIIL 425
LLG C L + EY +L FL F ++ G+ L +Q
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT 485
A G+ YL E + IHRD+ NVL+ ++L KIADFGL+R + K G
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMGR 179
Query: 486 LG--YTAPEYAIHGQLSEKVDAYSFGVLVLEIIS--GTKSSETKGEEGEYLLKRAWRLYE 541
L + A E + + K D +SFGVL+ EI+S GT Y LYE
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP----------YCGMTCAELYE 229
Query: 542 NGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
M++ P C E V E+ C + RP +++ L
Sbjct: 230 KLPQGYRMEK---PRNCDDE----VYELMRQCWRDRPYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 55/193 (28%), Positives = 94/193 (48%), Gaps = 8/193 (4%)
Query: 327 LGEGGFGDIYK-GTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCC 385
LG G G + K + G ++A K + IG E++++ ++ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 386 SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHR 445
+ + E+M SLD+ +K G + + I + GL YL+ + H RI+HR
Sbjct: 73 LNENNICMCMEFMDCGSLDRIY--KKGGPIPVEILGKIAVAVVEGLTYLY-NVH-RIMHR 128
Query: 446 DIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDA 505
DIKPSN+L++ Q K+ DFG++ E + ++ F GT Y +PE G+ + K D
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTVKSDV 185
Query: 506 YSFGVLVLEIISG 518
+S G+ ++E+ G
Sbjct: 186 WSLGISIIELALG 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 66/223 (29%), Positives = 100/223 (44%), Gaps = 24/223 (10%)
Query: 326 KLGEGGFGDIYKGT---LKNGKI-VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRL 381
+GEG FGD+Y+G +N KI VAVK S F E ++ H ++++L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 382 LGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL---GTARGLAYLHEDF 438
+G ++ P I V E L +L K +IL + LAYL
Sbjct: 73 IGVITENPVWI-VMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLES-- 125
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ 498
R +HRDI NVL+ K+ DFGL+R L + + ++K + + APE +
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 499 LSEKVDAYSFGVLVLEIIS-------GTKSSETKG--EEGEYL 532
+ D + FGV + EI+ G K+++ G E GE L
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL 227
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 30/213 (14%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKNGKI-VAVKKLA-----IGISRRTLSDFENEVRLISNV 373
++ + +G G +G + VA+KKL+ ++RT E+RL+ ++
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY----RELRLLKHM 71
Query: 374 HHRNLIRLLGCCSQGPEL------ILVYEYMANSSLDKFLFGEKRGSLNWKQ-RFDIILG 426
H N+I LL + L LV M + L+ + K L+ +F ++
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIV---KCQKLSDDHIQF-LVYQ 126
Query: 427 TARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTL 486
RGL Y+H IIHRD+KPSN+ +++D + KI DFGLAR T + T
Sbjct: 127 ILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT----DDEMTGYVATR 179
Query: 487 GYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISG 518
Y APE ++ ++ VD +S G ++ E+++G
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 80/294 (27%), Positives = 135/294 (45%), Gaps = 39/294 (13%)
Query: 317 ATRKFSEENKLGEGGFGDIYKGTLKNGKI-------VAVKKLAIGISRRTLSDFENEVRL 369
A K + +LG+G FG +Y+G K G + VA+K + S R +F NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAK-GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62
Query: 370 IS--NVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLN--------WKQ 419
+ N HH ++RLLG SQG +++ E M L +L + N K+
Sbjct: 63 MKEFNCHH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 420 RFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS 479
+ A G+AYL+ + + +HRD+ N ++ +D KI DFG+ R + E +
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 480 -TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWR 538
K + + +PE G + D +SFGV++ EI + +G E +L+
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-LAEQPYQGMSNEQVLR---F 233
Query: 539 LYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
+ E G L+D+ P+ C + + E+ MC Q RP+ E+++ +K
Sbjct: 234 VMEGG----LLDK---PDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 67/203 (33%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 319 RKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHH 375
F +++G G FG +Y T ++VAVKK++ + D EV+ + + H
Sbjct: 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH 80
Query: 376 RNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLH 435
N I GC + LV EY S+ D L + L + I G +GLAYLH
Sbjct: 81 PNTIEYKGCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLH 138
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI 495
+IHRDIK N+LL + Q K+ADFG A S F GT + APE +
Sbjct: 139 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS-----FVGTPYWMAPEVIL 190
Query: 496 ---HGQLSEKVDAYSFGVLVLEI 515
GQ KVD +S G+ +E+
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKK--------LAIGISRRTLSDFENEVRLI 370
K+ + +K+GEG +G ++K + G+IVA+KK + I+ R E+R++
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR-------EIRML 54
Query: 371 SNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARG 430
+ H NL+ L+ + +L LV+EY ++ L++ L RG + II T +
Sbjct: 55 KQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRG-VPEHLIKKIIWQTLQA 112
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
+ + H+ IHRD+KP N+L+ Q K+ DFG AR+L T + T Y A
Sbjct: 113 VNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARIL-TGPGDDYTDYVATRWYRA 168
Query: 491 PEYAI-HGQLSEKVDAYSFGVLVLEIISG 518
PE + Q VD ++ G + E+++G
Sbjct: 169 PELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 61/214 (28%), Positives = 109/214 (50%), Gaps = 36/214 (16%)
Query: 327 LGEGGFGDIYKG-TLKNGKIVAVKKLAIG--ISRR-------TLSDFENEVRLISNVHHR 376
+G+G +G +Y + G+++AVK++ + I+ R + +E+ + ++ H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 377 NLIRLLGCCSQGPELILVY-EYMANSSLDKFL-----FGEKRGSLNWKQRFDIILGTARG 430
N+++ LG E + ++ EY+ S+ L F E+ +Q G
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ-------VLEG 120
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL---LPENQSHLSTKFAGTLG 487
LAYLH I+HRD+K N+L+D D KI+DFG+++ + +N ++S + G++
Sbjct: 121 LAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ--GSVF 175
Query: 488 YTAPEYAIHGQ---LSEKVDAYSFGVLVLEIISG 518
+ APE IH S KVD +S G +VLE+ +G
Sbjct: 176 WMAPE-VIHSYSQGYSAKVDIWSLGCVVLEMFAG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 326 KLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGC 384
++G G FG+++ G L+ + VAVK + + F E R++ H N++RL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 385 CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIH 444
C+Q + +V E + FL E L K+ ++ A G+ YL E H IH
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYL-ESKHC--IH 117
Query: 445 RDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT----LGYTAPEYAIHGQLS 500
RD+ N L+ + KI+DFG++R E + + G + +TAPE +G+ S
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 501 EKVDAYSFGVLVLEIIS 517
+ D +SFG+L+ E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 39/205 (19%)
Query: 315 VSATRKFSEENKLGEGGFGDIYKG-TLKNGKIVAVKKLAIGISRRTLSDFEN-------- 365
S R + KLGEG FG++YK +K G++VA+KK+ + + ++
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI-------LMHNEKDGFPITALR 56
Query: 366 EVRLISNVHHRNLIRLL--------GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNW 417
E++++ + H N++ L+ + + +V YM L L L
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLL-ENPSVKLTE 114
Query: 418 KQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477
Q +L G+ YLHE+ I+HRDIK +N+L+D+ KIADFGLAR +
Sbjct: 115 SQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171
Query: 478 LSTKFAG----------TLGYTAPE 492
G T Y PE
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 80/315 (25%), Positives = 145/315 (46%), Gaps = 46/315 (14%)
Query: 320 KFSEENKLGEGGFGDIYKGTL----KNGKI-VAVKKLAIGISRRTLSDFENEVRLISNVH 374
+F + LG G FG +YKG + KI VA+K+L S + + +E ++++V
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEK-----RGSLNWKQRFDIILGTAR 429
+ ++ RLLG C + L+ + M L ++ K + LNW + A+
Sbjct: 68 NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 120
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT-LGY 488
G+ YL E R++HRD+ NVL+ KI DFGLA+LL ++ + + +
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177
Query: 489 TAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSE-TKGEEGEYLLKRAWRLYENGTHW 546
A E +H + + D +S+GV V E+++ G+K + E +L++ RL +
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ----- 232
Query: 547 ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA----LLKSTSSSLL--G 600
P CT + V I + C A+SRP E++ + + L+ G
Sbjct: 233 --------PPICTID----VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 280
Query: 601 NKPLLKPTFVETDYR 615
++ + P+ ++++
Sbjct: 281 DERMHLPSPTDSNFY 295
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 22/200 (11%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLG 383
LG G FG + K +GK A+K L+ + + + NE R++ ++ H L+ L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQ-RF---DIILGTARGLAYLHEDFH 439
L LV EY+ L F K G RF ++L L YLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGEL--FSHLRKSGRFPEPVARFYAAQVVLA----LEYLH---S 119
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL 499
+ I++RD+KP N+LLD D KI DFG A+ + L GT Y APE I +
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAPE-IILSKG 174
Query: 500 SEK-VDAYSFGVLVLEIISG 518
K VD ++ G+L+ E+++G
Sbjct: 175 YGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 327 LGEGGFGDIYKGTLKNG-------KIVAVKKLAIGISRR----TLSDFENEVRLI-SNVH 374
LG G FG +YK KN K + V A G +R ++ D +EV +I +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFL--FGEKRGSLNWKQRFDIILGTARGLA 432
H N++R + L +V + + + L + EK+ ++ ++I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPE 492
YLH++ RI+HRD+ P+N++L +D + I DFGLA+ S L++ GT+ Y+ PE
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTSV-VGTILYSCPE 183
Query: 493 YAIHGQLSEKVDAYSFGVLVLEI 515
+ EK D ++FG ++ ++
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 68/228 (29%), Positives = 107/228 (46%), Gaps = 13/228 (5%)
Query: 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFE-NEVRLISNVHHRN 377
F + LG+GGFG++ ++ GK+ A KKL I +R NE +++ V+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
++ L L LV M L ++ + GL LH++
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG 497
RI++RD+KP N+LLDD +I+D GLA +PE Q+ GT+GY APE +
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--VGTVGYMAPEVVKNE 176
Query: 498 QLSEKVDAYSFGVLVLEIISG-----TKSSETKGEEGEYLLKRAWRLY 540
+ + D ++ G L+ E+I+G + + K EE E L+K Y
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEY 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 78/287 (27%), Positives = 123/287 (42%), Gaps = 46/287 (16%)
Query: 327 LGEGGFGDIYKGTLKNGKI---VAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLL 382
+GEG FG + K +K + A+K++ S+ DF E+ ++ + HH N+I LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 383 GCCSQGPELILVYEYMANSSLDKFL-----------FGEKRGS---LNWKQRFDIILGTA 428
G C L L EY + +L FL F + L+ +Q A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 429 RGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG- 487
RG+ YL + + IHRD+ N+L+ ++ KIADFGL+R Q K G L
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLPV 175
Query: 488 -YTAPEYAIHGQLSEKVDAYSFGVLVLEIIS--GTKSSETKGEEGEYLLKRAWRLYENGT 544
+ A E + + D +S+GVL+ EI+S GT Y LYE
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP----------YCGMTCAELYEKLP 225
Query: 545 HWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
+++ P C E V ++ C + RP+ ++++ L
Sbjct: 226 QGYRLEK---PLNCDDE----VYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-18
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKL-----AIGISRRTLSDFENEVRLIS 371
T ++ + +G G FG + G+ VA+KK+ +++RT E++L+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY----RELKLLK 64
Query: 372 NVHHRNLIRLLGC-CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARG 430
++ H N+I L S ++ V E + + L + L + + Q F + RG
Sbjct: 65 HLRHENIISLSDIFISPLEDIYFVTELLG-TDLHRLL-TSRPLEKQFIQYF--LYQILRG 120
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
L Y+H ++HRD+KPSN+L++++ KI DFGLAR+ Q T + T Y A
Sbjct: 121 LKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRA 173
Query: 491 PEYAIHGQ-LSEKVDAYSFGVLVLEIISG 518
PE + Q +VD +S G + E++ G
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 69/286 (24%), Positives = 118/286 (41%), Gaps = 37/286 (12%)
Query: 327 LGEGGFGDIYKGTLKNGKI---VAVKKLAIGISRRT-LSDFENEVRLISNVHHRNLIRLL 382
LGEG FG + +G L VAVK + I I R+ + DF +E + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 383 GCCSQG------PELILVYEYMANSSLDKFLFGEKRGS----LNWKQRFDIILGTARGLA 432
G C Q P +++ +M + L FL + G L + + A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT-LGYTAP 491
YL IHRD+ N +L++++ +ADFGL++ + + + A + + A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 492 EYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEY--LLKRAWRLYENGTHWELM 549
E + K D +SFGV + EI + ++ E E L++ RL +
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ-------- 235
Query: 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595
P +C + + + C RP+ + L+
Sbjct: 236 -----PPDCL----DGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 16/215 (7%)
Query: 310 RLKDLVSA---TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFE- 364
+L+ +VS +K++ K+G+G G +Y + G+ VA+K+ + + ++ +
Sbjct: 7 KLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQ--MNLQQQPKKELII 64
Query: 365 NEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDII 424
NE+ ++ H N++ L G EL +V EY+A SL + ++ Q +
Sbjct: 65 NEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVC 121
Query: 425 LGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL-ARLLPENQSHLSTKFA 483
+ L +LH + ++IHRDIK N+LL D K+ DFG A++ PE QS ST
Sbjct: 122 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST-MV 176
Query: 484 GTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
GT + APE KVD +S G++ +E++ G
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 325 NKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFE----NEVRLISNVHHRNLI 379
N++ EG +G +Y+ K G+IVA+KKL + + F E+ ++ + H N++
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKM---EKEKEGFPITSLREINILLKLQHPNIV 67
Query: 380 RL----LGCCSQGPELILVYEYMANSSLD-KFLFGEKRGSLNWKQRFDIILGTARGLAYL 434
+ +G S ++ +V EY+ + D K L + + ++L G+A+L
Sbjct: 68 TVKEVVVG--SNLDKIYMVMEYVEH---DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYA 494
H+++ I+HRD+K SN+LL++ KI DFGLAR T+ TL Y APE
Sbjct: 123 HDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVVTLWYRAPELL 178
Query: 495 I-HGQLSEKVDAYSFGVLVLEIISG 518
+ + S +D +S G + E+++
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 77/290 (26%), Positives = 125/290 (43%), Gaps = 46/290 (15%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKI---VAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLI 379
++ +GEG FG + K +K + A+K++ S+ DF E+ ++ + HH N+I
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEK--------------RGSLNWKQRFDIIL 425
LLG C L L EY + +L FL + +L+ +Q
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT 485
ARG+ YL + + IHRD+ N+L+ ++ KIADFGL+R Q K G
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 184
Query: 486 LG--YTAPEYAIHGQLSEKVDAYSFGVLVLEIIS--GTKSSETKGEEGEYLLKRAWRLYE 541
L + A E + + D +S+GVL+ EI+S GT E L + +RL +
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 244
Query: 542 NGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
P C E V ++ C + RP+ ++++ L
Sbjct: 245 -------------PLNCDDE----VYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-18
Identities = 68/215 (31%), Positives = 97/215 (45%), Gaps = 34/215 (15%)
Query: 326 KLGEGGFGDIYKG-TLKNGKIVAVKKLAI-----GISRRTLSDFENEVRLISNVHHRNLI 379
K+GEG +G +YK GK+VA+KK + GI L E+ L+ + I
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL----REISLLQMLSESIYI 63
Query: 380 -RLLGC-----CSQGPELILVYEYMANSSLDKFLFGEKRGS-----LNWKQRFDIILGTA 428
RLL + P L LV+EY+ +S L KF+ RG + F L
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL--L 120
Query: 429 RGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP-KIADFGLAR--LLPENQSHLSTKFAGT 485
+G+A+ H+ ++HRD+KP N+L+D KIAD GL R +P T T
Sbjct: 121 KGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS---YTHEIVT 174
Query: 486 LGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGT 519
L Y APE + S VD +S G + E+
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-17
Identities = 78/272 (28%), Positives = 128/272 (47%), Gaps = 35/272 (12%)
Query: 310 RLKDLVS---ATRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFE- 364
+L+ +VS +K++ K+G+G G ++ + G+ VA+K+ I + ++ +
Sbjct: 7 KLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQ--INLQKQPKKELII 64
Query: 365 NEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDII 424
NE+ ++ + + N++ L G EL +V EY+A SL + ++ Q +
Sbjct: 65 NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVC 121
Query: 425 LGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL-ARLLPENQSHLSTKFA 483
+ L +LH + ++IHRDIK NVLL D K+ DFG A++ PE QS ST
Sbjct: 122 RECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRST-MV 176
Query: 484 GTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYL----LKRAWRL 539
GT + APE KVD +S G++ +E++ G E YL L+ + +
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG---------EPPYLNENPLRALYLI 227
Query: 540 YENGTHWELMDESLDP------NECTKEAAEK 565
NGT E L P N C + EK
Sbjct: 228 ATNGTPELQNPEKLSPIFRDFLNRCLEMDVEK 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 41/215 (19%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS----RRTLSDFENEVRLISNVHHRNLIRL 381
LG G +G + K G I+AVK++ ++ +R L D + +R +V +
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMR---SVDCPYTVTF 65
Query: 382 LGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFD------------IILGTAR 429
G + ++ + E M ++SLDKF +K+ +D I + +
Sbjct: 66 YGALFREGDVWICMEVM-DTSLDKF----------YKKVYDKGLTIPEDILGKIAVSIVK 114
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYT 489
L YLH V IHRD+KPSNVL++ + Q K+ DFG++ L + S T AG Y
Sbjct: 115 ALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTIDAGCKPYM 170
Query: 490 APEYAIHGQLSE-----KVDAYSFGVLVLEIISGT 519
APE I+ +L++ K D +S G+ ++E+ +G
Sbjct: 171 APE-RINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 325 NKLGEGGFGDIYKGTLKNGKIVAVKKLAIGIS-----RRTLSDFENEVRLISNVHHRNLI 379
LG+G +G +Y G G+++AVK++ + S + + EV L+ ++ H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFL--FGEKRGSLNWKQRFDIILGTARGLAYLHED 437
+ LG C + + E++ S+ L FG + K I+ G+AYLH +
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL----DGVAYLHNN 121
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP-----ENQSHLSTKFAGTLGYTAPE 492
++HRDIK +NV+L + K+ DFG AR L S++ GT + APE
Sbjct: 122 ---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 493 YAIHGQLSEKVDAYSFGVLVLEIISG 518
K D +S G V E+ +G
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATG 204
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 66/232 (28%), Positives = 108/232 (46%), Gaps = 35/232 (15%)
Query: 316 SATRKFSEENK-LGEGGFGDIYKG-TLKNGKIVAVKKL-AIGISRRTLSDFEN------- 365
S + ++ ++ LGEG +G + K GKIVA+KK+ I IS D +
Sbjct: 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64
Query: 366 -----EVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQR 420
E+++++ + H N++ L+ +G + LV + MA S L K + +++ L Q
Sbjct: 65 FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV--DRKIRLTESQV 121
Query: 421 FDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR----------- 469
I+L GL LH+ + +HRD+ P+N+ ++ KIADFGLAR
Sbjct: 122 KCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 470 -LLPENQSHLS-TKFAGTLGYTAPEYAIHGQ-LSEKVDAYSFGVLVLEIISG 518
Q T TL Y APE + + VD +S G + E+++G
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
+KLGEG + ++KG K +VA+K++ + EV L+ N+ H N++ L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL-GTARGLAYLHEDFHVRI 442
L LV+EY+ +S L ++L + G+L I + RGL+Y H +I
Sbjct: 71 IIHTERCLTLVFEYL-DSDLKQYL--DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKI 124
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG-QLSE 501
+HRD+KP N+L+++ + K+ADFGLAR S + TL Y P+ + + S
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 502 KVDAYSFGVLVLEIISG 518
+D + G ++ E+ +G
Sbjct: 184 PIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 326 KLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCC 385
+LG+G FG +YK K ++A K+ S L D+ E+ ++++ H N+++LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 386 SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHR 445
L ++ E+ A ++D + +R L Q + T L YLHE+ +IIHR
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELER-PLTEPQIRVVCKQTLEALNYLHEN---KIIHR 127
Query: 446 DIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK--FAGTLGYTAPEYAIHGQLSE-- 501
D+K N+L D K+ADFG++ +N + + F GT + APE + +
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVS---AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 502 ---KVDAYSFGVLVLEI 515
K D +S G+ ++E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAI-----GISRRTLSDFENEVRLISNV 373
++ + K+GEG +G +YK + + +A+KK+ + G+ + E+ L+ +
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI----REISLLKEM 58
Query: 374 HHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAY 433
H N++RL L LV+EY+ + L K + + N + + RG+AY
Sbjct: 59 QHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDL-QPKIADFGLARL--LPENQSHLSTKFAGTLGYTA 490
H R++HRD+KP N+L+D K+ADFGLAR +P T TL Y A
Sbjct: 118 CHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP---VRTFTHEVVTLWYRA 171
Query: 491 PEYAIHG-QLSEKVDAYSFGVLVLEIIS 517
PE + S VD +S G + E+++
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 326 KLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCC 385
+LG+G FG +YK K +A K+ S L D+ E+ +++ +H +++LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 386 SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHR 445
+L ++ E+ ++D + RG L Q I L YLH ++IIHR
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVICRQMLEALQYLHS---MKIIHR 134
Query: 446 DIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK--FAGTLGYTAPEYAIHGQLSE-- 501
D+K NVLL D K+ADFG++ +N L + F GT + APE + + +
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVS---AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 502 ---KVDAYSFGVLVLEI 515
K D +S G+ ++E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 36/218 (16%)
Query: 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS--------RRTLSDFENEVRLIS 371
+ + +GEG +G + T K G VA+KK IS +RTL E++++
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKK----ISPFEHQTFCQRTL----REIKILR 58
Query: 372 NVHHRNLIRLLGCCSQGP-------ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDII 424
H N+I +L P ++ +V E M + L K + + S + Q F +
Sbjct: 59 RFKHENIIGILDI--IRPPSFESFNDVYIVQELM-ETDLYKLIKTQHL-SNDHIQYF--L 112
Query: 425 LGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS--TKF 482
RGL Y+H ++HRD+KPSN+LL+ + KI DFGLAR+ H T++
Sbjct: 113 YQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 483 AGTLGYTAPEYAIHGQLSEK-VDAYSFGVLVLEIISGT 519
T Y APE ++ + K +D +S G ++ E++S
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 64/225 (28%), Positives = 107/225 (47%), Gaps = 32/225 (14%)
Query: 317 ATRKFSEENKLGEGGFGDIYKGTL------KNGKIVAVKKLAIGISRRTLSDFENEVRLI 370
+T +F EE LGE FG +YKG L + + VA+K L +F++E +
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 371 SNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEK--------------RGSLN 416
S + H N++ LLG ++ L +++ Y ++S L +FL + +L
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 417 WKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476
I+ A G+ +L HV +H+D+ NVL+ D L KI+D GL R E +
Sbjct: 123 PADFVHIVTQIAAGMEFL-SSHHV--VHKDLATRNVLVFDKLNVKISDLGLFR---EVYA 176
Query: 477 HLSTKFAGT----LGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS 517
K G + + +PE ++G+ S D +S+GV++ E+ S
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 43/211 (20%)
Query: 306 PVNYRLKDLVSATRKFSEENKLGEGGFGDIYKG-TLKNGKIVAVKKLAI-----GISRRT 359
+ D VS K+ + K+G+G FG+++K K +IVA+KK+ + G
Sbjct: 2 QYEFPFCDEVS---KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA 58
Query: 360 LSDFENEVRLISNVHHRNLIRLLGCCSQGP--------ELILVYEYMA-------NSSLD 404
L E++++ + H N++ L+ C LV+E+ ++
Sbjct: 59 L----REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV 114
Query: 405 KFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIAD 464
KF E + ++ GL Y+H + +I+HRD+K +N+L+ D K+AD
Sbjct: 115 KFTLSEIK---------KVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD 162
Query: 465 FGLAR--LLPEN-QSHLSTKFAGTLGYTAPE 492
FGLAR L +N + + T TL Y PE
Sbjct: 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 81/292 (27%), Positives = 124/292 (42%), Gaps = 53/292 (18%)
Query: 327 LGEGGFGDIYKGTL----KNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
+G+G FG +Y GTL AVK L + F E ++ + H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 383 GCC--SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
G C S+G L+ V YM + L F+ E K L A+G+ YL
Sbjct: 63 GICLPSEGSPLV-VLPYMKHGDLRNFIRSETHNP-TVKDLIGFGLQVAKGMEYLASK--- 117
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN-----QSHLSTKFAGTLGYTAPEYAI 495
+ +HRD+ N +LD+ K+ADFGLAR + + +H K + + A E
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP--VKWMALESLQ 175
Query: 496 HGQLSEKVDAYSFGVLVLEIISGTKSSETKG----------EEGEYLLKRAWRLYENGTH 545
+ + K D +SFGVL+ E++ T+G + YLL + RL
Sbjct: 176 TQKFTTKSDVWSFGVLLWELM-------TRGAPPYPDVDSFDITVYLL-QGRRL------ 221
Query: 546 WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSS 597
L P C + + E+ L C RPT SE+V+ ++ S+
Sbjct: 222 -------LQPEYC----PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 26/206 (12%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLA-----IGISRRTLSDFENEVRLISNVHHRNLIR 380
+G G FG ++ T ++GK VA+KK+ + +R E++++ H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF----RELKMLCFFKHDNVLS 63
Query: 381 LLGCCSQGP------ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDI-ILGTARGLAY 433
L Q P E+ +V E M S L K + + S + + F IL RGL Y
Sbjct: 64 ALDIL-QPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSSDHVKVFLYQIL---RGLKY 118
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEY 493
LH I+HRDIKP N+L++ + KI DFGLAR+ ++S T+ T Y APE
Sbjct: 119 LHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEI 175
Query: 494 AIHGQ-LSEKVDAYSFGVLVLEIISG 518
+ + + VD +S G + E++
Sbjct: 176 LMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 14/214 (6%)
Query: 310 RLKDLVSA---TRKFSEENKLGEGGFGDIYKG-TLKNGKIVAVKKLAIGISRRTLSDFEN 365
+L+ +VS +K++ K+G+G G +Y + G+ VA+K++ + + N
Sbjct: 7 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK-ELIIN 65
Query: 366 EVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL 425
E+ ++ + N++ L G EL +V EY+A SL + ++ Q +
Sbjct: 66 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCR 122
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL-ARLLPENQSHLSTKFAG 484
+ L +LH + ++IHRDIK N+LL D K+ DFG A++ PE QS ST G
Sbjct: 123 ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRST-MVG 177
Query: 485 TLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
T + APE KVD +S G++ +E++ G
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 326 KLGEGGFGDIYKG-TLKNGKIVAVKKLAIGISRRTLS-DFENEVRLISNVH---HRNLIR 380
++G G +G +YK +G VA+K + + + L EV L+ + H N++R
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 381 LLGCCS-----QGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLH 435
L+ C+ + ++ LV+E++ + L +L L + D++ RGL +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS-TKFAGTLGYTAPEYA 494
+ I+HRD+KP N+L+ Q K+ADFGLAR+ ++ T TL Y APE
Sbjct: 126 AN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEVL 179
Query: 495 IHGQLSEKVDAYSFGVLVLEI 515
+ + VD +S G + E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 8/195 (4%)
Query: 326 KLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGC 384
KLGEG + +YKG + NG++VA+K +++ E L+ + H N++ L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 385 CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIH 444
L V+EYM ++ L +++ G + R + RGLAY+H I+H
Sbjct: 72 IHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH---GQHILH 126
Query: 445 RDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG-QLSEKV 503
RD+KP N+L+ + K+ADFGLAR S++ TL Y P+ + S +
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSAL 185
Query: 504 DAYSFGVLVLEIISG 518
D + G + +E++ G
Sbjct: 186 DIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 69/220 (31%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 327 LGEGGFGDI----YKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRL---ISNVHHRNLI 379
LG G FG + YK T + I A+KK I I+R + E R+ ++ H L+
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDI-IARDEVESLMCEKRIFETANSERHPFLV 65
Query: 380 RLLGCCSQGPELILVYEYMANSSL----DKFLFGEKRGSLNWKQRF---DIILGTARGLA 432
L C + V EY A L +F E R F ++LG L
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA------VFYAACVVLG----LQ 115
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST--KFAGTLGYTA 490
YLHE+ +I++RD+K N+LLD + KIADFGL + E F GT + A
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFLA 169
Query: 491 PEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE 530
PE + VD + GVL+ E++ G S G++ E
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVG--ESPFPGDDEE 207
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 34/209 (16%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFEN-----EVRLISNVHH-RNLI 379
+G G G +YK K G ++AVK++ RRT + EN ++ ++ H ++
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQM-----RRTGNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRF-DIILG-----TARGLAY 433
+ G ++ + E M+ + LDK L KR + + ILG + L Y
Sbjct: 78 KCYGYFITDSDVFICMELMS-TCLDKLL---KR----IQGPIPEDILGKMTVAIVKALHY 129
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEY 493
L E H +IHRD+KPSN+LLD K+ DFG++ L ++++ T+ AG Y APE
Sbjct: 130 LKEK-H-GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPER 185
Query: 494 ----AIHGQLSEKVDAYSFGVLVLEIISG 518
+ + + D +S G+ ++E+ +G
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATG 214
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 327 LGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRT----LSDFENEVRLISNVHHRNLIRL 381
LG+GGFG++ +KN GK+ A KKL ++ ++ E E+ + V+ ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 382 LGCCSQGPELILVYEYMANSSLDKFLF--GEKRGSLNWKQRFDIILGTAR---GLAYLHE 436
L LV M L ++ GE+ + +I +A+ G+ +LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME-----RVIHYSAQITCGILHLHS 113
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH 496
+ I++RD+KP NVLLDD +++D GLA L + ++ T+ AGT GY APE
Sbjct: 114 ---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKE 168
Query: 497 GQLSEKVDAYSFGVLVLEIISG 518
S VD ++ G + E+++G
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 32/195 (16%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKN---GKIVAVKKL------AIGISRRTLSDFENEVRLI 370
K+ E +G G +G +YK KN GK A+KK GIS+ E+ L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC----REIALL 56
Query: 371 SNVHHRNLIRLLGCC--SQGPELILVYEYMANSSLD--KFLFGEKRGSLNWKQRFDIILG 426
+ H N++ L+ + L+++Y + KF KR S+ ++
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 427 TARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP----KIADFGLARLLPENQSHLSTKF 482
G+ YLH ++ ++HRD+KP+N+L+ + KI D GLARL + L
Sbjct: 117 ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF---NAPLKPLA 170
Query: 483 AG-----TLGYTAPE 492
T+ Y APE
Sbjct: 171 DLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 5e-16
Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 11/171 (6%)
Query: 351 LAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGE 410
L IG TL E L+ NV+H ++IR+ G +V + +S L +L
Sbjct: 96 LKIGQKGTTLI----EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKR 150
Query: 411 KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470
R L Q I GL YLH RIIHRD+K N+ ++D Q I D G A+
Sbjct: 151 SR-PLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206
Query: 471 LPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKS 521
+ L AGT+ APE + + K D +S G+++ E+++ +
Sbjct: 207 PVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST 255
|
Length = 357 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
KLGEG + ++KG K +VA+K++ + EV L+ ++ H N++ L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL-GTARGLAYLHEDFHVRI 442
L LV+EY+ + L +++ + G++ I L RGLAY H ++
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYM--DDCGNIMSMHNVKIFLYQILRGLAYCHRR---KV 125
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI-HGQLSE 501
+HRD+KP N+L+++ + K+ADFGLAR S + TL Y P+ + + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184
Query: 502 KVDAYSFGVLVLEIISG 518
++D + G + E+ SG
Sbjct: 185 QIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 31/278 (11%)
Query: 327 LGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFE-----NEVRLISNV-HHRNLI 379
LG G FG + + T K AV K+A+ + + T E +E++++S++ +H N++
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
LLG C+ G ++++ EY L FL ++ L + A+G+A+L
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK-- 160
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAG-TLGYTAPEYAIHGQ 498
IHRD+ NVLL KI DFGLAR + + +++ A + + APE +
Sbjct: 161 -NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219
Query: 499 LSEKVDAYSFGVLVLEIIS--GTKSSETKGEEGEY-LLKRAWRLYENGTHWELMDESLDP 555
+ + D +S+G+L+ EI S + Y L+K +R+ P
Sbjct: 220 YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-------------AQP 266
Query: 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
E + +I C + RPT ++V L+
Sbjct: 267 EHAPAE----IYDIMKTCWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-16
Identities = 59/214 (27%), Positives = 104/214 (48%), Gaps = 14/214 (6%)
Query: 310 RLKDLVSA---TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFEN 365
+L+ +VS +K++ K+G+G G +Y + G+ VA++++ + + N
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-ELIIN 66
Query: 366 EVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL 425
E+ ++ + N++ L G EL +V EY+A SL + ++ Q +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCR 123
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL-ARLLPENQSHLSTKFAG 484
+ L +LH + ++IHRDIK N+LL D K+ DFG A++ PE + G
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVG 178
Query: 485 TLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
T + APE KVD +S G++ +E+I G
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 34/208 (16%)
Query: 326 KLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGC 384
KLGEG + +YKG K G++VA+K++ + E L+ ++ H N++ L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 385 CSQGPELILVYEYMANSSLDKFLFGEKRGSL----NWKQ-RFDIILGTARGLAYLHEDFH 439
L LV+EY+ ++ L +++ + G N + F ++ RGLAY H
Sbjct: 72 IHTKKTLTLVFEYL-DTDLKQYM--DDCGGGLSMHNVRLFLFQLL----RGLAYCH---Q 121
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARL--LPENQSHLSTKFAGTLGYTAP------ 491
R++HRD+KP N+L+ + + K+ADFGLAR +P S + TL Y P
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLARAKSVP---SKTYSNEVVTLWYRPPDVLLGS 178
Query: 492 -EYAIHGQLSEKVDAYSFGVLVLEIISG 518
EY S +D + G + E+ +G
Sbjct: 179 TEY------STSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-16
Identities = 71/230 (30%), Positives = 105/230 (45%), Gaps = 29/230 (12%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFE-NEVRLISNVHHRNLIRLLG 383
LG+GGFG++ ++ GK+ A KKL I +R NE +++ V+ R ++ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 384 CCSQGPELILVYEYMANSSLDKFL--------FGEKRGSLNWKQRFDIILGTARGLAYLH 435
L LV M L KF F E+R + I G L LH
Sbjct: 68 AYETKDALCLVLTLMNGGDL-KFHIYNMGNPGFDEERAVFYAAE---ITCG----LEDLH 119
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI 495
+ RI++RD+KP N+LLDD +I+D GLA +PE + GT+GY APE
Sbjct: 120 RE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE--TIRGRVGTVGYMAPEVVK 174
Query: 496 HGQLSEKVDAYSFGVLVLEIISG-----TKSSETKGEEGEYLLKRAWRLY 540
+ + + D + G L+ E+I G + + K EE E +K Y
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 9/200 (4%)
Query: 321 FSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAI--GISRRTLSDFENEVRLISNVHHRN 377
F E K+G G F ++Y+ T L + K VA+KK+ I + + D E+ L+ ++H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFL--FGEKRGSLNWKQRFDIILGTARGLAYLH 435
+I+ L + EL +V E L + + F +++ + + + + + ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI 495
R++HRDIKP+NV + K+ D GL R +++ + GT Y +PE
Sbjct: 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERIH 179
Query: 496 HGQLSEKVDAYSFGVLVLEI 515
+ K D +S G L+ E+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 52/193 (26%), Positives = 89/193 (46%), Gaps = 13/193 (6%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCC 385
LG G G +YK L +I+AVK + + I+ +E+ ++ +I G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 386 SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHR 445
+ + E+M SLD + + I + +GL YL + ++I+HR
Sbjct: 69 FVENRISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYL---WSLKILHR 119
Query: 446 DIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDA 505
D+KPSN+L++ Q K+ DFG++ L + ++ + GT Y APE Q D
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHSDV 176
Query: 506 YSFGVLVLEIISG 518
+S G+ +E+ G
Sbjct: 177 WSLGISFMELALG 189
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 17/200 (8%)
Query: 330 GGFGDIYKGTLKN-GKIVAVKKL--AIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCS 386
G +G ++ K+ G I A+K + A I + + E ++S +++L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 387 QGPE-LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHR 445
QG + L LV EY+ L L E GSL+ I L YLH IIHR
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLL--ENVGSLDEDVARIYIAEIVLALEYLHS---NGIIHR 117
Query: 446 DIKPSNVLLDDDLQPKIADFGLAR-------LLPENQSHLSTKFAGTLGYTAPEYAIHGQ 498
D+KP N+L+D + K+ DFGL++ + + + GT Y APE +
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177
Query: 499 LSEKVDAYSFGVLVLEIISG 518
S+ VD +S G ++ E + G
Sbjct: 178 HSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 76/301 (25%), Positives = 131/301 (43%), Gaps = 53/301 (17%)
Query: 326 KLGEGGFGDIY----KGTLKNGK-------------IVAVKKLAIGISRRTLSDFENEVR 368
KLGEG FG+++ +G K +VAVK L ++ +DF E++
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 369 LISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFG-EKRGSLNWKQRFDIILGT 427
++S + N+IRLL C L ++ EYM N L++FL E + + I T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 428 --------ARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR-LLPENQSHL 478
A G+ YL + +HRD+ N L+ + KIADFG++R L + +
Sbjct: 132 LIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKS---SETKGEE-----GE 530
+ + + + E + G+ + D ++FGV + EI++ K S+ E+ GE
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGE 248
Query: 531 YLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590
+ + ++Y P C + + ++ L C + A RP+ E+ A
Sbjct: 249 FFRDQGRQVY-----------LPKPALC----PDSLYKLMLSCWRRNAKERPSFQEIHAT 293
Query: 591 L 591
L
Sbjct: 294 L 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 70/277 (25%), Positives = 121/277 (43%), Gaps = 22/277 (7%)
Query: 321 FSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRN 377
F E K+G G F ++Y+ T L +G VA+KK+ I + + +D E+ L+ ++H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFL--FGEKRGSLNWKQRFDIILGTARGLAYLH 435
+I+ + EL +V E L + + F +++ + K + + L ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI 495
R++HRDIKP+NV + K+ D GL R +++ + GT Y +PE
Sbjct: 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERIH 179
Query: 496 HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555
+ K D +S G L+ E+ S G++ LY E D P
Sbjct: 180 ENGYNFKSDIWSLGCLLYEM--AALQSPFYGDK--------MNLYSLCKKIEQCDYPPLP 229
Query: 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
++ E ++V MC RP ++ V + K
Sbjct: 230 SDHYSEELRQLVN---MCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 8/196 (4%)
Query: 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
+KLGEG + +YKG K +VA+K++ + EV L+ ++ H N++ L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
L LV+EY+ + L ++L + S+N + RGL Y H +++
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVL 126
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG-QLSEK 502
HRD+KP N+L+++ + K+ADFGLAR S + TL Y P+ + S +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQ 185
Query: 503 VDAYSFGVLVLEIISG 518
+D + G + E+ +G
Sbjct: 186 IDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 42/221 (19%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFEN-------EVRLIS 371
KF ++GEG +G +YK K+ G++VA+KK+ R ++ E E++++
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKV------RLDNEKEGFPITAIREIKILR 61
Query: 372 NVHHRNLIRLLGCCSQGPELI----------LVYEYMANSSLDKFL------FGEKRGSL 415
++HRN++ L + + + LV+EYM + L L F E
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKS 120
Query: 416 NWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475
KQ + GL Y H+ +HRDIK SN+LL++ Q K+ADFGLARL +
Sbjct: 121 FMKQLLE-------GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170
Query: 476 SHLSTKFAGTLGYTAPEYAI-HGQLSEKVDAYSFGVLVLEI 515
S T TL Y PE + + +D +S G ++ E+
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 66/212 (31%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 327 LGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFE---NEVRLISNVHHRNLIRLL 382
LG+G FG + LK ++ AVK L + + D E E R+++ + L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD-DDVECTMTEKRVLALAGKHPFLTQL 61
Query: 383 GCCSQGPE-LILVYEYMANSSLDKFLFGEKRGSLNWKQRF---DIILGTARGLAYLHEDF 438
C Q + L V EY+ L + R + RF +I+LG L +LHE
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-RARFYAAEIVLG----LQFLHER- 115
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLAR--LLPENQSHLSTKFAGTLGYTAPEYAIH 496
II+RD+K NVLLD + KIADFG+ + +L ++ F GT Y APE +
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAPEILSY 170
Query: 497 GQLSEKVDAYSFGVLVLEIISGTKSSETKGEE 528
VD ++ GVL+ E+++G E E+
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPFEGDDED 202
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 74/216 (34%), Positives = 96/216 (44%), Gaps = 30/216 (13%)
Query: 327 LGEGGFGDIY----KGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
LG+G FG + KGT + I A+KK + L H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 383 GCCSQGPE-LILVYEYMANSSL-----DKFLFGEKRGSLNWKQRF---DIILGTARGLAY 433
C Q E L V EY+ L F E R RF +II G L +
Sbjct: 63 -CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARA------RFYAAEIICG----LQF 111
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEY 493
LH+ II+RD+K NVLLD D KIADFG+ + + ST F GT Y APE
Sbjct: 112 LHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPE- 166
Query: 494 AIHGQL-SEKVDAYSFGVLVLEIISGTKSSETKGEE 528
+ GQ +E VD +SFGVL+ E++ G + E+
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 68/229 (29%), Positives = 108/229 (47%), Gaps = 31/229 (13%)
Query: 306 PVNYRL---KDLVSATRKFSEENKLGEGGFGDIYKG-TLKNGKIVAVKKLA-----IGIS 356
P YR K + ++ + +G G +G + K G VAVKKL+ I +
Sbjct: 1 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 60
Query: 357 RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLN 416
+RT E+RL+ ++ H N+I LL + L E + L L G ++
Sbjct: 61 KRTY----RELRLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIV 112
Query: 417 WKQRFD------IILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470
Q+ +I RGL Y+H IIHRD+KPSN+ +++D + KI DFGLAR
Sbjct: 113 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 169
Query: 471 LPENQSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISG 518
+ T + T Y APE ++ ++ VD +S G ++ E+++G
Sbjct: 170 TDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 22/202 (10%)
Query: 327 LGEGGFGDIYKGTLKNGKIV----AVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
LG GGFG + +K+ VKK I + +E ++ +H +++L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI-VETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLN-WKQRFDIILGTARGLAYLHEDFHVR 441
+ ++ EY L L RG + + RF I YLH +
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARF-YIACVVLAFEYLH---NRG 113
Query: 442 IIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK-FAGTLGYTAPEYAI---HG 497
II+RD+KP N+LLD + K+ DFG A+ L +S T F GT Y APE + +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPEIILNKGYD 170
Query: 498 QLSEKVDAYSFGVLVLEIISGT 519
VD +S G+L+ E+++G
Sbjct: 171 FS---VDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 39/211 (18%)
Query: 325 NKLGEGGFGDIYKG-TLKNGKIVAVKKLAIGISRRTLSDFE-----NEVRLISNV-HHRN 377
K+GEG F ++ K + K GK A+K + ++ E E++ + + H N
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-----KKHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 378 LIRLL--------GCCSQGPEL--ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGT 427
++RL+ G + EL + +YE + K EKR ++ + ++
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMDMNLYELIKGR---KRPLPEKR-VKSY--MYQLL--- 110
Query: 428 ARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG 487
+ L ++H I HRDIKP N+L+ DD+ K+ADFG R + + T++ T
Sbjct: 111 -KSLDHMH---RNGIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPY--TEYISTRW 163
Query: 488 YTAPEYAI-HGQLSEKVDAYSFGVLVLEIIS 517
Y APE + G K+D ++ G + EI+S
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 58/198 (29%), Positives = 102/198 (51%), Gaps = 17/198 (8%)
Query: 326 KLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGC 384
K+GEG G + K +G+ VAVK + + +R F NEV ++ + H+N++ +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHQNVVEMYKS 86
Query: 385 CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIH 444
G EL ++ E++ +L + + R LN +Q + + L YLH +IH
Sbjct: 87 YLVGEELWVLMEFLQGGALTD-IVSQTR--LNEEQIATVCESVLQALCYLHSQ---GVIH 140
Query: 445 RDIKPSNVLLDDDLQPKIADFG----LARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLS 500
RDIK ++LL D + K++DFG +++ +P+ +S GT + APE
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-----LVGTPYWMAPEVISRTPYG 195
Query: 501 EKVDAYSFGVLVLEIISG 518
+VD +S G++V+E++ G
Sbjct: 196 TEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 77/314 (24%), Positives = 128/314 (40%), Gaps = 46/314 (14%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLG 383
LG+GGFG++ ++ GK+ A KKL R+ + NE R++ V+ R ++ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
L LV M L ++ + ++ GL L + RI+
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIV 124
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKV 503
+RD+KP N+LLDD +I+D GLA +PE ++ GT+GY APE + + +
Sbjct: 125 YRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR--VGTVGYMAPEVINNEKYTFSP 182
Query: 504 DAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL--DPNECTKE 561
D + G L+ E+I G + +R + E +D + D E +++
Sbjct: 183 DWWGLGCLIYEMIQG---------------QSPFRKRKERVKREEVDRRVKEDQEEYSEK 227
Query: 562 AAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNKPLLKPTFVETDYRKTPADT 621
+E I M R L + G K P F ++++ A+
Sbjct: 228 FSEDAKSICRMLLTKNPKER---------LGCRGNGAAGVK--QHPIFKNINFKRLEAN- 275
Query: 622 STSTALLLLMLQPP 635
ML+PP
Sbjct: 276 ---------MLEPP 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 18/198 (9%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLG 383
+G G FG ++ + + A+K +AI I + NE R++ V H +IRL
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRF---DIILGTARGLAYLHEDFHV 440
L ++ EY+ L +L R S N F +I+ L YLH
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFS-NSTGLFYASEIVCA----LEYLHS---K 120
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLS 500
I++RD+KP N+LLD + K+ DFG A+ L + L GT Y APE +
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL----CGTPEYLAPEVIQSKGHN 176
Query: 501 EKVDAYSFGVLVLEIISG 518
+ VD ++ G+L+ E++ G
Sbjct: 177 KAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 8/211 (3%)
Query: 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRN 377
F + LG+GGFG++ ++ GK+ A K+L R+ S NE +++ V+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
++ L L LV M L ++ ++ GL LH +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG 497
++RD+KP N+LLDD +I+D GLA +PE +S GT+GY APE +
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR--VGTVGYMAPEVLNNQ 176
Query: 498 QLSEKVDAYSFGVLVLEIISGTKSSETKGEE 528
+ + D + G L+ E+I G + E+
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 65/196 (33%), Positives = 89/196 (45%), Gaps = 47/196 (23%)
Query: 346 VAVKKLAIGISRRTLSDFEN---------EVRLISNVHHRNLIRLLGC------CSQGPE 390
VA+KKL SR F+N E+ L+ V+H+N+I LL + +
Sbjct: 44 VAIKKL----SR----PFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95
Query: 391 LILVYEYM-AN------SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
+ LV E M AN LD +R S Q G+ +LH II
Sbjct: 96 VYLVMELMDANLCQVIQMDLD-----HERMSYLLYQML-------CGIKHLHS---AGII 140
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKV 503
HRD+KPSN+++ D KI DFGLAR S + T + T Y APE + E V
Sbjct: 141 HRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENV 198
Query: 504 DAYSFGVLVLEIISGT 519
D +S G ++ E+I GT
Sbjct: 199 DIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 18/210 (8%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFE---NEVRLISNVHHRNLIRLL 382
LG+G FG + LK +G++ AVK L + + D E E R++S + + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD-DDVECTMTEKRILSLARNHPFLTQL 61
Query: 383 GCCSQGPE-LILVYEYMANSSLDKFLFGEKRGSLNWKQRF---DIILGTARGLAYLHEDF 438
CC Q P+ L V E++ L F + R + RF +I L +LH+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARARFYAAEIT----SALMFLHDK- 115
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ 498
II+RD+K NVLLD + K+ADFG+ + N ST F GT Y APE
Sbjct: 116 --GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEML 172
Query: 499 LSEKVDAYSFGVLVLEIISGTKSSETKGEE 528
VD ++ GVL+ E++ G E + E+
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 1e-14
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 27/209 (12%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-----HHRNLIR 380
+G G +G +YKG +K G++ A+K + + D E E++ N+ HHRN+
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDV------TGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 381 LLGC-CSQGP-----ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYL 434
G + P +L LV E+ S+ + K +L + I RGL++L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYA 494
H+ ++IHRDIK NVLL ++ + K+ DFG++ L +T F GT + APE
Sbjct: 128 HQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVI 183
Query: 495 IHGQLSE-----KVDAYSFGVLVLEIISG 518
+ + K D +S G+ +E+ G
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 66/231 (28%), Positives = 94/231 (40%), Gaps = 67/231 (29%)
Query: 323 EENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRL 381
+ ++G G FG + K K G I+AVK R+ S V + RL
Sbjct: 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVK------------------RIRSTVDEKEQKRL 49
Query: 382 L------GCCSQGPELILVY-------------EYMANSSLDKFLFGEKRGSLNWKQRFD 422
L S P ++ Y E M + SLDKF K K
Sbjct: 50 LMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM-DISLDKFY---KYVYEVLKSVIP 105
Query: 423 ------IILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476
I + T + L YL E+ IIHRD+KPSN+LLD + K+ DFG++ L + S
Sbjct: 106 EEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD--S 161
Query: 477 HLSTKFAGTLGYTAPE---------YAIHGQLSEKVDAYSFGVLVLEIISG 518
T+ AG Y APE Y + + D +S G+ + E+ +G
Sbjct: 162 IAKTRDAGCRPYMAPERIDPSARDGYDV------RSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 57/266 (21%), Positives = 113/266 (42%), Gaps = 24/266 (9%)
Query: 327 LGEGGFGD--IYKGTLKNGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLG 383
LG+G FG+ +Y+ T ++ +V K++ + +S + D NE+ ++S + H N+I
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
L++ EY +L + +K + + ++Y+H+ I+
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGIL 123
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKV 503
HRDIK N+ L K+ DFG++++L S T GT Y +PE + + K
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNFKS 182
Query: 504 DAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAA 563
D ++ G ++ E+++ ++ + L ++ + ++ + + E
Sbjct: 183 DIWALGCVLYELLTLKRTF-----DATNPLNLVVKIVQG--NYTPVVSVY-----SSELI 230
Query: 564 EKVVEIALMCTQSAANSRPTMSEVVA 589
V Q RPT EV+
Sbjct: 231 SLVHS----LLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 41/219 (18%)
Query: 319 RKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDF-----ENEVRLISN 372
+++ ++G G +G + + G+ VA+KKL SR S+ E+ L+ +
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL----SRPFQSEIFAKRAYRELTLLKH 70
Query: 373 VHHRNLIRLLGCCSQGP------ELILVYEYMANSSLDKFL---FGEKRGSLNWKQRFDI 423
+ H N+I LL + + LV YM + L K + E K ++ +
Sbjct: 71 MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSED------KVQY-L 122
Query: 424 ILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFA 483
+ GL Y+H IIHRD+KP N+ +++D + KI DFGLAR H +
Sbjct: 123 VYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMT 172
Query: 484 G---TLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISG 518
G T Y APE ++ ++ VD +S G ++ E+++G
Sbjct: 173 GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 27/209 (12%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-----HHRNLIR 380
+G G +G +YKG +K G++ A+K + + D E E++L N+ HHRN+
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDV------TEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 381 LLGC------CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYL 434
G +L LV E+ S+ + K +L I RGLA+L
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYA 494
H ++IHRDIK NVLL ++ + K+ DFG++ L +T F GT + APE
Sbjct: 138 HAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVI 193
Query: 495 I-----HGQLSEKVDAYSFGVLVLEIISG 518
+ D +S G+ +E+ G
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 10/202 (4%)
Query: 320 KFSEENKLGEGGFGD-IYKGTLKNGKIVAVKKLAIGISR---RTLSDFENEVRLISNVHH 375
K+ + K+GEG FG I + ++GK +K+ I IS+ + + EV ++SN+ H
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKE--INISKMSPKEREESRKEVAVLSNMKH 58
Query: 376 RNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLH 435
N+++ + L +V +Y L K + ++ Q D + L ++H
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI 495
+ +I+HRDIK N+ L D K+ DFG+AR+L + L+ GT Y +PE
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELARTCIGTPYYLSPEICE 174
Query: 496 HGQLSEKVDAYSFGVLVLEIIS 517
+ + K D ++ G ++ E+ +
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 60/196 (30%), Positives = 95/196 (48%), Gaps = 15/196 (7%)
Query: 326 KLGEGGFGDIYKG-TLKNGKIVAVK--KLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
++G G +GD+YK L G++ AVK KL G S + E+ ++ H N++
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
G +L + EY SL G L+ Q + T +GLAYLH
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLAYLHSKGK--- 127
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI---HGQL 499
+HRDIK +N+LL D+ K+ADFG+A + + + F GT + APE A +G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS-FIGTPYWMAPEVAAVEKNGGY 186
Query: 500 SEKVDAYSFGVLVLEI 515
++ D ++ G+ +E+
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 18/196 (9%)
Query: 330 GGFGDIYKGTLK-NGKIVAVKKL--AIGISRRTLSDFENEVR-LISNVHHRNLIRLLGCC 385
G FG +Y + G A+K L + I++ +++ + E ++ + +L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 386 SQGPELILVYEYMANSSLDKFLFGEKRGSL--NWKQRFDIILGTARGLAYLHEDFHVRII 443
L LV EY+ + + G L +W +++ I G+ LH+ II
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQY--IAEVVLGVEDLHQR---GII 119
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKV 503
HRDIKP N+L+D K+ DFGL+R EN+ KF GT Y APE + +
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAPETILGVGDDKMS 174
Query: 504 DAYSFGVLVLEIISGT 519
D +S G ++ E + G
Sbjct: 175 DWWSLGCVIFEFLFGY 190
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 34/208 (16%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCC 385
LG+G FG + LK G+ AVK L + L D + E ++ R+L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDV---VLIDDDVECTMVEK-------RVLALA 52
Query: 386 SQGPELILVYEYMANSSLDKFLF-------GEKRGSLNWKQRFDIILGTAR------GLA 432
+ P L + Y + + F G+ + K RFD+ T GL
Sbjct: 53 WENP--FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQ 110
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR--LLPENQSHLSTKFAGTLGYTA 490
+LH II+RD+K NV+LD D KIADFG+ + + +N+ ++ F GT Y A
Sbjct: 111 FLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR---ASTFCGTPDYIA 164
Query: 491 PEYAIHGQLSEKVDAYSFGVLVLEIISG 518
PE + + VD +SFGVL+ E++ G
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 28/205 (13%)
Query: 327 LGEGGFGDIYKG-TLKNGKIVAVKKLA-----IGISRRTLSDFENEVRLISNVHHRNLIR 380
+G G +G + + + VAVKKL+ + +RRT E+RL+ ++ H N+I
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY----RELRLLKHMKHENVIG 78
Query: 381 LLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFD------IILGTARGLAYL 434
LL + + E L L G ++ Q+ +I RGL Y+
Sbjct: 79 LLDVFTPATSI----ENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134
Query: 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYA 494
H IIHRD+KPSNV +++D + +I DFGLAR + T + T Y APE
Sbjct: 135 HS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM----TGYVATRWYRAPEIM 187
Query: 495 IHG-QLSEKVDAYSFGVLVLEIISG 518
++ ++ VD +S G ++ E++ G
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 54/199 (27%), Positives = 103/199 (51%), Gaps = 8/199 (4%)
Query: 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
F + ++LG G G ++K + K +G I+A K + + I + E++++ + ++
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
G E+ + E+M SLD+ L +K G + + + + +GL YL E
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH- 123
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL 499
+I+HRD+KPSN+L++ + K+ DFG++ L ++ ++ F GT Y +PE
Sbjct: 124 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHY 179
Query: 500 SEKVDAYSFGVLVLEIISG 518
S + D +S G+ ++E+ G
Sbjct: 180 SVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKNGK-IVAVKKLAIGISRRTLSDFE-NEVRLISNVHHRN 377
KF +GEG +G + K K K IVA+KK + + E++++ + N
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
++ L + +L LV+EY+ + L+ L G K R I + + + H++
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVR-SYIYQLIKAIHWCHKN 119
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG 497
I+HRDIKP N+L+ + K+ DFG AR L E + T++ T Y +PE +
Sbjct: 120 ---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 498 QLSEKVDAYSFGVLVLEIISG 518
+ VD +S G ++ E+ G
Sbjct: 177 PYGKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-13
Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 343 GKIVAVKKLAIGISR--RTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL-VYEYMA 399
G VA+K L + F E L + ++H N++ LL P L+ V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 400 NSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL---DD 456
+L + L + G+L + ++L LA H I+HRD+KP N+++
Sbjct: 63 GRTLREVLAAD--GALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGV 117
Query: 457 DLQPKIADFGLARLLP------ENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGV 510
K+ DFG+ LLP +T+ GT Y APE ++ D Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 511 LVLEIISG 518
+ LE ++G
Sbjct: 178 IFLECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 8/199 (4%)
Query: 321 FSEENKLGEGGFGDIYKGTLKNGKIVAVKKLA-IGISRRTLSDFENEVRLISNVHHRNLI 379
F ++LG G G + K K ++ +KL + I + E++++ + ++
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
G E+ + E+M SLD+ L KR + I RGLAYL E
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI--AVLRGLAYLREKH- 123
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL 499
+I+HRD+KPSN+L++ + K+ DFG++ L ++ ++ F GT Y +PE
Sbjct: 124 -QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHY 179
Query: 500 SEKVDAYSFGVLVLEIISG 518
S + D +S G+ ++E+ G
Sbjct: 180 SVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 49/201 (24%), Positives = 97/201 (48%), Gaps = 8/201 (3%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKNG-KIVAVKKLAI-GISRRTLSDFENEVRLISNVHHRN 377
K+ + +G G FG ++ K K+V +K++ + +++ +NE +++ + H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
+I + L++V EY +L +++ L+ + L ++H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 438 FHVRIIHRDIKPSNVLLDD-DLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH 496
I+HRD+K N+LLD + KI DFG++++L ++S T GT Y +PE
Sbjct: 121 ---LILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYT-VVGTPCYISPELCEG 175
Query: 497 GQLSEKVDAYSFGVLVLEIIS 517
++K D ++ G ++ E+ S
Sbjct: 176 KPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 57/181 (31%), Positives = 94/181 (51%), Gaps = 17/181 (9%)
Query: 346 VAVKKLAIGISRRTLSDFE-NEVRLISNVHHRNLIRLLGCCS------QGPELILVYEYM 398
VAVKKL+ +T + E+ L+ V+H+N+I LL + + ++ LV E M
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108
Query: 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL 458
+++L + + E L+ ++ ++ G+ +LH IIHRD+KPSN+++ D
Sbjct: 109 -DANLCQVIHME----LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDC 160
Query: 459 QPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
KI DFGLAR N + T + T Y APE + E VD +S G ++ E++ G
Sbjct: 161 TLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
Query: 519 T 519
+
Sbjct: 219 S 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 75/256 (29%), Positives = 111/256 (43%), Gaps = 41/256 (16%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEV-----RLISNVHHRNLIR 380
LG+G FG ++ LK + A+K L + L D + E R++S +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDV---VLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 381 LLGCCSQGPE-LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGT------ARGLAY 433
L C Q E L V EY+ L +F + +FD+ T GL +
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDL---MF-----HIQSCHKFDLPRATFYAAEIICGLQF 111
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEY 493
LH I++RD+K N+LLD D KIADFG+ + + T F GT Y APE
Sbjct: 112 LHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEI 167
Query: 494 AIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553
+ + + VD +SFGVL+ E++ G S G + E L MD
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIG--QSPFHGHDEEELF-----------QSIRMDNPC 214
Query: 554 DPNECTKEAAEKVVEI 569
P T+EA + +V++
Sbjct: 215 YPRWLTREAKDILVKL 230
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 44/220 (20%)
Query: 320 KFSEENKLGEGGFGDI-YKGTLKNGKIVAVKKLAIGISRRTLSDF-----ENEVRLISNV 373
++ + ++G G +G + + G VA+KKL R S+ E+RL+ ++
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL----YRPFQSELFAKRAYRELRLLKHM 71
Query: 374 HHRNLIRLLGCCSQGPELILVYEYMANSSLDKF--------LFGEKRGSLNWKQRFD--- 422
H N+I LL + + SLD+F G G L ++
Sbjct: 72 KHENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR 119
Query: 423 ---IILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS 479
++ +GL Y+H IIHRD+KP N+ +++D + KI DFGLAR + S +
Sbjct: 120 IQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEM- 172
Query: 480 TKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISG 518
T + T Y APE ++ ++ VD +S G ++ E+++G
Sbjct: 173 TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 320 KFSEENKLGEGGFGDIY--KGTLKNGKIVAVKKLAIGISRRTLSDFE---NEVRLISNVH 374
++ K+GEG FG IY K + V +K+ I +++ + + E EV L++ +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKE--IDLTKMPVKEKEASKKEVILLAKMK 57
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILG----TARG 430
H N++ + L +V EY L K + +RG L + D IL + G
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSE---DQILSWFVQISLG 113
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDD-LQPKIADFGLARLLPENQSHLSTKFAGTLGYT 489
L ++H+ +I+HRDIK N+ L + + K+ DFG+AR L + L+ GT Y
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYL 169
Query: 490 APEYAIHGQLSEKVDAYSFGVLVLEI 515
+PE + + K D +S G ++ E+
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 62/205 (30%), Positives = 92/205 (44%), Gaps = 28/205 (13%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVR--------LISNVHHRN 377
+G+G FG + K +GK AVK L + + E + L+ NV H
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-----KKEQKHIMAERNVLLKNVKHPF 57
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRF---DIILGTARGLAYL 434
L+ L +L V +Y+ L L E+ + RF +I A L YL
Sbjct: 58 LVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERS-FPEPRARFYAAEI----ASALGYL 112
Query: 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYA 494
H + II+RD+KP N+LLD + DFGL + E+ ST F GT Y APE
Sbjct: 113 HS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPE-V 167
Query: 495 IHGQLSEK-VDAYSFGVLVLEIISG 518
+ Q ++ VD + G ++ E++ G
Sbjct: 168 LRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 327 LGEGGFGDIYKGTLKN---------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN 377
LG+G F +IYKG L+ G+ V+V +G R F L+S + H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRG-SLNWKQRFDIILGTARGLAYLHE 436
L++L G C + E I+V EY+ LD FL EK SL+WK D+ A L YL +
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119
Query: 437 DFHVRIIHRDIKPSNVLL---DDDLQP----KIADFGLARLLPENQSHLSTKFAGTLGYT 489
+++H ++ N+L+ + K++D G+ + + + + +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----RIPWI 171
Query: 490 APEYAIHGQ--LSEKVDAYSFGVLVLEIISGTK 520
APE +GQ L+ D +SFG +LEI S +
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 84/338 (24%), Positives = 131/338 (38%), Gaps = 95/338 (28%)
Query: 327 LGEGGFGDIYKGT---LKNG---KIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLI 379
LG G FG + + + ++ + VAVK L G + E++++ ++ HH N++
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 380 RLLGCCSQ--GPELILVYEYMANSSLDKFL----------------FGEKRGSLNWKQRF 421
LLG C++ GP +++V EY +L +L E + KQR
Sbjct: 75 NLLGACTKPGGPLMVIV-EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133
Query: 422 DII-------------------------------------------LGTARGLAYLHEDF 438
D + ARG+ +L
Sbjct: 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR- 192
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAG-TLGYTAPEYAIHG 497
+ IHRD+ N+LL ++ KI DFGLAR + ++ ++ A L + APE
Sbjct: 193 --KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK 250
Query: 498 QLSEKVDAYSFGVLVLEIISGTKSSETKG----EEGEYLLKRAWRLYENGTHWELMDESL 553
+ + D +SFGVL+ EI S +S G EE LK R+
Sbjct: 251 VYTTQSDVWSFGVLLWEIFS-LGASPYPGVQIDEEFCRRLKEGTRMRA------------ 297
Query: 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
P T E + I L C + RPT SE+V +L
Sbjct: 298 -PEYATPE----IYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 327 LGEGGFGDIY---KGTLKN-GKIVAVK---KLAIGISRRTLSDFENEVRLISNVHHRNLI 379
LG+GG+G ++ K T + GKI A+K K I +++ + + E ++ V H ++
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGS-LNWKQRF---DIILGTARGLAYLH 435
L+ G +L L+ EY++ L F+ E+ G + F +I L L +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLA----LEHLH 117
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI 495
II+RD+KP N+LLD K+ DFGL + + T F GT+ Y APE +
Sbjct: 118 ---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMAPEILM 173
Query: 496 HGQLSEKVDAYSFGVLVLEIISGT 519
+ VD +S G L+ ++++G
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 327 LGEGGFGDIY---------KGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN 377
LG+G FG ++ G L K++ KK + + R + E ++ ++ V+H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVL--KKATLKVRDRVRTKMERDI--LAEVNHPF 59
Query: 378 LIRLLGCCSQGPELILVYEYMANSSL-----DKFLFGEKRGSLNWKQRFDIILGTARGLA 432
+++L +L L+ +++ L + +F E+ + A L
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-------LALALD 112
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPE 492
+LH + II+RD+KP N+LLD++ K+ DFGL++ + + F GT+ Y APE
Sbjct: 113 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPE 168
Query: 493 YAIHGQLSEKVDAYSFGVLVLEIISGT 519
++ D +SFGVL+ E+++G+
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGS 195
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 21/199 (10%)
Query: 326 KLGEGGFGDIYKG-TLKNGKIVAVK--KLAIGISRRTLSDF---ENEVRLISNVHHRNLI 379
++G G +GD+YK + G++ A+K KL G DF + E+ ++ + H N++
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPG------EDFAVVQQEIIMMKDCKHSNIV 69
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
G + +L + E+ SL G L+ Q + T +GL YLH
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIY--HVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI---H 496
+HRDIK +N+LL D+ K+ADFG++ + + + F GT + APE A
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS-FIGTPYWMAPEVAAVERK 183
Query: 497 GQLSEKVDAYSFGVLVLEI 515
G ++ D ++ G+ +E+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 41/129 (31%), Positives = 70/129 (54%), Gaps = 7/129 (5%)
Query: 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKP 449
E+ + E+M SLD+ L +K G + I + RGL YL E +I+HRD+KP
Sbjct: 73 EISICMEHMDGGSLDQVL--KKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKP 128
Query: 450 SNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFG 509
SN+L++ + K+ DFG++ L ++ ++ F GT Y +PE + + D +S G
Sbjct: 129 SNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLG 185
Query: 510 VLVLEIISG 518
+ ++E+ G
Sbjct: 186 LSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 5e-13
Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 13/195 (6%)
Query: 327 LGEGGFGDIYKGTL----KNGKIVAVKKLAI-GISRRTLSDFENEVRLISNVHHRNLIRL 381
+G+G +G++ +L +GK +KKL + SRR E E +L+S + H N++
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 382 LGCCSQGP-ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
L +V + L L +K L Q + + A L YLHE
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK--- 121
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLS 500
I+HRD+K NV L K+ D G+AR+L ENQ +++ GT Y +PE + +
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPELFSNKPYN 180
Query: 501 EKVDAYSFGVLVLEI 515
K D ++ G V E+
Sbjct: 181 YKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 30/223 (13%)
Query: 306 PVNYRLKDLVSATRKFSEENKLGEGGFGDIYKG-TLKNGKIVAVKKLAIGI----SRRTL 360
P N+RL L LG+G FG +Y G+ +AVK++ + + +
Sbjct: 1 PTNWRLGKL------------LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEV 48
Query: 361 SDFENEVRLISNVHHRNLIRLLGCCSQGPE--LILVYEYMANSSLDKFLFGEKRGSLNWK 418
+ E E++L+ N+ H +++ GC E L + E+M S+ L + G+L
Sbjct: 49 NALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTEN 106
Query: 419 QRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478
G++YLH + I+HRDIK +N+L D K+ DFG ++ L L
Sbjct: 107 VTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL--QTICL 161
Query: 479 S----TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS 517
S GT + +PE K D +S G V+E+++
Sbjct: 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 36/214 (16%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-----HHRNLIR 380
+G+G +G +YK T K+G + AVK L +SD + E+ N+ +H N+++
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKIL------DPISDVDEEIEAEYNILQSLPNHPNVVK 83
Query: 381 LLGCCSQ-----GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFD------IILGTAR 429
G + G +L LV E S+ + + +G L QR D I+ G
Sbjct: 84 FYGMFYKADKLVGGQLWLVLELCNGGSVTELV----KGLLICGQRLDEAMISYILYGALL 139
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYT 489
GL +LH + RIIHRD+K +N+LL + K+ DFG++ L + +T GT +
Sbjct: 140 GLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWM 195
Query: 490 APEY-AIHGQLSEKVDA----YSFGVLVLEIISG 518
APE A Q DA +S G+ +E+ G
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAI--GISRRTLSDFEN-----EVRLISNVHHR 376
+ +LG+G FG +Y +K+ K VA ++L + I L+ E E +L+S + H
Sbjct: 5 QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRG--SLNWKQRFDIILGTARGLAYL 434
+++ + ++ EY LD L K +L+ Q + + G+ Y+
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYA 494
H+ RI+HRD+K N+ L ++L KI DFG++RLL L+T F GT Y +PE
Sbjct: 123 HQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEAL 177
Query: 495 IHGQLSEKVDAYSFGVLVLEI 515
H K D +S G ++ E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 327 LGEGGFGDIYKG-TLKNGKIVAVKKLAIGI----SRRTLSDFENEVRLISNVHHRNLIRL 381
LG+G FG +Y + G+ +A K++ + + +S E E++L+ N+ H +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 382 LGCCSQGPE--LILVYEYMANSSLDKFL--FGEKRGSLNWKQRFDIILGTARGLAYLHED 437
GC E L + EYM S+ L +G S+ K I+ G++YLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLHSN 125
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLA-RLLPENQSHLSTK-FAGTLGYTAPEYAI 495
I+HRDIK +N+L D K+ DFG + RL S + GT + +PE
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 496 HGQLSEKVDAYSFGVLVLEIIS 517
K D +S G V+E+++
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 58/211 (27%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLA-----IGISRRTLSDFENEVRLIS 371
K+ +G G +G + + + VA+KK+A ++RTL E++L+
Sbjct: 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL----REIKLLR 59
Query: 372 NVHHRNLIRLLGCC-----SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILG 426
++ H N+I + ++ +VYE M ++ L + + + S + Q F +
Sbjct: 60 HLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYF--LYQ 116
Query: 427 TARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTL 486
RGL Y+H ++HRD+KPSN+LL+ + KI DFGLAR E + T++ T
Sbjct: 117 LLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM-TEYVVTR 172
Query: 487 GYTAPEYAIH-GQLSEKVDAYSFGVLVLEII 516
Y APE ++ + + +D +S G + E++
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
++LG+G +G +YK + G +A+K++ + + + E+ ++ ++ G
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 384 CCSQGPELILVYEYMANSSLDKFLFG-EKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
+ + EYM SLDK G + I +GL +L E+ + I
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--I 124
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSE- 501
IHRD+KP+NVL++ + Q K+ DFG++ L + L+ G Y APE G ++
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTNIGCQSYMAPERIKSGGPNQN 181
Query: 502 -----KVDAYSFGVLVLEIISG 518
+ D +S G+ +LE+ G
Sbjct: 182 PTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 73/290 (25%), Positives = 117/290 (40%), Gaps = 46/290 (15%)
Query: 325 NKLGEGGFGDIYKGTLKNGKIVA---VKKLAIGISRRTLSDFENEVRLISNVHHRNLIRL 381
+++G G FG + G G A VK+L + F EV+ ++H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 382 LGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTA----RGLAYLHE- 436
LG C + +LV E+ L +L RG + + D++ A GL +LH+
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSN-RGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLA-RLLPENQSHLSTKFAGTLGYTAPEY-- 493
DF IH D+ N L DL KI D+GLA PE+ A L + APE
Sbjct: 120 DF----IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 494 AIHGQL-----SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWEL 548
L ++K + +S GV + E L A + Y + + ++
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWE-----------------LFTAADQPYPDLSDEQV 218
Query: 549 M-------DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
+ D L + + +++ E+ C +RPT EV LL
Sbjct: 219 LKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 47/192 (24%), Positives = 90/192 (46%), Gaps = 17/192 (8%)
Query: 335 IYKGTLKNGKIV--AVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG----CCSQG 388
IYKG N +++ KK G + + ENE++ + + N++++ G
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGH-KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 389 PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIK 448
P L L+ EY L + L EK L++K + D+ + +GL L++ + ++++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLT 150
Query: 449 PSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYA--IHGQLSEKVDAY 506
+ L+ ++ + KI GL ++L S K + Y + + I + + K D Y
Sbjct: 151 SVSFLVTENYKLKIICHGLEKIL----SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIY 206
Query: 507 SFGVLVLEIISG 518
S GV++ EI +G
Sbjct: 207 SLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 71/246 (28%), Positives = 109/246 (44%), Gaps = 35/246 (14%)
Query: 327 LGEGGFGDIY----KGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
LG+G FG + KGT + I +KK I + + E R+++ + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 383 GCCSQGPE-LILVYEYMANSSLDKFLFGEKRGSLNWKQRF---DIILGTARGLAYLHEDF 438
CC Q + L V EY+ L F R + RF ++ L L +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDL-MFQIQRSRKFDEPRSRFYAAEVTLA----LMFLHRH- 115
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLAR--LLPENQSHLSTKFAGTLGYTAPEYAIH 496
+I+RD+K N+LLD + K+ADFG+ + +L +T F GT Y APE
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---TTTTFCGTPDYIAPEILQE 170
Query: 497 GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556
+ VD ++ GVL+ E+++G E E+ L+E+ H D+ L P
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPFEADNED---------DLFESILH----DDVLYPV 217
Query: 557 ECTKEA 562
+KEA
Sbjct: 218 WLSKEA 223
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 37/216 (17%)
Query: 327 LGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRL---- 381
LG G G ++ + K VAVKK+ + +++ E+++I + H N++++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 382 ----------LGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGL 431
+G ++ + +V EYM + L L + S + F L RGL
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL-EQGPLSEEHARLFMYQL--LRGL 127
Query: 432 AYLHEDFHVRIIHRDIKPSNVLLD-DDLQPKIADFGLARLLPENQSH-------LSTKFA 483
Y+H ++HRD+KP+NV ++ +DL KI DFGLAR++ + SH L TK+
Sbjct: 128 KYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW- 183
Query: 484 GTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISG 518
Y +P + ++ +D ++ G + E+++G
Sbjct: 184 ----YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 71/291 (24%), Positives = 122/291 (41%), Gaps = 52/291 (17%)
Query: 327 LGEGGFGDIYKGTLK----NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRL 381
LG+G FG + + LK + + VAVK L I S + +F E + H N+I+L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 382 LGCC----SQG--PELILVYEYMANSSLDKFLF----GEKRGSLNWKQRFDIILGTARGL 431
+G ++G P +++ +M + L FL GE+ +L + ++ A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 432 AYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ-------SHLSTKFAG 484
YL IHRD+ N +L++++ +ADFGL++ + S L K+
Sbjct: 127 EYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 485 TLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE---YLLKRAWRLYE 541
Y H D ++FGV + EI++ ++ E E YL+K RL +
Sbjct: 184 LESLADNVYTTHS------DVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK-GNRLKQ 236
Query: 542 NGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
P +C ++ V E+ C RP+ + L+
Sbjct: 237 -------------PPDCLED----VYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 43/226 (19%)
Query: 327 LGEGGFGDIY----KGTLKNGKIVAVK---KLAIGISRRTLSDFENEVRLISNVHHRNLI 379
LG G +G ++ G GK+ A+K K I +T H R
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAE------------HTRTER 55
Query: 380 RLLGCCSQGPELI-LVYEYMANSSLDKFL----FGEKRGSLNWKQRFD----------II 424
++L + P L+ L Y + ++ L L GE L ++ F I+
Sbjct: 56 QVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIV 115
Query: 425 LGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAG 484
L L +LH+ + II+RDIK N+LLD + + DFGL++ + + F G
Sbjct: 116 LA----LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCG 168
Query: 485 TLGYTAPEYAIHGQL--SEKVDAYSFGVLVLEIISGTKSSETKGEE 528
T+ Y APE G + VD +S GVL E+++G GE+
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 9e-12
Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 319 RKFSEENKLGEGGFGDI---YKGTLKNGKIVAVKKLAIGISRRTLSDFE-NEVRLISNVH 374
+++ +G G G + Y L VA+KKL+ +T + E+ L+ V+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 375 HRNLIRLLGCCSQGPELILVYE-YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAY 433
H+N+I LL + L + Y+ +D L + L+ ++ ++ G+ +
Sbjct: 75 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 134
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEY 493
LH IIHRD+KPSN+++ D KI DFGLAR S + T + T Y APE
Sbjct: 135 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 189
Query: 494 AIHGQLSEKVDAYSFGVLVLEII 516
+ E VD +S G ++ E++
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 28/222 (12%)
Query: 306 PVNYRLKDLVSATRKFSEENKLGEGGFGDIYKG-TLKNGKIVAVKKLAIGI----SRRTL 360
PVN+RL L LG G FG++Y G+ +AVK++ + + +
Sbjct: 1 PVNWRLGKL------------LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEV 48
Query: 361 SDFENEVRLISNVHHRNLIRLLGCCSQGPE--LILVYEYMANSSLDKFLFGEKRGSLNWK 418
+ E E++L+ N+ H +++ GC E L + EYM S+ L + G+L
Sbjct: 49 NALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTEN 106
Query: 419 QRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLA-RLLPENQSH 477
+G++YLH + I+HRDIK +N+L D K+ DFG + R+ S
Sbjct: 107 VTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSG 163
Query: 478 LSTK-FAGTLGYTAPEYAIHGQ-LSEKVDAYSFGVLVLEIIS 517
K GT + +PE I G+ K D +S V+E+++
Sbjct: 164 TGIKSVTGTPYWMSPE-VISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 44/158 (27%), Positives = 68/158 (43%), Gaps = 13/158 (8%)
Query: 362 DFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRF 421
E+ ++ + HR +I L+ + +V M D F + ++ G L +Q
Sbjct: 132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAI 188
Query: 422 DIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK 481
I LAYLH IIHRD+K N+ LD+ + DFG A L H T
Sbjct: 189 TIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA---HPDTP 242
Query: 482 ----FAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEI 515
++GTL +PE K D +S G+++ E+
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 39/103 (37%), Positives = 57/103 (55%), Gaps = 8/103 (7%)
Query: 428 ARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK--FAGT 485
A GL +LH II+RD+K NV+LD + KIADFG+ + EN T F GT
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFCGT 164
Query: 486 LGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE 528
Y APE + + VD ++FGVL+ E+++G + + E+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 207
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 327 LGEGGFGDIYKGTLKN-GKIVAVKKLA--IGISRRTLSDFENEVRLI--SNVHHRNLIRL 381
+G+G FG +Y+ K+ +I A+K L+ ++++ ++ E ++ + + I
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 382 LGCCSQGP-ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
L Q +L LV +YM+ L F +K G + + I L +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLALEHLHKY--- 115
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLARL-LPENQSHLSTKFAGTLGYTAPEYAIHGQ- 498
I++RD+KP N+LLD + DFGL++ L +N+ + F GT Y APE + +
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKG 173
Query: 499 LSEKVDAYSFGVLVLEIISG 518
++ VD +S GVLV E+ G
Sbjct: 174 YTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 327 LGEGGFGDIY----KGTLKNGKIVA---VKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
LG G +G ++ +GK+ A +KK I +T E +++ ++ +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 380 RLLGCCSQ-GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRF--DIILGTARGLAYLHE 436
L Q +L L+ +Y+ L L +R Q + +I+L L +LH+
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLA----LEHLHK 123
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH 496
+ II+RDIK N+LLD + + DFGL++ E++ + F GT+ Y AP+
Sbjct: 124 ---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180
Query: 497 GQL--SEKVDAYSFGVLVLEIISGTKSSETKGEE 528
G + VD +S GVL+ E+++G GE+
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 327 LGEGGFGDIYKGTLKNGKI--VAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLL 382
LG G FG + T KN VA+K+ I ++ + +E ++++ ++H + L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH-VR 441
G L LV E++ FL KR D+ A + + E +
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP------NDVGCFYAAQIVLIFEYLQSLN 151
Query: 442 IIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSE 501
I++RD+KP N+LLD D K+ DFG A+++ + +++ GT Y APE ++ +
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-DTRTY---TLCGTPEYIAPEILLNVGHGK 207
Query: 502 KVDAYSFGVLVLEIISG 518
D ++ G+ + EI+ G
Sbjct: 208 AADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 319 RKFSEENKLGEGGFGDI---YKGTLKNGKIVAVKKLAIGISRRTLSDFE-NEVRLISNVH 374
+++ +G G G + Y L+ + VA+KKL+ +T + E+ L+ V+
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 81
Query: 375 HRNLIRLLGCCSQGPELILVYE-YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAY 433
H+N+I LL + L + Y+ +D L + L+ ++ ++ G+ +
Sbjct: 82 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEY 493
LH IIHRD+KPSN+++ D KI DFGLAR S + T + T Y APE
Sbjct: 142 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 196
Query: 494 AIHGQLSEKVDAYSFGVLVLEIISG 518
+ E VD +S G ++ E+I G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 60/196 (30%), Positives = 88/196 (44%), Gaps = 10/196 (5%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKL--AIGISRRTLSDFENEVR-LISNVHHRNLIRLL 382
+G+G FG + K +GK AVK L I ++R+ E L+ NV H L+ L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
+L V +++ L F +R + RF A L YLH + I
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL-FFHLQRERSFPEPRARF-YAAEIASALGYLHS---INI 117
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEK 502
++RD+KP N+LLD + DFGL + QS +T F GT Y APE
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 503 VDAYSFGVLVLEIISG 518
VD + G ++ E++ G
Sbjct: 177 VDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 24/202 (11%)
Query: 326 KLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISN-------VHHRN 377
++G+GG+G ++ K+ G+IVA+K++ + L NEVR +
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRM----KKSLLFKL-NEVRHVLTERDILTTTKSEW 62
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQ-RFDIILGTARGLAYLHE 436
L++LL L L EY+ L G L+ RF + + LHE
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AVDALHE 119
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH 496
+ IHRD+KP N L+D K+ DFGL++ + G+ Y APE
Sbjct: 120 ---LGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRG 172
Query: 497 GQLSEKVDAYSFGVLVLEIISG 518
VD +S G ++ E + G
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 326 KLGEGGFGDI----YKGTLKNGKIVAVKKLAIGIS-----RRTLSDFENEVRLISNVH-H 375
+LG+G +G + T + VA+KK+ S +R L E++L+ + H
Sbjct: 7 ELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRAL----RELKLLRHFRGH 61
Query: 376 RNLIRL--LGCCSQGP--ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGL 431
+N+ L + G EL L YE + + L + + + + Q F I GL
Sbjct: 62 KNITCLYDMDIVFPGNFNELYL-YEELMEADLHQIIRSGQPLTDAHFQSF--IYQILCGL 118
Query: 432 AYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP----ENQSHLSTKFAGTLG 487
Y+H ++HRD+KP N+L++ D + KI DFGLAR EN + T++ T
Sbjct: 119 KYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVATRW 174
Query: 488 YTAPEYAIHGQ-LSEKVDAYSFGVLVLEIISGT 519
Y APE + Q ++ +D +S G ++ E++
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 59/195 (30%), Positives = 92/195 (47%), Gaps = 9/195 (4%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVK--KLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
LG+G FG + K +GK A+K K + I++ ++ E R++ N H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
L V EY+ L L E+ S + + + + +A L YLH +I+
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSA--LDYLHSG---KIV 117
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKV 503
+RD+K N++LD D KI DFGL + + + + T F GT Y APE V
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGRAV 176
Query: 504 DAYSFGVLVLEIISG 518
D + GV++ E++ G
Sbjct: 177 DWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 61/203 (30%), Positives = 88/203 (43%), Gaps = 25/203 (12%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVK--KLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
LG+G FG + K GK A+K K + I++ ++ E R++ N H L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 384 CCSQGPELILVYEYMANSSLDKFL-----FGEKRGSLNWKQRF---DIILGTARGLAYLH 435
L V EY L L F E R RF +I+ L YLH
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA------RFYGAEIVSA----LGYLH 112
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI 495
+++RD+K N++LD D KI DFGL + + + + T F GT Y APE
Sbjct: 113 SC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLE 168
Query: 496 HGQLSEKVDAYSFGVLVLEIISG 518
VD + GV++ E++ G
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 83/334 (24%), Positives = 130/334 (38%), Gaps = 86/334 (25%)
Query: 327 LGEGGFGDIYKGTL------KNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLI 379
LG G FG + + + + VAVK L G + +E++++ ++ +H N++
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVV 74
Query: 380 RLLGCCS--QGPELILV----YEYMAN--------------------------------- 400
LLG C+ GP +++V Y ++N
Sbjct: 75 NLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVD 134
Query: 401 ----SSLDKFLFGE----KRGSLN--------WKQRF---DII---LGTARGLAYLHEDF 438
+ LF GS N WK D+I ARG+ +L
Sbjct: 135 RRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR- 193
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAG-TLGYTAPEYAIHG 497
+ IHRD+ N+LL ++ KI DFGLAR + ++ ++ A L + APE
Sbjct: 194 --KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDK 251
Query: 498 QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557
+ + D +SFGVL+ EI S S + E +R ++GT P
Sbjct: 252 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR----LKDGTRMRA------PEN 301
Query: 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
T E + I L C Q RPT S +V +L
Sbjct: 302 ATPE----IYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 78/339 (23%), Positives = 131/339 (38%), Gaps = 91/339 (26%)
Query: 327 LGEGGFGDIYKGT------LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLI 379
LG G FG + + + VAVK L G + +E++++ ++ HH N++
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 380 RLLGCCSQ-GPELILVYEYMANSSLDKFLFGEK--------------RGSLNW------- 417
LLG C++ G L+++ E+ +L +L ++ +G +
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 418 KQRFDIILGT--------------------------------------------ARGLAY 433
K+R D I + A+G+ +
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAG-TLGYTAPE 492
L + IHRD+ N+LL ++ KI DFGLAR + ++ ++ A L + APE
Sbjct: 195 LASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251
Query: 493 YAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552
+ + D +SFGVL+ EI S S + E +R + GT
Sbjct: 252 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR----LKEGTRMRA---- 303
Query: 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
P+ T E + + L C + RPT SE+V L
Sbjct: 304 --PDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 19/197 (9%)
Query: 327 LGEGGFGDIYKGTLKNG-KIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCC 385
+GEG FG N + A+K++ + S + D E L++ + H N++
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 386 SQGPELILVYEYMANSSLDKFLFGEKRGSL-------NWKQRFDIILGTARGLAYLHEDF 438
L +V EY L + + +RG L W + G+ ++HE
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKI-KLQRGKLFPEDTILQW------FVQMCLGVQHIHEK- 119
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ 498
R++HRDIK N+ L + + K+ DFG ARLL ++ T + GT Y PE +
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVPPEIWENMP 176
Query: 499 LSEKVDAYSFGVLVLEI 515
+ K D +S G ++ E+
Sbjct: 177 YNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 65/248 (26%), Positives = 97/248 (39%), Gaps = 66/248 (26%)
Query: 327 LGEGGFGDIY----KGTLKNGKIVAVKKL--AIGISRRTLSDFENEVRLISNVHHRNLIR 380
+G G FG+++ K T G++ A+K L + I R ++ E ++++ +++
Sbjct: 9 IGRGAFGEVWLVRDKDT---GQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 381 LLGCCSQGPE-LILVYEYMANSSLDKFLFGEKRGSLNWKQRFD----------IILGTAR 429
L Q E L LV EYM G+ L K F ++L
Sbjct: 66 LY-YSFQDEEHLYLVMEYMPG--------GDLMNLLIRKDVFPEETARFYIAELVLA--- 113
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLA--------RLLPENQSHLSTK 481
L +H+ IHRDIKP N+L+D D K+ADFGL R N SH
Sbjct: 114 -LDSVHKLGF---IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 482 FA--------------------GTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTK- 520
GT Y APE + D +S GV++ E++ G
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
Query: 521 -SSETKGE 527
S+T E
Sbjct: 230 FYSDTLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 327 LGEGGFGDIY----KGTLKNGKIVAVK---KLAIGISRRTLSDFENEVRLISNVHHRNLI 379
LG G +G ++ GK+ A+K K A+ +T+ E ++ +V +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 380 RLLGCCSQG-PELILVYEYMANSSLDKFLFGEKRGSLNWKQRF---DIILGTARGLAYLH 435
L Q +L L+ +Y++ + L+ S + + RF +IIL L +LH
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED-EVRFYSGEIILA----LEHLH 122
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI 495
+ + I++RDIK N+LLD + + DFGL++ + + F GT+ Y APE I
Sbjct: 123 K---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE-II 178
Query: 496 HGQL--SEKVDAYSFGVLVLEIISGTKSSETKGE 527
G+ + VD +S G+L+ E+++G +GE
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 41/103 (39%), Positives = 60/103 (58%), Gaps = 8/103 (7%)
Query: 428 ARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ-SHLSTK-FAGT 485
A GL +LH II+RD+K NV+LD + KIADFG+ + EN ++TK F GT
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGT 164
Query: 486 LGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE 528
Y APE + + VD ++FGVL+ E+++G E + E+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 28/210 (13%)
Query: 327 LGEGGFGDIYK-GTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-----HHRNLIR 380
+G+G +G ++K KNG AVK L + D + E+ N+ H N+++
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL------DPIHDIDEEIEAEYNILKALSDHPNVVK 79
Query: 381 LLGC-----CSQGPELILVYEYMANSSLDKFLFGE-KRGSLNWKQRFDIILGTA-RGLAY 433
G G +L LV E S+ + G KRG + IL A GL +
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQH 139
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEY 493
LH + + IHRD+K +N+LL + K+ DFG++ L + +T GT + APE
Sbjct: 140 LHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAPEV 195
Query: 494 -AIHGQL----SEKVDAYSFGVLVLEIISG 518
A QL + D +S G+ +E+ G
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 37/210 (17%)
Query: 327 LGEGGFGDIYKGTLK--NGKIVAVK---KLAIGISR-RTLSDFENEVRLISNVHHRN--L 378
+G GGFG++Y G K GK+ A+K K I + + TL+ NE ++S V +
Sbjct: 2 IGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLA--LNERIMLSLVSTGDCPF 58
Query: 379 IRLLGCCSQGPE-LILVYEYMANSSLDKFL-----FGEKRGSLNWKQRF---DIILGTAR 429
I + P+ L + + M L L F E + RF +IILG
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA------EMRFYAAEIILG--- 109
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYT 489
L ++H F +++RD+KP+N+LLD+ +I+D GLA + + H S GT GY
Sbjct: 110 -LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 490 APEYAIHG-QLSEKVDAYSFGVLVLEIISG 518
APE G D +S G ++ +++ G
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 60/198 (30%), Positives = 89/198 (44%), Gaps = 15/198 (7%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKL--AIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
LG+G FG + K G+ A+K L + I++ ++ E R++ N H L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRF---DIILGTARGLAYLHEDFHV 440
L V EY AN F +R + RF +I+ L YLH
Sbjct: 63 AFQTHDRLCFVMEY-ANGGELFFHLSRERVFTEERARFYGAEIV----SALEYLHSR--- 114
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLS 500
+++RDIK N++LD D KI DFGL + + + + T F GT Y APE
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYG 173
Query: 501 EKVDAYSFGVLVLEIISG 518
VD + GV++ E++ G
Sbjct: 174 RAVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 321 FSEENKLGEGGFGDIY----KGTLKNGKIVAVKKL--AIGISRRTLSDFENEVRLISNVH 374
F ++ +G G FG++ K T G I A+K + ++ +++ T+S FE E ++S +
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYL 434
+ +L L LV EY L L+ R++ YL
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDL-----------LSLLNRYEDQFDEDMAQFYL 108
Query: 435 HE------DFH-VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG 487
E H + +HRDIKP NVL+D K+ADFG A L N+ S GT
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD 168
Query: 488 YTAPEY--AIHGQLSE----KVDAYSFGVLVLEIISGT 519
Y APE ++G + D +S GV+ E+I G
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 63/197 (31%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVK---KLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
+G+G FG + K K AVK K AI + L+ NV H L+ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
+L V +Y+ L L E R L + RF A L YLH + I
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARF-YAAEIASALGYLHS---LNI 117
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEK 502
++RD+KP N+LLD + DFGL + E+ ST F GT Y APE +H Q ++
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPE-VLHKQPYDR 175
Query: 503 -VDAYSFGVLVLEIISG 518
VD + G ++ E++ G
Sbjct: 176 TVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 34/86 (39%), Positives = 47/86 (54%), Gaps = 7/86 (8%)
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPE 492
YLH II+RD+KP N+LLD+ K+ DFG A+ +P+ L GT Y APE
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL----CGTPEYLAPE 185
Query: 493 YAIHGQLSEKVDAYSFGVLVLEIISG 518
+ VD ++ GVL+ E I+G
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 29/206 (14%)
Query: 327 LGEGGFGDIYKGTLK--NGKIVAVK---KLAIGISR-RTLSDFENEVRLISNVHHRN--L 378
+G GGFG++Y G K GK+ A+K K I + + TL+ NE ++S V +
Sbjct: 2 IGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLA--LNERIMLSLVSTGDCPF 58
Query: 379 IRLLGCCSQGPE-LILVYEYMANSSLDKFLFGEKRGSLNWKQ-RF---DIILGTARGLAY 433
I + P+ L + + M L L + G + K+ RF +IILG L +
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILG----LEH 112
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEY 493
+H F +++RD+KP+N+LLD+ +I+D GLA + + H S GT GY APE
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 166
Query: 494 AIHGQ-LSEKVDAYSFGVLVLEIISG 518
G D +S G ++ +++ G
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 58/196 (29%), Positives = 87/196 (44%), Gaps = 10/196 (5%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKL--AIGISRRTLSDFENEVR-LISNVHHRNLIRLL 382
+G+G FG + K +G AVK L + ++ + E L+ N+ H L+ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
+L V +Y+ L F +R L + RF A + YLH + I
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL-FFHLQRERCFLEPRARF-YAAEVASAIGYLHS---LNI 117
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEK 502
I+RD+KP N+LLD + DFGL + E + ST F GT Y APE
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPYDRT 176
Query: 503 VDAYSFGVLVLEIISG 518
VD + G ++ E++ G
Sbjct: 177 VDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 45/143 (31%), Positives = 71/143 (49%), Gaps = 10/143 (6%)
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
L +L C L V EY+ L + ++ G Q + GL +LH
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH-LSTK-FAGTLGYTAPEYAI 495
II+RD+K NV+LD + KIADFG+ + E+ ++T+ F GT Y APE
Sbjct: 121 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPEIIA 174
Query: 496 HGQLSEKVDAYSFGVLVLEIISG 518
+ + VD +++GVL+ E+++G
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 9e-10
Identities = 26/76 (34%), Positives = 34/76 (44%), Gaps = 2/76 (2%)
Query: 167 SKNNIIGSRAG-ANDDDDKNSTAVYGIAQCVETISETGCQNCLSGAFDNIQR-CLGSAFG 224
S N S G A VYG+AQC +S + C++CL+ A ++R C G
Sbjct: 31 SSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRSCLATAVSELRRCCPNKKGG 90
Query: 225 WAVDAGCFLRYSDTPF 240
CFLRY PF
Sbjct: 91 RIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 15/198 (7%)
Query: 327 LGEGGFGDIY----KGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
+G+G FG + + T + + ++K I +SR ++ E +++ V+ I L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNC-PFIVPL 58
Query: 383 GCCSQGPE-LILVYEYMANSSLDKFLFGEKRGSLN-WKQRFDIILGTARGLAYLHEDFHV 440
Q PE L LV ++ L F ++ G + + RF L LH+
Sbjct: 59 KFSFQSPEKLYLVLAFINGGEL--FHHLQREGRFDLSRARF-YTAELLCALENLHK---F 112
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLS 500
+I+RD+KP N+LLD + DFGL +L ++ +T F GT Y APE + +
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGYT 171
Query: 501 EKVDAYSFGVLVLEIISG 518
+ VD ++ GVL+ E+++G
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 14/198 (7%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVK--KLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
LG+G FG + K G+ A+K K + +++ ++ E R++ N H L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRF---DIILGTARGLAYLHEDFHV 440
L V EY AN F +R + RF +I+ L YLH + +V
Sbjct: 63 SFQTHDRLCFVMEY-ANGGELFFHLSRERVFSEDRARFYGAEIV----SALDYLHSEKNV 117
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLS 500
++RD+K N++LD D KI DFGL + ++ + + T F GT Y APE
Sbjct: 118 --VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYG 174
Query: 501 EKVDAYSFGVLVLEIISG 518
VD + GV++ E++ G
Sbjct: 175 RAVDWWGLGVVMYEMMCG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 58/233 (24%)
Query: 316 SATRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSD--FEN-EVRLIS 371
S + + N +G G FG +Y+ + + VA+KK+ L D ++N E+ ++
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV--------LQDPQYKNRELLIMK 114
Query: 372 NVHHRNLIRL-----LGCCSQGPELIL-----------VYEYMA-----NSSLDKFLFGE 410
N++H N+I L C + + I V++YM N +L FL
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL 174
Query: 411 KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP-KIADFGLAR 469
L R LAY+H F I HRD+KP N+L+D + K+ DFG A+
Sbjct: 175 YSYQL------------CRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219
Query: 470 LLPENQ---SHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISG 518
L Q S++ ++F Y APE + + +D +S G ++ E+I G
Sbjct: 220 NLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-09
Identities = 53/229 (23%), Positives = 89/229 (38%), Gaps = 48/229 (20%)
Query: 326 KLGEGGFGDIYKG-TLKNGKIVAVKKLAIGISRRTLSDFE-------NEVRLISNVHHRN 377
+G+GG G++Y + VA+KK+ R LS+ E ++ +++ H
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI-----REDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFL------------FGEKRGSLNWKQRFDIIL 425
++ + CS G + Y+ +L L EK + F I
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL--------------L 471
T + Y+H ++HRD+KP N+LL + I D+G A
Sbjct: 124 AT---IEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 472 PENQSHLST---KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS 517
T K GT Y APE + SE D Y+ GV++ ++++
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 429 RGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR--LLPENQSHLSTKFAGTL 486
R L Y+H + HRD+KP N+L + D + KI DFGLAR + T + T
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 487 GYTAPEY--AIHGQLSEKVDAYSFGVLVLEIISG 518
Y APE + + + +D +S G + E+++G
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 326 KLGEGGFGDIYKGTLKNG---KIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
++G G FG + G + +G V VK+L + S + F E + ++ H NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSL-----NWKQR--FDIILGTARGLAYLH 435
G C++ +LV E+ L +L ++ L QR +I A GL +LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI----ALGLLHLH 117
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL-LPENQSHLSTKFAGTLGYTAPEYA 494
++ IH D+ N LL DL KI D+GL+ E+ + L + APE
Sbjct: 118 KN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 495 --IHGQL-----SEKVDAYSFGVLVLEI 515
+HG L +++ + +S GV + E+
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 8e-09
Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 312 KDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLIS 371
K + A R +EE + G +G K +++A K++ G R ENE+ +
Sbjct: 163 KIFICALRASTEEAEARRG-VNSTNQGKPKCERLIA-KRVKAG--SRAAIQLENEILALG 218
Query: 372 NVHHRNLIRLLGCCSQGPELILVYE---YMANSSLDKFLFG-EKRGSLNWK------QRF 421
++H N++++ E IL E YM D L+ + +WK Q
Sbjct: 219 RLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR 270
Query: 422 DIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK 481
I+ + Y+H+ ++IHRDIK N+ L+ D + + DFG A + +
Sbjct: 271 AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYG 327
Query: 482 FAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS 517
+ GT+ +PE E D +S G+++L+++S
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 26/169 (15%)
Query: 428 ARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS--TKFAGT 485
A G+ +L +HRD+ NVL+ + KI DFGLAR + + +++S + F
Sbjct: 249 ANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL-P 304
Query: 486 LGYTAPEYAIHGQLSEKVDAYSFGVLVLEI--ISGTKSSETKGEEGEY-LLKRAWRLYEN 542
L + APE + + D +SFG+L+ EI + GT E E Y +KR +R+ +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP 364
Query: 543 GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
H A++++ EI C + RP S++V L+
Sbjct: 365 -AH----------------ASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 16/149 (10%)
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRF---DIILGTARGL 431
H L+ L C L V E+++ L F +R RF +I L L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL-MFHMQRQRKLPEEHARFYSAEISLA----L 109
Query: 432 AYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR--LLPENQSHLSTKFAGTLGYT 489
+LHE II+RD+K NVLLD + K+ D+G+ + + P + ++ F GT Y
Sbjct: 110 NFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCGTPNYI 163
Query: 490 APEYAIHGQLSEKVDAYSFGVLVLEIISG 518
APE VD ++ GVL+ E+++G
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 48/146 (32%), Positives = 70/146 (47%), Gaps = 16/146 (10%)
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRF---DIILGTARGLAYL 434
L+ L C L LV EY+ L F +R RF +I + L +L
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL-MFHMQRQRKLPEEHARFYAAEICIA----LNFL 112
Query: 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR--LLPENQSHLSTKFAGTLGYTAPE 492
HE II+RD+K NVLLD D K+ D+G+ + L P + ++ F GT Y APE
Sbjct: 113 HER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT---TSTFCGTPNYIAPE 166
Query: 493 YAIHGQLSEKVDAYSFGVLVLEIISG 518
+ VD ++ GVL+ E+++G
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 45/209 (21%)
Query: 326 KLGEGGFGDIY----KGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-----HR 376
KL +G FG + K T K + V+K+ I + + E VH +
Sbjct: 23 KLIDGKFGKVSVLKHKPTQK----LFVQKI---IKAKNFNAIE------PMVHQLMKDNP 69
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE 436
N I+L + +L+ +Y+ + L F +K G L+ + II L LH+
Sbjct: 70 NFIKLYYSVTTLKGHVLIMDYIKDGDL--FDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 437 DFHVRIIHRDIKPSNVLLDDDL-QPKIADFGLARLLPENQSHLSTKFAGTLGYTAPE--- 492
H IIH DIK NVL D + + D+GL ++ + + GTL Y +PE
Sbjct: 128 --H-NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-----IGTPSCYDGTLDYFSPEKIK 179
Query: 493 ---YAIHGQLSEKVDAYSFGVLVLEIISG 518
Y + D ++ GVL E+++G
Sbjct: 180 GHNYDVS------FDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 49/150 (32%), Positives = 70/150 (46%), Gaps = 16/150 (10%)
Query: 374 HHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRF---DIILGTARG 430
+H L+ L C L V EY+ L F +R RF +I L
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLA---- 108
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR--LLPENQSHLSTKFAGTLGY 488
L YLHE II+RD+K NVLLD + K+ D+G+ + L P + ++ F GT Y
Sbjct: 109 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNY 162
Query: 489 TAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
APE VD ++ GVL+ E+++G
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 60/218 (27%), Positives = 91/218 (41%), Gaps = 19/218 (8%)
Query: 311 LKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIV-AVKKLA-IGISRRTLSDFENEVR 368
+ L F +G G FG++ K+ K V A+K L+ + +R+ S F E R
Sbjct: 35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 369 LISNVHHRNLIRLLGCCSQGPE-LILVYEYMANSSLDKFLFGEKRGSLNWKQRF--DIIL 425
I + I L Q + L +V EYM L L W + + +++L
Sbjct: 95 DIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVL 153
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLA-RLLPENQSHLSTKFAG 484
L +H + IHRD+KP N+LLD K+ADFG ++ T G
Sbjct: 154 A----LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA-VG 205
Query: 485 TLGYTAPEY----AIHGQLSEKVDAYSFGVLVLEIISG 518
T Y +PE G + D +S GV + E++ G
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 21/231 (9%)
Query: 366 EVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL 425
E ++ ++H ++I+L G + L+ + D + + + ++ I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIER 189
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT 485
R + YLHE+ RIIHRDIK N+ ++ + DFG A + ++ +AGT
Sbjct: 190 SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 486 LGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKS-SETKGEEGEYLLKRAWRLY--EN 542
+ APE VD +S G+++ E+ + S E G +G+ R +L +
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRS 306
Query: 543 GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAA---NSRPTMSEVVAL 590
GTH PNE +A + EI + + ++ SRP + + L
Sbjct: 307 GTH---------PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYEL 348
|
Length = 391 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 323 EENKLGEGGFGDIYKGTLKNG---KIVAVKKL-AIGISRRTLSDFENEVRLISNVHHRNL 378
E K+G G +G +YK K+G + A+K++ GIS E+ L+ + H N+
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----REIALLRELKHPNV 60
Query: 379 IRL--LGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTAR------- 429
I L + ++ L+++Y + F R S K+ + G +
Sbjct: 61 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKF--HRASKANKKPVQLPRGMVKSLLYQIL 118
Query: 430 -GLAYLHEDFHVRIIHRDIKPSNVLL----DDDLQPKIADFGLARLLPENQSHLS--TKF 482
G+ YLH ++ ++HRD+KP+N+L+ + + KIAD G ARL L+
Sbjct: 119 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 483 AGTLGYTAPEYAIHGQ-LSEKVDAYSFGVLVLEIIS 517
T Y APE + + ++ +D ++ G + E+++
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 35/213 (16%)
Query: 327 LGEGGFGDIYKGTLKN-------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
LG+G F I+KG + K + K+ R F ++S + H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSL---NWKQRFDIILGTARGLAY-LH 435
G C G E I+V EY+ SLD +L +K +L +WK L A+ LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWK------LEVAKQLAWALH 114
Query: 436 EDFHVRIIHRDIKPSNVLL--DDDLQP------KIADFGLA-RLLPENQSHLSTKFAGTL 486
+ H ++ NVLL ++D + K++D G++ +LP+ +
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI------LLERI 168
Query: 487 GYTAPEYAIHGQ-LSEKVDAYSFGVLVLEIISG 518
+ PE + Q LS D +SFG + EI SG
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 9e-08
Identities = 38/155 (24%), Positives = 59/155 (38%), Gaps = 17/155 (10%)
Query: 322 SEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI-- 379
S L G +Y K+ V +K SR +D E EV ++ + + L
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDEDYV-LKINP---SREKGADREREVAILQLLARKGLPVP 56
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE-DF 438
++L L+ E++ +LD+ EK L LA LH+
Sbjct: 57 KVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIA-------EQLAEL--LAKLHQLPL 107
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473
V + H D+ P N+L+DD I D+ A P
Sbjct: 108 LV-LCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 53/183 (28%), Positives = 77/183 (42%), Gaps = 41/183 (22%)
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS-HLSTKFAGTLGYT 489
L +H +IHRDIK +N+LL + K+ DFG +++ S + F GT Y
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 490 APEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549
APE S+K D +S GVL+ E+++ LKR ++ E+M
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLT---------------LKRP---FDGENMEEVM 254
Query: 550 DESLD------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNKP 603
++L P + E E V AL+ S RP SSS L N P
Sbjct: 255 HKTLAGRYDPLPPSISPEMQEIVT--ALLS--SDPKRRP------------SSSKLLNMP 298
Query: 604 LLK 606
+ K
Sbjct: 299 ICK 301
|
Length = 496 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 57/199 (28%), Positives = 86/199 (43%), Gaps = 13/199 (6%)
Query: 327 LGEGGFGDIYKGTLKNG-KIVAVKKLA-IGISRRTLSDFENEVRLISNVHHRNLIRLLGC 384
+G G FG++ K+ K+ A+K L+ + +R+ S F E R I + + L C
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 385 CSQGPE-LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
Q + L +V EYM L L W + + TA + L + +I
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFY-----TAEVVLALDAIHSMGLI 164
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEY----AIHGQL 499
HRD+KP N+LLD K+ADFG + E GT Y +PE G
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYY 224
Query: 500 SEKVDAYSFGVLVLEIISG 518
+ D +S GV + E++ G
Sbjct: 225 GRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 26/207 (12%)
Query: 327 LGEGGFGDIYKGTLKNG-KIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLG 383
+G G FG++ LKN K+ A+K L + R + F E ++ N ++ + L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF----- 438
L LV +Y L L +F+ L YL E
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLL-----------SKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 439 --HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI- 495
+ +HRDIKP N+L+D + ++ADFG L E+ + S+ GT Y +PE
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 496 ----HGQLSEKVDAYSFGVLVLEIISG 518
G+ + D +S GV + E++ G
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 323 EENKLGEGGFGDIYKGTLKNGKI---VAVKKL-AIGISRRTLSDFENEVRLISNVHHRNL 378
E K+G G +G +YK K+GK A+K++ GIS E+ L+ + H N+
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----REIALLRELKHPNV 60
Query: 379 IRL--LGCCSQGPELILVYEYMANSSLDKFLF------GEKRGSLNWKQRFDIILGTARG 430
I L + ++ L+++Y + F +K L ++ G
Sbjct: 61 IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLL----DDDLQPKIADFGLARLLPENQSHLS--TKFAG 484
+ YLH ++ ++HRD+KP+N+L+ + + KIAD G ARL L+
Sbjct: 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 485 TLGYTAPEYAIHGQ-LSEKVDAYSFGVLVLEIIS 517
T Y APE + + ++ +D ++ G + E+++
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 36/96 (37%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 428 ARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTL- 486
A+G+ +L IHRD+ NVLL D KI DFGLAR + N S+ K L
Sbjct: 222 AQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDI-MNDSNYVVKGNARLP 277
Query: 487 -GYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKS 521
+ APE + + D +S+G+L+ EI S KS
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 57/249 (22%), Positives = 93/249 (37%), Gaps = 64/249 (25%)
Query: 321 FSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIR 380
F KLGEG FG +YK +L N + K + + +++ V + N R
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVL----KKATEY-GAVEIWMNERVRRACP 188
Query: 381 LLGCCS-------------QGPELILVYEYMANSSL-------------DKFLFGEKRGS 414
C+ + E LV+ Y S+L + +L G+ +
Sbjct: 189 --NSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDL 246
Query: 415 LNWKQRFDIILGTARG-----LAYLHEDFHVRIIHRDIKPSNVLLDDDLQP-KIADFGLA 468
+R + I+ T L LH I+HRD+KP N++ + KI D G A
Sbjct: 247 PKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
Query: 469 RLLPENQSHLSTKFAGTLGYTAPE-YAIHGQ---------------------LSEKVDAY 506
L +++ +F Y APE Y + Q L ++ D Y
Sbjct: 304 ADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363
Query: 507 SFGVLVLEI 515
S G++ L++
Sbjct: 364 SAGLIFLQM 372
|
Length = 566 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 44/188 (23%), Positives = 90/188 (47%), Gaps = 16/188 (8%)
Query: 337 KGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396
+G+ K+VA K + R + +E+ ++ H +++ +L+L+ E
Sbjct: 88 RGSDPKEKVVA--KFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145
Query: 397 YMANSSLDKFLFGEKRGSLNWKQR------FDIILGTARGLAYLHEDFHVRIIHRDIKPS 450
Y + L+K + + L +++ + I+L L E +++HRD+K +
Sbjct: 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLA-------LDEVHSRKMMHRDLKSA 198
Query: 451 NVLLDDDLQPKIADFGLARLLPENQS-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFG 509
N+ L K+ DFG ++ ++ S +++ F GT Y APE + S+K D +S G
Sbjct: 199 NIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLG 258
Query: 510 VLVLEIIS 517
V++ E+++
Sbjct: 259 VILYELLT 266
|
Length = 478 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 48/205 (23%), Positives = 81/205 (39%), Gaps = 21/205 (10%)
Query: 327 LGEGGFGDIYKGTLKNGKIVAVKKLAI-GISRRTLSDFENEVRLISNVHHRNLIRLLGCC 385
+ + K +VAVKK+ + S+ L + E+ + H N++ +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 386 SQGPELILVYEYMANSS---LDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
EL +V MA S L K F E L I+ L Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF---ILKDVLNALDYIH---SKGF 122
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLAR-LLPENQS----HLSTKFA-GTLGYTAPEY--- 493
IHR +K S++LL D + ++ + ++ + H K + L + +PE
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182
Query: 494 AIHGQLSEKVDAYSFGVLVLEIISG 518
+ G +EK D YS G+ E+ +G
Sbjct: 183 NLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEY 493
+H + +HRDIKP NVLLD + ++ADFG + ++ + S+ GT Y +PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 494 --AIH---GQLSEKVDAYSFGVLVLEIISG 518
A+ G+ + D +S GV + E++ G
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 19/156 (12%)
Query: 369 LISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEK-RGSLNWKQRFDIILGT 427
L+S V H +L + G C +G E I+V E++ + LD L EK R + WK +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--ITVAQQL 126
Query: 428 ARGLAYLHEDFHVRIIHRDIKPSNVL-----LDDDLQP--KIADFGLARLLPENQSHLST 480
A L+YL + ++H ++ N+L L + P K++D G++ + +
Sbjct: 127 ASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVE- 182
Query: 481 KFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEI 515
+ + APE G LS D +SFG +LEI
Sbjct: 183 ----RIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 30/85 (35%), Positives = 45/85 (52%), Gaps = 5/85 (5%)
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEY--AIH- 496
+ +HRDIKP NVLLD + ++ADFG L + + S GT Y +PE A+
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 497 --GQLSEKVDAYSFGVLVLEIISGT 519
G+ + D +S GV + E++ G
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 56/234 (23%), Positives = 98/234 (41%), Gaps = 49/234 (20%)
Query: 327 LGEGGFGDIYKGTLKN-GKIVAVKKL--AIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
+G G FG++ K+ G I A+KKL + + + ++ E +++ + + L
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN-PWVVKLY 67
Query: 384 CCSQGPE-LILVYEYMANSSLDKFLFGEKRGSLNWKQ-RFDIILGTARGLAYLHEDFHVR 441
Q L L+ EY+ + L K+ + ++ RF I T + +H+ +
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRF-YIAETILAIDSIHK---LG 121
Query: 442 IIHRDIKPSNVLLDDDLQPKIADFGL------------ARLL--------------PENQ 475
IHRDIKP N+LLD K++DFGL R+L P +
Sbjct: 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181
Query: 476 SHLSTKF-----------AGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
+ + GT Y APE + +++ D +S GV++ E++ G
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 53/217 (24%), Positives = 88/217 (40%), Gaps = 15/217 (6%)
Query: 310 RLKDLVSATRKFSEENKLGEGGFGDI----YKGTLKNGKIVAVKKLAIGISRRTLSDFEN 365
+++DL + +G G FG++ +K T K + + K + I R + F
Sbjct: 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAFFWE 92
Query: 366 EVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL 425
E +++ + +++L L +V EYM L L W + +
Sbjct: 93 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFY---- 147
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT 485
TA + L + IHRD+KP N+LLD K+ADFG + + GT
Sbjct: 148 -TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 206
Query: 486 LGYTAPEY----AIHGQLSEKVDAYSFGVLVLEIISG 518
Y +PE G + D +S GV + E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 57/246 (23%), Positives = 98/246 (39%), Gaps = 44/246 (17%)
Query: 321 FSEENKLGEGGFGDIYKGTLKN-GKIVAVKKL--AIGISRRTLSDFENEVRLISNVHHRN 377
F +G G FG++ K+ G I A+K L A + + ++ E ++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
++++ L L+ E++ + L K+ +L+ + I T + +H+
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQ- 119
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGL------------------------------ 467
+ IHRDIKP N+LLD K++DFGL
Sbjct: 120 --LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 468 ----ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKS-- 521
A +N+ L+ GT Y APE + ++ D +S GV++ E++ G
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 522 SETKGE 527
SET E
Sbjct: 238 SETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 56/246 (22%), Positives = 96/246 (39%), Gaps = 44/246 (17%)
Query: 321 FSEENKLGEGGFGDIYKGTLKN-GKIVAVKKL--AIGISRRTLSDFENEVRLISNVHHRN 377
F +G G FG++ K+ G + A+K L A + + + E ++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
++++ L L+ E++ + L K+ +L ++ I T + +H+
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIHQ- 119
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGL------------------------------ 467
+ IHRDIKP N+LLD K++DFGL
Sbjct: 120 --LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 468 ----ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKS-- 521
A N+ L+ GT Y APE + ++ D +S GV++ E++ G
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 522 SETKGE 527
SET E
Sbjct: 238 SETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 17/106 (16%)
Query: 427 TARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR--------------LLP 472
T L YLH + I+HRD+KP N+L+ K+ DFGL++ +
Sbjct: 110 TVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 473 ENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
+ + L + GT Y APE + + VD ++ G+++ E + G
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 428 ARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS--TKFAGT 485
ARG+ +L +HRD+ NVLL KI DFGLAR + + +++S + F
Sbjct: 247 ARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL-P 302
Query: 486 LGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS--GTKSSETKGEEGEY-LLKRAWRLYEN 542
+ + APE + D +S+G+L+ EI S GT + Y +K +R+ +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAK- 361
Query: 543 GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPT---MSEVVALL 591
P+ T+E V +I + C S RP+ +S++V L
Sbjct: 362 ------------PDHATQE----VYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 47/203 (23%), Positives = 84/203 (41%), Gaps = 16/203 (7%)
Query: 326 KLGEGGFGDIYKGTLKNGKIVA---VKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
++G G FG + + VA VK+L S + ++F + + H N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGE--KRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
G C + +LV+EY L +L E R + + A G+ ++H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---H 118
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLA-RLLPENQSHLSTKFAGTLGYTAPEY--AIHG 497
+H D+ N L DL K+ D+G+ E+ L + APE HG
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178
Query: 498 QL-----SEKVDAYSFGVLVLEI 515
L ++ + ++ GV + E+
Sbjct: 179 GLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 39/226 (17%)
Query: 326 KLGEGGFGDIYKGTLKNGKIVAVKKLAI---GISRRTLSDFENEVRLISNVHHRNLIR-- 380
K+G G FG+++ K + K AI G+ R S EV ++ + H+N++R
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWK-AISYRGLKEREKSQLVIEVNVMRELKHKNIVRYI 78
Query: 381 --LLGCCSQGPELILVYEYMANSSLDKFLFGEKR--GSLNWKQRFDIILGTARGLAYLHE 436
L +Q +L ++ E+ L + + + G + DI LAY H
Sbjct: 79 DRFLNKANQ--KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN 136
Query: 437 ----DFHVRIIHRDIKPSNVLLDDDLQ-----------------PKIADFGLARLLP-EN 474
R++HRD+KP N+ L ++ KI DFGL++ + E+
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES 196
Query: 475 QSHLSTKFAGTLGYTAPEYAIHGQLS--EKVDAYSFGVLVLEIISG 518
+H GT Y +PE +H S +K D ++ G ++ E+ SG
Sbjct: 197 MAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
|
Length = 1021 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 428 ARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTL- 486
A+G+++L IHRD+ N+LL KI DFGLAR + N S+ K L
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI-RNDSNYVVKGNARLP 279
Query: 487 -GYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS 517
+ APE + + + D +S+G+L+ EI S
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 29/209 (13%)
Query: 327 LGEGGFGDIYKGTLK-----------NGKIVAVKKLAIGISRRTLS-DFENEVRLISNVH 374
LG G IY G L K + V + S R +S F ++ V
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYL 434
H++++ L G C + E I+V E++ LD F+ K L +F + A L+YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPWKFKVAKQLASALSYL 121
Query: 435 HEDFHVRIIHRDIKPSNVLL-----DDDLQP--KIADFGLARLLPENQSHLSTKFAGTLG 487
+ ++H ++ N+LL D + P K++D G+ + Q + +
Sbjct: 122 EDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE-----RIP 173
Query: 488 YTAPEYAIHGQ-LSEKVDAYSFGVLVLEI 515
+ APE + LS D +SFG + EI
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 33/122 (27%), Positives = 47/122 (38%), Gaps = 46/122 (37%)
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLA---------------------------------- 468
IHRDIKP N+L+D D K+ DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 469 -----RLLP-------ENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEII 516
RL P ++Q L+ GT Y APE + ++ D +S GV++ E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 517 SG 518
G
Sbjct: 243 VG 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 67/303 (22%), Positives = 116/303 (38%), Gaps = 67/303 (22%)
Query: 312 KDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLIS 371
+D+ +T++F + LGEG FG + + + K K+ + + T D + E++ +
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYT-RDAKIEIQFME 180
Query: 372 NVHHRNLIRLLGCCSQGPELILVYEYMANSS--------------LDKFLFGEKRGSLNW 417
V R + P L+ + Y N + LD + K G +
Sbjct: 181 KV------RQADPADRFP-LMKIQRYFQNETGHMCIVMPKYGPCLLDWIM---KHGPFSH 230
Query: 418 KQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD----------------DDLQPK 461
+ II T L Y H + H ++H D+KP N+L++ D + +
Sbjct: 231 RHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVR 288
Query: 462 IADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKS 521
I D G ++ H T T Y +PE + D +S G ++ E+ +G
Sbjct: 289 ICDLGGCC----DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG--- 341
Query: 522 SETKGEEGEYLLKRAWRLYENGTHWELMDESLD--PNECTKEAAEKVVEIALMCTQSAAN 579
K + ++N H LM+++L P+E A E A + SA
Sbjct: 342 ------------KLLYDTHDNLEHLHLMEKTLGRLPSEW---AGRCGTEEARLLYNSAGQ 386
Query: 580 SRP 582
RP
Sbjct: 387 LRP 389
|
Length = 467 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 43/144 (29%), Positives = 67/144 (46%), Gaps = 8/144 (5%)
Query: 330 GGFGDIYKGTLKN-GKIVAVK--KLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCS 386
G FG +Y G KN K+ AVK K A I++ + + E ++ ++ L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 387 QGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRD 446
+ LV EY+ + L G + + I A L YLH H IIHRD
Sbjct: 75 SANNVYLVMEYLIGGDVKSLL--HIYGYFDEEMAVKYISEVALALDYLHR--H-GIIHRD 129
Query: 447 IKPSNVLLDDDLQPKIADFGLARL 470
+KP N+L+ ++ K+ DFGL+++
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 29/75 (38%), Positives = 40/75 (53%), Gaps = 10/75 (13%)
Query: 401 SSLDKFLFGEKRGSLNW---KQRFDIILGTAR----GLAYLHEDFHVRIIHRDIKPSNVL 453
L++F+ K+ N K+ ++I G R GL LH + I+HRDIKP N+L
Sbjct: 285 GCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLL 341
Query: 454 LDDDLQPKIADFGLA 468
+ D Q KI DFG A
Sbjct: 342 VTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 31/122 (25%), Positives = 45/122 (36%), Gaps = 46/122 (37%)
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLA---------------------------------- 468
IHRDIKP N+L+D D K+ DFGL
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 469 ------------RLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEII 516
R ++Q L+ GT Y APE + ++ D +S GV++ E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 517 SG 518
G
Sbjct: 243 VG 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 34/119 (28%), Positives = 50/119 (42%), Gaps = 33/119 (27%)
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP----------------- 472
L YLH + I++RD+KP N+LL + ++DF L++
Sbjct: 115 ALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 473 -----------ENQSHLSTKFAGTLGYTAPEYAIHGQ-LSEKVDAYSFGVLVLEIISGT 519
E S S F GT Y APE I G VD ++ G+L+ E++ GT
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 16/25 (64%), Positives = 19/25 (76%)
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGL 467
IHRDIKP N+L+D D K+ DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 15/26 (57%), Positives = 20/26 (76%)
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLA 468
IHRDIKP N+L+D K++DFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 26/88 (29%), Positives = 43/88 (48%), Gaps = 7/88 (7%)
Query: 327 LGEGGFGDIYKGTL------KNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLI 379
LG G FG + + T N VAVK L +E++++S++ H+N++
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFL 407
LLG C+ G ++++ EY L FL
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 33/93 (35%), Positives = 46/93 (49%), Gaps = 9/93 (9%)
Query: 442 IIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKF----AGTLGYTAPEYAIHG 497
IIHRDIK NVL++ + DFG A + ST F AGT+ APE
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFA---RGSWSTPFHYGIAGTVDTNAPEVLAGD 337
Query: 498 QLSEKVDAYSFGVLVLEIISGTKS--SETKGEE 528
+ VD +S G+++ E T S S ++G+E
Sbjct: 338 PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE 370
|
Length = 461 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 47/186 (25%), Positives = 83/186 (44%), Gaps = 14/186 (7%)
Query: 343 GKIVAVKKLAI-GISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANS 401
G +V V+ + + L +NEV L H N++ + G L ++ +MA
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 402 SLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPK 461
S + L ++ +I+ G RGL YLH++ + IHR+IK S++L+ D
Sbjct: 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY---IHRNIKASHILISGDGLVS 141
Query: 462 IADFG-LARLLPENQSHLST----KFA-GTLGYTAPEYA---IHGQLSEKVDAYSFGVLV 512
++ L L+ Q +F+ L + +PE ++G + K D YS G+
Sbjct: 142 LSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIYSVGITA 200
Query: 513 LEIISG 518
E+ +G
Sbjct: 201 CELATG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 658 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.01 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.01 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.96 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.92 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.7 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.65 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.6 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.52 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.39 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.23 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.22 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.17 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.15 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.13 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.12 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.06 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.99 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.81 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.8 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.73 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.7 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.64 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.58 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.57 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.57 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.51 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.49 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.36 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.25 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.22 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.09 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.04 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.84 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.81 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.8 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.41 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.12 | |
| PLN02236 | 344 | choline kinase | 96.05 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.94 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.92 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.73 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.73 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.66 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.44 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.4 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.31 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.23 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.02 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.96 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.41 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.6 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-57 Score=473.49 Aligned_cols=289 Identities=46% Similarity=0.774 Sum_probs=256.5
Q ss_pred CCcccchHHHHHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeE
Q 006168 305 GPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGC 384 (658)
Q Consensus 305 ~~~~~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 384 (658)
....|++++|..||++|+..+.||+|+||.||+|.+++|..||||++......+ ..+|.+|++++.+++|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 456799999999999999999999999999999999999999999887643332 6779999999999999999999999
Q ss_pred eecCC-eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEe
Q 006168 385 CSQGP-ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIA 463 (658)
Q Consensus 385 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~ 463 (658)
|.+.+ +.+||||||++|+|.++|+......|+|.+|++||.++|+||+|||+.+.+.|+|||||++|||||+++++||+
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99998 59999999999999999986554489999999999999999999999988899999999999999999999999
Q ss_pred eccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc-chhhHHHHHHHHhhc
Q 006168 464 DFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE-EGEYLLKRAWRLYEN 542 (658)
Q Consensus 464 DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~-~~~~l~~~~~~~~~~ 542 (658)
|||+++..+.......+...||.+|+|||++..+..++|+|||||||+|+||+||+++.+.... ....+.+|++..+.+
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 9999976654111111111899999999999999999999999999999999999998886553 445589999999999
Q ss_pred CcccccccccCCCCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 543 GTHWELMDESLDPNECTK-EAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 543 ~~~~~~~d~~l~~~~~~~-~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
+...+++|+.+.....+. +...++..++.+|++.+|.+||+|.||+++|+.+
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 999999999986455554 6788899999999999999999999999999765
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=396.63 Aligned_cols=259 Identities=34% Similarity=0.528 Sum_probs=213.8
Q ss_pred CccCcccccCceEEEEEEecCCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCC-eEEEEEeccC
Q 006168 322 SEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP-ELILVYEYMA 399 (658)
Q Consensus 322 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~~~ 399 (658)
...+.||+|+||+||+|.++....||||++.... .....+.|.+|+.+|.+++|||||+++|+|.+.. .+++|||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3455699999999999999855559999997532 2222679999999999999999999999999887 7999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC-eeecCcCCCcEEEcCCC-CeEEeeccCccccCCCCcc
Q 006168 400 NSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVR-IIHRDIKPSNVLLDDDL-QPKIADFGLARLLPENQSH 477 (658)
Q Consensus 400 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dik~~NIll~~~~-~~kl~DfGla~~~~~~~~~ 477 (658)
+|+|.++++......+++..+++|+.|||+||.|||++ + ||||||||+||||+.++ ++||+|||+++...... .
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 99999999765567899999999999999999999998 6 99999999999999997 99999999998764432 2
Q ss_pred ccccccCCcccccccccc--cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 478 LSTKFAGTLGYTAPEYAI--HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~--~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
..+...||+.|||||++. ...|+.|+|||||||++|||+||+.||..... . +.+......+..
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~----~~~~~v~~~~~R---------- 264 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V----QVASAVVVGGLR---------- 264 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H----HHHHHHHhcCCC----------
Confidence 334478999999999999 66999999999999999999999999986554 1 111222222211
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCC
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLL 599 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 599 (658)
...+......+..++.+||+.||..||++.+++..|+.+.....
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 12222345679999999999999999999999999997754333
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=379.63 Aligned_cols=250 Identities=27% Similarity=0.433 Sum_probs=211.1
Q ss_pred ccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCC-eEEEEEeccCC
Q 006168 323 EENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP-ELILVYEYMAN 400 (658)
Q Consensus 323 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~~~~ 400 (658)
..+.||+|..|+|||++++ +++.+|+|.+.........+++.+|++++++.+|||||.++|.|.+.. ...++||||++
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 4578999999999999987 688999999976666677789999999999999999999999999888 59999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
|||++++. ..+.+++...-+|+.+|++||.|||+. .+||||||||+|||++..|++||+|||.++.+... ...
T Consensus 163 GSLd~~~k--~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~ 235 (364)
T KOG0581|consen 163 GSLDDILK--RVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IAN 235 (364)
T ss_pred CCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcc
Confidence 99999994 347799999999999999999999963 29999999999999999999999999999877544 456
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCH
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTK 560 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 560 (658)
.++||..|||||.+.+..|+.++||||||++++|+.+|+.|+...........+...... .+. +...+.
T Consensus 236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~p----------pP~lP~ 304 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEP----------PPRLPE 304 (364)
T ss_pred cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCC----------CCCCCc
Confidence 789999999999999999999999999999999999999999875332222221111111 111 112222
Q ss_pred -HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 561 -EAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 561 -~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+.++..++..||++||.+|||+.|+++.
T Consensus 305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 356779999999999999999999999864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=391.18 Aligned_cols=252 Identities=32% Similarity=0.519 Sum_probs=215.3
Q ss_pred ccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCC
Q 006168 323 EENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSS 402 (658)
Q Consensus 323 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 402 (658)
..+.||+|.||.||.|.++....||+|.+... ....+.|.+|+++|++|+|+|||+++|+|..++.++||||||++|+
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 46789999999999999998889999999863 4456789999999999999999999999999889999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccccc
Q 006168 403 LDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKF 482 (658)
Q Consensus 403 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 482 (658)
|.++|....+..+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+||||++...++........
T Consensus 288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~ 364 (468)
T KOG0197|consen 288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG 364 (468)
T ss_pred HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence 99999765677799999999999999999999999 999999999999999999999999999997666665555555
Q ss_pred cCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHH
Q 006168 483 AGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKE 561 (658)
Q Consensus 483 ~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 561 (658)
.-+..|.|||.+..+.++.|||||||||+||||+| |+.|+...... .+ .+.+..|. .-..|..
T Consensus 365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--ev----~~~le~Gy----------Rlp~P~~ 428 (468)
T KOG0197|consen 365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--EV----LELLERGY----------RLPRPEG 428 (468)
T ss_pred CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH--HH----HHHHhccC----------cCCCCCC
Confidence 66789999999999999999999999999999999 67776554331 11 22222221 1122334
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 562 AAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 562 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
.+..+.+|+..||+.+|++|||++.+...|+.+.
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 5567999999999999999999999999998873
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=387.17 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=215.5
Q ss_pred cCCCccCcccccCceEEEEEEe-cCCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTL-KNGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
.+|...+.||+|||+.+|.++. ..|+.||+|++.+. ......+...+|+++.++|+|||||+++++|++.+.+|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5788999999999999999997 78999999999763 24455678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
|+|.+++|..++. ++.++++.++..+++||+.||.|||+. +|+|||||..|+||+++.++||+|||||..+..+.
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999994 677899999999999999999999999 99999999999999999999999999999886543
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.. ..+.+|||.|+|||++.....+..+||||+|||+|-||.|++||+...-. ...+.+... .
T Consensus 173 Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk------ety~~Ik~~-----------~ 234 (592)
T KOG0575|consen 173 ER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK------ETYNKIKLN-----------E 234 (592)
T ss_pred cc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH------HHHHHHHhc-----------C
Confidence 33 34589999999999999999999999999999999999999999865321 111111111 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...|...+.+..+||..+|+.||.+|||+++|+..
T Consensus 235 Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 12333455678999999999999999999999963
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=361.14 Aligned_cols=203 Identities=31% Similarity=0.560 Sum_probs=182.4
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
..+|...++||+|.||+||+|+++ ++..||||.+.... .....+.+..|+.+|+.++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888889999999999999987 58999999997643 4555677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC------CCeEEeeccCcc
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD------LQPKIADFGLAR 469 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~------~~~kl~DfGla~ 469 (658)
|||.+|+|.++|+ +++.+++.....++.|||.||++||++ +||||||||.||||+.. -.+||+|||+++
T Consensus 89 EyC~gGDLs~yi~--~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR--RRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999994 556899999999999999999999999 99999999999999764 468999999999
Q ss_pred ccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc
Q 006168 470 LLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE 527 (658)
Q Consensus 470 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~ 527 (658)
.+... ....+.+|++-|||||+++.++|+.|+|+||+|+||||+++|+.||.....
T Consensus 164 ~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 164 FLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 88633 334568999999999999999999999999999999999999999986544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=353.95 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=211.6
Q ss_pred cCCCccCcccccCceEEEEEE-ecCCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeee-EeecCCe-EEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLG-CCSQGPE-LILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lV 394 (658)
.+|.+.++||+|.||+||++. +.+|..+|.|.+..+ .+....+....|+.+|++|+|||||++++ .+.++.+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 356778999999999999998 558999999999754 34555678899999999999999999999 4555555 8999
Q ss_pred EeccCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhHhcCC-CCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 395 YEYMANSSLDKFLFGEK--RGSLNWKQRFDIILGTARGLAYLHEDFH-VRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
|||+..|+|.++|++-+ +..+++..+|+++.|++.||.++|+.-. .-|.||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999996543 3459999999999999999999999322 13999999999999999999999999999988
Q ss_pred CCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 472 PENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 472 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
.... ......+|||.||+||.+.+.+|+.||||||+||++|||+.-++||.+.+ +.+. .+....++.
T Consensus 179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----~~~L-~~KI~qgd~------ 245 (375)
T KOG0591|consen 179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----LLSL-CKKIEQGDY------ 245 (375)
T ss_pred cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----HHHH-HHHHHcCCC------
Confidence 5543 34567899999999999999999999999999999999999999998652 2111 122333321
Q ss_pred cCCCCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 552 SLDPNECT-KEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 552 ~l~~~~~~-~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
..++ .-++..+.+||..|+..||+.||+...++..+.+
T Consensus 246 ----~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 ----PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ----CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1223 5577889999999999999999996655555544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=362.50 Aligned_cols=254 Identities=26% Similarity=0.345 Sum_probs=205.5
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccc------cHHHHHHHHHHHhccCCCccceeeeEeecCCe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRR------TLSDFENEVRLISNVHHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 390 (658)
.+.|.+.+.||+|+||.|-+|..+ +|+.||||++++..... ......+|+++|++|+|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 356778899999999999999965 79999999997642211 23345799999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC---CCeEEeeccC
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD---LQPKIADFGL 467 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~---~~~kl~DfGl 467 (658)
.|+||||+++|.|.+.+. ..+.+.+..-..+++|++.|+.|||+. ||+||||||+|||+..+ ..+||+|||+
T Consensus 251 ~YmVlE~v~GGeLfd~vv--~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV--ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred eEEEEEEecCccHHHHHH--hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccch
Confidence 999999999999999984 445577778889999999999999999 99999999999999655 7799999999
Q ss_pred ccccCCCCccccccccCCcccccccccccCCC---CCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCc
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL---SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGT 544 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~---s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 544 (658)
|+...+ .....+.+||+.|.|||++.+..+ ..|.|+||+|||||-+++|.+||.....+. .+.+ ....|.
T Consensus 326 AK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~e----QI~~G~ 398 (475)
T KOG0615|consen 326 AKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLKE----QILKGR 398 (475)
T ss_pred hhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cHHH----HHhcCc
Confidence 998753 334567899999999999977643 348899999999999999999997654322 1111 111111
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 545 HWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 545 ~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
... ....-.+..++..++|.+||..||++|||+.|+++.
T Consensus 399 y~f-------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 399 YAF-------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ccc-------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 111 112234567789999999999999999999999864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=388.75 Aligned_cols=257 Identities=28% Similarity=0.508 Sum_probs=217.9
Q ss_pred cCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
.+....+.||+|.||+||+|+.. +...||||.++...+.+...+|++|+++++.|+|||||+|+|+|.+++.++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 44556788999999999999854 356799999998766668899999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCe
Q 006168 393 LVYEYMANSSLDKFLFGEK------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP 460 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~ 460 (658)
+|+|||.+|+|.+||.... ..+|+..+.+.||.|||.|+.||-++ .+|||||..+|+||.++..+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 9999999999999995321 22388999999999999999999998 99999999999999999999
Q ss_pred EEeeccCccccCCCCccccc-cccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHH
Q 006168 461 KIADFGLARLLPENQSHLST-KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWR 538 (658)
Q Consensus 461 kl~DfGla~~~~~~~~~~~~-~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~ 538 (658)
||+||||++..-..+.+... +..-+.+||+||.++.++||++||||||||+|||+++ |+.|+....++ .+.+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------EVIe 716 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------EVIE 716 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH------HHHH
Confidence 99999999977555544433 4455779999999999999999999999999999999 78888765442 2233
Q ss_pred HhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 539 LYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 539 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
...++++++ +++..+.++..|+..||+.+|.+||+++||-..|+..
T Consensus 717 ~i~~g~lL~----------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 717 CIRAGQLLS----------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred HHHcCCccc----------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 344454433 3444556799999999999999999999999999876
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=388.87 Aligned_cols=272 Identities=28% Similarity=0.494 Sum_probs=227.9
Q ss_pred ccchHHHHHHhcCC---------CccCcccccCceEEEEEEecC----CcEEEEEEcccccccccHHHHHHHHHHHhccC
Q 006168 308 NYRLKDLVSATRKF---------SEENKLGEGGFGDIYKGTLKN----GKIVAVKKLAIGISRRTLSDFENEVRLISNVH 374 (658)
Q Consensus 308 ~~~~~~l~~a~~~f---------~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 374 (658)
.++|||--.|...| .+++.||.|.||.|++|+++- ...||||.++.+.+++...+|+.|+.||.+++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 46777766665554 467899999999999999872 45799999999888888999999999999999
Q ss_pred CCccceeeeEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE
Q 006168 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL 454 (658)
Q Consensus 375 h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll 454 (658)
||||++|.|+......+++|.|||+||+|+.||.. +.+++++.++..|.++||.|++||-+. ++|||||.++|||+
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~-~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILV 764 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILV 764 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhh-cCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhheee
Confidence 99999999999999999999999999999999954 446799999999999999999999998 99999999999999
Q ss_pred cCCCCeEEeeccCccccCCCCcccccccc--CCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhh
Q 006168 455 DDDLQPKIADFGLARLLPENQSHLSTKFA--GTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEY 531 (658)
Q Consensus 455 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~ 531 (658)
+.+...|++||||++.+.++.....+... -+.+|.|||.+..++++.+||||||||||||.++ |.+|+....+. +
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ--d 842 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--D 842 (996)
T ss_pred ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH--H
Confidence 99999999999999988665533333222 3579999999999999999999999999999888 88888655442 1
Q ss_pred HHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCC
Q 006168 532 LLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLL 599 (658)
Q Consensus 532 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 599 (658)
.+.. +++ +.+| ..+.+.+..|.+|++.|||+|-.+||++.+|+..|.++..+..
T Consensus 843 VIka----Ie~-------gyRL---PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 843 VIKA----IEQ-------GYRL---PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred HHHH----HHh-------ccCC---CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 2211 111 1122 2345566789999999999999999999999999998854433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=343.81 Aligned_cols=243 Identities=25% Similarity=0.397 Sum_probs=204.6
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
-++|+..+.||+|+||+||.++.+ +++.+|+|++.+. ....+......|..+|.+++||.||+++-.|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 468999999999999999999976 5889999999764 2334567789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
+||+.||.|...| .+.+.+++..+.-++..|+.||.|||+. +||||||||+|||||++|+++|+|||+++.....
T Consensus 104 ld~~~GGeLf~hL--~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHL--QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHH--HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999999999 4567799999999999999999999999 9999999999999999999999999999965443
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
.. .+..++||+.|||||++.+..|+..+|.||+|+++|||++|.+||...... ....+. ..++.
T Consensus 179 ~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-----~~~~~I-~~~k~--------- 242 (357)
T KOG0598|consen 179 GD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-----KMYDKI-LKGKL--------- 242 (357)
T ss_pred CC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-----HHHHHH-hcCcC---------
Confidence 22 234589999999999999999999999999999999999999999765431 111111 11110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRP 582 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RP 582 (658)
...+.-...+..+++...++.||++|.
T Consensus 243 -~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 -PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 111222345689999999999999995
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=344.22 Aligned_cols=262 Identities=24% Similarity=0.372 Sum_probs=216.3
Q ss_pred hcCCCccCcccccCceEEEEEEe-cCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTL-KNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.+.|+....||.|..++||+|+. +.++.||||++.........+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 35788899999999999999994 46899999999877666778999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
||.+||+.++++..-...+++..+..|.+++++||.|||.+ |.||||||+.||||+++|.+||+|||.+..+.+...
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999776666799999999999999999999999 999999999999999999999999998876644432
Q ss_pred cc---cccccCCccccccccccc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 477 HL---STKFAGTLGYTAPEYAIH--GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 477 ~~---~~~~~gt~~y~APE~~~~--~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
.. ...++||+.|||||+++. ..|+.|+||||||++.+||.+|..||....+....+.. +. +........
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-----Lq-n~pp~~~t~ 255 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-----LQ-NDPPTLLTS 255 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-----hc-CCCCCcccc
Confidence 22 146799999999999654 37999999999999999999999999765543222111 11 112111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.+ ..+........+.+++..||++||.+|||++++++
T Consensus 256 ~~-~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 256 GL-DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cC-ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11 22223344557999999999999999999999984
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=346.67 Aligned_cols=255 Identities=29% Similarity=0.435 Sum_probs=206.9
Q ss_pred cCCCccCcccccCceEEEEEEecC-CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCC--eEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP--ELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~ 395 (658)
.++...+.||+|.||.||++...+ |...|||.+....... .+.+.+|+.+|.+++|||||+.+|.....+ .+++.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 456678899999999999999764 8999999987642222 677899999999999999999999855544 699999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC-CCCeEEeeccCccccCC-
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD-DLQPKIADFGLARLLPE- 473 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~-~~~~kl~DfGla~~~~~- 473 (658)
||+++|+|.+++.+... .|++..+..++.||++||+|||++ +|+|+||||+|||++. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 99999999999965544 799999999999999999999998 9999999999999999 79999999999987764
Q ss_pred -CCccccccccCCcccccccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 474 -NQSHLSTKFAGTLGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 474 -~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
..........||+.|||||++..+.. ..++|||||||+++||+||++||..... ...+..........
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~----~~~~~~~ig~~~~~------ 241 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE----EAEALLLIGREDSL------ 241 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc----hHHHHHHHhccCCC------
Confidence 11222336789999999999997543 3599999999999999999999875411 11122222222211
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
..++...+.+..+++..|++.||++|||++++++..-
T Consensus 242 ----P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 242 ----PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ----CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 1334445677999999999999999999999998653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=329.30 Aligned_cols=265 Identities=23% Similarity=0.427 Sum_probs=209.3
Q ss_pred cCCCccCcccccCceEEEEEEecC-CcEEEEEEcccccccccH-HHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTL-SDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
++|+...++|+|+||.|||+++++ |+.||||++......... +-..+|+++|++++|+|+|.++.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 567788899999999999999884 999999999765443333 445899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|++..-|+++- .....++.+.+.+++.|++.|+.|+|++ +++||||||+|||++.++.+||||||+|+.+.. ..
T Consensus 82 ~~dhTvL~eLe--~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELE--RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred ecchHHHHHHH--hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 99986666554 3344589999999999999999999999 999999999999999999999999999998864 34
Q ss_pred cccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchh-hHHH--------HHHHHhhcCccc
Q 006168 477 HLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE-YLLK--------RAWRLYENGTHW 546 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~-~l~~--------~~~~~~~~~~~~ 546 (658)
...|..+.|..|.|||.+.+ .+|....||||+||++.||++|.+.|.+..+-.+ .++. ...+++......
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 45667888999999999987 6899999999999999999999999887766222 2111 112222222211
Q ss_pred ccc-cccC-CCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 547 ELM-DESL-DPNECT---KEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 547 ~~~-d~~l-~~~~~~---~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.-+ -+.. .++... ......+.+++..||+.||.+|++-++++.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111 0000 011111 123446899999999999999999999873
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.77 Aligned_cols=260 Identities=27% Similarity=0.471 Sum_probs=207.2
Q ss_pred HhcCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecC-
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQG- 388 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 388 (658)
..++|.+.++||+|+||.||+|.+. +++.||||++...........+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3468889999999999999999742 35689999987544444556789999999999 899999999988654
Q ss_pred CeEEEEEeccCCCCHHHHhhcCC---------------------------------------------------------
Q 006168 389 PELILVYEYMANSSLDKFLFGEK--------------------------------------------------------- 411 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 411 (658)
...++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 46899999999999999986421
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc-cccccCCcc
Q 006168 412 ---RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL-STKFAGTLG 487 (658)
Q Consensus 412 ---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~ 487 (658)
...+++..+..++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++......... .....++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 13488899999999999999999998 99999999999999999999999999998654332221 223456788
Q ss_pred cccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHH
Q 006168 488 YTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKV 566 (658)
Q Consensus 488 y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l 566 (658)
|+|||++.+..++.++||||||+++|||++ |+.||........ + ......+.... .+...+..+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~----~~~~~~~~~~~----------~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-F----CQRLKDGTRMR----------APENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-H----HHHHhcCCCCC----------CCCCCCHHH
Confidence 999999999999999999999999999997 9999875443211 1 11122221111 112234568
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 567 VEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 567 ~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.+|+.+||+.||.+|||+.||+++|+.+
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=350.27 Aligned_cols=268 Identities=25% Similarity=0.371 Sum_probs=211.7
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC-CCccceeeeEeecCC-eEE
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQGP-ELI 392 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~ 392 (658)
...++|...++||.|.||.||+|+.+ .|+.||||+++......+...-.+|+..|++|+ |||||+|.+++.+.+ .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34578888999999999999999955 689999999986433322333478999999998 999999999998888 999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
+|||||+. +|.+++.++ +..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.+.
T Consensus 87 fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 99999976 999999765 67799999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchh-hHHHHHHHHhhcCcccc---
Q 006168 473 ENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE-YLLKRAWRLYENGTHWE--- 547 (658)
Q Consensus 473 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~--- 547 (658)
... ..|..+.|..|.|||++.. +-|+.+.|+|++|||++||.+-++.|.+..+-++ .-+-.+..........+
T Consensus 162 Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 543 3466788999999999864 6899999999999999999999999887765222 11111111001111111
Q ss_pred ---cccccCC---C---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 548 ---LMDESLD---P---NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 548 ---~~d~~l~---~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+.-.++ + ...-...+.++.+++.+|+.+||.+|||+.+.+++
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111110 0 01112256789999999999999999999999975
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=353.78 Aligned_cols=250 Identities=27% Similarity=0.444 Sum_probs=213.4
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
..|....+||+|..|.||.+... +++.||||++.. ......+.+.+|+.+|+..+|+|||.+++.|..++++++||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l-~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDL-RKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEe-ccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 46777889999999999999854 688999999976 3444556679999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
|++|+|.+.+ ....+++.++..|++++++||+|||.+ +|+|||||.+|||++.++.+||+|||++..+.....
T Consensus 352 m~ggsLTDvV---t~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 352 MEGGSLTDVV---TKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred cCCCchhhhh---hcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 9999999998 344599999999999999999999999 999999999999999999999999999998866554
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
.....+||+.|||||++....|.+|.||||||++++||+.|.+||-.... +...+....++.. ...
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-----lrAlyLIa~ng~P---------~lk 490 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----LRALYLIATNGTP---------KLK 490 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-----HHHHHHHhhcCCC---------CcC
Confidence 45568999999999999999999999999999999999999999875332 2222333333321 122
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+...+..+.+++.+||+.|+++||++.|+|+.
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 344556779999999999999999999999974
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=345.57 Aligned_cols=265 Identities=27% Similarity=0.408 Sum_probs=210.4
Q ss_pred cCCCccCcccccCceEEEEEEe-cCCcEEEEEEcccccccc-cHHHHHHHHHHHhccCCCccceeeeEeecC--CeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTL-KNGKIVAVKKLAIGISRR-TLSDFENEVRLISNVHHRNLIRLLGCCSQG--PELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 394 (658)
+.|+..++||+|.||.||+++. .+|+.||+|++..+.... ...-..+||.+|++|+||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4566678999999999999995 479999999998754333 345568999999999999999999998776 689999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
+|||++ +|.-++. ...-.+++.++..++.|+++||.|+|+. +|+|||||.+|||||.+|.+||+|||||+++...
T Consensus 197 FeYMdh-DL~GLl~-~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLS-SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecccc-hhhhhhc-CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999998 8888873 2344699999999999999999999999 9999999999999999999999999999998877
Q ss_pred CccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh--cCcccccccc
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYE--NGTHWELMDE 551 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~--~~~~~~~~d~ 551 (658)
.....|..+-|..|.|||.+.+. .|+.+.|+||.||||.||+.|++.+.+..+-.+ +..+.++.. ....|...+-
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ--l~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ--LHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH--HHHHHHHhCCCChhccccccC
Confidence 77777888889999999999875 799999999999999999999999887665211 112222211 1112221110
Q ss_pred c---C--CCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 552 S---L--DPNECT-------KEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 552 ~---l--~~~~~~-------~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
. . ....+. ...+...++|+..+|..||.+|.|+.++++.
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0 0 011111 1223457889999999999999999998853
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=342.89 Aligned_cols=252 Identities=26% Similarity=0.396 Sum_probs=211.1
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 392 (658)
.-++|..++.||+|+|++|++++.+ .++.+|||++.+. ..+...+-...|-+.|.+| .||.|++|+--|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3468889999999999999999965 6899999998653 2233344567788899999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
+|+||.++|+|.++| .+.+.|++.....++.+|+.||+|||++ |||||||||+|||||+++++||+|||.|+.+.
T Consensus 151 FvLe~A~nGdll~~i--~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLI--KKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEecCCCcHHHHH--HHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 999999999999999 4557899999999999999999999999 99999999999999999999999999999885
Q ss_pred CCCcc----------cc--ccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh
Q 006168 473 ENQSH----------LS--TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLY 540 (658)
Q Consensus 473 ~~~~~----------~~--~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~ 540 (658)
..... .. ..++||..|.+||.+..+..+..+|+|+|||+||+|+.|++||...++. .+.+.+..+
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--liFqkI~~l- 302 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY--LIFQKIQAL- 302 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH--HHHHHHHHh-
Confidence 43222 11 3589999999999999999999999999999999999999999876542 122222221
Q ss_pred hcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 541 ENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 541 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+. .++...++.+.+|+.+.|..||.+|+|..+|-+.
T Consensus 303 ---------~y-----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 ---------DY-----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ---------cc-----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 12 2233334678999999999999999999988754
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.46 Aligned_cols=263 Identities=27% Similarity=0.458 Sum_probs=205.2
Q ss_pred cCCCccCcccccCceEEEEEEecC-----------------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCcccee
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN-----------------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRL 381 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 381 (658)
++|...++||+|+||.||++.+++ +..||+|.+..........+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578888999999999999998643 336999998764444456789999999999999999999
Q ss_pred eeEeecCCeEEEEEeccCCCCHHHHhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeee
Q 006168 382 LGCCSQGPELILVYEYMANSSLDKFLFGEK-----------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIH 444 (658)
Q Consensus 382 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 444 (658)
++++.+.+..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999885321 12478899999999999999999998 9999
Q ss_pred cCcCCCcEEEcCCCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhC--CCC
Q 006168 445 RDIKPSNVLLDDDLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG--TKS 521 (658)
Q Consensus 445 ~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG--~~p 521 (658)
|||||+|||+++++.+||+|||+++.+...... ......++..|+|||++..+.++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865433221 22244567899999999999999999999999999999975 445
Q ss_pred CCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 522 SETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 522 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
+.... ..................... ..+...+..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus 242 ~~~~~--~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELT--DEQVIENAGEFFRDQGRQVYL-------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCC--HHHHHHHHHHHhhhccccccc-------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 54332 222333322222211110000 0011223568999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=388.90 Aligned_cols=262 Identities=26% Similarity=0.454 Sum_probs=215.0
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.+.|...+.||+|+||.||+|+.. ++..||||++..... ....|++.+++++|||||+++|+|.+.+..++|||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 356778889999999999999974 789999999864221 12356889999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++|+|.++++ .++|..+.+|+.||++||+|||..+.++|+||||||+||+++.++.+++. ||.......
T Consensus 764 y~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 764 YIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 999999999993 38999999999999999999997666699999999999999999988876 665543321
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
.....+++.|+|||++.+..++.|+|||||||++|||+||+.|+.........+.+|+...+........+|+.+...
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 122367899999999999999999999999999999999999986544444456666655554444555566655322
Q ss_pred -CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 557 -ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 557 -~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
..+.++..++.+++.+||+.||++||||.||+++|+.+.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 344566778999999999999999999999999999874
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=373.44 Aligned_cols=264 Identities=30% Similarity=0.497 Sum_probs=216.5
Q ss_pred cCCCccCcccccCceEEEEEEecC--Cc----EEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN--GK----IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
++.+..+.||+|.||.||.|...+ |. .||||.+.+..+.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 344566789999999999999763 43 499999998778888999999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccC
Q 006168 393 LVYEYMANSSLDKFLFGEK-----RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL 467 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGl 467 (658)
+++|||++|+|..+|.+.+ ...|+....+.++.|||+|+.|||++ ++|||||..+|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999996542 23499999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCcccc-ccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcc
Q 006168 468 ARLLPENQSHLS-TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTH 545 (658)
Q Consensus 468 a~~~~~~~~~~~-~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 545 (658)
|+.+...+.... ....-...|||||.++.+.++.|+|||||||+||||+| |..|+....... + ...+.++.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--v----~~~~~~gg- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--V----LLDVLEGG- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH--H----HHHHHhCC-
Confidence 995544333222 22244579999999999999999999999999999999 667776544311 1 11122221
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCC
Q 006168 546 WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGN 601 (658)
Q Consensus 546 ~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~ 601 (658)
+| +.+...++.+.+|+..||+.+|++||++..|++.+..+.....+.
T Consensus 922 ------RL---~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 922 ------RL---DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred ------cc---CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 11 122334567999999999999999999999999999886555543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=344.07 Aligned_cols=247 Identities=28% Similarity=0.458 Sum_probs=212.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+. ..+.+.+.+.+|++++++++|||||.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999977 5889999999763 445567788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+.+ +|..+| ...+.|+++.+..|+.++..||.|||++ +|+|||+||.|||++..+.+|++|||+++.... .+
T Consensus 82 ~a~g-~L~~il--~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTIL--EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT 154 (808)
T ss_pred hhhh-hHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence 9987 999999 4567799999999999999999999999 999999999999999999999999999998755 34
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
...+.+.|||-|||||.+.++.|+..+|.||+|||+||+++|++||... .+.+.+..... | +.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~--------d----~v 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILK--------D----PV 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhc--------C----CC
Confidence 4566889999999999999999999999999999999999999998542 12222211111 1 12
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
..+......+..++...|++||.+|.|-.+++.
T Consensus 218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 233456677999999999999999999999884
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.04 Aligned_cols=247 Identities=21% Similarity=0.308 Sum_probs=199.5
Q ss_pred cCcccccCceEEEEEEecCCcEEEEEEccccccc--ccHHHHHHHHHHHhccCCCccceeeeEeec----CCeEEEEEec
Q 006168 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISR--RTLSDFENEVRLISNVHHRNLIRLLGCCSQ----GPELILVYEY 397 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~E~ 397 (658)
...||+|++|.||+|.+ +|+.||||++...... ...+.+.+|+.+|++++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46799999999999998 5889999998753211 114678899999999999999999999876 4578999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++|+|.+++. ....+++...+.++.+++.||.|||+. .+++||||||+|||+++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~--~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 104 CTRGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCCcHHHHHh--hCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999994 345799999999999999999999973 178899999999999999999999999998654322
Q ss_pred ccccccCCccccccccccc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIH--GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~--~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .+.... ...+.. .
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~i---~~~~~~-----~---- 241 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDLI---INKNNS-----L---- 241 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHHH---HhcCCC-----C----
Confidence 23467899999999976 68999999999999999999999999754321 111111 111110 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+...+..+.+++.+||+.||++|||+.||++.|+..
T Consensus 242 -~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 242 -KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred -CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11112345699999999999999999999999999876
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.97 Aligned_cols=265 Identities=26% Similarity=0.467 Sum_probs=213.5
Q ss_pred hHHHHHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCC
Q 006168 311 LKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP 389 (658)
Q Consensus 311 ~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 389 (658)
.+++..-.+.+.....||+|.||+||+|.|. ..||||.+... .+.+..+.|++|+..+++-+|.||+-+.|+|....
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3556666667778899999999999999996 46999999764 34557889999999999999999999999998887
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
. .+|+.+|++.+|+.+|+..+ ..++..+.+.|++|||+|+.|||.+ +|||||||..||+|.+++.+||+||||+.
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred e-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccccee
Confidence 7 99999999999999997544 6699999999999999999999999 99999999999999999999999999996
Q ss_pred ccCCC-CccccccccCCccccccccccc---CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcc
Q 006168 470 LLPEN-QSHLSTKFAGTLGYTAPEYAIH---GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTH 545 (658)
Q Consensus 470 ~~~~~-~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 545 (658)
.-..- .........|...|||||++.. .+|+..+||||||+|+|||++|..|+.....+.. + +..++-
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI-i-------fmVGrG 608 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI-I-------FMVGRG 608 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-E-------EEeccc
Confidence 43211 1112224567789999999964 3789999999999999999999999983222211 1 111221
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 546 WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 546 ~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.-..|... ...+.+.++.+|+..||..++++||.+.+|+.+|+.+
T Consensus 609 ~l~pd~s~----~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 609 YLMPDLSK----IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred ccCccchh----hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 11122221 2233456799999999999999999999999988877
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=345.49 Aligned_cols=247 Identities=30% Similarity=0.495 Sum_probs=206.7
Q ss_pred ccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCC
Q 006168 323 EENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSS 402 (658)
Q Consensus 323 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 402 (658)
+.+-||.|+-|.||+|+++ ++.||||+++. .-+.+|+-|++|+||||+.+.|+|.....++||||||..|-
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~e--------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRE--------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhh--------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 4578999999999999997 68899998864 12467889999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccccc
Q 006168 403 LDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKF 482 (658)
Q Consensus 403 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 482 (658)
|...| +....++......|..+||.|+.|||.+ .|||||||.-||||..+..+||+|||-++...+. .....+
T Consensus 199 L~~VL--ka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSF 271 (904)
T KOG4721|consen 199 LYEVL--KAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSF 271 (904)
T ss_pred HHHHH--hccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhh
Confidence 99999 4566799999999999999999999999 9999999999999999999999999999876543 223368
Q ss_pred cCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHH
Q 006168 483 AGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEA 562 (658)
Q Consensus 483 ~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 562 (658)
.||..|||||++.+.+.++|.|||||||||||||||..|+........ +|..- ...| .-..+...
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----IwGVG---------sNsL-~LpvPstc 336 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----IWGVG---------SNSL-HLPVPSTC 336 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-----EEecc---------CCcc-cccCcccC
Confidence 999999999999999999999999999999999999999865432111 11110 0111 22334445
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCC
Q 006168 563 AEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLG 600 (658)
Q Consensus 563 ~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 600 (658)
++-+.-|+++||+..|.+||++++++..|+-..+.++.
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~ 374 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLS 374 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhc
Confidence 56689999999999999999999999999877555544
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=351.11 Aligned_cols=259 Identities=25% Similarity=0.435 Sum_probs=206.4
Q ss_pred hcCCCccCcccccCceEEEEEEe------cCCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTL------KNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 390 (658)
.++|+..+.||+|+||.||++++ .++..||||++.........+.+.+|+++++.+ +||||+++++++..++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999974 235689999987544444556789999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCC-----------------------------------------------------------
Q 006168 391 LILVYEYMANSSLDKFLFGEK----------------------------------------------------------- 411 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 411 (658)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999985422
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 412 --------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 412 --------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 12478999999999999999999998 9999999999999999999999999999876443221
Q ss_pred c-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 478 L-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 478 ~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
. .....++..|+|||++.+..++.++||||||+++|||++ |..||....... .+ .+....+....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~----~~~~~~~~~~~-------- 337 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KF----YKMIKEGYRML-------- 337 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HH----HHHHHhCccCC--------
Confidence 1 123345678999999999999999999999999999998 788876543221 11 11122111000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.+...+.++.+|+.+||+.||++|||+.||+++|++.
T Consensus 338 --~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 --SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0111234689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=339.39 Aligned_cols=249 Identities=26% Similarity=0.435 Sum_probs=213.6
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
..|+..+.||+|.||.||+|... .++.||+|++.........+++++|+.+|.+++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35666789999999999999965 68899999998877778889999999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+.+|++.+.+ .....+++..+.-|++++..||.|||.+ +.+|||||+.|||+..+|.+||+|||.+..+......
T Consensus 93 ~~gGsv~~lL--~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 93 CGGGSVLDLL--KSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred hcCcchhhhh--ccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 9999999999 3344468888889999999999999999 9999999999999999999999999999887655443
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
. .+++||+.|||||++....|+.|+||||||++.+||++|.+|+....+. ++.-++.+.. +..
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm---------------rvlflIpk~~-PP~ 230 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM---------------RVLFLIPKSA-PPR 230 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc---------------eEEEeccCCC-CCc
Confidence 3 6789999999999999889999999999999999999999998654431 1112222222 222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
+.......+.+++..||++||+.||++.++++
T Consensus 231 L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 231 LDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 23345567999999999999999999999984
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=310.38 Aligned_cols=264 Identities=28% Similarity=0.403 Sum_probs=209.1
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccccccc-HHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRT-LSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
++|...++||+|.||.||+|+.. +|+.||||++..+...++ .....+|++.|+.++|+||+.++++|.+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46777889999999999999954 799999999987543333 3457899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
||+. +|+..|.+ +...|+...+..++.++++||+|||++ .|+||||||.|+|++++|.+||+|||+++.+.....
T Consensus 82 fm~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred eccc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9987 99999843 445699999999999999999999999 999999999999999999999999999999865543
Q ss_pred cccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh---hcCccc---ccc
Q 006168 477 HLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLY---ENGTHW---ELM 549 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~---~~~~~~---~~~ 549 (658)
. .+..+-|..|.|||.+.+. .|+...|+||.|||+.||+-|.+-|.+..+- ++ +..+.+.. .+..+. ++.
T Consensus 157 ~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQ-L~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 157 I-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQ-LSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred c-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HH-HHHHHHHcCCCCcccCccccccc
Confidence 3 3334778999999999875 7999999999999999999988777655441 11 22222222 111111 111
Q ss_pred ccc-------CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 550 DES-------LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 550 d~~-------l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
|.. ...+..-........+++..++..||.+|+|++|++++
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 110 00111222345567999999999999999999999976
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=333.59 Aligned_cols=256 Identities=27% Similarity=0.440 Sum_probs=206.9
Q ss_pred cCCCccCcccccCceEEEEEEec----CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK----NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
++|.+.+.||+|+||.||+|.++ .+..||+|.+...........+.+|+..+++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56788899999999999999864 35689999987654444456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999998532 35699999999999999999999998 9999999999999999999999999987654322
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
.........++..|+|||.+.+..++.++||||||+++||+++ |+.||...... .+... ...+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~----~~~~~~-------- 226 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKA----VEDGFR-------- 226 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHH----HHCCCC--------
Confidence 2111123345678999999999999999999999999999875 99998654321 11111 111110
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
...+...+..+.+++..||+.+|.+||++.+|++.|++.
T Consensus 227 --~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 --LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011223445689999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=350.80 Aligned_cols=259 Identities=26% Similarity=0.438 Sum_probs=206.5
Q ss_pred hcCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 390 (658)
.++|.+.+.||+|+||.||+++.. ++..||+|++...........+.+|+++++.+ +|+||+++++++...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457888999999999999998842 34579999997544444456788999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCC-----------------------------------------------------------
Q 006168 391 LILVYEYMANSSLDKFLFGEK----------------------------------------------------------- 411 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 411 (658)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc-cccc
Q 006168 412 ---------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH-LSTK 481 (658)
Q Consensus 412 ---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~ 481 (658)
...+++.++++++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 12478899999999999999999998 9999999999999999999999999999865433221 1223
Q ss_pred ccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCH
Q 006168 482 FAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTK 560 (658)
Q Consensus 482 ~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 560 (658)
..++..|+|||++.+..++.++||||||+++|||++ |+.||........ + ......+. . . ..+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~----~~~~~~~~--~---~-----~~~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-F----YKMVKRGY--Q---M-----SRPD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-H----HHHHHccc--C---c-----cCCC
Confidence 345678999999999999999999999999999997 9999875433221 1 11111110 0 0 0111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 561 EAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 561 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+.++.+++.+||+.||.+|||+.+|+++|+++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1235689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=335.08 Aligned_cols=251 Identities=27% Similarity=0.388 Sum_probs=203.7
Q ss_pred CCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
|...+.||+|+||.||++... +++.||+|.+.... .......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667889999999999999965 78999999986432 123345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++|+|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET- 157 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe-
Confidence 9999999888655555699999999999999999999998 999999999999999999999999999987543221
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
.....||..|+|||++.+..++.++|||||||++|||++|+.||........ ........... ...
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~-----------~~~ 223 (285)
T cd05631 158 -VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRVKED-----------QEE 223 (285)
T ss_pred -ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHhhcc-----------ccc
Confidence 2345789999999999999999999999999999999999999976543211 01111111110 111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPT-----MSEVVA 589 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 589 (658)
.+...+..+.+|+.+||+.||.+||+ ++++++
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 22233457899999999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=330.22 Aligned_cols=255 Identities=29% Similarity=0.505 Sum_probs=210.6
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
.++|++.++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC--chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 3578889999999999999999888889999998642 33467889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.......+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999999665556799999999999999999999998 9999999999999999999999999999876543322
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
......++..|+|||++..+.++.++||||||+++|||++ |+.||...... ...... ..+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~----~~~~~~---------- 223 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSAL----QRGYRM---------- 223 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHH----HcCCCC----------
Confidence 2233456778999999998899999999999999999998 88888653321 111111 111100
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
......+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111234568999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=341.52 Aligned_cols=251 Identities=24% Similarity=0.419 Sum_probs=208.2
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc----ccccHHHHHHHHHHHhccC-CCccceeeeEeecCC
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI----SRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQGP 389 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 389 (658)
...++|...+.||+|+||.|+.|... ++..||+|.+.... .....+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568889999999999999999865 68999999776531 1123456678999999998 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC-CCeEEeeccCc
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD-LQPKIADFGLA 468 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~-~~~kl~DfGla 468 (658)
..++||||+.+|+|.+++.. .+++.+.+...+++|++.|++|||+. +|+||||||+|||++.+ +++||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999954 67899999999999999999999999 99999999999999999 99999999999
Q ss_pred cccCCCCccccccccCCcccccccccccCC-CC-CcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccc
Q 006168 469 RLLPENQSHLSTKFAGTLGYTAPEYAIHGQ-LS-EKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHW 546 (658)
Q Consensus 469 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~s-~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 546 (658)
.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||....... +. .+ ...+.
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~--l~---~k-i~~~~-- 239 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN--LY---RK-IRKGE-- 239 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH--HH---HH-HhcCC--
Confidence 9874 2223455689999999999999877 86 78999999999999999999998733211 11 11 11111
Q ss_pred ccccccCCCCCCCHHH-HHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 547 ELMDESLDPNECTKEA-AEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 547 ~~~d~~l~~~~~~~~~-~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
-.++... +.++..++.+|+..||..|+|+.+|++
T Consensus 240 ---------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 240 ---------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ---------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1122222 567999999999999999999999993
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=348.78 Aligned_cols=258 Identities=31% Similarity=0.481 Sum_probs=209.1
Q ss_pred HhcCCCccCcccccCceEEEEEEecC--C--cE-EEEEEccc--ccccccHHHHHHHHHHHhccCCCccceeeeEeecCC
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLKN--G--KI-VAVKKLAI--GISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP 389 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 389 (658)
..++....++||+|.||.||+|+++. + .. ||||.... ........+|.+|+++|++++|||||+++|++....
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34455566899999999999999763 2 23 89999874 245677889999999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
.+++|||+|.||+|+++|.... ..++..+++.++.+.|.||+|||++ +++||||.++|+|+..++.+||+||||++
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999995332 3699999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCccccc-cccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccc
Q 006168 470 LLPENQSHLST-KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWE 547 (658)
Q Consensus 470 ~~~~~~~~~~~-~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 547 (658)
.-.. ..... ...-+..|+|||.+..+.|+.++|||||||++||+++ |..|+...... .+..+ ...++-
T Consensus 311 ~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~k---I~~~~~--- 380 (474)
T KOG0194|consen 311 AGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAK---IVKNGY--- 380 (474)
T ss_pred CCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHH---HHhcCc---
Confidence 5431 11111 1235679999999999999999999999999999999 77787654432 11111 111111
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 548 LMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 548 ~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
+-..+...+..+..++.+||..+|++||||.++.+.|+.+.
T Consensus 381 -------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 381 -------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred -------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 11122244567889999999999999999999999999874
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=333.47 Aligned_cols=250 Identities=32% Similarity=0.576 Sum_probs=197.9
Q ss_pred ccCcccccCceEEEEEEec-----CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 323 EENKLGEGGFGDIYKGTLK-----NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 323 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
..+.||.|.||.||+|.+. .+..|+||.+.........++|.+|++.+++++||||++++|++.+.+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999987 25689999996544445578999999999999999999999999988889999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc-
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS- 476 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~- 476 (658)
+++|+|.++|.......+++..++.|+.||++||.|||+. +++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999776567899999999999999999999998 999999999999999999999999999987633222
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
...........|+|||.+....++.++||||||+++|||++ |+.|+..... ..+... ..++....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~----~~~~~~~~-------- 225 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEK----LKQGQRLP-------- 225 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHH----HHTTEETT--------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccc----ccccccce--------
Confidence 22234456789999999999999999999999999999999 6777754422 222221 12221111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 591 (658)
.+...+..+.+++..||..+|++|||+.++++.|
T Consensus 226 --~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 --IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112345689999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=335.06 Aligned_cols=253 Identities=22% Similarity=0.351 Sum_probs=206.2
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
..++|+.++.||+|+||.||+++-+ +|+.+|+|++++. ....+.+..+.|-.+|....+|+||+|+-.|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999976 5999999999874 345667888999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||++||++..+| .+.+.|++.....++.+++.|+..||+. |+|||||||+|+|||..|++||+||||+.-+..
T Consensus 219 iMEylPGGD~mTLL--~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL--MRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHH--HhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999 5667899999999999999999999999 999999999999999999999999999853311
Q ss_pred C----------------------Ccc-----c-------------------cccccCCcccccccccccCCCCCcccchh
Q 006168 474 N----------------------QSH-----L-------------------STKFAGTLGYTAPEYAIHGQLSEKVDAYS 507 (658)
Q Consensus 474 ~----------------------~~~-----~-------------------~~~~~gt~~y~APE~~~~~~~s~ksDV~S 507 (658)
. ... . ....+|||.|||||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0 000 0 01368999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCC---H
Q 006168 508 FGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPT---M 584 (658)
Q Consensus 508 fGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~ 584 (658)
||||+||||.|.+||.......-.--...|+.. +.. +. ......+..+||.+|+. ||++|.- +
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-----l~f------P~--~~~~s~eA~DLI~rll~-d~~~RLG~~G~ 439 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRET-----LKF------PE--EVDLSDEAKDLITRLLC-DPENRLGSKGA 439 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-----ccC------CC--cCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence 999999999999999877653221111112211 000 11 11122578899999999 9999975 4
Q ss_pred HHHH
Q 006168 585 SEVV 588 (658)
Q Consensus 585 ~evl 588 (658)
.||-
T Consensus 440 ~EIK 443 (550)
T KOG0605|consen 440 EEIK 443 (550)
T ss_pred HHHh
Confidence 4444
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=330.03 Aligned_cols=266 Identities=22% Similarity=0.358 Sum_probs=205.4
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
++|++.+.||+|+||.||+++.+ +++.||+|++.... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47889999999999999999986 58899999986532 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|++++.+..+. .....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLE--EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99998776654 2345699999999999999999999998 999999999999999999999999999987654333
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhH-HHH--------HHHHhhcCc-cc
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYL-LKR--------AWRLYENGT-HW 546 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l-~~~--------~~~~~~~~~-~~ 546 (658)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||.......... ... .++.+.... ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 33345678999999999999899999999999999999999999997654321110 000 001110000 00
Q ss_pred ccccccCC-CC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 547 ELMDESLD-PN----ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 547 ~~~d~~l~-~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
....+... .. ......+..+.+++.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 00 011123456999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=337.46 Aligned_cols=264 Identities=25% Similarity=0.437 Sum_probs=219.6
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
+...+.++||+|-||.|.+.....+..||||.++.+.......+|.+|+++|.+++|||||+|+|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 45567889999999999999998889999999998777777799999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++|+|.+++.......+.-....+|+.||+.||+||.+. ++|||||.+.|+|+|+++++||+|||+++-+-..+.+.
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999765545556677788999999999999998 99999999999999999999999999999665444433
Q ss_pred -cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh--CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 479 -STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS--GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 479 -~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt--G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
..+.+-+.+|||||.+..++++++||||+||+++||+++ ...|+.... .++.++....+...+.....+
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt--~e~vven~~~~~~~~~~~~~l------ 766 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT--DEQVVENAGEFFRDQGRQVVL------ 766 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh--HHHHHHhhhhhcCCCCcceec------
Confidence 346667889999999999999999999999999999876 556665433 334455544444433222211
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+.-.+..+.++++.||..+-++||++++|...|.+.
T Consensus 767 -~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 -SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 12223445689999999999999999999999988764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=331.10 Aligned_cols=256 Identities=27% Similarity=0.531 Sum_probs=209.0
Q ss_pred cCCCccCcccccCceEEEEEEecC------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
++|...+.||+|+||.||+|.... ...|++|.+...........+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998653 25799999875444445667899999999999999999999999989999
Q ss_pred EEEeccCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC
Q 006168 393 LVYEYMANSSLDKFLFGEKR--------------GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL 458 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~ 458 (658)
++|||+++++|.+++..... ..+++..++.++.|++.||.|||+. +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999854321 4588999999999999999999998 999999999999999999
Q ss_pred CeEEeeccCccccCCCCc-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHH
Q 006168 459 QPKIADFGLARLLPENQS-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRA 536 (658)
Q Consensus 459 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~ 536 (658)
.+||+|||++........ .......+++.|+|||++.++.++.++||||||+++|||++ |..||...... .+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~--- 236 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVI--- 236 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH---
Confidence 999999999986543322 22334456889999999999999999999999999999998 99898654331 111
Q ss_pred HHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 537 WRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 537 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
..+..+... ..+...+.++.+|+.+||+.||.+||++.||++.|++
T Consensus 237 -~~i~~~~~~----------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 -EMIRSRQLL----------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHcCCcC----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 112111111 1223345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=325.31 Aligned_cols=252 Identities=27% Similarity=0.454 Sum_probs=204.9
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
++|+..+.||+|+||.||++.++++..+|+|.+... .....++.+|++++++++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC--CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 457788899999999999999988889999987642 334568899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.........
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 82 ENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999998543 34689999999999999999999998 99999999999999999999999999998654333222
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
.....++..|+|||++....++.++||||||+++|||++ |+.||...... ...... ..+... .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i----~~~~~~--~-------- 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMI----SRGFRL--Y-------- 221 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH----HCCCCC--C--------
Confidence 223345678999999988899999999999999999999 88888644321 111111 111100 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
.+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 01112346899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=338.30 Aligned_cols=264 Identities=24% Similarity=0.340 Sum_probs=207.0
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|++.+.||+|+||.||+++.+ ++..+|+|.+...........+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468899999999999999999976 5888999998764444445679999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 84 HMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 9999999999943 35689999999999999999999985 169999999999999999999999999997653322
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcC--ccc--------
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG--THW-------- 546 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~~~-------- 546 (658)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||...... .+..........+ ...
T Consensus 159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccccCCccccCcccc
Confidence 23457899999999999999999999999999999999999999643321 1111100000000 000
Q ss_pred --------------------cccc---ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 547 --------------------ELMD---ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 547 --------------------~~~d---~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+..+ ....+.........++.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 0000011111245679999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=325.03 Aligned_cols=255 Identities=31% Similarity=0.489 Sum_probs=208.8
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
.++|++.+.||+|++|.||+|.+.+++.||+|.+... ....+++.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG--TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC--cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 4678889999999999999999888889999998653 23457799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999999654445699999999999999999999998 9999999999999999999999999999876533221
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
.......+..|+|||++.+..++.++||||||++++||++ |+.|+...... .+.. ....... .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~----~~~~~~~----------~ 223 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQ----QVDQGYR----------M 223 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHH----HHHcCCC----------C
Confidence 1112233468999999998999999999999999999999 88888643321 1111 1111100 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
..+...+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1112234579999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=327.70 Aligned_cols=255 Identities=28% Similarity=0.477 Sum_probs=208.3
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
.+|.+.++||+|+||.||+|.++ +++.||+|.+.. ......++.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecC--CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 35778899999999999999976 588999999864 233457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.......+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999999655556799999999999999999999998 9999999999999999999999999999876443222
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
......++..|+|||++.+..++.++||||||+++|||++ |..|+...... .+ ++....+.. .
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~----~~~~~~~~~----------~ 224 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QV----YELLEKGYR----------M 224 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HH----HHHHHCCCC----------C
Confidence 2222334678999999998999999999999999999998 88887643221 11 122211110 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+...+..+.+++.+||+.+|++|||+.+++++|+.+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11222345699999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=338.70 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=201.0
Q ss_pred CCCccCcccccCceEEEEEEec----CCcEEEEEEccccc---ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK----NGKIVAVKKLAIGI---SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 391 (658)
+|++.+.||+|+||.||+++.. +++.||+|++.... .....+.+..|+.++.++ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999999853 57899999986421 223345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 ~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999984 345699999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 472 PENQSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 472 ~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ....+.... .+
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~------~~ 227 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILK------CD 227 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhc------CC
Confidence 44433333456799999999998765 4789999999999999999999999754331110 111111111 01
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRP-----TMSEVVAL 590 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 590 (658)
.. .+......+.+++.+||+.||++|| ++.++++.
T Consensus 228 ~~-----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 PP-----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CC-----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11 1122345688999999999999999 67777753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=327.30 Aligned_cols=258 Identities=32% Similarity=0.523 Sum_probs=212.6
Q ss_pred HHhcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
....+|+..++||.|+||.||+|...+++.+++|.+... ......++.+|+.+++.++||||+++++++...+..++||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD-DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc-chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 345678889999999999999999988999999998753 3334667899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++++|.+++.......+++..++.++.||+.||.|||+. +|+|+||||+||++++++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999999765566799999999999999999999998 99999999999999999999999999998764332
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
.. .....++..|+|||.+.+..++.++||||||+++++|++ |+.|+..... ........ .+..
T Consensus 159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~~----~~~~--------- 222 (261)
T cd05148 159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQIT----AGYR--------- 222 (261)
T ss_pred cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHH----hCCc---------
Confidence 21 223446778999999998899999999999999999998 7888864332 11111111 1100
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
...+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 -MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 011123345689999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=345.21 Aligned_cols=260 Identities=24% Similarity=0.401 Sum_probs=208.4
Q ss_pred HhcCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccC-CCccceeeeEeecCC
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQGP 389 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 389 (658)
..++|.+.+.||+|+||.||+|++. .+..||||++.........+.+.+|++++++++ ||||+++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3568888999999999999999863 234799999976444445578999999999996 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhhcCC----------------------------------------------------------
Q 006168 390 ELILVYEYMANSSLDKFLFGEK---------------------------------------------------------- 411 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 411 (658)
..++||||+++|+|.++|+...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999885421
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc
Q 006168 412 ------------------------------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD 455 (658)
Q Consensus 412 ------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~ 455 (658)
...+++..++.++.||++||.|||+. +|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 12478889999999999999999998 999999999999999
Q ss_pred CCCCeEEeeccCccccCCCCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHH
Q 006168 456 DDLQPKIADFGLARLLPENQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLL 533 (658)
Q Consensus 456 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~ 533 (658)
+++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+........ +
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~- 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-F- 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-H-
Confidence 99999999999998664332221 223456788999999999999999999999999999997 8888865432211 1
Q ss_pred HHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 534 KRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 534 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
......+... ..+...+..+.+++.+||+.+|++|||+.+|+++|+.+
T Consensus 350 ---~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 350 ---YNKIKSGYRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred ---HHHHhcCCCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 1111111100 11123345789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=336.57 Aligned_cols=242 Identities=24% Similarity=0.294 Sum_probs=198.4
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCC
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANS 401 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 401 (658)
+.||+|+||.||+++.+ +|+.||+|++.... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999975 68999999987532 2334567789999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccccc
Q 006168 402 SLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK 481 (658)
Q Consensus 402 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 481 (658)
+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~ 154 (323)
T cd05571 81 ELFFHLS--RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccc
Confidence 9999984 345799999999999999999999998 99999999999999999999999999987542221 12234
Q ss_pred ccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHH
Q 006168 482 FAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKE 561 (658)
Q Consensus 482 ~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 561 (658)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... ...+. ...+..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~----~~~~~-----------~~~p~~ 217 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFEL----ILMEE-----------IRFPRT 217 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHH----HHcCC-----------CCCCCC
Confidence 67999999999999999999999999999999999999999654321 11111 11110 011223
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 006168 562 AAEKVVEIALMCTQSAANSRP-----TMSEVVA 589 (658)
Q Consensus 562 ~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 589 (658)
....+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 345689999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=310.95 Aligned_cols=237 Identities=27% Similarity=0.387 Sum_probs=203.0
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|+..+.||.|+||.|.+++.+ +|..+|+|++.+. ....+.++..+|..+|+.+.||.++++++.+.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56778899999999999999977 5888999999764 23345667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|-|..++ ++.++++++...-++.+|+.||+|||+. +|++|||||+|||+|.+|.+||.|||+++.+...
T Consensus 124 eyv~GGElFS~L--rk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYL--RKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHH--HhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999999999 4567899999999999999999999999 9999999999999999999999999999987543
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.-+.+|||.|+|||++....+..++|-|||||++|||+.|.+||...... .+. +..-+++
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~--~iY----~KI~~~~----------- 257 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI--QIY----EKILEGK----------- 257 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH--HHH----HHHHhCc-----------
Confidence 34689999999999999999999999999999999999999999876551 111 1111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCC
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSR 581 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~R 581 (658)
-.+|.-....+.+|+...++.|-.+|
T Consensus 258 v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 12334445568899999999998888
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=304.57 Aligned_cols=251 Identities=28% Similarity=0.397 Sum_probs=213.6
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
+.++|++++.||+|.||.||.|+.+ ++-.||+|++.+.. ..+...++.+|+++-+.|+||||++++++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3468899999999999999999976 57789999997642 23345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
++||..+|.|...|......++++.....++.|+|.||.|+|.. +++||||||+|+|++..+.+||+|||.+..-+
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 99999999999999877778899999999999999999999998 99999999999999999999999999997654
Q ss_pred CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
.......+||..|++||...+..++.+.|+|++|++.||++.|.+||+....+ .....+.+. |
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--etYkrI~k~----------~--- 238 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--ETYKRIRKV----------D--- 238 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH--HHHHHHHHc----------c---
Confidence 22345679999999999999999999999999999999999999999876531 111111111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
-.++...+....++|..|+..+|.+|.+..||++.
T Consensus 239 --~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 239 --LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 11223345568999999999999999999999875
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=334.15 Aligned_cols=246 Identities=23% Similarity=0.319 Sum_probs=202.5
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+.+.||+|+||.||++..+ +++.||+|++.... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999976 68899999986421 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLR--NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 9999999999984 345699999999999999999999998 9999999999999999999999999999866432
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||...... .+... ...+.
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~~~~----i~~~~----------- 214 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--GIYEK----ILAGK----------- 214 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH----HHhCC-----------
Confidence 22357899999999999889999999999999999999999998754321 11111 11111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPT-----MSEVVAL 590 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 590 (658)
...+......+.+++.+||+.||.+||+ +.++++.
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0112222456899999999999999995 7777644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=329.40 Aligned_cols=266 Identities=29% Similarity=0.460 Sum_probs=204.1
Q ss_pred CccCcccccCceEEEEEEe-----cCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecC--CeEEEE
Q 006168 322 SEENKLGEGGFGDIYKGTL-----KNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG--PELILV 394 (658)
Q Consensus 322 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 394 (658)
...+.||+|+||+||++.. .+++.||+|.+...........+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7789999999999988653 357889999987543334567788999999999999999999988653 468999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++++|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 87 ~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 87 MEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 999999999999843 4599999999999999999999998 9999999999999999999999999999876443
Q ss_pred Cccc--cccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 475 QSHL--STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 475 ~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
.... .....++..|+|||.+.+..++.++||||||++++||++|+.|+........................+.++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 2211 12234566799999999889999999999999999999999997654321111111100000000111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
. ....+...+..+.+++..||+.+|++|||+++|+++|+.+
T Consensus 241 ~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 241 M-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred C-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1 1112223446799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=338.59 Aligned_cols=254 Identities=20% Similarity=0.336 Sum_probs=206.1
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+.+.||+|+||.||+|+.. +++.||+|++.... .......+.+|++++.+++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46888999999999999999987 58899999987532 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999994 345689999999999999999999998 999999999999999999999999999986543
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... +. ..+.... .
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~i~~-~~-----~~~~~~~-~ 222 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--TWENLKY-WK-----ETLQRPV-Y 222 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--HHHHHHh-cc-----ccccCCC-C
Confidence 2234678999999999999999999999999999999999999997543321 1111100 00 0010000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.......+..+.+++..||+.+|.+||++.++++.
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00012235578999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=323.76 Aligned_cols=256 Identities=30% Similarity=0.517 Sum_probs=208.5
Q ss_pred cCCCccCcccccCceEEEEEEecC----CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
++|+..+.||+|+||.||+|.++. ...||+|.+..........+|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578889999999999999999753 4579999987654455567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+|+||||+|||+++++.+||+|||+++.+...
T Consensus 84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 9999999999998542 34799999999999999999999998 9999999999999999999999999999877522
Q ss_pred Cccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 475 QSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 475 ~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
.... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .+.. ....+...
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~----~~~~~~~~------ 227 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIK----AVEDGYRL------ 227 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHH----HHHcCCCC------
Confidence 2221 122345678999999999999999999999999999998 98888543321 1111 11111000
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+...+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 228 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11122345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=337.96 Aligned_cols=246 Identities=22% Similarity=0.327 Sum_probs=202.7
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+.+.||+|+||.||+++++ +++.||+|.+.... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888999999999999999986 58899999986431 2234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLR--KAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 9999999999984 345689999999999999999999998 99999999999999999999999999998764322
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. .+....+..
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~----~~~i~~~~~---------- 232 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--RI----YEKILAGRL---------- 232 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--HH----HHHHhcCCc----------
Confidence 2357899999999999999999999999999999999999999654321 11 111111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPT-----MSEVVAL 590 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 590 (658)
..+......+.+++..||+.||.+||+ +.++++.
T Consensus 233 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 -KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011112346889999999999999997 6777643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=324.72 Aligned_cols=263 Identities=29% Similarity=0.428 Sum_probs=200.0
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhc--cCCCccceeeeEeecCC----eEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISN--VHHRNLIRLLGCCSQGP----ELI 392 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~ 392 (658)
+.....+.||+|.||.||||.++ ++.||||+++. +..+.|++|-++.+- ++|+||+++++.-..++ +++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 34445678999999999999997 49999999864 455678888777765 58999999999976665 899
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcC------CCCeeecCcCCCcEEEcCCCCeEEeecc
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF------HVRIIHRDIKPSNVLLDDDLQPKIADFG 466 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~Dik~~NIll~~~~~~kl~DfG 466 (658)
||+||.++|+|.++| +...++|....+|+..+++||+|||+.. +++|+|||||++||||..|++..|+|||
T Consensus 285 LVt~fh~kGsL~dyL---~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYL---KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EEeeeccCCcHHHHH---HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999999 4567999999999999999999999754 5789999999999999999999999999
Q ss_pred CccccCCCCccc-cccccCCcccccccccccC-CCC-----CcccchhhhHHHHHHHhCCCCCCCC-Ccchhh-------
Q 006168 467 LARLLPENQSHL-STKFAGTLGYTAPEYAIHG-QLS-----EKVDAYSFGVLVLEIISGTKSSETK-GEEGEY------- 531 (658)
Q Consensus 467 la~~~~~~~~~~-~~~~~gt~~y~APE~~~~~-~~s-----~ksDV~SfGvvl~elltG~~p~~~~-~~~~~~------- 531 (658)
++..+....... ....+||.+|||||++.+. .+. .+.||||+|.|||||++...-.... .++-+.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999886544332 2257999999999998653 222 3689999999999999975544210 000000
Q ss_pred ---HHHHHHHHhh-cCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 532 ---LLKRAWRLYE-NGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 532 ---l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
-++..+.... +..-..+.+... ....+..+.+.+..||..||+.|.|+.=|-+.+..+
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~-----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWR-----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhh-----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 0111222221 111112222211 113456799999999999999999999998888766
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=338.22 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=208.5
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
-|..++.||.|+-|.|-+|++. +|+.+|||++.+. .+......+.+|+-+|+-+.|||++++++++.+..++|||.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 3567889999999999999975 7999999999763 233345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++|-|.+++ .++++|++.+..+.++||+.|+.|+|.. +|+|||+||+|+|||..+++||+|||||.+-..+
T Consensus 93 yv~gGELFdyl--v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-- 165 (786)
T KOG0588|consen 93 YVPGGELFDYL--VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-- 165 (786)
T ss_pred ecCCchhHHHH--HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence 99999999999 5678899999999999999999999998 9999999999999999999999999999864332
Q ss_pred cccccccCCcccccccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
..-.+.+|.+.|.+||++++.+| ..++||||.|||||.||||+.||+..+ -..++..+. .| ..
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN--ir~LLlKV~----~G-~f--------- 229 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN--IRVLLLKVQ----RG-VF--------- 229 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--HHHHHHHHH----cC-cc---------
Confidence 23345799999999999999988 479999999999999999999998432 222322221 11 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+.+...+.++.+|+.+|+..||+.|.|+.||++.
T Consensus 230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1223344568999999999999999999999985
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=336.89 Aligned_cols=259 Identities=28% Similarity=0.489 Sum_probs=205.9
Q ss_pred hcCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeec-CC
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQ-GP 389 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~ 389 (658)
.++|.+.+.||+|+||.||+|... +++.||+|++.........+.+.+|+.++.++ +|+||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357889999999999999999743 24789999987543344456788999999999 89999999998854 46
Q ss_pred eEEEEEeccCCCCHHHHhhcCCC---------------------------------------------------------
Q 006168 390 ELILVYEYMANSSLDKFLFGEKR--------------------------------------------------------- 412 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 412 (658)
.++++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 78999999999999999853221
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc-cccccCCcccc
Q 006168 413 --GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL-STKFAGTLGYT 489 (658)
Q Consensus 413 --~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~ 489 (658)
..++|..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++..+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 2589999999999999999999998 99999999999999999999999999998764433222 22345677899
Q ss_pred cccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHH
Q 006168 490 APEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVE 568 (658)
Q Consensus 490 APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~ 568 (658)
|||++.+..++.++|||||||++|||++ |+.||....... .+ .+....+... ..+.....++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~----~~~~~~~~~~----------~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EF----CRRLKEGTRM----------RAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HH----HHHHhccCCC----------CCCccCCHHHHH
Confidence 9999999999999999999999999998 998886533221 11 1111111110 111223456899
Q ss_pred HHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 569 IALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 569 li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
++.+||+.+|++||++.||+++|+.+
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=335.82 Aligned_cols=262 Identities=26% Similarity=0.456 Sum_probs=219.3
Q ss_pred HHHHHHhcCCCccCcccccCceEEEEEEecC-CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCe
Q 006168 312 KDLVSATRKFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 312 ~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 390 (658)
++++--..+....++||-|.||.||.|.|+. .-.||||.++. .....++|+.|+.+|+.++|||+|+|+|+|.....
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE--DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh--cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 3444444456677899999999999999985 56799999985 45678999999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
+|||+|||.+|+|.++|..-.+..++...++.|+.||+.|++||..+ ++|||||..+|.|+.++..+|++||||+++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999999877777799999999999999999999998 999999999999999999999999999999
Q ss_pred cCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccc
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
+..+.........-...|.|||-+....++.|+|||+|||+||||.| |..|+..... ..++.+++++--.+
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl------SqVY~LLEkgyRM~-- 486 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYGLLEKGYRMD-- 486 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH------HHHHHHHhcccccc--
Confidence 87665444334445679999999999999999999999999999999 7777754332 22334443332111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
-++.++..+++|++.||+++|.+||++.|+-+.++..
T Consensus 487 --------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 487 --------GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred --------CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 1233445799999999999999999999999888754
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=322.37 Aligned_cols=252 Identities=27% Similarity=0.457 Sum_probs=204.6
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
++|...+.||+|+||.||++.++++..+|+|.+... .....++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC--cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 357778899999999999999887778999988642 234567899999999999999999999999989999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++|+|.+++... ...+++..++.++.||+.||.|||+. +++|+||||+||++++++.+||+|||+++.........
T Consensus 82 ~~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 82 SNGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999999998543 23689999999999999999999998 99999999999999999999999999998664433222
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
.....++..|++||.+....++.++||||||+++|||++ |+.|+...... .... ....+... .
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~----~~~~~~~~----------~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVE----KVSQGLRL----------Y 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHH----HHhcCCCC----------C
Confidence 223345678999999988889999999999999999999 88888654321 1111 11111100 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
.+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11112457899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=334.60 Aligned_cols=252 Identities=22% Similarity=0.358 Sum_probs=216.5
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCCe-EEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPE-LILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 395 (658)
++|...++||+|+||.++..+.+ +++.+++|.+... .+........+|+.++++++|||||.+.+.+.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999977 5788999998754 333444577899999999999999999999999888 99999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
+|++||+|.+.|...+...++++.++.++.|++.|+.|||++ +|+|||||+.||+++.+..+||+|||+++.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999877767799999999999999999999988 99999999999999999999999999999886654
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
......+||+.|+.||.+.+.+|..|+|||||||++|||++-+++|...+... +...+.+. + .
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~--Li~ki~~~-------------~-~ 223 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE--LILKINRG-------------L-Y 223 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH--HHHHHhhc-------------c-C
Confidence 23446899999999999999999999999999999999999999997654321 22111111 0 2
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+..+..++..++..|++.+|..||++.+++.+
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 34455667789999999999999999999999865
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=327.59 Aligned_cols=258 Identities=27% Similarity=0.469 Sum_probs=206.0
Q ss_pred HhcCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCe
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 390 (658)
++++|+..+.||+|+||.||+|.++ .+..||+|.+..........++.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5678999999999999999999854 2567999998653333445678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEE
Q 006168 391 LILVYEYMANSSLDKFLFGEK--------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKI 462 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl 462 (658)
.++||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 999999999999999985422 12368889999999999999999998 9999999999999999999999
Q ss_pred eeccCccccCCCCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHh
Q 006168 463 ADFGLARLLPENQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLY 540 (658)
Q Consensus 463 ~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 540 (658)
+|||+++......... .....++..|+|||++.++.++.++||||||+++|||++ |..|+...... ... +..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~----~~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVL----RFV 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HHH
Confidence 9999987654332211 123345778999999999999999999999999999999 67787543321 111 111
Q ss_pred hcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 541 ENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 541 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
.++.... .+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 235 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111111 112234568999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.26 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=195.7
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
+|+..++||+|+||.||++++. +++.||||++...........+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4456788999999999999976 689999999865444444577899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++++|.+. ..+.+..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.+..... .
T Consensus 155 ~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 224 (353)
T PLN00034 155 DGGSLEGT------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P 224 (353)
T ss_pred CCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence 99998643 2356778889999999999999998 999999999999999999999999999987643221 1
Q ss_pred cccccCCccccccccccc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCcch-hhHHHHHHHHhhcCccccccccc
Q 006168 479 STKFAGTLGYTAPEYAIH-----GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEG-EYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~-----~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||....... ..+... .. ...
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~-~~~-------- 292 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA---IC-MSQ-------- 292 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH---Hh-ccC--------
Confidence 234578999999998743 234568999999999999999999997433211 111111 00 000
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....+.....++.+++.+||+.||++|||+.||++.
T Consensus 293 --~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 --PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111122334569999999999999999999999974
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=332.88 Aligned_cols=242 Identities=21% Similarity=0.341 Sum_probs=196.0
Q ss_pred ccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCCH
Q 006168 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSL 403 (658)
Q Consensus 327 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 403 (658)
||+|+||.||+++.. +++.||+|++... ........+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999976 5889999998643 1334456788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccccccc
Q 006168 404 DKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFA 483 (658)
Q Consensus 404 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 483 (658)
.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 81 FHHLQ--REGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 99984 345699999999999999999999998 99999999999999999999999999998643222 2233467
Q ss_pred CCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHH
Q 006168 484 GTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAA 563 (658)
Q Consensus 484 gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 563 (658)
||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .... + ....+....
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--~~~~---~~~~-~-----------~~~~~~~~~ 217 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--EMYR---KILQ-E-----------PLRFPDGFD 217 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH--HHHH---HHHc-C-----------CCCCCCcCC
Confidence 999999999999999999999999999999999999999754321 1111 1111 1 011222334
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHH
Q 006168 564 EKVVEIALMCTQSAANSRPTMSEVVALL 591 (658)
Q Consensus 564 ~~l~~li~~cl~~dp~~RPt~~evl~~L 591 (658)
..+.+++.+||+.||.+||+...+.+.|
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 5689999999999999998654444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=331.23 Aligned_cols=256 Identities=26% Similarity=0.445 Sum_probs=204.7
Q ss_pred cCCCccCcccccCceEEEEEEec-CCc----EEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGK----IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
.+|+..+.||+|+||.||+|++. +++ .||+|.+.........+++.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999864 333 48999987544445567899999999999999999999999764 5789
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
|+||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 86 v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999999998532 34589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcccc-ccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 474 NQSHLS-TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 474 ~~~~~~-~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
...... ....++..|+|||++.+..++.++||||||+++|||++ |+.|+...... .+ ......+....
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~----~~~~~~~~~~~---- 231 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EI----SSILEKGERLP---- 231 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HH----HHHHhCCCCCC----
Confidence 332221 12334678999999999999999999999999999998 99988653321 11 11111111100
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
.+......+.+++.+||+.+|.+||++.+++..|....
T Consensus 232 ------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 232 ------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred ------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01112346889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=327.64 Aligned_cols=263 Identities=23% Similarity=0.378 Sum_probs=201.6
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|...++||+|+||.||+|+.+ +++.||+|.+...........+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999976 68899999987543344456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++ +|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LDS-DLKQYLDN-CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCc-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 985 89888843 234588999999999999999999998 999999999999999999999999999976533221
Q ss_pred ccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh-----------cC-c
Q 006168 478 LSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYE-----------NG-T 544 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~-----------~~-~ 544 (658)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........ .....+... .. .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE--LHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhccccchh
Confidence 1234567899999998875 5689999999999999999999999975443211 111111110 00 0
Q ss_pred ccccccccCCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 545 HWELMDESLDPN---ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 545 ~~~~~d~~l~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
......+..... ........++.+++..||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000 000112346889999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=332.90 Aligned_cols=245 Identities=26% Similarity=0.384 Sum_probs=195.2
Q ss_pred CCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHH---hccCCCccceeeeEeecCCeEEEE
Q 006168 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLI---SNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
|.+.+.||+|+||.||++..+ +++.||||++.... .....+.+..|++++ ++++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999976 68999999986531 223345566666554 567899999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++++|..++. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 99999999998873 35699999999999999999999998 9999999999999999999999999998754322
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ..... ...+.
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~~~~~----i~~~~---------- 217 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--EVFDS----IVNDE---------- 217 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--HHHHH----HHhCC----------
Confidence 2 1223467999999999999999999999999999999999999998754321 11111 11111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRP-----TMSEVVA 589 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 589 (658)
...+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 218 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 -VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 011122345688999999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.08 Aligned_cols=256 Identities=28% Similarity=0.510 Sum_probs=208.1
Q ss_pred cCCCccCcccccCceEEEEEEecC------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
++|.+.+.||+|+||.||+|...+ ++.||+|.+......+..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 567888999999999999998743 47899999876444445678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCe
Q 006168 393 LVYEYMANSSLDKFLFGEK------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP 460 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~ 460 (658)
+||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999995432 23488999999999999999999998 99999999999999999999
Q ss_pred EEeeccCccccCCCCc-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHH
Q 006168 461 KIADFGLARLLPENQS-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWR 538 (658)
Q Consensus 461 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~ 538 (658)
||+|||++........ .......+++.|+|||++.++.++.++||||||+++|||++ |+.||...... .....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~--- 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIEC--- 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHH---
Confidence 9999999976533221 12233456788999999999999999999999999999999 99998654332 12211
Q ss_pred HhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 539 LYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 539 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
...+... ..+...+..+.+++..||+.||++||++.||++.|++
T Consensus 237 -~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 -ITQGRLL----------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -HHcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111111 1112234569999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=319.93 Aligned_cols=253 Identities=31% Similarity=0.524 Sum_probs=206.2
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
++|.+.++||+|+||.||++..+++..+|+|.+... ....+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPG--TMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCC--CCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 568888999999999999999888889999998753 234567999999999999999999999885 45689999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++..+.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999999655555699999999999999999999998 99999999999999999999999999998764433222
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ...... ...+. ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~----~~~~~----------~~~ 223 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQ----VERGY----------RMP 223 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH----HHcCC----------CCC
Confidence 223345678999999988899999999999999999999 8888864322 111111 11110 011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
.+...+..+.+++.+|++.+|.+|||+.++++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 122334579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=325.88 Aligned_cols=256 Identities=27% Similarity=0.504 Sum_probs=205.7
Q ss_pred cCCCccCcccccCceEEEEEEec-----CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-----NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
++|+..+.||+|+||.||+|.+. ++..+++|.+...........+.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 46778899999999999999852 4678999999754444555788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC
Q 006168 394 VYEYMANSSLDKFLFGEK---------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL 458 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~ 458 (658)
||||+++++|.+++.... ...+++.+++.++.|++.||.|||+. +|+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999985321 23488999999999999999999998 999999999999999999
Q ss_pred CeEEeeccCccccCCCCc-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHH
Q 006168 459 QPKIADFGLARLLPENQS-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRA 536 (658)
Q Consensus 459 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~ 536 (658)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||..... ..+.+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~-- 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIE-- 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHH--
Confidence 999999999986543321 12223445778999999998899999999999999999999 8888865432 11111
Q ss_pred HHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 537 WRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 537 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
........ ..+...+..+.+++.+||+.||.+||++.+|+++|+.
T Consensus 238 --~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 --MVRKRQLL----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111 1112234568999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=329.26 Aligned_cols=265 Identities=26% Similarity=0.429 Sum_probs=202.0
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|.+.++||+|+||.||+|+.+ +++.||+|++...........+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 6889999998754333444567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+. ++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 996 578777743 345689999999999999999999998 99999999999999999999999999987543222
Q ss_pred cccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCc--ccc------
Q 006168 477 HLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGT--HWE------ 547 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--~~~------ 547 (658)
.......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.........+. .......... .+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE-RIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH-HHHHHhCCCChhhccchhhcc
Confidence 12234568899999999865 4588999999999999999999999976544222211 1111110000 000
Q ss_pred cccc-cC---CCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 548 LMDE-SL---DPNECTK-----EAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 548 ~~d~-~l---~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
..++ .. .+..... .....+.+++..||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 00 0000000 01245789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=320.88 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=210.7
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|++.+.||+|+||.||+|+.+ +++.||||.+... ........+.+|++++++++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999975 6899999987542 22333457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 396 EYMANSSLDKFLFGE--KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 396 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999888532 234589999999999999999999998 999999999999999999999999999987644
Q ss_pred CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+.........+... ......
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~----~~~~~~-------- 225 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK----IEQCDY-------- 225 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH----HhcCCC--------
Confidence 322 1223568889999999998889999999999999999999999986543322222211 111110
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
+.......+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 226 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 226 -PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1112234456799999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=319.33 Aligned_cols=254 Identities=29% Similarity=0.483 Sum_probs=208.1
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
.++|.+.++||+|+||.||++..++++.||+|.+... .....++.+|+.++++++|+||+++++++. .+..++||||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG--SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCC--CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 4578889999999999999999989999999998742 334578999999999999999999999874 4578999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.......+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999998665556799999999999999999999998 9999999999999999999999999999876533322
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
......++..|+|||++....++.++||||||++++||++ |+.||...... .+... ...+...
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~----~~~~~~~---------- 222 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQN----LERGYRM---------- 222 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHH----HHcCCCC----------
Confidence 2223456778999999998899999999999999999999 99998654321 11111 1111100
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
..+...+.++.+++.+||+.+|++|||++++++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1112234569999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=339.83 Aligned_cols=253 Identities=21% Similarity=0.318 Sum_probs=197.7
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
.+|++.+.||+|+||.||+++.. +++.||||.+.... .......+.+|++++++++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999976 58899999986421 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++. ..+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLI--RLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999994 345689999999999999999999998 99999999999999999999999999975331100
Q ss_pred ------------------------------------------ccccccccCCcccccccccccCCCCCcccchhhhHHHH
Q 006168 476 ------------------------------------------SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVL 513 (658)
Q Consensus 476 ------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ 513 (658)
........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00112357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 006168 514 EIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRP---TMSEVVAL 590 (658)
Q Consensus 514 elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP---t~~evl~~ 590 (658)
||++|+.||......... . .......... + .........+.+++.+|+ .+|.+|+ ++.++++.
T Consensus 236 ell~G~~Pf~~~~~~~~~--~---~i~~~~~~~~-----~---~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAETQ--L---KVINWETTLH-----I---PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHHH--H---HHhccCcccc-----C---CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999999765432111 1 1110000000 0 000112344667777765 5999999 88888864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=321.26 Aligned_cols=251 Identities=28% Similarity=0.451 Sum_probs=203.2
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
.+|++.+.||+|+||.||++.++++..+|+|.+... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG--AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC--CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 357788999999999999999887788999998642 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.........
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 82 ANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999999998543 34689999999999999999999998 99999999999999999999999999998654332221
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ....+. .. .
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~----~~~~~~-----~~-----~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVE----SVSAGY-----RL-----Y 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHH----HHHcCC-----cC-----C
Confidence 222234568999999999999999999999999999999 78888643321 1111 111110 00 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 591 (658)
.+...+..+.+++.+||+.+|++|||+.||++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1112345799999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=331.81 Aligned_cols=263 Identities=24% Similarity=0.375 Sum_probs=204.5
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|+..++||+|+||.||++.++ ++..+|+|.+...........+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999987 5888999988754344445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++++|.+++. ....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~--~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 84 HMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred cCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 999999999994 345689999999999999999999974 269999999999999999999999999997653321
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccc----------
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHW---------- 546 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~---------- 546 (658)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... +. ........+...
T Consensus 159 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE--LE-LMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred --cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH--HH-HHhcCcccCCccccccCcccCC
Confidence 234578999999999998899999999999999999999999986543211 00 000000000000
Q ss_pred -------------------ccccccC---CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 547 -------------------ELMDESL---DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 547 -------------------~~~d~~l---~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+... .+.........++.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000 0000001123568999999999999999999999853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=347.65 Aligned_cols=257 Identities=23% Similarity=0.343 Sum_probs=211.2
Q ss_pred hcCCCccCcccccCceEEEEEEecCC-cEEEEEEcccccccccHHHHHHHHHHHhccC-CCccceeeeE-eec------C
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNG-KIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGC-CSQ------G 388 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~ 388 (658)
..+.++.+.|.+|||+.||.+....+ ..+|+|++... .+..++...+|+++|++|+ |+|||.+++. ... .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 34566789999999999999998765 99999999874 7788899999999999996 9999999993 211 2
Q ss_pred CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCc
Q 006168 389 PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLA 468 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla 468 (658)
-+++|.||||++|+|-+++..+....|++.++++|+.|+++|+++||.. +++|||||||-+||||..+++.||||||.+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 4689999999999999999766666799999999999999999999996 678999999999999999999999999998
Q ss_pred cccCCCCcccc--------ccccCCccccccccc---ccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHH
Q 006168 469 RLLPENQSHLS--------TKFAGTLGYTAPEYA---IHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAW 537 (658)
Q Consensus 469 ~~~~~~~~~~~--------~~~~gt~~y~APE~~---~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~ 537 (658)
........... -...-|+.|.|||.+ .+...++|+|||+|||+||-|+....||+..+.-
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--------- 264 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--------- 264 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---------
Confidence 74322221100 023458999999987 5678999999999999999999999999865431
Q ss_pred HHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 538 RLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 538 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
.++........ ...+...+..||..||+.||.+||++-+|++.+-.+.
T Consensus 265 ---------aIlng~Y~~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 265 ---------AILNGNYSFPP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred ---------eEEeccccCCC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 12222221111 2457788999999999999999999999999888764
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=332.99 Aligned_cols=243 Identities=24% Similarity=0.302 Sum_probs=198.8
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCC
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANS 401 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 401 (658)
+.||+|+||.||++..+ +++.||+|++.... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999975 68999999987532 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccccc
Q 006168 402 SLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK 481 (658)
Q Consensus 402 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 481 (658)
+|.+++. ....+++.++..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 81 ELFFHLS--RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred CHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 9998884 345699999999999999999999998 99999999999999999999999999987543222 12234
Q ss_pred ccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHH
Q 006168 482 FAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKE 561 (658)
Q Consensus 482 ~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 561 (658)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... ..... ...+..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~~~~~----~~~~~-----------~~~p~~ 217 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFEL----ILMED-----------IKFPRT 217 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--HHHHH----hccCC-----------ccCCCC
Confidence 67999999999999999999999999999999999999999654321 11111 11000 011222
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 006168 562 AAEKVVEIALMCTQSAANSRP-----TMSEVVAL 590 (658)
Q Consensus 562 ~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 590 (658)
....+.+++.+||+.||.+|| ++.++++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 345689999999999999997 88988864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.26 Aligned_cols=263 Identities=24% Similarity=0.409 Sum_probs=198.2
Q ss_pred cCCCccCcccccCceEEEEEEec--CCcEEEEEEcccccc-cccHHHHHHHHHHHhcc---CCCccceeeeEee-----c
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK--NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNV---HHRNLIRLLGCCS-----Q 387 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 387 (658)
++|.+.+.||+|+||.||+++.. +++.||+|++..... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47888999999999999999863 468899999865322 22234566777777665 6999999999985 3
Q ss_pred CCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccC
Q 006168 388 GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL 467 (658)
Q Consensus 388 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGl 467 (658)
....++||||++ ++|.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999997 5999998655556699999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh---cCc
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYE---NGT 544 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~---~~~ 544 (658)
++..... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .+........ ...
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPGEED 232 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhh
Confidence 9865433 22334578999999999998999999999999999999999999997654321 1111111110 000
Q ss_pred ccc---cccccCC---C---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 545 HWE---LMDESLD---P---NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 545 ~~~---~~d~~l~---~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
... .....+. . ..........+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 0000000 0 0011123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=323.89 Aligned_cols=253 Identities=27% Similarity=0.374 Sum_probs=204.2
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.|+..+.||+|+||.||++... +++.||+|++.... .......+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999975 68899999986432 12223557889999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++|+|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999988655455699999999999999999999998 999999999999999999999999999987543222
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ............ ..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--~~~~~~~~~~~~-----------~~ 222 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--KREEVERRVKED-----------QE 222 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--HHHHHHHHhhhc-----------cc
Confidence 223478999999999999999999999999999999999999997543311 111111111110 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRP-----TMSEVVAL 590 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 590 (658)
..+...+..+.+++..||+.||.+|| ++.++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 22233456789999999999999999 78787654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=319.69 Aligned_cols=254 Identities=31% Similarity=0.512 Sum_probs=206.3
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
++|.+.++||+|+||.||+|.+++...||+|++... ....+++.+|++++++++||||+++++++.+ +..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC--ccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 568889999999999999999887778999998742 2345678999999999999999999998754 5689999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++|+|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++..+.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999654445689999999999999999999998 99999999999999999999999999998765433222
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
.....++..|+|||+..+..++.++||||||+++|||++ |+.||...... .... ....+. ...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~~~~----~~~~~~----------~~~ 223 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLD----QVERGY----------RMP 223 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--HHHH----HHhcCC----------CCC
Confidence 223456778999999998999999999999999999999 77777644321 1111 111110 011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.+...+..+.+++.+|++.+|++||++.++++.|+..
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1233456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=324.60 Aligned_cols=264 Identities=27% Similarity=0.463 Sum_probs=208.6
Q ss_pred hcCCCccCcccccCceEEEEEEecC-----------------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccce
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN-----------------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIR 380 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 380 (658)
.++|++.+.||+|+||.||++.+.+ +..||+|.+.........+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999998653 24689999876544556678999999999999999999
Q ss_pred eeeEeecCCeEEEEEeccCCCCHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCc
Q 006168 381 LLGCCSQGPELILVYEYMANSSLDKFLFGEK---------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSN 451 (658)
Q Consensus 381 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~N 451 (658)
+++++..++..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. +|+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999985433 12589999999999999999999998 99999999999
Q ss_pred EEEcCCCCeEEeeccCccccCCCCc-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh--CCCCCCCCCcc
Q 006168 452 VLLDDDLQPKIADFGLARLLPENQS-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS--GTKSSETKGEE 528 (658)
Q Consensus 452 Ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt--G~~p~~~~~~~ 528 (658)
|+++.++.++|+|||+++....... .......++..|+|||++..+.++.++||||||+++|||++ |..|+....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999986543322 12234556789999999998899999999999999999998 555664332
Q ss_pred hhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 529 GEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 529 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
...........+......... ..+...+.++.+++.+||+.||.+|||+.||++.|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYL-------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred hHHHHHHHHhccccccccccC-------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 222223322222111111111 1112233579999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=325.37 Aligned_cols=262 Identities=25% Similarity=0.446 Sum_probs=203.6
Q ss_pred cCCCccCcccccCceEEEEEEecC---------------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeee
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN---------------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 383 (658)
++|.+.+.||+|+||.||+++..+ ...||+|.+...........+.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999987642 23589999876444445567999999999999999999999
Q ss_pred EeecCCeEEEEEeccCCCCHHHHhhcCC----------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEE
Q 006168 384 CCSQGPELILVYEYMANSSLDKFLFGEK----------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVL 453 (658)
Q Consensus 384 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIl 453 (658)
++...+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 9999999999999999999999985422 12378999999999999999999998 9999999999999
Q ss_pred EcCCCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhC--CCCCCCCCcchh
Q 006168 454 LDDDLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG--TKSSETKGEEGE 530 (658)
Q Consensus 454 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG--~~p~~~~~~~~~ 530 (658)
+++++.+||+|||++..+...... ......++..|+|||++.++.++.++||||||++++||+++ ..||..... .
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--~ 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--E 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--H
Confidence 999999999999999765433211 12234457789999999999999999999999999999984 455543322 2
Q ss_pred hHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 531 YLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 531 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
.......+........... ..+...+..+.+|+.+||+.+|++||++.+|++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 2222222222111100000 011112357999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=332.73 Aligned_cols=242 Identities=24% Similarity=0.301 Sum_probs=197.5
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCC
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANS 401 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 401 (658)
+.||+|+||.||+++.+ +|+.||+|.+.... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999975 68999999986532 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccccc
Q 006168 402 SLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK 481 (658)
Q Consensus 402 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 481 (658)
+|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 ~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 154 (323)
T cd05595 81 ELFFHLS--RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence 9998884 345699999999999999999999998 99999999999999999999999999987542221 12234
Q ss_pred ccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHH
Q 006168 482 FAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKE 561 (658)
Q Consensus 482 ~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 561 (658)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... ..... ...+..
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~~~----~~~~~-----------~~~p~~ 217 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFEL----ILMEE-----------IRFPRT 217 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--HHHHH----HhcCC-----------CCCCCC
Confidence 57899999999999999999999999999999999999998654321 11111 11000 011222
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 006168 562 AAEKVVEIALMCTQSAANSRP-----TMSEVVA 589 (658)
Q Consensus 562 ~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 589 (658)
....+.+++..||+.||.+|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 345689999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=316.91 Aligned_cols=248 Identities=25% Similarity=0.466 Sum_probs=212.0
Q ss_pred cCCCccCcccccCceEEEEEEe-cCCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTL-KNGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
.+|++.+.||+|.||.|-++.. ..|+.||||.|.++ .+++.+-.+.+|+++|+.|+||||+.++.+|+..+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677888999999999999985 67999999999765 34455667899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||..+|.|.+++ ..++.|++.+...+++||..|+.|+|.+ +++|||||.+|||||.++++||+|||++-++...
T Consensus 133 EYaS~GeLYDYi--Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~- 206 (668)
T KOG0611|consen 133 EYASGGELYDYI--SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK- 206 (668)
T ss_pred EecCCccHHHHH--HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc-
Confidence 999999999999 5677899999999999999999999999 9999999999999999999999999999887543
Q ss_pred ccccccccCCcccccccccccCCCC-CcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLS-EKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s-~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
...++++|++-|.+||++.+.+|. +..|-|||||+||-|+.|..||++..... + .+.+..|...+
T Consensus 207 -kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~--l----vrQIs~GaYrE------- 272 (668)
T KOG0611|consen 207 -KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR--L----VRQISRGAYRE------- 272 (668)
T ss_pred -cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH--H----HHHhhcccccC-------
Confidence 345678999999999999999884 78999999999999999999998754321 1 12223332222
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 591 (658)
.+.+....-||+|||..||++|.|+.+|...-
T Consensus 273 -----P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 -----PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -----CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11223477899999999999999999998653
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=315.52 Aligned_cols=248 Identities=29% Similarity=0.478 Sum_probs=201.5
Q ss_pred CcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCCHH
Q 006168 325 NKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLD 404 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 404 (658)
+.||+|+||.||+|..++++.+|+|.+...........+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988899999999876444444567899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccccccC
Q 006168 405 KFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAG 484 (658)
Q Consensus 405 ~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 484 (658)
+++... ...+++..++.++.|++.+|.|||+. +++|+||||+||+++.++.+||+|||++...............+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKK-KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 998533 34689999999999999999999998 99999999999999999999999999987643332222222344
Q ss_pred CcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHH
Q 006168 485 TLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAA 563 (658)
Q Consensus 485 t~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 563 (658)
+..|+|||++..+.++.++||||||+++||+++ |..||...... .... ....+... ..+...+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~----~~~~~~~~----------~~~~~~~ 220 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QARE----QVEKGYRM----------SCPQKCP 220 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHH----HHHcCCCC----------CCCCCCC
Confidence 678999999998999999999999999999998 88888654321 1111 11111100 1111234
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 564 EKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 564 ~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
..+.+++.+|++.+|++||++.|++++|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 57999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=317.18 Aligned_cols=253 Identities=30% Similarity=0.512 Sum_probs=205.5
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
++|.+..+||+|++|.||++.++++..+|+|.+... ....+.+.+|++++++++|||++++++++. .+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG--TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC--CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 467788999999999999999887778999988642 234567899999999999999999999885 45688999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999999655555689999999999999999999998 99999999999999999999999999998764433222
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
.....++..|+|||++.+..++.++||||||+++|||++ |+.|+...... ..... ...+.. ..
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~----~~~~~~----------~~ 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQ----VERGYR----------MP 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HHcCCC----------CC
Confidence 223446778999999998899999999999999999999 88888653321 11111 111100 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
.+...+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 122345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=334.04 Aligned_cols=247 Identities=22% Similarity=0.302 Sum_probs=202.6
Q ss_pred hcCCCccCcccccCceEEEEEEecC--CcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN--GKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
.++|.+.+.||+|+||.||+|.+++ +..||+|++.... .......+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3578889999999999999998653 3689999986421 23345678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+++|+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 109 v~Ey~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLR--RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999994 345699999999999999999999998 999999999999999999999999999987643
Q ss_pred CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ....+..
T Consensus 184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~----~i~~~~~-------- 245 (340)
T PTZ00426 184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--LIYQ----KILEGII-------- 245 (340)
T ss_pred C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--HHHH----HHhcCCC--------
Confidence 2 22457899999999999988999999999999999999999999754321 1111 1111110
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRP-----TMSEVVAL 590 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 590 (658)
..+......+.+++.+|++.||.+|+ +++++++.
T Consensus 246 ---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11122234588999999999999995 88888764
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=317.65 Aligned_cols=248 Identities=27% Similarity=0.454 Sum_probs=199.0
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCCH
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSL 403 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 403 (658)
+.||+|+||.||++++. +++.+|+|.+...........+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999976 68999999886544445567899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc-cccc
Q 006168 404 DKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL-STKF 482 (658)
Q Consensus 404 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~~ 482 (658)
.+++.. ....+++..++.++.|+++||.|||+. +|+||||||+|||++.++.+||+|||++.......... ....
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRT-EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 999843 234689999999999999999999998 99999999999999999999999999987643321111 1112
Q ss_pred cCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHH
Q 006168 483 AGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKE 561 (658)
Q Consensus 483 ~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 561 (658)
..+..|+|||.+.++.++.++||||||+++|||++ |..|+...... .. ........ ....+..
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~----~~~~~~~~----------~~~~~~~ 220 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QT----REAIEQGV----------RLPCPEL 220 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HH----HHHHHcCC----------CCCCccc
Confidence 23457999999999999999999999999999998 87777543321 11 11111110 1111223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 562 AAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 562 ~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
.+..+.+++.+||+.+|++|||+.+|+++|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.28 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=211.5
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|+..+.||+|+||.||+|... +++.||+|.+... ......+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999987 7899999988632 22334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 396 EYMANSSLDKFLFGE--KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 396 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||+++++|.+++... ....+++..++.++.+++.||.|||+. +|+||||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988542 234589999999999999999999998 999999999999999999999999999886643
Q ss_pred CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+.........+.. ....+..
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~-------- 225 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----KIEKCDY-------- 225 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh----hhhcCCC--------
Confidence 322 123356888999999999889999999999999999999999998654322211111 1111111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
...........+.+++.+||+.+|++|||+.+|+++|+.+
T Consensus 226 -~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 226 -PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1111123456789999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.98 Aligned_cols=245 Identities=26% Similarity=0.375 Sum_probs=207.4
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeE
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 391 (658)
...++|...++||+|.||+|+++.++ +++.+|||.++++ ....+.+..+.|.+++... +||.+++++.+|+..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578999999999999999999987 5889999999875 3456677788898888877 599999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||+.||++..+ ...+.+++....-++..|+.||.|||++ +||+||||.+|||||.+|++||+||||++..
T Consensus 445 ~fvmey~~Ggdm~~~---~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHH---IHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEecCCCcEEEE---EecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999994433 3557799999999999999999999999 9999999999999999999999999999965
Q ss_pred CCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 472 PENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 472 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
..... .+.+++||+.|||||++.+..|+.+.|-|||||+|||||.|..||...+++. +.+.+ . .|
T Consensus 519 m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee--~FdsI----~-------~d- 583 (694)
T KOG0694|consen 519 MGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE--VFDSI----V-------ND- 583 (694)
T ss_pred CCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHH----h-------cC-
Confidence 43222 3557999999999999999999999999999999999999999998765532 11111 0 11
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTM 584 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 584 (658)
...+|...+.+...|+.+++.+||++|.-+
T Consensus 584 ---~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 ---EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 123455566779999999999999999876
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=327.29 Aligned_cols=241 Identities=26% Similarity=0.377 Sum_probs=192.4
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
+.||+|+||.||+|+.+ +++.||+|.+.... .....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 57889999987532 223344556677777654 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQ--SSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 99999984 345699999999999999999999998 99999999999999999999999999998653322 2233
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCH
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTK 560 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 560 (658)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. ... ... ...+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~~~~---~i~-~~~-----------~~~~~ 217 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELFD---SIL-NDR-----------PHFPR 217 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--HHHH---HHH-cCC-----------CCCCC
Confidence 567999999999999999999999999999999999999999754331 1111 111 100 11122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 006168 561 EAAEKVVEIALMCTQSAANSRPTMS-EVV 588 (658)
Q Consensus 561 ~~~~~l~~li~~cl~~dp~~RPt~~-evl 588 (658)
.....+.+++..||+.||.+||++. +++
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 2345688999999999999999875 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=324.21 Aligned_cols=256 Identities=31% Similarity=0.485 Sum_probs=205.5
Q ss_pred CCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
+|.+.+.||+|+||.||+|... ....+++|.+...........+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999864 2357899988754444456788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCc
Q 006168 394 VYEYMANSSLDKFLFGEK----------------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSN 451 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~N 451 (658)
|+||+.+++|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999885321 13488999999999999999999998 99999999999
Q ss_pred EEEcCCCCeEEeeccCccccCCCCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcch
Q 006168 452 VLLDDDLQPKIADFGLARLLPENQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEG 529 (658)
Q Consensus 452 Ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~ 529 (658)
||+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||++++||++ |+.|+.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 999999999999999998654332211 223345678999999988899999999999999999999 8888854332
Q ss_pred hhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 530 EYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 530 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
+.+ +......... ..+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 236 ~~~----~~~~~~~~~~----------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 236 ERL----FNLLKTGYRM----------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred HHH----HHHHhCCCCC----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 111 2222211100 11122345689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=317.19 Aligned_cols=256 Identities=31% Similarity=0.517 Sum_probs=210.1
Q ss_pred HhcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
..++|.+.++||+|+||.||++.+++++.+|||.+... ....+++.+|+.++++++|+||+++++++......++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG--TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC--ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 34688899999999999999999888889999998742 3445789999999999999999999999999899999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++++|.+++.......+++..+..++.+++.||.|||+. +++|+||||+||++++++.+||+|||++..+.....
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999999665555799999999999999999999998 999999999999999999999999999987654322
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.......++..|+|||.+.+..++.++||||||++++||++ |+.|+..... ....... ..+. .
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~----~~~~-----~----- 222 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQV----ERGY-----R----- 222 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----HcCC-----C-----
Confidence 22223345678999999998899999999999999999999 8888854332 1122211 1110 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
...+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01111224568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=329.29 Aligned_cols=243 Identities=24% Similarity=0.407 Sum_probs=196.6
Q ss_pred CcccccCceEEEEEEec----CCcEEEEEEccccc---ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 325 NKLGEGGFGDIYKGTLK----NGKIVAVKKLAIGI---SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+.||+|+||.||+++.. +++.||+|.+.... .......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999853 57899999986421 223345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++. ..+.+.+..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLE--REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 99999999984 345688999999999999999999998 999999999999999999999999999875432221
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .... ... .+. ..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--~~~~---~~~-~~~-----------~~ 218 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--KTID---KIL-KGK-----------LN 218 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--HHHH---HHH-cCC-----------CC
Confidence 223467999999999999888999999999999999999999999754321 1111 111 111 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRP-----TMSEVVAL 590 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 590 (658)
.+......+.+++.+||+.+|++|| ++.++++.
T Consensus 219 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1122235689999999999999999 78887763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=337.61 Aligned_cols=253 Identities=21% Similarity=0.333 Sum_probs=198.0
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.|...+.||+|+||.||+|+.. +++.||+|++.... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999875 58899999986531 23345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++|+|.+++. +...+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLI--RMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999984 345689999999999999999999998 999999999999999999999999999764321100
Q ss_pred ----------------------------------------------cccccccCCcccccccccccCCCCCcccchhhhH
Q 006168 477 ----------------------------------------------HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGV 510 (658)
Q Consensus 477 ----------------------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGv 510 (658)
.......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012357999999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHHH
Q 006168 511 LVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALM--CTQSAANSRPTMSEVV 588 (658)
Q Consensus 511 vl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~--cl~~dp~~RPt~~evl 588 (658)
++|||++|+.||.......... +......... + +. ......++.+++.+ |+..+|..||++.+++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~-----~i~~~~~~~~-----~-~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQL-----KVINWENTLH-----I-PP--QVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHH-----HHHccccccC-----C-CC--CCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 9999999999997644321111 1110000000 0 00 01123456677766 5667777799999998
Q ss_pred HH
Q 006168 589 AL 590 (658)
Q Consensus 589 ~~ 590 (658)
..
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=326.01 Aligned_cols=260 Identities=30% Similarity=0.472 Sum_probs=209.2
Q ss_pred HHhcCCCccCcccccCceEEEEEEecC------CcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecC
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLKN------GKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQG 388 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 388 (658)
...++|+..+.||+|+||.||++.+.+ ...+|+|.+......+...++.+|+++++++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 345678889999999999999998652 3679999987644445556789999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE
Q 006168 389 PELILVYEYMANSSLDKFLFGE--------------KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL 454 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll 454 (658)
+..++||||+++|+|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence 9999999999999999998542 234589999999999999999999998 99999999999999
Q ss_pred cCCCCeEEeeccCccccCCCCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhH
Q 006168 455 DDDLQPKIADFGLARLLPENQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYL 532 (658)
Q Consensus 455 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l 532 (658)
+.++.+||+|||+++.+....... .....++..|+|||++.+..++.++||||||+++|||++ |..|+...... .+
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~ 243 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--EL 243 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--HH
Confidence 999999999999998765432211 223345678999999999999999999999999999998 88887643321 11
Q ss_pred HHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 533 LKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 533 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.+....+... ..+......+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 244 ----~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 ----FKLLKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ----HHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1111111111 11122345689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=337.32 Aligned_cols=253 Identities=22% Similarity=0.331 Sum_probs=205.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+.+.||+|+||.||+++.. +++.||||++.... .......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47888999999999999999976 68999999987532 2244567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999543 6799999999999999999999998 99999999999999999999999999998764433
Q ss_pred ----------------------------ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc
Q 006168 476 ----------------------------SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE 527 (658)
Q Consensus 476 ----------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~ 527 (658)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122345789999999999999999999999999999999999999976542
Q ss_pred chhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 006168 528 EGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPT-MSEVVAL 590 (658)
Q Consensus 528 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~~ 590 (658)
.. .. .+........ .+ +.. ...+..+.+++..|++ ||.+||+ +.++++.
T Consensus 236 ~~--~~---~~i~~~~~~~-----~~-p~~--~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QE--TY---NKIINWKESL-----RF-PPD--PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH--HH---HHHhccCCcc-----cC-CCC--CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11 11 1111100000 00 000 1134568899999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.64 Aligned_cols=251 Identities=26% Similarity=0.449 Sum_probs=208.0
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+|+..+.||+|++|.||++..+ +++.|++|.+... ........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999976 6889999998642 2344567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999999765556799999999999999999999998 999999999999999999999999999987654332
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
......|++.|+|||++.+..++.++||||||++++||++|+.||..... ..... + ...+.. ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~---~-~~~~~~----------~~ 220 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALIL---K-IIRGVF----------PP 220 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHH---H-HHcCCC----------CC
Confidence 22345688999999999999999999999999999999999999865442 11111 1 111111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 222345679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=335.51 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=200.9
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|+..+.||+|+||.||+++.. +++.||||++.... .......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999976 58999999986531 2234566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLM--KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999984 345699999999999999999999998 99999999999999999999999999987643211
Q ss_pred cc-------------------------------------ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhC
Q 006168 476 SH-------------------------------------LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518 (658)
Q Consensus 476 ~~-------------------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG 518 (658)
.. ......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 01124699999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 006168 519 TKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPT---MSEVVAL 590 (658)
Q Consensus 519 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~~ 590 (658)
+.||....... ... .......... . +.. ......+.+++..|+. +|.+|++ +.++++.
T Consensus 236 ~~Pf~~~~~~~--~~~---~i~~~~~~~~-----~-~~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNPQE--TYR---KIINWKETLQ-----F-PDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCHHH--HHH---HHHcCCCccC-----C-CCC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99997544311 111 1111000000 0 010 1123467888999986 8999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=318.22 Aligned_cols=259 Identities=24% Similarity=0.380 Sum_probs=209.6
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|++.+.||+|+||.||++..+ +++.++||.+... .......++.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46788899999999999999964 7899999987642 12234467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 396 EYMANSSLDKFLFGE--KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 396 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||+++++|.+++... ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988532 234589999999999999999999998 999999999999999999999999999886643
Q ss_pred CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
... ......++..|+|||++.+..++.++||||||+++|||++|..|+.....+...+... ..... .+
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~-----~~-- 226 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----IEQCD-----YP-- 226 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhh----hhcCC-----CC--
Confidence 322 1223568899999999998899999999999999999999999986543321111111 11100 01
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..........+.+++.+||+.+|++||||.+|++++++.
T Consensus 227 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 --PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111123456799999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=328.50 Aligned_cols=248 Identities=21% Similarity=0.315 Sum_probs=197.3
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
+.||+|+||.||+++.+ +++.||+|++.... .......+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999976 58899999997532 223346688999999988 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (329)
T cd05588 81 GDLMFHMQ--RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS 154 (329)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence 99998884 345799999999999999999999998 99999999999999999999999999987532211 1223
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcc---hhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE---GEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+..+....... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~ 223 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-----------R 223 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-----------C
Confidence 467899999999999999999999999999999999999999643221 11111222222221110 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPT------MSEVVA 589 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt------~~evl~ 589 (658)
.+...+..+.+++..||+.||.+||+ +.++++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11223456899999999999999997 566664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=335.19 Aligned_cols=259 Identities=21% Similarity=0.270 Sum_probs=198.9
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|.+.+.||+|+||.||++... +++.||+|.... ..+.+|++++++++||||+++++++......++|+|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 57999999999999999999975 688999997532 3467899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+. ++|..++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 165 ~~-~~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 165 YK-TDLYCYLA--AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred CC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 96 68888884 345689999999999999999999998 9999999999999999999999999999754333222
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc-----chhhHHHHHHHHhhcC--c------
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE-----EGEYLLKRAWRLYENG--T------ 544 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~-----~~~~l~~~~~~~~~~~--~------ 544 (658)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+..... .....+....+..... .
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 33356799999999999999999999999999999999999988754321 0111111111110000 0
Q ss_pred --ccccc----c-ccCCCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 545 --HWELM----D-ESLDPNE-----CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 545 --~~~~~----d-~~l~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+.. . ....+.. .....+..+.+++.+||+.||.+|||+.|+++.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 0 0000000 011235578999999999999999999999863
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=323.82 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=203.8
Q ss_pred CCCccCcccccCceEEEEEEecC------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLKN------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
+|...++||+|+||.||+|.+.+ ++.||+|++...........+.+|+.++..++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46667899999999999998642 578999999754333334678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC
Q 006168 394 VYEYMANSSLDKFLFGE--------------KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ 459 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~ 459 (658)
++||+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 99999999999998421 123488999999999999999999998 9999999999999999999
Q ss_pred eEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHH
Q 006168 460 PKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAW 537 (658)
Q Consensus 460 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~ 537 (658)
+||+|||+++........ ......+++.|+|||.+.++.++.++||||||+++|||++ |..|+...... .+.
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~---- 236 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVI---- 236 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----
Confidence 999999998866433221 1223456789999999998999999999999999999998 77777543221 111
Q ss_pred HHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 538 RLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 538 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
.....+... ..+...+..+.+++..||+.+|.+||++.+|+..|+.
T Consensus 237 ~~i~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQVL----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCCcC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 112221111 1122344568999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=325.23 Aligned_cols=259 Identities=26% Similarity=0.440 Sum_probs=208.6
Q ss_pred hcCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 390 (658)
.++|...+.||+|+||.||++... .+..||+|++.........+.+.+|+++++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357889999999999999999742 35579999987543344456789999999999 79999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.++||||+++|+|.+++.......+++.++..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccc
Confidence 99999999999999999654444589999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCccccc
Q 006168 471 LPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWEL 548 (658)
Q Consensus 471 ~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 548 (658)
....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+........ +. +....+..
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~----~~~~~~~~--- 262 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FY----KLIKEGYR--- 262 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HH----HHHHcCCc---
Confidence 6443221 1223456778999999999999999999999999999998 8888865433211 11 11111110
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 549 MDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 549 ~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
...+...+..+.+++.+||+.+|++|||+.||++.|++.
T Consensus 263 -------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 -------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 001112245699999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.27 Aligned_cols=246 Identities=27% Similarity=0.386 Sum_probs=196.9
Q ss_pred ccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCCH
Q 006168 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSL 403 (658)
Q Consensus 327 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 403 (658)
||+|+||+||++... +++.||+|.+.... .....+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999876 68899999986432 122345678899999999999999999999999999999999999999
Q ss_pred HHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccccc
Q 006168 404 DKFLFGE--KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK 481 (658)
Q Consensus 404 ~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 481 (658)
.+++... ....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++..+..... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 9887532 334699999999999999999999998 999999999999999999999999999986644332 2234
Q ss_pred ccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHH
Q 006168 482 FAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKE 561 (658)
Q Consensus 482 ~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 561 (658)
..||+.|+|||++.+..++.++||||||+++|||++|+.||......... ........ .. ....+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~--------~~---~~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRIL--------ND---SVTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHhhc--------cc---CCCCccc
Confidence 57899999999999999999999999999999999999999754432110 00000000 00 1112233
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 006168 562 AAEKVVEIALMCTQSAANSRP-----TMSEVVA 589 (658)
Q Consensus 562 ~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 589 (658)
.+..+.+++..||+.||++|| +++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 456789999999999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=335.26 Aligned_cols=253 Identities=21% Similarity=0.323 Sum_probs=198.3
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+.++||+|+||.||++... +++.||||++.... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47888999999999999999865 68899999986421 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLI--KYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999984 345689999999999999999999998 99999999999999999999999999996432110
Q ss_pred cc----------------------------------------------ccccccCCcccccccccccCCCCCcccchhhh
Q 006168 476 SH----------------------------------------------LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFG 509 (658)
Q Consensus 476 ~~----------------------------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfG 509 (658)
.. ......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 00124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHH
Q 006168 510 VLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSR---PTMSE 586 (658)
Q Consensus 510 vvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~R---Pt~~e 586 (658)
|++|||++|+.||...... ..... .......... +.. .....++.+++..|++ +|.+| |++.|
T Consensus 236 vil~elltG~~Pf~~~~~~--~~~~~---i~~~~~~~~~------p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 236 AIMFECLIGWPPFCSENSH--ETYRK---IINWRETLYF------PDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred hhhhhhhcCCCCCCCCCHH--HHHHH---HHccCCccCC------CCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 9999999999999654331 11111 1110000000 110 1123458889999997 66665 69999
Q ss_pred HHHH
Q 006168 587 VVAL 590 (658)
Q Consensus 587 vl~~ 590 (658)
+++.
T Consensus 302 ~l~h 305 (377)
T cd05629 302 IKSH 305 (377)
T ss_pred HhcC
Confidence 8875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.71 Aligned_cols=203 Identities=25% Similarity=0.402 Sum_probs=176.4
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|+..+.||+|+||+||++... +++.||+|++.... .......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47888999999999999999876 58899999986521 2233467888999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++. +...+++..+..++.|++.||.|||+. +|+||||||+|||++.++++||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999994 345799999999999999999999998 99999999999999999999999999987653211
Q ss_pred c----------------------------------cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCC
Q 006168 476 S----------------------------------HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKS 521 (658)
Q Consensus 476 ~----------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p 521 (658)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001235799999999999999999999999999999999999999
Q ss_pred CCCCC
Q 006168 522 SETKG 526 (658)
Q Consensus 522 ~~~~~ 526 (658)
|....
T Consensus 236 f~~~~ 240 (363)
T cd05628 236 FCSET 240 (363)
T ss_pred CCCCC
Confidence 97544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=331.99 Aligned_cols=253 Identities=24% Similarity=0.310 Sum_probs=204.1
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+.+.||+|+||.||++..+ +++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999976 68899999987532 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999999532 35699999999999999999999998 99999999999999999999999999998765444
Q ss_pred ccccccccCCcccccccccc------cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccc
Q 006168 476 SHLSTKFAGTLGYTAPEYAI------HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~------~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
........||+.|+|||++. ...++.++|||||||++|||++|+.||....... .. .+..........
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~---~~i~~~~~~~~~- 230 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--TY---NNIMNFQRFLKF- 230 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--HH---HHHHcCCCccCC-
Confidence 33334567899999999986 4567899999999999999999999996543311 11 111111111110
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
+. ....+..+.+++..|++ +|.+|||+.++++
T Consensus 231 -----~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 231 -----PE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -----CC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00 11234568899999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=323.13 Aligned_cols=256 Identities=28% Similarity=0.505 Sum_probs=207.2
Q ss_pred cCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
++|...+.||+|+||.||++... ++..+++|.+.. ......+.+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC-ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 45777889999999999999753 355689998864 23344567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC
Q 006168 393 LVYEYMANSSLDKFLFGEK--------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL 458 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~ 458 (658)
+||||+++++|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 9999999999999995432 23489999999999999999999998 999999999999999999
Q ss_pred CeEEeeccCccccCCCCc-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHH
Q 006168 459 QPKIADFGLARLLPENQS-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRA 536 (658)
Q Consensus 459 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~ 536 (658)
.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.|+....... .
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~---- 234 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--V---- 234 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H----
Confidence 999999999976543322 12234556789999999999999999999999999999999 999876543211 1
Q ss_pred HHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 537 WRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 537 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
++....+...+. +...+..+.+++.+||+.+|++|||+.+|+++|+.+
T Consensus 235 ~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 235 IECITQGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHhCCCCCCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111222221111 112345689999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.92 Aligned_cols=243 Identities=22% Similarity=0.322 Sum_probs=193.7
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
+.||+|+||.||+++.+ +++.||+|.+.... .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 57899999987532 233455678899888877 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
|+|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (329)
T cd05618 81 GDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTS 154 (329)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccc
Confidence 99998884 345699999999999999999999998 99999999999999999999999999987542221 1223
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc---chhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE---EGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~---~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
...||+.|+|||++.+..++.++||||||+++|||++|+.||..... .......+.++...... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-----------~~ 223 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----------IR 223 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-----------CC
Confidence 46789999999999999999999999999999999999999964222 11111122222222111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTM 584 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~ 584 (658)
.+......+.+++.+||+.||++||+.
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 222334568899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=320.82 Aligned_cols=257 Identities=29% Similarity=0.448 Sum_probs=204.5
Q ss_pred HhcCCCccCcccccCceEEEEEEecC------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCe
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLKN------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 390 (658)
.+++|.+.+.||+|++|.||+|.+.+ +..|++|.+...........|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678889999999999999999763 567999988754444445678999999999999999999999999889
Q ss_pred EEEEEeccCCCCHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC---CeEE
Q 006168 391 LILVYEYMANSSLDKFLFGEKR-----GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL---QPKI 462 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~---~~kl 462 (658)
.++||||+++++|.+++..... ..+++..++.++.||+.||.|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865432 2589999999999999999999998 999999999999998754 5999
Q ss_pred eeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHh
Q 006168 463 ADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLY 540 (658)
Q Consensus 463 ~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~ 540 (658)
+|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~----~~ 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVME----FV 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH----HH
Confidence 999999876332211 1112334568999999999999999999999999999997 88888654332 1111 11
Q ss_pred hcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 541 ENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 541 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
...... ..+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 235 ~~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111100 111223456899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=320.59 Aligned_cols=255 Identities=27% Similarity=0.444 Sum_probs=202.9
Q ss_pred cCCCccCcccccCceEEEEEEec-CCc----EEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGK----IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
++|...+.||+|+||.||+|.+. +++ .+++|.+..........++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46778899999999999999974 344 4788887643333445678889999999999999999999854 56789
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
++||+++|+|.+++.. ....+++..+..++.||+.||.|||+. +++||||||+|||+++++.+||+|||+++.+..
T Consensus 86 i~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 9999999999999953 335699999999999999999999998 999999999999999999999999999987643
Q ss_pred CCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 474 NQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 474 ~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
.... ..+...++..|+|||++.++.++.++||||||+++|||++ |+.|+...... .+ .+....+.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~----~~~~~~~~~~~~--- 232 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EV----PDLLEKGERLAQ--- 232 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HH----HHHHHCCCcCCC---
Confidence 3222 2234567789999999999999999999999999999998 98888654321 11 111222211110
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
+.. ....+.+++.+||..+|++|||+.|+++.|..+
T Consensus 233 ---~~~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 233 ---PQI----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred ---CCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111 234578899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=318.50 Aligned_cols=249 Identities=25% Similarity=0.328 Sum_probs=198.3
Q ss_pred ccccCceEEEEEEec-CCcEEEEEEcccccc--cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCCH
Q 006168 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS--RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSL 403 (658)
Q Consensus 327 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 403 (658)
||+|+||.||+++.+ +|+.+|+|++..... ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999976 589999999864221 12234556799999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccccccc
Q 006168 404 DKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFA 483 (658)
Q Consensus 404 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 483 (658)
.+++.......+++..+..++.||+.||.|||+. +|+||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 9988655556699999999999999999999998 99999999999999999999999999998764332 223457
Q ss_pred CCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHH
Q 006168 484 GTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAA 563 (658)
Q Consensus 484 gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 563 (658)
|+..|+|||++.+..++.++|||||||++|||++|+.||......... .+....... .. +. . .....+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~-~~----~~--~----~~~~~~ 223 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-EELKRRTLE-DE----VK--F----EHQNFT 223 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH-HHHHHHhhc-cc----cc--c----ccccCC
Confidence 899999999999999999999999999999999999998754331110 011111111 00 00 0 011234
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 564 EKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 564 ~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
.++.+++..||+.||++||++.|+++.+.
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 56899999999999999999988775543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=337.03 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=203.8
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
..++|++.+.||+|+||.||+++.+ +++.||+|++... ........+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568899999999999999999976 5889999998642 122334567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 121 v~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999999843 3588889999999999999999998 999999999999999999999999999987644
Q ss_pred CCccccccccCCcccccccccccC----CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccc
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHG----QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
..........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ... ...........
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~---~i~~~~~~~~~- 268 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--TYS---KIMDHKNSLTF- 268 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH--HHH---HHHcCCCcCCC-
Confidence 332223356799999999998653 47899999999999999999999997544311 111 11111111110
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANS--RPTMSEVVAL 590 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 590 (658)
+. ....+..+.+++..||+.+|.+ ||++.++++.
T Consensus 269 -----~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 269 -----PD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -----CC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11 1123457899999999999987 9999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=318.77 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=205.1
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-------------ccccHHHHHHHHHHHhccCCCcccee
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-------------SRRTLSDFENEVRLISNVHHRNLIRL 381 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~niv~l 381 (658)
...+.|++.+.||+|.||.|-+++.. +++.||||++.+.. .....+...+|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 44578999999999999999999965 68999999996531 01124578999999999999999999
Q ss_pred eeEeec--CCeEEEEEeccCCCCHHHHhhcCCCCC-CCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC
Q 006168 382 LGCCSQ--GPELILVYEYMANSSLDKFLFGEKRGS-LNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL 458 (658)
Q Consensus 382 ~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~ 458 (658)
+.+..+ .+.+|||+|||..|.+... ..... |++.+.++++.++..||+|||.+ +||||||||+|+||+++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 999865 4689999999998887543 23444 99999999999999999999999 999999999999999999
Q ss_pred CeEEeeccCccccCCCCc----cccccccCCcccccccccccCC----CCCcccchhhhHHHHHHHhCCCCCCCCCcchh
Q 006168 459 QPKIADFGLARLLPENQS----HLSTKFAGTLGYTAPEYAIHGQ----LSEKVDAYSFGVLVLEIISGTKSSETKGEEGE 530 (658)
Q Consensus 459 ~~kl~DfGla~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~----~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~ 530 (658)
++||+|||.+..+..... ......+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||.....
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--- 324 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--- 324 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---
Confidence 999999999987733211 1122578999999999987743 35689999999999999999999975432
Q ss_pred hHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 531 YLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 531 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
++...+ ++...+.... ..+..+++.+||+++|++||++|.+..+|.....-.
T Consensus 325 --~~l~~K---------Ivn~pL~fP~-~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 325 --LELFDK---------IVNDPLEFPE-NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred --HHHHHH---------HhcCcccCCC-cccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 111111 1222221111 224567899999999999999999999998776543
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=297.17 Aligned_cols=259 Identities=27% Similarity=0.369 Sum_probs=208.2
Q ss_pred hcCCCccCcccccCceEEEEEE-ecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecC-----CeE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG-----PEL 391 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 391 (658)
.++|.+.+.||+|||+-||+++ ..+++.+|+|++... +.++.+..++|++..++++|||+++++++...+ .+.
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~-~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH-SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeecc-chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 4688999999999999999998 557899999999863 457788899999999999999999999987543 358
Q ss_pred EEEEeccCCCCHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 392 ILVYEYMANSSLDKFLFGEKR--GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
||+++|...|+|.+.+...+. ..+++.+++.|+.+|++||++||+.. +++.||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999865433 35999999999999999999999973 369999999999999999999999999987
Q ss_pred ccCCCCcc--------ccccccCCcccccccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHH
Q 006168 470 LLPENQSH--------LSTKFAGTLGYTAPEYAI---HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWR 538 (658)
Q Consensus 470 ~~~~~~~~--------~~~~~~gt~~y~APE~~~---~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~ 538 (658)
...-.-.. .-.....|..|.|||.+. +...++++|||||||+||+|+.|..||+..-.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------- 246 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------- 246 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence 65322111 011346789999999874 45678999999999999999999999863222
Q ss_pred HhhcCcccc--cccccCC-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 539 LYENGTHWE--LMDESLD-PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 539 ~~~~~~~~~--~~d~~l~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.|.... +....+. +... ..++.+.+++.+|++.||.+||+..+++..+..+
T Consensus 247 ---~GgSlaLAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 ---QGGSLALAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ---cCCeEEEeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 222111 1111111 1111 2677899999999999999999999999998765
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.41 Aligned_cols=262 Identities=22% Similarity=0.351 Sum_probs=197.4
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecC-----CeEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG-----PELI 392 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 392 (658)
+|++.++||+|+||.||+|+.+ +++.||||++.... .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5778899999999999999976 68999999986421 223345788999999999999999999987543 3589
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
+||||+. ++|.+++. ....+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIK--ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHH--hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999996 68998884 345699999999999999999999998 99999999999999999999999999998653
Q ss_pred CCCc--cccccccCCccccccccccc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHH----------
Q 006168 473 ENQS--HLSTKFAGTLGYTAPEYAIH--GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWR---------- 538 (658)
Q Consensus 473 ~~~~--~~~~~~~gt~~y~APE~~~~--~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~---------- 538 (658)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ......
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ--LDLITDLLGTPSPETI 232 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH--HHHHHHHhCCCCHHHH
Confidence 2221 11234678999999999865 6789999999999999999999999965432110 000000
Q ss_pred -HhhcCcccccc---cccCCCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 539 -LYENGTHWELM---DESLDPNECT---KEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 539 -~~~~~~~~~~~---d~~l~~~~~~---~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
........+.+ .... +.... ......+.+++.+||+.||++|||++|+++.
T Consensus 233 ~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQ-PVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccC-CCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000 0000 00000 0123457899999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.16 Aligned_cols=242 Identities=26% Similarity=0.339 Sum_probs=195.6
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCC-ccceeeeEeecCCeEEEEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHR-NLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~ 395 (658)
+|++.+.||+|+||.||+|+.+ +++.||+|++.... .....+.+..|.+++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999976 47899999987532 234456788899999999765 6888999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQ--QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999984 345689999999999999999999998 99999999999999999999999999987532221
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+ ....
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i----~~~~----------- 217 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQSI----MEHN----------- 217 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHH----HcCC-----------
Confidence 1223457899999999999999999999999999999999999999754321 111111 1110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTM 584 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 584 (658)
...+......+.+++.+||+.||.+||+.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11122234568899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=344.63 Aligned_cols=250 Identities=18% Similarity=0.271 Sum_probs=202.9
Q ss_pred CCCccCcccccCceEEEEEEec-C-CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-N-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
.|...+.||+|+||.||++... + ++.||+|.+... .......+.+|+.+++.++||||+++++++...+..+|||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 4778899999999999999865 3 678888877542 334445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 398 MANSSLDKFLFGE--KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 398 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
+++|+|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988542 234689999999999999999999998 99999999999999999999999999998765432
Q ss_pred c-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 476 S-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 476 ~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... .. .+...
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--~~~~~---~~-~~~~~-------- 289 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--EIMQQ---VL-YGKYD-------- 289 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH---HH-hCCCC--------
Confidence 2 1233567999999999999999999999999999999999999998653321 11111 11 11110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
..+...+..+.+++..||+.||++||++.+++.
T Consensus 290 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 --PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111223456899999999999999999999874
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=329.53 Aligned_cols=239 Identities=23% Similarity=0.331 Sum_probs=194.3
Q ss_pred CcccccCceEEEEEEe----cCCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccC
Q 006168 325 NKLGEGGFGDIYKGTL----KNGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMA 399 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 399 (658)
+.||+|+||.||+++. .+|+.||+|++.... .......+.+|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 357899999987532 22234567889999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccc
Q 006168 400 NSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS 479 (658)
Q Consensus 400 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 479 (658)
+|+|.+++. +...+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 82 ~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~ 155 (318)
T cd05582 82 GGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKA 155 (318)
T ss_pred CCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cce
Confidence 999999984 345699999999999999999999998 99999999999999999999999999998653322 123
Q ss_pred ccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCC
Q 006168 480 TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECT 559 (658)
Q Consensus 480 ~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 559 (658)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ... .. ...+
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~---i~~-~~-----------~~~p 218 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--ETMTM---ILK-AK-----------LGMP 218 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--HHHHH---HHc-CC-----------CCCC
Confidence 3467899999999999888999999999999999999999998654321 11111 111 10 0112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHH
Q 006168 560 KEAAEKVVEIALMCTQSAANSRPTMSE 586 (658)
Q Consensus 560 ~~~~~~l~~li~~cl~~dp~~RPt~~e 586 (658)
......+.+++.+||+.||++||++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 223456889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.94 Aligned_cols=257 Identities=27% Similarity=0.499 Sum_probs=206.8
Q ss_pred cCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
++|.+.+.||+|+||.||++... ++..+|+|.+.. ......+.+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC-cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 57888999999999999999852 345689998865 23445677999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeE
Q 006168 393 LVYEYMANSSLDKFLFGEK-----------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPK 461 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~k 461 (658)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999985322 23489999999999999999999998 999999999999999999999
Q ss_pred EeeccCccccCCCCc-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHH
Q 006168 462 IADFGLARLLPENQS-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRL 539 (658)
Q Consensus 462 l~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~ 539 (658)
|+|||+++....... .......++..|+|||++.+..++.++||||||++++||++ |+.||...... .... .
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--~~~~----~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIE----C 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----H
Confidence 999999986543221 11223445778999999998899999999999999999999 88887654321 1111 1
Q ss_pred hhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 540 YENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 540 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...+..... ... .+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 235 i~~~~~~~~------~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 ITQGRVLQR------PRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHcCCcCCC------CCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 122211111 111 2346899999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=320.11 Aligned_cols=263 Identities=24% Similarity=0.438 Sum_probs=203.8
Q ss_pred cCCCccCcccccCceEEEEEEec-----------------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCcccee
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-----------------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRL 381 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 381 (658)
++|++.++||+|+||.||++... +...+|+|.+..........++.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57889999999999999998643 2346899998754444456789999999999999999999
Q ss_pred eeEeecCCeEEEEEeccCCCCHHHHhhcCCC---------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcE
Q 006168 382 LGCCSQGPELILVYEYMANSSLDKFLFGEKR---------GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNV 452 (658)
Q Consensus 382 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NI 452 (658)
++++...+..++||||+++++|.+++..... ..+++.+++.++.|++.||+|||+. +++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999864321 2378889999999999999999998 999999999999
Q ss_pred EEcCCCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh--CCCCCCCCCcch
Q 006168 453 LLDDDLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS--GTKSSETKGEEG 529 (658)
Q Consensus 453 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt--G~~p~~~~~~~~ 529 (658)
|+++++.++|+|||+++.+...... ......++..|++||....+.++.++||||||+++|||++ |..|+.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-- 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence 9999999999999999865433221 1223344678999999988999999999999999999998 5566654322
Q ss_pred hhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 530 EYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 530 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
.................... ..+...+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQVIENTGEFFRDQGRQVYL-------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHHHhhccccccC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 12222211111111000000 0011223578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.99 Aligned_cols=257 Identities=31% Similarity=0.515 Sum_probs=207.7
Q ss_pred hcCCCccCcccccCceEEEEEEecC------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 391 (658)
.++|.+.+.||+|+||.||+|..++ +..||+|.+...........+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578889999999999999998753 3689999987544444556789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEe
Q 006168 392 ILVYEYMANSSLDKFLFGEK--------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIA 463 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~ 463 (658)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 99999999999999985432 23478999999999999999999998 99999999999999999999999
Q ss_pred eccCccccCCCCc-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhh
Q 006168 464 DFGLARLLPENQS-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYE 541 (658)
Q Consensus 464 DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 541 (658)
|||+++.+..... .......++..|+|||.+.++.++.++||||||+++|||++ |+.|+..... ..+.. ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~----~~~ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLK----FVI 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHH----HHh
Confidence 9999986543322 12234456789999999998899999999999999999998 8888764332 11211 121
Q ss_pred cCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 542 NGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 542 ~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
.+..... +. ..+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 236 ~~~~~~~------~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGGHLDL------PE----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCCCCCC------CC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 2211111 11 124579999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=330.07 Aligned_cols=243 Identities=23% Similarity=0.294 Sum_probs=197.3
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCC
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANS 401 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 401 (658)
+.||+|+||.||++... +++.||+|.+.... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999965 68999999987532 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 402 SLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE-DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 402 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
+|.+++. ....+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (325)
T cd05594 81 ELFFHLS--RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMK 154 (325)
T ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccc
Confidence 9999884 34569999999999999999999997 5 899999999999999999999999999875432221 223
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCH
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTK 560 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 560 (658)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... ..... ...+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~~~~----i~~~~-----------~~~p~ 217 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFEL----ILMEE-----------IRFPR 217 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HHHHH----HhcCC-----------CCCCC
Confidence 457999999999999999999999999999999999999999654321 11111 11110 01112
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 006168 561 EAAEKVVEIALMCTQSAANSRP-----TMSEVVAL 590 (658)
Q Consensus 561 ~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 590 (658)
.....+.+++.+||+.||++|+ ++.++++.
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2345688999999999999996 89998854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=316.29 Aligned_cols=257 Identities=28% Similarity=0.525 Sum_probs=207.0
Q ss_pred hcCCCccCcccccCceEEEEEEecC-C---cEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN-G---KIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
.++|+..+.||+|+||.||+|+++. + ..+++|.+.........+++.+|++++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3577888999999999999999763 3 37999998764444456788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999999853 335699999999999999999999998 999999999999999999999999999986643
Q ss_pred CCccccc--cccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 474 NQSHLST--KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 474 ~~~~~~~--~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
......+ ....+..|+|||++....++.++||||||+++|||++ |+.|+...... .+. +....+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~----~~i~~~~------ 227 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVM----KAINDGF------ 227 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHH----HHHhcCC------
Confidence 3222211 2223457999999998899999999999999999998 99998654321 111 1111110
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
........+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011112345689999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.61 Aligned_cols=263 Identities=25% Similarity=0.403 Sum_probs=208.3
Q ss_pred HHHHhcCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccC-CCccceeeeEee
Q 006168 314 LVSATRKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGCCS 386 (658)
Q Consensus 314 l~~a~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 386 (658)
+....++|.+.++||+|+||.||+|++. .++.||+|++.........+.+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3344567788899999999999999864 246899999976444444567899999999997 999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHhhcCCC------------------------------------------------------
Q 006168 387 QGPELILVYEYMANSSLDKFLFGEKR------------------------------------------------------ 412 (658)
Q Consensus 387 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------ 412 (658)
..+..++||||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999964321
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCC
Q 006168 413 ------------------------------------------GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPS 450 (658)
Q Consensus 413 ------------------------------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~ 450 (658)
..+++..++.++.||+.||.|||+. +|+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 2367888899999999999999998 9999999999
Q ss_pred cEEEcCCCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcc
Q 006168 451 NVLLDDDLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEE 528 (658)
Q Consensus 451 NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~ 528 (658)
|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 999999999999999999865332221 1223456789999999998899999999999999999998 88887643321
Q ss_pred hhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 529 GEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 529 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
. .+ ......+... ..+...+..+.+++..||+.+|.+||++++|++.|+.+
T Consensus 349 ~-~~----~~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 349 E-QF----YNAIKRGYRM----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred H-HH----HHHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 11 1111111100 01112345799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=314.49 Aligned_cols=248 Identities=26% Similarity=0.458 Sum_probs=198.8
Q ss_pred cccccCceEEEEEEec---CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCC
Q 006168 326 KLGEGGFGDIYKGTLK---NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSS 402 (658)
Q Consensus 326 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 402 (658)
.||+|+||.||+|.+. .+..||+|.+.........+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 355799999876444444577999999999999999999999885 457899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccc--c
Q 006168 403 LDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS--T 480 (658)
Q Consensus 403 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~--~ 480 (658)
|.+++.. ....+++..+++++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..+........ +
T Consensus 81 L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 9999853 345699999999999999999999998 999999999999999999999999999986544332211 1
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCC
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECT 559 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 559 (658)
...++..|+|||.+....++.++||||||+++|||++ |+.||....... . ......+.. ...+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~~~----------~~~~ 220 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--V----MSFIEQGKR----------LDCP 220 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--H----HHHHHCCCC----------CCCC
Confidence 2233578999999988889999999999999999996 999986543211 1 111222111 1112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 560 KEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 560 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
...+..+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 22345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=313.29 Aligned_cols=251 Identities=31% Similarity=0.494 Sum_probs=207.3
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
.++|...+.||+|+||.||++... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 357888899999999999999875 78999999875322 567899999999999999999999999989999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999999655555799999999999999999999998 999999999999999999999999999987632221
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
....+..|+|||++..+.++.++||||||++++|+++ |+.|+..... ..+... ...+...
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~----~~~~~~~---------- 218 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPH----VEKGYRM---------- 218 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHH----HhcCCCC----------
Confidence 2344668999999998899999999999999999998 8888864432 112111 1111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+...+..+.+++.+||+.+|++|||+.+++++|+++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11122345789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=313.68 Aligned_cols=254 Identities=27% Similarity=0.489 Sum_probs=207.6
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
.++|...++||+|+||.||++.+.++..+++|.+... ......+.+|++++++++|+||+++.+++.+ ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 4678899999999999999999888888999988642 3345678999999999999999999999887 778999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..+......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999999655555689999999999999999999998 9999999999999999999999999999876543322
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
......++..|+|||++..+.++.++||||||++++++++ |+.|+...... .+.. ....+...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~----~~~~~~~~---------- 222 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIR----ALERGYRM---------- 222 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHH----HHhCCCCC----------
Confidence 2223445678999999998899999999999999999999 88888653321 1111 11111110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
......+..+.+++.+|++.+|++||++.+++++|+.
T Consensus 223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112334569999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=315.75 Aligned_cols=247 Identities=28% Similarity=0.461 Sum_probs=197.9
Q ss_pred cccccCceEEEEEEec---CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCC
Q 006168 326 KLGEGGFGDIYKGTLK---NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANS 401 (658)
Q Consensus 326 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 401 (658)
+||+|+||.||+|.++ ++..+|+|++.... .....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 57889999986432 2234567899999999999999999999885 45679999999999
Q ss_pred CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc--c
Q 006168 402 SLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL--S 479 (658)
Q Consensus 402 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~--~ 479 (658)
+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++.......... .
T Consensus 81 ~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQ--KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999984 335689999999999999999999998 99999999999999999999999999998764433221 1
Q ss_pred ccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCC
Q 006168 480 TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558 (658)
Q Consensus 480 ~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 558 (658)
....++..|+|||.+....++.++||||||+++|||++ |+.||...... .+.. ....+.... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~----~i~~~~~~~----------~ 219 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQ----MIESGERME----------C 219 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHCCCCCC----------C
Confidence 22334678999999988889999999999999999998 99998654321 1111 122221111 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 559 TKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 559 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
+...+..+.+++.+||+.||++||++.+|++.|++.
T Consensus 220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 122345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=314.35 Aligned_cols=251 Identities=21% Similarity=0.332 Sum_probs=207.1
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
+|++.+.||+|+||.||++... +++.+|+|.+.........+.+.+|+.++++++|+||+++++.+..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999976 688999999865444455678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++++|.+++.......+++..++.++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++..+.... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 999999988655556689999999999999999999998 99999999999999999999999999997664322 12
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 558 (658)
.....|++.|+|||++.+..++.++||||||+++|+|++|+.||....... .. .... .+... ..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~---~~~~-~~~~~----------~~ 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN--LI---LKVC-QGSYK----------PL 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH--HH---HHHh-cCCCC----------CC
Confidence 234578899999999998899999999999999999999999986533211 11 1111 11111 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 559 TKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 559 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+...+..+.+++.+||+.||++|||+.+|+..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 22234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=302.15 Aligned_cols=264 Identities=25% Similarity=0.355 Sum_probs=206.6
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccH-HHHHHHHHHHhccCCCccceeeeEeec--CCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTL-SDFENEVRLISNVHHRNLIRLLGCCSQ--GPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 394 (658)
++|+..+.|++|.||.||+|+.+ +++.||+|+++......+. -...+|+.+|.+.+|||||.+-.+... -+..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45677899999999999999976 6899999999865433332 235899999999999999999988753 4679999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
||||++ +|..++... .+++...++.-++.|+++||+|||.+ .|+|||||++|+|++..|.+||+|||+|+.+...
T Consensus 156 Me~~Eh-DLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHHh-hHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999998 999988543 36799999999999999999999999 9999999999999999999999999999998665
Q ss_pred CccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh--cCcccccccc
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYE--NGTHWELMDE 551 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~--~~~~~~~~d~ 551 (658)
. ...|..+-|..|.|||.+.+. .|+++.|+||+|||+.||+++++.|.+..+-.+ +..+.+... .+..|.-++.
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ--l~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ--LDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH--HHHHHHHhCCCccccCCCccc
Confidence 3 345677889999999999875 699999999999999999999998877665221 222222221 1112211111
Q ss_pred cC-------C-------CCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 552 SL-------D-------PNECTKE-AAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 552 ~l-------~-------~~~~~~~-~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.. . ...+... ..+.-.+++...+..||.+|-|++|.++.
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00 0 0011111 34667889999999999999999998864
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=333.27 Aligned_cols=258 Identities=22% Similarity=0.284 Sum_probs=203.2
Q ss_pred HHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCe
Q 006168 314 LVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 314 l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 390 (658)
+....++|++.+.||+|+||.||+++.+ +++.+|+|.+... ........+.+|+.+++.++||||+++++++..++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3444578999999999999999999976 5889999998642 122334567899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++..
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 9999999999999999843 3588999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCccccccccCCcccccccccccC----CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccc
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAIHG----QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHW 546 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 546 (658)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .. .+........
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~--~~---~~i~~~~~~~ 266 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG--TY---SKIMDHKNSL 266 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH--HH---HHHHhCCccc
Confidence 654333233456799999999998754 37899999999999999999999997543211 11 1111111111
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 006168 547 ELMDESLDPNECTKEAAEKVVEIALMCTQSAANS--RPTMSEVVAL 590 (658)
Q Consensus 547 ~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 590 (658)
.. + .....+..+.+++..|++.++.+ ||++.|+++.
T Consensus 267 ~~------p--~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NF------P--EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CC------C--CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 10 0 01123456788899999865543 8999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=323.83 Aligned_cols=258 Identities=29% Similarity=0.463 Sum_probs=205.9
Q ss_pred hcCCCccCcccccCceEEEEEEec--------CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecC
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK--------NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQG 388 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 388 (658)
.++|.+.+.||+|+||.||++... +...+|+|.+..........++..|+++++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357889999999999999999853 23579999987543444566788999999999 799999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE
Q 006168 389 PELILVYEYMANSSLDKFLFGEKR--------------GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL 454 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll 454 (658)
+..++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+. +++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999964321 3489999999999999999999998 99999999999999
Q ss_pred cCCCCeEEeeccCccccCCCCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhH
Q 006168 455 DDDLQPKIADFGLARLLPENQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYL 532 (658)
Q Consensus 455 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l 532 (658)
+.++.+||+|||++.......... .....++..|+|||++.+..++.++||||||+++|||++ |+.|+..... +.+
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--~~~ 251 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EEL 251 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHH
Confidence 999999999999987654322111 112234568999999998899999999999999999998 7788754322 111
Q ss_pred HHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 533 LKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 533 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.. ....+... ..+......+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus 252 ~~----~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 252 FK----LLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HH----HHHcCCCC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11 11111111 11122345788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=321.74 Aligned_cols=262 Identities=25% Similarity=0.474 Sum_probs=205.6
Q ss_pred cCCCccCcccccCceEEEEEEec-----CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecC--CeE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-----NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG--PEL 391 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 391 (658)
+.|.+.+.||+|+||.||++.+. ++..||+|.+...........+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 34678899999999999999843 47889999987544455567899999999999999999999998765 568
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.+
T Consensus 84 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence 9999999999999998432 34589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcc--ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc---------chhhHHHHHHHHh
Q 006168 472 PENQSH--LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE---------EGEYLLKRAWRLY 540 (658)
Q Consensus 472 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~---------~~~~l~~~~~~~~ 540 (658)
...... ......++..|+|||++.+..++.++||||||+++|||++++.|...... ..+..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 443221 12235567789999999988999999999999999999998766432211 0111111111111
Q ss_pred hcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 541 ENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 541 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+... ..+...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 240 ~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRL----------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111 11122345799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=320.03 Aligned_cols=260 Identities=30% Similarity=0.478 Sum_probs=206.6
Q ss_pred HHhcCCCccCcccccCceEEEEEEecC------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCC
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLKN------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP 389 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 389 (658)
...++|++.+.||+|+||.||+|..++ +..||+|.+...........+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 346789999999999999999997542 45799999875433344556889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeE
Q 006168 390 ELILVYEYMANSSLDKFLFGEK--------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPK 461 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~k 461 (658)
..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999995422 23367788899999999999999998 999999999999999999999
Q ss_pred EeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHH
Q 006168 462 IADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRL 539 (658)
Q Consensus 462 l~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~ 539 (658)
|+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |..|+...... .... .
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~~----~ 233 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVLK----F 233 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----H
Confidence 9999999865432221 1223345678999999999999999999999999999999 67787543221 1111 1
Q ss_pred hhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 540 YENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 540 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
...+.... .+...+..+.+++.+||+.+|++|||+.++++.|++.
T Consensus 234 ~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 VMDGGYLD----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHcCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11111111 1112235799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=321.54 Aligned_cols=261 Identities=26% Similarity=0.464 Sum_probs=202.3
Q ss_pred cCCCccCcccccCceEEEEEEec-----CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeec--CCeE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-----NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ--GPEL 391 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 391 (658)
++|...+.||+|+||.||++..+ ++..||+|++.. ......+.+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH-STAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 57788899999999999999853 578999999865 334456788999999999999999999998743 3568
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||++++++.+||+|||++...
T Consensus 83 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999999998532 34699999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCccc--cccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcch----------hhHHHHHHHH
Q 006168 472 PENQSHL--STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEG----------EYLLKRAWRL 539 (658)
Q Consensus 472 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~----------~~l~~~~~~~ 539 (658)
....... .....++..|+|||++.+..++.++||||||++++||++|..++....... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4433211 112234456999999998899999999999999999999877654322100 0000000111
Q ss_pred hhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 540 YENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 540 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.... . ....+...+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 239 ~~~~---------~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNN---------G-RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcC---------C-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1110 0 0011122345699999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=323.57 Aligned_cols=238 Identities=22% Similarity=0.323 Sum_probs=189.3
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHH-HHhccCCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVR-LISNVHHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
+.||+|+||.||+++.. +++.||+|++.... .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 58899999986431 1222344555554 67889999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
++|...+. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05603 81 GELFFHLQ--RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS 154 (321)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence 99998884 345688999999999999999999998 99999999999999999999999999987542222 1233
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCH
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTK 560 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 560 (658)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+... .. ... ...+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~---i~-~~~-----------~~~~~ 217 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS--QMYDN---IL-HKP-----------LQLPG 217 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH--HHHHH---Hh-cCC-----------CCCCC
Confidence 467899999999999989999999999999999999999999754321 11111 11 110 11122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH
Q 006168 561 EAAEKVVEIALMCTQSAANSRPTMS 585 (658)
Q Consensus 561 ~~~~~l~~li~~cl~~dp~~RPt~~ 585 (658)
.....+.+++.+||+.||.+||+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 2345689999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=345.27 Aligned_cols=259 Identities=21% Similarity=0.314 Sum_probs=206.7
Q ss_pred HHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCC-
Q 006168 313 DLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP- 389 (658)
Q Consensus 313 ~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 389 (658)
+.....++|.+.+.||+|+||+||+++.. +++.||||++... ........+.+|+..+..++|+||+++...+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 33445579999999999999999999865 6899999998653 23444567889999999999999999988764332
Q ss_pred -------eEEEEEeccCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCe
Q 006168 390 -------ELILVYEYMANSSLDKFLFGEK--RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP 460 (658)
Q Consensus 390 -------~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~ 460 (658)
..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence 3689999999999999986432 34689999999999999999999998 99999999999999999999
Q ss_pred EEeeccCccccCCCCc-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHH
Q 006168 461 KIADFGLARLLPENQS-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRL 539 (658)
Q Consensus 461 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~ 539 (658)
||+|||+++.+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+.. .
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~--~~~~----~ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME--EVMH----K 256 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHH----H
Confidence 9999999987643322 2233567999999999999999999999999999999999999998653321 1111 1
Q ss_pred hhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 540 YENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 540 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+.. ...+...+..+.+++..||+.||.+||++.++++.
T Consensus 257 ~~~~~~----------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGRY----------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCCC----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111 11122334569999999999999999999999864
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=323.32 Aligned_cols=259 Identities=29% Similarity=0.465 Sum_probs=207.6
Q ss_pred HhcCCCccCcccccCceEEEEEEec--------CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeec
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK--------NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQ 387 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 387 (658)
..++|.+.+.||+|+||.||+++.. ++..||+|.+..........++.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567888899999999999999742 24579999987544445567899999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEE
Q 006168 388 GPELILVYEYMANSSLDKFLFGEK--------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVL 453 (658)
Q Consensus 388 ~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIl 453 (658)
....++||||+++|+|.+++.... ...+++.++..++.||++||.|||+. +|+||||||+|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 999999999999999999996532 23488899999999999999999998 9999999999999
Q ss_pred EcCCCCeEEeeccCccccCCCCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhh
Q 006168 454 LDDDLQPKIADFGLARLLPENQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEY 531 (658)
Q Consensus 454 l~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~ 531 (658)
+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..|+..... ..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~ 247 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EE 247 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HH
Confidence 9999999999999998764433222 223445678999999998899999999999999999998 6777654321 11
Q ss_pred HHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 532 LLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 532 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
+ .+....+... ..+...+..+.+++.+||+.+|.+|||+.||++.|+++
T Consensus 248 ~----~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 248 L----FKLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred H----HHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 1 1112211111 11122345689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.03 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=209.0
Q ss_pred hcCCCccCcccccCceEEEEEEecC-----CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeec-CCeE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN-----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ-GPEL 391 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 391 (658)
.++|...+.||+|+||.||+|.+.+ +..|++|++...........+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999999875 788999998754455556788999999999999999999998765 5778
Q ss_pred EEEEeccCCCCHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeec
Q 006168 392 ILVYEYMANSSLDKFLFGEKR------GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADF 465 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~Df 465 (658)
++++||+++++|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999854322 4599999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcC
Q 006168 466 GLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENG 543 (658)
Q Consensus 466 Gla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 543 (658)
|+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.|+..... ..+.. ....+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~----~~~~~ 235 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAA----YLKDG 235 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHH----HHHcC
Confidence 999866433322 1223456778999999988889999999999999999999 9998865322 11111 11111
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 544 THWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 544 ~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
... ......+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 236 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 236 YRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 100 01112245689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=314.14 Aligned_cols=252 Identities=23% Similarity=0.377 Sum_probs=204.3
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc----cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS----RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
++|...+.||+|++|.||++... +++.+|+|.+..... ......+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999965 689999999864321 2234578899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
|+||+++++|.+++. ....+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999984 335689999999999999999999998 999999999999999999999999999976543
Q ss_pred CCcccc--ccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 474 NQSHLS--TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 474 ~~~~~~--~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
...... ....++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...+......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~------- 224 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-----AIFKIATQPT------- 224 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-----HHHHHhccCC-------
Confidence 222111 23567889999999999899999999999999999999999986432211 1111111110
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....+......+.+++..||..+|.+|||+.++++.
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 ---NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111222344568999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=328.17 Aligned_cols=244 Identities=28% Similarity=0.468 Sum_probs=205.2
Q ss_pred cccccCceEEEEEEecC-CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCCHH
Q 006168 326 KLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLD 404 (658)
Q Consensus 326 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 404 (658)
.||+|.||+||.|+..+ ...+|||.+... ..+..+-+.+|+.+-++|+|.|||+++|.+.+++.+-+.||-++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek-dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK-DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc-cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 69999999999999775 456899999863 4455677889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCC--CHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC-CCCeEEeeccCccccCCCCcccccc
Q 006168 405 KFLFGEKRGSL--NWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD-DLQPKIADFGLARLLPENQSHLSTK 481 (658)
Q Consensus 405 ~~l~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~ 481 (658)
++|. .+=++| ++.+.--+.+||++||.|||++ .|||||||-+|||++. .|.+||+|||-++.+.. -+..+.+
T Consensus 661 sLLr-skWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TET 735 (1226)
T KOG4279|consen 661 SLLR-SKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTET 735 (1226)
T ss_pred HHHH-hccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCccccc
Confidence 9993 344666 7888888999999999999999 9999999999999965 68999999999987643 2334557
Q ss_pred ccCCcccccccccccC--CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCC
Q 006168 482 FAGTLGYTAPEYAIHG--QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECT 559 (658)
Q Consensus 482 ~~gt~~y~APE~~~~~--~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 559 (658)
+.||..|||||++-.| .|..++|||||||++.||.||++||...+....-... .| +... ..+.+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk-------VG-myKv------HP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK-------VG-MYKV------HPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh-------hc-ceec------CCCCc
Confidence 8899999999999876 5889999999999999999999999765543211111 01 0110 34677
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 560 KEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 560 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.+.+.+...+|++|+.++|.+||++.++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 888999999999999999999999999986
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=314.12 Aligned_cols=255 Identities=22% Similarity=0.439 Sum_probs=202.2
Q ss_pred CCccCcccccCceEEEEEEecC----CcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCe-----
Q 006168 321 FSEENKLGEGGFGDIYKGTLKN----GKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPE----- 390 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 390 (658)
|.+.+.||+|+||.||+|.+.. +..||+|++.... .......+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4677899999999999998752 3679999987532 23345678999999999999999999999866554
Q ss_pred -EEEEEeccCCCCHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeec
Q 006168 391 -LILVYEYMANSSLDKFLFGEK----RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADF 465 (658)
Q Consensus 391 -~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~Df 465 (658)
.++|+||+++|+|..++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 799999999999999885432 23589999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCCCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcC
Q 006168 466 GLARLLPENQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENG 543 (658)
Q Consensus 466 Gla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 543 (658)
|+++......... .....++..|+|||++....++.++||||||+++|||++ |..|+..... ..+.+.. ..+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~~~----~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYL----RHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH----HcC
Confidence 9998764433221 112345678999999988899999999999999999999 8888754332 1122211 111
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 544 THWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 544 ~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
... ..+...+..+.+++.+||+.||.+|||+.||++.|+.+
T Consensus 232 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRL----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 11223345799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=315.80 Aligned_cols=256 Identities=29% Similarity=0.512 Sum_probs=206.3
Q ss_pred cCCCccCcccccCceEEEEEEec-C---CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-N---GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
++|.+.+.||+|+||.||+|.+. + +..+|+|.+...........+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999864 2 3479999987544444567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++++|.+++... ...+++.+++.++.|++.||.|||+. +++||||||+|||++.++.++|+|||++..+...
T Consensus 84 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 9999999999999532 34689999999999999999999998 9999999999999999999999999999876543
Q ss_pred Cccccc--cccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 475 QSHLST--KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 475 ~~~~~~--~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
.....+ ...++..|+|||++.+..++.++||||||+++||+++ |+.||...... ..... ..++. .
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~----~~~~~--~---- 227 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKA----IEEGY--R---- 227 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHH----HhCCC--c----
Confidence 322221 2233568999999998899999999999999999887 99998654321 11111 11110 0
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
. ..+...+..+.+++.+|++.+|.+||+|.++++.|+.+
T Consensus 228 -~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -L---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -C---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 01112345689999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.00 Aligned_cols=255 Identities=29% Similarity=0.433 Sum_probs=202.3
Q ss_pred cCCCccCcccccCceEEEEEEecC-Cc--EEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN-GK--IVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 394 (658)
++|++.+.||+|+||.||+|+.++ +. .+++|.+.........+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999999764 33 47888886433344456789999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCe
Q 006168 395 YEYMANSSLDKFLFGEK--------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP 460 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~ 460 (658)
+||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999995422 13488999999999999999999998 99999999999999999999
Q ss_pred EEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHH
Q 006168 461 KIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRL 539 (658)
Q Consensus 461 kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~ 539 (658)
||+|||++....... .......+..|+|||++....++.++||||||+++|||++ |+.||...... .+.. .
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--~~~~----~ 230 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--ELYE----K 230 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHH----H
Confidence 999999986432111 1111233557999999998899999999999999999998 98998654321 1111 1
Q ss_pred hhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 540 YENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 540 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
...+. . ...+...+..+.+|+.+||+.+|.+|||+.++++.|+.+
T Consensus 231 ~~~~~-----~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 231 LPQGY-----R-----MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred HhcCC-----C-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11110 0 011122345689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=315.44 Aligned_cols=255 Identities=24% Similarity=0.433 Sum_probs=199.7
Q ss_pred CCccCcccccCceEEEEEEecC-Cc--EEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecC------Ce
Q 006168 321 FSEENKLGEGGFGDIYKGTLKN-GK--IVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG------PE 390 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 390 (658)
|.+.+.||+|+||.||+|++.+ +. .+|+|.+.... .....+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999764 33 58999886532 334467789999999999999999999987432 35
Q ss_pred EEEEEeccCCCCHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeecc
Q 006168 391 LILVYEYMANSSLDKFLFGE----KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFG 466 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG 466 (658)
.++||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 78999999999999887432 223489999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCc
Q 006168 467 LARLLPENQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGT 544 (658)
Q Consensus 467 la~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 544 (658)
+++.+....... .....+++.|++||++.+..++.++||||||+++|||++ |+.||..... ..+ ++....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~----~~~~~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEI----YDYLRQGN 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHH----HHHHHcCC
Confidence 998764433211 123345678999999999999999999999999999999 7888754322 111 12222221
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 545 HWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 545 ~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
... .+...+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 232 ~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 1112334689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=323.81 Aligned_cols=243 Identities=26% Similarity=0.359 Sum_probs=196.6
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
+.||+|+||.||++..+ +++.||+|++.... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 57899999987532 233456677899999888 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (318)
T cd05570 81 GDLMFHIQ--RSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS 154 (318)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence 99999884 345799999999999999999999998 999999999999999999999999999875322221 223
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCH
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTK 560 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 560 (658)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. ...... ...+.
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~~~----~i~~~~-----------~~~~~ 217 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELFQ----SILEDE-----------VRYPR 217 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HHHH----HHHcCC-----------CCCCC
Confidence 456899999999999999999999999999999999999999654321 1111 111111 01112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 006168 561 EAAEKVVEIALMCTQSAANSRPTM-----SEVVAL 590 (658)
Q Consensus 561 ~~~~~l~~li~~cl~~dp~~RPt~-----~evl~~ 590 (658)
..+..+.+++.+||+.||.+||++ .++++.
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 234568999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=324.85 Aligned_cols=243 Identities=25% Similarity=0.333 Sum_probs=196.2
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
+.||+|+||.||+|+.+ +++.||+|++.... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 47899999987532 233445677889988866 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
|+|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05591 81 GDLMFQIQ--RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTT 154 (321)
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccc
Confidence 99999884 345689999999999999999999998 99999999999999999999999999987543222 1233
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCH
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTK 560 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 560 (658)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+... ...+.. ..+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~~~----i~~~~~-----------~~p~ 217 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--DLFES----ILHDDV-----------LYPV 217 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--HHHHH----HHcCCC-----------CCCC
Confidence 467899999999999999999999999999999999999999754432 11111 111110 0111
Q ss_pred HHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 006168 561 EAAEKVVEIALMCTQSAANSRP-------TMSEVVAL 590 (658)
Q Consensus 561 ~~~~~l~~li~~cl~~dp~~RP-------t~~evl~~ 590 (658)
.....+.+++..||+.||++|| ++.++++.
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1234688999999999999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.62 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=194.7
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
+|+..++||+|+||.||+++.. +++.||+|++.... .......+.+|++++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999975 58899999986531 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC-
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ- 475 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~- 475 (658)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 9999999999843 35689999999999999999999998 99999999999999999999999999975331100
Q ss_pred ---------------------------------------------ccccccccCCcccccccccccCCCCCcccchhhhH
Q 006168 476 ---------------------------------------------SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGV 510 (658)
Q Consensus 476 ---------------------------------------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGv 510 (658)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012357999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHH
Q 006168 511 LVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPT---MSEV 587 (658)
Q Consensus 511 vl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~ev 587 (658)
++|||++|+.||......... ........... . + .......++.+++..++ .+|.+|++ +.++
T Consensus 237 il~elltG~~Pf~~~~~~~~~-----~~i~~~~~~~~-----~-p--~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQ-----MKVINWQTSLH-----I-P--PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHH-----HHHHccCCCcC-----C-C--CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 999999999999754432111 11111000000 0 0 01112334666666655 49999997 7776
Q ss_pred HH
Q 006168 588 VA 589 (658)
Q Consensus 588 l~ 589 (658)
++
T Consensus 303 ~~ 304 (382)
T cd05625 303 KA 304 (382)
T ss_pred hc
Confidence 64
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=317.47 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=202.8
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecC-----
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQG----- 388 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----- 388 (658)
.+++.|+..+.||+|+||.||+|... +++.||+|++.. .......+.+|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~--~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV--TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEc--CCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 46778889999999999999999976 588999999864 234556789999999998 799999999998642
Q ss_pred -CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccC
Q 006168 389 -PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL 467 (658)
Q Consensus 389 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGl 467 (658)
...++||||+++++|.+++.......+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 4689999999999999999665556799999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCcccccccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAI-----HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN 542 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 542 (658)
+........ ......|+..|+|||++. +..++.++|||||||++|||++|+.|+......... .....
T Consensus 158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~~~~~- 230 (272)
T cd06637 158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----FLIPR- 230 (272)
T ss_pred ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----HHHhc-
Confidence 986543222 223467899999999986 346888999999999999999999998643321111 01111
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 543 GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 543 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.. ...+ .....+..+.+++.+||+.+|.+|||+.++++
T Consensus 231 ~~-----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NP-----APRL----KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CC-----CCCC----CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 0111 11123346899999999999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=317.71 Aligned_cols=254 Identities=27% Similarity=0.487 Sum_probs=203.3
Q ss_pred cCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
+++...++||+|+||.||++... ++..+++|.+.. ........+.+|+++++.++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc-CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 46677899999999999999742 356799998865 34455678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC
Q 006168 393 LVYEYMANSSLDKFLFGEKR-------------GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ 459 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~ 459 (658)
+||||+++++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 99999999999999864321 3489999999999999999999998 9999999999999999999
Q ss_pred eEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHH
Q 006168 460 PKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAW 537 (658)
Q Consensus 460 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~ 537 (658)
+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ...
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~--- 235 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIE--- 235 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHH---
Confidence 999999999765432211 1223345788999999999999999999999999999998 888875433211 111
Q ss_pred HHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 538 RLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 538 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
....+... ..+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 236 -~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 -CITQGREL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -HHHcCccC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11111111 111122346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=328.11 Aligned_cols=259 Identities=27% Similarity=0.474 Sum_probs=203.4
Q ss_pred hcCCCccCcccccCceEEEEEEe------cCCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeec-CC
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTL------KNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQ-GP 389 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~ 389 (658)
.++|.+.+.||+|+||.||+|.. .+++.||||++...........+.+|+.++.++ +||||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999974 247889999997544444456788999999999 78999999998854 45
Q ss_pred eEEEEEeccCCCCHHHHhhcCC----------------------------------------------------------
Q 006168 390 ELILVYEYMANSSLDKFLFGEK---------------------------------------------------------- 411 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 411 (658)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6899999999999999985421
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc-cccccc
Q 006168 412 -------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH-LSTKFA 483 (658)
Q Consensus 412 -------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~ 483 (658)
...+++..+..++.||++||.|||+. +|+||||||+|||+++++.+||+|||++..+...... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12378888999999999999999998 9999999999999999999999999999865332221 112334
Q ss_pred CCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHH
Q 006168 484 GTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEA 562 (658)
Q Consensus 484 gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 562 (658)
++..|+|||.+.+..++.++||||||+++|||++ |..|+........ + .....++..... +. ..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~----~~~~~~~~~~~~------~~----~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-F----CRRLKEGTRMRA------PD----YT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-H----HHHHhccCCCCC------CC----CC
Confidence 5678999999999999999999999999999997 8888765332211 1 111111111110 11 12
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 563 AEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 563 ~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
...+.+++..||+.+|++|||+.||++.|+.+
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 34689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.71 Aligned_cols=237 Identities=27% Similarity=0.367 Sum_probs=192.9
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
+.||+|+||.||+++.+ +++.||+|++.... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999976 58899999986531 234456677888888876 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
|+|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~--~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (320)
T cd05590 81 GDLMFHIQ--KSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS 154 (320)
T ss_pred chHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence 99999884 345699999999999999999999998 99999999999999999999999999987543222 1233
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCH
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTK 560 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 560 (658)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+.. ....+.. ..+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~----~i~~~~~-----------~~~~ 217 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLFE----AILNDEV-----------VYPT 217 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHH----HHhcCCC-----------CCCC
Confidence 467999999999999999999999999999999999999999754331 1111 1111110 1111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH
Q 006168 561 EAAEKVVEIALMCTQSAANSRPTM 584 (658)
Q Consensus 561 ~~~~~l~~li~~cl~~dp~~RPt~ 584 (658)
.....+.+++..||+.||.+||++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCC
Confidence 234568999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=324.16 Aligned_cols=242 Identities=26% Similarity=0.342 Sum_probs=195.9
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 395 (658)
+|.+.+.||+|+||.||+++.+ +++.||+|.+.... .......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999976 57899999987532 223345567788888777 6899999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQ--QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999884 345699999999999999999999998 99999999999999999999999999997543222
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+. ...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i~----~~~----------- 217 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIM----EHN----------- 217 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHHHH----hCC-----------
Confidence 1223467899999999999999999999999999999999999999754321 2221111 111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTM 584 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 584 (658)
...+.....++.+++.+|++.+|.+|++.
T Consensus 218 ~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11122334568999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=311.31 Aligned_cols=248 Identities=30% Similarity=0.454 Sum_probs=199.0
Q ss_pred CcccccCceEEEEEEecC----CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLKN----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
++||+|+||.||+|.+.. +..+|+|.+.........+++.+|++++++++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998542 26899999876433345678899999999999999999999875 4568999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
++|.+++.. ...+++..++.++.|++.+|.|||+. +++|+||||+|||++.++.+||+|||+++...........
T Consensus 80 ~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 999999953 34799999999999999999999998 9999999999999999999999999999876443322211
Q ss_pred --cccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 481 --KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 481 --~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
...++..|+|||.+....++.++||||||+++|||++ |+.||..... ..+.... ..... ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~----~~~~~----------~~ 218 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAML----ESGER----------LP 218 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHH----HcCCc----------CC
Confidence 2233568999999998999999999999999999998 8998865432 2222221 11111 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.+...+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1122345689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=318.49 Aligned_cols=257 Identities=26% Similarity=0.482 Sum_probs=206.0
Q ss_pred hcCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 391 (658)
.++|++.+.||+|+||.||++..+ ++..||+|.+..........++.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999864 46789999987644444567799999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCc
Q 006168 392 ILVYEYMANSSLDKFLFGEK--------------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSN 451 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~N 451 (658)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999985321 12478899999999999999999998 99999999999
Q ss_pred EEEcCCCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcch
Q 006168 452 VLLDDDLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEG 529 (658)
Q Consensus 452 Ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~ 529 (658)
||+++++.++|+|||++......... .......+..|+|||.+.+..++.++||||||+++|||++ |..|+......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 99999999999999998765332211 1122344678999999998999999999999999999998 77777543221
Q ss_pred hhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 530 EYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 530 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
.. ......+.... .+...+.++.+++.+||+.+|.+|||+.|+++.|++
T Consensus 240 -~~----~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -EV----IYYVRDGNVLS----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -HH----HHHHhcCCCCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 11222222111 111234569999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=322.45 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=202.2
Q ss_pred cCCCccCcccccCceEEEEEEec-CCc--EEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGK--IVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 394 (658)
++|++.+.||+|+||.||+|.++ ++. .+++|++...........+.+|++++.++ +||||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57788899999999999999975 344 46888776534445567889999999999 899999999999999999999
Q ss_pred EeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCe
Q 006168 395 YEYMANSSLDKFLFGEK--------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP 460 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~ 460 (658)
|||+++++|.+++.... ...+++.+++.++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999996432 23589999999999999999999998 99999999999999999999
Q ss_pred EEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHH
Q 006168 461 KIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRL 539 (658)
Q Consensus 461 kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~ 539 (658)
||+|||++....... ......++..|+|||++....++.++||||||++++||+| |..||...... .....
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~---- 235 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEK---- 235 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHHHH----
Confidence 999999986432111 1112234668999999988889999999999999999998 99988643321 11111
Q ss_pred hhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 540 YENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 540 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
...+... ..+...+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 236 ~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 236 LPQGYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HhcCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111000 01112234689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=322.75 Aligned_cols=256 Identities=22% Similarity=0.296 Sum_probs=198.9
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|++.+.||+|+||.||+++.. +++.||+|.+... ......+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47888999999999999999976 5889999998642 22334566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 99999999999843 245689999999999999999999998 99999999999999999999999999997665443
Q ss_pred ccccccccCCccccccccccc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 476 SHLSTKFAGTLGYTAPEYAIH-----GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
........||+.|+|||++.. +.++.++|||||||++|||++|+.||...... +...............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-----~~~~~i~~~~~~~~~~- 230 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHKEHFQFP- 230 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-----HHHHHHHcCCCcccCC-
Confidence 333334579999999999863 46788999999999999999999998653321 1111111111111110
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHH
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQS--AANSRPTMSEVVAL 590 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~--dp~~RPt~~evl~~ 590 (658)
......+..+.+++.+|+.. ++..||++.++++.
T Consensus 231 ------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 231 ------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00111344577788776654 44448899998875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=321.38 Aligned_cols=258 Identities=29% Similarity=0.475 Sum_probs=206.1
Q ss_pred cCCCccCcccccCceEEEEEEec--------CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCC
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK--------NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGP 389 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 389 (658)
++|.+.++||+|+||.||+++.. ....+|+|.+..........++.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57788999999999999999752 24579999987544445567789999999999 6999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc
Q 006168 390 ELILVYEYMANSSLDKFLFGEK--------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD 455 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~ 455 (658)
..++||||+++|+|.+++.... ...+++.++..++.||+.||.|||+. +|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 9999999999999999996432 23489999999999999999999998 999999999999999
Q ss_pred CCCCeEEeeccCccccCCCCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHH
Q 006168 456 DDLQPKIADFGLARLLPENQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLL 533 (658)
Q Consensus 456 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~ 533 (658)
+++.+||+|||+++......... .....++..|+|||.+.++.++.++||||||+++|||++ |..||..... ..+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~~~~ 246 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--EELF 246 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--HHHH
Confidence 99999999999998664332211 112234567999999999999999999999999999999 8888754322 1111
Q ss_pred HHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 534 KRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 534 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
.....+...+ .+...+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 247 ----~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 247 ----KLLREGHRMD----------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ----HHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111111111 11122346889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=310.27 Aligned_cols=249 Identities=29% Similarity=0.451 Sum_probs=202.1
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEee-cCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCS-QGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~ 397 (658)
++|.+.+.||+|+||.||++..+ +..+++|.+... ...+.+.+|+.++++++|+|++++++++. .++..++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 47888899999999999999875 788999988542 33567899999999999999999999764 55678999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.......+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999999655555699999999999999999999998 99999999999999999999999999987543322
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
....++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ..+... ...+.. .
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~----~~~~~~----------~ 218 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPR----VEKGYK----------M 218 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HhcCCC----------C
Confidence 22344668999999998899999999999999999998 8888764322 111111 111110 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11122345689999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=316.35 Aligned_cols=256 Identities=27% Similarity=0.439 Sum_probs=204.5
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCc----EEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGK----IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
.++|...++||+|+||.||+|++. +++ .||+|.+..........++.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 357888899999999999999864 444 4899998754445556788999999999999999999999975 4578
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
+++||+++|+|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 85 l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 999999999999998532 35699999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 473 ENQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 473 ~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ..+.. ....+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~----~~~~~~~~~--- 231 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPD----LLEKGERLP--- 231 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH----HHHCCCcCC---
Confidence 433221 112345678999999999999999999999999999998 8888754332 11111 111111110
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.+...+..+.+++.+||+.||++||++.++++.|+..
T Consensus 232 -------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 232 -------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred -------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1112345689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=329.94 Aligned_cols=263 Identities=25% Similarity=0.345 Sum_probs=201.0
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCC-----eEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP-----ELI 392 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 392 (658)
+|+..++||+|+||.||++... +++.||||++.... .....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999975 68999999986421 2234567889999999999999999999998766 789
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
+|+||+. ++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999997 57888773 445799999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcc------
Q 006168 473 ENQSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTH------ 545 (658)
Q Consensus 473 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~------ 545 (658)
.......+...++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ....+.+.......
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ--QLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCCCCHHHHHHh
Confidence 4433333445688999999998774 57899999999999999999999997654311 11111110000000
Q ss_pred ----cc-cccccCCCC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 546 ----WE-LMDESLDPN------ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 546 ----~~-~~d~~l~~~------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.. +......+. ........++.+++.+||+.||.+|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 000000000 0111224568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.91 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=201.3
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|...+.||+|+||.||+++.. +++.||+|.+..........++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36778889999999999999864 68899999987544444556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 9999997552 478889999999999999999998 99999999999999999999999999998654321
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhH-HHHHHHHhhcCcccccccccCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYL-LKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l-~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||.......... .....+...... ...+
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--- 220 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL--- 220 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC---
Confidence 234578999999999999999999999999999999999999986533211111 001111111110 0111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.......++.+++.+||+.+|++||++.|+++.
T Consensus 221 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 -PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111233568999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=312.25 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=194.3
Q ss_pred CcccccCceEEEEEEecC---CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCC
Q 006168 325 NKLGEGGFGDIYKGTLKN---GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANS 401 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 401 (658)
+.||+|+||.||+|.+.+ +..+|+|.+...........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998653 45799999875444444567899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCC---CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 402 SLDKFLFGEKR---GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 402 sL~~~l~~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
+|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++++||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999964322 2467888889999999999999998 99999999999999999999999999987543322211
Q ss_pred -cccccCCcccccccccccC-------CCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccc
Q 006168 479 -STKFAGTLGYTAPEYAIHG-------QLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 479 -~~~~~gt~~y~APE~~~~~-------~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||....... ...... .+......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~~----~~~~~~~~ 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYTV----REQQLKLP 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHh----hcccCCCC
Confidence 2234577889999998642 35789999999999999996 999986543321 111111 11111111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
++.+ .......+.+++..|+ .+|++|||+.||+..|+
T Consensus 232 ~~~~-----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRL-----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCcc-----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111 1112345788999999 58999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=323.68 Aligned_cols=243 Identities=22% Similarity=0.298 Sum_probs=194.2
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
+.||+|+||.||++... +++.||+|++.... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 57899999997532 223456688999999888 699999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
|+|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~--~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (327)
T cd05617 81 GDLMFHMQ--RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS 154 (327)
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence 99998884 345699999999999999999999998 99999999999999999999999999987532221 1223
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcc-hhhHHHHHHHHhhcCcccccccccCCCCCCC
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE-GEYLLKRAWRLYENGTHWELMDESLDPNECT 559 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 559 (658)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... .........+...... ...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------~~~p 223 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-----------IRIP 223 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-----------CCCC
Confidence 467999999999999999999999999999999999999999653321 1111122222221111 1122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH
Q 006168 560 KEAAEKVVEIALMCTQSAANSRPTM 584 (658)
Q Consensus 560 ~~~~~~l~~li~~cl~~dp~~RPt~ 584 (658)
...+..+.+++.+||+.||.+||++
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 2234568899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=311.82 Aligned_cols=249 Identities=30% Similarity=0.476 Sum_probs=201.7
Q ss_pred CcccccCceEEEEEEecC--C--cEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLKN--G--KIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
+.||+|++|.||+|.+.+ + ..||+|.+.........+.+.+|++++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999753 3 36999999764433556789999999999999999999999988 889999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc--
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL-- 478 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~-- 478 (658)
++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..+.......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999999654435699999999999999999999998 99999999999999999999999999998765432221
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
.....++..|+|||++.+..++.++||||||+++|||++ |+.|+...... ........ .... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~---~~~~----------~~ 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKIDK---EGER----------LE 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHh---cCCc----------CC
Confidence 123457789999999999999999999999999999999 99998644321 12111111 1110 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
.+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11223457999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=313.15 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=201.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|++.+.||+|+||.||+|+.. +++.||+|++... .......+.+|+.++++++||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE-PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC-ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 57889999999999999999975 6889999998642 334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..+.....
T Consensus 88 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 88 CGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 99999999984 345689999999999999999999998 999999999999999999999999999986643221
Q ss_pred ccccccCCcccccccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 478 LSTKFAGTLGYTAPEYAI---HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~---~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
......|+..|+|||.+. ...++.++||||||++++||++|+.|+.......... . ..... ...+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-----~-~~~~~---~~~~~~- 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-----L-MSKSN---FQPPKL- 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-----e-eecCC---CCCCCC-
Confidence 122356888999999884 3457889999999999999999999985432211000 0 00000 000000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 591 (658)
......+..+.+++.+||+.+|++|||++++++.|
T Consensus 232 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 --KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 01112345789999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=314.07 Aligned_cols=255 Identities=28% Similarity=0.523 Sum_probs=204.2
Q ss_pred CCCccCcccccCceEEEEEEecC-C---cEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLKN-G---KIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
+|.+.+.||+|+||.||+|.++. + ..||||.+..........+|..|+.++++++||||+++++++..+...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778999999999999999763 3 3699999876444555678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++++|.+++... .+.+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999998532 45689999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccc--ccccc--CCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 476 SHL--STKFA--GTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 476 ~~~--~~~~~--gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
... ..... .+..|+|||++....++.++||||||+++||+++ |..||...... .....+ ....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i----~~~~------ 228 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAI----EQDY------ 228 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHH----HcCC------
Confidence 211 11111 2457999999999999999999999999999886 99988654321 122211 1110
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.+ ..+.+.+..+.+++..||+.+|.+||++.+|+.+|+..
T Consensus 229 -~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 -RL---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -cC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 01122345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=322.31 Aligned_cols=238 Identities=25% Similarity=0.332 Sum_probs=190.0
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHH-HHhccCCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVR-LISNVHHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
+.||+|+||.||+++.+ +|+.||+|++.... ......++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999976 68999999986431 1222344555544 56789999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (323)
T cd05575 81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS 154 (323)
T ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence 99999884 345789999999999999999999998 99999999999999999999999999987542222 2233
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCH
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTK 560 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 560 (658)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... ...+. + ..+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~----i~~~~--------~---~~~~ 217 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--EMYDN----ILNKP--------L---RLKP 217 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH--HHHHH----HHcCC--------C---CCCC
Confidence 567999999999999999999999999999999999999999754321 11111 11110 0 0111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH
Q 006168 561 EAAEKVVEIALMCTQSAANSRPTMS 585 (658)
Q Consensus 561 ~~~~~l~~li~~cl~~dp~~RPt~~ 585 (658)
..+..+.+++.+||+.||.+||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 2245689999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=322.03 Aligned_cols=241 Identities=26% Similarity=0.348 Sum_probs=193.4
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
+.||+|+||.||+++.+ +|+.||+|.+.... .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 58899999987532 123445667788888754 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 81 GDLMFHIQ--DKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 99999884 345689999999999999999999998 99999999999999999999999999987532211 1233
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCH
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTK 560 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 560 (658)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+. ..... . ..+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~----~~~~~------~-----~~~~ 217 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFES----IRVDT------P-----HYPR 217 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHH----HHhCC------C-----CCCC
Confidence 567899999999999999999999999999999999999999654321 11111 11110 1 1111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 006168 561 EAAEKVVEIALMCTQSAANSRPTMS-EVV 588 (658)
Q Consensus 561 ~~~~~l~~li~~cl~~dp~~RPt~~-evl 588 (658)
....++.+++.+||+.||++||++. +++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 2345688999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=330.60 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=205.9
Q ss_pred hHHHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeec
Q 006168 311 LKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ 387 (658)
Q Consensus 311 ~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 387 (658)
+.++....++|++.+.||+|+||.||+++.+ +++.+|+|.+... ........+.+|+.+++.++||||+++++.+..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455566789999999999999999999977 5889999998642 122334567899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccC
Q 006168 388 GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL 467 (658)
Q Consensus 388 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGl 467 (658)
++..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999999999843 3588899999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCcccccccccccC----CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcC
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHG----QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG 543 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~----~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 543 (658)
+...............||+.|+|||++... .++.++|||||||++|||++|+.||....... . ..+.....
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~---~~~i~~~~ 263 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--T---YSKIMNHK 263 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH--H---HHHHHcCC
Confidence 987654333333456799999999998654 37899999999999999999999997543211 1 11111111
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 006168 544 THWELMDESLDPNECTKEAAEKVVEIALMCTQSAANS--RPTMSEVVALL 591 (658)
Q Consensus 544 ~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~L 591 (658)
..... ......+..+.+++..|+..++.+ ||++.++++..
T Consensus 264 ~~~~~--------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 264 NSLTF--------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CcccC--------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11111 011123456889999999854443 78999988754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=317.98 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=204.6
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|+..+.||+|+||.||+|+.. +++.|++|.+... .......+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecC-CcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 57888899999999999999965 6889999998753 233457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++. ...+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~---~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 99 LAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred cCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 99999999984 34589999999999999999999998 999999999999999999999999999876543221
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
......+++.|+|||.+.+..++.++|||||||++|||++|+.||........ +. ...... .. ...
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~----~~~~~~-~~--------~~~ 237 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LY----LIATNG-TP--------ELQ 237 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HH----HHhcCC-CC--------CCC
Confidence 12335688999999999988899999999999999999999999965433111 11 011110 00 011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+......+.+++.+||+.+|++|||+.+|++.
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 123344668999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.42 Aligned_cols=249 Identities=35% Similarity=0.570 Sum_probs=205.1
Q ss_pred CcccccCceEEEEEEecC----CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLKN----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
+.||+|+||.||++.... +..|++|.+...........+.+|++.++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999764 7889999997654433468899999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 401 SSLDKFLFGEK-------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 401 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999996532 36699999999999999999999998 999999999999999999999999999987754
Q ss_pred CCc-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 474 NQS-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 474 ~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
... .......++..|+|||.+....++.++||||||++++||++ |..|+..... ..+. +....+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~----~~~~~~~~------ 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVL----EYLRKGYR------ 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHH----HHHHcCCC------
Confidence 432 12234567889999999988899999999999999999999 5888865532 1111 11111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
...+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112223567999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=314.94 Aligned_cols=250 Identities=27% Similarity=0.392 Sum_probs=201.5
Q ss_pred CCccCcccccCceEEEEEEec-CCcEEEEEEcccccc--cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS--RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
|+..+.||+|+||.||++... +++.||+|.+..... ......+.+|+.++++++|+|++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999976 688999999865321 22234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 9999999998655555699999999999999999999998 999999999999999999999999999876543222
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcch-hhHHHHHHHHhhcCcccccccccCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEG-EYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ..... ...... . .
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~~------~-----~ 222 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKEV------Q-----E 222 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhhh------h-----h
Confidence 223478999999999999999999999999999999999999997543311 11111 111000 0 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPT-----MSEVVA 589 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 589 (658)
..+......+.+++..||+.||++||| +.|+++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 111223346889999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.91 Aligned_cols=263 Identities=24% Similarity=0.377 Sum_probs=203.2
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|.+.+.||+|+||.||++... ++..+|+|.+..........++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999976 57889999886543344456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.. ...+++..+..++.|+++||.|||+. .+++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 81 MDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 999999999943 36689999999999999999999973 289999999999999999999999999987553321
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcc------------
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTH------------ 545 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~------------ 545 (658)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...............
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccCCCC
Confidence 23457889999999998888999999999999999999999998643321 110000000000000
Q ss_pred --------cccccccC---CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 546 --------WELMDESL---DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 546 --------~~~~d~~l---~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+..+... .+..........+.+++.+||+.+|++|||+.+|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 0000011234568999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=321.24 Aligned_cols=244 Identities=23% Similarity=0.300 Sum_probs=191.7
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHH-HHHhccCCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEV-RLISNVHHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
+.||+|+||.||+++.. +++.||+|++.... ......++..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 57889999986421 122233444444 456788999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
|+|.+++. ....+.+.....++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~ 154 (325)
T cd05602 81 GELFYHLQ--RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTS 154 (325)
T ss_pred CcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcc
Confidence 99999984 345688889999999999999999998 99999999999999999999999999997543222 1233
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCH
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTK 560 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 560 (658)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... . ... .....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i---~-~~~-----------~~~~~ 217 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNI---L-NKP-----------LQLKP 217 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HHHHHH---H-hCC-----------cCCCC
Confidence 567999999999999999999999999999999999999999754321 111111 1 110 01111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 006168 561 EAAEKVVEIALMCTQSAANSRPTMSEVVALL 591 (658)
Q Consensus 561 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 591 (658)
.....+.+++..|++.+|.+||++.+.+..+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 2345689999999999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=321.24 Aligned_cols=242 Identities=25% Similarity=0.355 Sum_probs=193.7
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhc-cCCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISN-VHHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
+.||+|+||.||+|+.. +++.||+|++.... .......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 47899999987532 12334556778888876 4999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
|+|.+++. ....+++.++..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (316)
T cd05619 81 GDLMFHIQ--SCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTC 154 (316)
T ss_pred CcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-cee
Confidence 99999984 345689999999999999999999998 999999999999999999999999999875422211 223
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCH
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTK 560 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 560 (658)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+... ..... . ..+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~----i~~~~------~-----~~~~ 217 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQS----IRMDN------P-----CYPR 217 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHH----HHhCC------C-----CCCc
Confidence 45789999999999999999999999999999999999999865432 111111 11110 0 1112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 006168 561 EAAEKVVEIALMCTQSAANSRPTMS-EVVA 589 (658)
Q Consensus 561 ~~~~~l~~li~~cl~~dp~~RPt~~-evl~ 589 (658)
.....+.+++.+||+.||.+||++. ++.+
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 2345688999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.01 Aligned_cols=251 Identities=25% Similarity=0.354 Sum_probs=200.8
Q ss_pred CCccCcccccCceEEEEEEec-CCcEEEEEEcccccc--cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS--RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
|+..+.||+|+||+||++... +++.+|+|.+..... ......+.+|++++++++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 567788999999999999975 688999999864321 22234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 9999999988655555799999999999999999999998 99999999999999999999999999997653322
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
......|+..|+|||++.+..++.++||||||+++|||++|+.||........ ............ ..
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~~~~~~-----------~~ 223 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRRVLETE-----------EV 223 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhhccc-----------cc
Confidence 12345789999999999999999999999999999999999999975433111 111111111110 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPT-----MSEVVA 589 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 589 (658)
........+.+|+..||+.||++||+ +.++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 12223456889999999999999999 556665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=323.08 Aligned_cols=259 Identities=29% Similarity=0.465 Sum_probs=206.4
Q ss_pred hcCCCccCcccccCceEEEEEEecC--------CcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecC
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN--------GKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQG 388 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 388 (658)
..+|.+.+.||+|+||.||++.... +..||+|.+..........++.+|+++++++ +||||+++++++.+.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3568889999999999999997531 2368999887544445567899999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE
Q 006168 389 PELILVYEYMANSSLDKFLFGEK--------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL 454 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll 454 (658)
+..+++|||+++|+|.+++.... ...+++.+++.++.|++.||.|||+. +|+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence 99999999999999999986432 23488999999999999999999998 99999999999999
Q ss_pred cCCCCeEEeeccCccccCCCCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhH
Q 006168 455 DDDLQPKIADFGLARLLPENQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYL 532 (658)
Q Consensus 455 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l 532 (658)
++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..|+...... .+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~ 245 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--EL 245 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HH
Confidence 999999999999998664432211 122334568999999999999999999999999999998 77887543221 11
Q ss_pred HHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 533 LKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 533 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
.+....+... ..+...+..+.+++.+||+.+|.+|||+.|+++.|+.+.
T Consensus 246 ----~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 246 ----FKLLKEGHRM----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ----HHHHHcCCCC----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 1111111111 111123456889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.15 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=192.2
Q ss_pred CcccccCceEEEEEEecC---CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCC
Q 006168 325 NKLGEGGFGDIYKGTLKN---GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANS 401 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 401 (658)
+.||+|+||.||+|...+ ...+++|.+...........+.+|+++++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 45789998765444444567889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCC---CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc-
Q 006168 402 SLDKFLFGEKR---GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH- 477 (658)
Q Consensus 402 sL~~~l~~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~- 477 (658)
+|.+++..... ...++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999965332 2357888899999999999999998 9999999999999999999999999998754322211
Q ss_pred ccccccCCccccccccccc-------CCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccc
Q 006168 478 LSTKFAGTLGYTAPEYAIH-------GQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~-------~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
......++..|+|||++.. ..++.++||||||+++|||++ |..|+...... .... ...... .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~---~~~~~~-~~~~~ 231 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QVLK---QVVREQ-DIKLP 231 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHH---HHhhcc-CccCC
Confidence 1123445678999998743 356889999999999999999 67777543321 1111 111111 11111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
++ ..+......+.+++..|| .||++|||+++|++.|.
T Consensus 232 ~~-----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KP-----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CC-----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11 122234456778889998 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=320.54 Aligned_cols=266 Identities=24% Similarity=0.408 Sum_probs=201.6
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|...++||+|+||.||+|+.+ +++.||+|++...........+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999976 57889999987544444455778999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++ +|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDD-CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 985 88887743 234589999999999999999999998 999999999999999999999999999976533222
Q ss_pred ccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchh-hHHHH--------HHHHhhcCcccc
Q 006168 478 LSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE-YLLKR--------AWRLYENGTHWE 547 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~-~l~~~--------~~~~~~~~~~~~ 547 (658)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ..... .|..........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1223467899999998865 4688999999999999999999999976543211 11100 011110000000
Q ss_pred cccc-cCCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 548 LMDE-SLDPN---ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 548 ~~d~-~l~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+. ...+. .........+.+++.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000 00000 0011234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=309.09 Aligned_cols=252 Identities=27% Similarity=0.536 Sum_probs=203.6
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
.+|+..+.||+|+||.||++.+.++..+|+|.+... ......+.+|++++++++|||++++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG--AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC--CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 367778999999999999999887889999998642 233567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++++|.+++.. ....++++.++.++.+++.+|.|||+. +++|+||||+||+++.++.+||+|||++..........
T Consensus 82 ~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 82 EHGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999999853 234689999999999999999999998 99999999999999999999999999998654332221
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
.....++.+|+|||.+.++.++.++||||||+++|||++ |+.|+...... .+... ...+ ..... +
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~----~~~~--~~~~~----~-- 223 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVET----INAG--FRLYK----P-- 223 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHH----HhCC--CCCCC----C--
Confidence 222345678999999998899999999999999999998 88888643321 11111 1111 01111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
...+..+.+|+.+||+.+|++|||+.+|++.|.
T Consensus 224 --~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 --RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 112356999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=302.92 Aligned_cols=265 Identities=28% Similarity=0.407 Sum_probs=206.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccc-cHHHHHHHHHHHhccCCCc-cceeeeEeecCC------
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRR-TLSDFENEVRLISNVHHRN-LIRLLGCCSQGP------ 389 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 389 (658)
..|...++||+|.||+||+|+.+ +|+.||+|++......+ .-....+|+.++++|+|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45666778999999999999966 68999999998644322 2345689999999999999 999999998776
Q ss_pred eEEEEEeccCCCCHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccC
Q 006168 390 ELILVYEYMANSSLDKFLFGEKR--GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL 467 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGl 467 (658)
.+++|+||++. +|.+++..... ..++...+..++.||+.||.|||++ +|+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 89999999976 99999855443 3577788999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc--Cc
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN--GT 544 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~~ 544 (658)
|+.+.-... ..+..++|..|.|||++.+. .|+...||||+|||+.||++++.-|....+ ...+..+.+.... ++
T Consensus 167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTPNEK 243 (323)
T ss_pred HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCCCcc
Confidence 997653332 24567889999999999887 799999999999999999999888876655 2223333333321 12
Q ss_pred cccccc----ccCC------CCCCCHHH---HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 545 HWELMD----ESLD------PNECTKEA---AEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 545 ~~~~~d----~~l~------~~~~~~~~---~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.|..+. .... +....... .....+++.+|++.+|.+|.|+...+++
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 222111 1100 00111111 1368899999999999999999999876
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.53 Aligned_cols=258 Identities=25% Similarity=0.387 Sum_probs=204.2
Q ss_pred HHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeE
Q 006168 313 DLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 313 ~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 391 (658)
|++.+++++.....||+|+||.||+|++. ++..|++|.+... .....+.+.+|++++++++|+||+++++++..++..
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF 80 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC-CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence 34556778878889999999999999966 5778999988653 334567889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC-CCCeEEeeccCc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSL--NWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD-DLQPKIADFGLA 468 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~-~~~~kl~DfGla 468 (658)
++|+||+++++|.+++... ...+ ++..+..++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSK-WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEEEecCCCCCHHHHHHHh-cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 9999999999999999543 2334 8888999999999999999998 9999999999999976 679999999998
Q ss_pred cccCCCCccccccccCCcccccccccccCC--CCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccc
Q 006168 469 RLLPENQSHLSTKFAGTLGYTAPEYAIHGQ--LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHW 546 (658)
Q Consensus 469 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 546 (658)
........ ......++..|+|||++.+.. ++.++||||||+++|||++|+.|+.......... +.......
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~----~~~~~~~~-- 229 (268)
T cd06624 157 KRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM----FKVGMFKI-- 229 (268)
T ss_pred eecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH----hhhhhhcc--
Confidence 76543222 122346789999999986643 7899999999999999999999986533211111 11000000
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 547 ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 547 ~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....+.....++.+++.+||+.+|.+|||+.++++.
T Consensus 230 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 230 --------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 111223344568999999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.25 Aligned_cols=249 Identities=28% Similarity=0.449 Sum_probs=196.6
Q ss_pred CcccccCceEEEEEEecC-Cc--EEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLKN-GK--IVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
+.||+|+||.||+|++++ +. .+++|.+.........+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999864 43 47889887533445567889999999999 899999999999999999999999999
Q ss_pred CCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeecc
Q 006168 401 SSLDKFLFGEK--------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFG 466 (658)
Q Consensus 401 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG 466 (658)
|+|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999985432 12488999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcc
Q 006168 467 LARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTH 545 (658)
Q Consensus 467 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 545 (658)
++....... .......+..|+|||++....++.++||||||++++||++ |..||...... ... +....+..
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~----~~~~~~~~ 229 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELY----EKLPQGYR 229 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--HHH----HHHhCCCC
Confidence 986322111 1112233567999999988899999999999999999997 99998543221 111 11111110
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 546 WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 546 ~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.+ .+......+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 230 ~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 230 LE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CC----------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00 1112234688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=322.24 Aligned_cols=243 Identities=25% Similarity=0.309 Sum_probs=192.2
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHH-HHhccCCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVR-LISNVHHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
+.||+|+||.||+++.. +|+.+|+|++.... .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999975 68999999986431 2233345555554 56779999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
|+|..++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (325)
T cd05604 81 GELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTT 154 (325)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcc
Confidence 99998884 445799999999999999999999998 99999999999999999999999999987542221 1233
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCH
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTK 560 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 560 (658)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. . ...... .+ ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~---~-~~~~~~------~~-----~~ 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--EMYD---N-ILHKPL------VL-----RP 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--HHHH---H-HHcCCc------cC-----CC
Confidence 567999999999999999999999999999999999999999754321 1111 1 111110 01 11
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 561 EAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 561 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.....+.+++..|++.+|.+||++.+.++.
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 223468899999999999999998644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.63 Aligned_cols=257 Identities=24% Similarity=0.381 Sum_probs=206.7
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|++.+.||+|+||+||++... +++.||+|++.........+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56778899999999999999975 58899999887544445567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++. ..+.+++..+..++.+++.+|.|||+. .+++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 85 MDCGSLDRIYK--KGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred CCCCCHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999999884 345699999999999999999999973 279999999999999999999999999987542221
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcch------hhHHHHHHHHhhcCcccccccc
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEG------EYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~------~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
.....|+..|+|||++.++.++.++|||||||++|||++|+.||....... ..+........... .+
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 231 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PP 231 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CC
Confidence 224578999999999988899999999999999999999999997544311 11111111111100 01
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
.+ .....+..+.+++.+||+.||++|||+.||+++..
T Consensus 232 ~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 232 RL----PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CC----CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 11 11123456899999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.68 Aligned_cols=250 Identities=27% Similarity=0.414 Sum_probs=194.4
Q ss_pred CcccccCceEEEEEEecC----CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEee-cCCeEEEEEeccC
Q 006168 325 NKLGEGGFGDIYKGTLKN----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCS-QGPELILVYEYMA 399 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~~~ 399 (658)
+.||+|+||.||+|.+.+ +..+|+|++.........+.+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 45799999864333445678889999999999999999999875 4556899999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc--
Q 006168 400 NSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH-- 477 (658)
Q Consensus 400 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~-- 477 (658)
+|+|.+++... ...+++..+..++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 99999998532 34578888899999999999999998 9999999999999999999999999999765332111
Q ss_pred -ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCC-CCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 478 -LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTK-SSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 478 -~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~-p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
......++..|+|||++.+..++.++||||||+++|||++|+. |+.... ...+... ...+...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~----~~~~~~~--------- 221 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVY----LLQGRRL--------- 221 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH----HhcCCCC---------
Confidence 1123455778999999998999999999999999999999654 443321 1112111 1111100
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+...+..+.+++..||+.+|++||++.+|++.|+++
T Consensus 222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 01112235689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=316.53 Aligned_cols=262 Identities=27% Similarity=0.498 Sum_probs=205.7
Q ss_pred cCCCccCcccccCceEEEEEEec-----CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeec--CCeE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-----NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ--GPEL 391 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 391 (658)
+.|...+.||+|+||.||++++. +++.+|+|.+...........|.+|+++++.++||||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999864 3678999998753332346789999999999999999999999877 5679
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 9999999999999999532 23599999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCccc--cccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchh---------hHHHHHHHHh
Q 006168 472 PENQSHL--STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE---------YLLKRAWRLY 540 (658)
Q Consensus 472 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~---------~l~~~~~~~~ 540 (658)
....... .....++..|++||.+.+..++.++||||||++++||++|+.|+........ ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 5332211 1123455679999999988999999999999999999999988754322110 0011111111
Q ss_pred hcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 541 ENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 541 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+.. ...+...+.++.+++.+||+.+|.+|||+.||+++|+.+
T Consensus 240 ~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGER----------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCCc----------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11110 011122345799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=318.33 Aligned_cols=256 Identities=21% Similarity=0.299 Sum_probs=198.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+.++||+|+||.||+++++ +++.+|+|.+... ........+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47888999999999999999977 4778999998642 12233455888999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ey~~~g~L~~~l~~-~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99999999999953 234689999999999999999999998 99999999999999999999999999997654433
Q ss_pred ccccccccCCcccccccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 476 SHLSTKFAGTLGYTAPEYAI-----HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
........||+.|+|||++. ...++.++|||||||++|||++|+.||...... +.............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-----~~~~~i~~~~~~~~--- 228 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHKERFQ--- 228 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-----HHHHHHhCCCcccc---
Confidence 33333467999999999986 356889999999999999999999999754321 11111111111000
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAAN--SRPTMSEVVAL 590 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~--~RPt~~evl~~ 590 (658)
. + ......+..+.+++.+|+..++. .||++.|+++.
T Consensus 229 --~-p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 --F-P-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --C-C-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0 11112345678888887755444 47899988865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=320.36 Aligned_cols=242 Identities=25% Similarity=0.347 Sum_probs=195.3
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccC-CCccceeeeEeecCCeEEEEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 395 (658)
+|+..+.||+|+||.||++..+ +++.||+|++.... .....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999976 68899999987532 2334566788999998885 577888999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++. ....+++.++..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQ--QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999984 345699999999999999999999998 99999999999999999999999999987543222
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+..... ...
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--~~~~~~i~----~~~----------- 217 (323)
T cd05615 156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--DELFQSIM----EHN----------- 217 (323)
T ss_pred c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHH----hCC-----------
Confidence 1 22345689999999999999999999999999999999999999975432 11221111 110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTM 584 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 584 (658)
...+...+..+.+++.+||+.+|.+|++.
T Consensus 218 ~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01122234568899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=345.72 Aligned_cols=259 Identities=21% Similarity=0.329 Sum_probs=204.2
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc--cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS--RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+.++||+|+||.||+|+.. +++.||+|++..... ....+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999976 589999999875322 223467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeecc
Q 006168 396 EYMANSSLDKFLFGEK---------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFG 466 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG 466 (658)
||+++|+|.+++.... ...+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 12367788899999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCc-----------------cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcch
Q 006168 467 LARLLPENQS-----------------HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEG 529 (658)
Q Consensus 467 la~~~~~~~~-----------------~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~ 529 (658)
+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 01123579999999999999999999999999999999999999986532211
Q ss_pred hhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcC
Q 006168 530 EYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRP-TMSEVVALLKST 594 (658)
Q Consensus 530 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~~ 594 (658)
.... ... .++.- . ......+..+.+++.+|++.||++|| +++++++.|+..
T Consensus 239 --i~~~--~~i--------~~P~~-~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 --ISYR--DVI--------LSPIE-V-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred --hhhh--hhc--------cChhh-c-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1000 000 00000 0 00112345688999999999999995 677788877765
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.57 Aligned_cols=248 Identities=29% Similarity=0.473 Sum_probs=200.7
Q ss_pred CcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCCHH
Q 006168 325 NKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLD 404 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 404 (658)
++||+|+||.||++.+++++.|++|.+...........+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987799999999876433345678999999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccc-cccc
Q 006168 405 KFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS-TKFA 483 (658)
Q Consensus 405 ~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~~~ 483 (658)
+++... ...+++..++.++.+++.+|.|||++ +++||||||+|||++.++.+||+|||++........... ....
T Consensus 81 ~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 998532 34689999999999999999999998 999999999999999999999999999986542221111 1223
Q ss_pred CCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHH
Q 006168 484 GTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEA 562 (658)
Q Consensus 484 gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 562 (658)
++..|+|||.+.++.++.++||||||++++||++ |..|+....... ... ...... ....+...
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~----~~~~~~----------~~~~~~~~ 220 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRE----RIESGY----------RMPAPQLC 220 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHH----HHhcCC----------CCCCCccC
Confidence 4567999999998899999999999999999999 777775443211 111 111100 00112233
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 563 AEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 563 ~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
+..+.+++.+||+.+|.+|||+.||++.|+
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 457999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=311.59 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=204.6
Q ss_pred cCCCccCcccccCceEEEEEEecC----CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
++|...+.||+|+||.||+|.+.+ ...|++|...........+.+.+|+.++++++||||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999998653 246899988764444556789999999999999999999999875 457899
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 9999999999999532 34589999999999999999999998 9999999999999999999999999999876544
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
.....+...++..|+|||.+....++.++||||||++++|+++ |+.||....... .... ...+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~----~~~~~~~------- 227 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGR----IENGERL------- 227 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH----HHcCCcC-------
Confidence 3222223345568999999988889999999999999999986 999986543321 1111 1111111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+...+..+.+++.+|+..+|.+|||+.++++.|+.+
T Consensus 228 ---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 228 ---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01122345699999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=310.68 Aligned_cols=250 Identities=26% Similarity=0.448 Sum_probs=206.0
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|+..+.||.|++|.||+|+.. +++.||+|.+...........+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46788899999999999999976 58899999987644455567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++...... .
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 153 (274)
T cd06609 81 CGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-S 153 (274)
T ss_pred eCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc-c
Confidence 999999999843 3799999999999999999999998 99999999999999999999999999998775432 1
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
......++..|+|||++.+..++.++||||||+++|||++|+.|+....... .. .. ...... +.+. .
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~---~~-~~~~~~-----~~~~-~- 220 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VL---FL-IPKNNP-----PSLE-G- 220 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HH---HH-hhhcCC-----CCCc-c-
Confidence 2234568889999999999899999999999999999999999986543211 11 11 111111 1110 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+..+.+++.+||..+|++|||++++++.
T Consensus 221 --~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 --NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred --cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0134568999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=308.63 Aligned_cols=249 Identities=24% Similarity=0.426 Sum_probs=205.2
Q ss_pred cCCCccCcccccCceEEEEEEecC-CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|+..+.||+|+||.||++.+.+ ++.+++|.+.... ..+++.+|++++++++||||+++++++......++++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 678889999999999999999875 7899999986532 267899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 80 CGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999999843 345699999999999999999999998 999999999999999999999999999987644321
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
......++..|+|||++.+..++.++||||||+++|||++|+.|+.......... ...... .. ...
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~------~~~~~~-----~~---~~~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF------MIPNKP-----PP---TLS 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh------hhccCC-----CC---CCC
Confidence 2234557889999999998899999999999999999999999987543321110 000000 00 011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.+......+.+++.+||+.+|++|||+.||++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 12234457899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=306.35 Aligned_cols=246 Identities=24% Similarity=0.407 Sum_probs=209.9
Q ss_pred CCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccC
Q 006168 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMA 399 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 399 (658)
|.+..+||+|+||.||++.++ .|+.+|||.+.. ...++++.+|+.++++.+.|++|+++|.+.....+++|||||.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 446789999999999999987 599999999975 3567899999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccc
Q 006168 400 NSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS 479 (658)
Q Consensus 400 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 479 (658)
-|++.+++. .++.+|++.++..+++..+.||+|||.. .-+|||||+.||||+.+|.+||+|||.+..+.+... ..
T Consensus 112 AGSiSDI~R-~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KR 186 (502)
T KOG0574|consen 112 AGSISDIMR-ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KR 186 (502)
T ss_pred CCcHHHHHH-HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hh
Confidence 999999984 5667899999999999999999999998 899999999999999999999999999987644322 23
Q ss_pred ccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC-CCCC
Q 006168 480 TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD-PNEC 558 (658)
Q Consensus 480 ~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~ 558 (658)
..+.||+-|||||++..-.|..++||||||+...||..|++|+....+.... -++....+ .-..
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---------------FMIPT~PPPTF~K 251 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---------------FMIPTKPPPTFKK 251 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---------------EeccCCCCCCCCC
Confidence 4678999999999999999999999999999999999999998654331100 01111111 1123
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 559 TKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 559 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
+.+.+.++.++++.||-++|++|-|+.++++
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 5667888999999999999999999999885
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=310.47 Aligned_cols=251 Identities=24% Similarity=0.428 Sum_probs=202.3
Q ss_pred CCCccCcccccCceEEEEEEecCCcEEEEEEccccc-----ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGI-----SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
+|...+.||+|+||.||+|...+++.+|+|.+.... .......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467889999999999999998889999999886432 122345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
+||+++++|.+++. +...+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILN--RFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999994 335689999999999999999999998 9999999999999999999999999998765321
Q ss_pred C-----ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccc
Q 006168 475 Q-----SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 475 ~-----~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
. ........|+..|+|||++.+..++.++||||||++++||++|+.||.......... ....... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-----~~~~~~~----~ 226 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-----YIGAHRG----L 226 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH-----HhhhccC----C
Confidence 1 111224568899999999998899999999999999999999999996543211110 0000000 0
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.+ ..+......+.+++.+||+.+|.+||++.++++
T Consensus 227 ~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 MP-----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CC-----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01 112233456899999999999999999999885
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.10 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=204.3
Q ss_pred cCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
++|...+.||+|+||.||+++.+ +.+.|++|.+..........++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999965 246799998865332224578999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCC-------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeec
Q 006168 393 LVYEYMANSSLDKFLFGEKR-------GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADF 465 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~Df 465 (658)
+||||+++|+|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999964431 2589999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCc
Q 006168 466 GLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGT 544 (658)
Q Consensus 466 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~ 544 (658)
|++...............++..|+|||.+.+..++.++||||||++++||++ |..||...... .+.. ....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~----~~~~~~ 235 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLN----RLQAGK 235 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHH----HHHcCC
Confidence 9987543332222233456778999999988889999999999999999999 67777533221 1111 111111
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 545 HWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 545 ~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
.... .+...+..+.+++.+||+.+|.+|||+.+++.+|+
T Consensus 236 ~~~~---------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 LELP---------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1110 11123356999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=307.77 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=196.2
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCC-----eEEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP-----ELIL 393 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 393 (658)
.|...+.+|.|.||.||+|.+. +++.||||+...+.. .-.+|+++|+.++|||||+|+-+|.... ...|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 4566789999999999999976 478999999865321 2257999999999999999999885432 3568
Q ss_pred EEeccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC-CCeEEeeccCccc
Q 006168 394 VYEYMANSSLDKFLFGE--KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD-LQPKIADFGLARL 470 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~-~~~kl~DfGla~~ 470 (658)
|||||+. +|.+.+... .+..++...+.-++.||.+||.|||+. +|+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999987 999888542 245688888889999999999999998 99999999999999987 8999999999998
Q ss_pred cCCCCccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh---c----
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYE---N---- 542 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~---~---- 542 (658)
+..+... .....|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+... ..++. .+.+.+. .
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~-eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLV-EIIKVLGTPTREDIK 251 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHH-HHHHHhCCCCHHHHh
Confidence 8655433 234567889999999875 799999999999999999999998877443 12222 2222211 0
Q ss_pred ---CcccccccccCCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 543 ---GTHWELMDESLDPN----ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 543 ---~~~~~~~d~~l~~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
....+.-.+.+... ........+..+++.++++.+|.+|.++.|++.
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 01011111111111 123344567999999999999999999999885
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=321.58 Aligned_cols=255 Identities=27% Similarity=0.455 Sum_probs=214.5
Q ss_pred cCCCccCcccccCceEEEEEEecC---Cc--EEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN---GK--IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
+.....+.||.|-||.||+|++.+ |+ .||||.-+.+......+.|..|..+|++++|||||+|+|+|.+. ..++
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 344556789999999999999653 32 48999988776777789999999999999999999999999764 6899
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
|||.++-|-|..+|.. ++..|+......++.||+.+|+|||+. ++|||||..+|||+...--+||+|||+++.+.+
T Consensus 468 vmEL~~~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEecccchhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 9999999999999953 445699999999999999999999999 999999999999999999999999999999988
Q ss_pred CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
......+...-+..|||||-+.-.+++.+||||-|||.+||++. |.+||....+.... ...++|+
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI------~~iEnGe-------- 609 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI------GHIENGE-------- 609 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE------EEecCCC--------
Confidence 87776666666789999999999999999999999999999987 89999765442110 0111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.-.+++..+..|..|+.+||..+|.+||++.++...|..+
T Consensus 610 --RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 610 --RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred --CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 1234445566799999999999999999999999877654
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=311.30 Aligned_cols=250 Identities=30% Similarity=0.507 Sum_probs=199.8
Q ss_pred CcccccCceEEEEEEecC-------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 325 NKLGEGGFGDIYKGTLKN-------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+.||+|+||.||+|+..+ ++.+++|.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998753 2579999886544445567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC-----CeEEeeccC
Q 006168 398 MANSSLDKFLFGEK-----RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL-----QPKIADFGL 467 (658)
Q Consensus 398 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~-----~~kl~DfGl 467 (658)
+++++|.+++.... ...+++.+++.++.|++.||.|||+. +++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996432 23488999999999999999999998 999999999999999877 899999999
Q ss_pred ccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcc
Q 006168 468 ARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTH 545 (658)
Q Consensus 468 a~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 545 (658)
+......... ......++..|+|||++.++.++.++||||||+++|||++ |+.|+...... ..... ...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~----~~~~~~ 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQH----VTAGGR 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHH----HhcCCc
Confidence 9765332211 1223345678999999999999999999999999999998 99888643321 11111 111110
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 546 WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 546 ~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
...+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 232 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 232 ----------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ----------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 01122345678999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=306.16 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=204.2
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeec-CCeEEEEEe
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ-GPELILVYE 396 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E 396 (658)
+|++.+.||+|++|.||++..+ +++.+|+|++.... .....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999976 57889999986532 23445678999999999999999999998764 446899999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++++|.+++.......+++.++..++.+++.||.+||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 99999999999765556699999999999999999999998 99999999999999999999999999998764322
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
.......+++.|+|||++.+..++.++||||||++++||++|+.|+....... . ..... .+.. .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~---~~~~~-~~~~----------~ 220 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS--L---VYRII-EGKL----------P 220 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH--H---HHHHH-hcCC----------C
Confidence 22334568899999999999999999999999999999999999986433211 1 11111 1111 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+......+.+++.+|++.+|++|||+.++++.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1223344679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=333.77 Aligned_cols=253 Identities=29% Similarity=0.444 Sum_probs=211.9
Q ss_pred CccCcccccCceEEEEEEec-CC----cEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 322 SEENKLGEGGFGDIYKGTLK-NG----KIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 322 ~~~~~lg~G~~g~Vy~~~~~-~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
...++||+|+||+||+|.|- .| -+||+|++......+...++.+|+-+|.+|+|||+++|+|+|.... +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34678999999999999863 33 4699999987777777899999999999999999999999998766 899999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
||+.|+|.++++. .+..+-.+..+.|..|||+||.|||++ ++|||||..+||||.+-..+||.|||+++.+..+..
T Consensus 778 ~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred hcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999964 556799999999999999999999998 999999999999999999999999999999876655
Q ss_pred cccc-cccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 477 HLST-KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 477 ~~~~-~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
.... ...-.+.|||-|.+....|+.++|||||||.+|||+| |..|.+....+ .+-++++.++-
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~------eI~dlle~geR--------- 918 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE------EIPDLLEKGER--------- 918 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH------HhhHHHhcccc---------
Confidence 5443 3334568999999999999999999999999999999 88887654432 12222322221
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
-..++....++..++.+||..|+..||+++++...+.+..
T Consensus 919 -LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 919 -LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred -CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 1233445567999999999999999999999998887653
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.80 Aligned_cols=252 Identities=33% Similarity=0.567 Sum_probs=204.1
Q ss_pred CCccCcccccCceEEEEEEecC-----CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 321 FSEENKLGEGGFGDIYKGTLKN-----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
|++.+.||.|+||.||++.+.+ +..||+|.+.........+.+..|++.+++++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999764 37899999976444336778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999654433399999999999999999999998 99999999999999999999999999998765443
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
........+++.|+|||.+....++.++||||||++++||++ |+.|+..... ..+... ...+...
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~----~~~~~~~-------- 223 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEY----LKKGYRL-------- 223 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HhcCCCC--------
Confidence 222222347789999999988889999999999999999998 7777654222 111111 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 591 (658)
..+...+..+.+++.+|+..+|++|||+.++++.|
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 --PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11112345699999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=303.42 Aligned_cols=269 Identities=25% Similarity=0.375 Sum_probs=205.9
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeec-----C
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ-----G 388 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 388 (658)
.....|...+.||+|.||.|+++..+ +|+.||||++... ......++-.+|+++|+.++|+||+.+++.+.- -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34456666789999999999999976 6899999999732 344456778999999999999999999999854 4
Q ss_pred CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCc
Q 006168 389 PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLA 468 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla 468 (658)
+.+|+|+|+|+ .+|.+.| +.++.|+.....-++.||++||+|+|+. +|+||||||+|+|++.+..+||+|||+|
T Consensus 99 ~DvYiV~elMe-tDL~~ii--k~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQII--KSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred ceeEEehhHHh-hHHHHHH--HcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 67899999995 4999999 3444599999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCC-CccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCc-chhhHHHH--------HH
Q 006168 469 RLLPEN-QSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGE-EGEYLLKR--------AW 537 (658)
Q Consensus 469 ~~~~~~-~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~-~~~~l~~~--------~~ 537 (658)
+..... .....|..+.|..|.|||.+.. ..|+.+.||||.|||+.||++|++-|.+... ....++.. ..
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 987543 1223467788999999999865 5899999999999999999999998876653 11111111 11
Q ss_pred HHhhcCcccccccccCC--CCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 538 RLYENGTHWELMDESLD--PNEC---TKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 538 ~~~~~~~~~~~~d~~l~--~~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...........+..... +..+ -.......++|+.+||..||.+|+|++|.++.
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111111111111000 0000 01233468899999999999999999999864
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.43 Aligned_cols=261 Identities=22% Similarity=0.239 Sum_probs=197.5
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
..+|.+.+.||+|+||.||++.+. .++.||||.... ..+.+|++++++++|+|||++++++..++..++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 457889999999999999999987 478899996432 245789999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
++. ++|.+++.. ....++|..++.|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 241 ~~~-~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 241 KYR-SDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred ccC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 995 688888743 234699999999999999999999998 999999999999999999999999999987643322
Q ss_pred c-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcc------hhhHHHHHHHHhh-cCccccc
Q 006168 477 H-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE------GEYLLKRAWRLYE-NGTHWEL 548 (658)
Q Consensus 477 ~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~------~~~l~~~~~~~~~-~~~~~~~ 548 (658)
. ......||..|+|||++.+..++.++|||||||++|||++|..++...... ...+...+..... .......
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1 223467999999999999999999999999999999999988765432211 1111111111000 0000000
Q ss_pred c----------------cccCCCCCCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 549 M----------------DESLDPNECT--KEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 549 ~----------------d~~l~~~~~~--~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
. .......... ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0000000000 0122368899999999999999999999975
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=318.24 Aligned_cols=256 Identities=21% Similarity=0.288 Sum_probs=199.5
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+.+.||+|+||.||+++.+ +++.||+|.+... ........+.+|..++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999976 5788999998642 12233455788999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999532 35689999999999999999999998 99999999999999999999999999998765443
Q ss_pred ccccccccCCccccccccccc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 476 SHLSTKFAGTLGYTAPEYAIH-----GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
........||+.|+|||++.+ +.++.++||||||+++|||++|+.||...... +.............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~i~~~~~~~~--- 228 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNHEERFQ--- 228 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-----HHHHHHHcCCCccc---
Confidence 333334679999999999875 56889999999999999999999999654321 11111111111000
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANS--RPTMSEVVAL 590 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 590 (658)
+ + ......+..+.+++.+|+..++.+ |++++++++.
T Consensus 229 --~-p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 --F-P-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred --C-C-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 0 111123456888999988865544 4678888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=308.64 Aligned_cols=254 Identities=25% Similarity=0.417 Sum_probs=207.4
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|+..+.||+|++|.||++.++ +++.+++|++..........++.+|++++++++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36777889999999999999987 68899999987654445567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE-DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
+++++|.+++.... ..+++..+..++.|++++|.|||+ . +++|+||||+||++++++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999985432 678999999999999999999999 7 999999999999999999999999999876532211
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
....++..|+|||++.+..++.++||||||+++++|++|+.|+................... ... .
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~----------~ 222 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-EPP----------P 222 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-CCC----------C
Confidence 12678889999999999999999999999999999999999987654322222222211111 110 1
Q ss_pred CCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 557 ECTKE-AAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 557 ~~~~~-~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+.. ....+.+++..||..+|++|||+.+++..
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11111 45568999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=308.08 Aligned_cols=240 Identities=25% Similarity=0.399 Sum_probs=188.3
Q ss_pred CcccccCceEEEEEEecC-------------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeE
Q 006168 325 NKLGEGGFGDIYKGTLKN-------------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 391 (658)
+.||+|+||.||+|++.+ ...|++|.+... .......+.+|+.+++.++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 368999999999998642 235899987642 334456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC-------eEEee
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ-------PKIAD 464 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~-------~kl~D 464 (658)
++||||+++++|+.++.. ....+++..++.++.||++||.|||+. +|+||||||+|||++.++. +|++|
T Consensus 80 ~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999988843 335699999999999999999999998 9999999999999987654 89999
Q ss_pred ccCccccCCCCccccccccCCcccccccccc-cCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhc
Q 006168 465 FGLARLLPENQSHLSTKFAGTLGYTAPEYAI-HGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYEN 542 (658)
Q Consensus 465 fGla~~~~~~~~~~~~~~~gt~~y~APE~~~-~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 542 (658)
||++...... ....++..|+|||.+. ...++.++||||||+++|||++ |+.|+....... ..+...
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~- 223 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE------KERFYE- 223 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH------HHHHHh-
Confidence 9998755322 1245788999999886 4678999999999999999984 777765432111 011111
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 543 GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 543 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
+.. . . .. .....+.+|+.+||+.||.+||++.+|++.|+
T Consensus 224 ~~~-~-----~-~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 GQC-M-----L-VT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCc-c-----C-CC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 100 0 0 01 11346889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=313.19 Aligned_cols=248 Identities=28% Similarity=0.465 Sum_probs=202.9
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
.|+..+.||+|+||.||+|.+. +++.||+|.+.........+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4556788999999999999875 578899999875444455678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++++|.+++. ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++..+..... .
T Consensus 85 ~~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 85 GGGSALDLLK---PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 9999999883 35689999999999999999999998 999999999999999999999999999986643321 1
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 558 (658)
.....++..|+|||++.+..++.++||||||++++||++|+.|+....... ... . ...+. ....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~---~-~~~~~----------~~~~ 221 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLF---L-IPKNS----------PPTL 221 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHh---h-hhcCC----------CCCC
Confidence 223567889999999998899999999999999999999999986432211 000 0 11110 1111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 559 TKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 559 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....+..+.+++.+||+.+|++||++.+|++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 22345568999999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=309.53 Aligned_cols=249 Identities=27% Similarity=0.466 Sum_probs=206.4
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
..|+..+.||+|+||.||+|.+. +++.||+|.+...........+.+|+.++++++||||+++++++..+...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35667789999999999999976 58899999987544445567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 84 LGGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 99999999983 35689999999999999999999998 999999999999999999999999999976643321
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
......++..|+|||++.+..++.++||||||+++|||++|+.|+....... ... ..... . ...
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~----~~~~~---------~-~~~ 220 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--VLF----LIPKN---------N-PPT 220 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--Hhh----hhhcC---------C-CCC
Confidence 2234567889999999998889999999999999999999999986543211 000 00000 0 122
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.....+..+.+++..||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 344566779999999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.75 Aligned_cols=262 Identities=25% Similarity=0.370 Sum_probs=196.8
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccccc-ccHHHHHHHHHHHhcc---CCCccceeeeEeec-----CC
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR-RTLSDFENEVRLISNV---HHRNLIRLLGCCSQ-----GP 389 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 389 (658)
+|++.+.||+|+||.||+++.+ +++.||+|.+...... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999976 5889999998653222 2234556677777665 79999999998854 34
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
..++||||+++ +|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 58999999985 898888655555699999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc---Cccc
Q 006168 470 LLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN---GTHW 546 (658)
Q Consensus 470 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~---~~~~ 546 (658)
...... ......|+..|+|||++.+..++.++|||||||++|||++|++||....... ........... ....
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHHHhCCCChhhCc
Confidence 664322 2234568899999999999999999999999999999999999986543321 11111111100 0000
Q ss_pred c-------cccccCC--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 547 E-------LMDESLD--PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 547 ~-------~~d~~l~--~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
. .+.+... .........+.+.+++.+||+.||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0000000 00111223456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=305.53 Aligned_cols=252 Identities=21% Similarity=0.338 Sum_probs=207.7
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+|+..+.||+|+||.||.++.. +++.+++|.+... .......++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5788899999999999999865 5889999988643 2345567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.......+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999655456799999999999999999999998 999999999999999999999999999987644332
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
......+++.|+|||.+.+..++.++||||||++++||++|+.|+...... +...... .+... .
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~-~~~~~----------~ 220 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKIV-QGNYT----------P 220 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHH-cCCCC----------C
Confidence 233456899999999998888999999999999999999999998653321 1111111 11111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 591 (658)
.+...+..+.+++.+||+.+|.+||++.++++.+
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1123345689999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=323.15 Aligned_cols=245 Identities=31% Similarity=0.475 Sum_probs=204.7
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.|...+.||.|+||.||-++.. +.+.||||++... .+.+.+.++.+|+..|++++|||++.+-|||......+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4667788999999999999954 7889999999753 344557889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
||-| |-.+++. -.+.+|.+.++..|..+.++||+|||+. +.||||||+.||||.+.|.+||+|||.+......
T Consensus 107 YClG-SAsDlle-VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-- 179 (948)
T KOG0577|consen 107 YCLG-SASDLLE-VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-- 179 (948)
T ss_pred HHhc-cHHHHHH-HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence 9965 7777773 3456799999999999999999999999 9999999999999999999999999999765433
Q ss_pred cccccccCCcccccccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 477 HLSTKFAGTLGYTAPEYAI---HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~---~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
..++|||.|||||++. .|.|+-|+||||||++..||...++|....+...- .+-+..+ +.
T Consensus 180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-----LYHIAQN-es-------- 242 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQN-ES-------- 242 (948)
T ss_pred ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-----HHHHHhc-CC--------
Confidence 3579999999999985 58999999999999999999999999876544211 1111111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
+.-...+.+..+.+++..||++-|.+|||..++++
T Consensus 243 -PtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 -PTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -CCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 12224567788999999999999999999999884
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.27 Aligned_cols=239 Identities=25% Similarity=0.399 Sum_probs=187.4
Q ss_pred cccccCceEEEEEEecC-------------------------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccce
Q 006168 326 KLGEGGFGDIYKGTLKN-------------------------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIR 380 (658)
Q Consensus 326 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 380 (658)
.||+|+||.||+|.+.. ...|++|.+... .......+.+|+.++++++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-HRDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-HHHHHHHHHHHHHHHhcCCCCCeee
Confidence 69999999999998531 135899988642 2333467888999999999999999
Q ss_pred eeeEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC--
Q 006168 381 LLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL-- 458 (658)
Q Consensus 381 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~-- 458 (658)
+++++......++||||+++|+|..++.. ..+.+++..+..++.||++||+|||+. +|+||||||+|||++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999999843 345689999999999999999999998 999999999999997643
Q ss_pred -----CeEEeeccCccccCCCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHH-hCCCCCCCCCcchhh
Q 006168 459 -----QPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEII-SGTKSSETKGEEGEY 531 (658)
Q Consensus 459 -----~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~ell-tG~~p~~~~~~~~~~ 531 (658)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+.......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-- 229 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence 3799999988643221 12356788999998876 56899999999999999995 6888886543211
Q ss_pred HHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 532 LLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 532 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
... ..... ..+ +.. ....+.+++..||+.+|++|||+.+|++.|+
T Consensus 230 ~~~----~~~~~-------~~~-~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KER----FYEKK-------HRL-PEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHH----HHHhc-------cCC-CCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111 11100 001 111 1235899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=306.12 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=208.1
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|++.+.||.|+||.||+|... ++..+++|++...........+.+|++.++.++|+||+++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999965 67899999987544444678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 398 MANSSLDKFLFGEKR-GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999965433 5699999999999999999999998 999999999999999999999999999987654332
Q ss_pred c---ccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 477 H---LSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 477 ~---~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
. ......|+..|+|||++... .++.++||||||++++||++|+.|+....... .+ .+..... ...
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~----~~~~~~~------~~~ 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VL----MLTLQND------PPS 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hH----HHHhcCC------CCC
Confidence 2 22345688999999999877 78999999999999999999999986543321 11 1111110 011
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
+.........+..+.+++..||+.||++||++.+|++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1011111234567899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.38 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=204.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|+..+.||.|++|.||+|... +++.|++|.+... .....+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc-cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 46888999999999999999864 6899999998653 334467789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++. ...+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 98 LAGGSLTDVVT---ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred cCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999999884 34589999999999999999999998 999999999999999999999999999886543322
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||.......... ..... .... ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~-----~~~~~-~~~~--------~~ 236 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATN-GTPE--------LQ 236 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhc-CCcc--------cC
Confidence 1234568889999999998899999999999999999999999986654321111 01110 0000 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+...+..+.+++.+||..||.+|||+.+|++.
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 122234568899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=318.47 Aligned_cols=258 Identities=19% Similarity=0.287 Sum_probs=196.5
Q ss_pred ccCccccc--CceEEEEEEec-CCcEEEEEEcccccc-cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 323 EENKLGEG--GFGDIYKGTLK-NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 323 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
..++||+| +|++||++..+ +|+.||+|++..... ......+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 78999999875 689999999875432 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc-
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH- 477 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~- 477 (658)
++|+|.+++.......+++..++.++.|++.||.|||+. +|+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999654455699999999999999999999998 9999999999999999999999999865443211110
Q ss_pred -----ccccccCCccccccccccc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 478 -----LSTKFAGTLGYTAPEYAIH--GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 478 -----~~~~~~gt~~y~APE~~~~--~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..... .+.....++
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~-----~~~~~~~~~ 232 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKL-----NGTVPCLLD 232 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHHh-----cCCcccccc
Confidence 1112356778999999876 4689999999999999999999999965332111 10000 000000000
Q ss_pred -------------------ccC----------------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 551 -------------------ESL----------------DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 551 -------------------~~l----------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
... ............+.+++.+||+.||++|||+.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 000122234557899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=309.64 Aligned_cols=252 Identities=28% Similarity=0.480 Sum_probs=200.9
Q ss_pred CCccCcccccCceEEEEEEecC-CcEEEEEEccccccccc-HHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 321 FSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRT-LSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
|+..+.||+|+||+||+++... ++.+|+|++........ .....+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999999874 67899999976432222 223456999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++++|.+++. ....+++..++.++.|+++||.+||+. +|+|+||||+||++++++.++|+|||.+..... ....
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNEN 154 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSE
T ss_pred cccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cccc
Confidence 9999999995 456789999999999999999999998 999999999999999999999999999976422 2223
Q ss_pred cccccCCcccccccccc-cCCCCCcccchhhhHHHHHHHhCCCCCCCCCc-chhhHHHHHHH-HhhcCcccccccccCCC
Q 006168 479 STKFAGTLGYTAPEYAI-HGQLSEKVDAYSFGVLVLEIISGTKSSETKGE-EGEYLLKRAWR-LYENGTHWELMDESLDP 555 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~-~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~-~~~~l~~~~~~-~~~~~~~~~~~d~~l~~ 555 (658)
.....++..|+|||++. +..++.++||||+|+++++|++|+.|+..... +.......... ... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~-- 223 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP---------SSS-- 223 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH---------HHT--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc---------ccc--
Confidence 34567899999999998 78899999999999999999999999986622 11111111110 000 000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.........+.+++..||+.||++||++.++++.
T Consensus 224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred -cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000012679999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=326.48 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=197.1
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|+..+.||+|+||.||+++.+ +++.||+|++... ........+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999976 5889999998642 12334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++. +...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999984 345699999999999999999999998 99999999999999999999999999987543211
Q ss_pred c----------------------------------cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCC
Q 006168 476 S----------------------------------HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKS 521 (658)
Q Consensus 476 ~----------------------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p 521 (658)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 001235799999999999999999999999999999999999999
Q ss_pred CCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 006168 522 SETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPT---MSEVVA 589 (658)
Q Consensus 522 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~ 589 (658)
|....... ... .......... + +... ....++.+++.+++ .||.+|++ +.++++
T Consensus 236 f~~~~~~~--~~~---~i~~~~~~~~-----~-p~~~--~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 236 FCSETPQE--TYR---KVMNWKETLV-----F-PPEV--PISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCHHH--HHH---HHHcCCCcee-----c-CCCC--CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 97544321 111 1111000000 0 0110 12345777777766 49999986 555554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=310.74 Aligned_cols=255 Identities=27% Similarity=0.454 Sum_probs=205.2
Q ss_pred cCCCccCcccccCceEEEEEEecC-Cc----EEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN-GK----IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
.+|...+.||+|+||.||+|.+++ |+ .+|+|.+..........++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567788999999999999999753 33 5899988765444556788999999999999999999999987 78999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 99999999999998532 34599999999999999999999998 999999999999999999999999999987653
Q ss_pred CCcccc-ccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 474 NQSHLS-TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 474 ~~~~~~-~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
...... ....++..|+|||.+....++.++||||||+++|||++ |+.|+..... ..+.. ....+...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~----~~~~~~~~----- 230 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPD----LLEKGERL----- 230 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHH----HHhCCCCC-----
Confidence 332211 12233568999999988899999999999999999999 9999865432 11111 11111110
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+......+.+++.+||..+|.+||++.++++.|+..
T Consensus 231 -----~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 231 -----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11111234688999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=305.13 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=205.6
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|+..+.||+|+||.||++... +++.+++|.+... .....+.+.+|++++++++||||+++++++...+..+++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE-PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC-chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 57888999999999999999975 5788999998753 333567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||++..+.....
T Consensus 82 ~~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 82 CGGGSLQDIYQV-TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 999999998843 235699999999999999999999998 999999999999999999999999999986643221
Q ss_pred ccccccCCcccccccccccC---CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHG---QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~---~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+.......... .... ... ...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-----~~~~-~~~----~~~-- 224 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-----LISK-SNF----PPP-- 224 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHh-ccC----CCc--
Confidence 22345688899999999776 88999999999999999999999986544321111 0000 000 000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
........+..+.+++.+||+.+|.+|||+.+|+.
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01122344567999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=310.30 Aligned_cols=250 Identities=25% Similarity=0.387 Sum_probs=199.6
Q ss_pred CCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccC
Q 006168 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMA 399 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 399 (658)
|++.+.||+|+||.||++... ++..+++|.+... .......+.+|+++++.++||||+++++++..++..++||||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 456788999999999999976 4778899988652 34456778999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccc
Q 006168 400 NSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS 479 (658)
Q Consensus 400 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 479 (658)
+++|..++.. ....+++..+..++.|+++||.|||+. +++||||||+|||++.++.+||+|||++....... ...
T Consensus 86 ~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (282)
T cd06643 86 GGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 160 (282)
T ss_pred CCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence 9999988753 345699999999999999999999998 99999999999999999999999999987653322 122
Q ss_pred ccccCCcccccccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 480 TKFAGTLGYTAPEYAI-----HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 480 ~~~~gt~~y~APE~~~-----~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
....++..|+|||++. +..++.++|||||||++|||++|+.|+....... .... ... .....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~----~~~-~~~~~------- 227 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLK----IAK-SEPPT------- 227 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHH----Hhh-cCCCC-------
Confidence 3456889999999984 3457889999999999999999999986543211 1111 110 00000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 228 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 228 -LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122234578999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=324.65 Aligned_cols=261 Identities=22% Similarity=0.304 Sum_probs=200.6
Q ss_pred hcCCCccCcccccCceEEEEEEec---CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK---NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
..+|.+.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 357899999999999999999754 3578999987542 2356899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
||++. ++|.+++ .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 165 ~e~~~-~~l~~~l--~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 165 MPKYK-CDLFTYV--DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred ehhcC-CCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 99996 5888888 3456799999999999999999999998 9999999999999999999999999999866443
Q ss_pred Ccc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcc-hhhHHHHHHHHhhcCccc------
Q 006168 475 QSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE-GEYLLKRAWRLYENGTHW------ 546 (658)
Q Consensus 475 ~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~-~~~l~~~~~~~~~~~~~~------ 546 (658)
... ......||+.|+|||++....++.++|||||||++|||++|+.||...... ....+..+.+........
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 322 223567999999999999999999999999999999999999999764431 111111111111100000
Q ss_pred -------ccccccCCCC-CC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 547 -------ELMDESLDPN-EC-----TKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 547 -------~~~d~~l~~~-~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
........+. .. .......+.+++.+||+.||++|||+.|++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 00 01123467889999999999999999999975
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=309.47 Aligned_cols=254 Identities=23% Similarity=0.419 Sum_probs=203.2
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|+..+.||+|+||.||++..+ +++.||+|.+...........+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36778899999999999999987 68999999886543444457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 398 MANSSLDKFLFGEK-RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 398 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
+++++|..++.... ...+++..+..++.|++.||.|||+. .+|+|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 99999999885432 23699999999999999999999963 289999999999999999999999999997653322
Q ss_pred cccccccCCcccccccccccC------CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 477 HLSTKFAGTLGYTAPEYAIHG------QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~------~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ..... .....+.
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~-~~~~~~~------ 226 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQL-SAIVDGD------ 226 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHH-HHHhhcC------
Confidence 2234678899999998554 35889999999999999999999986533211 11111 1111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....+......+.+++.+||+.+|++||++.++++.
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 ----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 112233356678999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=309.31 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=201.1
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|...+.||+|+||.||+++.. +++.||+|.+... .......+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC-chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 46778889999999999999875 5889999998653 233456688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++. ..+.+++.++..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....... .
T Consensus 88 ~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06645 88 CGGGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-A 161 (267)
T ss_pred cCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-c
Confidence 99999999984 345799999999999999999999998 99999999999999999999999999987654322 1
Q ss_pred ccccccCCcccccccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 478 LSTKFAGTLGYTAPEYAI---HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~---~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
......|+..|+|||++. .+.++.++|||||||++|||++|+.|+........ + ........... ..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~----~~~~~~~~~~~----~~- 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-L----FLMTKSNFQPP----KL- 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-H----HhhhccCCCCC----cc-
Confidence 223457899999999874 45688999999999999999999999865432111 1 11111000000 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.. ....+..+.+++.+||+.+|++||++++|++.
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00 01123468899999999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=314.05 Aligned_cols=264 Identities=24% Similarity=0.387 Sum_probs=201.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|...++||+|+||.||+++.+ +++.||+|.+...........+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999976 57899999987544444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
++ ++|.+++... ...+++..+..++.||++||.|||+. +|+|+||||+|||+++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 97 5898888532 34689999999999999999999998 999999999999999999999999999976533221
Q ss_pred ccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-----------hcCcc
Q 006168 478 LSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLY-----------ENGTH 545 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~-----------~~~~~ 545 (658)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||....... ......... .....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE--QLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCChhhchhhhcccc
Confidence 12234568899999988654 57889999999999999999999987544321 111111111 00000
Q ss_pred ccccc-ccCCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 546 WELMD-ESLDP---NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 546 ~~~~d-~~l~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....+ +.... ..........+.+++.+|++.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 00000 00011234468899999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=304.86 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=205.7
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+|+..+.||+|+||.+|++... +++.||+|++... .......++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5788899999999999999865 6889999998642 2234456889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.......+++..++.++.|++.||.|||+. +++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999998654445689999999999999999999998 999999999999999999999999999986644322
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
......|++.|+|||++.+..++.++||||||+++++|++|+.|+...... .. ...... +.. ..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--~~---~~~~~~-~~~----------~~ 220 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK--NL---VLKIIR-GSY----------PP 220 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH--HH---HHHHhc-CCC----------CC
Confidence 122456888999999999999999999999999999999999998643221 11 111111 111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+......+.+++.+||+.+|.+||++.+|++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 122334569999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=312.04 Aligned_cols=251 Identities=24% Similarity=0.401 Sum_probs=205.1
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC-ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 367889999999999999999964 6899999998753 33345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++++|.+++. ...+++.++..++.|++.||.|||+. +++||||||+|||++.++.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 97 YLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred ccCCCCHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999999983 34589999999999999999999998 999999999999999999999999999876543322
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........... ....+ ....
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~---------~~~~ 235 (297)
T cd06656 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNG---------TPEL 235 (297)
T ss_pred -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCC---------CCCC
Confidence 12345688899999999998999999999999999999999999965433111000 00000 0011
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+......+.+++.+||+.+|++||++.+|++.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223344568899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.75 Aligned_cols=247 Identities=30% Similarity=0.416 Sum_probs=206.4
Q ss_pred ccCcccccCceEEEEEEecC--Cc--EEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 323 EENKLGEGGFGDIYKGTLKN--GK--IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 323 ~~~~lg~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
..++||+|.||.|++|.|+. |+ .||||.+..+.......+|.+|+.+|.+|+|||+++|||+..+ ....+|+|++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 45789999999999999873 44 4899999875555578999999999999999999999999987 7889999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
+.|+|.+.|+...+..|-...+..++.|||.||.||.++ ++|||||..+|+||-..-.+||+||||.+.+..+....
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 999999999876667799999999999999999999999 99999999999999999999999999999886654332
Q ss_pred -cc-cccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 479 -ST-KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 479 -~~-~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.+ ...-...|+|||.+.+++++.+||||+|||++|||+| |..||.+... .++++. +++++ .
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--~qIL~~----iD~~e----------r 333 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--IQILKN----IDAGE----------R 333 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--HHHHHh----ccccc----------c
Confidence 22 3344678999999999999999999999999999999 6678765432 222221 11111 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
-.-++..+++++++++.||..+|.+|||+..|.+
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 1234456778999999999999999999999974
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=309.08 Aligned_cols=265 Identities=25% Similarity=0.381 Sum_probs=199.3
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+|+..+.||+|++|.||+|+.+ +++.||+|++.... .......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999976 68999999986532 223346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 398 MANSSLDKFLFGEKR-GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
++ ++|.+++..... ..+++..+..++.||++||.|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 689888854333 5699999999999999999999998 99999999999999999999999999997654322
Q ss_pred cccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhH--HH-------HHHHHhhcCc-c
Q 006168 477 HLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYL--LK-------RAWRLYENGT-H 545 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l--~~-------~~~~~~~~~~-~ 545 (658)
.......+++.|+|||++.+. .++.++||||||++++||++|+.|+.......... .. ..|....... .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 122334678899999988654 57899999999999999999999987543311100 00 0000000000 0
Q ss_pred cccccccCC--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 546 WELMDESLD--PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 546 ~~~~d~~l~--~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
......... ........+.++.+++.+||+.||.+|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 00001113456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=316.43 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=212.6
Q ss_pred HhcCCCccCcccccCceEEEEEEecC-CcEEEEEEcccccc--cccHHHHHHHHHHHhccC-CCccceeeeEeecCCeEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGIS--RRTLSDFENEVRLISNVH-HRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 392 (658)
..+.|...+.||+|.||.||+++.+. |+.+|+|.+.+... ......+.+|+.+|+++. |||||.+.+.+...+.++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34578888999999999999999875 99999999976432 234578999999999998 999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC----CCeEEeeccCc
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD----LQPKIADFGLA 468 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~----~~~kl~DfGla 468 (658)
+|||++.+|.|.+.|... .+++.....++.||++++.|||+. +|+||||||+|+|+... +.+|++|||++
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999655 399999999999999999999998 99999999999999543 57999999999
Q ss_pred cccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccc
Q 006168 469 RLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWEL 548 (658)
Q Consensus 469 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 548 (658)
..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.......... ....++.
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~~--- 255 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGDF--- 255 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCCC---
Confidence 98766 334567899999999999999999999999999999999999999998776543322 1111111
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 549 MDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 549 ~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.... +.-......+.+++..++..||..|+|+.++++.
T Consensus 256 ---~f~~-~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ---DFTS-EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---CCCC-CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1111 1112345679999999999999999999999984
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.28 Aligned_cols=262 Identities=22% Similarity=0.330 Sum_probs=205.7
Q ss_pred cchHHHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEee
Q 006168 309 YRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCS 386 (658)
Q Consensus 309 ~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 386 (658)
+.++.+..+.++|++.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI--HDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc--cchHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 455677788899999999999999999999875 5789999987532 22345688899999999 6999999999873
Q ss_pred -----cCCeEEEEEeccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC
Q 006168 387 -----QGPELILVYEYMANSSLDKFLFGE--KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ 459 (658)
Q Consensus 387 -----~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~ 459 (658)
.++..++||||+++++|.+++... ....+++..+..++.|+++||.|||+. +|+||||||+||++++++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence 346789999999999999987532 335689999999999999999999998 9999999999999999999
Q ss_pred eEEeeccCccccCCCCccccccccCCccccccccccc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHH
Q 006168 460 PKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH-----GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLK 534 (658)
Q Consensus 460 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~ 534 (658)
+||+|||++........ ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+....... .+.
T Consensus 163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-~~~- 239 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-ALF- 239 (286)
T ss_pred EEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-HHh-
Confidence 99999999986643221 2234568999999998753 457889999999999999999999986543211 110
Q ss_pred HHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 535 RAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 535 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.. ......... .+......+.+++.+||+.+|++|||+.||++.
T Consensus 240 ---~~-~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 ---KI-PRNPPPTLH--------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ---hc-cccCCCccc--------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00 000000000 111123468999999999999999999999975
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=304.43 Aligned_cols=253 Identities=21% Similarity=0.358 Sum_probs=191.0
Q ss_pred CcccccCceEEEEEEecCC---cEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCC
Q 006168 325 NKLGEGGFGDIYKGTLKNG---KIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANS 401 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 401 (658)
+.||+|+||.||++...++ ..+++|.+.........+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999986543 3567777665433445678999999999999999999999999999999999999999
Q ss_pred CHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC-ccc
Q 006168 402 SLDKFLFGEK--RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ-SHL 478 (658)
Q Consensus 402 sL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~-~~~ 478 (658)
+|.+++.... ...+++..+..++.||++||.|||+. +++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999996432 23467778889999999999999998 99999999999999999999999999986432211 111
Q ss_pred cccccCCccccccccccc-------CCCCCcccchhhhHHHHHHHhC-CCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 479 STKFAGTLGYTAPEYAIH-------GQLSEKVDAYSFGVLVLEIISG-TKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~-------~~~s~ksDV~SfGvvl~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+..... . .....+ . .+......+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~-~~~~~~---~-~~~~~~~~~ 231 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-R-EVLNHV---I-KDQQVKLFK 231 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-H-HHHHHH---H-hhcccccCC
Confidence 234567889999998753 2457899999999999999975 556643322 1 111111 1 112222333
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
+.+. ......+.+++..|| .+|++||++.+|++.|.
T Consensus 232 ~~~~-----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLE-----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccC-----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3321 113356888999999 67999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=305.32 Aligned_cols=249 Identities=26% Similarity=0.461 Sum_probs=201.2
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccccc--------ccHHHHHHHHHHHhccCCCccceeeeEeecCCe
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR--------RTLSDFENEVRLISNVHHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 390 (658)
+|...+.||+|++|.||+|... +++.+|+|.+...... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999875 5889999988643211 123568899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.++||||+++++|.+++. ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN--NYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHH--hccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999994 345689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCcc-----ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcc
Q 006168 471 LPENQSH-----LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTH 545 (658)
Q Consensus 471 ~~~~~~~-----~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 545 (658)
....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... . ..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~----~~~~~~---- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-A----IFKIGE---- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-H----HHHHhc----
Confidence 6432111 1123457889999999998899999999999999999999999987543211 1 111100
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 546 WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 546 ~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
... ...+...+..+.+++.+||+.+|.+||++.+|++
T Consensus 227 --~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 --NAS-----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --cCC-----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 011 1122234567899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=308.51 Aligned_cols=266 Identities=24% Similarity=0.404 Sum_probs=202.7
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
++|+..+.||+|+||.||+++.+ +++.||+|++..... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999987 589999999865322 2234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++++|..++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999999988873 344699999999999999999999998 999999999999999999999999999987644322
Q ss_pred cccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhh-HHHHH--------HHHhhcCccc
Q 006168 477 HLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEY-LLKRA--------WRLYENGTHW 546 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~-l~~~~--------~~~~~~~~~~ 546 (658)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||......... ..... ...+......
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 1223457889999999876 56789999999999999999999999754432111 00000 0000000000
Q ss_pred -ccccccCCC-C---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 547 -ELMDESLDP-N---ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 547 -~~~d~~l~~-~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....+.... . ......+..+.+++.+||+.+|++|||+.|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000000 0 0001234678999999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.76 Aligned_cols=240 Identities=25% Similarity=0.407 Sum_probs=188.9
Q ss_pred CcccccCceEEEEEEecC--------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 325 NKLGEGGFGDIYKGTLKN--------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
+.||+|+||.||+|..+. ...+++|.+.. ......+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcc-hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 469999999999998642 23488888754 233445678899999999999999999999999899999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC--------eEEeeccCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ--------PKIADFGLA 468 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~--------~kl~DfGla 468 (658)
|+++|+|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++. ++++|||++
T Consensus 80 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 80 YVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred cCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999999543 33689999999999999999999998 9999999999999987765 699999988
Q ss_pred cccCCCCccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCC-CCCCCCCcchhhHHHHHHHHhhcCccc
Q 006168 469 RLLPENQSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGT-KSSETKGEEGEYLLKRAWRLYENGTHW 546 (658)
Q Consensus 469 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~-~p~~~~~~~~~~l~~~~~~~~~~~~~~ 546 (658)
...... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+....... . . ......
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-~-~----~~~~~~--- 221 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-K-L----QFYEDR--- 221 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-H-H----HHHHcc---
Confidence 654321 234678899999999874 5799999999999999999995 4443222111 0 0 011100
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 547 ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 547 ~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
...+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 222 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ---------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111112346899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=309.45 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=201.6
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|++.++||+|+||.||+|+.. +++.+++|.+.. ......+.+.+|++++++++||||+++++.+..++..++||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET-KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 56888999999999999999976 488999999875 3444567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|..++.. ....+++..+..++.|++.+|.|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 91 ~~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~ 165 (292)
T cd06644 91 CPGGAVDAIMLE-LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q 165 (292)
T ss_pred CCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence 999999888743 235699999999999999999999998 99999999999999999999999999987543221 1
Q ss_pred ccccccCCcccccccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 478 LSTKFAGTLGYTAPEYAI-----HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
......++..|+|||++. ...++.++||||||+++|||++|+.|+....... ...+.. .....
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~~~~~-~~~~~------ 233 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VLLKIA-KSEPP------ 233 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-----HHHHHh-cCCCc------
Confidence 223456788999999984 3457889999999999999999999986533211 111111 11100
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....+......+.+++.+||+.+|++||++.++++.
T Consensus 234 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 234 --TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 001122334568999999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.37 Aligned_cols=196 Identities=24% Similarity=0.399 Sum_probs=162.0
Q ss_pred cCcccccCceEEEEEEec---CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeec--CCeEEEEEecc
Q 006168 324 ENKLGEGGFGDIYKGTLK---NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ--GPELILVYEYM 398 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~~ 398 (658)
.++||+|+||.||+|+.+ +++.+|+|.+... .....+.+|++++++++||||+++++++.. +...++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC---CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 568999999999999965 4678999998642 233567899999999999999999998854 45689999998
Q ss_pred CCCCHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE----cCCCCeEEeeccC
Q 006168 399 ANSSLDKFLFGE-------KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL----DDDLQPKIADFGL 467 (658)
Q Consensus 399 ~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll----~~~~~~kl~DfGl 467 (658)
.+ +|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+|||+ +..+.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 65 887776422 123589999999999999999999998 99999999999999 4567899999999
Q ss_pred ccccCCCCcc--ccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 006168 468 ARLLPENQSH--LSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKG 526 (658)
Q Consensus 468 a~~~~~~~~~--~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~ 526 (658)
++.+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 9876543221 22356789999999998774 58999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=304.58 Aligned_cols=238 Identities=27% Similarity=0.454 Sum_probs=189.4
Q ss_pred CcccccCceEEEEEEecCCc-----------EEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 325 NKLGEGGFGDIYKGTLKNGK-----------IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
+.||+|+||.||+|.+.+.. .+++|.+.... .....+.+|+.++++++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH--RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch--hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46999999999999987533 57888775432 226788999999999999999999999988 77899
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC-------CeEEeecc
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL-------QPKIADFG 466 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~-------~~kl~DfG 466 (658)
||||+++|+|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 78 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 78 VEEYVKFGPLDVFLHRE-KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEEcCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999998543 23689999999999999999999998 999999999999999887 79999999
Q ss_pred CccccCCCCccccccccCCcccccccccccC--CCCCcccchhhhHHHHHHHhC-CCCCCCCCcchhhHHHHHHHHhhcC
Q 006168 467 LARLLPENQSHLSTKFAGTLGYTAPEYAIHG--QLSEKVDAYSFGVLVLEIISG-TKSSETKGEEGEYLLKRAWRLYENG 543 (658)
Q Consensus 467 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDV~SfGvvl~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~ 543 (658)
++..... .....++..|+|||++... .++.++||||||+++|||++| ..|+....... . ...+...
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--~----~~~~~~~ 222 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--K----ERFYQDQ 222 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--H----HHHHhcC
Confidence 9986543 1223567789999998876 789999999999999999995 66664432211 0 0111110
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 544 THWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 544 ~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
.. . +.. ....+.+++.+||..+|.+|||+.+|++.|+
T Consensus 223 ~~-------~-~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 HR-------L-PMP----DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC-------C-CCC----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0 000 1157899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=318.64 Aligned_cols=265 Identities=26% Similarity=0.358 Sum_probs=199.8
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecC-----
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG----- 388 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 388 (658)
...++|...+.||+|+||.||++... +|+.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34578999999999999999999975 58899999986432 233456788999999999999999999998644
Q ss_pred -CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccC
Q 006168 389 -PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL 467 (658)
Q Consensus 389 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGl 467 (658)
...++||||+++ +|.+.+. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 357999999976 5666652 3488999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhh-------------HHH
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEY-------------LLK 534 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~-------------l~~ 534 (658)
++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... +..
T Consensus 170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 97643321 223457899999999999999999999999999999999999999754321100 000
Q ss_pred ----HHHHHhhcCcc------cccccccCCC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 535 ----RAWRLYENGTH------WELMDESLDP--NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 535 ----~~~~~~~~~~~------~~~~d~~l~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
........... .+.......+ ..........+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000 0000000000 01111224568999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=294.84 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=202.9
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++.|++.+.||+|.|+.||+.... .|+.+|+|.+... .+....+++.+|+++-+.|+|||||+|.+.+.+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456777889999999999998865 6899999988642 34457889999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC---CCCeEEeeccCccccC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD---DLQPKIADFGLARLLP 472 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~---~~~~kl~DfGla~~~~ 472 (658)
|+|.+++|-.-|- .+.-.++...-..++||+++|.|+|.+ +|||||+||+|+|+-. ..-+||+|||++..+.
T Consensus 90 e~m~G~dl~~eIV--~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIV--AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999965552 223477788889999999999999999 9999999999999943 3458999999999886
Q ss_pred CCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 473 ENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 473 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
........+|||+|||||++...+|+..+|||+-|||||-|+.|..||...... .+.+.+ ..+.. +
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--rlye~I----~~g~y-d----- 230 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYEQI----KAGAY-D----- 230 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--HHHHHH----hcccc-C-----
Confidence 223344678999999999999999999999999999999999999999764332 222221 11110 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
. +...-....++..+|+++||..||.+|.|+.|.++
T Consensus 231 ~-~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 Y-PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred C-CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 0 11111223456899999999999999999998874
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=310.01 Aligned_cols=260 Identities=25% Similarity=0.399 Sum_probs=206.7
Q ss_pred cchHHHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEee
Q 006168 309 YRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCS 386 (658)
Q Consensus 309 ~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 386 (658)
.++.++....+.|+..+.||+|+||.||+|... +++.+|+|.+.. ......++..|+.++.++ +|+||+++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~--~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV--TEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEec--ChHHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 355666677889999999999999999999975 588999998864 233456788999999998 7999999999985
Q ss_pred c------CCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCe
Q 006168 387 Q------GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP 460 (658)
Q Consensus 387 ~------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~ 460 (658)
. .+..+++|||+++|+|.+++.......+++..+..++.||+.||.|||+. +|+|+||||+||++++++.+
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 3 46789999999999999999665556689999999999999999999998 99999999999999999999
Q ss_pred EEeeccCccccCCCCccccccccCCcccccccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHH
Q 006168 461 KIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI-----HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKR 535 (658)
Q Consensus 461 kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~ 535 (658)
+|+|||++........ ......|+..|+|||.+. ...++.++||||||+++|||++|+.||..........
T Consensus 161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--- 236 (282)
T cd06636 161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--- 236 (282)
T ss_pred EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---
Confidence 9999999876543221 122456889999999875 3468889999999999999999999986433211110
Q ss_pred HHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 536 AWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 536 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.... ... ........+..+.+++.+||+.||.+|||+.||++
T Consensus 237 --~~~~------~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 --LIPR------NPP----PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --hHhh------CCC----CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000 000 11111223457999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=330.11 Aligned_cols=261 Identities=23% Similarity=0.329 Sum_probs=193.9
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecC-------
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG------- 388 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 388 (658)
..++|...+.||+|+||.||+|... +++.||||++.... ....+|+.++++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3467999999999999999999975 58899999885421 2345799999999999999999886321
Q ss_pred -CeEEEEEeccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC-CeEEee
Q 006168 389 -PELILVYEYMANSSLDKFLFG--EKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL-QPKIAD 464 (658)
Q Consensus 389 -~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~-~~kl~D 464 (658)
..+++||||+++ +|.+++.. .....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 246799999985 77766643 2345699999999999999999999998 999999999999998665 699999
Q ss_pred ccCccccCCCCccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcC
Q 006168 465 FGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG 543 (658)
Q Consensus 465 fGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 543 (658)
||+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|++||....... .+. ...+.....
T Consensus 215 FGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~-~i~~~~~~p 290 (440)
T PTZ00036 215 FGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLV-RIIQVLGTP 290 (440)
T ss_pred cccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHH-HHHHHhCCC
Confidence 999987643322 2245789999999998764 68999999999999999999999997544321 111 111111000
Q ss_pred ----------cccccccccCCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 544 ----------THWELMDESLDP----NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 544 ----------~~~~~~d~~l~~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+.--+.... ..++...+.++.+++.+||+.||.+|||+.|+++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000000000 01112234578999999999999999999999853
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=305.07 Aligned_cols=254 Identities=25% Similarity=0.452 Sum_probs=202.3
Q ss_pred CCCccCcccccCceEEEEEEecC--CcEEEEEEcccc---------cccccHHHHHHHHHHHhc-cCCCccceeeeEeec
Q 006168 320 KFSEENKLGEGGFGDIYKGTLKN--GKIVAVKKLAIG---------ISRRTLSDFENEVRLISN-VHHRNLIRLLGCCSQ 387 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~---------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 387 (658)
+|++.+.||+|+||.||+|.++. ++.+|+|.+... .......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999875 688999987532 112234567788888865 799999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeec
Q 006168 388 GPELILVYEYMANSSLDKFLFGE--KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADF 465 (658)
Q Consensus 388 ~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~Df 465 (658)
++..++||||+++++|.+++... ....+++..++.++.|++.+|.|||+. .+++|+||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999987432 345699999999999999999999963 17999999999999999999999999
Q ss_pred cCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcc
Q 006168 466 GLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTH 545 (658)
Q Consensus 466 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 545 (658)
|++....... ......|+..|++||.+.++.++.++||||||+++|||++|+.|+...... .... .. .++..
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--~~~~---~~-~~~~~ 230 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--SLAT---KI-VEAVY 230 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--HHHH---HH-hhccC
Confidence 9998764433 234567889999999999989999999999999999999999998543221 1111 11 11111
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 546 WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 546 ~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
... ........+.+++.+||+.||++||++.||.++|+
T Consensus 231 ~~~---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 EPL---------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CcC---------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 110 01122356899999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=304.48 Aligned_cols=266 Identities=23% Similarity=0.350 Sum_probs=204.5
Q ss_pred HhcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhcc--CCCccceeeeEeecC----Ce
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV--HHRNLIRLLGCCSQG----PE 390 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~ 390 (658)
..+.....+.||+|.||+||+|.|+ |+.||||++.. .+...+.+|.++.+.+ +|+||+.+++.-..+ .+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3456777889999999999999997 89999999853 3456777888888775 999999999875433 46
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhc-----CCCCeeecCcCCCcEEEcCCCCeEEeec
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED-----FHVRIIHRDIKPSNVLLDDDLQPKIADF 465 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dik~~NIll~~~~~~kl~Df 465 (658)
++||++|.++|||.|+| .+..++.+..++++..+|.||+|||-. .+|.|.|||||+.||||..++...|+|+
T Consensus 284 LwLvTdYHe~GSL~DyL---~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYL---NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEeeecccCCcHHHHH---hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 89999999999999999 346799999999999999999999954 3688999999999999999999999999
Q ss_pred cCccccCCCCccc---cccccCCcccccccccccC----CC--CCcccchhhhHHHHHHHhC----------CCCCCCCC
Q 006168 466 GLARLLPENQSHL---STKFAGTLGYTAPEYAIHG----QL--SEKVDAYSFGVLVLEIISG----------TKSSETKG 526 (658)
Q Consensus 466 Gla~~~~~~~~~~---~~~~~gt~~y~APE~~~~~----~~--s~ksDV~SfGvvl~elltG----------~~p~~~~~ 526 (658)
|||.......... ....+||-+|||||++... .+ -..+||||||+|+||+.-. +.||...-
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 9998765543222 2357899999999998543 12 1368999999999999763 34554332
Q ss_pred cchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 527 EEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 527 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
+.+...-+ ..+.+ -.+.+.+.++..-...+....+.+|++.||..||..|-|+-.+-+.|.++.
T Consensus 441 p~DPs~ee-MrkVV----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 441 PSDPSFEE-MRKVV----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCCCHHH-Hhcce----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 21111110 01111 112233333333345567788999999999999999999999999998873
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=309.03 Aligned_cols=266 Identities=24% Similarity=0.390 Sum_probs=205.6
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
++|+..+.||+|+||.||++.++ +++.|++|++.... .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999977 58899999986532 23345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|++++.+..++ .+...+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLE--ASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99987777665 2345589999999999999999999998 999999999999999999999999999987755443
Q ss_pred cccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHH----------HHhhcCcc
Q 006168 477 HLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAW----------RLYENGTH 545 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~----------~~~~~~~~ 545 (658)
.......++..|+|||++... .++.++||||||+++|+|++|+.|+....... .+..... ..+.....
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHhhhcccCcc
Confidence 233456788899999999888 88999999999999999999999887543311 1111000 00000000
Q ss_pred cc---ccccc---CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 546 WE---LMDES---LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 546 ~~---~~d~~---l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.. ..+.. ......+...+.++.+++.+||+.+|++|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 00000 00001122235679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=304.24 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=196.7
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc----ccccHHHHHHHHHHHhccCCCccceeeeEeec--CCeE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI----SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ--GPEL 391 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 391 (658)
.+|...+.||+|+||.||++... ++..|++|++.... ..+....+.+|+.++++++||||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999975 58899999886421 12334568899999999999999999999865 4678
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++++||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 999999999999999843 34589999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCcc--ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccc
Q 006168 472 PENQSH--LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 472 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
...... ......++..|+|||++.+..++.++||||||+++|||++|+.||....... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~~~~~~~~~~----- 226 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----AIFKIATQPT----- 226 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----HHHHHhcCCC-----
Confidence 332111 1123568889999999998889999999999999999999999986542211 1111111000
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
....+......+..++ .||..+|++||+++||++
T Consensus 227 -----~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 -----NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -----CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1112233344566666 688899999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.04 Aligned_cols=263 Identities=27% Similarity=0.433 Sum_probs=201.6
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccccc-ccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR-RTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
++|+..++||+|+||.||++.++ +++.||+|++...... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999986 5899999998653222 235678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++++|.++.. ....+++.++..++.||++||.|||+. +++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEK--YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999988773 334599999999999999999999998 99999999999999999999999999998764433
Q ss_pred cccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc--Cccccc-----
Q 006168 477 HLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN--GTHWEL----- 548 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~~~~~~----- 548 (658)
...+...++..|+|||++.+ ..++.++||||||++++||++|+.|+....... ........... ....+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID--QLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH--HHHHHHHHhCCCchhhHHHhccch
Confidence 22334567889999999875 457889999999999999999998886543211 10000100000 000000
Q ss_pred -ccccCCCC--------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 549 -MDESLDPN--------ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 549 -~d~~l~~~--------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
++....+. ......+..+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000 001123467999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=303.75 Aligned_cols=247 Identities=30% Similarity=0.489 Sum_probs=200.4
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
++|.+.+.||+|+||.||++.. +++.||+|.+... .....+.+|+.++++++|||++++++++... ..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4678899999999999999975 5788999998642 2346789999999999999999999998654 479999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++++|.+++.......+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999999655555689999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
.....+..|+|||++.++.++.++||||||+++|||++ |+.||...... .+. .....+... .
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~----~~~~~~~~~----------~ 217 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EVK----ECVEKGYRM----------E 217 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HHH----HHHhCCCCC----------C
Confidence 12334578999999998999999999999999999998 88888644321 111 111111100 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
.+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 112234568999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=302.64 Aligned_cols=249 Identities=27% Similarity=0.441 Sum_probs=202.8
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc----ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI----SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
+|...+.||+|++|.||+|..+ +++.|++|.+.... ..+..+.+.+|++++++++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999987 78999999986532 123456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 999999999999843 34689999999999999999999998 9999999999999999999999999998865433
Q ss_pred CccccccccCCcccccccccccCC-CCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQ-LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
. ......++..|++||.+.... ++.++||||||+++|+|++|+.||...... . ..++.......
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-~----~~~~~~~~~~~-------- 220 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-A----AVFKIGRSKEL-------- 220 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-H----HHHHHHhcccC--------
Confidence 2 223456889999999987776 899999999999999999999998654321 1 11111110111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+......+.+++.+||+.+|.+||++.++++.
T Consensus 221 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 --PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11122234568899999999999999999999853
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=313.16 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=201.7
Q ss_pred cCCCccCcccccCceEEEEEEec-CCc----EEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGK----IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
++|...+.||+|+||.||+|.+. ++. .+|+|.+..........++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 56778899999999999999864 343 57999887543334445788999999999999999999998654 4679
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
++||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence 9999999999999853 234689999999999999999999998 999999999999999999999999999987643
Q ss_pred CCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 474 NQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 474 ~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
..... .....++..|+|||++.+..++.++||||||+++|||++ |+.|+..... .... +....+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~----~~~~~~~~~~---- 231 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIP----DLLEKGERLP---- 231 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHH----HHHHCCCCCC----
Confidence 32221 123345678999999998899999999999999999998 8888864332 1111 1111111110
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.+......+.+++..||..+|++||++.++++.|+.+
T Consensus 232 ------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 232 ------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111234688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=343.86 Aligned_cols=257 Identities=22% Similarity=0.378 Sum_probs=200.4
Q ss_pred HHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeec--CCe
Q 006168 315 VSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ--GPE 390 (658)
Q Consensus 315 ~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 390 (658)
....++|.+.++||+|+||.||++... .+..+|+|.+... ........+..|+.++++|+|||||++++++.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344578999999999999999999976 4778999988643 233445678999999999999999999998854 457
Q ss_pred EEEEEeccCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhHhcCC----CCeeecCcCCCcEEEcC--------
Q 006168 391 LILVYEYMANSSLDKFLFGEK--RGSLNWKQRFDIILGTARGLAYLHEDFH----VRIIHRDIKPSNVLLDD-------- 456 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~ivH~Dik~~NIll~~-------- 456 (658)
++|||||+++|+|.++|.... ...+++..++.|+.||+.||.|||+... .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999985422 3569999999999999999999998521 25999999999999964
Q ss_pred ---------CCCeEEeeccCccccCCCCccccccccCCccccccccccc--CCCCCcccchhhhHHHHHHHhCCCCCCCC
Q 006168 457 ---------DLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH--GQLSEKVDAYSFGVLVLEIISGTKSSETK 525 (658)
Q Consensus 457 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDV~SfGvvl~elltG~~p~~~~ 525 (658)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||++|+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2348999999998654322 2234579999999999864 45889999999999999999999999654
Q ss_pred CcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 526 GEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 526 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.... .+. ....... .+... ..+..+.+|+..||+.+|.+||++.+++.
T Consensus 247 ~~~~-qli----~~lk~~p-------~lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFS-QLI----SELKRGP-------DLPIK----GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHH-HHH----HHHhcCC-------CCCcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 3211 111 1111110 11011 12356899999999999999999999983
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=310.05 Aligned_cols=262 Identities=24% Similarity=0.354 Sum_probs=206.5
Q ss_pred cchHHHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEee
Q 006168 309 YRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCS 386 (658)
Q Consensus 309 ~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 386 (658)
+.++++..++++|.+.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.+++++ +|||++++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc--ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 455677788899999999999999999999975 6889999998642 23346678899999999 8999999999986
Q ss_pred cC-----CeEEEEEeccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC
Q 006168 387 QG-----PELILVYEYMANSSLDKFLFGE--KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ 459 (658)
Q Consensus 387 ~~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~ 459 (658)
.. +..++||||+++++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 43 4689999999999999988532 335689999999999999999999998 9999999999999999999
Q ss_pred eEEeeccCccccCCCCccccccccCCcccccccccccC-----CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHH
Q 006168 460 PKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG-----QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLK 534 (658)
Q Consensus 460 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~ 534 (658)
+||+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.|+....... .+
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~-- 242 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TL-- 242 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HH--
Confidence 99999999886543221 12235688999999987543 36889999999999999999999986543211 11
Q ss_pred HHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 535 RAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 535 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+.. ....... ..+......+.+++.+||+.+|++||++.|+++.
T Consensus 243 --~~~~-~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 --FKIP-RNPPPTL--------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred --HHHh-cCCCCCC--------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111 1111111 0112234569999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=301.23 Aligned_cols=250 Identities=22% Similarity=0.399 Sum_probs=203.8
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+|+..+.||+|+||.||++... +++.+|+|++... ........+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5778899999999999999875 6889999998653 2334567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC-CCeEEeeccCccccCCCCc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD-LQPKIADFGLARLLPENQS 476 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~-~~~kl~DfGla~~~~~~~~ 476 (658)
+++++|.+++.......+++..+..++.+++.+|.|||+. +++|+||||+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 9999999999655555699999999999999999999998 99999999999999865 458999999998764332
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
......++..|+|||.+.+..++.++||||||+++++|++|+.|+...... ..... ... +.. .
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~---~~~-~~~----------~ 219 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLK---IMS-GTF----------A 219 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--HHHHH---HHh-cCC----------C
Confidence 122356888999999999888999999999999999999999998654321 11111 111 110 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+...+..+.+++.+||+.+|.+|||+.|+++.
T Consensus 220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1112234568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=290.09 Aligned_cols=252 Identities=27% Similarity=0.393 Sum_probs=203.8
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc---cccH----HHHHHHHHHHhcc-CCCccceeeeEeecC
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS---RRTL----SDFENEVRLISNV-HHRNLIRLLGCCSQG 388 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~----~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 388 (658)
-++|...+.||.|..++|-+...+ .|+.+|+|++..... .+.. +.-.+|+.+|+++ .||+|+.+.++++..
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356778889999999999998866 688999999864321 1112 2346799999998 699999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCc
Q 006168 389 PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLA 468 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla 468 (658)
.-+++|+|.|+.|-|.++| ...-.+++++..+|++|+.+|++|||.. +||||||||+|||+|++.++||+|||++
T Consensus 96 sF~FlVFdl~prGELFDyL--ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYL--TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred chhhhhhhhcccchHHHHh--hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecccee
Confidence 9999999999999999999 4556799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCccccccccCCccccccccccc------CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc
Q 006168 469 RLLPENQSHLSTKFAGTLGYTAPEYAIH------GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN 542 (658)
Q Consensus 469 ~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 542 (658)
..+.... .....+|||+|+|||.+.. ..|+...|+|+.||++|-|+.|.+||.... +++ ..+...+
T Consensus 171 ~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk----Qml--MLR~Ime 242 (411)
T KOG0599|consen 171 CQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK----QML--MLRMIME 242 (411)
T ss_pred eccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH----HHH--HHHHHHh
Confidence 9886543 3456899999999999853 468889999999999999999999985321 111 1122333
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 543 GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 543 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
|+..- ..+.=.+.+....+||.+||+.||.+|.|++|++.
T Consensus 243 GkyqF-------~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 243 GKYQF-------RSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ccccc-------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 32110 01111234567899999999999999999999985
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=317.41 Aligned_cols=193 Identities=27% Similarity=0.355 Sum_probs=166.0
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
...+|.+.+.||+|+||.||+|+.+ +++.||+|..... ....|+.++++++||||+++++++...+..++|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 3457999999999999999999976 4778999975432 2356999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+. ++|.+++.. ....+++..+..|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 137 e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 137 PHYS-SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EccC-CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 9995 588888743 345699999999999999999999998 99999999999999999999999999997532221
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSE 523 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~ 523 (658)
......||..|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 2234578999999999999999999999999999999999766553
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=315.50 Aligned_cols=241 Identities=24% Similarity=0.347 Sum_probs=188.4
Q ss_pred ccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcc---CCCccceeeeEeecCCeEEEEEeccCC
Q 006168 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNV---HHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 327 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
||+|+||.||+++.+ +++.||+|++.... .......+..|..++... +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999976 58999999986421 122334455677777655 699999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
|+|.+++. ....+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||++........ ...
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~ 154 (330)
T cd05586 81 GELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTN 154 (330)
T ss_pred ChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Ccc
Confidence 99999884 446699999999999999999999998 999999999999999999999999999875432221 223
Q ss_pred cccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCC
Q 006168 481 KFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECT 559 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 559 (658)
...||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .+ .+....+.. .+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--~~----~~~i~~~~~------~~~~~--- 219 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--QM----YRNIAFGKV------RFPKN--- 219 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--HH----HHHHHcCCC------CCCCc---
Confidence 46799999999998765 4899999999999999999999998654321 11 111111111 11111
Q ss_pred HHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 006168 560 KEAAEKVVEIALMCTQSAANSRP----TMSEVVA 589 (658)
Q Consensus 560 ~~~~~~l~~li~~cl~~dp~~RP----t~~evl~ 589 (658)
.....+.+++.+||+.||.+|| ++.++++
T Consensus 220 -~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 -VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1234688999999999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=307.66 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=203.0
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|.+.+.||+|+||.||++.++ +++.+|+|.+.. ......+.+..|++++++++||||+++++.+..+...++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI-ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee-CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 457888999999999999999975 688999999865 234455778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 83 FCDGGALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred ccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999999843 234699999999999999999999998 999999999999999999999999999876533221
Q ss_pred cccccccCCcccccccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 477 HLSTKFAGTLGYTAPEYAI-----HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
......+++.|+|||.+. ...++.++||||||+++|||++|+.|+....... .. .+. ..+.. +
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~---~~~-~~~~~-----~ 226 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VL---LKI-LKSEP-----P 226 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HH---HHH-hcCCC-----C
Confidence 223456889999999975 3456789999999999999999999986543211 11 111 11110 0
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+ ..+...+..+.+++..||+.+|.+||++.+|++.
T Consensus 227 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TL---DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred Cc---CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00 1112234568899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=312.08 Aligned_cols=255 Identities=22% Similarity=0.293 Sum_probs=203.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccccc--ccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR--RTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|...+.||+|++|.||++... +++.+|+|.+...... ...+.+..|+++++.++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888899999999999999976 4899999998754222 24567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+.+++|.+++.......+++..+..++.|+++||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999999655556799999999999999999999998 99999999999999999999999999987553221
Q ss_pred cc----------------------------ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc
Q 006168 476 SH----------------------------LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE 527 (658)
Q Consensus 476 ~~----------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~ 527 (658)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11134688899999999988999999999999999999999999865443
Q ss_pred chhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 006168 528 EGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591 (658)
Q Consensus 528 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 591 (658)
... + . +... ..... ......+..+.+++.+||+.+|++|||....++.|
T Consensus 238 ~~~-~-~---~~~~---------~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l 286 (316)
T cd05574 238 DET-F-S---NILK---------KEVTF-PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI 286 (316)
T ss_pred HHH-H-H---HHhc---------CCccC-CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHH
Confidence 211 1 1 1111 00000 01111456799999999999999999944444433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=329.80 Aligned_cols=268 Identities=19% Similarity=0.307 Sum_probs=194.5
Q ss_pred HHHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCC------CccceeeeE
Q 006168 312 KDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHH------RNLIRLLGC 384 (658)
Q Consensus 312 ~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~ 384 (658)
+++...+++|.+.++||+|+||.||++... .++.||||++... .....++..|+++++.++| .++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV--PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc--hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 344456789999999999999999999975 5788999998632 2233456667777777654 458889998
Q ss_pred eecC-CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC-----
Q 006168 385 CSQG-PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL----- 458 (658)
Q Consensus 385 ~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~----- 458 (658)
+... ...++|||++ +++|.+++. +.+.+++..+..|+.||+.||.|||++ .+|+||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~--~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIM--KHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccc
Confidence 8654 5789999988 668888884 345799999999999999999999972 2899999999999998765
Q ss_pred -----------CeEEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc
Q 006168 459 -----------QPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE 527 (658)
Q Consensus 459 -----------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~ 527 (658)
.+||+|||++..... ..+...||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 499999998764321 23456899999999999999999999999999999999999999976543
Q ss_pred ch-hhHHHHH-------HHH-hhcCccccccc------ccCCC---------C-CCCHHHHHHHHHHHHHccccCCCCCC
Q 006168 528 EG-EYLLKRA-------WRL-YENGTHWELMD------ESLDP---------N-ECTKEAAEKVVEIALMCTQSAANSRP 582 (658)
Q Consensus 528 ~~-~~l~~~~-------~~~-~~~~~~~~~~d------~~l~~---------~-~~~~~~~~~l~~li~~cl~~dp~~RP 582 (658)
.. ...+... |.. .......++++ +...+ . .........+.+|+..||+.||++||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 11 1111110 000 00000000000 00000 0 00001234578999999999999999
Q ss_pred CHHHHHHH
Q 006168 583 TMSEVVAL 590 (658)
Q Consensus 583 t~~evl~~ 590 (658)
|+.|+++.
T Consensus 431 ta~e~L~H 438 (467)
T PTZ00284 431 NARQMTTH 438 (467)
T ss_pred CHHHHhcC
Confidence 99999973
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.60 Aligned_cols=252 Identities=29% Similarity=0.504 Sum_probs=202.8
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+|...+.||+|+||.||+|... +++.|++|.+..... ......+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5778899999999999999975 688999999875322 23567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.. ...+++..+..++.+++.||.|||+. +|+|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 999999999843 34589999999999999999999998 9999999999999999999999999999876543332
Q ss_pred ccc---cccCCcccccccccccCC---CCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 478 LST---KFAGTLGYTAPEYAIHGQ---LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 478 ~~~---~~~gt~~y~APE~~~~~~---~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
... ...++..|+|||++.... ++.++||||||++++|+++|+.||.......... ..... +. .+
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~----~~~~~-~~-----~~ 225 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM----FHVGA-GH-----KP 225 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH----HHHhc-CC-----CC
Confidence 211 356788999999998766 8899999999999999999999986543211111 11110 11 01
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.+ +. .......+.+++.+||+.+|.+|||+.+++.
T Consensus 226 ~~-~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PI-PD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CC-Cc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11 01 1112456889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.57 Aligned_cols=252 Identities=28% Similarity=0.420 Sum_probs=208.9
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|+..+.||+|++|.||+++.+ +++.|++|++...........+.+|++.+.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999987 48999999987643334567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE-DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
+++++|.+++.. ...+++..++.++.|++++|.|||+ . +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 999999999943 3679999999999999999999999 8 999999999999999999999999999987644332
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc-chhhHHHHHHHHhhcCcccccccccCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE-EGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ....+..... ....
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~---------- 220 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPP---------- 220 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCC----------
Confidence 2 2245678899999999999999999999999999999999999876542 1112222111 1110
Q ss_pred CCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 556 NECTKE-AAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 556 ~~~~~~-~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+.. .+..+.+++..||..+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111122 45679999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=308.27 Aligned_cols=263 Identities=23% Similarity=0.389 Sum_probs=198.8
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+|+..+.||+|+||.||+++.+ +|+.+|+|++.... .......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999976 68899999986532 222345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++ +|.+++.. ....+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CDQ-DLKKYFDS-CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CCC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 974 78877743 245699999999999999999999998 999999999999999999999999999986543322
Q ss_pred ccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh-----------cCcc
Q 006168 478 LSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYE-----------NGTH 545 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~-----------~~~~ 545 (658)
......++..|+|||++.+. .++.++||||||+++|||++|+.|+......... .....+... ....
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH-HHHHHHHhCCCChHHhHHhhhccc
Confidence 12234678899999998765 4789999999999999999999986543332111 111111110 0000
Q ss_pred cc---cccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 546 WE---LMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 546 ~~---~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.. ...............+..+.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 000000000111123467889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.52 Aligned_cols=251 Identities=25% Similarity=0.432 Sum_probs=203.9
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEee--cCCeEEEEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCS--QGPELILVY 395 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lV~ 395 (658)
+|++.+.||.|+||.||++... +++.+|+|.+... ......+.+.+|++++++++||||+++++++. .+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999865 6889999998643 23344567889999999999999999999875 345689999
Q ss_pred eccCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhH-----hcCCCCeeecCcCCCcEEEcCCCCeEEeeccCc
Q 006168 396 EYMANSSLDKFLFGEK--RGSLNWKQRFDIILGTARGLAYLH-----EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLA 468 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH-----~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla 468 (658)
||+++++|.+++.... ...+++..++.++.||+.||.||| +. +++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999985432 356999999999999999999999 65 9999999999999999999999999999
Q ss_pred cccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccc
Q 006168 469 RLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWEL 548 (658)
Q Consensus 469 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 548 (658)
........ ......+++.|+|||.+.+..++.++||||||+++++|++|+.|+..... ..+.. ....+..
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~----~~~~~~~--- 227 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLAS----KIKEGKF--- 227 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHH----HHhcCCC---
Confidence 87654332 12345689999999999998999999999999999999999999875432 11111 1111111
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 549 MDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 549 ~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+...+..+.+++.+|++.+|++||++.+|++.
T Consensus 228 -------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 12223345679999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=303.91 Aligned_cols=261 Identities=26% Similarity=0.356 Sum_probs=204.4
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeec--CCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ--GPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 395 (658)
++|...+.||.|++|.||++... +++.+|+|.+...........+.+|++++++++||||+++++++.. .+.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999985 5889999998754444456778999999999999999999999854 34789999
Q ss_pred eccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 396 EYMANSSLDKFLFGE--KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 396 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||+++++|.+++... ....+++..+..++.||++||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887532 335589999999999999999999998 999999999999999999999999999875532
Q ss_pred CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...........+.. .......... +....
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~ 232 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SYIVNMPNPE-LKDEP 232 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-HHHhcCCchh-hccCC
Confidence 22 1234578899999999999999999999999999999999999976532111111111 1111111111 11111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
......+..+.+++.+||+.+|.+|||+.||++.
T Consensus 233 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 233 ---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1112245678999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=301.25 Aligned_cols=253 Identities=26% Similarity=0.478 Sum_probs=203.2
Q ss_pred CCCccCcccccCceEEEEEEe-cCCcEEEEEEcccccc-----cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTL-KNGKIVAVKKLAIGIS-----RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
+|+..+.||+|++|.||++.. .+++.||+|.+..... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 4689999999864221 1235678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC-CeEEeeccCccccC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL-QPKIADFGLARLLP 472 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~-~~kl~DfGla~~~~ 472 (658)
|+||+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLS--KYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999984 345689999999999999999999998 999999999999998776 59999999998764
Q ss_pred CCCcc---ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccc
Q 006168 473 ENQSH---LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 473 ~~~~~---~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
..... ......++..|+|||.+.+..++.++||||||+++++|++|+.|+........ .....+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~------ 227 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALIFKIASAT------ 227 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHHHHHhccC------
Confidence 33211 12235688999999999888899999999999999999999999864332111 11111111000
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.....+......+.+++.+|++.+|.+|||+.++++
T Consensus 228 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 ----TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 012233445567999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=316.52 Aligned_cols=198 Identities=27% Similarity=0.432 Sum_probs=175.2
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC-C-----CccceeeeEeecCCeEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-H-----RNLIRLLGCCSQGPELI 392 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~ 392 (658)
+|.+.+.||+|.||.|-++... +++.||||+++. ......+-..|+.+|..|+ | -|+|+++++|..++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN--~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN--KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc--ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 8899999999999999999965 699999999974 4455667788999999996 4 38999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC--CCeEEeeccCccc
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD--LQPKIADFGLARL 470 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~--~~~kl~DfGla~~ 470 (658)
||+|.+.. +|.++|+..+-..|+...+..|+.||+.||.+||+. +|||.||||+||||.+. ..+||+|||.+..
T Consensus 265 iVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999976 999999888878899999999999999999999998 99999999999999654 4699999999987
Q ss_pred cCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE 527 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~ 527 (658)
....-. ....+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+..+
T Consensus 341 ~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 341 ESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 643322 45667789999999999999999999999999999999887776654
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.20 Aligned_cols=266 Identities=25% Similarity=0.388 Sum_probs=201.0
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++++|...+.||+|+||.||+|... +++.||+|++...........+.+|+++++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4678999999999999999999875 688999999875433444456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+. ++|.+++.. ....+++..+..++.|++.||.|||+. +|+|+||||+|||++.++++||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9996 677777643 234588889999999999999999998 99999999999999999999999999987643322
Q ss_pred ccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcC---------cc
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG---------TH 545 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---------~~ 545 (658)
. ......+++.|+|||++.+. .++.++||||||+++|||++|+.||.......+.+. ..+...... ..
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 158 Q-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLE-KIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred C-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHH-HHHHHcCCCChhhhhhhhhc
Confidence 1 12234578899999998764 578899999999999999999999975543222221 122211100 00
Q ss_pred cccccccC---CCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 546 WELMDESL---DPNEC-----TKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 546 ~~~~d~~l---~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
........ .+... .......+.+++.+|++.||.+|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000 00000 0011346889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.96 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=196.5
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHH-HhccCCCccceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRL-ISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
++|++.+.||+|+||.||+++.+ +|+.||+|++..........++..|+.. ++.++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999976 6899999998764333344556666665 566799999999999999999999999
Q ss_pred ccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 397 YMANSSLDKFLFGE--KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 397 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|++ |+|.+++... ....+++..++.++.||+.||.|||++ .+++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 6888877542 234699999999999999999999984 27999999999999999999999999999865432
Q ss_pred CccccccccCCccccccccccc----CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIH----GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~----~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
. ..+...++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.......+.+.. .. .+..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~-~~~~----- 225 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ----VV-EEPS----- 225 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH----HH-hcCC-----
Confidence 2 1233568889999998854 45688999999999999999999998643322221111 11 1111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
..+. ....+..+.+++..||+.+|.+||++.+|++
T Consensus 226 ~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 PQLP----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 1123456899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=302.15 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=200.1
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccccc---------ccHHHHHHHHHHHhccCCCccceeeeEeecCC
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR---------RTLSDFENEVRLISNVHHRNLIRLLGCCSQGP 389 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 389 (658)
+|...+.||+|+||.||+|... +++.+|+|.+...... ...+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999865 6889999987532110 11346788999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +++||||+|+||++++++.++|+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 99999999999999999843 35799999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcc-ccccccCCcccccccccccCC--CCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccc
Q 006168 470 LLPENQSH-LSTKFAGTLGYTAPEYAIHGQ--LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHW 546 (658)
Q Consensus 470 ~~~~~~~~-~~~~~~gt~~y~APE~~~~~~--~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 546 (658)
........ ......|+..|+|||.+.... ++.++||||||++++|+++|+.|+...... ....+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~- 230 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMFKLGNKRSA- 230 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHHHhhccccC-
Confidence 65432211 123456889999999987654 889999999999999999999998533221 111111111111
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 547 ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 547 ~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+. .......+..+.+++..||+.+|.+|||+.+|++.
T Consensus 231 ~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 PPIP-----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CcCC-----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111 11112335679999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=318.04 Aligned_cols=265 Identities=25% Similarity=0.332 Sum_probs=200.0
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecC-----
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG----- 388 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 388 (658)
...++|...+.||+|+||.||++... .++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45578999999999999999999865 58899999986532 223346778899999999999999999988543
Q ss_pred -CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccC
Q 006168 389 -PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL 467 (658)
Q Consensus 389 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGl 467 (658)
...++||||+++ +|.+.+. ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999976 6766662 3488999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhh--HHH-----------
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEY--LLK----------- 534 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~--l~~----------- 534 (658)
++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......... ...
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98653322 223457899999999999989999999999999999999999999754321110 000
Q ss_pred ----HHHHHhhcCcc------cccccccC-C-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 535 ----RAWRLYENGTH------WELMDESL-D-PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 535 ----~~~~~~~~~~~------~~~~d~~l-~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
........... .......+ . ...........+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000000 00000000 0 001112234568999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=310.07 Aligned_cols=256 Identities=20% Similarity=0.279 Sum_probs=203.0
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|...+.||+|+||.||++... .++.|++|.+.... .......+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999976 57899999987532 1234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 99999999999943 35689999999999999999999998 99999999999999999999999999986421110
Q ss_pred --------------ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh
Q 006168 476 --------------SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYE 541 (658)
Q Consensus 476 --------------~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~ 541 (658)
........++..|+|||++.+..++.++||||||+++|||++|+.||..... ..+... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--~~~~~~---~~~ 230 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--EELFGQ---VIS 230 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH---HHh
Confidence 0011134678899999999988999999999999999999999999864322 111111 111
Q ss_pred cCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 006168 542 NGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593 (658)
Q Consensus 542 ~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~ 593 (658)
+.. ..+. .....+..+.+++.+||+.+|++||+..++.+.|+.
T Consensus 231 -~~~---~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 -DDI---EWPE-----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -ccc---CCCC-----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 100 0000 011234568999999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=308.49 Aligned_cols=248 Identities=26% Similarity=0.392 Sum_probs=199.7
Q ss_pred CCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccC
Q 006168 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMA 399 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 399 (658)
|.....||+|+||.||++... ++..||||.+... .....+.+.+|+.+++.++|+||+++++.+..++..++||||++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 334467999999999999975 5889999998652 33445678899999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccc
Q 006168 400 NSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS 479 (658)
Q Consensus 400 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 479 (658)
+++|.+++. ...+++.++..++.||+.||.|||+. +|+||||||+||++++++.+||+|||++........ ..
T Consensus 103 ~~~L~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 175 (292)
T cd06658 103 GGALTDIVT---HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KR 175 (292)
T ss_pred CCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cC
Confidence 999999883 34689999999999999999999998 999999999999999999999999999876533222 12
Q ss_pred ccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCC
Q 006168 480 TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECT 559 (658)
Q Consensus 480 ~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 559 (658)
....|+..|+|||.+.+..++.++||||||+++|||++|+.|+....... ....... .+...+ . ..
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~~---------~~~~~~-~--~~ 241 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AMRRIRD---------NLPPRV-K--DS 241 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh---------cCCCcc-c--cc
Confidence 33568899999999988899999999999999999999999986533211 1111100 011111 0 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 560 KEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 560 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
......+..++..||+.||.+|||+.++++.
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1234568899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=305.20 Aligned_cols=264 Identities=27% Similarity=0.445 Sum_probs=199.9
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|+..+.||+|++|.||+|..+ +++.||+|.+...........+.+|++++++++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67888999999999999999976 68899999987543333345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++ +|.+++... ...+++.....++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LDT-DLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 985 999988543 34689999999999999999999998 999999999999999999999999999875432211
Q ss_pred ccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCc--cc-------c
Q 006168 478 LSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGT--HW-------E 547 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--~~-------~ 547 (658)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||......... ....++...... .+ +
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ-LHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-HHHHHHhcCCCChhhhhhhhhccc
Confidence 1223356889999999875 45889999999999999999999998655422211 111121111100 00 0
Q ss_pred cccccC---CCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 548 LMDESL---DPNE-----CTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 548 ~~d~~l---~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
...... .... ........+.+++..||+.+|++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 0000 00011256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.34 Aligned_cols=264 Identities=26% Similarity=0.398 Sum_probs=203.9
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+|.+.+.||+|++|.||+|... +|+.|++|++..... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999975 689999999875332 33457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+ +++|.+++... ...+++.+++.++.||+++|.|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 99999998543 35699999999999999999999998 9999999999999999999999999999876544322
Q ss_pred ccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcC-----------cc
Q 006168 478 LSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG-----------TH 545 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~-----------~~ 545 (658)
......++..|+|||.+.+. .++.++||||||++++||++|++++...... ............. ..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI--EQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH--HHHHHHHHHcCCCChHHHhhccCcch
Confidence 23345788999999998654 4689999999999999999997777544321 1111111111100 00
Q ss_pred cccccccCCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 546 WELMDESLDP----NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 546 ~~~~d~~l~~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+..+...... .....+....+.+++.+||+.+|.+|||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 00111234679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.99 Aligned_cols=255 Identities=26% Similarity=0.417 Sum_probs=203.1
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCC----
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGP---- 389 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~---- 389 (658)
.++++|+..+.||+|++|.||+|..+ +++.+++|.+... ....+.+.+|+++++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII--EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 45689999999999999999999986 5789999998653 23457789999999999 7999999999996543
Q ss_pred --eEEEEEeccCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeec
Q 006168 390 --ELILVYEYMANSSLDKFLFGEK--RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADF 465 (658)
Q Consensus 390 --~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~Df 465 (658)
..++||||+++++|.+++.... ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence 5899999999999999986433 45799999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCCCccccccccCCccccccccccc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh
Q 006168 466 GLARLLPENQSHLSTKFAGTLGYTAPEYAIH-----GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLY 540 (658)
Q Consensus 466 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~ 540 (658)
|++....... .......|+..|+|||++.. ..++.++||||||++++||++|+.||....... .+. +..
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~----~~~ 231 (275)
T cd06608 158 GVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALF----KIP 231 (275)
T ss_pred ccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHH----Hhh
Confidence 9987654322 22234568899999998753 356789999999999999999999986432211 111 111
Q ss_pred hcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 541 ENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 541 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+.. +. ...+......+.+++.+||..||++|||+.+|++.
T Consensus 232 -~~~~-----~~---~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 -RNPP-----PT---LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -ccCC-----CC---CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1100 01 11122345679999999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=303.56 Aligned_cols=248 Identities=27% Similarity=0.460 Sum_probs=203.2
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
-|...+.||+|+||.||+|... +++.+|+|.+...........+.+|+.++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667789999999999999865 688999999865444445678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++++|.+++. ...+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||++..+..... .
T Consensus 85 ~~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06641 85 GGGSALDLLE---PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence 9999999983 34689999999999999999999998 999999999999999999999999999876643221 1
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 558 (658)
.....++..|+|||++.+..++.++||||||++++||++|+.|+...... .... . ..... ....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~---~-~~~~~----------~~~~ 221 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLF---L-IPKNN----------PPTL 221 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHH---H-HhcCC----------CCCC
Confidence 22356788999999998888999999999999999999999998643321 1111 1 11111 1112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 559 TKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 559 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....+..+.+++.+||+.+|.+||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 22334568899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=301.35 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=198.9
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc----ccccHHHHHHHHHHHhccCCCccceeeeEeecC--CeE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI----SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG--PEL 391 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 391 (658)
++|++.+.||+|+||.||++..+ +++.||+|.+.... .....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999976 58899999875321 122346788999999999999999999998663 568
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||+++++|.+++.. ...+++....+++.|++.+|.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 899999999999999843 34588999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCc--cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccc
Q 006168 472 PENQS--HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 472 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||....... .. .+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~----~~~~~~~~----- 226 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-AI----FKIATQPT----- 226 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-HH----HHHhcCCC-----
Confidence 32211 11223568899999999988889999999999999999999999986432211 11 11110000
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....+......+.+++.+|+. +|++||+++||++.
T Consensus 227 -----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 -----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 112334455678889999985 89999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.53 Aligned_cols=249 Identities=27% Similarity=0.466 Sum_probs=202.7
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC---CCccceeeeEeecCCeEEEEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH---HRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~ 395 (658)
.|+..+.||+|+||.||+|.+. +++.||+|.+..........++.+|+.++++++ |||++++++++..++..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677889999999999999974 689999999876545556678899999999996 999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++++|.+++.. ..+++..++.++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 99999999999843 3799999999999999999999998 99999999999999999999999999998765443
Q ss_pred ccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
. ......|+..|+|||.+.++ .++.++||||||+++|+|++|+.||....... .. ....... .+.+.
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~-~~~~~~~-----~~~~~ 223 (277)
T cd06917 156 S-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AM-MLIPKSK-----PPRLE 223 (277)
T ss_pred c-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hh-hccccCC-----CCCCC
Confidence 2 22345688999999998764 46899999999999999999999986533211 00 0000100 01111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.. ..+..+.+++.+||+.||++||++.++++.
T Consensus 224 ~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 224 DN----GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred cc----cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11 134568999999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.49 Aligned_cols=255 Identities=23% Similarity=0.398 Sum_probs=199.4
Q ss_pred CCccCcccccCceEEEEEEec----CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCC------
Q 006168 321 FSEENKLGEGGFGDIYKGTLK----NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP------ 389 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 389 (658)
|.+.+.||+|+||.||+|.+. +++.||||++.... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999864 36889999986532 2334667889999999999999999999885432
Q ss_pred eEEEEEeccCCCCHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeec
Q 006168 390 ELILVYEYMANSSLDKFLFGEK----RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADF 465 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~Df 465 (658)
..++++||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 3478999999999998874322 22488999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcC
Q 006168 466 GLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENG 543 (658)
Q Consensus 466 Gla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 543 (658)
|+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.|+..... ..+... ....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~----~~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNY----LIKG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHH----HHcC
Confidence 999866433221 1223445678999999998899999999999999999999 7888754322 112111 1111
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 544 THWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 544 ~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.... .+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 232 ~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1000 0112335799999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.73 Aligned_cols=245 Identities=25% Similarity=0.351 Sum_probs=201.4
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|+..+.||+|+||.||++... +++.+|+|.+.... .......+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999976 58999999986421 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++++|.+++.. ...+++..+..++.|+++||.|||+. +|+|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 99999999999843 46799999999999999999999998 9999999999999999999999999999876443
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.....+++.|+|||.+.+...+.++||||||+++++|++|+.|+..... ..... ....+.
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~----~~~~~~----------- 214 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--IQIYE----KILEGK----------- 214 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHH----HHhcCC-----------
Confidence 2345688999999999888899999999999999999999999865432 11111 111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRP-----TMSEVVA 589 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 589 (658)
...+......+.+++.+||+.||.+|| ++.|+++
T Consensus 215 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 011222345789999999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=306.26 Aligned_cols=262 Identities=26% Similarity=0.413 Sum_probs=200.7
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+|+..+.||.|++|.||+|+.. +++.||||++.... .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999976 68899999986532 223346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+. ++|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 6899988665566799999999999999999999998 999999999999999999999999999876543221
Q ss_pred ccccccCCcccccccccccCC-CCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcC--c----------
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQ-LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG--T---------- 544 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~-~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~---------- 544 (658)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||........ +... .+..... .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRI-FRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHH-HHHhCCCChhhhhhhhHHHH
Confidence 122345688999999887654 68899999999999999999999875443211 1110 0000000 0
Q ss_pred ----ccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 545 ----HWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 545 ----~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
........+ ..........+.+++.+||+.||.+|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPKWARQDF--SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhcccccccCH--HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000 00011123457899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=298.17 Aligned_cols=253 Identities=24% Similarity=0.317 Sum_probs=208.2
Q ss_pred cCCCccCcccccCceEEEEEEecC-CcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
+.|+..+.||+|.-|+||++.+++ +..+|+|++.+. .......+.+.|.+||+.++||.++.|+..++.++..+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456667899999999999999885 588999999764 23455677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC--
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE-- 473 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~-- 473 (658)
|||+||+|..+++.+....+++..+.-++..|+-||+|||-. |||.|||||+||||.++|++-|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999999877777899999999999999999999998 999999999999999999999999998753211
Q ss_pred -------------------------------CCc----------------------cccccccCCcccccccccccCCCC
Q 006168 474 -------------------------------NQS----------------------HLSTKFAGTLGYTAPEYAIHGQLS 500 (658)
Q Consensus 474 -------------------------------~~~----------------------~~~~~~~gt~~y~APE~~~~~~~s 500 (658)
... ..+..++||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 011246899999999999999999
Q ss_pred CcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCC
Q 006168 501 EKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANS 580 (658)
Q Consensus 501 ~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~ 580 (658)
.+.|.|+|||++|||+.|+-||.+.+...- +. .++-+.+.....+ ..+..+.+||+..|.+||.+
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~T-l~-------------NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKET-LR-------------NIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhh-HH-------------HHhcCCCcCCCCC-cchhHHHHHHHHHhccChhh
Confidence 999999999999999999999987665321 11 1111111111111 44567999999999999999
Q ss_pred CCC----HHHHHH
Q 006168 581 RPT----MSEVVA 589 (658)
Q Consensus 581 RPt----~~evl~ 589 (658)
|.- +.||-+
T Consensus 379 Rlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 379 RLGSKRGAAEIKR 391 (459)
T ss_pred hhccccchHHhhc
Confidence 998 777764
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=315.69 Aligned_cols=262 Identities=26% Similarity=0.379 Sum_probs=197.4
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecC-----
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG----- 388 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 388 (658)
...++|...+.||+|+||.||++... +++.||||++.... .......+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45578999999999999999999865 68899999986532 223345678899999999999999999987533
Q ss_pred -CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccC
Q 006168 389 -PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL 467 (658)
Q Consensus 389 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGl 467 (658)
...++++|++ +++|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence 4578999998 679988873 35699999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc----
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN---- 542 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~---- 542 (658)
++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ...........
T Consensus 165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 238 (343)
T cd07878 165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGTPSPE 238 (343)
T ss_pred ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCCHH
Confidence 9865432 234578999999999877 578999999999999999999999986543211 11111110000
Q ss_pred -------Ccccccccc--cCCCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 543 -------GTHWELMDE--SLDPNE---CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 543 -------~~~~~~~d~--~l~~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
......+.. ...... ........+.+++.+|++.||.+|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 000000 000112357899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=315.32 Aligned_cols=262 Identities=26% Similarity=0.346 Sum_probs=199.5
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecC------
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG------ 388 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 388 (658)
..++|...+.||+|+||.||++... .++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999965 58899999986532 233456788999999999999999999987543
Q ss_pred CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCc
Q 006168 389 PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLA 468 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla 468 (658)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999975 7777663 3488999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHH----------
Q 006168 469 RLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWR---------- 538 (658)
Q Consensus 469 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~---------- 538 (658)
+...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||....... ....+.+
T Consensus 174 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 174 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGTPCPEFM 249 (364)
T ss_pred cccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHH
Confidence 8653322 2234578999999999999999999999999999999999999997544311 0000000
Q ss_pred ---------HhhcCcc-----c-ccccccCCC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 539 ---------LYENGTH-----W-ELMDESLDP--NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 539 ---------~~~~~~~-----~-~~~d~~l~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+... . +.....+.+ ..........+.+++.+|++.||.+|||+.++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 0 000000000 01111223568899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=308.88 Aligned_cols=196 Identities=24% Similarity=0.401 Sum_probs=161.1
Q ss_pred cCcccccCceEEEEEEecC---CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEee--cCCeEEEEEecc
Q 006168 324 ENKLGEGGFGDIYKGTLKN---GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCS--QGPELILVYEYM 398 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lV~E~~ 398 (658)
..+||+|+||.||+|+.++ +..||+|.+... .....+.+|++++++++||||+++++++. .+...++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT---GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC---CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 4689999999999999753 578999988642 23356789999999999999999999884 356789999998
Q ss_pred CCCCHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE----cCCCCeEEeeccC
Q 006168 399 ANSSLDKFLFGE-------KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL----DDDLQPKIADFGL 467 (658)
Q Consensus 399 ~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll----~~~~~~kl~DfGl 467 (658)
.+ +|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 75 777766321 123488999999999999999999998 99999999999999 5667899999999
Q ss_pred ccccCCCCcc--ccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCC
Q 006168 468 ARLLPENQSH--LSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKG 526 (658)
Q Consensus 468 a~~~~~~~~~--~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~ 526 (658)
++.+...... ......||+.|+|||++.+. .++.++||||||+++|||+||+.||....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 9876543221 12345789999999998764 58999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=308.86 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=199.6
Q ss_pred CccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCC
Q 006168 322 SEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 322 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
.....||+|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec-ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 34457999999999999975 6899999998653 334456788999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
++|.+++. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..+..... ...
T Consensus 103 ~~L~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 103 GALTDIVS---QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred CCHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence 99999873 34689999999999999999999998 999999999999999999999999999876543321 223
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCH
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTK 560 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 560 (658)
...|+..|+|||++.+..++.++||||||++++||++|+.||....... ... . ...... .. .....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~---~-~~~~~~-~~-------~~~~~ 241 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMK---R-LRDSPP-PK-------LKNAH 241 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH---H-HhccCC-CC-------ccccC
Confidence 4568899999999998899999999999999999999999987543211 111 1 111100 00 00111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 561 EAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 561 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.....+.+++.+||+.+|.+||++.+|++.
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 223468899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.41 Aligned_cols=251 Identities=22% Similarity=0.394 Sum_probs=203.5
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+|...+.||+|+||.||++..+ +|..+|+|.+.... .....+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999976 58899999986531 223456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC-eEEeeccCccccCCCCc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ-PKIADFGLARLLPENQS 476 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~-~kl~DfGla~~~~~~~~ 476 (658)
+++++|.+++.......+++..+..++.|+++||.|||+. +++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 9999999999655555689999999999999999999998 9999999999999998854 6999999998764332
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
.......|++.|+|||++.+..++.++||||||++++||++|+.|+...... +....... +...
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~~---------- 220 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-----QLVLKICQ-GYFA---------- 220 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHhc-ccCC----------
Confidence 2223356889999999998888999999999999999999999998643321 11111111 1110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
......+..+.+++.+||+.+|++|||+.+|++.
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111233569999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.80 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=204.2
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|...+.||+|+||.||++... +++.|++|.+... .....+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 68888999999999999999865 6789999998642 334456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 98 LAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCCcHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 99999999984 34588999999999999999999998 999999999999999999999999999876544332
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
......+++.|++||.+.++.++.++||||||+++||+++|+.||.......... .....+. + ...
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-----~~~~~~~------~---~~~ 236 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNGT------P---ELQ 236 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-----ehhcCCC------C---CCC
Confidence 2233468889999999998899999999999999999999999996543311100 0000000 0 011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+......+.+++.+||+.+|.+||++.+++.+
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122344568899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.05 Aligned_cols=248 Identities=24% Similarity=0.316 Sum_probs=203.5
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
+|...+.||+|+||.||++..+ +++.||+|.+.... .....+.+.+|++++++++||||+++++++..++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999976 58999999987532 22456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++++|.+++.. ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQ--KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 9999999999843 35799999999999999999999998 99999999999999999999999999998764432
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+......... ........ . ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~--~---------~~ 219 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD---QIRAKQET--A---------DV 219 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH---HHHHHhcc--c---------cc
Confidence 223456888999999999888999999999999999999999998765432111 11111110 0 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTM--SEVV 588 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~--~evl 588 (658)
..+...+..+.+++.+||+.||.+||+. +|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1222334679999999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=303.55 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=197.9
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC-CCccceeeeEeecCCeEEEEEec
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+|...+.||+|+||.||++... +++.+|+|.+...........+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556788999999999999976 589999999875443445667899999999996 99999999999988999999999
Q ss_pred cCCCCHHHH---hhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 398 MANSSLDKF---LFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 398 ~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
+.. +|.++ +.......+++..+..++.+++.||+|||+. .+++||||||+||+++.++.+||+|||++..+...
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 874 55443 3333346799999999999999999999973 28999999999999999999999999999765432
Q ss_pred CccccccccCCcccccccccccC---CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHG---QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~---~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
.. .....|+..|+|||.+.+. .++.++||||||+++|||++|+.||..... ..+...+... +.. +
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~-~~~-----~ 229 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVK-GDP-----P 229 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcC-CCC-----C
Confidence 21 2234678899999998776 689999999999999999999999865331 1111111111 111 1
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+ ........+..+.+++.+||+.+|++|||+.+|++.
T Consensus 230 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 IL-SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cC-CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 111112345679999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=302.62 Aligned_cols=263 Identities=27% Similarity=0.400 Sum_probs=199.9
Q ss_pred CCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
|+..+.||.|++|.||+|..+ +|+.||+|++..... ......+.+|++++++++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999975 699999999875322 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
+ ++|.+++.......+++..++.++.|+++||.|||+. +++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 6899998654445799999999999999999999998 9999999999999999999999999999765432211
Q ss_pred cccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh-c-Ccc-------ccc
Q 006168 479 STKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYE-N-GTH-------WEL 548 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~-~-~~~-------~~~ 548 (658)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||.......+ +.. ..+... . ... .+.
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFR-IFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHHHhCCCChHHhhhhhhchhh
Confidence 2233568899999988664 578999999999999999999999875443211 111 111000 0 000 000
Q ss_pred ---cccc--CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 549 ---MDES--LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 549 ---~d~~--l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+... ..........+..+.+++.+|++.+|.+|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 00001112233568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=300.89 Aligned_cols=254 Identities=28% Similarity=0.409 Sum_probs=206.2
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
..++.|+..+.||+|++|.||++.++ +++.+++|++..... ....+.+|++++++++|+|++++++++...+..++|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 34567888899999999999999987 688999999875322 567789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
+||+++++|.+++.... ..+++..++.++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 94 MEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 99999999999995432 3799999999999999999999998 9999999999999999999999999998765432
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
.. ......++..|++||++.+..++.++||||||+++|+|++|+.|+........ . . .. ......
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-~-~---~~-~~~~~~-------- 234 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-L-F---LI-TTKGIP-------- 234 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-H-H---HH-HhcCCC--------
Confidence 21 12234578899999999888899999999999999999999999864332111 1 1 11 011110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
........+..+.+++.+||+.+|.+|||+.+|++.
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 001111234568999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=303.58 Aligned_cols=263 Identities=27% Similarity=0.390 Sum_probs=200.6
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccccc----ccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR----RTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
+|...+.||+|++|.||+|..+ +++.|++|++...... .....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999976 6899999999753222 2245567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+ +++|.+++.... ..+++..++.++.||++||.|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 899999995432 3699999999999999999999998 9999999999999999999999999999876443
Q ss_pred CccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcC---------c
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG---------T 544 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---------~ 544 (658)
.. ......+++.|+|||.+.+ ..++.++||||||++++||++|..++....... ......+..... .
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhhhhccc
Confidence 22 1223456788999998865 467899999999999999999977775443311 111111111000 0
Q ss_pred ccccccccC----CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 545 HWELMDESL----DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 545 ~~~~~d~~l----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
......... ............+.+++.+||+.+|++|||+.||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000 0001112235678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=309.77 Aligned_cols=265 Identities=25% Similarity=0.371 Sum_probs=199.6
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecC-----Ce
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG-----PE 390 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 390 (658)
.+++|.+.++||+|+||.||+|+.. +|+.||+|++...........+.+|+.++++++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999865 68999999986433344556788999999999999999999987543 35
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.++|+||+.+ +|.+++ ....+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 83 ~~lv~e~~~~-~l~~~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 83 VYIVQELMET-DLYKLI---KTQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEEehhccc-CHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 8999999975 888777 335699999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCcc--ccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCc---
Q 006168 471 LPENQSH--LSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGT--- 544 (658)
Q Consensus 471 ~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--- 544 (658)
....... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCCHHH
Confidence 5432221 1124568899999998755 468999999999999999999999986543211 1111111111000
Q ss_pred --------cccc---ccc--cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 545 --------HWEL---MDE--SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 545 --------~~~~---~d~--~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+. +.. .............++.+++.+||+.+|++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 000 000000001224568999999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=303.94 Aligned_cols=247 Identities=29% Similarity=0.462 Sum_probs=198.5
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
+.|...+.||+|+||.||+|... +++.||+|.+... ......+++.+|+++++.++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56888899999999999999976 6899999988642 22233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+. |+|.+++.. ....+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9997 577777642 335699999999999999999999998 9999999999999999999999999998765332
Q ss_pred ccccccccCCcccccccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 476 SHLSTKFAGTLGYTAPEYAI---HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~---~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
....++..|+|||++. .+.++.++||||||+++|||++|+.|+........ ...... ...
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-----~~~~~~-~~~------- 231 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQ-NDS------- 231 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-----HHHHhc-CCC-------
Confidence 2346788999999874 45688999999999999999999999865432111 111111 000
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+.......+..+.+++.+||+.+|++||++.+|+..
T Consensus 232 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 --PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111122345679999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=300.60 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=200.9
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
.|...+.||+|++|.||++..+ +++.+++|++.. ......+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~-~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDL-RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEec-cchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 4555679999999999999965 688999998864 23344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++........ .
T Consensus 99 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 99 EGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred CCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 99999999843 5689999999999999999999998 999999999999999999999999998876543222 2
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 558 (658)
.....|++.|+|||.+.+..++.++||||||++++||++|+.|+...... .... . ...... +.+ ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~~---~-~~~~~~-----~~~---~~ 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAMK---R-IRDNLP-----PKL---KN 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHHH---H-HHhcCC-----CCC---cc
Confidence 23356889999999998888999999999999999999999998653321 1111 1 111110 000 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 559 TKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 559 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....+..+.+++.+||+.+|++|||+.++++.
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 11234579999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.00 Aligned_cols=250 Identities=27% Similarity=0.449 Sum_probs=204.7
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
+|+..+.||+|++|.||++..+ +++.+++|++..... .....+.+|++++++++|+|++++++++...+..++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 4677889999999999999986 688999999876322 45678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++++|.+++.... ..+++..+..++.|++++|.+||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 80 SGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 9999999985432 5799999999999999999999998 999999999999999999999999999987654332
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 558 (658)
.....++..|++||++....++.++||||||+++++|++|+.|+.......... .. ......... .
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-----~~-~~~~~~~~~--------~ 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF-----KI-ATNGPPGLR--------N 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH-----HH-HhcCCCCcC--------c
Confidence 234568899999999998889999999999999999999999986543211110 00 001111110 0
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 559 TKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 559 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.......+.+++.+||+.||++|||+.++++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11124569999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=295.56 Aligned_cols=243 Identities=23% Similarity=0.347 Sum_probs=197.2
Q ss_pred ccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCCH
Q 006168 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSL 403 (658)
Q Consensus 327 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 403 (658)
||.|++|.||+++.. +++.+++|.+.... .....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999976 48899999986532 223457789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccccccc
Q 006168 404 DKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFA 483 (658)
Q Consensus 404 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 483 (658)
.+++.. ...+++..+..++.||++||.|||+. +++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRD--RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 999943 34589999999999999999999998 99999999999999999999999999998764432 222356
Q ss_pred CCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHH
Q 006168 484 GTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAA 563 (658)
Q Consensus 484 gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 563 (658)
++..|++||.+....++.++||||||+++|||++|+.|+.....+........ . .+.. ....+....
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~-~~~~---------~~~~~~~~~ 220 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI---L-KGNG---------KLEFPNYID 220 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH---h-ccCC---------CCCCCcccC
Confidence 78899999999888899999999999999999999999976553222221111 1 0000 111222225
Q ss_pred HHHHHHHHHccccCCCCCCC-----HHHHHH
Q 006168 564 EKVVEIALMCTQSAANSRPT-----MSEVVA 589 (658)
Q Consensus 564 ~~l~~li~~cl~~dp~~RPt-----~~evl~ 589 (658)
..+.+++..||+.+|.+||+ +.|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 67999999999999999999 555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=299.04 Aligned_cols=245 Identities=28% Similarity=0.352 Sum_probs=195.2
Q ss_pred ccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCCH
Q 006168 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSL 403 (658)
Q Consensus 327 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 403 (658)
||+|+||+||++..+ +|+.+|+|.+.... .......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 68899999986422 223345677899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccccccc
Q 006168 404 DKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFA 483 (658)
Q Consensus 404 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 483 (658)
.+++.......+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++....... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 9999655545799999999999999999999998 99999999999999999999999999987654321 222346
Q ss_pred CCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHH
Q 006168 484 GTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAA 563 (658)
Q Consensus 484 gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 563 (658)
++..|+|||++.++.++.++||||||+++++|++|+.||......... ......... . ....+....
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~--------~---~~~~~~~~~ 222 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK--EELKRRTLE--------M---AVEYPDKFS 222 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH--HHHHhcccc--------c---cccCCccCC
Confidence 788999999998888999999999999999999999998654431110 000000000 0 111222335
Q ss_pred HHHHHHHHHccccCCCCCC-----CHHHHHH
Q 006168 564 EKVVEIALMCTQSAANSRP-----TMSEVVA 589 (658)
Q Consensus 564 ~~l~~li~~cl~~dp~~RP-----t~~evl~ 589 (658)
..+.+++..||+.+|.+|| ++.++++
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 5789999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=301.42 Aligned_cols=265 Identities=25% Similarity=0.374 Sum_probs=197.5
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcc-CCCccceeeeEeecCCe-----
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPE----- 390 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~----- 390 (658)
++|+..+.||+|+||.||+|.+. +++.||+|.+..... ......+.+|+.+++++ +||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999976 689999998865322 22346788999999999 46999999999877655
Q ss_pred EEEEEeccCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC-CCCeEEeecc
Q 006168 391 LILVYEYMANSSLDKFLFGEK---RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD-DLQPKIADFG 466 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~-~~~~kl~DfG 466 (658)
.++||||+++ +|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 8888875433 23589999999999999999999998 9999999999999998 8899999999
Q ss_pred CccccCCCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc--C
Q 006168 467 LARLLPENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN--G 543 (658)
Q Consensus 467 la~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~ 543 (658)
++..+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||......... . ...+.... .
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~-~-~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL-L-HIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH-H-HHHHHhCCCCh
Confidence 9986533221 1223356788999998865 45789999999999999999999998754432111 1 11111100 0
Q ss_pred cccccc-c-------ccCCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 544 THWELM-D-------ESLDP---NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 544 ~~~~~~-d-------~~l~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+... . +...+ ..........+.+++..||+.||.+||++.|++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000 0 00000 00011245668999999999999999999998853
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=299.48 Aligned_cols=263 Identities=27% Similarity=0.464 Sum_probs=201.4
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
+|+..++||+|++|.||+|+.+ +|+.||||++...........+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999986 588999999876544445567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 399 ANSSLDKFLFGEK-RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 399 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
++ +|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 8888875433 34599999999999999999999998 999999999999999999999999999976543221
Q ss_pred ccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcC--ccc------cc
Q 006168 478 LSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG--THW------EL 548 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~~~------~~ 548 (658)
......++..|++||.+.+. .++.++||||||+++|||++|+.||....... ......+..... ..+ ..
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED--QLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhHHHHhcCch
Confidence 12234578899999988664 57889999999999999999999987544321 111111110000 000 00
Q ss_pred ccccCCC------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 549 MDESLDP------NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 549 ~d~~l~~------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
+...... .......+..+.+++..|++.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0011123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.74 Aligned_cols=263 Identities=25% Similarity=0.378 Sum_probs=201.1
Q ss_pred CCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecC--CeEEEEEe
Q 006168 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG--PELILVYE 396 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~E 396 (658)
|++.+.||+|++|.||+|+.. +++.+|+|++.... .......+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999977 48899999997643 233456788999999999999999999999887 89999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++ +|.+++... ...+++..++.++.||++||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9985 898888433 25799999999999999999999998 999999999999999999999999999987655433
Q ss_pred cccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc--Cccccccc---
Q 006168 477 HLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN--GTHWELMD--- 550 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~~~~~~~d--- 550 (658)
...+...++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ......+.... ...+..+.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE--QLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCchhhccccccch
Confidence 22334567889999998765 467899999999999999999999987554321 11111111100 00000000
Q ss_pred ------ccCC-----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 551 ------ESLD-----PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 551 ------~~l~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.... ........+..+.+++.+||+.+|.+||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000 000111125678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.04 Aligned_cols=252 Identities=21% Similarity=0.368 Sum_probs=201.4
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEccc-ccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAI-GISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 395 (658)
.+.|++.++||+||.+.||++...+.+.+|+|++.. ..+.+....|.+|+.+|.+| .|.+||+|++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 456888999999999999999999889999888754 34556678899999999999 4999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||=+. +|..+|.........| .+..+..|+++++.++|++ +|||-||||.|+|+-. |.+||+|||+|..+..+.
T Consensus 440 E~Gd~-DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECGDI-DLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecccc-cHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 98654 9999996554444556 7778999999999999999 9999999999999975 589999999999887665
Q ss_pred ccc-cccccCCcccccccccccC-----------CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcC
Q 006168 476 SHL-STKFAGTLGYTAPEYAIHG-----------QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG 543 (658)
Q Consensus 476 ~~~-~~~~~gt~~y~APE~~~~~-----------~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 543 (658)
+.. ....+||+.||+||.+... +.+.+|||||+|||||+|+.|+.||..... .+ .+
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~-aK----- 581 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QI-AK----- 581 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HH-HH-----
Confidence 443 3367999999999998532 356899999999999999999999864221 11 11
Q ss_pred cccccccccC--CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 544 THWELMDESL--DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 544 ~~~~~~d~~l--~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+..+.|+.. .....+.. .+++++++.||+.||++|||..|||+.
T Consensus 582 -l~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 -LHAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -HHhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 112233321 11111111 239999999999999999999999964
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.33 Aligned_cols=264 Identities=23% Similarity=0.356 Sum_probs=200.0
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-cccHHHHHHHHHHHhccCCCccceeeeEeecC--CeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNVHHRNLIRLLGCCSQG--PELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 394 (658)
++|+..+.||+|+||.||+|..+ +++.+++|.+..... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888899999999999999986 588999999875322 22234577899999999999999999998776 889999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++ +|.+++... ...+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++..+...
T Consensus 85 ~e~~~~-~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVEH-DLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcCc-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999985 999888542 34699999999999999999999998 9999999999999999999999999999876543
Q ss_pred CccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchh--hHHH-------HHHHHhhc--
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE--YLLK-------RAWRLYEN-- 542 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~--~l~~-------~~~~~~~~-- 542 (658)
.. ......+++.|+|||.+.+. .++.++||||||++++||++|+.||........ .+.. ..|..+..
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred cc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 22 12234578899999998764 468999999999999999999999875443111 0000 01111100
Q ss_pred ----CcccccccccCCCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 543 ----GTHWELMDESLDPNECTKE-AAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 543 ----~~~~~~~d~~l~~~~~~~~-~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
....+.....+ ...++.. ....+.+++..||+.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000000 0111111 3566889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.30 Aligned_cols=265 Identities=27% Similarity=0.411 Sum_probs=199.3
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
++|+..+.||+|++|.||+|..+ +++.||+|.+..... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999976 688999999865322 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC-CCCeEEeeccCccccCCCC
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD-DLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~-~~~~kl~DfGla~~~~~~~ 475 (658)
|++ ++|.+++.......+++..+..++.||+.||.|||+. +++|+||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 5888877544444578889999999999999999998 9999999999999985 5679999999997654322
Q ss_pred ccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcC--cccc----c
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG--THWE----L 548 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~~~~----~ 548 (658)
...+...+++.|+|||++.+. .++.++||||||+++|+|++|+.||........ +.. ........ ..+. +
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFK-IFRILGTPNEETWPGVTSL 234 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHH-HHHHhCCCChhhccccccc
Confidence 122334678899999988664 578999999999999999999999876443211 111 11111000 0000 0
Q ss_pred cc-----ccCCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 549 MD-----ESLDPN---ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 549 ~d-----~~l~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+ +..... ........++.+++.+|++.+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000000 0111234568999999999999999999999863
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=296.74 Aligned_cols=243 Identities=22% Similarity=0.301 Sum_probs=188.5
Q ss_pred cccccCceEEEEEEec-CCcEEEEEEcccccc--cccHHHHHHHHHHH---hccCCCccceeeeEeecCCeEEEEEeccC
Q 006168 326 KLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS--RRTLSDFENEVRLI---SNVHHRNLIRLLGCCSQGPELILVYEYMA 399 (658)
Q Consensus 326 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 399 (658)
.||+|+||.||++... +++.+|+|.+..... ......+.+|..++ ...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 588999998865321 12223344454433 33479999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccc
Q 006168 400 NSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS 479 (658)
Q Consensus 400 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 479 (658)
+++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.++|+|||++....... .
T Consensus 81 ~~~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 152 (279)
T cd05633 81 GGDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (279)
T ss_pred CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence 999999884 345699999999999999999999998 99999999999999999999999999987653322 2
Q ss_pred ccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCC
Q 006168 480 TKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558 (658)
Q Consensus 480 ~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 558 (658)
....|+..|+|||.+.+ ..++.++||||||++++||++|+.||............ ..... . ....
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~~~------~-----~~~~ 218 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLT------V-----NVEL 218 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH---HHhhc------C-----CcCC
Confidence 23468999999999864 46899999999999999999999999754332111111 11000 0 1112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 006168 559 TKEAAEKVVEIALMCTQSAANSRP-----TMSEVVAL 590 (658)
Q Consensus 559 ~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 590 (658)
+...+..+.+++..||+.||.+|| |+.++++.
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 233456789999999999999999 59888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=298.58 Aligned_cols=249 Identities=22% Similarity=0.346 Sum_probs=209.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.-|..++.||+|.|..|-++++- .|+.||||++.+. ...-...++.+|++.|+-++|||||+||.+......+|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45677889999999999999854 7999999999763 233345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc-CCCCeEEeeccCccccCCCC
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD-DDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~-~~~~~kl~DfGla~~~~~~~ 475 (658)
+=++|+|.+||.. ....+.+....+++.||+.|+.|+|+. .+|||||||+||.+- .-|-+||.|||++-.+....
T Consensus 98 LGD~GDl~DyImK-He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK-HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred ecCCchHHHHHHh-hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999999954 334599999999999999999999998 999999999999875 45889999999998775543
Q ss_pred ccccccccCCcccccccccccCCCC-CcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLS-EKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s-~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
..+..+|+..|-|||++.+..|. ++.||||||||||-|++|+.||+..++.. . +..++|-
T Consensus 174 --kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE-T-------------LTmImDC--- 234 (864)
T KOG4717|consen 174 --KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE-T-------------LTMIMDC--- 234 (864)
T ss_pred --hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-h-------------hhhhhcc---
Confidence 34567999999999999999886 68999999999999999999998655421 1 1112222
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....+.....++.+||..||..||.+|.+.+||+..
T Consensus 235 KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 234566778899999999999999999999998853
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.74 Aligned_cols=268 Identities=26% Similarity=0.348 Sum_probs=200.9
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-cccHHHHHHHHHHHhccCCCccceeeeEeecCC----
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP---- 389 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 389 (658)
...++|++.+.||+|+||.||+|..+ +++.||+|++..... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999986 588999999865322 233456788999999999999999999986654
Q ss_pred ------eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEe
Q 006168 390 ------ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIA 463 (658)
Q Consensus 390 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~ 463 (658)
..++|+||+++ +|.+++.. ....+++..+..++.||+.||.|||+. +|+|+||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES-GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999986 77776643 244699999999999999999999998 99999999999999999999999
Q ss_pred eccCccccCCCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc
Q 006168 464 DFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN 542 (658)
Q Consensus 464 DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 542 (658)
|||++...............++..|+|||.+.+ ..++.++||||||++++||++|+.|+...... ..+....+....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~--~~~~~~~~~~~~ 236 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL--AQLELISRLCGS 236 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCC
Confidence 999998765443222233456788999998865 35789999999999999999999998754321 111111111100
Q ss_pred Cc-----------ccccccccCCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 543 GT-----------HWELMDESLDP----NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 543 ~~-----------~~~~~d~~l~~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.. .....+..... .......+..+.+++..||+.+|.+||++.+|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00000000000 00001124578999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=298.59 Aligned_cols=257 Identities=23% Similarity=0.342 Sum_probs=202.7
Q ss_pred CCCccCcccccCceEEEEEEec----CCcEEEEEEccccc---ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK----NGKIVAVKKLAIGI---SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 391 (658)
+|...+.||+|++|.||+++.. +++.||||.+.... .....+.+.+|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677889999999999999853 57889999886421 123346688999999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||+++++|.+++. ....+++..+..++.|++++|.|||+. +++||||||+||+++.++.++|+|||++..+
T Consensus 81 ~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLY--QREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHh--hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999984 335689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCccccccccCCcccccccccccCC--CCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccc
Q 006168 472 PENQSHLSTKFAGTLGYTAPEYAIHGQ--LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 472 ~~~~~~~~~~~~gt~~y~APE~~~~~~--~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
............|+..|+|||.+.+.. .+.++||||||++++||++|+.|+........ ...........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~------- 227 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSEISRRILKS------- 227 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-HHHHHHHHHcc-------
Confidence 444332233456889999999987665 78899999999999999999999864332111 01111111110
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
. ...+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 228 ~-----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 K-----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred C-----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 111222335688999999999999999999998887653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=289.23 Aligned_cols=252 Identities=29% Similarity=0.465 Sum_probs=206.9
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecC--CeEEEEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG--PELILVY 395 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 395 (658)
+|...+.||+|++|.||+|..+ +++.|++|++.... .....+.+.+|++.+++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999987 68899999986532 124567889999999999999999999999888 8999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++++|.+++... ..+++..++.++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 999999999998543 3899999999999999999999998 99999999999999999999999999998775543
Q ss_pred cc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 476 SH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 476 ~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
.. ......++..|++||.+.....+.++||||||+++++|++|+.|+....... ...+.......
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~---------- 221 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM----AALYKIGSSGE---------- 221 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH----HHHHhccccCC----------
Confidence 21 1234568889999999988889999999999999999999999987654211 11111111011
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....+...+..+.+++.+|++.+|.+||++.++++.
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111222335679999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=324.53 Aligned_cols=268 Identities=21% Similarity=0.338 Sum_probs=190.4
Q ss_pred hcCCCccCcccccCceEEEEEEecC--CcEEEEEE--------------ccc--ccccccHHHHHHHHHHHhccCCCccc
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN--GKIVAVKK--------------LAI--GISRRTLSDFENEVRLISNVHHRNLI 379 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~--------------~~~--~~~~~~~~~~~~E~~~l~~l~h~niv 379 (658)
.++|.+.++||+|+||+||++.++. +...++|. +.+ .........+.+|+++|++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987642 22222221 110 01222345688999999999999999
Q ss_pred eeeeEeecCCeEEEEEeccCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC
Q 006168 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEK---RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD 456 (658)
Q Consensus 380 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~ 456 (658)
++++++...+..++|+|++.. +|.+++.... ...........|+.||+.||.|||+. +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 999999999999999999864 7777664322 12234566778999999999999998 9999999999999999
Q ss_pred CCCeEEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCC-CCCCcc-hhhHHH
Q 006168 457 DLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSS-ETKGEE-GEYLLK 534 (658)
Q Consensus 457 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~-~~~~~~-~~~l~~ 534 (658)
++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.++ ...... ...+..
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 999999999999877554433344567999999999999999999999999999999999987644 322221 122211
Q ss_pred HHHHHhh--cCc-------cccccccc-C--CCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 535 RAWRLYE--NGT-------HWELMDES-L--DPNECT-----KEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 535 ~~~~~~~--~~~-------~~~~~d~~-l--~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.. .... ..+ ..+.++.. + .....+ ......+.+++.+||+.||.+|||+.|+++.
T Consensus 383 ~~-~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 383 II-DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HH-HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11 1100 000 00000000 0 000000 0112356788999999999999999999864
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=295.69 Aligned_cols=260 Identities=23% Similarity=0.336 Sum_probs=195.3
Q ss_pred CCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC-CCccceeeeEeecC--CeEEEEEe
Q 006168 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQG--PELILVYE 396 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~E 396 (658)
|++.++||+|+||.||++... +++.||+|++.............+|+..+.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566789999999999999965 688999999875433333344567889999885 99999999999877 88999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|++ ++|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++. +.+||+|||++........
T Consensus 81 ~~~-~~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKG-RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 997 588887743 235699999999999999999999998 9999999999999999 9999999999987643322
Q ss_pred cccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-----------hcCc
Q 006168 477 HLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLY-----------ENGT 544 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~-----------~~~~ 544 (658)
.....++..|+|||++.. +.++.++|||||||++|||++|+.||....... ......... ....
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHHHHhhcccc
Confidence 223467889999997654 567889999999999999999999996544311 111111110 0000
Q ss_pred ccccccccCCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 545 HWELMDESLDP---NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 545 ~~~~~d~~l~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
......+.... .......+..+.+++.+||+.+|++||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000 00112345789999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=297.95 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=198.2
Q ss_pred CCCccCcccccCceEEEEEEe----cCCcEEEEEEccccc---ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeE
Q 006168 320 KFSEENKLGEGGFGDIYKGTL----KNGKIVAVKKLAIGI---SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 391 (658)
+|++.+.||+|+||.||++.. .+|+.||+|++.... .....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467789999999999999986 368899999986421 122346788999999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||+++++|.+++. ....+++..+..++.|+++||.|||+. +++||||+|+|||++.++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLS--QRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999984 345689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCccccccccCCcccccccccccC--CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccc
Q 006168 472 PENQSHLSTKFAGTLGYTAPEYAIHG--QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 472 ~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
............|+..|+|||.+... .++.++||||||+++|+|++|+.|+....... ............
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~------- 227 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQAEISRRILKS------- 227 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cHHHHHHHhhcc-------
Confidence 44333333345688999999998753 46789999999999999999999986433211 111111111110
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRP-----TMSEVVA 589 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 589 (658)
....+......+.+++.+||+.+|++|| +..++++
T Consensus 228 -----~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 -----EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -----CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0111223345689999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=300.57 Aligned_cols=265 Identities=29% Similarity=0.378 Sum_probs=198.6
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccccc-ccHHHHHHHHHHHhccCCCccceeeeEeecC--CeEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR-RTLSDFENEVRLISNVHHRNLIRLLGCCSQG--PELIL 393 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 393 (658)
.++|+..+.||+|+||.||+|..+ +|+.||+|.+...... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467889999999999999999976 5899999998653222 2234567899999999999999999998654 56899
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+.+ +|.+++... ...+++.++..++.||+.||.|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 86 v~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999975 888887432 35699999999999999999999998 999999999999999999999999999987654
Q ss_pred CCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc--Ccccc---
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN--GTHWE--- 547 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~~~~~--- 547 (658)
... ..+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ........... ...+.
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 161 PAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE--QLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred ccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCChhhchhhh
Confidence 321 1223345788999999865 467899999999999999999999987544311 11111111100 00000
Q ss_pred ------cccccCCC-CCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 548 ------LMDESLDP-NEC---TKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 548 ------~~d~~l~~-~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+...... ... .......+.+++..|++.||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 000 01124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=298.42 Aligned_cols=253 Identities=23% Similarity=0.392 Sum_probs=196.6
Q ss_pred cCCCccCcccccCceEEEEEEecC-CcEEEEEEcccccccccHHHHHHHHHHHhccC-CCccceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E 396 (658)
++|++.+.||+|+||.||++.+++ ++.||||++..........++..|+.++.+.. ||||+++++++......++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567888999999999999999875 89999999875433344566777887776664 9999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+.+ +|.+++.. ....+++..+..++.||+.||.|||+. .+|+||||+|+||++++++.+||+|||++..+.....
T Consensus 95 ~~~~-~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 95 LMST-CLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred ccCc-CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 9864 77777643 234799999999999999999999973 2899999999999999999999999999976643222
Q ss_pred cccccccCCcccccccccccCC----CCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQ----LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~----~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
.....++..|+|||.+.... ++.++||||||+++|||++|+.||.......+.+ .+.... ....
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~-~~~~----- 238 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL----TKILQE-EPPS----- 238 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHH----HHHhcC-CCCC-----
Confidence 22345788999999986543 7899999999999999999999986432221111 111111 1100
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
. ........++.+++.+||+.||.+||++.++++.
T Consensus 239 ~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 L---PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0011234568999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=292.34 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=199.2
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc----cccccHHHHHHHHHHHhccCCCccceeeeEeecC--CeE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG----ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG--PEL 391 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 391 (658)
.+|.+.+.||+|+||.||++... +++.||+|.+... ...+....+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999975 5899999987532 1223456788999999999999999999998654 568
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++|+||+++++|.+++. ....+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK--AYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999984 334589999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCc--cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccc
Q 006168 472 PENQS--HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 472 ~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
..... ...+...++..|+|||++.+..++.++||||||++++||++|+.||....... ... +..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~----~~~~~~-~---- 226 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AIF----KIATQP-T---- 226 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HHH----HHHcCC-C----
Confidence 32111 11224568899999999998889999999999999999999999986532211 111 111000 0
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
....+......+.+++.+|++ +|..||+..+++.
T Consensus 227 -----~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 -----KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 112334455679999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=291.06 Aligned_cols=249 Identities=28% Similarity=0.427 Sum_probs=205.0
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+|++.++||+|+||.||++..+ +++.+++|.+.... ......++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999865 68899999986532 234456778999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 398 MANSSLDKFLFGEK--RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 398 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
+++++|.+++.+.. ...+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999985422 35689999999999999999999998 9999999999999999999999999999876543
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
......++..|++||.+.+..++.++|+||||++++||++|+.|+...... .+... ...+. .
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~----~~~~~----------~ 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYK----VQRGK----------Y 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH----HhcCC----------C
Confidence 222346788999999999999999999999999999999999998654321 11111 11111 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+......+.+++..|++.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 12223455679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=290.60 Aligned_cols=250 Identities=24% Similarity=0.303 Sum_probs=194.4
Q ss_pred hHHHHHHhcCCCccCcc--cccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEee
Q 006168 311 LKDLVSATRKFSEENKL--GEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCS 386 (658)
Q Consensus 311 ~~~l~~a~~~f~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 386 (658)
..++..-.++|.+.+.+ |+|+||.||++..+ ++..+|+|.+...... .. |+.....+ +||||+++++.+.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~----~~--e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN----AI--EPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc----hh--hHHHHHHhhcCCCEEEEEEEEe
Confidence 34455556777777776 99999999999975 6888999987642111 11 22222222 7999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC-CeEEeec
Q 006168 387 QGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL-QPKIADF 465 (658)
Q Consensus 387 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~-~~kl~Df 465 (658)
..+..++||||+++++|.+++.. ...+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 99999999999999999999943 34799999999999999999999998 999999999999999998 9999999
Q ss_pred cCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcc
Q 006168 466 GLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTH 545 (658)
Q Consensus 466 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 545 (658)
|++....... ...++..|+|||++.+..++.++||||||++++||++|+.||............+.... .
T Consensus 155 g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~--- 224 (267)
T PHA03390 155 GLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--Q--- 224 (267)
T ss_pred ccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--c---
Confidence 9987654322 24688999999999998999999999999999999999999975433221111111111 0
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 006168 546 WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPT-MSEVVA 589 (658)
Q Consensus 546 ~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~ 589 (658)
. ........+..+.+++..||+.+|.+||+ ++++++
T Consensus 225 -----~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 -----K---KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -----c---cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 11112234567999999999999999996 688874
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=295.33 Aligned_cols=264 Identities=24% Similarity=0.340 Sum_probs=199.1
Q ss_pred CCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC-CCccceeeeEeecCCeEEEEEecc
Q 006168 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
|.+.+.||+|++|+||+|+.. +++.|+||++.............+|+..+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999986 478899999875433333345567999999999 999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
+|+|.+++.......+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 88999988655445799999999999999999999998 999999999999999999999999999986643221
Q ss_pred cccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHH--H---------HHHHHhhcCccc
Q 006168 479 STKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLL--K---------RAWRLYENGTHW 546 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~--~---------~~~~~~~~~~~~ 546 (658)
.....++..|+|||++.. ..++.++||||||++++||++|+.||........... . +...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 233567889999998754 4678999999999999999999999865543211100 0 000000000000
Q ss_pred ccccccCC--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 547 ELMDESLD--PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 547 ~~~d~~l~--~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+..... ...........+.+++.+||+.+|++|||+.|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 000001114579999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=289.28 Aligned_cols=251 Identities=24% Similarity=0.429 Sum_probs=206.5
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+|...+.||.|+||.||++... +++.+++|++.... .......+.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999976 58899999987532 224567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 398 MANSSLDKFLFGEK--RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 398 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
+++++|.+++.... ...+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999996543 36699999999999999999999998 99999999999999999999999999998764433
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.......|++.|+|||.+....++.++||||||+++++|++|+.|+...... .+.. ... ....
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~---~~~-~~~~---------- 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--ELAL---KIL-KGQY---------- 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--HHHH---HHh-cCCC----------
Confidence 2233457888999999999889999999999999999999999998654321 1111 111 1111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+......+.+++.+||..+|++|||+.++++.
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11122334568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.09 Aligned_cols=267 Identities=21% Similarity=0.350 Sum_probs=200.9
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeec----CCeE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ----GPEL 391 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 391 (658)
.++|+..+.||+|+||.||++..+ +++.||+|++.... .......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478899999999999999999976 58999999987532 22345677889999999999999999998753 3568
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||+. ++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999996 58999884 345599999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCcc---ccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchh-hHHH--------HHHH
Q 006168 472 PENQSH---LSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE-YLLK--------RAWR 538 (658)
Q Consensus 472 ~~~~~~---~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~-~l~~--------~~~~ 538 (658)
...... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .... ..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 432221 1234578899999999866 4688999999999999999999999965432110 0000 0000
Q ss_pred HhhcCcccccccccCCCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 539 LYENGTHWELMDESLDPNE-----CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 539 ~~~~~~~~~~~d~~l~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
........+.++....... .....+..+.+++..||+.+|.+|||+.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000010000000001 112235679999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=299.20 Aligned_cols=262 Identities=20% Similarity=0.253 Sum_probs=196.1
Q ss_pred cCcccccCceEEEEEEecCCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCC
Q 006168 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSS 402 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 402 (658)
.+.+|.|+++.||++.. +++.||||++... ........+.+|+++++.++|+||+++++++...+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34445555555555554 6899999998754 344566789999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc------
Q 006168 403 LDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS------ 476 (658)
Q Consensus 403 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~------ 476 (658)
|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999755556689999999999999999999998 999999999999999999999999998875532211
Q ss_pred cccccccCCccccccccccc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHH----hh-------cC
Q 006168 477 HLSTKFAGTLGYTAPEYAIH--GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRL----YE-------NG 543 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~--~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~----~~-------~~ 543 (658)
.......++..|+|||++.. ..++.++||||||+++|||++|+.||....... .+.+..... .. ..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCccccccCchhhhcC
Confidence 11223457788999999866 358899999999999999999999997543321 111111000 00 00
Q ss_pred cccc----cccccC---CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 544 THWE----LMDESL---DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 544 ~~~~----~~d~~l---~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.... ..+... ............+.+++.+||+.||++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 000000 0112233455678999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=295.96 Aligned_cols=245 Identities=25% Similarity=0.372 Sum_probs=197.5
Q ss_pred cCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCC
Q 006168 324 ENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSS 402 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 402 (658)
..+||+|+||.||++..+ +++.||+|++.. ........+.+|+.+++.++|+||+++++++..++..++||||+++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDL-RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecc-cchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 357999999999999875 689999999864 233455678999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccccc
Q 006168 403 LDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKF 482 (658)
Q Consensus 403 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 482 (658)
|.+++. ...+++..+..++.|++.+|+|||+. +++|+||+|+||++++++.++|+|||++........ .....
T Consensus 104 L~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 104 LTDIVT---HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 999873 34589999999999999999999998 999999999999999999999999999876543221 22335
Q ss_pred cCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHH
Q 006168 483 AGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEA 562 (658)
Q Consensus 483 ~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 562 (658)
.|+..|++||++.+..++.++||||||+++|||++|+.|+...... ......... ....+ ......
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~---------~~~~~---~~~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDN---------LPPKL---KNLHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhh---------CCccc---CCcccC
Confidence 6889999999998888999999999999999999999998643321 111111000 00010 001122
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 563 AEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 563 ~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+.+++.+||+.+|.+||++.++++.
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 3458899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=309.90 Aligned_cols=251 Identities=22% Similarity=0.372 Sum_probs=203.8
Q ss_pred cCCCccCcccccCceEEEEEEecCCcE-EEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKI-VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+.|.++..||.|+||.||++..++... .|-|.|.. .+.+.+++|.-|+++|...+||+||+|++.|...+.+++..||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 345567889999999999999886444 46666654 5677889999999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
|.||-.+.++.. -...|++.++.-+++|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+..... ...
T Consensus 111 C~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~q 185 (1187)
T KOG0579|consen 111 CGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQ 185 (1187)
T ss_pred cCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHh
Confidence 999999998853 345699999999999999999999999 999999999999999999999999998864321 222
Q ss_pred ccccccCCcccccccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 478 LSTKFAGTLGYTAPEYAI-----HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
....+.|||.|||||+++ ..+|+.++||||||++|.||..+.+|-...+.... + .+. ...+...++
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV-l----lKi-aKSePPTLl--- 256 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-L----LKI-AKSEPPTLL--- 256 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH-H----HHH-hhcCCCccc---
Confidence 344689999999999975 46899999999999999999999988654333211 1 111 111222221
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.+......+.+++..||.+||..||++.++++
T Consensus 257 -----qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 -----QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -----CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 23345667999999999999999999999985
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=298.91 Aligned_cols=249 Identities=30% Similarity=0.458 Sum_probs=198.3
Q ss_pred CCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
|...+.||+|+||.||+++.. ++..+|+|++.... .......+.+|++++++++|||++++++++..++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667889999999999999975 68899999986431 223345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+.+ +|.+++.. ....+++.++..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~g-~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 107 CLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CCC-CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 975 77777643 345699999999999999999999998 9999999999999999999999999998754322
Q ss_pred ccccccCCcccccccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 478 LSTKFAGTLGYTAPEYAI---HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~---~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
....|+..|+|||++. .+.++.++||||||+++|||++|+.|+....... .+. .....+.
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~----~~~~~~~---------- 241 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALY----HIAQNES---------- 241 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHH----HHHhccC----------
Confidence 2346788999999974 4578999999999999999999999986532211 111 1111110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
........+..+.+++.+||+.+|.+||++.+|++.+...
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 242 PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 0111123345689999999999999999999999865443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=294.93 Aligned_cols=260 Identities=19% Similarity=0.272 Sum_probs=187.4
Q ss_pred hcCCCccCcccccCceEEEEEEecC----CcEEEEEEcccccccccH----------HHHHHHHHHHhccCCCccceeee
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN----GKIVAVKKLAIGISRRTL----------SDFENEVRLISNVHHRNLIRLLG 383 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~----------~~~~~E~~~l~~l~h~niv~l~~ 383 (658)
.++|.+.+.||+|+||.||+|.+.+ +..+++|........... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3678899999999999999999764 345677754322111000 11223344556778999999999
Q ss_pred EeecCC----eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC
Q 006168 384 CCSQGP----ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ 459 (658)
Q Consensus 384 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~ 459 (658)
++.... ..++++|++.. ++.+.+.. ....++..+..|+.|++.||.|||+. +|+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence 875443 34778887754 66666632 23467888999999999999999998 9999999999999999999
Q ss_pred eEEeeccCccccCCCCcc------ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHH
Q 006168 460 PKIADFGLARLLPENQSH------LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLL 533 (658)
Q Consensus 460 ~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~ 533 (658)
++|+|||+++.+...... ......||+.|+|||++.+..++.++|||||||+++||++|+.||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999999876432211 11235699999999999999999999999999999999999999976643222211
Q ss_pred HHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 534 KRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 534 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
......... +....+.... .+..+.+++..|++.+|++||++.++++.|+
T Consensus 245 ~~~~~~~~~-----~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 245 AAKCDFIKR-----LHEGKIKIKN----ANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HhHHHHHHH-----hhhhhhccCC----CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111111100 0001111111 2356999999999999999999999998763
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=304.31 Aligned_cols=265 Identities=26% Similarity=0.352 Sum_probs=200.7
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecC-----
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG----- 388 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 388 (658)
...++|...+.||+|+||.||++... +++.||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 34578999999999999999999975 68999999986432 233345678899999999999999999988543
Q ss_pred -CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccC
Q 006168 389 -PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL 467 (658)
Q Consensus 389 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGl 467 (658)
...++||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 357999999965 88887732 289999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchh-------------hHHH
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE-------------YLLK 534 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~-------------~l~~ 534 (658)
++...... ......++..|+|||.+.+..++.++||||||+++++|++|+.||........ .+..
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 165 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred ceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 98754322 12345678899999999999999999999999999999999999865432110 0000
Q ss_pred H---HHHHhhc-Cc------ccccccccCCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 535 R---AWRLYEN-GT------HWELMDESLDP---NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 535 ~---~~~~~~~-~~------~~~~~d~~l~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
. ....+.. .. ..+.+...+.+ ..........+.+++.+||+.||.+|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0000000 00 00111111100 01122345678999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=336.49 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=207.1
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
..+-++....+||.|.||.||.+... +|+..|+|.+... ......+...+|+.++..++|||+|+++|+-.+++.++|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 34457778889999999999999954 6899999988653 234556778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
.||||++|+|.+.+. ....+++.....+..|++.|+.|||++ +||||||||.||+|+.+|.+|++|||.|..+..
T Consensus 1312 FMEyC~~GsLa~ll~--~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHhccCcHHHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999999983 334466666677889999999999999 999999999999999999999999999998755
Q ss_pred CCccc---cccccCCcccccccccccCC---CCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccc
Q 006168 474 NQSHL---STKFAGTLGYTAPEYAIHGQ---LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWE 547 (658)
Q Consensus 474 ~~~~~---~~~~~gt~~y~APE~~~~~~---~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 547 (658)
+.... .....||+.|||||++.+.+ ..-+.||||+|||++||+||++||.....+-..... +..|.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~-----V~~gh--- 1458 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH-----VAAGH--- 1458 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH-----HhccC---
Confidence 43221 22578999999999997643 456899999999999999999999765443211111 11111
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 548 LMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 548 ~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....|...+.+-.+++..||+.||++|-++.|+++.
T Consensus 1459 -------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 -------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 233455567778999999999999999999988875
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=298.45 Aligned_cols=268 Identities=22% Similarity=0.351 Sum_probs=195.9
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-cccHHHHHHHHHHHhccCCCccceeeeEeecCC------
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP------ 389 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 389 (658)
.++|+..++||+|+||.||++..+ +++.||||.+..... ......+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357889999999999999999976 689999998864322 223345678999999999999999999986543
Q ss_pred --eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccC
Q 006168 390 --ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL 467 (658)
Q Consensus 390 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGl 467 (658)
..++||||+.+ +|.+++.. ....+++.+++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence 45999999975 88887743 234689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCcc---ccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchh-hHHHHHHHHhh-
Q 006168 468 ARLLPENQSH---LSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE-YLLKRAWRLYE- 541 (658)
Q Consensus 468 a~~~~~~~~~---~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~-~l~~~~~~~~~- 541 (658)
+..+...... ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........ ..+........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9866433221 12234578899999988664 478899999999999999999998865443111 11111110000
Q ss_pred ----cCcccccccccCCCCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 542 ----NGTHWELMDESLDPNEC---------TKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 542 ----~~~~~~~~d~~l~~~~~---------~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.....+..+....+... .......+.+++.+||+.||.+|||++++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000000000000000 00112457799999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.62 Aligned_cols=264 Identities=24% Similarity=0.357 Sum_probs=200.2
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecC-----Ce
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG-----PE 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 390 (658)
.++|.+.+.||+|+||.||+++.. +++.||||.+... ........+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467889999999999999999965 6899999998643 1233456778899999999999999999988643 35
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.++||||+. ++|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR--SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 899999996 68988884 345699999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHH----------
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRL---------- 539 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~---------- 539 (658)
..... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||....... ........
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH--QLKLITELLGSPSEEDLG 234 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHHhCCCChHHhh
Confidence 64332 22234567889999998865 468999999999999999999999986543211 01111110
Q ss_pred -hhcCcccccccc---cCC--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 540 -YENGTHWELMDE---SLD--PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 540 -~~~~~~~~~~d~---~l~--~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.......+.+.. ... ........+..+.+++.+||+.+|++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000000000 000 000111235668999999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=278.79 Aligned_cols=249 Identities=22% Similarity=0.376 Sum_probs=202.1
Q ss_pred ccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC-CCccceeeeEeecCCeEEEEEeccCC
Q 006168 323 EENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 323 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
....||.|..|.|++.+.+ .|..+|||.+......++.++++..++++..-+ +|+||+.+|+|..+..+++-||.|..
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 3567999999999999977 589999999998777778888888888877664 89999999999999999999999954
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
.++.++. ...+++++..+-++...+..||.||.++ .+|+|||+||+|||+|+.|++||+|||++..+-+.. ..+
T Consensus 176 -C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Aht 249 (391)
T KOG0983|consen 176 -CAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHT 249 (391)
T ss_pred -HHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccc--ccc
Confidence 5666664 3456688888889999999999999987 389999999999999999999999999998765443 345
Q ss_pred cccCCccccccccccc---CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 481 KFAGTLGYTAPEYAIH---GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~---~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
+..|-+.|||||.+.- ..|+.++||||||+.|+||.||+.|+.....+-+.+... ..+ +. +.|+...
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv----ln~-eP-----P~L~~~~ 319 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV----LNE-EP-----PLLPGHM 319 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH----Hhc-CC-----CCCCccc
Confidence 6689999999999853 478899999999999999999999998765543333221 111 11 2221111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+..+.+++..||++|+.+||...++++.
T Consensus 320 ---gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 320 ---GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ---CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 145679999999999999999999999864
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=297.69 Aligned_cols=246 Identities=27% Similarity=0.388 Sum_probs=206.9
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
+.|..-+.||+||||.||-.+.+ +|+-+|.|++.+. ...++....++|-.+|.+++.+.||.+--.|+..+.++||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 56788889999999999999876 5889999988542 22345566789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
..|.||+|.-+|.+.....+++....-++.+|+-||++||+. +||.||+||+|||||+.|+++|+|+|+|..+.+..
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 999999999988766666799999999999999999999999 99999999999999999999999999999887665
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC--
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL-- 553 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l-- 553 (658)
.. +..+||.+|||||++.++.|+...|-|||||+||||+.|+.||....+... ++.+|...
T Consensus 342 ~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---------------~eEvdrr~~~ 404 (591)
T KOG0986|consen 342 PI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---------------REEVDRRTLE 404 (591)
T ss_pred cc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh---------------HHHHHHHHhc
Confidence 43 234899999999999999999999999999999999999999976543110 01111111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTM 584 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 584 (658)
....++...+++...|....|++||++|.--
T Consensus 405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred chhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 1345566677789999999999999998643
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=295.56 Aligned_cols=262 Identities=27% Similarity=0.422 Sum_probs=202.0
Q ss_pred CCccCcccccCceEEEEEEec-CCcEEEEEEccccccc-ccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR-RTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
|...+.||+|++|.||++..+ +++.+++|++...... .....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999976 6889999998653222 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++ +|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 DT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred CC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 75 888887442 35799999999999999999999998 99999999999999999999999999998775443 12
Q ss_pred cccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcC--cccccccc----
Q 006168 479 STKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG--THWELMDE---- 551 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~~~~~~d~---- 551 (658)
.....++..|+|||.+.+. .++.++||||||+++++|++|+.||........ ........... ..+..+..
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ--LFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCchHhcccchhhhhh
Confidence 2334678899999998876 789999999999999999999999865443111 11111110000 00000000
Q ss_pred ---------cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 552 ---------SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 552 ---------~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.............++.+++..||+.||.+||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000011122346789999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=304.06 Aligned_cols=265 Identities=26% Similarity=0.410 Sum_probs=199.8
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhcc-CCCccceeeeEeec--CCeE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQ--GPEL 391 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--~~~~ 391 (658)
..++|+..+.||+|+||.||+|... +++.+|+|++... ........+.+|+.+++++ +||||+++++++.. +...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578889999999999999999976 5889999988542 2233445677899999999 99999999999864 3468
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||++ ++|..++.. ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999997 599988843 2789999999999999999999998 9999999999999999999999999999866
Q ss_pred CCCCc----cccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHH-------
Q 006168 472 PENQS----HLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRL------- 539 (658)
Q Consensus 472 ~~~~~----~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~------- 539 (658)
..... .......|+..|+|||++.+ ..++.++||||||+++|||++|+.||........ .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~ 235 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ--LEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHH
Confidence 44322 12234568999999998765 4678999999999999999999999865432111 1100000
Q ss_pred ----hhcCcccccccccC-----CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 540 ----YENGTHWELMDESL-----DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 540 ----~~~~~~~~~~d~~l-----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.........++... .........+..+.+++.+||+.+|.+|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000110000 0001111135678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=299.52 Aligned_cols=267 Identities=22% Similarity=0.323 Sum_probs=197.8
Q ss_pred CCCccCcccccCceEEEEEEecC---CcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecC--CeEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLKN---GKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG--PELI 392 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 392 (658)
+|...++||+|+||.||+|..+. ++.||+|.+.... .......+.+|+.++++++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788999999999999999754 7899999987532 123346678899999999999999999999887 8899
Q ss_pred EEEeccCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC----CCCeEEeec
Q 006168 393 LVYEYMANSSLDKFLFGEK---RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD----DLQPKIADF 465 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~----~~~~kl~Df 465 (658)
+||||+++ +|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 6766663222 23689999999999999999999998 9999999999999999 899999999
Q ss_pred cCccccCCCCcc--ccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcch-------hhHHHH
Q 006168 466 GLARLLPENQSH--LSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEG-------EYLLKR 535 (658)
Q Consensus 466 Gla~~~~~~~~~--~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~-------~~l~~~ 535 (658)
|++......... ......++..|+|||.+.+. .++.++||||||++++||++|+.||....... ......
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 999876443221 12245678899999988764 57899999999999999999999997554321 000111
Q ss_pred HHHHhhc-----------C-cccc---cccccCCC-CCCCH------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 536 AWRLYEN-----------G-THWE---LMDESLDP-NECTK------EAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 536 ~~~~~~~-----------~-~~~~---~~d~~l~~-~~~~~------~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....... . .... ........ ..... .....+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111000 0 0000 00000000 00000 233468999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=288.17 Aligned_cols=248 Identities=27% Similarity=0.469 Sum_probs=203.8
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+|+..+.||+|++|.||++... +++.|++|.+..... ......+.+|++++++++|||++++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999876 578999999875321 13557889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.. ...+++..+..++.|++.+|.|||+. +|+||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 999999999843 36799999999999999999999998 9999999999999999999999999999876543322
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
.....++..|+|||......++.++||||||+++++|++|+.|+...... ...+.... ... ..
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~----------~~ 218 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AALFRIVQ-DDH----------PP 218 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHhc-cCC----------CC
Confidence 23456788999999998888899999999999999999999998654321 11111111 111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.+......+.+++.+||+.+|++|||+.+++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 12223457899999999999999999999884
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=291.16 Aligned_cols=245 Identities=23% Similarity=0.317 Sum_probs=191.2
Q ss_pred CcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHH-HhccCCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRL-ISNVHHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
+.||+|+||.||++... +++.||+|.+.... .......+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999975 58899999986431 11222344455444 4455899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
++|.+++. ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++..... ..
T Consensus 82 ~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIK--TLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 99999984 335689999999999999999999998 999999999999999999999999999875433 22
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCH
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTK 560 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 560 (658)
...++..|+|||.+.+..++.++||||||+++|||++|..|+...... ... .....+... . ......
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~----~~~~~~~~~------~-~~~~~~ 218 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--AVF----DNILSRRIN------W-PEEVKE 218 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--HHH----HHHHhcccC------C-CCcccc
Confidence 346788999999998888999999999999999999999998654321 111 111111100 0 111111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 561 EAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 561 ~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
..+..+.+++.+||+.+|++||++.++.+.|.
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 23456999999999999999998877766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=300.58 Aligned_cols=261 Identities=22% Similarity=0.329 Sum_probs=194.8
Q ss_pred Cccccc--CceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEG--GFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
..||+| +||+||++... +|+.||+|.+.... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 99999999975 68999999986532 233457789999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc--
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL-- 478 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~-- 478 (658)
++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998655455699999999999999999999998 99999999999999999999999998654332211100
Q ss_pred ----cccccCCcccccccccccC--CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHH--------------
Q 006168 479 ----STKFAGTLGYTAPEYAIHG--QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWR-------------- 538 (658)
Q Consensus 479 ----~~~~~gt~~y~APE~~~~~--~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~-------------- 538 (658)
.....++..|+|||++.+. .++.++||||||++++||++|+.||........ .......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCccccccchh
Confidence 0112345679999998764 478999999999999999999999865432111 1000000
Q ss_pred --H-------hhc---------CcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 539 --L-------YEN---------GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 539 --~-------~~~---------~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
. ... .......+..+ ...........+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 000 00000000111 112233456779999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=290.28 Aligned_cols=246 Identities=24% Similarity=0.406 Sum_probs=197.9
Q ss_pred ccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCCH
Q 006168 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSL 403 (658)
Q Consensus 327 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 403 (658)
||+|+||.||+++.. +++.+++|.+.... .......+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 48999999986532 124567789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc-------
Q 006168 404 DKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS------- 476 (658)
Q Consensus 404 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~------- 476 (658)
.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 9999543 4799999999999999999999998 999999999999999999999999999876533211
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
.......++..|++||.......+.++||||||++++||++|+.|+...... .... ... .+... . +.
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~---~~~-~~~~~------~-~~ 222 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--EIFQ---NIL-NGKIE------W-PE 222 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHH---HHh-cCCcC------C-Cc
Confidence 1223456788999999998888999999999999999999999998654321 1111 111 11100 0 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
.. ..+..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 223 ~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 DV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 10 12467899999999999999999977777665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=294.79 Aligned_cols=249 Identities=25% Similarity=0.381 Sum_probs=203.4
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccC-CCccceeeeEeecCCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 394 (658)
++|...+.||+|+||.||++... +++.|++|++.... .......+.+|++++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999976 68999999986521 2334567889999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++++|.+++. +...+++..++.++.|++.||.|||+. +++|+||+|+||+++.+++++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~--~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIR--KYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999994 334799999999999999999999998 9999999999999999999999999999866443
Q ss_pred Cc-------------------cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHH
Q 006168 475 QS-------------------HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKR 535 (658)
Q Consensus 475 ~~-------------------~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~ 535 (658)
.. .......++..|+|||.+....++.++||||||++++++++|+.|+...... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--LTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--HHHHH
Confidence 22 1122456788999999998888999999999999999999999998755421 11111
Q ss_pred HHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 006168 536 AWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTM----SEVVA 589 (658)
Q Consensus 536 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~----~evl~ 589 (658)
.. . . ....+...+..+.+++..||+.+|.+||++ .++++
T Consensus 234 ~~---~-------~-----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 IL---K-------L-----EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH---h-------c-----CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11 0 0 011222335569999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=290.83 Aligned_cols=243 Identities=23% Similarity=0.318 Sum_probs=188.9
Q ss_pred cccccCceEEEEEEec-CCcEEEEEEccccccc--ccHHHHHHHH---HHHhccCCCccceeeeEeecCCeEEEEEeccC
Q 006168 326 KLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR--RTLSDFENEV---RLISNVHHRNLIRLLGCCSQGPELILVYEYMA 399 (658)
Q Consensus 326 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 399 (658)
.||+|+||.||++... +++.||+|.+...... .....+..|. .+++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 5889999998653211 1122234443 34445689999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccc
Q 006168 400 NSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS 479 (658)
Q Consensus 400 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 479 (658)
+++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++..+.... .
T Consensus 81 g~~L~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~ 152 (278)
T cd05606 81 GGDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (278)
T ss_pred CCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence 999999884 345699999999999999999999998 99999999999999999999999999987653322 2
Q ss_pred ccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCC
Q 006168 480 TKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558 (658)
Q Consensus 480 ~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 558 (658)
....|+..|+|||.+.++ .++.++||||||+++|||++|+.||............ +.... .. ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~------~~-----~~~ 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLT------MA-----VEL 218 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHhhc------cC-----CCC
Confidence 234689999999998755 6899999999999999999999999765332111111 11000 00 111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 006168 559 TKEAAEKVVEIALMCTQSAANSRP-----TMSEVVAL 590 (658)
Q Consensus 559 ~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 590 (658)
+...+..+.+++.+|+..+|.+|| ++.++++.
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 222346799999999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=289.13 Aligned_cols=261 Identities=28% Similarity=0.418 Sum_probs=197.2
Q ss_pred CCccCcccccCceEEEEEEecC-CcEEEEEEcccccccc-cHHHHHHHHHHHhcc---CCCccceeeeEeecCCe-----
Q 006168 321 FSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRR-TLSDFENEVRLISNV---HHRNLIRLLGCCSQGPE----- 390 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 390 (658)
|++.+.||+|+||.||+|+++. ++.||+|++....... ....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999874 8999999997532222 234566787777665 69999999999987766
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.+++|||+.+ +|.+++.......+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999999975 898888654445699999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccc---
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWE--- 547 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~--- 547 (658)
...... .....++..|+|||++.+..++.++||||||++++||++|+.|+...... .......+.........
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHHcCCCChHhcCC
Confidence 643321 12345788999999999999999999999999999999998888654331 11111111110000000
Q ss_pred -------cccccC--CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 548 -------LMDESL--DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 548 -------~~d~~l--~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
...... ............+.+++.+||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000 001112234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=306.26 Aligned_cols=245 Identities=25% Similarity=0.403 Sum_probs=199.5
Q ss_pred ccCcccccCceEEEEEEec-CCcEEEEEEc---ccccccccHHHHHHHHHHHhccCCCccceeeeEeecCC--eEEEEEe
Q 006168 323 EENKLGEGGFGDIYKGTLK-NGKIVAVKKL---AIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP--ELILVYE 396 (658)
Q Consensus 323 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~---~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~E 396 (658)
...+||+|.|-+||+|... +|..||--.+ ....+....+.|..|+++|+.|+||||++++.++.+.. ...+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3467999999999999976 4666763333 22345566789999999999999999999999997654 4889999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC-CCeEEeeccCccccCCCC
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD-LQPKIADFGLARLLPENQ 475 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~-~~~kl~DfGla~~~~~~~ 475 (658)
.|..|+|..|+. +.+.++.+.+..|++||++||.|||++ .|+|+|||||-+||+|+.+ |.+||+|+|||.......
T Consensus 124 L~TSGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 124 LFTSGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred cccCCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999999994 445688899999999999999999997 5699999999999999875 899999999999875543
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
...+.|||.|||||.+. ..|.+..||||||+.++||+|+..|+..-.... .+++.+..|.-...+...-
T Consensus 201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A-----QIYKKV~SGiKP~sl~kV~-- 269 (632)
T KOG0584|consen 201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA-----QIYKKVTSGIKPAALSKVK-- 269 (632)
T ss_pred ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH-----HHHHHHHcCCCHHHhhccC--
Confidence 33479999999999776 789999999999999999999999986544432 2344444443333332222
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
..++.+||..|+.. .++|||+.|+|+
T Consensus 270 -------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 -------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 23589999999999 999999999996
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=321.81 Aligned_cols=264 Identities=28% Similarity=0.448 Sum_probs=213.8
Q ss_pred HHHHHhcCCCccCcccccCceEEEEEEecC--------CcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeee
Q 006168 313 DLVSATRKFSEENKLGEGGFGDIYKGTLKN--------GKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLG 383 (658)
Q Consensus 313 ~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 383 (658)
.++...++..+.+.||+|.||.|++|.... ...||||.+.......+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 344445555667799999999999998541 3569999998776667788999999999999 6999999999
Q ss_pred EeecCCeEEEEEeccCCCCHHHHhhcCC------------C--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCC
Q 006168 384 CCSQGPELILVYEYMANSSLDKFLFGEK------------R--GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKP 449 (658)
Q Consensus 384 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~ 449 (658)
+|..++..++|+||+.+|+|.++|...+ . ..|+....+.++.|||.|++||++. ++|||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999996554 0 1388999999999999999999998 999999999
Q ss_pred CcEEEcCCCCeEEeeccCccccCCCCccccccccC--CcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCC
Q 006168 450 SNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAG--TLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKG 526 (658)
Q Consensus 450 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~ 526 (658)
+|||+.++..+||+|||+++..............| ...|||||.+....|+.|+|||||||+||||+| |..|+....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999765544443332333 456999999999999999999999999999999 666765422
Q ss_pred cchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 527 EEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 527 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
. ...+ ++...+|...+ .|.....++.++++.||+.+|++||++.++++.|+..
T Consensus 527 ~-~~~l----~~~l~~G~r~~----------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 P-TEEL----LEFLKEGNRME----------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred c-HHHH----HHHHhcCCCCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1 1122 33344443222 2223345699999999999999999999999999874
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.51 Aligned_cols=267 Identities=22% Similarity=0.367 Sum_probs=201.4
Q ss_pred HHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeec-CC
Q 006168 313 DLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ-GP 389 (658)
Q Consensus 313 ~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 389 (658)
++..++++|++.+.||+|+||.||++... +++.||+|++.... .....+.+..|++++++++||||+++++++.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 44567889999999999999999999866 78999999886432 23345678899999999999999999999865 56
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
..++|+||+ +++|.+++. ...+++.....++.|+++||.|||+. +|+||||+|+|||+++++.+||+|||++.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 789999998 458988873 34688889999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhh-HHH--------HHHHH
Q 006168 470 LLPENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEY-LLK--------RAWRL 539 (658)
Q Consensus 470 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~-l~~--------~~~~~ 539 (658)
..... .....++..|+|||++.+ ..++.++||||||++++||++|+.||......... ... ...+.
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54322 123467889999998866 56899999999999999999999998654321110 000 00000
Q ss_pred hhcCcccccccccCCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 540 YENGTHWELMDESLDPNECT-----KEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 540 ~~~~~~~~~~d~~l~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+...+.+.........+ ......+.+++.+||+.+|++|||+.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00011111110000001111 1134678999999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=322.34 Aligned_cols=256 Identities=28% Similarity=0.424 Sum_probs=195.2
Q ss_pred HHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecC-----
Q 006168 315 VSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG----- 388 (658)
Q Consensus 315 ~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 388 (658)
-+-..+|++.+.||+||||.|||++++ ||+.||||+|....+......+.+|+..|++|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345678999999999999999999988 89999999998755666677889999999999999999987542100
Q ss_pred --------------------------------------------------------------------------------
Q 006168 389 -------------------------------------------------------------------------------- 388 (658)
Q Consensus 389 -------------------------------------------------------------------------------- 388 (658)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 006168 389 ----------------------------------PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYL 434 (658)
Q Consensus 389 ----------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~L 434 (658)
..+||=||||+...|.+++.+..... .....|+++++|++||.|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence 01467788888877777774332211 4677899999999999999
Q ss_pred HhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC-----------------CCCccccccccCCcccccccccccC
Q 006168 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP-----------------ENQSHLSTKFAGTLGYTAPEYAIHG 497 (658)
Q Consensus 435 H~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~-----------------~~~~~~~~~~~gt~~y~APE~~~~~ 497 (658)
|+. +||||||||.||+||++..+||+|||++.... .......|..+||.-|+|||.+.+.
T Consensus 714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 999 99999999999999999999999999998721 0111134567899999999998664
Q ss_pred ---CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHcc
Q 006168 498 ---QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCT 574 (658)
Q Consensus 498 ---~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl 574 (658)
+|+.|+|+||+|||++||+. ||....+.. .. ...++.+....- ..+.......=..+|.+++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa-~i----L~~LR~g~iP~~-------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA-SI----LTNLRKGSIPEP-------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHH-HH----HHhcccCCCCCC-------cccccccchHHHHHHHHHh
Confidence 59999999999999999984 455443321 11 122233332221 1112223344578999999
Q ss_pred ccCCCCCCCHHHHHH
Q 006168 575 QSAANSRPTMSEVVA 589 (658)
Q Consensus 575 ~~dp~~RPt~~evl~ 589 (658)
+.||.+|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999985
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.12 Aligned_cols=249 Identities=29% Similarity=0.444 Sum_probs=197.2
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
+.|...+.||+|+||.||+|+.. +++.+++|.+... .......++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34667788999999999999976 5788999988642 22233457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+. |+|.+++.. ....+++.++..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9997 588777643 235689999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccCCcccccccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 476 SHLSTKFAGTLGYTAPEYAI---HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~---~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
....++..|+|||.+. .+.++.++||||||+++|||++|+.|+....... .+ .. ...+..
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~----~~-~~~~~~------- 231 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-AL----YH-IAQNES------- 231 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HH----HH-HhhcCC-------
Confidence 2346788999999974 3568889999999999999999999975432211 01 01 111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
+..........+.+++.+||+.+|++||++.+|++...
T Consensus 232 --~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 232 --PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred --CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 11111233456899999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.17 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=199.8
Q ss_pred CCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecC------CeEEE
Q 006168 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG------PELIL 393 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 393 (658)
+...+.||+|+||.||+|+++ .|+.||||.+.........+...+|+++|++++|+|||+++++-... ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 344578999999999999966 69999999998766667778889999999999999999999986543 35799
Q ss_pred EEeccCCCCHHHHhhcCCCC-CCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc--CCC--CeEEeeccCc
Q 006168 394 VYEYMANSSLDKFLFGEKRG-SLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD--DDL--QPKIADFGLA 468 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~--~~~--~~kl~DfGla 468 (658)
|||||.+|||...|....+. .|++.+.+.+..++..||.|||++ +|+||||||.||++- ++| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999654443 499999999999999999999998 999999999999993 334 3799999999
Q ss_pred cccCCCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcC----
Q 006168 469 RLLPENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG---- 543 (658)
Q Consensus 469 ~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~---- 543 (658)
+.++++. ..+.++||..|++||.+.. +.|+...|.|||||++||++||..||........ ..+..|......
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~-~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN-NKEIMWHIITKKPSGV 248 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc-cchhhhhhhccCCCce
Confidence 9886654 5677899999999999984 8899999999999999999999999976654321 111112222111
Q ss_pred ----------cccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 006168 544 ----------THWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRP 582 (658)
Q Consensus 544 ----------~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP 582 (658)
.....-.-. .+..........+...+..++..+|.+|-
T Consensus 249 ~i~~~~~eNgpv~~s~~lP-~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLP-QPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eEeeecccCCceeeeccCC-CcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 111000000 12234445566677778888888888887
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=300.93 Aligned_cols=267 Identities=23% Similarity=0.360 Sum_probs=204.7
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-cccHHHHHHHHHHHhccCCCccceeeeEeecCC-----eEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP-----ELI 392 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 392 (658)
+|.+.+.||+|++|.||+++.. +++.|++|++..... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5778899999999999999976 489999999875322 344578899999999999999999999987765 789
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
+||||+++ +|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++....
T Consensus 81 lv~e~~~~-~l~~~l~--~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMET-DLHKVIK--SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchhh-hHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 99999984 8988884 334799999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCc--cccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh---------
Q 006168 473 ENQS--HLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLY--------- 540 (658)
Q Consensus 473 ~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~--------- 540 (658)
.... .......++..|+|||++.+. .++.++||||||+++++|++|+.||........ ........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ--LNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHhcCCCChhHhh
Confidence 4321 122345678899999999887 889999999999999999999999876543111 11111100
Q ss_pred --hcCcccccccccCCC-----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcC
Q 006168 541 --ENGTHWELMDESLDP-----NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL--LKST 594 (658)
Q Consensus 541 --~~~~~~~~~d~~l~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~--L~~~ 594 (658)
......+.+...... .......+..+.+++.+||+.+|.+|||+.++++. ++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 000000000000000 00111235678999999999999999999999974 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.70 Aligned_cols=265 Identities=25% Similarity=0.351 Sum_probs=196.1
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccccc-ccHHHHHHHHHHHhccCCCccceeeeEeecC-------
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR-RTLSDFENEVRLISNVHHRNLIRLLGCCSQG------- 388 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 388 (658)
.++|++.++||+|+||.||+|..+ +++.+|+|++...... .....+.+|++++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999976 5889999998653222 2234678899999999999999999987443
Q ss_pred -CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccC
Q 006168 389 -PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL 467 (658)
Q Consensus 389 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGl 467 (658)
..+++|+||+.+ +|...+.. ....+++..+..++.|+++||.|||+. +|+|+||||+||++++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 347999999975 67776643 345699999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCcc----------ccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHH
Q 006168 468 ARLLPENQSH----------LSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRA 536 (658)
Q Consensus 468 a~~~~~~~~~----------~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~ 536 (658)
+......... ..+...+++.|+|||.+.+. .++.++||||||+++|||++|++||....... .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~--~~~~~ 239 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID--QLHLI 239 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence 9865432211 11234678889999988654 58899999999999999999999986544321 11111
Q ss_pred HHHhhcCc---------ccccc----cccCCCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 537 WRLYENGT---------HWELM----DESLDPN--ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 537 ~~~~~~~~---------~~~~~----d~~l~~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
+.....-. ..... ....... .........+.+++.+||+.||.+|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 11111000 00000 0000000 000112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=300.77 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=194.9
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecC------C
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG------P 389 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 389 (658)
.++|...+.||+|+||.||+|+.. +++.||+|++.... .......+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999975 68999999986532 223345688999999999999999999998654 3
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
..++|+||+.. +|..++ ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 56999999975 777665 23589999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHH---------
Q 006168 470 LLPENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRL--------- 539 (658)
Q Consensus 470 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~--------- 539 (658)
..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .....+..
T Consensus 166 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 166 HADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHH
Confidence 64322 123467889999999876 468899999999999999999999997543211 11111110
Q ss_pred --hhcCcccccccc--cCCCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 540 --YENGTHWELMDE--SLDPNEC---TKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 540 --~~~~~~~~~~d~--~l~~~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.........+.. ....... .......+.+++.+||+.||++||++.+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000000 0000000 01123468899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=291.76 Aligned_cols=245 Identities=29% Similarity=0.446 Sum_probs=194.1
Q ss_pred CCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
|...++||+|+||.||+|+.. +++.|++|++.... .......+.+|++++++++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999975 58899999986422 223345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+. |+|.+++.. ....+++.++..++.||+.+|.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 96 577777743 345699999999999999999999998 999999999999999999999999998864322
Q ss_pred ccccccCCcccccccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 478 LSTKFAGTLGYTAPEYAI---HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~---~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
.....|+..|+|||++. .+.++.++||||||+++|||++|+.|+........ ....... ...
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~~-~~~-------- 238 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQN-DSP-------- 238 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhc-CCC--------
Confidence 22356888999999984 45688999999999999999999999865432111 1111111 111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..........+.+++.+||+.+|.+||++.+++..
T Consensus 239 -~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 -TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111223468899999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=299.09 Aligned_cols=249 Identities=21% Similarity=0.359 Sum_probs=207.6
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
...|.+.+.||+|.|+.|.++++. .+..||||.+.+.. .......+.+|+++|..|+|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 457888999999999999999976 58999999998753 2333466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||..+|.+.++|. +.+.+.+.....++.|+.++++|||++ .|||||||++||||+.+.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~- 208 (596)
T KOG0586|consen 135 EYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG- 208 (596)
T ss_pred EeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc-
Confidence 9999999999994 456677788999999999999999999 9999999999999999999999999999988633
Q ss_pred ccccccccCCcccccccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
.......|++.|.|||++.+.+| .+.+|+||+|++||-|++|..||++..-.. .++ ..+...
T Consensus 209 -~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~----------Lr~----rvl~gk-- 271 (596)
T KOG0586|consen 209 -LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE----------LRP----RVLRGK-- 271 (596)
T ss_pred -ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc----------ccc----hheeee--
Confidence 34556899999999999998876 579999999999999999999998643210 000 000011
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
-..+.-...++.+++++++-.+|.+|++++++.+.
T Consensus 272 -~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 272 -YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11223344568999999999999999999999753
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=297.54 Aligned_cols=268 Identities=26% Similarity=0.360 Sum_probs=201.0
Q ss_pred chHHHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeec
Q 006168 310 RLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ 387 (658)
Q Consensus 310 ~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 387 (658)
..+++..++++|.+.+.||+|+||.||++... +++.||+|++.... .....+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34567778899999999999999999999864 68899999986532 22334667889999999999999999998854
Q ss_pred C------CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeE
Q 006168 388 G------PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPK 461 (658)
Q Consensus 388 ~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~k 461 (658)
. ...+++++++ +++|.+++. ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence 3 3468888887 779988873 34599999999999999999999998 999999999999999999999
Q ss_pred EeeccCccccCCCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHH-
Q 006168 462 IADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRL- 539 (658)
Q Consensus 462 l~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~- 539 (658)
|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+ ....+.
T Consensus 161 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~-~~~~~~~ 234 (345)
T cd07877 161 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QL-KLILRLV 234 (345)
T ss_pred Eeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH-HHHHHHh
Confidence 9999998764322 223567889999998866 568899999999999999999999986543211 11 100000
Q ss_pred ----------hhcCcccc---cccccCC--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 540 ----------YENGTHWE---LMDESLD--PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 540 ----------~~~~~~~~---~~d~~l~--~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+....... .+..... ...........+.+++..|++.||.+||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000000 0000000 000000124468899999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.47 Aligned_cols=264 Identities=25% Similarity=0.382 Sum_probs=198.0
Q ss_pred HHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCC---
Q 006168 315 VSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP--- 389 (658)
Q Consensus 315 ~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 389 (658)
....++|.+.+.||+|+||.||++... ++..||||++.... .......+.+|++++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 345678999999999999999999865 68999999986432 2233456889999999999999999999986543
Q ss_pred ---eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeecc
Q 006168 390 ---ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFG 466 (658)
Q Consensus 390 ---~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG 466 (658)
..++||||+ +++|.+++. ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 468999999 679988873 35699999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhH--HH-------HH
Q 006168 467 LARLLPENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYL--LK-------RA 536 (658)
Q Consensus 467 la~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l--~~-------~~ 536 (658)
++...... .....+++.|+|||.+.+ ..++.++||||||+++++|++|+.||.......... .. ..
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99865332 123467889999999876 468899999999999999999999987543211100 00 00
Q ss_pred HHHhhcCccccccccc--CCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 537 WRLYENGTHWELMDES--LDP---NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 537 ~~~~~~~~~~~~~d~~--l~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
+...........+... ... ..........+.+++.+|++.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000000 000 0001122346889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=281.29 Aligned_cols=264 Identities=24% Similarity=0.334 Sum_probs=215.2
Q ss_pred hHHHHHHhcCCCccCcccccCceEEEEEEecC------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeE
Q 006168 311 LKDLVSATRKFSEENKLGEGGFGDIYKGTLKN------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGC 384 (658)
Q Consensus 311 ~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 384 (658)
.++|.....++.....+.+|.||.||.|.|.+ .+.|-+|.++...++-+...+..|.-++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 45666666788888899999999999997753 456788888776777778889999999999999999999999
Q ss_pred eec-CCeEEEEEeccCCCCHHHHhh-----cCC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC
Q 006168 385 CSQ-GPELILVYEYMANSSLDKFLF-----GEK-RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD 457 (658)
Q Consensus 385 ~~~-~~~~~lV~E~~~~gsL~~~l~-----~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~ 457 (658)
+.+ .+..+++|.++.-|+|..+|. +.+ .+.++-.+...++.|++.|++|||++ ++||.||..+|.++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 865 467899999999999999996 222 23478888999999999999999999 99999999999999999
Q ss_pred CCeEEeeccCccccCCCCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCc-chhhHHH
Q 006168 458 LQPKIADFGLARLLPENQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGE-EGEYLLK 534 (658)
Q Consensus 458 ~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~-~~~~l~~ 534 (658)
.++||+|=.+++.+...+.+. ......+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++ +-+..+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl- 511 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL- 511 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH-
Confidence 999999999999776555443 334556789999999999999999999999999999999 7778765443 211111
Q ss_pred HHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 535 RAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 535 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.+|.- -..+.+.++++..++.-||...|++||++++++.-|...
T Consensus 512 ------kdGyR----------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 512 ------KDGYR----------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ------hccce----------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 11111 112233456799999999999999999999999998765
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=293.87 Aligned_cols=265 Identities=26% Similarity=0.337 Sum_probs=197.8
Q ss_pred hcCCCc-cCcccccCceEEEEEEec-CCcEEEEEEcccccccc-------------cHHHHHHHHHHHhccCCCccceee
Q 006168 318 TRKFSE-ENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRR-------------TLSDFENEVRLISNVHHRNLIRLL 382 (658)
Q Consensus 318 ~~~f~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~l~ 382 (658)
.++|.. .+.||+|+||.||++..+ +++.||||.+....... ....+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 355653 467999999999999976 68999999986432111 012477899999999999999999
Q ss_pred eEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEE
Q 006168 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKI 462 (658)
Q Consensus 383 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl 462 (658)
+++...+..++||||+. |+|.+++. ....+++.....++.|++.||.|||+. +|+|+||+|+||+++.++.+||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 99999999999999997 58999884 345689999999999999999999998 9999999999999999999999
Q ss_pred eeccCccccCCCC-------------ccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcc
Q 006168 463 ADFGLARLLPENQ-------------SHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEE 528 (658)
Q Consensus 463 ~DfGla~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~ 528 (658)
+|||++....... ........++..|+|||++.+. .++.++||||||+++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999998664111 1111233567889999998764 4689999999999999999999998765432
Q ss_pred hhhHHHHHHHHhhcCcc---ccc--------ccccCCC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 529 GEYLLKRAWRLYENGTH---WEL--------MDESLDP--NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 529 ~~~l~~~~~~~~~~~~~---~~~--------~d~~l~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
. ....+......... ... ....... ..........+.+++..||+.+|++|||+.|++..
T Consensus 241 ~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 D--QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred H--HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1 12222221111000 000 0000000 00011224568899999999999999999999964
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=287.57 Aligned_cols=262 Identities=30% Similarity=0.427 Sum_probs=200.2
Q ss_pred CCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
|+..+.||+|++|.||+|+.. +++.+++|.+.... .....+.+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999977 48999999987643 2333567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
+ ++|.+++.... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++........ .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 8 58999995432 4699999999999999999999998 999999999999999999999999999987644322 2
Q ss_pred cccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHH-----------HhhcCccc
Q 006168 479 STKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWR-----------LYENGTHW 546 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~-----------~~~~~~~~ 546 (658)
.....++..|+|||.+.+. .++.++||||||++++||++|+.|+........ .....+ ....-...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ--LFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHHHHhCCCcHHHHHhhcccccc
Confidence 2234557789999998776 889999999999999999999988865443111 111111 11000000
Q ss_pred ccccccCCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 547 ELMDESLDPN---ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 547 ~~~d~~l~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+..-+..... .........+.+++..||+.+|++||++.+|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000000 0001124579999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=284.54 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=195.8
Q ss_pred CCCccCcccccCceEEEEEEecC-CcEEEEEEccc---c-cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAI---G-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~---~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
+|.+.++||+|+||.||+++... +..+++|.+.. . .......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57788999999999999998753 44455554432 1 1223345677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 395 YEYMANSSLDKFLFG--EKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
|||+++++|.+++.. .....+++..++.++.|+++||.|||+. +++|+||+|+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998854 2345699999999999999999999998 9999999999999975 569999999987664
Q ss_pred CCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 473 ENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 473 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
.... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ........ .+.
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~-~~~-------- 221 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLRIV-EGP-------- 221 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHH-cCC--------
Confidence 3322 22345678899999999888889999999999999999999999854321 11111111 111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....+...+..+.+++.+||+.+|++||++.++++.
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 --TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111233445678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=296.83 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=194.9
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecC--------
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG-------- 388 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 388 (658)
..+|...+.||.|+||.||+|... +++.||+|.+... .....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecC-CCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 368889999999999999999976 5889999998653 335567789999999999999999999876543
Q ss_pred ------CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC-CCCeE
Q 006168 389 ------PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD-DLQPK 461 (658)
Q Consensus 389 ------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~-~~~~k 461 (658)
...++||||++ ++|.+++. ...+++..+..++.||++||.|||+. +|+||||||+||+++. ++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 35799999997 58988873 34689999999999999999999998 9999999999999974 56789
Q ss_pred EeeccCccccCCCCccc--cccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHH
Q 006168 462 IADFGLARLLPENQSHL--STKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWR 538 (658)
Q Consensus 462 l~DfGla~~~~~~~~~~--~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~ 538 (658)
|+|||++..+....... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||........ .......
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~ 234 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILES 234 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh
Confidence 99999998654322111 123467889999998755 4678899999999999999999999965443111 0000000
Q ss_pred Hhhc---------CcccccccccCCCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 539 LYEN---------GTHWELMDESLDPN-----ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 539 ~~~~---------~~~~~~~d~~l~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.... ......+....... ........++.+++..||+.||.+|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 00000000000000 0011233568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=279.29 Aligned_cols=237 Identities=27% Similarity=0.384 Sum_probs=194.1
Q ss_pred ccccCceEEEEEEec-CCcEEEEEEcccccc--cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCCH
Q 006168 327 LGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS--RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSL 403 (658)
Q Consensus 327 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 403 (658)
||+|+||.||++..+ +++.+++|.+..... ......+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999976 588999999875322 22456789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccccccc
Q 006168 404 DKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFA 483 (658)
Q Consensus 404 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 483 (658)
.+++.. ...+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSK--EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 999943 34689999999999999999999998 99999999999999999999999999998764432 1233456
Q ss_pred CCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHH
Q 006168 484 GTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAA 563 (658)
Q Consensus 484 gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 563 (658)
++..|++||...+...+.++|+||||+++|||++|+.|+..... ...... ... . ....+...+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~---~~~-~-----------~~~~~~~~~ 217 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEK---ILK-D-----------PLRFPEFLS 217 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHH---Hhc-C-----------CCCCCCCCC
Confidence 88899999999888899999999999999999999999864432 111111 111 0 011122224
Q ss_pred HHHHHHHHHccccCCCCCCCHHH
Q 006168 564 EKVVEIALMCTQSAANSRPTMSE 586 (658)
Q Consensus 564 ~~l~~li~~cl~~dp~~RPt~~e 586 (658)
..+.+++.+||..||++||++.+
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 56899999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=292.26 Aligned_cols=262 Identities=23% Similarity=0.323 Sum_probs=193.1
Q ss_pred CCCccCcccccCceEEEEEEec-C--CcEEEEEEccccccc-ccHHHHHHHHHHHhcc-CCCccceeeeEeec----CCe
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-N--GKIVAVKKLAIGISR-RTLSDFENEVRLISNV-HHRNLIRLLGCCSQ----GPE 390 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 390 (658)
+|...+.||+|+||.||+++.. . +..||+|++...... ...+.+.+|+++++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999976 3 778999998643222 2356788899999999 59999999987533 245
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.++++||+. ++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788899986 58998883 445699999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCcc---ccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHH--------
Q 006168 471 LPENQSH---LSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWR-------- 538 (658)
Q Consensus 471 ~~~~~~~---~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~-------- 538 (658)
+...... ......|+..|+|||++.+ ..++.++||||||+++++|++|+.||....... .......
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 232 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD--QLNQILQVLGTPDEE 232 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH--HHHHHHHHhCCCCHH
Confidence 6433221 1224578999999998766 468999999999999999999999986543210 1110000
Q ss_pred ---HhhcCccccc---ccc--cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 539 ---LYENGTHWEL---MDE--SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 539 ---~~~~~~~~~~---~d~--~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.......... ... ..............+.+++.+|++.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 000 00000000112356899999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=295.35 Aligned_cols=262 Identities=26% Similarity=0.392 Sum_probs=198.6
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCe---
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPE--- 390 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 390 (658)
...++|...+.||+|++|.||+|+.. +++.||+|++.... .......+.+|+.++++++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999986 57899999986432 22334667889999999999999999998766554
Q ss_pred ---EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccC
Q 006168 391 ---LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL 467 (658)
Q Consensus 391 ---~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGl 467 (658)
.++|+||+ +++|.+++. ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVK---CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 569999884 35699999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh------
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLY------ 540 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~------ 540 (658)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+.......
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~--~~~~i~~~~~~~~~~ 238 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID--QLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHhcCCCCHH
Confidence 9865432 233467889999999865 367899999999999999999999986543311 111111100
Q ss_pred -----hcCcccccccccCC--CCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 541 -----ENGTHWELMDESLD--PNE---CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 541 -----~~~~~~~~~d~~l~--~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
........+..... ... .....+..+.+++.+||+.+|++|||+.+|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000000000 000 001125679999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=268.96 Aligned_cols=263 Identities=23% Similarity=0.345 Sum_probs=204.0
Q ss_pred cchHHHHHHhcCCCccCcccccCceEEEEEE-ecCCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEee
Q 006168 309 YRLKDLVSATRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCS 386 (658)
Q Consensus 309 ~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 386 (658)
-+++|+.+.|+ +.||+|+|+.|-.++ +.+|..+|||++.+ ..........+|++++.+- .|+||++|+++|+
T Consensus 73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidK-q~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDK-QPGHSRSRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhc-CCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 45677777764 569999999999887 67899999999987 4566678889999999998 5999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC---CeEEe
Q 006168 387 QGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL---QPKIA 463 (658)
Q Consensus 387 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~---~~kl~ 463 (658)
+++.+|||||-|.+|+|...|+ ++..+++.+..++.++|+.||.+||.+ +|.|||+||+|||-.+.. -+||+
T Consensus 147 dd~~FYLVfEKm~GGplLshI~--~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQ--KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ccceEEEEEecccCchHHHHHH--HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeee
Confidence 9999999999999999999984 445699999999999999999999999 999999999999996554 48999
Q ss_pred eccCccccCC--CCcc----ccccccCCcccccccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCc-----
Q 006168 464 DFGLARLLPE--NQSH----LSTKFAGTLGYTAPEYAI-----HGQLSEKVDAYSFGVLVLEIISGTKSSETKGE----- 527 (658)
Q Consensus 464 DfGla~~~~~--~~~~----~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~----- 527 (658)
||.+..-... +-+. .....+|+..|||||+.. ...|+.+.|.||||||||-|++|.+||.+.-.
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 9988754321 1111 223578899999999872 24688899999999999999999999976532
Q ss_pred c-hhh---HHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 528 E-GEY---LLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 528 ~-~~~---l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
+ ++. -.+....-+.+|. .+..|+. =...+.+..+++...+..++.+|.++.+++.
T Consensus 302 drGe~Cr~CQ~~LFesIQEGk-YeFPdkd------WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGK-YEFPDKD------WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCCccHHHHHHHHHHHhccC-CcCChhh------hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1 111 1111111122221 1111111 0124566788999999999999999998886
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=277.39 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=199.2
Q ss_pred ccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEEeccCC
Q 006168 323 EENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 323 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
....||.|.||+|+|-.++ .|+.+|||++.....+.+.++++.|.+...+- +.||||+++|.+...+..++-||.|.-
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~ 147 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI 147 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence 3567999999999999976 69999999998766667778888898876554 799999999999888899999999965
Q ss_pred CCHHHHh---hcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 401 SSLDKFL---FGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 401 gsL~~~l---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
||+.+. ....+..+++.-+-.|+.-...||.||... ..|+||||||+|||||..|.+||+|||++..+.++-
T Consensus 148 -SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si-- 222 (361)
T KOG1006|consen 148 -SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI-- 222 (361)
T ss_pred -hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH--
Confidence 776554 334456699999999999999999999987 489999999999999999999999999998764332
Q ss_pred ccccccCCccccccccccc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIH--GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~--~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
..+.-.|-..|||||.+.. ..|+.+|||||||++|+|+.||+.|+..-.. +.+...... .+....+. .
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv-~gdpp~l~-----~ 292 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVV-IGDPPILL-----F 292 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHH-cCCCCeec-----C
Confidence 2345578889999999853 3589999999999999999999999865332 222222221 22222211 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.....+....+..++..|+.+|-.+||...++.++
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11122355679999999999999999999998864
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=274.76 Aligned_cols=242 Identities=26% Similarity=0.318 Sum_probs=201.7
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
.++|...+.||+|.||.|.+++-+ .++.+|+|++++. ....+..+-..|-++|+.-+||.+..|--.|+..+++++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888999999999999999976 6899999999765 3445556668899999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||..+|.|.-.| .+...+++....-+-..|+.||.|||++ +||.||||.+|.|+|.+|++||.|||+++.--..
T Consensus 247 MeyanGGeLf~HL--srer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 247 MEYANGGELFFHL--SRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEccCceEeeeh--hhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999998877 4455688888888999999999999998 9999999999999999999999999999854322
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
......++|||.|+|||++....|..+.|.|.+|||+|||++|+.||.....+. +.+.+ .. .
T Consensus 322 -g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--LFeLI----l~--------e--- 383 (516)
T KOG0690|consen 322 -GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--LFELI----LM--------E--- 383 (516)
T ss_pred -cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH--HHHHH----Hh--------h---
Confidence 223457899999999999999999999999999999999999999997654432 11111 00 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRP 582 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RP 582 (658)
.-.++.....+...|+.-.|.+||.+|.
T Consensus 384 d~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 DLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 1123444555688889999999999995
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=269.45 Aligned_cols=254 Identities=22% Similarity=0.264 Sum_probs=201.6
Q ss_pred HhcCCCcc-CcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeec----CC
Q 006168 317 ATRKFSEE-NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQ----GP 389 (658)
Q Consensus 317 a~~~f~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~ 389 (658)
++++|++. ++||-|-.|.|-....+ +++.+|+|++... ....+|+++--.. .|||||.+++++.. ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 45666654 57899999999999876 6899999998642 3457888877665 69999999999854 46
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC---CCCeEEeecc
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD---DLQPKIADFG 466 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~---~~~~kl~DfG 466 (658)
.+.+|||.|+||.|...|.+.....+++.+...|++||+.|+.|||+. +|.||||||+|+|... +..+||+|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 789999999999999999877777899999999999999999999999 9999999999999964 4568999999
Q ss_pred CccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccc
Q 006168 467 LARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHW 546 (658)
Q Consensus 467 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 546 (658)
+|+..... ......+-|+.|.|||++...+|+...|+||+||++|-|++|.+||.......... ...+.+..+. .
T Consensus 210 FAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp--gMk~rI~~gq-y 284 (400)
T KOG0604|consen 210 FAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKRRIRTGQ-Y 284 (400)
T ss_pred cccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh--hHHhHhhccC-c
Confidence 99875432 22345678999999999999999999999999999999999999998755421110 0011111111 1
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 547 ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 547 ~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+. +++.=...++...++|+.+|..+|.+|.|+.+++..
T Consensus 285 ~F------P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 EF------PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cC------CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11 111113456778999999999999999999999865
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=312.42 Aligned_cols=146 Identities=27% Similarity=0.459 Sum_probs=131.2
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+.++||+|+||.||+|.+. +++.||||++.... .......+..|+.+++.++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67888999999999999999977 68899999986421 2233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
||+.+++|.+++.. ...+++..++.|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999843 35689999999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=268.36 Aligned_cols=270 Identities=22% Similarity=0.344 Sum_probs=201.1
Q ss_pred hcCCCccCcccccCceEEEEEEecC-----CcEEEEEEccccccccc-HHHHHHHHHHHhccCCCccceeeeEeec-CCe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN-----GKIVAVKKLAIGISRRT-LSDFENEVRLISNVHHRNLIRLLGCCSQ-GPE 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 390 (658)
...|+...+||+|.||.||++.-++ .+.+|||++.......+ -...-+|+.+++.++||||+.|..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568889999999999999996442 33689999875322222 2456799999999999999999999876 788
Q ss_pred EEEEEeccCCCCHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC----CCeEEe
Q 006168 391 LILVYEYMANSSLDKFLFGEK---RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD----LQPKIA 463 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~----~~~kl~ 463 (658)
++|++||.++ +|..+|+..+ ...++...+..|+.||+.|+.|||++ -|+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 9999999998 8888886433 24599999999999999999999999 89999999999999877 899999
Q ss_pred eccCccccCCCCccc--cccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcc-------hhhHH
Q 006168 464 DFGLARLLPENQSHL--STKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEE-------GEYLL 533 (658)
Q Consensus 464 DfGla~~~~~~~~~~--~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~-------~~~l~ 533 (658)
|||+++.+...-... ...++-|..|.|||.+.+. .||.+.|||+.|||+.||+|-++.|...... ....+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999986654433 3367789999999999875 7899999999999999999988877654321 01122
Q ss_pred HHHHHHhhc--CcccccccccCC---------CCCCCH----H-------HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 006168 534 KRAWRLYEN--GTHWELMDESLD---------PNECTK----E-------AAEKVVEIALMCTQSAANSRPTMSEVVALL 591 (658)
Q Consensus 534 ~~~~~~~~~--~~~~~~~d~~l~---------~~~~~~----~-------~~~~l~~li~~cl~~dp~~RPt~~evl~~L 591 (658)
+.+.++..- ...|..+..... ...... . -.....+|+..+|+.||.+|.|+++.++..
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 222222211 111111111000 000000 0 012267899999999999999999988753
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=296.65 Aligned_cols=259 Identities=25% Similarity=0.406 Sum_probs=213.2
Q ss_pred chHHHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeec
Q 006168 310 RLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQ 387 (658)
Q Consensus 310 ~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 387 (658)
.++.+..-++.|++.+.||+|.+|.||+++.. +++..|+|++... ....++++.|.++++.+ +|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~--~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT--EDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC--ccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 34444556778999999999999999999955 7899999998753 44556788899999988 69999999999843
Q ss_pred -----CCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEE
Q 006168 388 -----GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKI 462 (658)
Q Consensus 388 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl 462 (658)
+++++||||||.+||.-++++......+.|+.+..|++.++.||.+||.+ .++|||||-.|||++.++.+||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 57899999999999999999887777899999999999999999999998 9999999999999999999999
Q ss_pred eeccCccccCCCCccccccccCCccccccccccc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHH
Q 006168 463 ADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH-----GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAW 537 (658)
Q Consensus 463 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~ 537 (658)
.|||++..+.... .......||+.|||||++.. ..|+..+|+||||++..||.-|.+|+....+..-.
T Consensus 165 vDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------ 237 (953)
T KOG0587|consen 165 VDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------ 237 (953)
T ss_pred eeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh------
Confidence 9999998774432 23446789999999999954 35677999999999999999999998655432110
Q ss_pred HHhhcCcccccccccCCC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 538 RLYENGTHWELMDESLDP-NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 538 ~~~~~~~~~~~~d~~l~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.. +....++ --.+....+++.++|..||.+|-++||++.++++
T Consensus 238 --------F~-IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 --------FL-IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --------cc-CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 01 1111111 1235667889999999999999999999999884
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=242.41 Aligned_cols=265 Identities=23% Similarity=0.382 Sum_probs=201.3
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccccccc-HHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRT-LSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+|...++||+|.||+||+++.+ .++.||+|++..+...++ -....+|+-+++.++|+|||++++....+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556678999999999999976 588999999976544333 35678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
|.. +|..+. +.-.+.++.+....++.|+++||.++|++ ++.|||+||.|.|++.+|+.||+|||+++.+.-.-..
T Consensus 83 cdq-dlkkyf-dslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 83 CDQ-DLKKYF-DSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred hhH-HHHHHH-HhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 965 888876 44567799999999999999999999999 9999999999999999999999999999988655433
Q ss_pred ccccccCCcccccccccccCC-CCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh-cCccc----ccccc
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQ-LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYE-NGTHW----ELMDE 551 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~-~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~-~~~~~----~~~d~ 551 (658)
. ...+-|..|.+|.++.+.+ |++..|+||-||++.||....+|.....+-..++....|.+-. .++.| .+.|.
T Consensus 158 y-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 158 Y-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred e-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 2 2345689999999998864 7899999999999999998666655444433333332222211 11112 22222
Q ss_pred cCCCCC--------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 552 SLDPNE--------CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 552 ~l~~~~--------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+.- .-+.....=.+++...+.-+|.+|.++++.++.
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 221110 111112233567778888899999999887753
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=271.72 Aligned_cols=220 Identities=17% Similarity=0.141 Sum_probs=177.1
Q ss_pred cCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCCHHHHhh
Q 006168 330 GGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLF 408 (658)
Q Consensus 330 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~ 408 (658)
|.+|.||+++.+ +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 889999999976 68899999987531 23455556666679999999999999999999999999999999984
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccccccCCccc
Q 006168 409 GEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGY 488 (658)
Q Consensus 409 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y 488 (658)
. ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.++|+|||++...... .....++..|
T Consensus 78 ~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 78 K--FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred H--hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 3 34699999999999999999999998 9999999999999999999999999988655332 1223456789
Q ss_pred ccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHH
Q 006168 489 TAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVE 568 (658)
Q Consensus 489 ~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~ 568 (658)
+|||.+....++.++||||+|+++|||++|+.|+....... .. .. ....+......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~-----~~-----~~~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NT-----HT-----TLNIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------cc-----cc-----ccCCcccCCHHHHH
Confidence 99999988889999999999999999999998764321100 00 00 00112223456899
Q ss_pred HHHHccccCCCCCCCHH
Q 006168 569 IALMCTQSAANSRPTMS 585 (658)
Q Consensus 569 li~~cl~~dp~~RPt~~ 585 (658)
++.+|++.||++||++.
T Consensus 208 li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 208 LLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHccCCHHHhcCCC
Confidence 99999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=302.96 Aligned_cols=262 Identities=23% Similarity=0.296 Sum_probs=213.2
Q ss_pred cchHHHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEe
Q 006168 309 YRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCC 385 (658)
Q Consensus 309 ~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 385 (658)
-.+.++.-..++|.+.+.||+|+||.|..++.+ .+++||+|++.+- .......-|..|-.+|..-+.+-|+++.-.|
T Consensus 65 ~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF 144 (1317)
T KOG0612|consen 65 KKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF 144 (1317)
T ss_pred HHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence 345566666789999999999999999999987 5889999999752 2234456788999999988999999999999
Q ss_pred ecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeec
Q 006168 386 SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADF 465 (658)
Q Consensus 386 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~Df 465 (658)
++..++|+|||||+||+|-.++. +-..++++...-++..|..||.-||+. |+|||||||+|||||..|++||+||
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlS--k~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLS--KFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred cCccceEEEEecccCchHHHHHh--hcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999999994 334799999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCCCccccccccCCccccccccccc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh
Q 006168 466 GLARLLPENQSHLSTKFAGTLGYTAPEYAIH-----GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLY 540 (658)
Q Consensus 466 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~-----~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~ 540 (658)
|.+..+..+....+...+|||.|++||++.. +.|...+|.||+||++|||+.|.-||... .++....++.
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm 294 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIM 294 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHh
Confidence 9999888777777778899999999999842 67999999999999999999999999643 3444434444
Q ss_pred hcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 006168 541 ENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPT---MSEVVA 589 (658)
Q Consensus 541 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~evl~ 589 (658)
...+.....+ ..+.++...+||...+. +|+.|.. +.++-.
T Consensus 295 ~hk~~l~FP~--------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 295 NHKESLSFPD--------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred chhhhcCCCc--------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 3332222211 11245567777776554 5667766 777764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=281.12 Aligned_cols=244 Identities=26% Similarity=0.428 Sum_probs=200.0
Q ss_pred cCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCC
Q 006168 324 ENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANS 401 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 401 (658)
.+.||.|.||+||-|+++ +|+.||||+|.+- ....+...+.+|+.+|++++||.||.+.-.|+..+..++|||-+.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 478999999999999976 7999999999753 4556668899999999999999999999999999999999999954
Q ss_pred CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC---CCeEEeeccCccccCCCCccc
Q 006168 402 SLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD---LQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 402 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~---~~~kl~DfGla~~~~~~~~~~ 478 (658)
++.+.|.....++|++..-.-++.||+.||.|||.+ +|+|.||||+|||+... ..+||+|||+++.+.+.. .
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--F 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--F 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh--h
Confidence 776777677788899999899999999999999999 99999999999999543 579999999999986543 4
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 558 (658)
...++||+.|+|||++.+..|...-|+||.|||+|--++|..||....+-.+++...+ .+ . +.+.
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa-----------FM---y-Pp~P 787 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA-----------FM---Y-PPNP 787 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc-----------cc---c-CCCc
Confidence 4568999999999999999999999999999999999999999965443222211110 00 0 1111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 006168 559 TKEAAEKVVEIALMCTQSAANSRPTMSEVV 588 (658)
Q Consensus 559 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl 588 (658)
=.+.....+++|...|+..-.+|-+.+.-+
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 123345678888888888888888877655
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=272.53 Aligned_cols=241 Identities=26% Similarity=0.352 Sum_probs=198.3
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 394 (658)
.+|.....||+|+||.|.++..+ ..+.+|||+++++. .....+--..|-++|.-. +.|.++++..+++.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 47888999999999999999877 46789999998752 222233335677777665 678999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+.+|+|--.| ..-+.+.+....-+|..||-||-+||++ +|+.||||.+|||||.+|++||+|||+++.---.
T Consensus 429 MEyvnGGDLMyhi--QQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 429 MEYVNGGDLMYHI--QQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEecCchhhhHH--HHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccC
Confidence 9999999998888 3456788999999999999999999999 9999999999999999999999999999853222
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
...+.+++||+.|+|||++...+|+...|.|||||+||||+.|++||+...++ .+.+.+.++
T Consensus 504 -~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~--elF~aI~eh--------------- 565 (683)
T KOG0696|consen 504 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQAIMEH--------------- 565 (683)
T ss_pred -CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHc---------------
Confidence 22244789999999999999999999999999999999999999999875543 233322221
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRP 582 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RP 582 (658)
.-.++...+.+...|....+.+.|.+|.
T Consensus 566 nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 2345666777888999999999999984
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=287.31 Aligned_cols=240 Identities=23% Similarity=0.317 Sum_probs=196.2
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++.|.....+|.|+|+.|-.+... +++..++|++... ..+-.+|+.++... +||||+++.+.+.++.+.++||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc-----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 567778888999999999999865 6888999998753 22345677665555 8999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE-cCCCCeEEeeccCccccCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL-DDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll-~~~~~~kl~DfGla~~~~~~ 474 (658)
|.+.++-|.+.+.. ..... .++..|+.+|+.++.|||++ ++|||||||+|||+ +..++++|+|||.++..+..
T Consensus 396 e~l~g~ell~ri~~--~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS--KPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hhccccHHHHHHHh--cchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999988887732 22233 77888999999999999998 99999999999999 58899999999999887554
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
....+-|..|.|||++....|++++|+||||++||+||+|+.|+.....+ ..+... . .
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~----i-------------~ 527 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTR----I-------------Q 527 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHh----h-------------c
Confidence 22335578999999999999999999999999999999999999876554 122111 1 1
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+....+....+|+.+||+.||.+||+|.++...
T Consensus 528 ~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 528 MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred CCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 223335566789999999999999999999999865
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=272.46 Aligned_cols=276 Identities=18% Similarity=0.266 Sum_probs=210.4
Q ss_pred ccCCcccchHHHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCC--C---
Q 006168 303 LQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHH--R--- 376 (658)
Q Consensus 303 ~~~~~~~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~--- 376 (658)
.+|-..|...|.. +++|.+...+|+|.||.|-..... .+..||||+++. -....+..+-|+++|.++.+ |
T Consensus 75 ~dGH~v~~~gD~l--~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~--V~kYreAa~iEi~vLqki~~~DP~g~ 150 (415)
T KOG0671|consen 75 KDGHYVYQVGDIL--TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN--VDKYREAALIEIEVLQKINESDPNGK 150 (415)
T ss_pred CCceEEEEecccc--ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH--HHHHhhHHHHHHHHHHHHHhcCCCCc
Confidence 3444455555544 789999999999999999999865 478999999863 23334455779999999932 2
Q ss_pred -ccceeeeEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc
Q 006168 377 -NLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD 455 (658)
Q Consensus 377 -niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~ 455 (658)
-+|++.++|...++.++|+|.+ |-|+.++|..+.-.+++...+..|+.|+++++++||+. +++|-||||+|||+.
T Consensus 151 ~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfv 226 (415)
T KOG0671|consen 151 FRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFV 226 (415)
T ss_pred eEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEe
Confidence 3788899999999999999999 44999999777777899999999999999999999999 999999999999983
Q ss_pred C--------------------CCCeEEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHH
Q 006168 456 D--------------------DLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEI 515 (658)
Q Consensus 456 ~--------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~el 515 (658)
+ +..+||+|||.+..-.+.. ..++.|..|.|||++.+..++.++||||+||||.||
T Consensus 227 ss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El 302 (415)
T KOG0671|consen 227 SSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL 302 (415)
T ss_pred ccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence 1 3458999999998755444 456789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCcch-hhHHHH--------------HHHHhhcCccc-----------ccccccCC---CCCCCHHHHHHH
Q 006168 516 ISGTKSSETKGEEG-EYLLKR--------------AWRLYENGTHW-----------ELMDESLD---PNECTKEAAEKV 566 (658)
Q Consensus 516 ltG~~p~~~~~~~~-~~l~~~--------------~~~~~~~~~~~-----------~~~d~~l~---~~~~~~~~~~~l 566 (658)
.+|...|..+.+.. -.+++. +.+....+.+. ...+...+ .-.....+..+|
T Consensus 303 ytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L 382 (415)
T KOG0671|consen 303 YTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL 382 (415)
T ss_pred eccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence 99999888766311 111111 11111111110 00000000 001234456789
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 006168 567 VEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 567 ~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+|+..||..||.+|+|+.|++..
T Consensus 383 fDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 383 FDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHHHccCccccccHHHHhcC
Confidence 999999999999999999998863
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=264.12 Aligned_cols=239 Identities=29% Similarity=0.408 Sum_probs=194.0
Q ss_pred CceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCCHHHHhhc
Q 006168 331 GFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFG 409 (658)
Q Consensus 331 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 409 (658)
+||.||++... +++.+++|++.........+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999987643322268899999999999999999999999999999999999999999999854
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccccccCCcccc
Q 006168 410 EKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYT 489 (658)
Q Consensus 410 ~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~ 489 (658)
. ..+++..++.++.+++.+|.+||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|+
T Consensus 81 ~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 R--GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred c--cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 3 2389999999999999999999998 99999999999999999999999999998765432 233456788999
Q ss_pred cccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHH
Q 006168 490 APEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEI 569 (658)
Q Consensus 490 APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l 569 (658)
+||.+....++.++||||||+++++|++|..|+...... ....+ ........ ...........+.++
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~----~~~~~~~~--------~~~~~~~~~~~~~~~ 220 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFK----KIGKPKPP--------FPPPEWKISPEAKDL 220 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHH----HHhccCCC--------CccccccCCHHHHHH
Confidence 999999888999999999999999999999998653221 11111 11111100 000000034579999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 006168 570 ALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 570 i~~cl~~dp~~RPt~~evl~ 589 (658)
+.+|+..+|++||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 99999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=293.50 Aligned_cols=260 Identities=23% Similarity=0.284 Sum_probs=171.6
Q ss_pred HhcCCCccCcccccCceEEEEEEec-C----CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeE------e
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-N----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGC------C 385 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~ 385 (658)
..++|...+.||+|+||.||+|++. + +..||+|++.... ..+.+..| .+.+..+.++..++.. .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 5678999999999999999999976 4 6899999875321 11111111 1222223333322221 2
Q ss_pred ecCCeEEEEEeccCCCCHHHHhhcCCCC------------------CCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCc
Q 006168 386 SQGPELILVYEYMANSSLDKFLFGEKRG------------------SLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDI 447 (658)
Q Consensus 386 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Di 447 (658)
..+...++||||+.+++|.+++...... ...+..+..++.||+.||.|||+. +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 4567899999999999999988543210 112344567999999999999998 9999999
Q ss_pred CCCcEEEcC-CCCeEEeeccCccccCCCCccccccccCCcccccccccccC----------------------CCCCccc
Q 006168 448 KPSNVLLDD-DLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG----------------------QLSEKVD 504 (658)
Q Consensus 448 k~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~----------------------~~s~ksD 504 (658)
||+|||+++ ++.+||+|||+++.+............+++.|+|||.+... .+..++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 57999999999987655444444567889999999965322 2445679
Q ss_pred chhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcc----cccccccCCCC-----CCCHHHHHHHHHHHHHccc
Q 006168 505 AYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTH----WELMDESLDPN-----ECTKEAAEKVVEIALMCTQ 575 (658)
Q Consensus 505 V~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~----~~~~d~~l~~~-----~~~~~~~~~l~~li~~cl~ 575 (658)
||||||+||||+++..+..... ......+...+.. ...+....... ...........+|+.+||+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNL------IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHH------HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 9999999999999765543211 0000000000000 00000000000 0000012235689999999
Q ss_pred cCCCCCCCHHHHHHH
Q 006168 576 SAANSRPTMSEVVAL 590 (658)
Q Consensus 576 ~dp~~RPt~~evl~~ 590 (658)
.||.+|||+.++++.
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999974
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=273.95 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=196.9
Q ss_pred cCCCccCcccccCceEEEEEE-ecCCcEEEEEEccccccccc------HHHHHHHHHHHhccCCCccceeeeEee-cCCe
Q 006168 319 RKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRT------LSDFENEVRLISNVHHRNLIRLLGCCS-QGPE 390 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~ 390 (658)
++|-..+.||+|||+.||++. +...+.||||+-....++.. .+...+|.++-+.|+||.||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 456678899999999999998 44678899998754333322 234578999999999999999999995 4567
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC---CCCeEEeeccC
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD---DLQPKIADFGL 467 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~---~~~~kl~DfGl 467 (658)
++-|.||+++.+|+-+|. ....+++++...|+.||+.||.||.+. +++|||-||||.||||.. -|.+||.|||+
T Consensus 543 FCTVLEYceGNDLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ceeeeeecCCCchhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 899999999999999994 345699999999999999999999986 679999999999999944 47899999999
Q ss_pred ccccCCCCcc------ccccccCCcccccccccccC----CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHH
Q 006168 468 ARLLPENQSH------LSTKFAGTLGYTAPEYAIHG----QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAW 537 (658)
Q Consensus 468 a~~~~~~~~~------~~~~~~gt~~y~APE~~~~~----~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~ 537 (658)
++.++.+... ......||..|++||.+.-+ +.+.|.||||.|||+|+.+.|++||....... .+++.
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-dILqe-- 696 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-DILQE-- 696 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-HHHhh--
Confidence 9988654322 23367899999999998544 57889999999999999999999997654322 22221
Q ss_pred HHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 006168 538 RLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVV 588 (658)
Q Consensus 538 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 588 (658)
..+...-.-.+++ .+....+...+|++||+.--++|....++.
T Consensus 697 -----NTIlkAtEVqFP~---KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 -----NTILKATEVQFPP---KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -----hchhcceeccCCC---CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1111111111111 112344688999999999999997665544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-33 Score=261.15 Aligned_cols=267 Identities=23% Similarity=0.420 Sum_probs=199.9
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccccccc-HHHHHHHHHHHhccCCCccceeeeEeec--------CC
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRT-LSDFENEVRLISNVHHRNLIRLLGCCSQ--------GP 389 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~ 389 (658)
.|....+||+|.||.||+++.+ .|+.||+|++......++ -....+|+++|..|+|+|++.++..|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4555678999999999999976 477899998754333333 3456899999999999999999998843 34
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
.+++|++++++ +|.-+|. .....++..++.+++.++..||.|+|+. .|+|||+|+.|+|++.++.+||+|||+++
T Consensus 98 t~ylVf~~ceh-DLaGlLs-n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLS-NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeeHHHhhh-hHHHHhc-CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence 58999999988 8888883 2335699999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCcc---ccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchh-hHHH--------HH
Q 006168 470 LLPENQSH---LSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE-YLLK--------RA 536 (658)
Q Consensus 470 ~~~~~~~~---~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~-~l~~--------~~ 536 (658)
.+...... ..+..+-|..|.+||.+.+ ..|+++.|||.-|||+.||.|+.+-+....+... .++. .+
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 77443322 2345667999999999876 4799999999999999999999888776655221 1111 12
Q ss_pred HHHhhcCccccccccc-CCCCCCC--HHH------HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 006168 537 WRLYENGTHWELMDES-LDPNECT--KEA------AEKVVEIALMCTQSAANSRPTMSEVVALL 591 (658)
Q Consensus 537 ~~~~~~~~~~~~~d~~-l~~~~~~--~~~------~~~l~~li~~cl~~dp~~RPt~~evl~~L 591 (658)
|....+-.+++.+... +..+... ++. ..+..+++..++..||.+|+++++++..-
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 2222222222222111 1111110 011 12567899999999999999999998653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=285.64 Aligned_cols=261 Identities=22% Similarity=0.284 Sum_probs=182.6
Q ss_pred HhcCCCccCcccccCceEEEEEEe-----------------cCCcEEEEEEcccccccccHHH--------------HHH
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTL-----------------KNGKIVAVKKLAIGISRRTLSD--------------FEN 365 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~~ 365 (658)
..++|.+.++||+|+||.||+|.+ .+++.||||++.... ....++ +..
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~-~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR-QGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc-hhhHHHHHhhhhhhhcccchhHH
Confidence 367899999999999999999974 235679999986421 112222 334
Q ss_pred HHHHHhccCCCcc-----ceeeeEeec--------CCeEEEEEeccCCCCHHHHhhcCC---------------------
Q 006168 366 EVRLISNVHHRNL-----IRLLGCCSQ--------GPELILVYEYMANSSLDKFLFGEK--------------------- 411 (658)
Q Consensus 366 E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~--------------------- 411 (658)
|+..+.+++|.++ ++++++|.. .+..+|||||+++++|.++++...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6677777766554 677787753 356899999999999999986421
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccccccCCccccc
Q 006168 412 -RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490 (658)
Q Consensus 412 -~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~A 490 (658)
...++|..+..++.|++++|.|||+. +|+||||||+|||++.++.+||+|||++...............+++.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 12356788999999999999999998 99999999999999999999999999997654332222223345789999
Q ss_pred ccccccCCC----------------------CCcccchhhhHHHHHHHhCCC-CCCCCCcchhh-----HHHHHHHHhhc
Q 006168 491 PEYAIHGQL----------------------SEKVDAYSFGVLVLEIISGTK-SSETKGEEGEY-----LLKRAWRLYEN 542 (658)
Q Consensus 491 PE~~~~~~~----------------------s~ksDV~SfGvvl~elltG~~-p~~~~~~~~~~-----l~~~~~~~~~~ 542 (658)
||.+..... ..+.||||+||+++||++|.. |+......... .....|+.+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998854321 235799999999999999875 55422111101 11112332222
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 006168 543 GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAA---NSRPTMSEVVAL 590 (658)
Q Consensus 543 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp---~~RPt~~evl~~ 590 (658)
... +.. ..........+++..++..+| .+|+|++|+++.
T Consensus 459 ~~~----~~~-----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QKY----DFS-----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cCC----Ccc-----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111 110 011224568889999998765 689999999864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=243.88 Aligned_cols=208 Identities=27% Similarity=0.393 Sum_probs=174.1
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 396 (658)
+.......||+|++|.|-+-++. +|+..|+|++......+..++..+|+.+..+- .+|.+|.++|........++-||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 44445678999999999999865 79999999998877777778888999877554 79999999999988899999999
Q ss_pred ccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 397 YMANSSLDKFLFG--EKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 397 ~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
.|.. ||+.+..+ .+.+.+++..+-+|+..+.+||.|||++ ..++|||+||+|||++.+|++|+||||++..+.++
T Consensus 126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 9976 88776533 3456699999999999999999999997 58999999999999999999999999999877543
Q ss_pred CccccccccCCccccccccccc----CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhh
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIH----GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEY 531 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~----~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~ 531 (658)
-. .+...|--.|||||.+.. ..|+-||||||||+.+.||.+++.|++....+-++
T Consensus 203 iA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~q 261 (282)
T KOG0984|consen 203 IA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQ 261 (282)
T ss_pred hH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHH
Confidence 22 223467789999999843 37899999999999999999999998765554333
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=254.88 Aligned_cols=249 Identities=21% Similarity=0.295 Sum_probs=202.5
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 392 (658)
..++|...+.||+|+|..|..++++ +.+.+|+|++++. ...+.....+.|-.+..+- +||.+|-+..+|+....++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3468999999999999999999976 5788999998764 3445566778888888766 7999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
+|.||+++|+|--.+ .++..|+++...-+...|..||.|||+. +|+.||||..|||+|.+|++||.|+|+.+.--
T Consensus 328 fvieyv~ggdlmfhm--qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEEecCcceeeeh--hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999997666 4556799999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc--chhhHHHHHHHHhhcCccccccc
Q 006168 473 ENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE--EGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 473 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
... ..+.+++||+.|+|||++.+..|....|.|++||+++||+.|+.||+..+. ..++--++..+..-+.
T Consensus 403 ~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek------- 474 (593)
T KOG0695|consen 403 GPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK------- 474 (593)
T ss_pred CCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh-------
Confidence 322 234478999999999999999999999999999999999999999976443 2222222222222111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRP 582 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP 582 (658)
....+...+.+...+++.-|++||.+|.
T Consensus 475 ----qiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 475 ----QIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ----cccccceeehhhHHHHHHhhcCCcHHhc
Confidence 1123444556678889999999999984
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=270.40 Aligned_cols=249 Identities=22% Similarity=0.341 Sum_probs=205.6
Q ss_pred CCCccCcccccCceEEEEEEecCCc-EEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 320 KFSEENKLGEGGFGDIYKGTLKNGK-IVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
++.....||-||||.|=++..+... .+|+|.+++. ....+.++...|-.+|...+.|.||++|.-|.+...+|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4455667999999999999976533 4888887653 345566788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
-|-+|.|...| +.++.++..+..-++..+.+|++|||++ +||.|||||+|.|||.+|-+||.|||+|+.+....
T Consensus 501 aClGGElWTiL--rdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~- 574 (732)
T KOG0614|consen 501 ACLGGELWTIL--RDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR- 574 (732)
T ss_pred hhcCchhhhhh--hhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence 99999999999 5677899999999999999999999999 99999999999999999999999999999876544
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
.+-+++||+.|.|||++.+...+.+.|.||||++++||++|.+||....+...+. . +-..++.-
T Consensus 575 -KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn--~-------------ILkGid~i 638 (732)
T KOG0614|consen 575 -KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN--L-------------ILKGIDKI 638 (732)
T ss_pred -ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH--H-------------HHhhhhhh
Confidence 3346899999999999999999999999999999999999999998766522111 0 11111122
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPT-----MSEVVAL 590 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~~ 590 (658)
.+|........++++.....+|.+|.- +.+|-+.
T Consensus 639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 639 EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 344455566889999999999999975 4555443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=283.52 Aligned_cols=244 Identities=26% Similarity=0.403 Sum_probs=189.8
Q ss_pred CCccCcccccCce-EEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEEecc
Q 006168 321 FSEENKLGEGGFG-DIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 321 f~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
|...+.+|.|..| .||+|... |+.||||++-. +-.....+|+..|+.- .|||||++++.-.+++..|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 4455678899887 58999995 78999999854 2334568999999888 6999999999999999999999999
Q ss_pred CCCCHHHHhhcC-C-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC-----CCCeEEeeccCcccc
Q 006168 399 ANSSLDKFLFGE-K-RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD-----DLQPKIADFGLARLL 471 (658)
Q Consensus 399 ~~gsL~~~l~~~-~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~-----~~~~kl~DfGla~~~ 471 (658)
.- +|.+++... . .........+.+..|++.||++||+. +||||||||.||||+. ..+++|+|||+++.+
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 76 999999653 1 11122245577899999999999998 9999999999999965 257999999999988
Q ss_pred CCCCccccc--cccCCcccccccccccCCCCCcccchhhhHHHHHHHhC-CCCCCCCCcchhhHHHHHHHHhhcCccccc
Q 006168 472 PENQSHLST--KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG-TKSSETKGEEGEYLLKRAWRLYENGTHWEL 548 (658)
Q Consensus 472 ~~~~~~~~~--~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG-~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 548 (658)
..+...... ...||.+|+|||.+....-+.+.||||+|||+|+.++| ++||...-....+++.. ......
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~-------~~~L~~ 734 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG-------NYTLVH 734 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC-------ccceee
Confidence 766554433 67899999999999998888999999999999999996 88987644322222111 100001
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 549 MDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 549 ~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
+ .... +. +..+||.+|+..+|..||++.+|+.
T Consensus 735 L------~~~~-d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 L------EPLP-DC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred e------ccCc-hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1 0111 11 6889999999999999999999983
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=268.86 Aligned_cols=204 Identities=24% Similarity=0.388 Sum_probs=175.7
Q ss_pred CCCccCcccccCceEEEEEEe-cCCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 320 KFSEENKLGEGGFGDIYKGTL-KNGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
-|..++.||-|+||+|.+++- ++...+|+|.+.+. ..+......+.|-.||..-+.+-||+|+-.|++.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 467788899999999999984 45678999998753 234556678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC-
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ- 475 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~- 475 (658)
|++||++-.+| .+.+-+.+....-++..+..|+++.|.. |+|||||||+|||||.+|++||.||||+.-+.-..
T Consensus 710 YIPGGDmMSLL--IrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 710 YIPGGDMMSLL--IRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred ccCCccHHHHH--HHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccc
Confidence 99999999998 3556788888888999999999999998 99999999999999999999999999986542100
Q ss_pred -------cc---------------------------------ccccccCCcccccccccccCCCCCcccchhhhHHHHHH
Q 006168 476 -------SH---------------------------------LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEI 515 (658)
Q Consensus 476 -------~~---------------------------------~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~el 515 (658)
.+ .....+||+.|+|||++....|+..+|.||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 00 01136799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCcc
Q 006168 516 ISGTKSSETKGEE 528 (658)
Q Consensus 516 ltG~~p~~~~~~~ 528 (658)
+.|+.||......
T Consensus 865 ~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 865 LVGQPPFLADTPG 877 (1034)
T ss_pred hhCCCCccCCCCC
Confidence 9999999876653
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-31 Score=248.21 Aligned_cols=265 Identities=25% Similarity=0.359 Sum_probs=201.2
Q ss_pred CccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecC-----CeEEEE
Q 006168 322 SEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG-----PELILV 394 (658)
Q Consensus 322 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lV 394 (658)
+..+.||-|.||.||.++.. +|+.||+|++..- .+-...+.+.+|+.+|..++|.|++..++...-. ++.|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34678999999999999976 7999999998642 1222346788999999999999999998876433 357889
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
+|.|.. +|..+| -..+.|+.+.+.-+..||++||+|||+. +|.||||||.|.|++.+..+||+|||+++..+.+
T Consensus 136 TELmQS-DLHKII--VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 136 TELMQS-DLHKII--VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHh-hhhhee--ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 999965 888887 4556799999999999999999999998 9999999999999999999999999999987777
Q ss_pred CccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCc-chhhHHH--------HHHHHhhcCc
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGE-EGEYLLK--------RAWRLYENGT 544 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~-~~~~l~~--------~~~~~~~~~~ 544 (658)
+....+..+-|..|.|||++++. .|+.+.||||.|||+.||+..+..|...++ +.-.++. .+.+..-+|.
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 76667777789999999999875 799999999999999999988877765554 2111111 1122222221
Q ss_pred ccccccccCCCC--------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 545 HWELMDESLDPN--------ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 545 ~~~~~d~~l~~~--------~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
-..++....... ..+.....+...+..+++..||+.|.+..+.+..+.
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111222211111 111223345677888899999999999998876543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=235.79 Aligned_cols=211 Identities=36% Similarity=0.616 Sum_probs=184.3
Q ss_pred ccccCceEEEEEEecC-CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCCHHH
Q 006168 327 LGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDK 405 (658)
Q Consensus 327 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 405 (658)
||+|.+|.||++...+ ++.+++|++...........+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999998753322235789999999999999999999999999999999999999999999
Q ss_pred HhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC-CCCeEEeeccCccccCCCCccccccccC
Q 006168 406 FLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD-DLQPKIADFGLARLLPENQSHLSTKFAG 484 (658)
Q Consensus 406 ~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~g 484 (658)
++.... ..+++..++.++.+++++|.+||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 985332 4689999999999999999999998 9999999999999999 89999999999987644321 1233567
Q ss_pred CcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHH
Q 006168 485 TLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAA 563 (658)
Q Consensus 485 t~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 563 (658)
...|++||..... ..+.+.|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999999887 888999999999999999
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 564 EKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 564 ~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 358899999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=246.74 Aligned_cols=263 Identities=24% Similarity=0.357 Sum_probs=196.7
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC-----C---CccceeeeEeec--
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-----H---RNLIRLLGCCSQ-- 387 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 387 (658)
.+|.+.++||.|.|++||++... +.+.||+|+.+. .+...+....||++|++++ | ..||+|++.|.+
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS--AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS--AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh--hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 68889999999999999999965 577899999863 3444566789999999983 3 369999999964
Q ss_pred --CCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC--------
Q 006168 388 --GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD-------- 457 (658)
Q Consensus 388 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~-------- 457 (658)
+.++++|+|++.. +|..+|.....+.++...+.+|++||+.||.|||.++ +|||-||||+|||+...
T Consensus 156 pNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred CCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhh
Confidence 5789999999954 8889997777778999999999999999999999986 99999999999998300
Q ss_pred --------------------------------------------------------------------------------
Q 006168 458 -------------------------------------------------------------------------------- 457 (658)
Q Consensus 458 -------------------------------------------------------------------------------- 457 (658)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------------------------------------------------------------CC
Q 006168 458 ------------------------------------------------------------------------------LQ 459 (658)
Q Consensus 458 ------------------------------------------------------------------------------~~ 459 (658)
.+
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 00
Q ss_pred eEEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc----chhhHHHH
Q 006168 460 PKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE----EGEYLLKR 535 (658)
Q Consensus 460 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~----~~~~l~~~ 535 (658)
+||+|||-|.-+.. ..|.-..|..|.|||++.+..|++.+|||||+|+++||+||-..|+.... ..+..+..
T Consensus 393 vKIaDlGNACW~~k----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 393 VKIADLGNACWVHK----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred EEEeeccchhhhhh----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 23333333322111 11222456679999999999999999999999999999999988876543 12222222
Q ss_pred HH--------HHhhcCcc-------------------cccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 006168 536 AW--------RLYENGTH-------------------WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVV 588 (658)
Q Consensus 536 ~~--------~~~~~~~~-------------------~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 588 (658)
+. .+...|.. |.+.+-......++.+...++.+++.=||+.+|++|||+.+.+
T Consensus 469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl 548 (590)
T KOG1290|consen 469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL 548 (590)
T ss_pred HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence 21 22222221 1111111123457788899999999999999999999999988
Q ss_pred HH
Q 006168 589 AL 590 (658)
Q Consensus 589 ~~ 590 (658)
+.
T Consensus 549 ~h 550 (590)
T KOG1290|consen 549 KH 550 (590)
T ss_pred cC
Confidence 64
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=233.35 Aligned_cols=200 Identities=34% Similarity=0.513 Sum_probs=173.2
Q ss_pred CCccCcccccCceEEEEEEecC-CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccC
Q 006168 321 FSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMA 399 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 399 (658)
|...+.||+|++|.||++...+ ++.+++|.+.........+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999875 889999999764322256789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccc
Q 006168 400 NSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS 479 (658)
Q Consensus 400 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 479 (658)
+++|.+++..... .+++..+..++.+++.+|.+||+. +++|+||+|.||+++.++.++|+|||++...........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999854322 289999999999999999999998 999999999999999999999999999987754431122
Q ss_pred ccccCCccccccccc-ccCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 006168 480 TKFAGTLGYTAPEYA-IHGQLSEKVDAYSFGVLVLEIISGTKSSET 524 (658)
Q Consensus 480 ~~~~gt~~y~APE~~-~~~~~s~ksDV~SfGvvl~elltG~~p~~~ 524 (658)
....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 345677899999998 667788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=226.62 Aligned_cols=257 Identities=20% Similarity=0.348 Sum_probs=197.4
Q ss_pred hcCCCccCcccccCceEEEEEE-ecCCcEEEEEEcccccccccHHHHHHHHHHHhccC-CCccceeeeEeecC--CeEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQG--PELIL 393 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~l 393 (658)
.++|++.+++|+|.+++||.|. ..++++++||.++. -..+.+.+|+.+|..|. ||||+++++...+. ....|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 4678889999999999999998 45788999999864 34568899999999996 99999999998664 56789
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC-CeEEeeccCccccC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL-QPKIADFGLARLLP 472 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~-~~kl~DfGla~~~~ 472 (658)
|+||+.+.+...+. +.|+...+...+.+++.||.|+|+. ||.|||+||.|+++|... .++|+|+|+|.++.
T Consensus 113 iFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred HhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99999998887665 5688888999999999999999999 999999999999999764 59999999999875
Q ss_pred CCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccc----
Q 006168 473 ENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWE---- 547 (658)
Q Consensus 473 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~---- 547 (658)
...... -.+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||........+++..+. .+...++..
T Consensus 185 p~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak-VLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK-VLGTDELYAYLNK 261 (338)
T ss_pred CCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH-HhChHHHHHHHHH
Confidence 544322 2345667889998876 46788999999999999999999999766655444443321 111100000
Q ss_pred ---cccccCC---------------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 548 ---LMDESLD---------------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 548 ---~~d~~l~---------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.+|+... ..+...-...+.++++...|..|..+|||+.|...
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0111110 00111112356889999999999999999998764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=252.12 Aligned_cols=196 Identities=26% Similarity=0.395 Sum_probs=167.4
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-------ccccHHHHHHHHHHHhccC---CCccceeeeEeecC
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-------SRRTLSDFENEVRLISNVH---HRNLIRLLGCCSQG 388 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 388 (658)
+|+..+.+|+|+||.|+.++++ +...|+||.|.+.. ....+-..-.|+.+|..|+ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 5788899999999999999987 46689999986531 1111223467999999997 99999999999999
Q ss_pred CeEEEEEecc-CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccC
Q 006168 389 PELILVYEYM-ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL 467 (658)
Q Consensus 389 ~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGl 467 (658)
+.+||+||-. ++.+|.++| ..+..+++.+...|++||+.|+++||+. +|||||||-+||.++.+|-+||+|||.
T Consensus 642 d~yyl~te~hg~gIDLFd~I--E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFI--EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CeeEEEecCCCCCcchhhhh--hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccc
Confidence 9999999976 456788888 4556799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCcccccccccccCCC-CCcccchhhhHHHHHHHhCCCCCC
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISGTKSSE 523 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~SfGvvl~elltG~~p~~ 523 (658)
+.+.... ....++||.+|.|||++.+.+| ...-|||++|++||-++....|+.
T Consensus 717 aa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9876443 2446899999999999998877 567899999999999988777753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=258.40 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=204.0
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|.....+|.|.+|.|||++.. .++..|+|.++. .......-.++|+-+++.-+|||||.++|.+..++.+++.||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkL-ep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKL-EPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeec-cCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 357888899999999999999976 688999999876 344566778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+.+|+|.+.- .-.++|++.++..+.+...+||+|||+. +-+|||||-.|||+++.+.+|++|||.+..+...-
T Consensus 93 ycgggslQdiy--~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 93 YCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred ecCCCccccee--eecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh-
Confidence 99999999987 3567899999999999999999999998 88999999999999999999999999987653321
Q ss_pred cccccccCCccccccccc---ccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 477 HLSTKFAGTLGYTAPEYA---IHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~---~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
.....+.||+.|||||+. ..+.|..++|||+.|+...|+-.-++|........ +..+.... ..++.-
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr------~l~LmTkS----~~qpp~ 236 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR------ALFLMTKS----GFQPPT 236 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH------HHHHhhcc----CCCCCc
Confidence 234468899999999987 46789999999999999999988777754333211 11111111 111111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVV 588 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 588 (658)
..-.....+.+.++++.|+.++|++|||++.++
T Consensus 237 --lkDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 237 --LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred --ccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 111223456799999999999999999998766
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=223.99 Aligned_cols=253 Identities=18% Similarity=0.305 Sum_probs=190.5
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeE-eecCCeEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGC-CSQGPELILV 394 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lV 394 (658)
.+.|.+.+.||+|.||.+-++.++ ..+.+++|-++.. .....+|.+|...--.| .|.||+.-++. |+..+...++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 467888999999999999999987 4678999988753 44568999998877667 58999988876 5666788899
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE-c-CCCCeEEeeccCccccC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL-D-DDLQPKIADFGLARLLP 472 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll-~-~~~~~kl~DfGla~~~~ 472 (658)
+||++.|+|..-+ ....+-+....+++.|++.||.|+|++ ++||||||.+|||| + +..++||+|||+.+..+
T Consensus 101 qE~aP~gdL~snv---~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 101 QEFAPRGDLRSNV---EAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eccCccchhhhhc---CcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999999887 335588888899999999999999999 99999999999999 3 34589999999987543
Q ss_pred CCCccccccccCCccccccccccc---C--CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccc
Q 006168 473 ENQSHLSTKFAGTLGYTAPEYAIH---G--QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWE 547 (658)
Q Consensus 473 ~~~~~~~~~~~gt~~y~APE~~~~---~--~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 547 (658)
.. .....-+..|.+||.... + ...+.+|||.||++++.++||+.||.......... |-|..|..+....
T Consensus 175 ~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y--~~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 175 TT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY--WEWEQWLKRKNPA 248 (378)
T ss_pred ce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH--HHHHHHhcccCcc
Confidence 21 112334567899998643 2 34678999999999999999999998543332222 2244454444433
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 006168 548 LMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591 (658)
Q Consensus 548 ~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 591 (658)
+.+. + ....+.+..+.++-+..++++|=-..++.++-
T Consensus 249 ~P~~------F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 249 LPKK------F-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred Cchh------h-cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 2211 1 11245678888899999999995555555443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=231.10 Aligned_cols=261 Identities=28% Similarity=0.357 Sum_probs=195.5
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecC------Ce
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG------PE 390 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 390 (658)
.+|...+.+|.|.- .|-.+... .++.||+|++... ......+...+|..++..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46667788888887 55555433 5889999988543 2345567788999999999999999999998533 46
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.|+|||+|.. +|...++ -.++-+++..|..|++.|++|||+. +|+||||||+||++..+..+||.|||+++.
T Consensus 96 ~y~v~e~m~~-nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhhhh-HHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 8999999965 8888874 3478889999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc-c-------------hh---hHH
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE-E-------------GE---YLL 533 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~-~-------------~~---~l~ 533 (658)
-... -..+..+.|..|.|||++.+..+.+..||||.||++.||++|+.-|.+... + .. .+.
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 4332 345677889999999999998899999999999999999999987764321 0 00 111
Q ss_pred HHHHHHhhcCc------ccccccccCCC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 534 KRAWRLYENGT------HWELMDESLDP--NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 534 ~~~~~~~~~~~------~~~~~d~~l~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+.......+ ..+.+...+-+ .+.+......+.+++..||-.||++|-+++++|+.
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 11111111110 01111111100 11222345568899999999999999999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-27 Score=235.34 Aligned_cols=266 Identities=25% Similarity=0.380 Sum_probs=201.0
Q ss_pred HHHHhcCCCccCcccccCceEEEEEEecC----CcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecC
Q 006168 314 LVSATRKFSEENKLGEGGFGDIYKGTLKN----GKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQG 388 (658)
Q Consensus 314 l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 388 (658)
+....+.|..+++||+|.|++||++.+.. .+.||+|.+... ..-..+.+|+++|..+ .+.||+++.+++..+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t---s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT---SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc---cCchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34455678899999999999999998543 678999999753 2335689999999999 599999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC-CCeEEeeccC
Q 006168 389 PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD-LQPKIADFGL 467 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~-~~~kl~DfGl 467 (658)
+.+.+|+||+++....+++ ..++...+..+++.+..||.++|.+ |||||||||+|+|.+.. ++-.|.|||+
T Consensus 108 d~v~ivlp~~~H~~f~~l~-----~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLY-----RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred CeeEEEecccCccCHHHHH-----hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechh
Confidence 9999999999999998888 3467888999999999999999999 99999999999999765 6789999999
Q ss_pred ccccCCCC-------------c------------------------------cccccccCCccccccccccc-CCCCCcc
Q 006168 468 ARLLPENQ-------------S------------------------------HLSTKFAGTLGYTAPEYAIH-GQLSEKV 503 (658)
Q Consensus 468 a~~~~~~~-------------~------------------------------~~~~~~~gt~~y~APE~~~~-~~~s~ks 503 (658)
+....... . .......||+||.|||++.. +.-++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97221000 0 00113579999999999876 4568899
Q ss_pred cchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHH----HH-----hhcCc--ccc---------------ccc-ccCCC-
Q 006168 504 DAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAW----RL-----YENGT--HWE---------------LMD-ESLDP- 555 (658)
Q Consensus 504 DV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~----~~-----~~~~~--~~~---------------~~d-~~l~~- 555 (658)
||||-|||++-+++++.||....++-..+.+.+. .- ...|. +++ -++ ..+..
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 9999999999999999999766554333322210 00 00111 111 111 11111
Q ss_pred -------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 556 -------NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 556 -------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.......+..+++++.+|+..||.+|.|+++.|+.
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 11111223478999999999999999999998864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-27 Score=239.72 Aligned_cols=209 Identities=22% Similarity=0.317 Sum_probs=172.8
Q ss_pred ccchHHHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC------CCccce
Q 006168 308 NYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH------HRNLIR 380 (658)
Q Consensus 308 ~~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~ 380 (658)
.+.+-|+ ...+|.+....|+|-|++|-+|... -|..||||+|... +--.+.=+.|+++|++|+ --|+++
T Consensus 423 rv~igE~--LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 423 RVRIGEL--LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred EEehhhh--hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 3444444 4578999999999999999999976 4889999999742 222344578999999995 348999
Q ss_pred eeeEeecCCeEEEEEeccCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC-
Q 006168 381 LLGCCSQGPELILVYEYMANSSLDKFLFGEKR-GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL- 458 (658)
Q Consensus 381 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~- 458 (658)
|+..|.+.+++|||+|-+.- +|.+.|..... -.|....+..++.|+.-||..|... +|+|.||||.|||+++..
T Consensus 499 l~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence 99999999999999998854 89999864332 3488899999999999999999998 999999999999999874
Q ss_pred CeEEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc
Q 006168 459 QPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE 527 (658)
Q Consensus 459 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~ 527 (658)
.+||||||.|....++.. +...-+.-|.|||++.+.+|+...|+||.||.||||.||+..|.+...
T Consensus 575 iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred eeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 589999999987655432 223344579999999999999999999999999999999998876554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=267.98 Aligned_cols=196 Identities=20% Similarity=0.245 Sum_probs=140.2
Q ss_pred hccCC-CccceeeeEe-------ecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCe
Q 006168 371 SNVHH-RNLIRLLGCC-------SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442 (658)
Q Consensus 371 ~~l~h-~niv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 442 (658)
+.++| +||+++++++ .+...+++++||+ +++|.++|.. ....+++.+++.++.||++||.|||++ +|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 34556 6888888887 2334678889988 5599999953 235699999999999999999999998 99
Q ss_pred eecCcCCCcEEEcC-------------------CCCeEEeeccCccccCCCCc---------------cccccccCCccc
Q 006168 443 IHRDIKPSNVLLDD-------------------DLQPKIADFGLARLLPENQS---------------HLSTKFAGTLGY 488 (658)
Q Consensus 443 vH~Dik~~NIll~~-------------------~~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~y 488 (658)
+||||||+||||+. ++.+|++|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566667776654211000 001124578899
Q ss_pred ccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHH
Q 006168 489 TAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVE 568 (658)
Q Consensus 489 ~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~ 568 (658)
+|||++.+..++.++|||||||+||||++|..|+..... .+...... .+.+. . .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~---------~~~~~-----~-~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHR---------VLPPQ-----I-LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHh---------hcChh-----h-hhcCHHHHH
Confidence 999999999999999999999999999998877542111 11000000 00000 0 011234568
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 006168 569 IALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 569 li~~cl~~dp~~RPt~~evl~ 589 (658)
++.+||+.+|.+||+|.||++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 889999999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=207.74 Aligned_cols=167 Identities=20% Similarity=0.191 Sum_probs=127.4
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
|+|.+++.. ....+++.+++.|+.||+.||.|||+. + ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----
Confidence 689999953 245699999999999999999999998 4 999999999999999 99998654322
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCH
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTK 560 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 560 (658)
..||+.|+|||++.+..++.++|||||||++|||++|+.|+.........+...... ..... .. ......
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~------~~--~~~~~~ 133 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG-MPADD------PR--DRSNLE 133 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH-hccCC------cc--ccccHH
Confidence 268899999999999999999999999999999999999986543322222111111 11000 00 001122
Q ss_pred HHHH--HHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 561 EAAE--KVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 561 ~~~~--~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.... .+.+++.+||+.+|.+||++.|+++.+...
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 2233 699999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=217.44 Aligned_cols=168 Identities=21% Similarity=0.240 Sum_probs=131.9
Q ss_pred HHHHhcCCCccCcccccCceEEEEEEec--CCcEEEEEEccccc----ccccHHHHHHHHHHHhccCCCccce-eeeEee
Q 006168 314 LVSATRKFSEENKLGEGGFGDIYKGTLK--NGKIVAVKKLAIGI----SRRTLSDFENEVRLISNVHHRNLIR-LLGCCS 386 (658)
Q Consensus 314 l~~a~~~f~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~ 386 (658)
.....++|...+.||+|+||+||+|+++ +++.+|||++.... .......|.+|+++|++++|+|+++ ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3455678999999999999999999875 57788999875321 1223456899999999999999985 4432
Q ss_pred cCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCc-CCCcEEEcCCCCeEEeec
Q 006168 387 QGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDI-KPSNVLLDDDLQPKIADF 465 (658)
Q Consensus 387 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Di-k~~NIll~~~~~~kl~Df 465 (658)
+..++||||+++++|.... ... ...++.+++++|.|||+. +|+|||| ||+|||++.++++||+||
T Consensus 91 --~~~~LVmE~~~G~~L~~~~---~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLAR---PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred --CCcEEEEEccCCCCHHHhC---ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 4579999999999996321 111 146788999999999998 9999999 999999999999999999
Q ss_pred cCccccCCCCcc-------ccccccCCcccccccccccC
Q 006168 466 GLARLLPENQSH-------LSTKFAGTLGYTAPEYAIHG 497 (658)
Q Consensus 466 Gla~~~~~~~~~-------~~~~~~gt~~y~APE~~~~~ 497 (658)
|+++.+...... ..+...+++.|.|||++...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999977543211 11356788899999998654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=210.38 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=194.7
Q ss_pred CCCccCcccccCceEEEEEEecCC--cEEEEEEcccccccccHHHHHHHHHHHhccCC----CccceeeeEe-ecCCeEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLKNG--KIVAVKKLAIGISRRTLSDFENEVRLISNVHH----RNLIRLLGCC-SQGPELI 392 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~ 392 (658)
+|.+.++||+|+||.||++..... ..+|+|........... .+..|..++..+.+ +++..+++.. ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 789999999999999999997653 57899987653222222 67888998888863 6889999998 4777889
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC-----CCeEEeeccC
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD-----LQPKIADFGL 467 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~-----~~~kl~DfGl 467 (658)
+||+.+ +.+|.++......+.++..+.++|+.|++.+|++||+. +++||||||.|+++... ..+.|.|||+
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 999988 56999987555557799999999999999999999998 99999999999999755 4699999999
Q ss_pred cc--ccCCCCc----cc---cccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHH
Q 006168 468 AR--LLPENQS----HL---STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWR 538 (658)
Q Consensus 468 a~--~~~~~~~----~~---~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~ 538 (658)
++ .+..... .. .....||..|.+++.+.+...+.+.|+||++.++.|++.|..||........ .....+
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~~~~ 251 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSKFEK 251 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHHHHH
Confidence 98 3322221 11 1245699999999999999999999999999999999999999865443211 000001
Q ss_pred HhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 539 LYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 539 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.... ..... .....+..+.++...+-..+...+|....+...|+..
T Consensus 252 ~~~~----~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 252 DPRK----LLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred Hhhh----hcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 0000 00000 1111223466666666668999999999999998766
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-24 Score=202.10 Aligned_cols=247 Identities=21% Similarity=0.349 Sum_probs=190.1
Q ss_pred ccCcccccCceEEEEEEecCCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCC
Q 006168 323 EENKLGEGGFGDIYKGTLKNGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANS 401 (658)
Q Consensus 323 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 401 (658)
...+|.+...|+.|+|+|+. ..++.|++... .+.....+|.+|.-.|+-+.||||++++|.|.....+.++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 34578889999999999974 45556766542 34445578999999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEe--eccCccccCCCCcccc
Q 006168 402 SLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIA--DFGLARLLPENQSHLS 479 (658)
Q Consensus 402 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~--DfGla~~~~~~~~~~~ 479 (658)
+|...|+....-..+-.+..+++.++|+|++|||+.. +-|..--|.+..|++|++.+++|+ |--++.. +.
T Consensus 273 slynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq--e~----- 344 (448)
T KOG0195|consen 273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--EV----- 344 (448)
T ss_pred HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee--cc-----
Confidence 9999998776666888999999999999999999973 234455789999999999988875 2211111 10
Q ss_pred ccccCCcccccccccccCCCC---CcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 480 TKFAGTLGYTAPEYAIHGQLS---EKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 480 ~~~~gt~~y~APE~~~~~~~s---~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
...-.+.||+||.++..+-+ .++|+|||.+++|||.|...||..-.+.. ...+..- |-+. .
T Consensus 345 -gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme-----cgmkial-----eglr-----v 408 (448)
T KOG0195|consen 345 -GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME-----CGMKIAL-----EGLR-----V 408 (448)
T ss_pred -ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh-----hhhhhhh-----cccc-----c
Confidence 11235789999999876543 57999999999999999999997644311 1111111 1121 2
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..++..+..+.+++.-|+..||.+||.+..|+-.|++.
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 23344556799999999999999999999999999875
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=177.80 Aligned_cols=99 Identities=40% Similarity=0.682 Sum_probs=76.5
Q ss_pred ccCCC---CCcc-CCchHHHHHHHHHHHHHHHHhcCC--CCceEEeccCCCCcEEEEEeccCCCChhhhHHHHHHHHHhh
Q 006168 20 NSGCS---QYNV-TNFSEFNSNLNATFKELREQLNGG--KKFATAQRTRGPDQVYTMVQCRRYVSTADCAACFTSAESLI 93 (658)
Q Consensus 20 ~~~c~---~~~~-~~~~~~~~~l~~ll~~l~~~~~~~--~~f~~~~~g~~~~~vygl~qC~~d~~~~~C~~Cl~~a~~~~ 93 (658)
|..|+ ++++ +++++|+.+++.||+.|++.++.. .+|++++.|.++++||||+||++|+++.+|..||+.|+..+
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~ 80 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANI 80 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCH
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHH
Confidence 56788 3466 578889999999999999997643 68999998888999999999999999999999999999999
Q ss_pred hh-cCCccCceEEccceEEEEecccc
Q 006168 94 RN-CSAANGARVIYLACSLRYESSSF 118 (658)
Q Consensus 94 ~~-c~~~~~~~v~~~~C~~ry~~~~f 118 (658)
.. |+++++|+||+++|+|||++++|
T Consensus 81 ~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 81 SSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHhCCCCceEEEECCCEEEEEECCCC
Confidence 98 99999999999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-21 Score=198.99 Aligned_cols=259 Identities=31% Similarity=0.468 Sum_probs=200.5
Q ss_pred CCccCcccccCceEEEEEEecCCcEEEEEEcccccccc--cHHHHHHHHHHHhccCCC-ccceeeeEeecCCeEEEEEec
Q 006168 321 FSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRR--TLSDFENEVRLISNVHHR-NLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~E~ 397 (658)
|...+.||.|+||.||++... ..+++|.+....... ....+.+|+.+++.+.|+ +++++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999987 889999997654443 377899999999999988 799999999777778999999
Q ss_pred cCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC-CeEEeeccCccccCCCC
Q 006168 398 MANSSLDKFLFGEKR-GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL-QPKIADFGLARLLPENQ 475 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~-~~kl~DfGla~~~~~~~ 475 (658)
+.++++.+++..... ..+.......++.|++.++.|+|+. +++||||||+||+++... .+++.|||++..+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977733221 2689999999999999999999998 899999999999999998 79999999998665443
Q ss_pred cc-----ccccccCCccccccccccc---CCCCCcccchhhhHHHHHHHhCCCCCCCCCcc--hhhHHHHHHHHhhcCcc
Q 006168 476 SH-----LSTKFAGTLGYTAPEYAIH---GQLSEKVDAYSFGVLVLEIISGTKSSETKGEE--GEYLLKRAWRLYENGTH 545 (658)
Q Consensus 476 ~~-----~~~~~~gt~~y~APE~~~~---~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~--~~~l~~~~~~~~~~~~~ 545 (658)
.. ......|+..|++||.+.. ..++...|+||+|++++++++|..|+...... ........+....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---- 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT---- 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC----
Confidence 32 2356789999999999987 57889999999999999999999996554431 1122222111111
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 546 WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 546 ~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
. ...... ...........+.+++..++..+|..|.++.+....
T Consensus 233 ~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPL-SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-cccccc-CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000 000002223568899999999999999999887764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=190.25 Aligned_cols=201 Identities=22% Similarity=0.324 Sum_probs=172.4
Q ss_pred cCCCccCcccccCceEEEEEE-ecCCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 396 (658)
-+|.++++||+|.||.++.|+ +-+++.||||..+.. ....++..|.+..+.| ..++|...+-|..++-+-.||+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 368899999999999999998 448999999987642 3345677888888777 57899999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC-----CCCeEEeeccCcccc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD-----DLQPKIADFGLARLL 471 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~-----~~~~kl~DfGla~~~ 471 (658)
.+ +-||+|++ +.-...++.+++..||.|++.-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+.+
T Consensus 105 LL-GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 105 LL-GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hh-CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 99 45898876 45566799999999999999999999999 9999999999999954 345899999999988
Q ss_pred CCCCcc------ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc
Q 006168 472 PENQSH------LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE 527 (658)
Q Consensus 472 ~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~ 527 (658)
.+..+. ......||.+||+-..+.+.+-+.+.|.-|||-|+...|-|..||.+...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 665432 23357899999999999999999999999999999999999999987544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-22 Score=220.58 Aligned_cols=255 Identities=22% Similarity=0.266 Sum_probs=191.0
Q ss_pred CccCcccccCceEEEEEEec-CCcEEEEEEcc----ccccccc-HHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 322 SEENKLGEGGFGDIYKGTLK-NGKIVAVKKLA----IGISRRT-LSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 322 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
...+.+|.|.+|.|+..... ..+..+.|... ....... ...+..|+.+-..++|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999988777643 33434444332 1111111 222667888888899999999888887776666669
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++ +|..++. ....+...++..++.|+..|+.|||+. +|.|||+|++|++++.++.+||+|||.+..+....
T Consensus 401 E~~~~-Dlf~~~~--~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM--SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHh--cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 9999983 335788899999999999999999999 99999999999999999999999999998775443
Q ss_pred c---cccccccCCcccccccccccCCCCC-cccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 476 S---HLSTKFAGTLGYTAPEYAIHGQLSE-KVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 476 ~---~~~~~~~gt~~y~APE~~~~~~~s~-ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
. .....+.|+..|+|||.+....|.+ ..||||.|+++..|++|+.||...........+. ... .....
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~------~~~--~~~~~ 546 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN------NYS--DQRNI 546 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh------ccc--ccccc
Confidence 3 3455788999999999999999976 6899999999999999999997655432221000 000 00000
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+.......+.+...++..+|+.||.+|-|+.+|++.
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 111222334556778899999999999999999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.3e-21 Score=177.98 Aligned_cols=266 Identities=19% Similarity=0.251 Sum_probs=198.3
Q ss_pred chHHHHHHhcCCCccCcccccCceEEEEEE-ecCCcEEEEEEcccccccccHHHHHHHHHHHhccCC-CccceeeeEeec
Q 006168 310 RLKDLVSATRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHH-RNLIRLLGCCSQ 387 (658)
Q Consensus 310 ~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~ 387 (658)
+.+++..+ .+|..+++||.|+||.+|.|. ..+|+.||||..... ....++.-|..+.+.|+| ..|..+..+..+
T Consensus 7 s~~~~iv~-gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e 82 (341)
T KOG1163|consen 7 SLEELIVG-GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---AKHPQLLYESKVYRILQGGVGIPHIRHYGTE 82 (341)
T ss_pred chhhheec-cceEEEEeecCCchhheeeeeeccCCceEEEEeeccc---CCCcchhHHHHHHHHhccCCCCchhhhhccc
Confidence 34444443 688899999999999999998 568999999987542 333467788899998865 678888888889
Q ss_pred CCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC---CCeEEee
Q 006168 388 GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD---LQPKIAD 464 (658)
Q Consensus 388 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~---~~~kl~D 464 (658)
+..-.+|||.+ +-+|++++. --...++.++++-++-|++.-++|+|.+ +++||||||+|+|..-+ ..+.|+|
T Consensus 83 ~~ynvlVMdLL-GPsLEdLfn-fC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 83 KDYNVLVMDLL-GPSLEDLFN-FCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred cccceeeeecc-CccHHHHHH-HHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEe
Confidence 99999999998 559988873 2345689999999999999999999999 99999999999999543 5699999
Q ss_pred ccCccccCCCCcc------ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcch-hhHHHHHH
Q 006168 465 FGLARLLPENQSH------LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEG-EYLLKRAW 537 (658)
Q Consensus 465 fGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~-~~l~~~~~ 537 (658)
||+++.+.+..+. ..+...||.+|.+-..+.+..-+...|+-|+|.+|..+.-|..||....... .+-.+.
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk-- 235 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK-- 235 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH--
Confidence 9999987554332 2346789999999888888888999999999999999999999998765421 111111
Q ss_pred HHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 538 RLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 538 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+....-. .+......+.++.-.+.-|-..--++-|...-+-+..+.+
T Consensus 236 --I~EkK~s~~------ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 236 --ISEKKMSTP------IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred --HHHhhcCCC------HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 111111100 1111122344577777778777777778776666555433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.4e-22 Score=220.39 Aligned_cols=250 Identities=20% Similarity=0.227 Sum_probs=187.3
Q ss_pred CCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHh--ccCCCccceeeeEeecCCeEEEEEec
Q 006168 320 KFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLIS--NVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++...+.||.+.|=+|.+++.++|. |+||++-+....-.+..|.++++-++ .++|||.+++.-.-....-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667889999999999999999887 88998876555556666666555444 45899999998887777778999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc--cCCCC
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL--LPENQ 475 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~--~~~~~ 475 (658)
+.+ +|.|.| ..+.-|...+..-|+.|++.||..+|.. +|+|||||.+||||+.-..+.|+||...+. ++++.
T Consensus 103 vkh-nLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VKH-NLYDRL--STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hhh-hhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 987 899988 4555588888899999999999999998 999999999999999999999999987653 33333
Q ss_pred ccccc----cccCCcccccccccccC-----------CCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHH
Q 006168 476 SHLST----KFAGTLGYTAPEYAIHG-----------QLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRL 539 (658)
Q Consensus 476 ~~~~~----~~~gt~~y~APE~~~~~-----------~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~ 539 (658)
....+ +.....+|+|||.+... ..+++.||||+||++.||++ |+++|... ++..+
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aY---- 247 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAY---- 247 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhH----
Confidence 22222 33445689999988541 26789999999999999988 56666421 12111
Q ss_pred hhcCc--ccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 540 YENGT--HWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 540 ~~~~~--~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
+.+. ..+.+-+.+ +...+.++++.|++.||++|.+++++++.-+..
T Consensus 248 -r~~~~~~~e~~Le~I--------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 248 -RSGNADDPEQLLEKI--------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred -hccCccCHHHHHHhC--------cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 1111 001110111 012488999999999999999999999875544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.1e-21 Score=182.23 Aligned_cols=140 Identities=19% Similarity=0.210 Sum_probs=109.6
Q ss_pred cCcccccCceEEEEEEecCCcEEEEEEccccccc-cc-------H-----------------HHHHHHHHHHhccCCCcc
Q 006168 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISR-RT-------L-----------------SDFENEVRLISNVHHRNL 378 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~-------~-----------------~~~~~E~~~l~~l~h~ni 378 (658)
...||+|+||.||+|...+|+.||||++..+... .. . .....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999889999999999753211 01 0 122459999999988776
Q ss_pred ceeeeEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHh-HhcCCCCeeecCcCCCcEEEcCC
Q 006168 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYL-HEDFHVRIIHRDIKPSNVLLDDD 457 (658)
Q Consensus 379 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dik~~NIll~~~ 457 (658)
.....+... ..+|||||++++++...+. ....+++.....++.|++.+|.+| |+. +|+||||||+|||++ +
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence 443332222 2389999999987765432 335689999999999999999999 687 999999999999998 4
Q ss_pred CCeEEeeccCcccc
Q 006168 458 LQPKIADFGLARLL 471 (658)
Q Consensus 458 ~~~kl~DfGla~~~ 471 (658)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.9e-21 Score=185.21 Aligned_cols=172 Identities=14% Similarity=0.159 Sum_probs=135.2
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccc--cHHH------HHHHHHHHhccCCCccceeeeEeecC-
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRR--TLSD------FENEVRLISNVHHRNLIRLLGCCSQG- 388 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~- 388 (658)
.++|...+.||.|+||.||+... ++..+|||.+....... .... +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 57999999999999999999655 57789999997532221 1122 68999999999999999999886532
Q ss_pred -------CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeE
Q 006168 389 -------PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPK 461 (658)
Q Consensus 389 -------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~k 461 (658)
...+|||||++|.+|.++. .++. ....+++.+|..+|+. +++|||+||+||++++++ ++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EE
Confidence 3589999999999998874 1222 2456999999999999 999999999999999988 99
Q ss_pred EeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh
Q 006168 462 IADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS 517 (658)
Q Consensus 462 l~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt 517 (658)
|+|||......+.... ..+.....+..++|||+||+.+..+..
T Consensus 175 liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 9999988765322211 114455667789999999999877653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=175.22 Aligned_cols=142 Identities=18% Similarity=0.208 Sum_probs=112.2
Q ss_pred cCcccccCceEEEEEEecCCcEEEEEEccccccc-c-------------------c-----HHHHHHHHHHHhccCCCcc
Q 006168 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISR-R-------------------T-----LSDFENEVRLISNVHHRNL 378 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~-------------------~-----~~~~~~E~~~l~~l~h~ni 378 (658)
...||+|++|.||+|...+|+.||||++...... . . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999888999999998754211 0 0 1224678999999999987
Q ss_pred ceeeeEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeecCcCCCcEEEcCC
Q 006168 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE-DFHVRIIHRDIKPSNVLLDDD 457 (658)
Q Consensus 379 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dik~~NIll~~~ 457 (658)
.....+... ..+|||||++++++..... ....++......++.|++.+|.+||+ . +|+||||||+|||++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 544443332 2489999999886544321 23457888999999999999999999 7 999999999999999 7
Q ss_pred CCeEEeeccCccccCC
Q 006168 458 LQPKIADFGLARLLPE 473 (658)
Q Consensus 458 ~~~kl~DfGla~~~~~ 473 (658)
+.++|+|||++.....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=193.25 Aligned_cols=216 Identities=26% Similarity=0.435 Sum_probs=165.0
Q ss_pred HhccCCCccceeeeEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCC
Q 006168 370 ISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKP 449 (658)
Q Consensus 370 l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~ 449 (658)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.-...++++|+.||.|||+. +-..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeecc
Confidence 4678999999999999999999999999999999999954 456699999999999999999999986 2239999999
Q ss_pred CcEEEcCCCCeEEeeccCccccCCC-CccccccccCCcccccccccccC-------CCCCcccchhhhHHHHHHHhCCCC
Q 006168 450 SNVLLDDDLQPKIADFGLARLLPEN-QSHLSTKFAGTLGYTAPEYAIHG-------QLSEKVDAYSFGVLVLEIISGTKS 521 (658)
Q Consensus 450 ~NIll~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~APE~~~~~-------~~s~ksDV~SfGvvl~elltG~~p 521 (658)
.|.++|....+||+|||+....... .........-...|.|||.+... ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998876431 11111122234579999998653 246789999999999999999999
Q ss_pred CCCCCc--chhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 006168 522 SETKGE--EGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSS 596 (658)
Q Consensus 522 ~~~~~~--~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 596 (658)
|..... +...++..+.+ .....+.+.+.... +....+..++..||..+|.+||++++|-..++....
T Consensus 158 ~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHHHHh-----cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 987544 22222222211 11112222221111 334479999999999999999999999998887643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.6e-19 Score=167.62 Aligned_cols=189 Identities=17% Similarity=0.087 Sum_probs=141.8
Q ss_pred CccCcccccCceEEEEEEecCCcEEEEEEcccccccc---cHHHHHHHHHHHhccC-CCccceeeeEeecCCeEEEEEec
Q 006168 322 SEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRR---TLSDFENEVRLISNVH-HRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 322 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
.+...|++|+||+||.+.- .+.+++.+.+....-.. ....+.+|+++|++|+ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997666 67888888776421110 1125789999999995 5889999886 346999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCc-CCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDI-KPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Di-k~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
+.+.+|.+.+.. ....++.|++++|.++|+. +|+|||| ||+|||+++++.++|+|||++........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998755411 1235778999999999999 9999999 79999999999999999999986554331
Q ss_pred c----c--------cccccCCcccccccccccC-CCC-CcccchhhhHHHHHHHhCCCCCCCCCc
Q 006168 477 H----L--------STKFAGTLGYTAPEYAIHG-QLS-EKVDAYSFGVLVLEIISGTKSSETKGE 527 (658)
Q Consensus 477 ~----~--------~~~~~gt~~y~APE~~~~~-~~s-~ksDV~SfGvvl~elltG~~p~~~~~~ 527 (658)
. . ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+....++
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 0 0122357788888754322 223 567888999999999999988765544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.8e-19 Score=176.86 Aligned_cols=231 Identities=21% Similarity=0.295 Sum_probs=152.3
Q ss_pred CccCcccccCceEEEEEEecC-CcEEEEEEcccc--cccccHHHHHHHHHHHhccCC----------CccceeeeEee--
Q 006168 322 SEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHH----------RNLIRLLGCCS-- 386 (658)
Q Consensus 322 ~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~-- 386 (658)
.....||.|+++.||.++... ++.+|+|..... ......+.+++|.-.+..+.+ -.++--++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 456789999999999999874 899999987542 344456778888766665432 12222222211
Q ss_pred -------cC---C-----eEEEEEeccCCCCHHHHhh---cCCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecC
Q 006168 387 -------QG---P-----ELILVYEYMANSSLDKFLF---GEKR--GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRD 446 (658)
Q Consensus 387 -------~~---~-----~~~lV~E~~~~gsL~~~l~---~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 446 (658)
.. + ..+++|+-+. ++|.+++. .... ..+....++.+..|+++.+++||+. +++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 11 1 2367788774 58877753 1111 2255667778889999999999999 999999
Q ss_pred cCCCcEEEcCCCCeEEeeccCccccCCCCccccccccCCccccccccccc--------CCCCCcccchhhhHHHHHHHhC
Q 006168 447 IKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH--------GQLSEKVDAYSFGVLVLEIISG 518 (658)
Q Consensus 447 ik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~s~ksDV~SfGvvl~elltG 518 (658)
|+|+|++++.+|.++|+||+.....+.... . ...+..|.+||.... -.++.+.|.|++|+++|.|++|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEE---G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceee---c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999988765433211 1 234578999997744 2578899999999999999999
Q ss_pred CCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCC
Q 006168 519 TKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSR 581 (658)
Q Consensus 519 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~R 581 (658)
..|+.......... + .-..+. +.++.+..||..+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~-------------~-------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPE-------------W-------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSG-------------G-------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcccccc-------------c-------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99997654321100 0 123455 778899999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.3e-20 Score=194.71 Aligned_cols=234 Identities=24% Similarity=0.292 Sum_probs=184.5
Q ss_pred cccccCceEEEEEE----ecCCcEEEEEEccccccc-ccHHHHHHHHHHHhccC-CCccceeeeEeecCCeEEEEEeccC
Q 006168 326 KLGEGGFGDIYKGT----LKNGKIVAVKKLAIGISR-RTLSDFENEVRLISNVH-HRNLIRLLGCCSQGPELILVYEYMA 399 (658)
Q Consensus 326 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~ 399 (658)
.+|+|.||.|++++ .+.|..+|+|.+.+.... ........|-.++...+ ||.+|++.-.++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999765 335778899988653211 11125567888888886 9999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccc
Q 006168 400 NSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS 479 (658)
Q Consensus 400 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 479 (658)
+|.|...+ .....+++.........++-++.++|+. +|+|||+|++||+++.+|++++.|||+++..-+....
T Consensus 81 gg~lft~l--~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 81 GGDLFTRL--SKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cchhhhcc--ccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 99998877 4445577777778888999999999999 9999999999999999999999999999876433322
Q ss_pred ccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCC
Q 006168 480 TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECT 559 (658)
Q Consensus 480 ~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 559 (658)
+||..|||||++. ......|-||||++++||+||..||.. .....+.+. ....+
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~~~~Il~~---------------~~~~p 207 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DTMKRILKA---------------ELEMP 207 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HHHHHHhhh---------------ccCCc
Confidence 8899999999988 567899999999999999999999875 111111110 22456
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH--HHHHHHHh
Q 006168 560 KEAAEKVVEIALMCTQSAANSRPTM--SEVVALLK 592 (658)
Q Consensus 560 ~~~~~~l~~li~~cl~~dp~~RPt~--~evl~~L~ 592 (658)
.+.......++..++..+|.+|.-. ..+.+.++
T Consensus 208 ~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 208 RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 6677778899999999999999755 34444433
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.9e-18 Score=164.83 Aligned_cols=137 Identities=17% Similarity=0.258 Sum_probs=106.2
Q ss_pred CCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhcc-----CCCccceeeeEeecCC---e-E
Q 006168 321 FSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-----HHRNLIRLLGCCSQGP---E-L 391 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~ 391 (658)
....+.||+|+||.||. +++....+||++... .....+.+.+|+.+++++ +||||++++|++..+. . +
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~-~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHR-GDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEecc-ccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34567899999999996 443333469988653 233457899999999999 5799999999998763 3 3
Q ss_pred EEEEec--cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHhHhcCCCCeeecCcCCCcEEEcC----CCCeEEee
Q 006168 392 ILVYEY--MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGL-AYLHEDFHVRIIHRDIKPSNVLLDD----DLQPKIAD 464 (658)
Q Consensus 392 ~lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~Dik~~NIll~~----~~~~kl~D 464 (658)
.+|+|| +.+++|.+++.+ ..+++. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 478999 558999999943 346555 35677888777 999999 9999999999999974 34799999
Q ss_pred ccCc
Q 006168 465 FGLA 468 (658)
Q Consensus 465 fGla 468 (658)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5434
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1e-17 Score=190.14 Aligned_cols=199 Identities=21% Similarity=0.240 Sum_probs=158.9
Q ss_pred HHHHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccC---CCccceeeeEeecCC
Q 006168 313 DLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVH---HRNLIRLLGCCSQGP 389 (658)
Q Consensus 313 ~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 389 (658)
+++...+.|.+.+.||+|+||+||+|...+|+.||+|.-.....++ |.--.+++.+|+ -+-|..+...+.-.+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 3444556788899999999999999998889999999987655443 222233444454 234445555555667
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc-------CCCCeEE
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD-------DDLQPKI 462 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~-------~~~~~kl 462 (658)
.-+||+||.+.|+|.+++. ..+.++|.....++.|++..+++||.. +|||+||||+|+||. +..-++|
T Consensus 768 ~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred cceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 7899999999999999994 556799999999999999999999999 999999999999993 2345899
Q ss_pred eeccCccccCCC-CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCC
Q 006168 463 ADFGLARLLPEN-QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTK 520 (658)
Q Consensus 463 ~DfGla~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~ 520 (658)
+|||-+..+.-- +.......++|-.+--+|...+..++...|.|.|.-+++-||.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999988654221 1123456788899999999999999999999999999999999964
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=164.48 Aligned_cols=147 Identities=18% Similarity=0.178 Sum_probs=113.5
Q ss_pred HHHhcCCCccCcccccCceEEEEEE--ecCCcEEEEEEcccccccc-----------------------cHHHHHHHHHH
Q 006168 315 VSATRKFSEENKLGEGGFGDIYKGT--LKNGKIVAVKKLAIGISRR-----------------------TLSDFENEVRL 369 (658)
Q Consensus 315 ~~a~~~f~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~E~~~ 369 (658)
..-...|.+.+.||+|++|.||+|. ..+|+.||+|++....... ....+..|++.
T Consensus 24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence 3333457788999999999999998 5689999999987532100 01235689999
Q ss_pred HhccCCC--ccceeeeEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC-eeecC
Q 006168 370 ISNVHHR--NLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVR-IIHRD 446 (658)
Q Consensus 370 l~~l~h~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~D 446 (658)
+.++.+. .+.+++++ ...++||||+++++|..... ....+...+...++.||+.+|.+||+. + |+|||
T Consensus 104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~D 174 (237)
T smart00090 104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGD 174 (237)
T ss_pred HHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCC
Confidence 9999753 33444443 23589999999988876542 233466667789999999999999998 8 99999
Q ss_pred cCCCcEEEcCCCCeEEeeccCcccc
Q 006168 447 IKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 447 ik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
|||+||+++ +++++|+|||++...
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhcc
Confidence 999999999 889999999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.9e-17 Score=158.78 Aligned_cols=147 Identities=20% Similarity=0.218 Sum_probs=114.6
Q ss_pred HHHHHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEccccccc---------------------ccHHHHHHHHHHH
Q 006168 312 KDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISR---------------------RTLSDFENEVRLI 370 (658)
Q Consensus 312 ~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l 370 (658)
.++......|...+.||+|+||.||++.+++|+.||||++..+... .....+..|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3445554457788999999999999999988999999987542100 0112357789999
Q ss_pred hccCCCc--cceeeeEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcC
Q 006168 371 SNVHHRN--LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIK 448 (658)
Q Consensus 371 ~~l~h~n--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik 448 (658)
..+.|++ ++..++. ...++||||+++++|..... ......++.+++.++.++|+. +|+|||||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 9998874 4444442 34589999999999977642 034567889999999999998 99999999
Q ss_pred CCcEEEcCCCCeEEeeccCccccCC
Q 006168 449 PSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 449 ~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
|+||++++++.++|+|||++..+..
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.9e-17 Score=158.65 Aligned_cols=135 Identities=22% Similarity=0.316 Sum_probs=113.0
Q ss_pred CcccccCceEEEEEEecCCcEEEEEEccccccc-c------cHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 325 NKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISR-R------TLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+.||+|++|.||+|.+ +|..+++|+....... . ....+.+|++++..+.|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999998 5778999976532111 1 124578899999999999988777777777788999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
+++++|.+++... .+ .+..++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998432 12 7889999999999999998 999999999999999 78999999998864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.3e-17 Score=180.46 Aligned_cols=143 Identities=22% Similarity=0.310 Sum_probs=114.6
Q ss_pred HHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEccccccc------ccHHHHHHHHHHHhccCCCccceeeeEeecC
Q 006168 315 VSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISR------RTLSDFENEVRLISNVHHRNLIRLLGCCSQG 388 (658)
Q Consensus 315 ~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 388 (658)
......|...+.||+|+||.||+|.+.+...++.+++...... ...+.+.+|+++++.++|++++....++...
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 3444556778999999999999999865443333222221111 1235688999999999999999888887777
Q ss_pred CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCc
Q 006168 389 PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLA 468 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla 468 (658)
...++||||+++++|.+++. ....++.+++++|.+||+. +++||||||+|||+ +++.++|+|||++
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 78899999999999999883 4578999999999999998 99999999999999 6779999999999
Q ss_pred ccc
Q 006168 469 RLL 471 (658)
Q Consensus 469 ~~~ 471 (658)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-16 Score=154.03 Aligned_cols=131 Identities=22% Similarity=0.306 Sum_probs=106.1
Q ss_pred cccccCceEEEEEEecCCcEEEEEEccccccc-------ccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 326 KLGEGGFGDIYKGTLKNGKIVAVKKLAIGISR-------RTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 326 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
.||+|+||.||+|.+ ++..+++|........ .....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999996 5688999986432111 11356778999999999887665555555666779999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
++++|.+++.... ..++.+++.+|.+||+. +++|+|++|.||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~~---------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN---------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH---------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998873211 07899999999999998 999999999999999 88999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=159.34 Aligned_cols=196 Identities=23% Similarity=0.316 Sum_probs=138.7
Q ss_pred CCCccceeeeEeec---------------------------CCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHH
Q 006168 374 HHRNLIRLLGCCSQ---------------------------GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILG 426 (658)
Q Consensus 374 ~h~niv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 426 (658)
+|||||++.++|.+ ...+|+||.-.+. +|.+++.. ...+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~---~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT---RHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc---CCCchHHHHHHHHH
Confidence 59999999987632 2357999998876 99999843 33555666778999
Q ss_pred HHHHHHHhHhcCCCCeeecCcCCCcEEE--cCC--CCeEEeeccCccccCCCCcc-----ccccccCCcccccccccccC
Q 006168 427 TARGLAYLHEDFHVRIIHRDIKPSNVLL--DDD--LQPKIADFGLARLLPENQSH-----LSTKFAGTLGYTAPEYAIHG 497 (658)
Q Consensus 427 ia~~L~~LH~~~~~~ivH~Dik~~NIll--~~~--~~~kl~DfGla~~~~~~~~~-----~~~~~~gt~~y~APE~~~~~ 497 (658)
+++|+.|||.+ +|.|||+|++|||+ |+| ..+.|+|||.+-.-+...-. ..-...|...-||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999 99999999999999 444 35789999977533221111 11134567788999987543
Q ss_pred --CC----CCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHH
Q 006168 498 --QL----SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIAL 571 (658)
Q Consensus 498 --~~----s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~ 571 (658)
+. -.|+|.|+.|.+.||+++...||...++.- ++ .+.+.+.++..+ +...+..+.+++.
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~---L~--~r~Yqe~qLPal----------p~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML---LD--TRTYQESQLPAL----------PSRVPPVARQLVF 491 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe---ec--hhhhhhhhCCCC----------cccCChHHHHHHH
Confidence 21 258999999999999999999997744311 11 011333222222 2233345889999
Q ss_pred HccccCCCCCCCHHHHHHHH
Q 006168 572 MCTQSAANSRPTMSEVVALL 591 (658)
Q Consensus 572 ~cl~~dp~~RPt~~evl~~L 591 (658)
..|+.||++||+..-....|
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999876555444
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.4e-17 Score=141.50 Aligned_cols=91 Identities=33% Similarity=0.611 Sum_probs=68.6
Q ss_pred chhHHHHHHHHHHHHHHHHHCCCC-ccceeeeeccccccCCCCCCCCCCCCcceEEEeeeccCccccccccchhhhhhhc
Q 006168 137 LQADAFKTAAQELLENLEVATPKI-NGFFAASKNNIIGSRAGANDDDDKNSTAVYGIAQCVETISETGCQNCLSGAFDNI 215 (658)
Q Consensus 137 ~~~~~f~~~~~~l~~~l~~~a~~~-~~~~a~~~~~~~~~~~~~~~~~~~~~~~vYglaQC~~Dls~~~C~~CL~~~~~~~ 215 (658)
.+...|...+.+||..|...++.. ...|+++... ...++||||+||++||++++|..||..++..+
T Consensus 14 ~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~-------------~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~ 80 (106)
T PF01657_consen 14 TDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAG-------------SGPDTVYGLAQCRGDLSPSDCRACLADAVANI 80 (106)
T ss_dssp -TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE---------------ST---EEEEEEE-TTS-HHHHHHHHHHHHCCH
T ss_pred CCCchHHHHHHHHHHHHHHHHhhccccCcEEeecC-------------CCCCeEEEEEEcCCCCChhhhHHHHHHHHHHH
Confidence 345569999999999997776543 4677766531 12378999999999999999999999999999
Q ss_pred cccc-cCCCceeeCCCCcccccCCCc
Q 006168 216 QRCL-GSAFGWAVDAGCFLRYSDTPF 240 (658)
Q Consensus 216 ~~~~-~~~~g~~~~~~C~lry~~~~f 240 (658)
+.|| +..+|+++..+|++||+.++|
T Consensus 81 ~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 81 SSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHhCCCCceEEEECCCEEEEEECCCC
Confidence 9877 578899999999999999887
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.7e-17 Score=169.82 Aligned_cols=122 Identities=33% Similarity=0.510 Sum_probs=108.0
Q ss_pred eEEEEEeccCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCc
Q 006168 390 ELILVYEYMANSSLDKFLFGEKR-GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLA 468 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla 468 (658)
.+++.|+++...+|.+||.+... ...++...+.++.|++.++.| + +.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 57899999999999999964433 348889999999999999999 4 8999999999999999999999999999
Q ss_pred cccCCCC-----ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh
Q 006168 469 RLLPENQ-----SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS 517 (658)
Q Consensus 469 ~~~~~~~-----~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt 517 (658)
....... ....+...||..||+||.+.+..|+.|+||||||++|+||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 8765544 234557889999999999999999999999999999999987
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4e-16 Score=173.67 Aligned_cols=209 Identities=20% Similarity=0.281 Sum_probs=143.0
Q ss_pred hcCCCccCcccccCceEEEEEEecC-CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
..+|+.++.|-.|++|.||.++++. .+.+|+| +.+.. .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~------lilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN------LILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc------hhhhc--cccccCCccee-----------------
Confidence 4678889999999999999999874 6678884 33210 01110 22222333333
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+=...+. .-+.++... +.+++|||+. +|+|||+||+|.+|+.-|++|+.|||+.+.......
T Consensus 136 ----gDc~tllk--~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ----GDCATLLK--NIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ----chhhhhcc--cCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 33334442 223344333 7789999998 999999999999999999999999999875421110
Q ss_pred ------------c--ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc
Q 006168 477 ------------H--LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN 542 (658)
Q Consensus 477 ------------~--~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 542 (658)
+ ....++||+.|+|||++....|....|.|++|+|+||.+-|+.||.....+ .++..+... +
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe--elfg~visd--~ 274 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--ELFGQVISD--D 274 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH--HHHhhhhhh--h
Confidence 0 122568999999999999999999999999999999999999999876442 222211110 0
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 006168 543 GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPT 583 (658)
Q Consensus 543 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt 583 (658)
....|- +.....+..+++.+.|+.+|..|--
T Consensus 275 i~wpE~----------dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 275 IEWPEE----------DEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred cccccc----------CcCCCHHHHHHHHHHHHhChHhhcc
Confidence 111111 2222345888999999999999953
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.3e-15 Score=136.27 Aligned_cols=135 Identities=23% Similarity=0.219 Sum_probs=115.1
Q ss_pred ccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCC--CccceeeeEeecCCeEEEEEeccCC
Q 006168 323 EENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHH--RNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 323 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..++.++| .++++++++....+..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 45789999999999999865 7899999865322 5678999999999976 5899999998888889999999998
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
+.+..+ +......++.+++++|.+||.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 78 ~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777543 5667788999999999999986445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.1e-15 Score=145.07 Aligned_cols=139 Identities=19% Similarity=0.241 Sum_probs=98.3
Q ss_pred cCcccccCceEEEEEEecCCcEEEEEEccccccc-ccHHH----------------------HHHHHHHHhccCCCc--c
Q 006168 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISR-RTLSD----------------------FENEVRLISNVHHRN--L 378 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~----------------------~~~E~~~l~~l~h~n--i 378 (658)
.+.||+|+||.||++...+++.||||++...... ..... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999987643111 11111 134555666654332 3
Q ss_pred ceeeeEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeecCcCCCcEEEcCC
Q 006168 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE-DFHVRIIHRDIKPSNVLLDDD 457 (658)
Q Consensus 379 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dik~~NIll~~~ 457 (658)
.+.+++ ...++||||++++.+........ ... .....++.+++.++.++|. . +|+|+||||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~--~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV--RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh--hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C
Confidence 444433 24589999999954322110000 011 6678899999999999999 7 999999999999999 8
Q ss_pred CCeEEeeccCccccCC
Q 006168 458 LQPKIADFGLARLLPE 473 (658)
Q Consensus 458 ~~~kl~DfGla~~~~~ 473 (658)
+.++|+|||.+.....
T Consensus 151 ~~~~liDfg~a~~~~~ 166 (187)
T cd05119 151 GKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcEEEEECcccccccC
Confidence 9999999999975533
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.6e-14 Score=142.46 Aligned_cols=137 Identities=19% Similarity=0.202 Sum_probs=106.0
Q ss_pred cCccc-ccCceEEEEEEecCCcEEEEEEccccc------------ccccHHHHHHHHHHHhccCCCcc--ceeeeEeecC
Q 006168 324 ENKLG-EGGFGDIYKGTLKNGKIVAVKKLAIGI------------SRRTLSDFENEVRLISNVHHRNL--IRLLGCCSQG 388 (658)
Q Consensus 324 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 388 (658)
...|| .||.|+||++... +..++||+..... .......+.+|++++.+|.|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45688 8999999999885 6788998874311 11223567889999999998875 6677765432
Q ss_pred C----eEEEEEeccCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEe
Q 006168 389 P----ELILVYEYMAN-SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIA 463 (658)
Q Consensus 389 ~----~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~ 463 (658)
. ..++|||++++ .+|.+++.. ..++.. .+.+|+++|.+||+. +|+||||||.|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 2 23599999997 689988832 345543 356899999999998 99999999999999999999999
Q ss_pred eccCcccc
Q 006168 464 DFGLARLL 471 (658)
Q Consensus 464 DfGla~~~ 471 (658)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99988753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.4e-15 Score=169.54 Aligned_cols=255 Identities=20% Similarity=0.277 Sum_probs=190.4
Q ss_pred cCCCccCcccccCceEEEEEEecC--CcEEEEEEccccc-ccccHHHHHHHHHHHhccC-CCccceeeeEeecCCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN--GKIVAVKKLAIGI-SRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 394 (658)
..|...+.||+|.|+.|-...... ...+|+|.+.... ..........|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456677789999999999887643 4567777775432 2333344556777777776 99999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhH-hcCCCCeeecCcCCCcEEEcCCC-CeEEeeccCccccC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLH-EDFHVRIIHRDIKPSNVLLDDDL-QPKIADFGLARLLP 472 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~Dik~~NIll~~~~-~~kl~DfGla~~~~ 472 (658)
.||..++++.+-+........+....-....|+..++.|+| .. ++.|+||||+|.+++..+ ..+++|||++..+.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999988773222224666677788999999999999 76 999999999999999999 99999999998876
Q ss_pred C--CCccccccccC-CcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccc
Q 006168 473 E--NQSHLSTKFAG-TLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWEL 548 (658)
Q Consensus 473 ~--~~~~~~~~~~g-t~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 548 (658)
. ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+............|.
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~------------ 244 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK------------ 244 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeec------------
Confidence 5 22333335677 9999999998884 456789999999999999999999876554322221111
Q ss_pred ccccCC-CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 549 MDESLD-PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 549 ~d~~l~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
..... ....-........++...++..+|..|.+.+++..
T Consensus 245 -~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 245 -SNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -ccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 11000 00111122345778888888899999999888754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.4e-13 Score=147.25 Aligned_cols=143 Identities=24% Similarity=0.318 Sum_probs=101.7
Q ss_pred cCcccccCceEEEEEEecCCcEEEEEEccccccccc---------------------------------------HHHHH
Q 006168 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRT---------------------------------------LSDFE 364 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~~~~~ 364 (658)
.+.||.|++|.||+|++++|+.||||+...+....- .-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 468999999999999999999999999865421110 01244
Q ss_pred HHHHHHhccC----CCccceeeeEe-ecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHhHhcC
Q 006168 365 NEVRLISNVH----HRNLIRLLGCC-SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTAR-GLAYLHEDF 438 (658)
Q Consensus 365 ~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~~~ 438 (658)
+|++.+.++. |.+-+.+-.++ ...+..+|||||+++++|.++...... .+ .+..++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC-
Confidence 5665555552 33333333333 224557999999999999887632211 12 24456666666 46788887
Q ss_pred CCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 439 ~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
+++|+|+||.||+++++++++|.|||++..+..
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=5.8e-13 Score=131.01 Aligned_cols=200 Identities=21% Similarity=0.271 Sum_probs=139.7
Q ss_pred HHHHHhccCCCccceeeeEeec-----CCeEEEEEeccCCCCHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHhHhcC
Q 006168 366 EVRLISNVHHRNLIRLLGCCSQ-----GPELILVYEYMANSSLDKFLFGEKR--GSLNWKQRFDIILGTARGLAYLHEDF 438 (658)
Q Consensus 366 E~~~l~~l~h~niv~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~ 438 (658)
-...|-++-|.|||++..|+.+ ..+..++.|||..|+|..+|.+.++ ..+......+|+.||..||.|||+.
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 3455666789999999999854 4568999999999999999976443 3488888889999999999999994
Q ss_pred CCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC----CccccccccCCcccccccccccCCCCCcccchhhhHHHHH
Q 006168 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN----QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLE 514 (658)
Q Consensus 439 ~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~----~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~e 514 (658)
.+.|+|+++.-+-|++..++-+|+.---- ..+... .........+-++|.+||+=...+.+.++|||+||+-.+|
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 67999999999999999999888753111 111000 0011113456789999998777778889999999999999
Q ss_pred HHhCCCCCC-CCCc-chhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 006168 515 IISGTKSSE-TKGE-EGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVV 588 (658)
Q Consensus 515 lltG~~p~~-~~~~-~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 588 (658)
|.-+..-.. .... ..+.....+... +.. ..-..++..|++..|..||+|.+++
T Consensus 275 mailEiq~tnseS~~~~ee~ia~~i~~---------len------------~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVEVEENIANVIIG---------LEN------------GLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HHHheeccCCCcceeehhhhhhhheee---------ccC------------ccccCcCcccccCCCCCCcchhhhh
Confidence 987754321 1111 111111100000 000 1123467889999999999999887
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.3e-13 Score=141.92 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=182.5
Q ss_pred cCCCccCcccc--cCceEEEEEEe--c-CCcEEEEEEcccccc-cccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeE
Q 006168 319 RKFSEENKLGE--GGFGDIYKGTL--K-NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 319 ~~f~~~~~lg~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 391 (658)
..|...+.+|. |.+|.||.+.. . ++..+|+|+-+.... ...-..=.+|+....++ .|+|.++....+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566788999 99999999987 3 688899998433221 12222234566666666 599999988889999999
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHhHhcCCCCeeecCcCCCcEEEcCC-CCeEEeecc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTAR----GLAYLHEDFHVRIIHRDIKPSNVLLDDD-LQPKIADFG 466 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~Dik~~NIll~~~-~~~kl~DfG 466 (658)
++-+|++. .+|..+.+. ....++....+.+..+..+ ||.++|+. .++|-|+||.||+..++ ...+++|||
T Consensus 194 fiqtE~~~-~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeecccc-chhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 99999997 588777742 2233777888888888888 99999998 99999999999999999 889999999
Q ss_pred CccccCCCCcc----ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc
Q 006168 467 LARLLPENQSH----LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN 542 (658)
Q Consensus 467 la~~~~~~~~~----~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 542 (658)
+...+....-. ......|...|++||.. ++-++.++|||++|.+.++..++.........
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------------- 332 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN--------------- 332 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC---------------
Confidence 99887654411 12234678899999954 56778999999999999999998765433211
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 543 GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 543 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
..|..++....+.++......++...+.++++.+|..|++...+..
T Consensus 333 -~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 333 -SSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -CCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1122222222233333333345666999999999999998877653
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.7e-12 Score=142.15 Aligned_cols=145 Identities=20% Similarity=0.239 Sum_probs=94.6
Q ss_pred cCCCccCcccccCceEEEEEEecC-CcEEEEEEcccccccc---------------------------------cHH---
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRR---------------------------------TLS--- 361 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---------------------------------~~~--- 361 (658)
..|+. +.||.|++|.||+|++++ |+.||||+++.+.... ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 789999999999999987 9999999997542110 001
Q ss_pred ---HHHHHHHHHhccC----CCccceeeeEeec-CCeEEEEEeccCCCCHHHHhhcCCCC----CCCHHHHHHHHHHHHH
Q 006168 362 ---DFENEVRLISNVH----HRNLIRLLGCCSQ-GPELILVYEYMANSSLDKFLFGEKRG----SLNWKQRFDIILGTAR 429 (658)
Q Consensus 362 ---~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~----~l~~~~~~~i~~~ia~ 429 (658)
+|.+|+..+.++. +.+.+.+-.++.+ ....+|||||++|+.|.++-.-...+ .+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 2344444444442 3333433333322 35678999999999998753111111 1222222223333
Q ss_pred HHHHhHhcCCCCeeecCcCCCcEEEcCCC----CeEEeeccCccccCCC
Q 006168 430 GLAYLHEDFHVRIIHRDIKPSNVLLDDDL----QPKIADFGLARLLPEN 474 (658)
Q Consensus 430 ~L~~LH~~~~~~ivH~Dik~~NIll~~~~----~~kl~DfGla~~~~~~ 474 (658)
++.. +++|+|+||.||+++.++ ++++.|||++..+...
T Consensus 276 ----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 ----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 3344 999999999999999888 9999999999877543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.7e-11 Score=115.69 Aligned_cols=130 Identities=22% Similarity=0.178 Sum_probs=96.8
Q ss_pred cCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccc-eeeeEeecCCeEEEEEeccCCCC
Q 006168 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI-RLLGCCSQGPELILVYEYMANSS 402 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~~~~gs 402 (658)
.+.|+.|.++.||+++.. ++.+++|...... .....+..|+..++.+.+.+++ +++.+.. +..++||||+++.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGT--ELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCc--ccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 357899999999999975 7789999875422 1234568899999998765554 4554432 34589999999988
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcC--CCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 403 LDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF--HVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 403 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
+.+.. . ....++.+++++|..||+.. ...++|+|++|.||+++ ++.+++.|||.+.
T Consensus 78 l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 75420 1 12345678999999999872 22369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.1e-11 Score=127.39 Aligned_cols=166 Identities=17% Similarity=0.242 Sum_probs=125.1
Q ss_pred ecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHH
Q 006168 340 LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQ 419 (658)
Q Consensus 340 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~ 419 (658)
..++.+|.|....... ........+-++.|+.++||||+++++.+...+..|||+|-+. .|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~-~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSN-GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCC-chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHH
Confidence 3468888888776533 2445667888999999999999999999999999999999986 46666632 33556
Q ss_pred HHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccccccCCcccccccccccCCC
Q 006168 420 RFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL 499 (658)
Q Consensus 420 ~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~ 499 (658)
..-.+.||+.||.|||+.+ +++|++|....|+|++.|+.||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 6678899999999999764 899999999999999999999999988865432221 001111122456666443222
Q ss_pred CCcccchhhhHHHHHHHhC
Q 006168 500 SEKVDAYSFGVLVLEIISG 518 (658)
Q Consensus 500 s~ksDV~SfGvvl~elltG 518 (658)
-..|.|-||++++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.9e-10 Score=113.51 Aligned_cols=144 Identities=22% Similarity=0.257 Sum_probs=112.7
Q ss_pred cCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCC--CccceeeeEeecC---CeEEEEEecc
Q 006168 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHH--RNLIRLLGCCSQG---PELILVYEYM 398 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lV~E~~ 398 (658)
.+.|+.|..+.||++...+|+.+++|.............+..|+++++.+.+ .++.+++.+.... +..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 3568999999999999877789999997643222245678999999999975 4467778877654 2568999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcC----------------------------------------
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF---------------------------------------- 438 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------------- 438 (658)
++.++.+.+. ...++...+..++.++++.|..||+..
T Consensus 83 ~G~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLL---RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCC---CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9998877552 145778888888999999999998521
Q ss_pred -------------CCCeeecCcCCCcEEEcC--CCCeEEeeccCccc
Q 006168 439 -------------HVRIIHRDIKPSNVLLDD--DLQPKIADFGLARL 470 (658)
Q Consensus 439 -------------~~~ivH~Dik~~NIll~~--~~~~kl~DfGla~~ 470 (658)
...++|+|+++.||++++ ++.+.|.||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246899999999999998 56689999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.2e-11 Score=128.96 Aligned_cols=251 Identities=21% Similarity=0.210 Sum_probs=178.0
Q ss_pred HHHhcCCCccCcccccCceEEEEEEec--CCcEEEEEEcccccccccHHHH-HHHHHHHhcc-CCCccceeeeEeecCCe
Q 006168 315 VSATRKFSEENKLGEGGFGDIYKGTLK--NGKIVAVKKLAIGISRRTLSDF-ENEVRLISNV-HHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 315 ~~a~~~f~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~-~~E~~~l~~l-~h~niv~l~~~~~~~~~ 390 (658)
...+.+|..+..||.|.|+.|++...+ ++..+++|.+.........+.+ ..|+.+...+ .|.++++....+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 344568899999999999999998754 5788999988764332222222 4566565555 58888888887777778
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC-CCeEEeeccCcc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD-LQPKIADFGLAR 469 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~-~~~kl~DfGla~ 469 (658)
.++=-||++++++...+ .....+++..++++..|++.++.++|+. .++|+|+||+||++..+ +.-+++|||...
T Consensus 341 ~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred ccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence 88999999999987766 3445588899999999999999999988 99999999999999875 788999999886
Q ss_pred ccCCCCccccccccCCcccc--cccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccc
Q 006168 470 LLPENQSHLSTKFAGTLGYT--APEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWE 547 (658)
Q Consensus 470 ~~~~~~~~~~~~~~gt~~y~--APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 547 (658)
.+.-.. ......-++. +++......+-.+.|+||||.-+.|.+++..-...... +.
T Consensus 416 ~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------------------~~ 473 (524)
T KOG0601|consen 416 RLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------------------SL 473 (524)
T ss_pred ccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc------------------ce
Confidence 432111 1112222333 45555556788899999999999999998654322111 11
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 548 LMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 548 ~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.+.....+ ..+ .....+..+...++..++..||.+.++..+.+.+
T Consensus 474 ~i~~~~~p-~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 474 TIRSGDTP-NLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred eeeccccc-CCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 11111101 111 1225677888889999999999998887665443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.6e-10 Score=106.14 Aligned_cols=138 Identities=14% Similarity=0.128 Sum_probs=100.2
Q ss_pred cCcccccCceEEEEEEecC-------CcEEEEEEccccc------------c---------cccHHHH----HHHHHHHh
Q 006168 324 ENKLGEGGFGDIYKGTLKN-------GKIVAVKKLAIGI------------S---------RRTLSDF----ENEVRLIS 371 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~---------~~~~~~~----~~E~~~l~ 371 (658)
...||.|--+.||.|...+ +..+|||+..... . ....+.+ ++|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998653 4789999874321 0 0012223 38999999
Q ss_pred ccCC--CccceeeeEeecCCeEEEEEeccCCCCHHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHh-HhcCCCCeeecCc
Q 006168 372 NVHH--RNLIRLLGCCSQGPELILVYEYMANSSLDK-FLFGEKRGSLNWKQRFDIILGTARGLAYL-HEDFHVRIIHRDI 447 (658)
Q Consensus 372 ~l~h--~niv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Di 447 (658)
++.. -++.+.+++ ..-+|||||+.+..+.. .+ +...++..+...+..+++.+|..| |+. +|+|+||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 9853 466666765 45689999998754422 22 122355566778889999999999 777 9999999
Q ss_pred CCCcEEEcCCCCeEEeeccCccccC
Q 006168 448 KPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 448 k~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
++.|||+++ +.+.|+|||.+....
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCC
Confidence 999999974 689999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.7e-09 Score=109.42 Aligned_cols=169 Identities=18% Similarity=0.272 Sum_probs=129.5
Q ss_pred CceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEee----cCCeEEEEEeccCC-CCHH
Q 006168 331 GFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCS----QGPELILVYEYMAN-SSLD 404 (658)
Q Consensus 331 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lV~E~~~~-gsL~ 404 (658)
--.+.||+... ||..|++||++... .+.......-++.++++.|+|+|++.+++. .+..++|||+|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r-~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDR-DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccc-ccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 34578999855 89999999995321 122223345678899999999999999886 34578999999986 5677
Q ss_pred HHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 405 KFLFGEK-------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 405 ~~l~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++.+... ....++..+|.++.|+..||.++|+. |+.-+-|.+.+||++.+.+++|+..|+...+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 6654321 22378899999999999999999998 9999999999999999999999999988766
Q ss_pred CCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCC
Q 006168 472 PENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKS 521 (658)
Q Consensus 472 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p 521 (658)
..+... -+. --.+-|.=.||.+++.|.||...
T Consensus 444 ~~d~~~---------------~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPTE---------------PLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCCc---------------chh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 444311 011 12367888999999999999654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.5e-09 Score=96.94 Aligned_cols=132 Identities=20% Similarity=0.278 Sum_probs=98.9
Q ss_pred CcccccCceEEEEEEecCCcEEEEEE-ccccccccc------HHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 325 NKLGEGGFGDIYKGTLKNGKIVAVKK-LAIGISRRT------LSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
..+++|+-+.+|.+.+.+ .++++|. +++.--... ...-.+|++++.+++--.|.--+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 357899999999998754 3455664 333211111 23356899999988655544444455566778899999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
+++..|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888432 356778888888999998 999999999999998875 99999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3e-09 Score=97.54 Aligned_cols=144 Identities=19% Similarity=0.281 Sum_probs=105.0
Q ss_pred ccCcccccCceEEEEEEecCCcEEEEEEc-ccccc------cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 323 EENKLGEGGFGDIYKGTLKNGKIVAVKKL-AIGIS------RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 323 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
....|-||+-+.|+++.++ |+...||.- .+.-. .-..+..++|+++|.++.--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567889999999999996 667666643 22211 111345678999999886544444444455556668899
Q ss_pred eccCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC---CeEEeeccCccc
Q 006168 396 EYMAN-SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL---QPKIADFGLARL 470 (658)
Q Consensus 396 E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~---~~kl~DfGla~~ 470 (658)
||+++ .++.+++...-............+..|-+.+.-||.+ +|+|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 4778888554444444444478899999999999999 999999999999996654 358999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.4e-10 Score=128.28 Aligned_cols=251 Identities=18% Similarity=0.236 Sum_probs=168.0
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
..-+.|.+.+-+-.|.++.++...-. .|...++|..... ......+....+-.++-..+||-++...--+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34466777788889999998887643 2433444433221 11111222223333333334565555444455678899
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
||++|..+++|...|+. .+..+.+.....+..+.+++++||.. .+.|+|++|.|+|...+++.++.|||......
T Consensus 881 L~~~~~~~~~~~Skl~~--~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHN--SGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhhHHhccCCchhhhhc--CCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccc
Confidence 99999999999998843 33455555566677788999999997 69999999999999999999999998433211
Q ss_pred C------C---------------C---------ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCC
Q 006168 473 E------N---------------Q---------SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSS 522 (658)
Q Consensus 473 ~------~---------------~---------~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~ 522 (658)
. . . ........||+.|.+||...+......+|.|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0 0 00122467899999999999999999999999999999999999998
Q ss_pred CCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 006168 523 ETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMS 585 (658)
Q Consensus 523 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 585 (658)
.....+.. .+.... .......-+.+......+++...+..+|.+|-.|.
T Consensus 1036 na~tpq~~------f~ni~~--------~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQI------FENILN--------RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhh------hhcccc--------CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 76554221 111111 11111122333445577888888899999997776
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=2e-08 Score=101.45 Aligned_cols=141 Identities=18% Similarity=0.115 Sum_probs=100.1
Q ss_pred cccccCceEEEEEEecCCcEEEEEEcccccccccH----------HHHHHHHHHHhccCCC--ccceeeeEeec-----C
Q 006168 326 KLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTL----------SDFENEVRLISNVHHR--NLIRLLGCCSQ-----G 388 (658)
Q Consensus 326 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~E~~~l~~l~h~--niv~l~~~~~~-----~ 388 (658)
.+-.-....|.+..+ +|+.+.||+.......+.. ..+.+|.+.+.++... ..++.+++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333445667766 5788999976432111111 1377898888888433 33445555533 2
Q ss_pred CeEEEEEeccCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC-------CCCe
Q 006168 389 PELILVYEYMANS-SLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD-------DLQP 460 (658)
Q Consensus 389 ~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~-------~~~~ 460 (658)
..-+||+|++++- +|.+++........+...+..++.+++..+.-||+. +|+|+|++++|||++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceE
Confidence 3578999999986 899988433334566677889999999999999999 9999999999999975 4679
Q ss_pred EEeeccCccc
Q 006168 461 KIADFGLARL 470 (658)
Q Consensus 461 kl~DfGla~~ 470 (658)
.|+||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=7.3e-08 Score=91.75 Aligned_cols=127 Identities=24% Similarity=0.303 Sum_probs=83.7
Q ss_pred EEEEEEecCCcEEEEEEcccccc-------------c--------cc----HHHHHHHHHHHhccCCC--ccceeeeEee
Q 006168 334 DIYKGTLKNGKIVAVKKLAIGIS-------------R--------RT----LSDFENEVRLISNVHHR--NLIRLLGCCS 386 (658)
Q Consensus 334 ~Vy~~~~~~~~~vavK~~~~~~~-------------~--------~~----~~~~~~E~~~l~~l~h~--niv~l~~~~~ 386 (658)
.||.|...+|..+|||....+.. . .. ....++|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999999999999998743200 0 00 12357899999999755 566666553
Q ss_pred cCCeEEEEEeccC--CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-hHhcCCCCeeecCcCCCcEEEcCCCCeEEe
Q 006168 387 QGPELILVYEYMA--NSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAY-LHEDFHVRIIHRDIKPSNVLLDDDLQPKIA 463 (658)
Q Consensus 387 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~ivH~Dik~~NIll~~~~~~kl~ 463 (658)
.-.|||||++ +..+..+.. . .++......++.+++..+.. +|.. +|+|+||.+.|||++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~-~---~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD-V---DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH-C---GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHh-c---cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 3479999999 555544331 1 12244566777888886655 4676 99999999999999988 99999
Q ss_pred eccCccccC
Q 006168 464 DFGLARLLP 472 (658)
Q Consensus 464 DfGla~~~~ 472 (658)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=8.3e-07 Score=91.18 Aligned_cols=261 Identities=16% Similarity=0.183 Sum_probs=156.6
Q ss_pred ccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEe------ec-CCeEEEE
Q 006168 323 EENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCC------SQ-GPELILV 394 (658)
Q Consensus 323 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~------~~-~~~~~lV 394 (658)
....||+|+-+.+|-.--- +.. +-|+..... ... . .+-+..|.+. .||-+-.-+.+= -. +....+.
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pp-pa~--~-aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPP-PAA--Q-AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchh-hch-hheeecCCC-chH--H-HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4678999999999964321 112 335544321 111 1 1122233333 566444322221 11 2236778
Q ss_pred EeccCCCC-HHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 395 YEYMANSS-LDKFLFGEK----RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 395 ~E~~~~gs-L~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
|..+++.- +..++.... -...+|.-.++.++.+|.+.+-||.. |.+-+|++++|+|+.+++.+.|.|-....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 88877642 333332111 12389999999999999999999998 99999999999999999999999865443
Q ss_pred ccCCCCccccccccCCcccccccccc-----cCCCCCcccchhhhHHHHHHHhC-CCCCCCCCc--chhhHHH-HHHHHh
Q 006168 470 LLPENQSHLSTKFAGTLGYTAPEYAI-----HGQLSEKVDAYSFGVLVLEIISG-TKSSETKGE--EGEYLLK-RAWRLY 540 (658)
Q Consensus 470 ~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~SfGvvl~elltG-~~p~~~~~~--~~~~l~~-~~~~~~ 540 (658)
.- .........+|...|.+||.-. +..-+...|.|.|||++++|+.| ++|+.+... +.....+ .+
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I---- 239 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI---- 239 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh----
Confidence 32 1222334567889999999754 23456789999999999999887 888865432 1111111 10
Q ss_pred hcCcccccccc----cCCCCCCCHH-HHHHHHHHHHHcccc--CCCCCCCHHHHHHHHhcCcCCC
Q 006168 541 ENGTHWELMDE----SLDPNECTKE-AAEKVVEIALMCTQS--AANSRPTMSEVVALLKSTSSSL 598 (658)
Q Consensus 541 ~~~~~~~~~d~----~l~~~~~~~~-~~~~l~~li~~cl~~--dp~~RPt~~evl~~L~~~~~~~ 598 (658)
..+.....-+. ...+...+.. .+..+..+..+|+.. ++.-|||++..+..|..+..++
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 00111100010 0112222222 234567778888855 3678999999888777654333
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.6e-07 Score=90.45 Aligned_cols=136 Identities=20% Similarity=0.219 Sum_probs=97.6
Q ss_pred CCccCcccccCceEEEEEEecCCcEEEEEEcccccc-------------------ccc--HHHHHHHHHHHhccCCC--c
Q 006168 321 FSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGIS-------------------RRT--LSDFENEVRLISNVHHR--N 377 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~--~~~~~~E~~~l~~l~h~--n 377 (658)
..++++||-|--+.||.|..++|.++|||.-..+.+ +.. ....++|.+.|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345789999999999999999999999997543210 000 12347789999988655 6
Q ss_pred cceeeeEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC
Q 006168 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD 457 (658)
Q Consensus 378 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~ 457 (658)
+.+.+++ +.-.+||||+++--|...- ++.+..-.|+..|++-+.-+-.. ||||+|+.+-||+++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence 6666654 4558999999986664321 23334444555555555555555 99999999999999999
Q ss_pred CCeEEeeccCccc
Q 006168 458 LQPKIADFGLARL 470 (658)
Q Consensus 458 ~~~kl~DfGla~~ 470 (658)
|.+.++||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999975543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.8e-07 Score=102.30 Aligned_cols=143 Identities=20% Similarity=0.293 Sum_probs=94.5
Q ss_pred CcccccCceEEEEEEecCCcEEEEEEccccccccc-----------------------------HH----------HHHH
Q 006168 325 NKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRT-----------------------------LS----------DFEN 365 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----------------------------~~----------~~~~ 365 (658)
+.|+.++-|.||+|++++|+.||||+.+.+..+.- .+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 68999999999999999999999999765421111 00 1334
Q ss_pred HHHHHhcc----CCCccceeeeEe-ecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHH-HHHhHhcCC
Q 006168 366 EVRLISNV----HHRNLIRLLGCC-SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARG-LAYLHEDFH 439 (658)
Q Consensus 366 E~~~l~~l----~h~niv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~-L~~LH~~~~ 439 (658)
|..-+.++ ++..-+++=.++ .-.+...|+|||++|-.+.+...-.. ..++.+.+ +..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i---a~~~~~~f~~q~~~d-- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKEL---AELLVRAFLRQLLRD-- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHH---HHHHHHHHHHHHHhc--
Confidence 55444444 122222222233 23456799999999999988753222 34553333 3333332 2222223
Q ss_pred CCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 440 ~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
+++|.|.+|.||+++.++++.+.|||+...+.+.
T Consensus 285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred -CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 9999999999999999999999999999877543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.8e-07 Score=88.25 Aligned_cols=106 Identities=25% Similarity=0.286 Sum_probs=83.2
Q ss_pred HHHHHHHHHHHhccCC--CccceeeeEeecC----CeEEEEEeccCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 006168 360 LSDFENEVRLISNVHH--RNLIRLLGCCSQG----PELILVYEYMANS-SLDKFLFGEKRGSLNWKQRFDIILGTARGLA 432 (658)
Q Consensus 360 ~~~~~~E~~~l~~l~h--~niv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~ 432 (658)
.....+|...+..+.. -...+.+++.... ...+||+|++++. +|.+++..... ++......++.++++.+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 3457788888777743 3345566666542 2458999999984 79999843222 667778899999999999
Q ss_pred HhHhcCCCCeeecCcCCCcEEEcCCC---CeEEeeccCccc
Q 006168 433 YLHEDFHVRIIHRDIKPSNVLLDDDL---QPKIADFGLARL 470 (658)
Q Consensus 433 ~LH~~~~~~ivH~Dik~~NIll~~~~---~~kl~DfGla~~ 470 (658)
-||+. +|+|+|+++.|||++.+. .+.|+||+-++.
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 999999999999998887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.5e-08 Score=108.46 Aligned_cols=151 Identities=22% Similarity=0.373 Sum_probs=103.5
Q ss_pred HHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc--------ccccccCCcccccccccc
Q 006168 424 ILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH--------LSTKFAGTLGYTAPEYAI 495 (658)
Q Consensus 424 ~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~--------~~~~~~gt~~y~APE~~~ 495 (658)
+.+++.||.|+|.. +++||++|.|++|.++..+..||+.|+.+......... ..--......|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 44556999999986 69999999999999999999999999988654332111 111223456899999999
Q ss_pred cCCCCCcccchhhhHHHHHHHhCCC-CCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHcc
Q 006168 496 HGQLSEKVDAYSFGVLVLEIISGTK-SSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCT 574 (658)
Q Consensus 496 ~~~~s~ksDV~SfGvvl~elltG~~-p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl 574 (658)
+...+.++|+||+|+++|-+..|.. -+...+..... ..... ..+.. .-.+..+.+.++.+=+.+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~----~~~~~-------~~~~~--~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY----SFSRN-------LLNAG--AFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchh----hhhhc-------ccccc--cccccccCcHHHHHHHHHHh
Confidence 9888999999999999999995444 33332221100 00000 00000 01122344566888888899
Q ss_pred ccCCCCCCCHHHHHH
Q 006168 575 QSAANSRPTMSEVVA 589 (658)
Q Consensus 575 ~~dp~~RPt~~evl~ 589 (658)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998877764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.3e-06 Score=82.03 Aligned_cols=139 Identities=15% Similarity=0.140 Sum_probs=105.0
Q ss_pred cccccCceEEEEEEecCCcEEEEEEccccc--c---cccHHHHHHHHHHHhccCC--CccceeeeEee-c----CCeEEE
Q 006168 326 KLGEGGFGDIYKGTLKNGKIVAVKKLAIGI--S---RRTLSDFENEVRLISNVHH--RNLIRLLGCCS-Q----GPELIL 393 (658)
Q Consensus 326 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~---~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~-~----~~~~~l 393 (658)
--|+||-+.|++-.+. |+.+-+|+-.... + +-....|.+|...|.+|.. -.+.+.. ++. . ...-+|
T Consensus 25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 3577899999998775 4478889864111 1 3356789999999999853 2344444 332 1 234689
Q ss_pred EEeccCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC--eEEeeccCcc
Q 006168 394 VYEYMAN-SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ--PKIADFGLAR 469 (658)
Q Consensus 394 V~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~--~kl~DfGla~ 469 (658)
|+|-+.+ .+|.+++......+.+...+..+..++++.+.-||+. ++.|+|+.+.|||++.++. ++++||.-++
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 9997763 5899988554455678888899999999999999999 9999999999999986666 9999997654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.9e-06 Score=82.25 Aligned_cols=138 Identities=17% Similarity=0.216 Sum_probs=85.7
Q ss_pred CcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCc--cceeeeEeecCCeEEEEEeccCCCC
Q 006168 325 NKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN--LIRLLGCCSQGPELILVYEYMANSS 402 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~E~~~~gs 402 (658)
..||+|..+.||+. .+..+++|..... .......+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~---~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG---FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC---CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999984 2456778887542 23456789999999986433 4677888877888899999999963
Q ss_pred -HHHHh---------------------hcCCCCCCCHHHHHH-HHH----------HHHH-HHHHhHhc-CCCCeeecCc
Q 006168 403 -LDKFL---------------------FGEKRGSLNWKQRFD-IIL----------GTAR-GLAYLHED-FHVRIIHRDI 447 (658)
Q Consensus 403 -L~~~l---------------------~~~~~~~l~~~~~~~-i~~----------~ia~-~L~~LH~~-~~~~ivH~Di 447 (658)
+...+ |...........+.. +.. .+.+ ...+|... ....++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 22111 111001111111110 000 0111 11222211 1346789999
Q ss_pred CCCcEEEcCCCCeEEeeccCcc
Q 006168 448 KPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 448 k~~NIll~~~~~~kl~DfGla~ 469 (658)
.|.||++++++ +.|.||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999988 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=2e-07 Score=100.38 Aligned_cols=195 Identities=19% Similarity=0.149 Sum_probs=141.7
Q ss_pred HHHHHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCc-cceeeeEeecCCe
Q 006168 312 KDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN-LIRLLGCCSQGPE 390 (658)
Q Consensus 312 ~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~ 390 (658)
..++..++-+...+..+++++++++|.+-...+....+.+... ....-++++|.+++||| .++.++-+..++.
T Consensus 235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY 308 (829)
T ss_pred CcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence 3444455555566778999999999998654444456665432 34567889999999999 7777777777888
Q ss_pred EEEEEeccCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 391 LILVYEYMANS-SLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 391 ~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
.+++++++..+ +-.... ....-.+...+...+.+.-.++|++||+. .-+|+| ||+..+ +..|..||+...
T Consensus 309 ~~i~~~i~s~~rs~~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEM-TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPP 379 (829)
T ss_pred cchhhhhhcCCccccccC-ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCc
Confidence 99999999877 221111 01111233444455666778899999986 458888 777766 578999999988
Q ss_pred ccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCC
Q 006168 470 LLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSE 523 (658)
Q Consensus 470 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~ 523 (658)
.+.... ......+++.|+|||+.....+..+-|+|++|+-..++.-|-+|-.
T Consensus 380 ~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 380 QLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 765543 2345688999999999999999999999999998888877766543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=6.1e-06 Score=90.02 Aligned_cols=144 Identities=19% Similarity=0.323 Sum_probs=92.5
Q ss_pred cCcccccCceEEEEEEecCCcEEEEEEccccccccc------------------------------------HHHHHHHH
Q 006168 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRT------------------------------------LSDFENEV 367 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------------~~~~~~E~ 367 (658)
.+.||.-+.|.||++++++|+.||||+-+.+....- +-+|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 468999999999999999999999999765422110 01244455
Q ss_pred HHHhcc----CCCc---cceeeeEe-ecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCC
Q 006168 368 RLISNV----HHRN---LIRLLGCC-SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439 (658)
Q Consensus 368 ~~l~~l----~h~n---iv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 439 (658)
+-..+. .|-+ -|.+=.++ .......|+||||+|..+.+.-.- ....++...+..-+ .++ |++....
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l---~~~--~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKL---VEA--YLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHH---HHH--HHHHHHh
Confidence 443333 3444 11122222 224568999999999988765421 23345555444333 332 2222222
Q ss_pred CCeeecCcCCCcEEEcC----CCCeEEeeccCccccCC
Q 006168 440 VRIIHRDIKPSNVLLDD----DLQPKIADFGLARLLPE 473 (658)
Q Consensus 440 ~~ivH~Dik~~NIll~~----~~~~kl~DfGla~~~~~ 473 (658)
.|++|.|=+|.||+++. ++.+.+-|||+......
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 38999999999999984 67899999999986644
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.17 E-value=2e-05 Score=75.88 Aligned_cols=136 Identities=15% Similarity=0.185 Sum_probs=87.1
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHH---------HHHHHHHhccC---CCccceeeeEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDF---------ENEVRLISNVH---HRNLIRLLGCC 385 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~---------~~E~~~l~~l~---h~niv~l~~~~ 385 (658)
.++|...+.+-......|.+-.. +|+.+++|...... ....+.| .+++..+.++. --.+..++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~-~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREEN-RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhh-hhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 45676666776666666666655 47889999876422 1111221 23333333332 22222322222
Q ss_pred -----ecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCe
Q 006168 386 -----SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP 460 (658)
Q Consensus 386 -----~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~ 460 (658)
......+|+|||++|..|.+.. .+++ .++..+.+++.-||+. |++|+|.+|.|+++++++ +
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~------~i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE------DIDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch------hcCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-E
Confidence 2234567999999998886653 1222 3456677889999999 999999999999999654 9
Q ss_pred EEeeccCcc
Q 006168 461 KIADFGLAR 469 (658)
Q Consensus 461 kl~DfGla~ 469 (658)
++.||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.9e-05 Score=78.26 Aligned_cols=142 Identities=20% Similarity=0.185 Sum_probs=85.4
Q ss_pred cCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCC--ccceeeeEeec---CCeEEEEEecc
Q 006168 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHR--NLIRLLGCCSQ---GPELILVYEYM 398 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lV~E~~ 398 (658)
.+.|+.|..+.||+....+ ..+++|..... .....+..|..+++.+... .+.+++.+... ....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 3578999999999999987 69999986542 4456788899998888533 35566664422 34579999999
Q ss_pred CCCCHHH----------------Hh---hcC--CCCCCCHHHH---------HHH------------HHHHHH-HHHHhH
Q 006168 399 ANSSLDK----------------FL---FGE--KRGSLNWKQR---------FDI------------ILGTAR-GLAYLH 435 (658)
Q Consensus 399 ~~gsL~~----------------~l---~~~--~~~~l~~~~~---------~~i------------~~~ia~-~L~~LH 435 (658)
++..+.. .+ +.. ....+.+... ... ...+.+ .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988777 11 111 1111111110 000 112222 333333
Q ss_pred hc----CCCCeeecCcCCCcEEEc-CCCCeEEeeccCcc
Q 006168 436 ED----FHVRIIHRDIKPSNVLLD-DDLQPKIADFGLAR 469 (658)
Q Consensus 436 ~~----~~~~ivH~Dik~~NIll~-~~~~~kl~DfGla~ 469 (658)
+. ....++|+|+.|.|||++ +++.+-|.||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 32 345799999999999999 56666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.1e-05 Score=91.34 Aligned_cols=148 Identities=18% Similarity=0.272 Sum_probs=93.8
Q ss_pred cCcccccCceEEEEEEecCC---cEEEEEEcccccccccHHHHHHHHHHHhccC-CCcc--ceeeeEeecC---CeEEEE
Q 006168 324 ENKLGEGGFGDIYKGTLKNG---KIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNL--IRLLGCCSQG---PELILV 394 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lV 394 (658)
.+.|+.|.+..+|+....++ ..+++|+............+.+|+++++.+. |.++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999887654 4678887654332234467889999999995 6654 7788887654 457899
Q ss_pred EeccCCCCHHH--------------------H---hhcCCCC---------CCCH--HHHHHHH---------------H
Q 006168 395 YEYMANSSLDK--------------------F---LFGEKRG---------SLNW--KQRFDII---------------L 425 (658)
Q Consensus 395 ~E~~~~gsL~~--------------------~---l~~~~~~---------~l~~--~~~~~i~---------------~ 425 (658)
|||+++..+.+ . ||..... +..+ .++..+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998865321 1 1111000 0011 1111111 1
Q ss_pred HHHHHHHHhHhcCC--------CCeeecCcCCCcEEEcCC-CC-eEEeeccCcccc
Q 006168 426 GTARGLAYLHEDFH--------VRIIHRDIKPSNVLLDDD-LQ-PKIADFGLARLL 471 (658)
Q Consensus 426 ~ia~~L~~LH~~~~--------~~ivH~Dik~~NIll~~~-~~-~kl~DfGla~~~ 471 (658)
.+.+.+.+|..+.. +.++|+|+++.|||++.+ .+ .-|.||+++..-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 22334566644322 359999999999999853 34 578999987653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.12 E-value=4.3e-05 Score=74.47 Aligned_cols=155 Identities=19% Similarity=0.222 Sum_probs=101.8
Q ss_pred ccchHHHHHHhcCCCccCc---ccccCceEEEEEEecCCcEEEEEEcccccccc------------------c-----HH
Q 006168 308 NYRLKDLVSATRKFSEENK---LGEGGFGDIYKGTLKNGKIVAVKKLAIGISRR------------------T-----LS 361 (658)
Q Consensus 308 ~~~~~~l~~a~~~f~~~~~---lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------~-----~~ 361 (658)
..+++.|....++..+... |..|--+.||+|.-.++..+|+|+.......- . ..
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 3556667776666655554 45677789999998889999999975421100 0 01
Q ss_pred HHHHHHHHHhccC--CCccceeeeEeecCCeEEEEEeccCCCCH-HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcC
Q 006168 362 DFENEVRLISNVH--HRNLIRLLGCCSQGPELILVYEYMANSSL-DKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438 (658)
Q Consensus 362 ~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ 438 (658)
...+|..-|+++. +-.+.+-+++. +-.|||||+....+ .-.| +.-++...+...+..++++.+.-|-..
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~~~- 185 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLYKE- 185 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHHHh-
Confidence 1245666666663 33444444443 34799999976411 1111 112233335667777888888877763
Q ss_pred CCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 439 ~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
.++||+||..-|||+. ++.+.|+|||-+....
T Consensus 186 -a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 186 -AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 3999999999999999 8899999999887543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.7e-05 Score=76.41 Aligned_cols=138 Identities=14% Similarity=0.127 Sum_probs=85.0
Q ss_pred ccccCc-eEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccC-CCccceeeeEeecCCeEEEEEeccCCCCHH
Q 006168 327 LGEGGF-GDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQGPELILVYEYMANSSLD 404 (658)
Q Consensus 327 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 404 (658)
|-.|.. ..||+...+ +..+.+|+..... ..+..+|+++++.+. +-.+.+++++....+..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 334444 789999765 4788888875321 345678999988884 444667788777666789999999998876
Q ss_pred HHh-------------------hcCCCC--CCC--HHHHHHHHH--------------------HHHHHHHHhHh----c
Q 006168 405 KFL-------------------FGEKRG--SLN--WKQRFDIIL--------------------GTARGLAYLHE----D 437 (658)
Q Consensus 405 ~~l-------------------~~~~~~--~l~--~~~~~~i~~--------------------~ia~~L~~LH~----~ 437 (658)
... +..... .+. ......... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 111000 111 000110000 01111222211 1
Q ss_pred CCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 438 ~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
..+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 23569999999999999998778899998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.2e-05 Score=75.10 Aligned_cols=104 Identities=25% Similarity=0.273 Sum_probs=83.0
Q ss_pred HHHHHHHhccCC-CccceeeeEeecCCeEEEEEeccCCCCHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC
Q 006168 364 ENEVRLISNVHH-RNLIRLLGCCSQGPELILVYEYMANSSLDKFLFG-EKRGSLNWKQRFDIILGTARGLAYLHEDFHVR 441 (658)
Q Consensus 364 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 441 (658)
.+|.-+++.+++ +++++++|+|-+ ++|.||...+++...-.. ..-..-+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888876 699999999933 779999998766422100 01124789999999999999999999865556
Q ss_pred eeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 442 IIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 442 ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
+.-.|++++|+-+++++++|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888899999999999999999999877644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00041 Score=66.71 Aligned_cols=130 Identities=20% Similarity=0.329 Sum_probs=90.4
Q ss_pred ccCcccccCceEEEEEEecCCcEEEEEEccccc---------------ccccHHHHHHHHHHHhccC------CCcccee
Q 006168 323 EENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGI---------------SRRTLSDFENEVRLISNVH------HRNLIRL 381 (658)
Q Consensus 323 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~E~~~l~~l~------h~niv~l 381 (658)
....||+|+.-.||.-- +.....||+..... ......+..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~HP--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHP--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEECC--CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 45679999999999754 34456677775432 1223566677777666665 8899999
Q ss_pred eeEeecCCeEEEEEeccCC------CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc
Q 006168 382 LGCCSQGPELILVYEYMAN------SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD 455 (658)
Q Consensus 382 ~~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~ 455 (658)
+|+.+.+--..+|+|.+.+ -+|.+++. .+.++. ...+. +-+-..||-++ .|+.+|++|.||++.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---~~~~~~-~~~~~---L~~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK---EGGLTE-ELRQA---LDEFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH---cCCccH-HHHHH---HHHHHHHHHHc---CCeecCCCcccEEEE
Confidence 9999999999999998754 24777872 334555 33333 34445677776 899999999999995
Q ss_pred CC--C--CeEEee
Q 006168 456 DD--L--QPKIAD 464 (658)
Q Consensus 456 ~~--~--~~kl~D 464 (658)
.. + .+.|.|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 33 2 466665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00042 Score=71.60 Aligned_cols=79 Identities=13% Similarity=0.083 Sum_probs=58.1
Q ss_pred CCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCC---CccceeeeEeec---CCeEEEE
Q 006168 321 FSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHH---RNLIRLLGCCSQ---GPELILV 394 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lV 394 (658)
....+.||.|..+.||+....+++ +.+|..+. ......+..|.+.|+.|.- -.+.++++++.. .+..+||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGN-PMPLMARS---FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCC-EEEEEecc---cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 344568999999999999876664 66676332 1123578999999998843 467888888754 3668999
Q ss_pred EeccCCCCH
Q 006168 395 YEYMANSSL 403 (658)
Q Consensus 395 ~E~~~~gsL 403 (658)
||+++++++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.0002 Score=71.45 Aligned_cols=73 Identities=16% Similarity=0.263 Sum_probs=46.1
Q ss_pred CcccccCce-EEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCC---ccceeeeEeecC---CeEEEEEec
Q 006168 325 NKLGEGGFG-DIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHR---NLIRLLGCCSQG---PELILVYEY 397 (658)
Q Consensus 325 ~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lV~E~ 397 (658)
+.|+.||.. .||+. +..+++|.... ......+.+|.+.+..+... .+.+.++..... ...+++||+
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~---~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA---AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc---cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 457777766 48875 23567776432 22345788999999888532 344445444332 234889999
Q ss_pred cCCCCHH
Q 006168 398 MANSSLD 404 (658)
Q Consensus 398 ~~~gsL~ 404 (658)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00034 Score=64.64 Aligned_cols=129 Identities=21% Similarity=0.267 Sum_probs=86.7
Q ss_pred CccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccce-eeeEeecCCeEEEEEeccCC
Q 006168 322 SEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIR-LLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 322 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lV~E~~~~ 400 (658)
.+.+.|++|++|.||+|.+.+ ..+|+|+-.. ......++.|+++|..++-.++-+ ++.|-. -.+.|||+.|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~---ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G 96 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRG-GEVALKVRRR---DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG 96 (201)
T ss_pred hhhhhhhcccccEEEEeeccC-ceEEEEEecC---CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence 346789999999999999974 5788887654 234567899999999988766654 444332 2445999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcC-CCcEEEcCCCCeEEeeccCccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIK-PSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik-~~NIll~~~~~~kl~DfGla~~ 470 (658)
-.|.++-... +-+. ...+++.---|... +|-|+.|. |..++|..+..+.|+||.-|..
T Consensus 97 ~~L~~~~~~~-----~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIGG-----DRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhcc-----cHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8887765211 2222 33444443334444 88898885 4444444444999999998863
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00043 Score=68.92 Aligned_cols=140 Identities=19% Similarity=0.230 Sum_probs=81.8
Q ss_pred cCcccccCceEEEEEEecC--CcEEEEEEcccccccccHHHHHHHHHHHhccCCCcc-ceeeeEeecCCeEEEEEeccCC
Q 006168 324 ENKLGEGGFGDIYKGTLKN--GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL-IRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~ 400 (658)
.+.|..|-...+|+....+ ++.+++|+.... .....+..+|+.+++.+...++ +++++... -.+||||+++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~--~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK--TELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCC--ccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCC
Confidence 3567778888999998764 678889976532 2222334578888888854333 44544432 2479999998
Q ss_pred CCHHHH-----------------hhcCCC---------CCC-CHHHHHHHHH----------------------HHHHHH
Q 006168 401 SSLDKF-----------------LFGEKR---------GSL-NWKQRFDIIL----------------------GTARGL 431 (658)
Q Consensus 401 gsL~~~-----------------l~~~~~---------~~l-~~~~~~~i~~----------------------~ia~~L 431 (658)
.++... +|.... ... -+..+..+.. .+...+
T Consensus 77 ~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 156 (235)
T cd05157 77 RTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEI 156 (235)
T ss_pred CcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHH
Confidence 775321 111110 011 1222111111 111111
Q ss_pred HHh----Hhc-CCCCeeecCcCCCcEEEcC-CCCeEEeeccCcc
Q 006168 432 AYL----HED-FHVRIIHRDIKPSNVLLDD-DLQPKIADFGLAR 469 (658)
Q Consensus 432 ~~L----H~~-~~~~ivH~Dik~~NIll~~-~~~~kl~DfGla~ 469 (658)
..| ... ....++|+|+.+.|||+++ +..+.|.||..+.
T Consensus 157 ~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 157 SWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 122 111 2347999999999999998 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00052 Score=79.61 Aligned_cols=197 Identities=20% Similarity=0.214 Sum_probs=137.8
Q ss_pred HHHHHHHHHhccCCCccceeeeEeecCCeEE----EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhc
Q 006168 362 DFENEVRLISNVHHRNLIRLLGCCSQGPELI----LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437 (658)
Q Consensus 362 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~ 437 (658)
...-|++.+.++.|+|++.++.|-.+..... +..|++..-++...+ ..-+.++....+.+..++.+||.|+|+.
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~--q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL--QSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH--hhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 3456777888889999999999976654333 445778887887777 3446688899999999999999999998
Q ss_pred CCCCeeecCcCCC---cEEEcCCCCeEEe--eccCccccCCCCccccccccCCcccccccccccCCCCC--cccchhhhH
Q 006168 438 FHVRIIHRDIKPS---NVLLDDDLQPKIA--DFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSE--KVDAYSFGV 510 (658)
Q Consensus 438 ~~~~ivH~Dik~~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~--ksDV~SfGv 510 (658)
...|.-+..+ +...+.++...++ ||+..+.+....... ...-+..|.+||......++. ..|+|.+|.
T Consensus 306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred ---ccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHH
Confidence 5555555554 5555667777777 998888765443322 223345677888776665544 479999999
Q ss_pred HHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 511 LVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 511 vl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+..+..|..+....... ..++ ..... ..+......|+..++++|+...+++..
T Consensus 381 l~~~~~~~~~i~~~~~~~-----------------~~~l-----~~~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAVP-----------------VSLL-----DVLST----SELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHhhhhhcCcccccccch-----------------hhhh-----ccccc----hhhhhhhhhhcchhhhhccchhhhhhc
Confidence 999999886543211100 0000 11111 147778889999999999999999986
Q ss_pred H
Q 006168 591 L 591 (658)
Q Consensus 591 L 591 (658)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 4
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00036 Score=70.57 Aligned_cols=138 Identities=15% Similarity=0.122 Sum_probs=79.0
Q ss_pred cccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCcc-ceeeeEeecCCeEEEEEeccCCCCHH
Q 006168 326 KLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL-IRLLGCCSQGPELILVYEYMANSSLD 404 (658)
Q Consensus 326 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~gsL~ 404 (658)
.+..|-...+|+... +++.+++|...... ..-..+..+|.++++.+....+ .+++.... -++||||++|..+.
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~-~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVC-KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCccc-ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 355677889998874 56788888764321 1111245788888888864433 34444432 36899999987653
Q ss_pred HH-----------------hhcCCC--CCCCHHHH-HHHHHH---------HHHHHHHhHhc-----CCCCeeecCcCCC
Q 006168 405 KF-----------------LFGEKR--GSLNWKQR-FDIILG---------TARGLAYLHED-----FHVRIIHRDIKPS 450 (658)
Q Consensus 405 ~~-----------------l~~~~~--~~l~~~~~-~~i~~~---------ia~~L~~LH~~-----~~~~ivH~Dik~~ 450 (658)
.. ||.... .+++.... .....+ +...+..+... ....++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 111111 11222211 111111 11112222211 1346999999999
Q ss_pred cEEEcCCCCeEEeeccCccc
Q 006168 451 NVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 451 NIll~~~~~~kl~DfGla~~ 470 (658)
||++++++ +.|.||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999876 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0011 Score=70.57 Aligned_cols=77 Identities=17% Similarity=0.152 Sum_probs=55.0
Q ss_pred cCcccccCceEEEEEEecCC-cEEEEEEcccc-----cc-cccHHHHHHHHHHHhccC---CCccceeeeEeecCCeEEE
Q 006168 324 ENKLGEGGFGDIYKGTLKNG-KIVAVKKLAIG-----IS-RRTLSDFENEVRLISNVH---HRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 393 (658)
.+.||.|.+..||++...+| +.++||.-... .. .-..+.+..|.+.|+.+. ..++++++.+- .+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 35799999999999999877 58999985321 11 124566778888888762 34567777763 355789
Q ss_pred EEeccCCCC
Q 006168 394 VYEYMANSS 402 (658)
Q Consensus 394 V~E~~~~gs 402 (658)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00061 Score=70.44 Aligned_cols=141 Identities=19% Similarity=0.194 Sum_probs=85.3
Q ss_pred cCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCc--cceeeeE------eecCCeEEEEE
Q 006168 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN--LIRLLGC------CSQGPELILVY 395 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lV~ 395 (658)
.+.|..|....+|+....+ ..+++|+... ........|++++..+.+.. +.+++.. ....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 4567777778999987654 4788888653 23456677888888774332 4444432 12345678999
Q ss_pred eccCCCCHHH-----------H---hhcC----CC-----CCCCHHHHH----------HHHHHHHHHHHHhHh----cC
Q 006168 396 EYMANSSLDK-----------F---LFGE----KR-----GSLNWKQRF----------DIILGTARGLAYLHE----DF 438 (658)
Q Consensus 396 E~~~~gsL~~-----------~---l~~~----~~-----~~l~~~~~~----------~i~~~ia~~L~~LH~----~~ 438 (658)
||++|..+.. . +|.. .. ....|.... .....+...+.++.+ ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999876532 0 1110 00 012222211 011123344445443 22
Q ss_pred CCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 439 ~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
..+++|+|+.|.|||++++..+.|.||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 3479999999999999998777899998775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0012 Score=63.05 Aligned_cols=126 Identities=25% Similarity=0.378 Sum_probs=89.6
Q ss_pred cCCCccCcccccCc-eEEEEEEecCCcEEEEEEccc---c--------ccc---------ccHHHHHHHHHHHhccC---
Q 006168 319 RKFSEENKLGEGGF-GDIYKGTLKNGKIVAVKKLAI---G--------ISR---------RTLSDFENEVRLISNVH--- 374 (658)
Q Consensus 319 ~~f~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~--------~~~---------~~~~~~~~E~~~l~~l~--- 374 (658)
.+++..+.||.|.- |.||+++.. |+.+|+|.... . ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 999999995 77999999211 0 000 11235788888888774
Q ss_pred CCcc--ceeeeEeecC------------------CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHh
Q 006168 375 HRNL--IRLLGCCSQG------------------PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYL 434 (658)
Q Consensus 375 h~ni--v~l~~~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~L 434 (658)
+.++ |+.+||..-. ..+.||.||++... .+.. .-+.+|.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHHH
Confidence 4456 8999987321 12467888876533 1222 2345666777889
Q ss_pred HhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCc
Q 006168 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLA 468 (658)
Q Consensus 435 H~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla 468 (658)
|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC---CeeeccCcccccc-----CCEEEecccC
Confidence 988 9999999999975 5689999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0035 Score=65.61 Aligned_cols=156 Identities=17% Similarity=0.205 Sum_probs=84.5
Q ss_pred cchHHHHHHhcCCCc-----cCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCC--cccee
Q 006168 309 YRLKDLVSATRKFSE-----ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHR--NLIRL 381 (658)
Q Consensus 309 ~~~~~l~~a~~~f~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l 381 (658)
.+.+++....+.|.. .+.|+.|....+|+....+| .+++|+.. .. .......|+.++..|... .+.+.
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~---~~~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-RL---TAEDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-cC---ChHHhHHHHHHHHHHHHCCCCCCcc
Confidence 344555544455543 34566777789999887655 68888764 11 223444455666555321 12333
Q ss_pred ee------EeecCCeEEEEEeccCCCCHH-----------HHh---hcCCC---------CCCCH-HHHHH---------
Q 006168 382 LG------CCSQGPELILVYEYMANSSLD-----------KFL---FGEKR---------GSLNW-KQRFD--------- 422 (658)
Q Consensus 382 ~~------~~~~~~~~~lV~E~~~~gsL~-----------~~l---~~~~~---------~~l~~-~~~~~--------- 422 (658)
+. +....+..++++||++|..+. +.| |.... ..+.| .....
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 32 112345678999999987531 111 11100 01112 11111
Q ss_pred ---HH-HHHHHHHHHhHh----cCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 423 ---II-LGTARGLAYLHE----DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 423 ---i~-~~ia~~L~~LH~----~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
.. ..+...+..+.+ ....+++|+|+++.|||++++...-|.||+.+.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 11 111112233321 134589999999999999977556899999775
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0005 Score=69.31 Aligned_cols=146 Identities=20% Similarity=0.211 Sum_probs=97.2
Q ss_pred cchHHHHHHhc---CCCccCcccccCceEEEEEEecCCcEEEEEEccccc-------------------ccccHH--HHH
Q 006168 309 YRLKDLVSATR---KFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGI-------------------SRRTLS--DFE 364 (658)
Q Consensus 309 ~~~~~l~~a~~---~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------------~~~~~~--~~~ 364 (658)
+.+-.|....+ -++++++||-|.-+.||.+-..+|++.++|.-..+. ++..+. ...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 44444444433 357889999999999999999999999998643220 111111 135
Q ss_pred HHHHHHhccCC-C-ccceeeeEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCe
Q 006168 365 NEVRLISNVHH-R-NLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442 (658)
Q Consensus 365 ~E~~~l~~l~h-~-niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 442 (658)
+|...|+.|.. . -+.+.+++ +.-++|||++.+-.|.+.- .-.+..++.. .+..-+.-|..+ |+
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~-----~v~d~~~ly~---~lm~~Iv~la~~---Gl 223 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR-----HVEDPPTLYD---DLMGLIVRLANH---GL 223 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee-----ecCChHHHHH---HHHHHHHHHHHc---Cc
Confidence 68888888742 2 34444544 3558999999887775432 1233333333 333334455566 99
Q ss_pred eecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 443 IHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 443 vH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
||+|..--||+++++..++++||--..
T Consensus 224 IHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 224 IHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred eecccchheeEEecCCCEEEeechHhh
Confidence 999999999999999999999996543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0013 Score=67.15 Aligned_cols=75 Identities=13% Similarity=0.214 Sum_probs=48.6
Q ss_pred CccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccC---CCccceeeeEeecCCeEEEEEecc
Q 006168 322 SEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVH---HRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 322 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
+..+.|+.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. .-.+.+.+++....+..+||+||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 345678889999999988 568889999864 233356888888888883 456778899887777779999999
Q ss_pred CCC
Q 006168 399 ANS 401 (658)
Q Consensus 399 ~~g 401 (658)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0095 Score=61.96 Aligned_cols=155 Identities=17% Similarity=0.192 Sum_probs=87.9
Q ss_pred hHHHHHHhcCCCc-----cCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCc--cceeee
Q 006168 311 LKDLVSATRKFSE-----ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN--LIRLLG 383 (658)
Q Consensus 311 ~~~l~~a~~~f~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~ 383 (658)
.++|...-++|.. .+.++.|....+|+....+| .+++|+.... ....+...|++++..|.... +.+++.
T Consensus 9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~---~~~~~i~~e~~~l~~L~~~g~pvp~~i~ 84 (307)
T TIGR00938 9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKR---VKAEELPFFLALTTHLAARGLPVPKPVK 84 (307)
T ss_pred HHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCC---CCHHHHHHHHHHHHHHHHCCCCCCcccc
Confidence 3455444445533 34566777789999876555 5778876431 12345566777777774222 334433
Q ss_pred Ee------ecCCeEEEEEeccCCCCHH-----------HH---hhcCCCC----------CCCHHHHH------------
Q 006168 384 CC------SQGPELILVYEYMANSSLD-----------KF---LFGEKRG----------SLNWKQRF------------ 421 (658)
Q Consensus 384 ~~------~~~~~~~lV~E~~~~gsL~-----------~~---l~~~~~~----------~l~~~~~~------------ 421 (658)
.. ...+..++++||++|..+. .. +|....+ .-.|....
T Consensus 85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 21 2245678999999886532 11 1110000 01111110
Q ss_pred HHHHHHHHHHHHhHh----cCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 422 DIILGTARGLAYLHE----DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 422 ~i~~~ia~~L~~LH~----~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
.....+...+.++.. ....+++|+|+++.||++++++...|.||+.+.
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 011123334555532 234689999999999999998777899998774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0058 Score=62.97 Aligned_cols=138 Identities=20% Similarity=0.309 Sum_probs=81.1
Q ss_pred eEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCC--CccceeeeEeecCC--eEEEEEeccCCCCHHHHhh
Q 006168 333 GDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHH--RNLIRLLGCCSQGP--ELILVYEYMANSSLDKFLF 408 (658)
Q Consensus 333 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lV~E~~~~gsL~~~l~ 408 (658)
-.+|..... ++++++++-.............+|.++|+.+.- .-+...+++|.++. ..+.||+|+++..+.+.+.
T Consensus 39 n~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 39 NDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred cceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 344444443 778888822223344556677888888888743 34455677776665 6799999998843322110
Q ss_pred cCC-----------------------------------CCC-CCHHHHHHHH--------HHHHHHHHHhHhcC-----C
Q 006168 409 GEK-----------------------------------RGS-LNWKQRFDII--------LGTARGLAYLHEDF-----H 439 (658)
Q Consensus 409 ~~~-----------------------------------~~~-l~~~~~~~i~--------~~ia~~L~~LH~~~-----~ 439 (658)
... ..+ -.|...++.+ -....-..+|+.+. .
T Consensus 118 ~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~ 197 (321)
T COG3173 118 PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGP 197 (321)
T ss_pred cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCC
Confidence 000 000 1111111100 01122233444332 3
Q ss_pred CCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 440 ~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
+.++|+|+++.|++++.+.-+-|.||+++..-
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 57999999999999999888999999998754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.01 Score=60.58 Aligned_cols=31 Identities=26% Similarity=0.654 Sum_probs=25.9
Q ss_pred CCeeecCcCCCcEEEcCCCC-eEEeeccCccc
Q 006168 440 VRIIHRDIKPSNVLLDDDLQ-PKIADFGLARL 470 (658)
Q Consensus 440 ~~ivH~Dik~~NIll~~~~~-~kl~DfGla~~ 470 (658)
+.++|+|+++.|||++++++ .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 46899999999999997555 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.01 Score=61.57 Aligned_cols=139 Identities=24% Similarity=0.301 Sum_probs=83.7
Q ss_pred CcccccCceEEEEEEecC-------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCcc-ceeeeEeecCCeEEEEEe
Q 006168 325 NKLGEGGFGDIYKGTLKN-------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL-IRLLGCCSQGPELILVYE 396 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E 396 (658)
+.|..|-...+|+....+ ++.+++|+.... .....+..+|.+++..+....+ .++++++.. .+|+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~--~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e 77 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQS--VELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEE 77 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCC--CcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhh
Confidence 456667777999988765 578999986542 2333456788888888853333 345555542 35899
Q ss_pred ccCCCCHHHH-----------------hhcCCCC-------CC--CHHHHHH--------------------------HH
Q 006168 397 YMANSSLDKF-----------------LFGEKRG-------SL--NWKQRFD--------------------------II 424 (658)
Q Consensus 397 ~~~~gsL~~~-----------------l~~~~~~-------~l--~~~~~~~--------------------------i~ 424 (658)
|++|..+... +|..... .. -|..+.. +.
T Consensus 78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (302)
T cd05156 78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL 157 (302)
T ss_pred eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence 9988766431 1111111 00 0111111 11
Q ss_pred HHHHHHHHHhHh------cCCCCeeecCcCCCcEEEcCC----CCeEEeeccCcc
Q 006168 425 LGTARGLAYLHE------DFHVRIIHRDIKPSNVLLDDD----LQPKIADFGLAR 469 (658)
Q Consensus 425 ~~ia~~L~~LH~------~~~~~ivH~Dik~~NIll~~~----~~~kl~DfGla~ 469 (658)
..+..-+..|.. .....++|+|+.+.|||++++ +.++|+||..+.
T Consensus 158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 122222334432 245689999999999999985 889999998775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.00019 Score=84.71 Aligned_cols=159 Identities=8% Similarity=-0.060 Sum_probs=117.0
Q ss_pred HHHHHHHHhccCCCccceeeeEee--cCCeEEEEEeccCCCCHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHhHhcC
Q 006168 363 FENEVRLISNVHHRNLIRLLGCCS--QGPELILVYEYMANSSLDKFLFGEKR--GSLNWKQRFDIILGTARGLAYLHEDF 438 (658)
Q Consensus 363 ~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~ 438 (658)
...|...++...|+++.....-.. +..+.+.+++|+..|.+.+.|..... ..++..-+.....+......-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344555666678998887666553 34567899999999999998854332 23555444444444455556655543
Q ss_pred C--CCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHH
Q 006168 439 H--VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEII 516 (658)
Q Consensus 439 ~--~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ell 516 (658)
+ .-.+|+++|+.|.++..+.++|++++|+.+.. .+.........+++.|+.|+...+-.++.++|+|..|+.+|++-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk-np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK-NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCccccccccccccc-CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 2 34789999999999999999999999999833 22333344567888999999999999999999999999999998
Q ss_pred hCCCCC
Q 006168 517 SGTKSS 522 (658)
Q Consensus 517 tG~~p~ 522 (658)
.|..++
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 776554
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.057 Score=57.58 Aligned_cols=74 Identities=11% Similarity=0.082 Sum_probs=50.4
Q ss_pred cCcccccCceEEEEEEecCCcEEEEEEccccc---cc---ccHHHHHHHHHHHhccC---CCccceeeeEeecCCeEEEE
Q 006168 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGI---SR---RTLSDFENEVRLISNVH---HRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV 394 (658)
.+.||.|....||+.... ++.++||+-.... .. .....-..|++.|+.+. ..++.+++.++. +.-+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 567899999999998874 5578899865211 00 12334445566666553 357888888887 446788
Q ss_pred EeccCC
Q 006168 395 YEYMAN 400 (658)
Q Consensus 395 ~E~~~~ 400 (658)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.055 Score=52.40 Aligned_cols=74 Identities=19% Similarity=0.252 Sum_probs=52.0
Q ss_pred cccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhcc---CCCccceeeeEeecCCeEEEEEeccCCCC
Q 006168 326 KLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV---HHRNLIRLLGCCSQGPELILVYEYMANSS 402 (658)
Q Consensus 326 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~E~~~~gs 402 (658)
++--|.--..|.... +..++-||+- ..+....|..|+.-|..| +.-++.+++..-...++.++|+||++-|.
T Consensus 23 ~v~gG~inea~~v~d-g~~~~FvK~n----~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 23 EVSGGDINEAWRLRD-GTDPFFVKCN----QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred ccCCccccceeEeec-CCcceEEEec----chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 344343334444333 4567888863 345567788888877777 44668888888899999999999999877
Q ss_pred HH
Q 006168 403 LD 404 (658)
Q Consensus 403 L~ 404 (658)
++
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 65
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.069 Score=56.41 Aligned_cols=140 Identities=19% Similarity=0.295 Sum_probs=81.5
Q ss_pred CcccccCceEEEEEEecC-----CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccc-eeeeEeecCCeEEEEEecc
Q 006168 325 NKLGEGGFGDIYKGTLKN-----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI-RLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~~ 398 (658)
..|-.|-.-.+|+..+.+ ++.|++|+.... . ...-+-.+|..+++.+..-++- ++++.+..+ .|+||+
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~-t-~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEG-V-ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCC-C-CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 345456677889887543 367888877543 2 2223347788888888644443 456666433 589999
Q ss_pred CCCCHHHH-----------------hhcCCC---C-CCCHHHHHHHHHH-----------------HHHHHHHhH----h
Q 006168 399 ANSSLDKF-----------------LFGEKR---G-SLNWKQRFDIILG-----------------TARGLAYLH----E 436 (658)
Q Consensus 399 ~~gsL~~~-----------------l~~~~~---~-~l~~~~~~~i~~~-----------------ia~~L~~LH----~ 436 (658)
++.+|... +|.... . ...|.++.++..+ +...+..|. .
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87776421 111110 0 1123333233211 111122222 1
Q ss_pred -cCCCCeeecCcCCCcEEEcC-CCCeEEeeccCccc
Q 006168 437 -DFHVRIIHRDIKPSNVLLDD-DLQPKIADFGLARL 470 (658)
Q Consensus 437 -~~~~~ivH~Dik~~NIll~~-~~~~kl~DfGla~~ 470 (658)
.....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22347999999999999986 46899999987753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.085 Score=54.79 Aligned_cols=30 Identities=27% Similarity=0.355 Sum_probs=25.9
Q ss_pred CCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 439 ~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
..+++|+|+++.||+++. +.+.|.||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 358999999999999988 678999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.097 Score=54.87 Aligned_cols=73 Identities=16% Similarity=0.176 Sum_probs=47.2
Q ss_pred cccccCceEEEEEEecCC-cEEEEEEccc-----c-cccccHHHHHHHHHHHhccC--CC-ccceeeeEeecCCeEEEEE
Q 006168 326 KLGEGGFGDIYKGTLKNG-KIVAVKKLAI-----G-ISRRTLSDFENEVRLISNVH--HR-NLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 326 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~-----~-~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lV~ 395 (658)
.||.|...-||++..++| +.|+||.-.. + .-+-...+..-|.+.|+... .| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 589999999999998765 6899997432 1 11233445566777776653 34 34444433 344557999
Q ss_pred eccCC
Q 006168 396 EYMAN 400 (658)
Q Consensus 396 E~~~~ 400 (658)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99865
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.12 Score=62.55 Aligned_cols=142 Identities=17% Similarity=0.217 Sum_probs=79.8
Q ss_pred CcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhcc-------CCCccceee-e----Eeec-CC--
Q 006168 325 NKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-------HHRNLIRLL-G----CCSQ-GP-- 389 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~l~-~----~~~~-~~-- 389 (658)
+.|+ |..-.+|+....+|..+++|+.+.. ........|.+.|..| .-|.+++.. | .... .+
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~---~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~ 106 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPS---EPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEP 106 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCc---cchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCce
Confidence 3454 4567889998888889999998753 2233444455566544 233333322 1 1111 12
Q ss_pred eEEEEEeccCCCCHHHHh-----------------hc--------CCCCCCCHHH-----------------HHHHHHHH
Q 006168 390 ELILVYEYMANSSLDKFL-----------------FG--------EKRGSLNWKQ-----------------RFDIILGT 427 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l-----------------~~--------~~~~~l~~~~-----------------~~~i~~~i 427 (658)
..+-+++|++|..|.+.. +. .....+.|.. ...++.++
T Consensus 107 ~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~ 186 (1013)
T PRK06148 107 RLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERF 186 (1013)
T ss_pred EEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHH
Confidence 467789999997775411 00 0011233321 11222233
Q ss_pred HHHHHH----hHhcCCCCeeecCcCCCcEEEcCCC--CeE-EeeccCccc
Q 006168 428 ARGLAY----LHEDFHVRIIHRDIKPSNVLLDDDL--QPK-IADFGLARL 470 (658)
Q Consensus 428 a~~L~~----LH~~~~~~ivH~Dik~~NIll~~~~--~~k-l~DfGla~~ 470 (658)
.+.+.- ........+||+|+.+.|||++.+. ++. |.|||-+..
T Consensus 187 ~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 187 LARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 332221 1122345799999999999999875 555 999997753
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.085 Score=54.65 Aligned_cols=141 Identities=19% Similarity=0.223 Sum_probs=94.1
Q ss_pred ccCcccccCceEEEEEEecCCcEEEEEEccccc--------------------cccc-----HHHHHHHHHHHhccCCCc
Q 006168 323 EENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGI--------------------SRRT-----LSDFENEVRLISNVHHRN 377 (658)
Q Consensus 323 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------------~~~~-----~~~~~~E~~~l~~l~h~n 377 (658)
+...|..|--+.||.+.-.+|..+|||+.+.+. +... .-....|++-|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345677899999999999999999999874320 0000 112356888888876544
Q ss_pred cceeeeEeecCCeEEEEEeccCCCCH-HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC
Q 006168 378 LIRLLGCCSQGPELILVYEYMANSSL-DKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD 456 (658)
Q Consensus 378 iv~l~~~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~ 456 (658)
|.----... ..-.|||+|+..... .-.| +...++...+..+-.+++.-+.-|-+.| ++||.||.--|+|+-+
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD 300 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC
Confidence 331111111 123789999864221 1111 2344777778888888888888888775 8999999999999865
Q ss_pred CCCeEEeeccCcccc
Q 006168 457 DLQPKIADFGLARLL 471 (658)
Q Consensus 457 ~~~~kl~DfGla~~~ 471 (658)
|.+.|+|-+-+...
T Consensus 301 -G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 -GKLYIIDVSQSVEH 314 (520)
T ss_pred -CEEEEEEccccccC
Confidence 47889998766543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.12 Score=53.81 Aligned_cols=138 Identities=27% Similarity=0.394 Sum_probs=83.0
Q ss_pred ccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCc------cceeeeEe----ecCCeEEEEEe
Q 006168 327 LGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN------LIRLLGCC----SQGPELILVYE 396 (658)
Q Consensus 327 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~----~~~~~~~lV~E 396 (658)
|.+ .-..+|+....+|+. ++|..... ....++..|...+..|.-.. +..+-|-. ......+-+++
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~---~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG---WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC---CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 444 456789998887776 88877642 44566777888888773211 22222221 11237888999
Q ss_pred ccCCCCHHH------------Hh---hc----C---C---CCCCCHHH-------------HHHHHHHHHHHHHHhHhcC
Q 006168 397 YMANSSLDK------------FL---FG----E---K---RGSLNWKQ-------------RFDIILGTARGLAYLHEDF 438 (658)
Q Consensus 397 ~~~~gsL~~------------~l---~~----~---~---~~~l~~~~-------------~~~i~~~ia~~L~~LH~~~ 438 (658)
|++|..+.. ++ |. - + .....|.. -.....++...+..+++..
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988772 11 10 0 0 11234431 0112334444444444322
Q ss_pred ----CCC---eeecCcCCCcEEEcCCCC-eEEeeccCcc
Q 006168 439 ----HVR---IIHRDIKPSNVLLDDDLQ-PKIADFGLAR 469 (658)
Q Consensus 439 ----~~~---ivH~Dik~~NIll~~~~~-~kl~DfGla~ 469 (658)
... +||+|+.|.||+++++.. ..+.||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 223 999999999999999985 8999999765
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.046 Score=53.37 Aligned_cols=122 Identities=19% Similarity=0.246 Sum_probs=61.7
Q ss_pred CcEEEEEEcccccccccHHHHHHHHHHHhccCCCcc-ceeeeEeecCCeEEEEEeccCCCCHHH-------Hh-------
Q 006168 343 GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL-IRLLGCCSQGPELILVYEYMANSSLDK-------FL------- 407 (658)
Q Consensus 343 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~gsL~~-------~l------- 407 (658)
.+.|.||+... .....-.-..|..+++.+..-++ .++++++.. ..|+||+++..|.. .+
T Consensus 2 ~~~~~~Ri~g~--~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l 75 (211)
T PF01633_consen 2 PEKYLVRIPGE--GTENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLL 75 (211)
T ss_dssp TSEEEEEEEES--CGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHH
T ss_pred CCEEEEEeCCC--CcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHH
Confidence 45778887654 34556677889999998865444 456665533 25779987665422 00
Q ss_pred ---hcC-----CCCCCCHHHHHHH----------------------HHHHHHHHHHhHh-----cCCCCeeecCcCCCcE
Q 006168 408 ---FGE-----KRGSLNWKQRFDI----------------------ILGTARGLAYLHE-----DFHVRIIHRDIKPSNV 452 (658)
Q Consensus 408 ---~~~-----~~~~l~~~~~~~i----------------------~~~ia~~L~~LH~-----~~~~~ivH~Dik~~NI 452 (658)
|.. ....--|.....+ ...+..-+..+.+ .....+.|+|+.+.||
T Consensus 76 ~~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Ni 155 (211)
T PF01633_consen 76 AKLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNI 155 (211)
T ss_dssp HHHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGE
T ss_pred HHHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccE
Confidence 100 0011112222222 1112222222221 1124799999999999
Q ss_pred EE-cCCCCeEEeeccCccc
Q 006168 453 LL-DDDLQPKIADFGLARL 470 (658)
Q Consensus 453 ll-~~~~~~kl~DfGla~~ 470 (658)
|+ +.++.++|+||..+..
T Consensus 156 l~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 156 LINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EETSSSSCEEE--GTT-EE
T ss_pred EeccCCCeEEEecHHHHhh
Confidence 99 8889999999987753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.19 Score=52.29 Aligned_cols=32 Identities=19% Similarity=0.307 Sum_probs=28.5
Q ss_pred CCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 439 ~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
..+++|+|+.+.|||+++++.+.+.||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45899999999999999999999999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.63 Score=48.77 Aligned_cols=94 Identities=10% Similarity=0.028 Sum_probs=56.1
Q ss_pred cccchHHHHHHhcCCCcc---C-cccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCC--ccce
Q 006168 307 VNYRLKDLVSATRKFSEE---N-KLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHR--NLIR 380 (658)
Q Consensus 307 ~~~~~~~l~~a~~~f~~~---~-~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~ 380 (658)
..++.+.+..+...+-.. + ..-.+.-..||+...+++..+++|....+ ......+..|++.+..|... .++.
T Consensus 9 ~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~--~~~~~~i~~E~~~l~~L~~~gipv~~ 86 (325)
T PRK11768 9 QTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE--RWSDAQILEEHAFALELAEAEIPVVA 86 (325)
T ss_pred CCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc--cCCHHHHHHHHHHHHHHHHCCCCCCC
Confidence 345666666666655321 1 11234556899999888888999986532 23456677788877777321 1222
Q ss_pred ee---e--EeecCCeEEEEEeccCCCC
Q 006168 381 LL---G--CCSQGPELILVYEYMANSS 402 (658)
Q Consensus 381 l~---~--~~~~~~~~~lV~E~~~~gs 402 (658)
.. | ....++..+.++++++|..
T Consensus 87 p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 87 PLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 11 1 1223456788999998764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.087 Score=50.73 Aligned_cols=154 Identities=16% Similarity=0.166 Sum_probs=93.5
Q ss_pred cCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCCHHHHhhc
Q 006168 330 GGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFG 409 (658)
Q Consensus 330 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 409 (658)
++..+.-++.-+- .+..+|++..-...-....|..+.+++++++ .|+++..- ......++.|+|-....
T Consensus 73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 3444555554333 3455666653222223456788888988875 46666632 44567889998853211
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccccccCCcccc
Q 006168 410 EKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYT 489 (658)
Q Consensus 410 ~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~ 489 (658)
.. ..++.-=+..|.-.|+. +.+.+|+|-.|+|||-|..|.+||.|-+.... .+..|.
T Consensus 142 -----~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~~V~~v 198 (308)
T PF07387_consen 142 -----NF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------NQVNMV 198 (308)
T ss_pred -----ch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh-------------heeeEE
Confidence 00 11222224567778865 45899999999999999999999999764421 011222
Q ss_pred cccccccCCCCCcccchhhhHHHHHHHhCCC
Q 006168 490 APEYAIHGQLSEKVDAYSFGVLVLEIISGTK 520 (658)
Q Consensus 490 APE~~~~~~~s~ksDV~SfGvvl~elltG~~ 520 (658)
--| ....++++.+-+|=.-++++....+
T Consensus 199 N~~---Y~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 199 NIE---YESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred eee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence 211 1345677888888777788776433
|
The function of this family is unknown. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.027 Score=60.47 Aligned_cols=47 Identities=21% Similarity=0.311 Sum_probs=36.7
Q ss_pred HHHHHHHHHHhccCCCccceeeeEeecC-CeEEEEEeccCCCCHHHHhh
Q 006168 361 SDFENEVRLISNVHHRNLIRLLGCCSQG-PELILVYEYMANSSLDKFLF 408 (658)
Q Consensus 361 ~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~ 408 (658)
..+.-...+++.+.|+|+...+++-... ....+|+|++. -||++.+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~ 74 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILK 74 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHH
Confidence 4556667788999999999999887543 45788899985 48888873
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.13 Score=53.95 Aligned_cols=140 Identities=19% Similarity=0.277 Sum_probs=79.4
Q ss_pred CcccccCceEEEEEEecC----CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccc-eeeeEeecCCeEEEEEeccC
Q 006168 325 NKLGEGGFGDIYKGTLKN----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI-RLLGCCSQGPELILVYEYMA 399 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~~~ 399 (658)
+.|..|-...+|+....+ +..|.+|+.... ....-+-.+|..+++.+..-++- ++++++..+ +|.+|++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~--t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~ 93 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPN--TDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFIN 93 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCC--cCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeehhhc
Confidence 345456677888887553 237888876542 22233446788888888655553 566665322 5899997
Q ss_pred CCCHHH-----------------HhhcCCC---C-CCCHHHHHHHHHH----------------------HHHHHHHhHh
Q 006168 400 NSSLDK-----------------FLFGEKR---G-SLNWKQRFDIILG----------------------TARGLAYLHE 436 (658)
Q Consensus 400 ~gsL~~-----------------~l~~~~~---~-~l~~~~~~~i~~~----------------------ia~~L~~LH~ 436 (658)
+..|.. .+|...- . .--|..+.++..+ +.+-+..+..
T Consensus 94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 173 (330)
T PLN02421 94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE 173 (330)
T ss_pred CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence 765521 1111110 0 1123322222211 1111222221
Q ss_pred -----cCCCCeeecCcCCCcEEEcC-CCCeEEeeccCccc
Q 006168 437 -----DFHVRIIHRDIKPSNVLLDD-DLQPKIADFGLARL 470 (658)
Q Consensus 437 -----~~~~~ivH~Dik~~NIll~~-~~~~kl~DfGla~~ 470 (658)
....-++|+|+.+.|||+++ ++.++++||..+..
T Consensus 174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11235899999999999975 57899999987753
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.23 Score=52.85 Aligned_cols=75 Identities=11% Similarity=0.080 Sum_probs=49.5
Q ss_pred cCcccccCceEEEEEEecC-CcEEEEEEccc----ccc-cccHHHHHHHHHHHhccC--CC-ccceeeeEeecCCeEEEE
Q 006168 324 ENKLGEGGFGDIYKGTLKN-GKIVAVKKLAI----GIS-RRTLSDFENEVRLISNVH--HR-NLIRLLGCCSQGPELILV 394 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~----~~~-~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lV 394 (658)
.+.||.|.-.-||++.+.+ ++.|+||.-.. +.+ +-..++..-|.+.|+.+. .| .+++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4578999999999999853 56799997421 111 233556677778877663 34 34445543 34456789
Q ss_pred EeccCC
Q 006168 395 YEYMAN 400 (658)
Q Consensus 395 ~E~~~~ 400 (658)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.60 E-value=0.61 Score=49.88 Aligned_cols=74 Identities=18% Similarity=0.342 Sum_probs=45.7
Q ss_pred CcccccCceEEEEEEecCC--cE-----EEEEEcccccccccHHHHHHHHHHHhccCCCccc-eeeeEeecCCeEEEEEe
Q 006168 325 NKLGEGGFGDIYKGTLKNG--KI-----VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI-RLLGCCSQGPELILVYE 396 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~E 396 (658)
+.|..|-...+|++...++ .. |.++... ......-+-.+|+++++.+...++- ++++.+.. ++|+|
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g--~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS--TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEecc--CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 4555577889999876543 22 3333321 1222223346789999999655554 46666643 69999
Q ss_pred ccCCCCHH
Q 006168 397 YMANSSLD 404 (658)
Q Consensus 397 ~~~~gsL~ 404 (658)
|+++..|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99987764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 658 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-55 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-54 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-44 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-43 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-43 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-42 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-40 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-28 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-28 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-28 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-28 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-28 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-28 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-28 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-28 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-28 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-28 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-28 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-28 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-28 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-28 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-28 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-28 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-28 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-28 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-28 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-28 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-26 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-26 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-26 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-26 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-26 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-26 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-26 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-26 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-26 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-26 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-26 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-26 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-25 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-25 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-25 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-25 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-24 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-24 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-24 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-24 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-24 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-24 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-24 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-24 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-24 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-24 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-24 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-24 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-24 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-23 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-23 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-23 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-23 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-23 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-23 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-23 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-23 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-22 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-22 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-22 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-22 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-22 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-22 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-22 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-22 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-22 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-22 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-22 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-22 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-22 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-22 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-22 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-21 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-21 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-21 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-21 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-21 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-21 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-21 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-21 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-21 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-21 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-21 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-20 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-20 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-20 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-20 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-20 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-20 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-20 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-19 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-19 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-19 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-19 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-19 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-18 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-18 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-18 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-18 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-18 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-18 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-18 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-18 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-18 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-18 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-18 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-18 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-18 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-17 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-17 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-17 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-17 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-17 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 658 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-156 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-134 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-128 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-88 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-73 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 9e-69 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 6e-68 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-65 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-65 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-64 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-63 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-62 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 4e-62 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 6e-58 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 9e-58 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-57 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-57 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-54 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-52 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-51 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-51 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-50 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 6e-50 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 6e-50 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 4e-49 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 6e-49 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-48 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 3e-48 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-48 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-48 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-48 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-48 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 5e-48 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 6e-48 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-47 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-47 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-47 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-47 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-47 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-47 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-47 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-47 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 6e-47 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 7e-47 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 9e-47 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-46 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-46 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 5e-46 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 6e-46 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-45 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-45 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 6e-45 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-44 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 5e-44 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 7e-44 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-43 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-43 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-43 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 4e-43 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-42 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-41 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-41 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 6e-41 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-40 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-40 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 5e-40 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-39 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-39 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-39 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-39 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 5e-39 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 9e-39 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-38 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 8e-38 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 9e-38 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-37 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-37 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-37 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 3e-37 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 5e-37 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 9e-37 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-36 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-36 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-36 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-36 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-36 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 6e-36 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-35 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-35 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 9e-35 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-34 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-34 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-33 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-33 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 3e-33 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-33 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-33 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 5e-33 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 8e-33 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-32 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-32 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-32 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-32 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-32 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-32 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 7e-32 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-31 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-31 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-31 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-31 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-31 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 4e-31 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 7e-31 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 8e-31 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-30 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-30 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-30 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-30 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 6e-30 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 8e-30 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 8e-30 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-30 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-29 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-29 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-29 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-29 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-29 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-29 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-29 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-29 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-29 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 4e-29 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 6e-29 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 7e-29 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-28 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-28 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-28 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-28 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-28 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-28 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-28 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 3e-28 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-28 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 4e-28 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 5e-28 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 5e-28 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-28 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 5e-28 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 9e-28 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 9e-28 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-27 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-27 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-27 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-27 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-27 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-27 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 5e-27 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 7e-27 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 8e-27 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-26 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-26 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-26 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-26 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 6e-26 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-25 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 2e-25 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 1e-14 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-25 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 4e-25 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 9e-25 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-08 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-24 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-24 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-24 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-24 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-24 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-24 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 4e-24 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 7e-24 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 8e-24 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-23 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-23 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-23 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 3e-23 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 5e-23 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-22 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-22 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-22 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-22 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-22 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-22 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-22 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 3e-22 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 6e-22 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-21 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-21 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-21 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-21 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 3e-21 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 4e-21 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 5e-21 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-20 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-20 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-20 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 5e-20 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-19 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-19 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 9e-19 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-18 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-18 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 4e-18 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 5e-18 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 5e-18 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-17 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-17 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 3e-17 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 3e-17 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 3e-17 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-17 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 4e-17 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 6e-17 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 7e-17 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 8e-17 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-16 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-12 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 7e-16 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 6e-15 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-13 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-13 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-04 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 4e-13 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 6e-13 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-12 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 7e-12 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-11 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-11 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 8e-11 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 8e-11 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-10 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-07 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 5e-07 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 5e-06 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 452 bits (1164), Expect = e-156
Identities = 118/290 (40%), Positives = 175/290 (60%), Gaps = 6/290 (2%)
Query: 309 YRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVR 368
+ L++L A+ FS +N LG GGFG +YKG L +G +VAVK+L ++ F+ EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 369 LISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGS--LNWKQRFDIILG 426
+IS HRNL+RL G C E +LVY YMAN S+ L L+W +R I LG
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 427 TARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTL 486
+ARGLAYLH+ +IIHRD+K +N+LLD++ + + DFGLA+L+ +H++T GT+
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199
Query: 487 GYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG---TKSSETKGEEGEYLLKRAWRLYENG 543
G+ APEY G+ SEK D + +GV++LE+I+G + ++ LL L +
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259
Query: 544 THWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
L+D L N +E E+++++AL+CTQS+ RP MSEVV +L+
Sbjct: 260 KLEALVDVDLQGNYKDEE-VEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 394 bits (1015), Expect = e-134
Identities = 108/299 (36%), Positives = 161/299 (53%), Gaps = 20/299 (6%)
Query: 311 LKDLVSATRKFSEE------NKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTL---S 361
+L + T F E NK+GEGGFG +YKG + N VAVKKLA + T
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75
Query: 362 DFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFG-EKRGSLNWKQR 420
F+ E+++++ H NL+ LLG S G +L LVY YM N SL L + L+W R
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 421 FDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ-SHLS 479
I G A G+ +LHE+ IHRDIK +N+LLD+ KI+DFGLAR + + ++
Sbjct: 136 CKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192
Query: 480 TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRL 539
++ GT Y APE + G+++ K D YSFGV++LEII+G + + E + LL +
Sbjct: 193 SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEI 250
Query: 540 Y-ENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSS 597
E T + +D+ + N+ + E + +A C N RP + +V LL+ ++S
Sbjct: 251 EDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 379 bits (975), Expect = e-128
Identities = 113/314 (35%), Positives = 177/314 (56%), Gaps = 12/314 (3%)
Query: 286 SRKSKKIQRGNISEATELQGPVNYR---LKDLVSATRKFSEENKLGEGGFGDIYKGTLKN 342
S+ SK N + ++ P L DL AT F + +G G FG +YKG L++
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 343 GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSS 402
G VA+K+ S + + +FE E+ +S H +L+ L+G C + E+IL+Y+YM N +
Sbjct: 63 GAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 403 LDKFLFGEKR--GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP 460
L + L+G S++W+QR +I +G ARGL YLH IIHRD+K N+LLD++ P
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVP 178
Query: 461 KIADFGLARLLPE-NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGT 519
KI DFG+++ E +Q+HLST GTLGY PEY I G+L+EK D YSFGV++ E++
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 520 KSSETKGEEGE-YLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAA 578
+ L + A + NG +++D +L ++ E+ K + A+ C ++
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSS 297
Query: 579 NSRPTMSEVVALLK 592
RP+M +V+ L+
Sbjct: 298 EDRPSMGDVLWKLE 311
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 3e-88
Identities = 79/313 (25%), Positives = 126/313 (40%), Gaps = 35/313 (11%)
Query: 311 LKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLS-DFENEVRL 369
++L + G FG ++K L + VAVK + S E EV
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFP---IQDKQSWQNEYEVYS 71
Query: 370 ISNVHHRNLIRLLGCCSQGP----ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL 425
+ + H N+++ +G +G +L L+ + SL FL K ++W + I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAE 128
Query: 426 GTARGLAYLHEDFHV-------RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478
ARGLAYLHED I HRDIK NVLL ++L IADFGLA +S
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 479 STKF-AGTLGYTAPEYAIHG-----QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYL 532
T GT Y APE ++D Y+ G+++ E+ S +++ G EY+
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD--GPVDEYM 246
Query: 533 LKRAWRLYENGTHWELMD----ESLDP---NECTK-EAAEKVVEIALMCTQSAANSRPTM 584
L + ++ + ++ + + P + K + E C A +R +
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 585 SEVVALLKSTSSS 597
V +
Sbjct: 307 GCVGERITQMQRL 319
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 3e-73
Identities = 75/325 (23%), Positives = 118/325 (36%), Gaps = 44/325 (13%)
Query: 317 ATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENE--VRLISNVH 374
+G G +G +YKG+L + + VAVK S +F NE + + +
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKNIYRVPLME 65
Query: 375 HRNLIRLLGCCSQGP-----ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTAR 429
H N+ R + + E +LV EY N SL K+L + +W + R
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTR 122
Query: 430 GLAYLHEDFHVR------IIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN-------QS 476
GLAYLH + I HRD+ NVL+ +D I+DFGL+ L N +
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 477 HLSTKFAGTLGYTAPEYA-------IHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEG 529
+ + GT+ Y APE ++VD Y+ G++ EI
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
Query: 530 EYLLKRAWRLYENGTHWELMDESLD-------PNECTK--EAAEKVVEIALMCTQSAANS 580
EY + + + T ++ P + A + E C A +
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302
Query: 581 RPTMSEVVALLKSTSSSLLGNKPLL 605
R T + NK +
Sbjct: 303 RLTAQXAEERMAELMMIWERNKSVS 327
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 9e-69
Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 30/288 (10%)
Query: 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKL-AIGISRRTLSDFENEVRLISNVHHRN 377
+ + K+G G FG +++ G VAVK L +++F EV ++ + H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFG-EKRGSLNWKQRFDIILGTARGLAYLHE 436
++ +G +Q P L +V EY++ SL + L R L+ ++R + A+G+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH 496
+ I+HR++K N+L+D K+ DFGL+RL + S AGT + APE
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 497 GQLSEKVDAYSFGVLVLEIISGTKSSETKGE---EGEYLLKRAWRLYENGTHWELMDESL 553
+EK D YSFGV++ E+ + + + + E+
Sbjct: 214 EPSNEKSDVYSFGVILWELAT--------LQQPWGNLNPAQVVAAVGFKCKRLEI----- 260
Query: 554 DPNECTKEAAEKVVEIALM--CTQSAANSRPTMSEVVALLKSTSSSLL 599
P + A ++ C + RP+ + ++ LL+ S +
Sbjct: 261 -PRNLNPQVAA------IIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 6e-68
Identities = 74/295 (25%), Positives = 119/295 (40%), Gaps = 33/295 (11%)
Query: 324 ENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
LG+G FG K T + G+++ +K+L I T F EV+++ + H N+++ +
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKEL-IRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
G + L + EY+ +L + W QR A G+AYLH + I
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH-------------LSTKFAGTLGYT 489
IHRD+ N L+ ++ +ADFGLARL+ + ++ G +
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 490 APEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549
APE EKVD +SFG+++ EII + L R +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEII-------GRVNADPDYLPR------TMDFGLNV 236
Query: 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNKPL 604
LD C I + C RP+ ++ L++ L G+ PL
Sbjct: 237 RGFLDR-YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 1e-65
Identities = 83/295 (28%), Positives = 122/295 (41%), Gaps = 31/295 (10%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+ E +G G FG + K + K VA+K++ S F E+R +S V+H N++
Sbjct: 9 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQI---ESESERKAFIVELRQLSRVNHPNIV 64
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFG-EKRGSLNWKQRFDIILGTARGLAYLHEDF 438
+L G C + LV EY SL L G E L ++G+AYLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 439 HVRIIHRDIKPSNVLLDDDLQ-PKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG 497
+IHRD+KP N+LL KI DFG A + + T G+ + APE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGS 178
Query: 498 QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557
SEK D +S+G+++ E+I+ +E R NGT L
Sbjct: 179 NYSEKCDVFSWGIILWEVITR----RKPFDEIGGPAFRIMWAVHNGTRPPL------IKN 228
Query: 558 CTKEAAEKVVEIALM--CTQSAANSRPTMSEVVALLKSTSSSLLG-NKPLLKPTF 609
K LM C + RP+M E+V ++ G ++PL P
Sbjct: 229 LPKPIES------LMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQ 277
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 1e-65
Identities = 82/290 (28%), Positives = 132/290 (45%), Gaps = 40/290 (13%)
Query: 320 KFSE---ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISR---RTLSDFENEVRLISNV 373
F+E E +G GGFG +Y+ G VAVK +T+ + E +L + +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 374 HHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAY 433
H N+I L G C + P L LV E+ L++ L G++ + + + ARG+ Y
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNY 120
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQP--------KIADFGLARLLPENQSHLSTKFAGT 485
LH++ V IIHRD+K SN+L+ ++ KI DFGLAR AG
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGA 177
Query: 486 LGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSET--KGEEGEYLLKRAWRLYENG 543
+ APE S+ D +S+GVL+ E+++G E +G +G L A+ + N
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG----EVPFRGIDG---LAVAYGVAMNK 230
Query: 544 THWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
+ P+ C E ++ C +SRP+ + ++ L +
Sbjct: 231 LALPI------PSTCP----EPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 3e-63
Identities = 70/291 (24%), Positives = 128/291 (43%), Gaps = 41/291 (14%)
Query: 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG------ISRRTLSDFENEVRLISN 372
+ E ++G+GGFG ++KG L + +VA+K L +G +F+ EV ++SN
Sbjct: 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 373 VHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLA 432
++H N+++L G P +V E++ L L + + W + ++L A G+
Sbjct: 80 LNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIE 136
Query: 433 YLHEDFHVRIIHRDIKPSNVLLD-----DDLQPKIADFGLARLLPENQSHLSTKFAGTLG 487
Y+ + + I+HRD++ N+ L + K+ADFGL++ H + G
Sbjct: 137 YMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQ 191
Query: 488 YTAPE--YAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG-- 543
+ APE A +EK D YSF +++ I++G + + Y G
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTG---------------EGPFDEYSYGKI 236
Query: 544 -THWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
+ +E L P ++ ++ + +C RP S +V L
Sbjct: 237 KFINMIREEGLRP-TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-62
Identities = 61/286 (21%), Positives = 108/286 (37%), Gaps = 39/286 (13%)
Query: 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRN 377
++ + KL E G+++KG G + VK L + S R DF E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 378 LIRLLGCCSQGPE--LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLH 435
++ +LG C P L+ +M SL L ++ Q L ARG+A+LH
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI 495
I + +V++D+D+ +I+ + S S + APE A+
Sbjct: 129 -TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPE-AL 180
Query: 496 HGQ----LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM-- 549
+ D +SF VL+ E+++ + + ++ E+
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREV------------------PFADLSNMEIGMK 222
Query: 550 --DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
E L P + V ++ +C RP +V +L+
Sbjct: 223 VALEGLRP-TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 4e-62
Identities = 75/286 (26%), Positives = 125/286 (43%), Gaps = 45/286 (15%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLL 382
++G G FG +YKG VAVK L + + + L F+NEV ++ H N++ +
Sbjct: 29 GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
G + P+L +V ++ SSL L K+ DI TARG+ YLH I
Sbjct: 87 GYSTA-PQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPE-NQSHLSTKFAGTLGYTAPE---YAIHGQ 498
IHRD+K +N+ L +D KI DFGLA + SH + +G++ + APE
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 499 LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWE----------L 548
S + D Y+FG+++ E+++G Y N + + L
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ------------------LPYSNINNRDQIIEMVGRGSL 243
Query: 549 MDESLD-PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
+ + C K + + C + + RP+ ++A ++
Sbjct: 244 SPDLSKVRSNCPKR----MKRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 6e-58
Identities = 59/285 (20%), Positives = 104/285 (36%), Gaps = 38/285 (13%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLL 382
+G+G FG +Y G VA++ + I + L F+ EV H N++ +
Sbjct: 38 GELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
G C P L ++ +L + K L+ + I +G+ YLH I
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKI-VLDVNKTRQIAQEIVKGMGYLHA---KGI 151
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARL----LPENQSHLSTKFAGTLGYTAPE------ 492
+H+D+K NV D+ + I DFGL + + G L + APE
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 493 ---YAIHGQLSEKVDAYSFGVLVLEIISGTKS-SETKGEEGEYLLKRAWRLYENGTHWEL 548
S+ D ++ G + E+ + E + + +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP--------- 261
Query: 549 MDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
+L KE + +I L C RPT ++++ +L+
Sbjct: 262 ---NLSQIGMGKE----ISDILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 9e-58
Identities = 70/309 (22%), Positives = 121/309 (39%), Gaps = 41/309 (13%)
Query: 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDF--ENEVRLISNVHHR 376
++ ++G+G +G+++ G + G+ VAVK + + E E+ + H
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVF----FTTEEASWFRETEIYQTVLMRHE 91
Query: 377 NLIRLLGCCSQG----PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLA 432
N++ + +G +L L+ +Y N SL +L K +L+ K + + GL
Sbjct: 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLC 148
Query: 433 YLHEDFHVR-----IIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL---STKFAG 484
+LH + I HRD+K N+L+ + IAD GLA + + + G
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 485 TLGYTAPE------YAIHGQLSEKVDAYSFGVLVL-EIISGTKSSETKGEEGEYLLKRAW 537
T Y PE H Q D YSFG L+L E+ + G EY L
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFG-LILWEVARRC---VSGGIVEEYQLPYHD 264
Query: 538 RLYENGTHWELMDE--------SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589
+ + ++ ++ + S + E ++ ++ C SR T V
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
Query: 590 LLKSTSSSL 598
L S S
Sbjct: 325 TLAKMSESQ 333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 4e-57
Identities = 67/316 (21%), Positives = 118/316 (37%), Gaps = 61/316 (19%)
Query: 319 RKFSEE----NKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDF--ENEVRLISN 372
R + + +G+G +G++++G+ G+ VAVK S R + E E+
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIF----SSRDEKSWFRETELYNTVM 58
Query: 373 VHHRNLIRLLGCCSQG----PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTA 428
+ H N++ + +L L+ Y SL +L + +L+ I+L A
Sbjct: 59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIA 115
Query: 429 RGLAYLHEDFHVR-----IIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL---ST 480
GLA+LH + I HRD+K N+L+ + Q IAD GLA + ++ + L +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 481 KFAGTLGYTAPE------YAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLK 534
GT Y APE ++VD ++FG+++ E+ S+ + K
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED-----YK 230
Query: 535 RAWRLYENGTHWELMD---------------ESLDPNECTKEAAEKVVEIALM--CTQSA 577
+ D + A+ LM C
Sbjct: 231 PPFY-DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK------LMKECWYQN 283
Query: 578 ANSRPTMSEVVALLKS 593
++R T + L
Sbjct: 284 PSARLTALRIKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-54
Identities = 69/302 (22%), Positives = 120/302 (39%), Gaps = 39/302 (12%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDF--ENEVRLISNVHHRNLIRL 381
+ +G+G FG++++G + G+ VAVK S R + E E+ + H N++
Sbjct: 47 QESIGKGRFGEVWRGKWR-GEEVAVKIF----SSREERSWFREAEIYQTVMLRHENILGF 101
Query: 382 LGCCSQ----GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
+ ++ +L LV +Y + SL +L R ++ + + L TA GLA+LH +
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 438 FHVR-----IIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL---STKFAGTLGYT 489
I HRD+K N+L+ + IAD GLA + GT Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 490 APE------YAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG 543
APE H + ++ D Y+ G++ EI G +Y L + +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG---GIHEDYQLPYYDLVPSDP 275
Query: 544 THWELMDE--------SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595
+ E+ ++ + EA + +I C + +R T + L S
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335
Query: 596 SS 597
Sbjct: 336 QQ 337
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-52
Identities = 68/282 (24%), Positives = 115/282 (40%), Gaps = 41/282 (14%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKI-VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
++G G FG+++ G L+ VAVK + + F E R++ H N++RL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
G C+Q + +V E + FL + L K ++ A G+ YL
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLES---KCC 234
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGY--TAPEYAIHGQLS 500
IHRD+ N L+ + KI+DFG++R + + ++ + TAPE +G+ S
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGV-YAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 501 EKVDAYSFGVLVLEIIS-------GTKSSETKG--EEGEYLLKRAWRLYENGTHWELMDE 551
+ D +SFG+L+ E S + +T+ E+G L
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRLPC---------------- 336
Query: 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
P C + V + C RP+ S + L+S
Sbjct: 337 ---PELC----PDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-51
Identities = 64/295 (21%), Positives = 129/295 (43%), Gaps = 36/295 (12%)
Query: 319 RKFSEENKLGEGGFGDIYKGTLK-----NGKIVAVKKLAIGISRRTLSDFENEVRLISNV 373
R LGEG FG + G+ VAVK L ++D + E+ ++ N+
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 374 HHRNLIRLLGCCSQGPE--LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGL 431
+H N+++ G C++ + L+ E++ + SL ++L + + +N KQ+ + +G+
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGM 139
Query: 432 AYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTL--GYT 489
YL + +HRD+ NVL++ + Q KI DFGL + + ++ + + K +
Sbjct: 140 DYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY 196
Query: 490 APEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRL----YENGTH 545
APE + + D +SFGV + E++ T + + ++ + T
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELL-------TYCDSDSSPMALFLKMIGPTHGQMTV 249
Query: 546 WELMDESLD-------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
L+ +L P C E V ++ C + ++R + ++ ++
Sbjct: 250 TRLV-NTLKEGKRLPCPPNCPDE----VYQLMRKCWEFQPSNRTSFQNLIEGFEA 299
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-51
Identities = 83/300 (27%), Positives = 127/300 (42%), Gaps = 38/300 (12%)
Query: 324 ENKLGEGGFGDIYKGTLKN-----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
LGEG FG + G++VAVK L + S ++ E+ ++ ++H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 379 IRLLGCCSQ--GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE 436
I+ GCC L LV EY+ SL +L R S+ Q G+AYLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTL--GYTAPEYA 494
IHRD+ NVLLD+D KI DFGLA+ +PE + + G + APE
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 495 IHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRL----YENGTHWELMD 550
+ D +SFGV + E++ T + + + L T L
Sbjct: 210 KEYKFYYASDVWSFGVTLYELL-------THCDSSQSPPTKFLELIGIAQGQMTVLRLT- 261
Query: 551 ESLD-------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNKP 603
E L+ P++C E V + C ++ A+ RPT ++ +LK+ G P
Sbjct: 262 ELLERGERLPRPDKCPAE----VYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-50
Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 48/285 (16%)
Query: 324 ENKLGEGGFGDIYKGTLK----NGKI-VAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
LG G FG +YKG KI VA+K+L S + + +E ++++V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
RLLG C + L+ + M L ++ E + ++ + + + A+G+ YL +
Sbjct: 80 CRLLGICLTST-VQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLED-- 135
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST---KFAGTLGYTAPEYAI 495
R++HRD+ NVL+ KI DFGLA+LL + K + + A E +
Sbjct: 136 -RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALESIL 192
Query: 496 HGQLSEKVDAYSFGVLVLEIIS-------GTKSSETKG--EEGEYLLKRAWRLYENGTHW 546
H + + D +S+GV V E+++ G +SE E+GE RL +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-------RLPQ----- 240
Query: 547 ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
P CT + V I C A+SRP E++
Sbjct: 241 --------PPICTID----VYMIMRKCWMIDADSRPKFRELIIEF 273
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 6e-50
Identities = 72/293 (24%), Positives = 131/293 (44%), Gaps = 28/293 (9%)
Query: 324 ENKLGEGGFGDIYKGTL-----KNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
+LG+G FG + G++VAVKKL + L DFE E+ ++ ++ H N+
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNI 104
Query: 379 IRLLGCCSQGPE--LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE 436
++ G C L L+ EY+ SL +L + + ++ + +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTL--GYTAPEYA 494
R IHRD+ N+L++++ + KI DFGL ++LP+++ + K G + APE
Sbjct: 164 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 495 IHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554
+ S D +SFGV++ E+ + + S++ E ++ + L+ E L
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN--DKQGQMIVFHLI-ELLK 277
Query: 555 -------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLG 600
P+ C E + I C + N RP+ ++ + + G
Sbjct: 278 NNGRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG 326
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 6e-50
Identities = 72/293 (24%), Positives = 131/293 (44%), Gaps = 28/293 (9%)
Query: 324 ENKLGEGGFGDIYKGTLK-----NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
+LG+G FG + G++VAVKKL + L DFE E+ ++ ++ H N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNI 73
Query: 379 IRLLGCCSQGPE--LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE 436
++ G C L L+ EY+ SL +L + + ++ + +G+ YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTL--GYTAPEYA 494
R IHRD+ N+L++++ + KI DFGL ++LP+++ K G + APE
Sbjct: 133 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 495 IHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554
+ S D +SFGV++ E+ + + S++ E ++ + L+ E L
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN--DKQGQMIVFHLI-ELLK 246
Query: 555 -------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLG 600
P+ C E + I C + N RP+ ++ + ++ G
Sbjct: 247 NNGRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 295
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 4e-49
Identities = 77/277 (27%), Positives = 129/277 (46%), Gaps = 39/277 (14%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
E KLG G FG+++ T VAVK + G F E ++ + H L++L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHA 250
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
++ P I + E+MA SL FL ++ + D A G+A++ + I
Sbjct: 251 VVTKEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYI 306
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHGQLSE 501
HRD++ +N+L+ L KIADFGLAR++ +N+ + KF + +TAPE G +
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP--IKWTAPEAINFGSFTI 364
Query: 502 KVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD------- 554
K D +SFG+L++EI+ T G Y ++ E++ +L+
Sbjct: 365 KSDVWSFGILLMEIV-------TYGRIP----------YPGMSNPEVI-RALERGYRMPR 406
Query: 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
P C +E + I + C ++ RPT + ++L
Sbjct: 407 PENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVL 439
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 6e-49
Identities = 80/343 (23%), Positives = 143/343 (41%), Gaps = 50/343 (14%)
Query: 324 ENKLGEGGFGDIYKGTLK----NGKI-VAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
LG G FG ++KG + KI V +K + R++ + + I ++ H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
+RLLG C L LV +Y+ SL + + RG+L + + + A+G+ YL E
Sbjct: 78 VRLLGLCPGSS-LQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLEE-- 133
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST---KFAGTLGYTAPEYAI 495
++HR++ NVLL Q ++ADFG+A LLP + L K + + A E
Sbjct: 134 -HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP--IKWMALESIH 190
Query: 496 HGQLSEKVDAYSFGVLVLEIIS-------GTKSSETKGEEGEYLLKRAWRLYENGTHWEL 548
G+ + + D +S+GV V E+++ G + +E LL++ RL +
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-----LLEKGERLAQ------- 238
Query: 549 MDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNKPLLKPT 608
P CT + V + + C N RPT E+ + + + P
Sbjct: 239 ------PQICTID----VYMVMVKCWMIDENIRPTFKELANEF----TRMARDPPRYLV- 283
Query: 609 FVETDYRKTPADTSTSTALLLLMLQPPSHKSQVDSPFNFWPSD 651
++ + A L L+ + ++D + +
Sbjct: 284 -IKRESGPGIAPGPEPHGLTNKKLEEVELEPELDLDLDLEAEE 325
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-48
Identities = 83/278 (29%), Positives = 129/278 (46%), Gaps = 37/278 (13%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
+LG G FG+++ G VAVK L G F E L+ + H+ L+RL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYA 75
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
+Q P I + EYM N SL FL L + D+ A G+A++ E I
Sbjct: 76 VVTQEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYI 131
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHGQLSE 501
HRD++ +N+L+ D L KIADFGLARL+ +N+ + KF + +TAPE +G +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTI 189
Query: 502 KVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD------P 555
K D +SFG+L+ EI+ T G Y T+ E++ P
Sbjct: 190 KSDVWSFGILLTEIV-------THGR----------IPYPGMTNPEVIQNLERGYRMVRP 232
Query: 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
+ C +E + ++ +C + RPT + ++L+
Sbjct: 233 DNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-48
Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 29/274 (10%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
++G G FG ++ G N VA+K + G DF E ++ + H L++L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYG 70
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
C + + LV E+M + L +L +RG + + L G+AYL E+ V I
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL-EEACV--I 126
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHGQLSE 501
HRD+ N L+ ++ K++DFG+ R + ++Q S TKF + + +PE + S
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFSRYSS 184
Query: 502 KVDAYSFGVLVLEIISGTKS--SETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECT 559
K D +SFGVL+ E+ S K E + +RLY+ P +
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-------------PRLAS 231
Query: 560 KEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
V +I C + RP S ++ L
Sbjct: 232 TH----VYQIMNHCWRERPEDRPAFSRLLRQLAE 261
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-48
Identities = 69/285 (24%), Positives = 119/285 (41%), Gaps = 43/285 (15%)
Query: 323 EENKLGEGGFGDIYKGTLK--NGKI-VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+ +LG G FG + +G + +I VA+K L G + + E +++ + + ++
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
RL+G C ++ V E L KFL KR + +++ + G+ YL E
Sbjct: 74 RLIGVCQAEALML-VMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEE--- 128
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTL--GYTAPEYAIHG 497
+HRD+ NVLL + KI+DFGL++ L + S+ + + AG + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 498 QLSEKVDAYSFGVLVLEIIS-------GTKSSETKG--EEGEYLLKRAWRLYENGTHWEL 548
+ S + D +S+GV + E +S K E E+G+ R+
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-------RMEC------- 234
Query: 549 MDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
P EC E + + C RP V +++
Sbjct: 235 ------PPECPPE----LYALMSDCWIYKWEDRPDFLTVEQRMRA 269
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 4e-48
Identities = 69/278 (24%), Positives = 116/278 (41%), Gaps = 41/278 (14%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
+G+G FGD+ G + G VAVK + + + F E +++ + H NL++LLG
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLG 253
Query: 384 CCSQ-GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
+ L +V EYMA SL +L R L L + YL
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 310
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEK 502
+HRD+ NVL+ +D K++DFGL + + + + K + +TAPE + S K
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTK 366
Query: 503 VDAYSFGVLVLEIIS-------GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555
D +SFG+L+ EI S + +++ +++ P
Sbjct: 367 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-----RVEKGYKMDA-------------P 408
Query: 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
+ C V ++ C A +RPT ++ L+
Sbjct: 409 DGCPPA----VYDVMKNCWHLDAATRPTFLQLREQLEH 442
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 4e-48
Identities = 86/274 (31%), Positives = 134/274 (48%), Gaps = 29/274 (10%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
E KLG+G FG+++ GT VA+K L G F E +++ + H L++L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA 246
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
S+ P I V EYM+ SL FL GE L Q D+ A G+AY+ + +
Sbjct: 247 VVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 302
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHGQLSE 501
HRD++ +N+L+ ++L K+ADFGLARL+ +N+ + KF + +TAPE A++G+ +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTI 360
Query: 502 KVDAYSFGVLVLEIISGTKSSETKGEE--GEYLLKRAWRLYENGTHWELMDESLDPNECT 559
K D +SFG+L+ E+ TKG + + E G M P EC
Sbjct: 361 KSDVWSFGILLTELT-------TKGRVPYPGMVNREVLDQVERGYR---MPC---PPECP 407
Query: 560 KEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
E + ++ C + RPT + A L+
Sbjct: 408 ----ESLHDLMCQCWRKEPEERPTFEYLQAFLED 437
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-48
Identities = 75/278 (26%), Positives = 130/278 (46%), Gaps = 39/278 (14%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKI-VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
++KLG G +G++Y+G K + VAVK L + +F E ++ + H NL++LL
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
G C++ P ++ E+M +L +L R ++ + + + YL +
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNF 339
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHGQLS 500
IHR++ N L+ ++ K+ADFGL+RL+ + +H KF + +TAPE + + S
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYNKFS 397
Query: 501 EKVDAYSFGVLVLEIIS-------GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553
K D ++FGVL+ EI + G S+ LL++ +R+
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-----LLEKDYRMER------------ 440
Query: 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
P C EKV E+ C Q + RP+ +E+
Sbjct: 441 -PEGCP----EKVYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-48
Identities = 76/315 (24%), Positives = 140/315 (44%), Gaps = 40/315 (12%)
Query: 324 ENKLGEGGFGDIYKGTLK----NGKI-VAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
LG G FG +YKG KI VA+K+L S + + +E ++++V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
RLLG C + L+ + M L ++ E + ++ + + + A+G+ YL +
Sbjct: 80 CRLLGICLTST-VQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLED-- 135
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST---KFAGTLGYTAPEYAI 495
R++HRD+ NVL+ KI DFGLA+LL + K + + A E +
Sbjct: 136 -RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP--IKWMALESIL 192
Query: 496 HGQLSEKVDAYSFGVLVLEIIS-GTKS-SETKGEEGEYLLKRAWRLYENGTHWELMDESL 553
H + + D +S+GV V E+++ G+K E +L++ RL +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ------------ 240
Query: 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSS------LLGNKPLLKP 607
P CT + V I + C A+SRP E++ + + G++ + P
Sbjct: 241 -PPICTID----VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 295
Query: 608 TFVETDYRKTPADTS 622
+ ++++ + D
Sbjct: 296 SPTDSNFYRALMDEE 310
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 6e-48
Identities = 81/283 (28%), Positives = 141/283 (49%), Gaps = 40/283 (14%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKI-----VAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
+ +G G FG++YKG LK VA+K L G + + DF E ++ H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
IRL G S+ ++++ EYM N +LDKFL EK G + Q ++ G A G+ YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYLAN-- 165
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGY--TAPEYAIH 496
+ +HRD+ N+L++ +L K++DFGL+R+L ++ T G + TAPE +
Sbjct: 166 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 497 GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD-- 554
+ + D +SFG+++ E++ T GE R Y ++ E+M ++++
Sbjct: 225 RKFTSASDVWSFGIVMWEVM-------TYGE----------RPYWELSNHEVM-KAINDG 266
Query: 555 -----PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
P +C + ++ + C Q RP +++V++L
Sbjct: 267 FRLPTPMDCPSA----IYQLMMQCWQQERARRPKFADIVSILD 305
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-47
Identities = 73/273 (26%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKI-VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
++KLG G +G++Y+G K + VAVK L +F E ++ + H NL++LL
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLL 75
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
G C++ P ++ E+M +L +L R ++ + + + YL +
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNF 132
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHGQLS 500
IHRD+ N L+ ++ K+ADFGL+RL+ + +H KF + +TAPE + + S
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYNKFS 190
Query: 501 EKVDAYSFGVLVLEIISGTKS--SETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558
K D ++FGVL+ EI + S + LL++ +R+ P C
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------PEGC 237
Query: 559 TKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
++ V E+ C Q + RP+ +E+
Sbjct: 238 PEK----VYELMRACWQWNPSDRPSFAEIHQAF 266
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-47
Identities = 86/274 (31%), Positives = 134/274 (48%), Gaps = 29/274 (10%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
E KLG+G FG+++ GT VA+K L G F E +++ + H L++L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE--AFLQEAQVMKKLRHEKLVQLYA 329
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
S+ P I V EYM+ SL FL GE L Q D+ A G+AY+ + +
Sbjct: 330 VVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 385
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHGQLSE 501
HRD++ +N+L+ ++L K+ADFGLARL+ +N+ + KF + +TAPE A++G+ +
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTI 443
Query: 502 KVDAYSFGVLVLEIISGTKSSETKGEE--GEYLLKRAWRLYENGTHWELMDESLDPNECT 559
K D +SFG+L+ E+ TKG + + E G M P EC
Sbjct: 444 KSDVWSFGILLTELT-------TKGRVPYPGMVNREVLDQVERGYR---MPC---PPECP 490
Query: 560 KEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
E + ++ C + RPT + A L+
Sbjct: 491 ----ESLHDLMCQCWRKEPEERPTFEYLQAFLED 520
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-47
Identities = 64/282 (22%), Positives = 111/282 (39%), Gaps = 40/282 (14%)
Query: 324 ENKLGEGGFGDIYKGTLK---NGKI-VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+GEG FGD+++G N + VA+K S F E + H +++
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
+L+G ++ P I + E L FL ++ SL+ + LAYL
Sbjct: 80 KLIGVITENPVWI-IMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLES--- 134
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHG 497
R +HRDI NVL+ + K+ DFGL+R + ++ K + + APE
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFR 192
Query: 498 QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD-----ES 552
+ + D + FGV + EI+ G + ++ + +++ E
Sbjct: 193 RFTSASDVWMFGVCMWEIL-------MHGV----------KPFQGVKNNDVIGRIENGER 235
Query: 553 LD-PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
L P C + + C + RP +E+ A L +
Sbjct: 236 LPMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLST 273
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-47
Identities = 70/276 (25%), Positives = 127/276 (46%), Gaps = 37/276 (13%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
+LG G FG + G + VA+K + G +F E +++ N+ H L++L G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYG 86
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
C++ + ++ EYMAN L +L E R +Q ++ + YL E +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYL-ESKQF--L 142
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHGQLSE 501
HRD+ N L++D K++DFGL+R + +++ S + +KF + ++ PE ++ + S
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLMYSKFSS 200
Query: 502 KVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD------P 555
K D ++FGVL+ EI + G+ YE T+ E + P
Sbjct: 201 KSDIWAFGVLMWEIY-------SLGK----------MPYERFTNSETAEHIAQGLRLYRP 243
Query: 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
+ +++ V I C A+ RPT +++ +
Sbjct: 244 HLASEK----VYTIMYSCWHEKADERPTFKILLSNI 275
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-47
Identities = 80/283 (28%), Positives = 126/283 (44%), Gaps = 43/283 (15%)
Query: 324 ENKLGEGGFGDIYKGTLK---NGKI-VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
E +G G G++ G L+ + VA+K L G + R DF +E ++ H N+I
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
RL G ++G ++V EYM N SLD FL G Q ++ G G+ YL +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYLSD--- 169
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGY--TAPEYAIHG 497
+ +HRD+ NVL+D +L K++DFGL+R+L ++ T G + TAPE
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 498 QLSEKVDAYSFGVLVLEIIS-------GTKSSETKG--EEGEYLLKRAWRLYENGTHWEL 548
S D +SFGV++ E+++ + + EEG RL
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY-------RLPA------- 275
Query: 549 MDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
P C + ++ L C RP S++V++L
Sbjct: 276 ------PMGCPHA----LHQLMLDCWHKDRAQRPRFSQIVSVL 308
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-47
Identities = 76/306 (24%), Positives = 129/306 (42%), Gaps = 42/306 (13%)
Query: 324 ENKLGEGGFGDIYKGTLKNGK----IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+G G FG +Y GTL + AVK L +S F E ++ + H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 380 RLLGCC--SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
LLG C S+G L+++ YM + L F+ + + K L A+G+ +L
Sbjct: 154 SLLGICLRSEGSPLVVL-PYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLAS- 210
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTL---GYTAPEYA 494
+ +HRD+ N +LD+ K+ADFGLAR + + + G + A E
Sbjct: 211 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 495 IHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554
+ + K D +SFGVL+ E+++ R Y + +++ L
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMT-----------------RGAPPYPDVNTFDITVYLLQ 311
Query: 555 ------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNKPL-LKP 607
P C + E+ L C A RP+ SE+V+ + + S+ +G + +
Sbjct: 312 GRRLLQPEYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNA 367
Query: 608 TFVETD 613
T+V
Sbjct: 368 TYVNVK 373
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 4e-47
Identities = 71/274 (25%), Positives = 122/274 (44%), Gaps = 29/274 (10%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
+LG G FG + G K VAVK + G +F E + + + H L++ G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE--DEFFQEAQTMMKLSHPKLVKFYG 70
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
CS+ + +V EY++N L +L L Q ++ G+A+L + I
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFI 126
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHGQLSE 501
HRD+ N L+D DL K++DFG+ R + ++Q S + TKF + ++APE + + S
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP--VKWSAPEVFHYFKYSS 184
Query: 502 KVDAYSFGVLVLEIISGTKS--SETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECT 559
K D ++FG+L+ E+ S K E + + RLY P+ +
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-------------PHLAS 231
Query: 560 KEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
+ +I C RPT ++++ ++
Sbjct: 232 DT----IYQIMYSCWHELPEKRPTFQQLLSSIEP 261
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 4e-47
Identities = 68/292 (23%), Positives = 122/292 (41%), Gaps = 39/292 (13%)
Query: 323 EENKLGEGGFGDIYKGTLKNGK----IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
+ +G+G FG +Y G + A+K L+ + + F E L+ ++H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 379 IRLLGCCSQG-PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
+ L+G ++ YM + L +F+ + + K L ARG+ YL E
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYLAE- 142
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTL---GYTAPEYA 494
+ +HRD+ N +LD+ K+ADFGLAR + + + + + +TA E
Sbjct: 143 --QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 495 IHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554
+ + K D +SFGVL+ E++ T+G Y + ++L
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELL-------TRGA----------PPYRHIDPFDLTHFLAQ 243
Query: 555 ------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLG 600
P C + ++ C ++ RPT +V ++ S+LLG
Sbjct: 244 GRRLPQPEYCPDS----LYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-47
Identities = 65/285 (22%), Positives = 113/285 (39%), Gaps = 46/285 (16%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKI----VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
LGEG FG++Y+G N K VAVK + F +E ++ N+ H +++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
+L+G + P I + E L +L + SL L + +AYL
Sbjct: 77 KLIGIIEEEPTWI-IMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLES--- 131
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGYTAPEYAIHG 497
+ +HRDI N+L+ K+ DFGL+R + + T+ + + +PE
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMSPESINFR 189
Query: 498 QLSEKVDAYSFGVLVLEIIS-------GTKSSETKG--EEGEYLLKRAWRLYENGTHWEL 548
+ + D + F V + EI+S ++ + G E+G+ RL +
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-------RLPK------- 235
Query: 549 MDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
P+ C + + C + RP +E+V L
Sbjct: 236 ------PDLCPPV----LYTLMTRCWDYDPSDRPRFTELVCSLSD 270
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 7e-47
Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 41/292 (14%)
Query: 324 ENKLGEGGFGDIYKGTLKNGK----IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+G G FG +Y GTL + AVK L +S F E ++ + H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 380 RLLGCC--SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
LLG C S+G L+++ YM + L F+ + + K L A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVL-PYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLAS- 146
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTL---GYTAPEYA 494
+ +HRD+ N +LD+ K+ADFGLAR + + + + G + A E
Sbjct: 147 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 495 IHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554
+ + K D +SFGVL+ E+++ R Y + +++ L
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMT-----------------RGAPPYPDVNTFDITVYLLQ 247
Query: 555 ------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLG 600
P C + E+ L C A RP+ SE+V+ + + S+ +G
Sbjct: 248 GRRLLQPEYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 9e-47
Identities = 75/281 (26%), Positives = 136/281 (48%), Gaps = 39/281 (13%)
Query: 324 ENKLGEGGFGDIYKGTLKNGK----IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+ +G G FG++ G LK VA+K L +G + + DF E ++ H N+I
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
RL G ++ +++V EYM N SLD FL + Q ++ G A G+ YL D
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYL-SDMG 167
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGY--TAPEYAIHG 497
+HRD+ N+L++ +L K++DFGL R+L ++ T G + T+PE +
Sbjct: 168 Y--VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 498 QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD--- 554
+ + D +S+G+++ E++ + GE R Y ++ +++ +++D
Sbjct: 226 KFTSASDVWSYGIVLWEVM-------SYGE----------RPYWEMSNQDVI-KAVDEGY 267
Query: 555 ----PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
P +C + ++ L C Q N+RP ++V++L
Sbjct: 268 RLPPPMDCPAA----LYQLMLDCWQKDRNNRPKFEQIVSIL 304
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-46
Identities = 69/277 (24%), Positives = 115/277 (41%), Gaps = 41/277 (14%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
+G+G FGD+ G + K VAVK + + + F E +++ + H NL++LLG
Sbjct: 26 LQTIGKGEFGDVMLGDYRGNK-VAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLG 81
Query: 384 CCSQG-PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
+ L +V EYMA SL +L R L L + YL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 138
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEK 502
+HRD+ NVL+ +D K++DFGL + + + + K + +TAPE + S K
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTK 194
Query: 503 VDAYSFGVLVLEIIS-------GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555
D +SFG+L+ EI S + +++ +++ P
Sbjct: 195 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-----RVEKGYKMDA-------------P 236
Query: 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
+ C V E+ C A RP+ ++ L+
Sbjct: 237 DGCPPA----VYEVMKNCWHLDAAMRPSFLQLREQLE 269
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-46
Identities = 73/286 (25%), Positives = 119/286 (41%), Gaps = 33/286 (11%)
Query: 324 ENKLGEGGFGDIYKGTLK-----NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
++LG+G FG + G +VAVK+L DF+ E++++ +H +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFI 86
Query: 379 IRLLGCCSQGPE--LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE 436
++ G L LV EY+ + L FL R L+ + +G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTL--GYTAPEYA 494
R +HRD+ N+L++ + KIADFGLA+LLP ++ + + G + APE
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 495 IHGQLSEKVDAYSFGVLVLEIIS---------GTKSSETKGEEGEYLLKRAWRLYENGTH 545
S + D +SFGV++ E+ + E L R L E G
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG-- 260
Query: 546 WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
+ + P C E V E+ +C + RP+ S + L
Sbjct: 261 -QRLPA---PPACPAE----VHELMKLCWAPSPQDRPSFSALGPQL 298
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-46
Identities = 68/284 (23%), Positives = 118/284 (41%), Gaps = 43/284 (15%)
Query: 324 ENKLGEGGFGDIYKGTLK--NGKI-VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIR 380
+ +LG G FG + +G + +I VA+K L G + + E +++ + + ++R
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 381 LLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
L+G C ++ V E L KFL KR + +++ + G+ YL E
Sbjct: 401 LIGVCQAEALML-VMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEE---K 455
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGY--TAPEYAIHGQ 498
+HR++ NVLL + KI+DFGL++ L + S+ + + AG APE +
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 499 LSEKVDAYSFGVLVLEIIS-------GTKSSETKG--EEGEYLLKRAWRLYENGTHWELM 549
S + D +S+GV + E +S K E E+G+ R+
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-------RMEC-------- 560
Query: 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
P EC E + + C RP V +++
Sbjct: 561 -----PPECPPE----LYALMSDCWIYKWEDRPDFLTVEQRMRA 595
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 6e-46
Identities = 72/286 (25%), Positives = 124/286 (43%), Gaps = 45/286 (15%)
Query: 323 EENKLGEGGFGDIYKGTLKNGKI---VAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNL 378
E+ +LG G FG + KG + K+ VAVK L + E ++ + + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
+R++G C ++ V E L+K+L ++ + K +++ + G+ YL E
Sbjct: 81 VRMIGICEAESWML-VMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEE-- 135
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTL--GYTAPEYAIH 496
+HRD+ NVLL KI+DFGL++ L ++++ + G + APE +
Sbjct: 136 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 497 GQLSEKVDAYSFGVLVLEIIS-------GTKSSETKG--EEGEYLLKRAWRLYENGTHWE 547
+ S K D +SFGVL+ E S G K SE E+GE R+
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-------RMGC------ 241
Query: 548 LMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
P C +E + ++ +C +RP + V L++
Sbjct: 242 -------PAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLRN 276
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-45
Identities = 63/301 (20%), Positives = 120/301 (39%), Gaps = 59/301 (19%)
Query: 324 ENKLGEGGFGDIYKGTLKNGK------IVAVKKLAIGISRRTLSDFENEVRLISNVHHRN 377
+LGE FG +YKG L VA+K L +F +E L + + H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFL--------------FGEKRGSLNWKQRFDI 423
++ LLG ++ L +++ Y ++ L +FL + +L +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 424 ILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFA 483
+ A G+ YL ++H+D+ NVL+ D L KI+D GL R +
Sbjct: 134 VAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA----DYYKL 186
Query: 484 GTLG-----YTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWR 538
+ APE ++G+ S D +S+GV++ E+ + G +
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF-------SYGL----------Q 229
Query: 539 LYENGTHWELMDESLD------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
Y ++ ++++ + P++C V + + C + RP ++ + L+
Sbjct: 230 PYCGYSNQDVVEMIRNRQVLPCPDDCPAW----VYALMIECWNEFPSRRPRFKDIHSRLR 285
Query: 593 S 593
+
Sbjct: 286 A 286
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-45
Identities = 75/291 (25%), Positives = 110/291 (37%), Gaps = 41/291 (14%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKI----VAVKKLAIGI--SRRTLSDFENEVRLISNVHHRN 377
KLG+G FG + +G VAVK L + + DF EV + ++ HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
LIRL G P + +V E SL L + +G + A G+ YL
Sbjct: 83 LIRLYGVVLTPP-MKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLES- 139
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGY--TAPEYAI 495
R IHRD+ N+LL KI DFGL R LP+N H + + + APE
Sbjct: 140 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 496 HGQLSEKVDAYSFGVLVLEIIS-------GTKSSETKGEEGEYLLKRAWRLYENGTHWEL 548
S D + FGV + E+ + G S+ + K RL
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----HKIDKEGERLPR------- 246
Query: 549 MDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLL 599
P +C ++ + + + C RPT + L + +
Sbjct: 247 ------PEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 6e-45
Identities = 63/280 (22%), Positives = 114/280 (40%), Gaps = 36/280 (12%)
Query: 324 ENKLGEGGFGDIYKGTLKNGK----IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+GEG FGD+++G + + VA+K S F E + H +++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
+L+G ++ P I + E L FL ++ SL+ + LAYL
Sbjct: 455 KLIGVITENPVWI-IMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLES--- 509
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL 499
R +HRDI NVL+ + K+ DFGL+R + ++ + ++K + + APE +
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 500 SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD-----ESLD 554
+ D + FGV + EI+ G + ++ + +++ E L
Sbjct: 570 TSASDVWMFGVCMWEIL-------MHGV----------KPFQGVKNNDVIGRIENGERLP 612
Query: 555 -PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
P C + + C + RP +E+ A L +
Sbjct: 613 MPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLST 648
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 66/316 (20%), Positives = 119/316 (37%), Gaps = 54/316 (17%)
Query: 324 ENKLGEGGFGDIYKGTLKNGK----IVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNL 378
LG+G FG + + LK VAVK L I + + +F E + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 379 IRLLGCCSQG------PELILVYEYMANSSLDKFL----FGEKRGSLNWKQRFDIILGTA 428
+L+G + P +++ +M + L FL GE +L + ++ A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 429 RGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG- 487
G+ YL IHRD+ N +L +D+ +ADFGL+R + + G
Sbjct: 148 CGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----QGCASK 200
Query: 488 ----YTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG 543
+ A E + D ++FGV + EI++ R Y
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT-----------------RGQTPYAGI 243
Query: 544 THWELMDESLD------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSS 597
+ E+ + + P EC +E V ++ C + RP+ + + L++
Sbjct: 244 ENAEIYNYLIGGNRLKQPPECMEE----VYDLMYQCWSADPKQRPSFTCLRMELENILGH 299
Query: 598 LLGNKPLLKPTFVETD 613
L P ++ +
Sbjct: 300 LSVLSTSQDPLYINIE 315
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-44
Identities = 75/297 (25%), Positives = 112/297 (37%), Gaps = 49/297 (16%)
Query: 324 ENKLGEGGFGDIYKGTLKNGK------IVAVKKLAIGISRRTLSDFENEVRLISNVHHRN 377
LG G FG++Y+G + VAVK L S + DF E +IS +H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFL-----FGEKRGSLNWKQRFDIILGTARGLA 432
++R +G Q ++ E MA L FL + SL + A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 433 YLHEDFHVRIIHRDIKPSNVLLD---DDLQPKIADFGLARLLPENQ---SHLSTKFAGTL 486
YL E+ H IHRDI N LL KI DFG+AR + +
Sbjct: 155 YL-EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP--V 209
Query: 487 GYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHW 546
+ PE + G + K D +SFGVL+ EI + G Y + ++
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIF-------SLGY----------MPYPSKSNQ 252
Query: 547 ELMDESLD------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSS 597
E+++ P C V I C Q RP + ++ ++ +
Sbjct: 253 EVLEFVTSGGRMDPPKNCPGP----VYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 7e-44
Identities = 71/326 (21%), Positives = 130/326 (39%), Gaps = 63/326 (19%)
Query: 325 NKLGEGGFGDIYKGTLKNGK------IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
+LG+G FG +Y+G K VA+K + S R +F NE ++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFL--------FGEKRGSLNWKQRFDIILGTARG 430
+RLLG SQG +++ E M L +L + + + A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGY-- 488
+AYL+ + +HRD+ N ++ +D KI DFG+ R + E + G G
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGKGLLP 203
Query: 489 ---TAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTH 545
+PE G + D +SFGV++ EI + A + Y+ ++
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------------LAEQPYQGLSN 246
Query: 546 WELMDESLD------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLL 599
+++ ++ P+ C + E+ MC Q RP+ E+++ +
Sbjct: 247 EQVLRFVMEGGLLDKPDNCPDM----LFELMRMCWQYNPKMRPSFLEIISSI-------- 294
Query: 600 GNKPLLKPTFVETDYRKTPADTSTST 625
K ++P F E + + +
Sbjct: 295 --KEEMEPGFREVSFYYSEENKLPEP 318
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 74/300 (24%), Positives = 125/300 (41%), Gaps = 59/300 (19%)
Query: 324 ENKLGEGGFGDIYKGTLKNGK------IVAVKKLAIGISRRTLSDFENEVRLISNVHHRN 377
+ +LGEG FG ++ N +VAVK L S DF+ E L++ + H++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQH 104
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFL-------------FGEKRGSLNWKQRFDII 424
++R G C++G L++V+EYM + L++FL G L Q +
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 425 LGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAG 484
A G+ YL + +HRD+ N L+ L KI DFG++R + + G
Sbjct: 165 SQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR----VG 217
Query: 485 TLG-----YTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRL 539
+ PE ++ + + + D +SFGV++ EI T G+ +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF-------TYGK----------QP 260
Query: 540 YENGTHWELMDESLD------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
+ ++ E +D P C E V I C Q R ++ +V A L++
Sbjct: 261 WYQLSNTEAIDCITQGRELERPRACPPE----VYAIMRGCWQREPQQRHSIKDVHARLQA 316
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-43
Identities = 75/301 (24%), Positives = 127/301 (42%), Gaps = 60/301 (19%)
Query: 324 ENKLGEGGFGDIYKGTLKNGK------IVAVKKLAIGISRRTLSDFENEVRLISNVHHRN 377
+ +LGEG FG ++ N +VAVK L + DF+ E L++N+ H +
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEH 78
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFL--------------FGEKRGSLNWKQRFDI 423
+++ G C G LI+V+EYM + L+KFL + +G L Q I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 424 ILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFA 483
A G+ YL +HRD+ N L+ +L KI DFG++R + +
Sbjct: 139 ASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR----V 191
Query: 484 GTLG-----YTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWR 538
G + PE ++ + + + D +SFGV++ EI T G+ +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF-------TYGK----------Q 234
Query: 539 LYENGTHWELMDESLD------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
+ ++ E+++ P C KE V ++ L C Q R + E+ +L
Sbjct: 235 PWFQLSNTEVIECITQGRVLERPRVCPKE----VYDVMLGCWQREPQQRLNIKEIYKILH 290
Query: 593 S 593
+
Sbjct: 291 A 291
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 76/299 (25%), Positives = 112/299 (37%), Gaps = 53/299 (17%)
Query: 324 ENKLGEGGFGDIYKGTLKNGK------IVAVKKLAIGISRRTLSDFENEVRLISNVHHRN 377
LG G FG++Y+G + VAVK L S + DF E +IS +H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFL-----FGEKRGSLNWKQRFDIILGTARGLA 432
++R +G Q ++ E MA L FL + SL + A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 433 YLHEDFHVRIIHRDIKPSNVLLD---DDLQPKIADFGLARLLPENQSHLSTKFAGTLGY- 488
YL E+ H IHRDI N LL KI DFG+AR + + G
Sbjct: 196 YL-EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK----GGCAML 248
Query: 489 ----TAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGT 544
PE + G + K D +SFGVL+ EI S + Y + +
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS-----------------LGYMPYPSKS 291
Query: 545 HWELMDESLD------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSS 597
+ E+++ P C V I C Q RP + ++ ++ +
Sbjct: 292 NQEVLEFVTSGGRMDPPKNCPGP----VYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-43
Identities = 76/323 (23%), Positives = 127/323 (39%), Gaps = 53/323 (16%)
Query: 301 TELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGK----IVAVKKLAIGI- 355
+ +L+D+V LGEG FG + +G LK VAVK + +
Sbjct: 16 PRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS 75
Query: 356 SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG-----PELILVYEYMANSSLDKFL--- 407
S+R + +F +E + + H N+IRLLG C + P+ +++ +M L +L
Sbjct: 76 SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135
Query: 408 -FGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFG 466
+ + ++ A G+ YL +HRD+ N +L DD+ +ADFG
Sbjct: 136 RLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFG 192
Query: 467 LARLLPENQSHLSTKFAGTLG-----YTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKS 521
L++ + + G + + A E + K D ++FGV + EI +
Sbjct: 193 LSKKIYSGDYYR----QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT---- 244
Query: 522 SETKGEEGEYLLKRAWRLYENGTHWELMDESLD------PNECTKEAAEKVVEIALMCTQ 575
R Y + E+ D L P +C E + EI C +
Sbjct: 245 -------------RGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDE----LYEIMYSCWR 287
Query: 576 SAANSRPTMSEVVALLKSTSSSL 598
+ RPT S + L+ SL
Sbjct: 288 TDPLDRPTFSVLRLQLEKLLESL 310
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 78/328 (23%), Positives = 128/328 (39%), Gaps = 56/328 (17%)
Query: 324 ENKLGEGGFGDIYKGTLKNGK---IVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLI 379
++ +GEG FG + K +K A+K++ S+ DF E+ ++ + HH N+I
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFL--------------FGEKRGSLNWKQRFDIIL 425
LLG C L L EY + +L FL +L+ +Q
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT 485
ARG+ YL + + IHRD+ N+L+ ++ KIADFGL+R +
Sbjct: 150 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP-- 204
Query: 486 LGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTH 545
+ + A E + + D +S+GVL+ EI+ + G Y T
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIV-------SLGG----------TPYCGMTC 247
Query: 546 WELMDESLD-------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSL 598
EL E L P C E V ++ C + RP+ ++++ L +
Sbjct: 248 AELY-EKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQILVSLN----RM 298
Query: 599 LGNKPLLKPTFVETDYRKTPADTSTSTA 626
L + T + + D S A
Sbjct: 299 LEERKTYVNTTLYEKFTYAGIDCSAEEA 326
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 70/321 (21%), Positives = 117/321 (36%), Gaps = 69/321 (21%)
Query: 324 ENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHR 376
LG G FG + + T VAVK L +E++++S++ H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSLDKFL------------FGEKRGSLNWKQRFDII 424
N++ LLG C+ G ++++ EY L FL F + + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 425 LGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAG 484
A+G+A+L IHRD+ NVLL + KI DFGLAR + + +++
Sbjct: 171 SQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI----VK 223
Query: 485 TLG-----YTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-------GTKSSETKGEEGEYL 532
+ APE + + D +S+G+L+ EI S G + L
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV----NSKFYKL 279
Query: 533 LKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
+K ++ M + P K + I C RPT ++ + L
Sbjct: 280 VKDGYQ----------MAQ---PAFAPKN----IYSIMQACWALEPTHRPTFQQICSFL- 321
Query: 593 STSSSLLGNKPLLKPTFVETD 613
+ + E D
Sbjct: 322 ---------QEQAQEDRRERD 333
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-41
Identities = 57/289 (19%), Positives = 110/289 (38%), Gaps = 48/289 (16%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKI--------VAVKKLAIGISRRTLSDFENEVRLISNVHH 375
LG+G F I+KG + V +K L R F ++S + H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSH 71
Query: 376 RNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLH 435
++L+ G C G E ILV E++ SLD +L + + +N + ++ A + +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFL- 129
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQP--------KIADFGLARLLPENQSHLSTKFAGTLG 487
E+ + IH ++ N+LL + K++D G++ + + +
Sbjct: 130 EENTL--IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---ILQER--IP 182
Query: 488 YTAPEYAIHGQL-SEKVDAYSFGVLVLEIISGTKSSETKGEE--GEYLLKRAWRLYENGT 544
+ PE + + + D +SFG + EI + G++ +R + YE+
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEIC-------SGGDKPLSALDSQRKLQFYEDR- 234
Query: 545 HWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
+ P + + C + RP+ ++ L S
Sbjct: 235 --HQLPA---PKAAE------LANLINNCMDYEPDHRPSFRAIIRDLNS 272
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-41
Identities = 66/300 (22%), Positives = 115/300 (38%), Gaps = 55/300 (18%)
Query: 324 ENKLGEGGFGDIYKGTLKNGK------IVAVKKLAIGISRRTLSDFENEVRLISNV-HHR 376
LG G FG + + T VAVK L +E++++S + +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSLDKFL----------------FGEKRGSLNWKQR 420
N++ LLG C+ G +++ EY L FL + +L+ +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 421 FDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480
A+G+A+L IHRD+ N+LL KI DFGLAR + + +++
Sbjct: 148 LSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV-- 202
Query: 481 KFAGTLG-----YTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKS---SETKGEEGEYL 532
+ APE + + + D +S+G+ + E+ S S + +
Sbjct: 203 --VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 533 LKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
+K +R M P E + +I C + RPT ++V L++
Sbjct: 261 IKEGFR----------MLS---PEHAPAE----MYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 82/298 (27%), Positives = 123/298 (41%), Gaps = 54/298 (18%)
Query: 324 ENKLGEGGFGDIYKGTLKNGK--------IVAVKKLAIGISRRTLSDFENEVRLISNV-H 374
LGEG FG + VAVK L + + LSD +E+ ++ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFL--------------FGEKRGSLNWKQR 420
H+N+I LLG C+Q L ++ EY + +L ++L + +K
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 421 FDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480
ARG+ YL + IHRD+ NVL+ ++ KIADFGLAR + +
Sbjct: 206 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK-- 260
Query: 481 KFAGTLG-----YTAPEYAIHGQLSEKVDAYSFGVLVLEIIS--GTKSSETKGEEGEYLL 533
T G + APE + + D +SFGVL+ EI + G+ EE LL
Sbjct: 261 --KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318
Query: 534 KRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
K R MD+ P CT E + + C + + RPT ++V L
Sbjct: 319 KEGHR----------MDK---PANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 359
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 4e-40
Identities = 83/298 (27%), Positives = 124/298 (41%), Gaps = 54/298 (18%)
Query: 324 ENKLGEGGFGDIYKGTL--------KNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-H 374
LGEG FG + K VAVK L + + LSD +E+ ++ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFL--------------FGEKRGSLNWKQR 420
H+N+I LLG C+Q L ++ EY + +L ++L + +K
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 421 FDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480
ARG+ YL + IHRD+ NVL+ ++ KIADFGLAR + +
Sbjct: 160 VSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK-- 214
Query: 481 KFAGTLG-----YTAPEYAIHGQLSEKVDAYSFGVLVLEIIS--GTKSSETKGEEGEYLL 533
T G + APE + + D +SFGVL+ EI + G+ EE LL
Sbjct: 215 --KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272
Query: 534 KRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
K R MD+ P CT E + + C + + RPT ++V L
Sbjct: 273 KEGHR----------MDK---PANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 313
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-40
Identities = 70/309 (22%), Positives = 122/309 (39%), Gaps = 67/309 (21%)
Query: 324 ENKLGEGGFGDIYKGTLKNGK------IVAVKKLAIGISRRTLSDFENEVRLISNVHHRN 377
+GEG FG +++ +VAVK L S +DF+ E L++ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFL----------------------FGEKRGSL 415
+++LLG C+ G + L++EYMA L++FL L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 416 NWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475
+ ++ I A G+AYL E + +HRD+ N L+ +++ KIADFGL+R +
Sbjct: 172 SCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 476 SHLSTKFAGTLGY-----TAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE 530
+ A PE + + + + D +++GV++ EI S
Sbjct: 229 YYK----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS------------- 271
Query: 531 YLLKRAWRLYENGTHWELMDESLD------PNECTKEAAEKVVEIALMCTQSAANSRPTM 584
+ Y H E++ D P C E + + +C RP+
Sbjct: 272 ----YGLQPYYGMAHEEVIYYVRDGNILACPENCPLE----LYNLMRLCWSKLPADRPSF 323
Query: 585 SEVVALLKS 593
+ +L+
Sbjct: 324 CSIHRILQR 332
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-39
Identities = 86/321 (26%), Positives = 128/321 (39%), Gaps = 63/321 (19%)
Query: 324 ENKLGEGGFGDIYKGTLKNGK--------IVAVKKLAIGISRRTLSDFENEVRLISNV-H 374
LGEG FG + VAVK L + + LSD +E+ ++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFL--------------FGEKRGSLNWKQR 420
H+N+I LLG C+Q L ++ EY + +L ++L L+ K
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 421 FDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480
ARG+ YL + IHRD+ NVL+ +D KIADFGLAR + +
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK-- 248
Query: 481 KFAGTLG-----YTAPEYAIHGQLSEKVDAYSFGVLVLEIIS--GTKSSETKGEEGEYLL 533
T G + APE + + D +SFGVL+ EI + G+ EE LL
Sbjct: 249 --KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306
Query: 534 KRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
K R MD+ P+ CT E + + C + + RPT ++V L
Sbjct: 307 KEGHR----------MDK---PSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 349
Query: 594 TSSSLLGNKPLLKPTFVETDY 614
+ + E Y
Sbjct: 350 I---------VALTSNQEMGY 361
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 79/305 (25%), Positives = 128/305 (41%), Gaps = 59/305 (19%)
Query: 324 ENKLGEGGFGDIYKGTLKNGK------IVAVKKLAIGISRRTLSDFENEVRLISNVHHRN 377
LGEG FG + K T + K VAVK L S L D +E ++ V+H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFL----------------------FGEKRGSL 415
+I+L G CSQ L+L+ EY SL FL +L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 416 NWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475
++G+ YL E ++++HRD+ N+L+ + + KI+DFGL+R + E
Sbjct: 148 TMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 476 SHLSTKFAGTLG-----YTAPEYAIHGQLSEKVDAYSFGVLVLEIIS--GTKSSETKGEE 528
S++ + G + A E + + D +SFGVL+ EI++ G E
Sbjct: 205 SYV----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 529 GEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVV 588
LLK R M+ P+ C++E + + L C + + RP +++
Sbjct: 261 LFNLLKTGHR----------MER---PDNCSEE----MYRLMLQCWKQEPDKRPVFADIS 303
Query: 589 ALLKS 593
L+
Sbjct: 304 KDLEK 308
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 65/275 (23%), Positives = 111/275 (40%), Gaps = 33/275 (12%)
Query: 326 KLGEGGFGDIYKGT-LKNGKIVAVKKLAI-GISRRTLSDFENEVRLISNVHHRNLIRLLG 383
++G G F +YKG + VA +L +++ F+ E ++ + H N++R
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 384 C----CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
++LV E M + +L +L ++ + K +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTR-T 149
Query: 440 VRIIHRDIKPSNVLLDDDL-QPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ 498
IIHRD+K N+ + KI D GLA L + + GT + APE +
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEM-YEEK 205
Query: 499 LSEKVDAYSFGVLVLEIISGTK-SSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557
E VD Y+FG+ +LE+ + SE + + +R +G D+ P
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKPASFDKVAIPE- 258
Query: 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
V EI C + + R ++ + LL
Sbjct: 259 --------VKEIIEGCIRQNKDERYSIKD---LLN 282
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 74/297 (24%), Positives = 119/297 (40%), Gaps = 54/297 (18%)
Query: 325 NKLGEGGFGDIYKGTLKN------GKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRN 377
LG G FG + + + VAVK L G + +E++++ ++ HH N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 378 LIRLLGCCSQ-GPELILVYEYMANSSLDKFL--------------FGEKRGSLNWKQRFD 422
++ LLG C++ G L+++ E+ +L +L + L +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 423 IILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKF 482
A+G+ +L + IHRD+ N+LL + KI DFGLAR + ++ ++
Sbjct: 153 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV---- 205
Query: 483 AGTLG-----YTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKS---SETKGEEGEYLLK 534
+ APE + + D +SFGVL+ EI S S EE LK
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 265
Query: 535 RAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591
R M P+ T E + + L C + RPT SE+V L
Sbjct: 266 EGTR----------MRA---PDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 305
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-39
Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 6/201 (2%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAI-GISRRTLSDFENEVRLISNVHHRN 377
K+ K+GEG FG ++G+ +K++ I +S + + EV +++N+ H N
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
+++ + L +V +Y L K + +K Q D + L ++H+
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG 497
+I+HRDIK N+ L D ++ DFG+AR+L GT Y +PE +
Sbjct: 145 ---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICENK 200
Query: 498 QLSEKVDAYSFGVLVLEIISG 518
+ K D ++ G ++ E+ +
Sbjct: 201 PYNNKSDIWALGCVLYELCTL 221
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-39
Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 319 RKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN 377
F E +G GGFG ++K +GK +K+ + + E EV+ ++ + H N
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR--VKYNNEKA---EREVKALAKLDHVN 65
Query: 378 LIRLLGC----------------CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRF 421
++ GC S+ L + E+ +L++++ + L+
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 422 DIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK 481
++ +G+ Y+H ++I+RD+KPSN+ L D Q KI DFGL L + T+
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TR 180
Query: 482 FAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTK 520
GTL Y +PE ++VD Y+ G+++ E++
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 65/306 (21%), Positives = 111/306 (36%), Gaps = 60/306 (19%)
Query: 324 ENKLGEGGFGDIYKGTLKNGK------IVAVKKLAIGISRRTLSDFENEVRLISNV-HHR 376
LG G FG + T VAVK L +E+++++ + H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSLDKFL---------------------FGEKRGSL 415
N++ LLG C+ + L++EY L +L E L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 416 NWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475
++ A+G+ +L +HRD+ NVL+ KI DFGLAR + +
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 476 SHLSTKFAGTLG-----YTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKS---SETKGE 527
+++ + APE G + K D +S+G+L+ EI S +
Sbjct: 227 NYV----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282
Query: 528 EGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
L++ ++ MD+ P T+E + I C + RP+ +
Sbjct: 283 NFYKLIQNGFK----------MDQ---PFYATEE----IYIIMQSCWAFDSRKRPSFPNL 325
Query: 588 VALLKS 593
+ L
Sbjct: 326 TSFLGC 331
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-38
Identities = 50/216 (23%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAI-GISRRTLSDFENEVRLISNV--HH 375
R +S ++G GG +++ + +I A+K + + +TL + NE+ ++ + H
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 376 RNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLH 435
+IRL + +V E N L+ +L +K+ S++ +R + +H
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ-SHLSTKFAGTLGYTAPE-- 492
+ I+H D+KP+N L+ D K+ DFG+A + + S + GT+ Y PE
Sbjct: 126 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 493 ---------YAIHGQLSEKVDAYSFGVLVLEIISGT 519
++S K D +S G ++ + G
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-38
Identities = 56/235 (23%), Positives = 100/235 (42%), Gaps = 24/235 (10%)
Query: 319 RKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN 377
+ + KLGEGGF + L +G A+K++ ++ + + E + +H N
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPN 87
Query: 378 LIRLLGCCSQ----GPELILVYEYMANSSLDKFL--FGEKRGSLNWKQRFDIILGTARGL 431
++RL+ C + E L+ + +L + +K L Q ++LG RGL
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 432 AYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL---PENQSHLST-----KFA 483
+H HRD+KP+N+LL D+ QP + D G E T
Sbjct: 148 EAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 484 GTLGYTAPE----YAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLK 534
T+ Y APE + H + E+ D +S G ++ ++ G + ++G+ +
Sbjct: 205 CTISYRAPELFSVQS-HCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 51/230 (22%), Positives = 99/230 (43%), Gaps = 22/230 (9%)
Query: 305 GPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAI-GISRRTLSDF 363
G N + + R +S ++G GG +++ + +I A+K + + +TL +
Sbjct: 14 GTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSY 73
Query: 364 ENEVRLISNVHHRNL--IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRF 421
NE+ ++ + + IRL + +V E N L+ +L +K+ S++ +R
Sbjct: 74 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERK 130
Query: 422 DIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ-SHLST 480
+ +H+ I+H D+KP+N L+ D K+ DFG+A + + S +
Sbjct: 131 SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 186
Query: 481 KFAGTLGYTAPE-----------YAIHGQLSEKVDAYSFGVLVLEIISGT 519
GT+ Y PE ++S K D +S G ++ + G
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 11/205 (5%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHR 376
F E K+G G F ++Y+ L +G VA+KK+ I + + +D E+ L+ ++H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSLDKFL--FGEKRGSLNWKQRFDIILGTARGLAYL 434
N+I+ + EL +V E L + + F +++ + + + + L ++
Sbjct: 93 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYA 494
H R++HRDIKP+NV + K+ D GL R + + GT Y +PE
Sbjct: 153 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPE-R 207
Query: 495 IHGQL-SEKVDAYSFGVLVLEIISG 518
IH + K D +S G L+ E+ +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAAL 232
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-37
Identities = 60/244 (24%), Positives = 100/244 (40%), Gaps = 32/244 (13%)
Query: 286 SRKSKKIQRGNISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKI 345
S S + G+ + + G +++ KD LG G G I + + +
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKISFCPKD------------VLGHGAEGTIVYRGMFDNRD 50
Query: 346 VAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVYEYMANSSLD 404
VAVK+ I S + EV+L+ H N+IR + E A + +
Sbjct: 51 VAVKR----ILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQE 106
Query: 405 KFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL-----DDDLQ 459
+K + + ++ T GLA+LH + I+HRD+KP N+L+ ++
Sbjct: 107 YVE--QKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIK 161
Query: 460 PKIADFGLARLLPENQSHLS--TKFAGTLGYTAPEY---AIHGQLSEKVDAYSFGVLVLE 514
I+DFGL + L + S + GT G+ APE + VD +S G +
Sbjct: 162 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYY 221
Query: 515 IISG 518
+IS
Sbjct: 222 VISE 225
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 53/223 (23%), Positives = 87/223 (39%), Gaps = 30/223 (13%)
Query: 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
F LG GGFG +++ K + A+K++ + EV+ ++ + H +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 379 IRLLGCC------------SQGPELILVYEYMANSSLDKFLFGEKRGS-LNWKQRFDIIL 425
+R S L + + +L ++ G I L
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL-----------PEN 474
A + +LH ++HRD+KPSN+ D K+ DFGL + P
Sbjct: 126 QIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 475 QSHLSTKFAGTLGYTAPEYAIHGQL-SEKVDAYSFGVLVLEII 516
T GT Y +PE IHG S KVD +S G+++ E++
Sbjct: 183 AYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELL 224
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-37
Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 310 RLKDLVSA---TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFEN 365
+L+ +VS +K++ K+G+G G +Y + G+ VA++++ + + N
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIIN 66
Query: 366 EVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL 425
E+ ++ + N++ L G EL +V EY+A SL + ++ Q +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCR 123
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT 485
+ L +LH + ++IHRDIK N+LL D K+ DFG + QS ST GT
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGT 179
Query: 486 LGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
+ APE KVD +S G++ +E+I G
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 9e-37
Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 46/235 (19%)
Query: 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHR 376
F E LG+G FG + K + + A+KK I + LS +EV L+++++H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK--IRHTEEKLSTILSEVMLLASLNHQ 62
Query: 377 NLIRLLGC-------------CSQGPELILVYEYMANSSL-----DKFLFGEKRGSLNW- 417
++R + L + EY N +L + L ++
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 418 KQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477
+Q I+ L+Y+H IIHRD+KP N+ +D+ KI DFGLA+ + +
Sbjct: 123 RQ---ILEA----LSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 478 LS-------------TKFAGTLGYTAPE-YAIHGQLSEKVDAYSFGVLVLEIISG 518
L T GT Y A E G +EK+D YS G++ E+I
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 9/211 (4%)
Query: 316 SATRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAI-GISRRTLSDFENEVRLISNV 373
S + +G G +G K +GKI+ K+L ++ +EV L+ +
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 374 HHRNLIRLLGC--CSQGPELILVYEYMANSSLDKFL--FGEKRGSLNWKQRFDIILGTAR 429
H N++R L +V EY L + ++R L+ + ++
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 430 GLAYLHE--DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG 487
L H D ++HRD+KP+NV LD K+ DFGLAR+L + S T F GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPY 181
Query: 488 YTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
Y +PE +EK D +S G L+ E+ +
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 212
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 73/307 (23%), Positives = 119/307 (38%), Gaps = 33/307 (10%)
Query: 287 RKSKKIQRGNISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKI 345
+ + RG SE LQ P + + F ++LG G +G+++K K +G++
Sbjct: 27 QPRRVSFRGEASET--LQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRL 84
Query: 346 VAVKKLAI-GISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVYEYMANSSL 403
AVK+ + + EV V H +RL +G L L E SL
Sbjct: 85 YAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSL 143
Query: 404 DKFLFGEKRG-SLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKI 462
+ E G SL Q + + T LA+LH ++H D+KP+N+ L + K+
Sbjct: 144 QQHC--EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKL 198
Query: 463 ADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSS 522
DFGL L + G Y APE + G D +S G+ +LE+
Sbjct: 199 GDFGLLVELGTAGAGEV--QEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACN---- 251
Query: 523 ETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRP 582
L G W+ + + P E T + ++ + +M + R
Sbjct: 252 --------------MELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRA 297
Query: 583 TMSEVVA 589
T ++A
Sbjct: 298 TAEALLA 304
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 12/218 (5%)
Query: 306 PVNYRLKDLVSATR----KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTL 360
PV L + + F++ K+G+G FG+++KG + K+VA+K + + + +
Sbjct: 5 PVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI 64
Query: 361 SDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQR 420
D + E+ ++S + + G + +L ++ EY+ S L + G L+ Q
Sbjct: 65 EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQI 121
Query: 421 FDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480
I+ +GL YLH + + IHRDIK +NVLL + + K+ADFG+A L + Q +T
Sbjct: 122 ATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178
Query: 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
F GT + APE K D +S G+ +E+ G
Sbjct: 179 -FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 50/248 (20%), Positives = 104/248 (41%), Gaps = 23/248 (9%)
Query: 288 KSKKIQRGNISEATELQGPVNYRLKDLVSAT-RKFSEENKLGEGGFGDIYKGTLKNGKIV 346
K ++ + T+ + + +S R +S ++G GG +++ + +I
Sbjct: 24 KFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIY 83
Query: 347 AVKKLAI-GISRRTLSDFENEVRLISNVHHRNL--IRLLGCCSQGPELILVYEYMANSSL 403
A+K + + +TL + NE+ ++ + + IRL + +V E N L
Sbjct: 84 AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDL 142
Query: 404 DKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIA 463
+ +L +K+ S++ +R + +H+ I+H D+KP+N L+ D K+
Sbjct: 143 NSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLI 196
Query: 464 DFGLARLLPENQSHLSTK-FAGTLGYTAPE-----------YAIHGQLSEKVDAYSFGVL 511
DFG+A + + + + G + Y PE ++S K D +S G +
Sbjct: 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 256
Query: 512 VLEIISGT 519
+ + G
Sbjct: 257 LYYMTYGK 264
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 58/238 (24%), Positives = 107/238 (44%), Gaps = 17/238 (7%)
Query: 285 ISRKSKKIQRGNISEATELQGPVNYRLKDLVSA---TRKFSEENKLGEGGFGDIYKGT-L 340
+ ++ Q G ++ L+ +V K+GEG G +
Sbjct: 13 LGTENLYFQSGVVTHEQFKA-----ALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK 67
Query: 341 KNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMAN 400
+G+ VAVK + + +R NEV ++ + H N++ + G EL ++ E++
Sbjct: 68 HSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126
Query: 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP 460
+L + + LN +Q + + LAYLH +IHRDIK ++LL D +
Sbjct: 127 GALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRV 180
Query: 461 KIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
K++DFG + ++ + GT + APE + +VD +S G++V+E++ G
Sbjct: 181 KLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 59/241 (24%), Positives = 106/241 (43%), Gaps = 22/241 (9%)
Query: 285 ISRKSKKIQRGNISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGT-LKNG 343
+ R + + TE PV+Y ++ + + ++G G FG++++ + G
Sbjct: 27 LQRLGPETEDNEGVLLTEKLKPVDYEYRE---EVHWMTHQPRVGRGSFGEVHRMKDKQTG 83
Query: 344 KIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSL 403
AVKK+ + + R E+ + + ++ L G +GP + + E + SL
Sbjct: 84 FQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137
Query: 404 DKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD-LQPKI 462
+ + ++ G L + + GL YLH RI+H D+K NVLL D + +
Sbjct: 138 GQLI--KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAAL 192
Query: 463 ADFGLARLLPENQSHLSTK----FAGTLGYTAPEYAIHGQ-LSEKVDAYSFGVLVLEIIS 517
DFG A L + S GT + APE + G+ KVD +S ++L +++
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKVDIWSSCCMMLHMLN 251
Query: 518 G 518
G
Sbjct: 252 G 252
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 12/213 (5%)
Query: 310 RLKDLVSA---TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFEN 365
+L + F KLGEG +G +YK + G+IVA+K++ + L +
Sbjct: 17 KLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV---ESDLQEIIK 73
Query: 366 EVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL 425
E+ ++ ++++ G + +L +V EY S+ + + +L + I+
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQ 132
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT 485
T +GL YLH R IHRDIK N+LL+ + K+ADFG+A L + + +T GT
Sbjct: 133 STLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGT 188
Query: 486 LGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
+ APE + D +S G+ +E+ G
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 19/218 (8%)
Query: 310 RLKDLVSA---TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGI--SRRTLSDF 363
+ +L + FS+ ++G G FG +Y ++N ++VA+KK++ S D
Sbjct: 42 DVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI 101
Query: 364 ENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDI 423
EVR + + H N I+ GC + LV EY S+ D L + L + +
Sbjct: 102 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAV 159
Query: 424 ILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFA 483
G +GLAYLH +IHRD+K N+LL + K+ DFG A ++ S F
Sbjct: 160 THGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FV 211
Query: 484 GTLGYTAPEYAIHGQLSE---KVDAYSFGVLVLEIISG 518
GT + APE + + KVD +S G+ +E+
Sbjct: 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-35
Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 39/241 (16%)
Query: 310 RLKDLVSATRKFSE----ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFEN 365
R+ ++ + + E LG G G + G+ VAVK+ +
Sbjct: 2 RIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR----MLIDFCDIALM 57
Query: 366 EVR-LISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLD----KFLFGEKRGSLNWKQR 420
E++ L + H N+IR + L + E + D K + E
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 421 FDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD-------------DDLQPKIADFGL 467
++ A G+A+LH ++IIHRD+KP N+L+ ++L+ I+DFGL
Sbjct: 118 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 468 ARLLPENQSHLSTK---FAGTLGYTAPE-------YAIHGQLSEKVDAYSFGVLVLEIIS 517
+ L QS T +GT G+ APE +L+ +D +S G + I+S
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 518 G 518
Sbjct: 235 K 235
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 47/283 (16%), Positives = 91/283 (32%), Gaps = 41/283 (14%)
Query: 312 KDLVSATRKFSEENKLGEGGFGDIYKGT------LKNGKIVAVKKLAIGISRRTLSDFEN 365
+ ++ + LGEG F +Y+ T KN + +K +F
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKV----QKPANPWEFYI 113
Query: 366 EVRLIS---NVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWK---- 418
+L+ ++ +LV E + +L + + K
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI--NLYKNTPEKVMPQ 171
Query: 419 -QRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP-----------KIADFG 466
+ + +H+ IIH DIKP N +L + + D G
Sbjct: 172 GLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228
Query: 467 LA---RLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSE 523
+ +L P+ + T T G+ E + + ++D + V ++ G +
Sbjct: 229 QSIDMKLFPKGT--IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG-TYMK 285
Query: 524 TKGEEGEYLLKRAWRLYENGTHW-ELMDESLDPNECTKEAAEK 565
K E GE + +R + W E L+ +C +
Sbjct: 286 VKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLD 328
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 12/207 (5%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHR 376
+ +LG+G FG +YK + G + A K + S L D+ E+ +++ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIET-KSEEELEDYIVEIEILATCDHP 76
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE 436
+++LLG +L ++ E+ ++D + E L Q + L +LH
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH 496
RIIHRD+K NVL+ + ++ADFG++ + + F GT + APE +
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMC 191
Query: 497 GQLSE-----KVDAYSFGVLVLEIISG 518
+ + K D +S G+ ++E+
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 15/228 (6%)
Query: 293 QRGNISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKL 351
Q+ EA Q LKD F + ++LG G G ++K + K +G ++A K +
Sbjct: 12 QQRKRLEAFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI 66
Query: 352 AIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEK 411
+ I + E++++ + ++ G E+ + E+M SLD+ L +K
Sbjct: 67 HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KK 124
Query: 412 RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471
G + + + + +GL YL E I+HRD+KPSN+L++ + K+ DFG++ L
Sbjct: 125 AGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182
Query: 472 PENQSHLSTKFAGTLGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISG 518
++ ++ F GT Y +PE + G S + D +S G+ ++E+ G
Sbjct: 183 IDSMAN---SFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVG 226
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 28/206 (13%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCC 385
LG+G +G +Y G L N +A+K++ R E+ L ++ H+N+++ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 386 SQGPELILVYEYMANSSLDKFLFGEKRGSLNW---------KQRFDIILGTARGLAYLHE 436
S+ + + E + SL L K G L KQ IL GL YLH+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQ----IL---EGLKYLHD 140
Query: 437 DFHVRIIHRDIKPSNVLLDDDL-QPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI 495
+ +I+HRDIK NVL++ KI+DFG ++ L T F GTL Y APE I
Sbjct: 141 N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPE-II 195
Query: 496 HGQL---SEKVDAYSFGVLVLEIISG 518
+ D +S G ++E+ +G
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATG 221
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 32/218 (14%)
Query: 326 KLGEGGFGDIYKGTLKNGKIVAVKKL----------------AIGISRRTLSDFENEVRL 369
L +G F I K+ K A+KK + DF+NE+++
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 370 ISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFD------I 423
I+++ + + G + E+ ++YEYM N S+ KF N+ I
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 424 ILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFA 483
I +Y+H + + I HRD+KPSN+L+D + + K++DFG + + + +
Sbjct: 157 IKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKG-SR 211
Query: 484 GTLGYTAPEYAIHGQLS---EKVDAYSFGVLVLEIISG 518
GT + PE + S KVD +S G+ + +
Sbjct: 212 GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 3e-33
Identities = 28/257 (10%), Positives = 61/257 (23%), Gaps = 42/257 (16%)
Query: 297 ISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIG- 354
++ Q L RK L G ++ ++ + A+K +G
Sbjct: 40 VTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGA 99
Query: 355 -ISRRTLSDFENEVRLISNVHHRNLIRLLGCC--------------------------SQ 387
SR L + + +
Sbjct: 100 ENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYA 159
Query: 388 GPELILVYEYMANSSLDKF----LFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
+L+ + F RG + R A L ++
Sbjct: 160 VANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV 216
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG--QLSE 501
H P N+ + D + + D + + + Y E+ +
Sbjct: 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTH 272
Query: 502 KVDAYSFGVLVLEIISG 518
++A+ G+ + +
Sbjct: 273 ALNAWQLGLSIYRVWCL 289
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 8/197 (4%)
Query: 326 KLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISR--RTLSDFENEVRLISNVHHRNLIRLL 382
KLG GG +Y VA+K + I TL FE EV S + H+N++ ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
+ LV EY+ +L +++ E G L+ + G+ + H+ +RI
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHD---MRI 132
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEK 502
+HRDIKP N+L+D + KI DFG+A+ L E + GT+ Y +PE A E
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 503 VDAYSFGVLVLEIISGT 519
D YS G+++ E++ G
Sbjct: 193 TDIYSIGIVLYEMLVGE 209
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HH 375
F +G G +G +YKG +K G++ A+K + ++ + + E+ ++ HH
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV--MDVTGDEEEEIKQEINMLKKYSHH 80
Query: 376 RNLIRLLGC------CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTAR 429
RN+ G +L LV E+ S+ + K +L + I R
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYT 489
GL++LH+ ++IHRDIK NVLL ++ + K+ DFG++ L +T F GT +
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWM 196
Query: 490 APEYAIHGQLSE-----KVDAYSFGVLVLEIISG 518
APE + + K D +S G+ +E+ G
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 8e-33
Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVR-LISNVHHRNL 378
+LG G +G + K +G+I+AVK++ ++ + ++ + V
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFL--FGEKRGSLNWKQRFDIILGTARGLAYLHE 436
+ G + ++ + E M ++SLDKF +K ++ I + + L +LH
Sbjct: 69 VTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH 496
+IHRD+KPSNVL++ Q K+ DFG++ L AG Y APE I+
Sbjct: 128 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMAPE-RIN 182
Query: 497 GQLSE-----KVDAYSFGVLVLEIISG 518
+L++ K D +S G+ ++E+
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAIL 209
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 47/212 (22%), Positives = 88/212 (41%), Gaps = 25/212 (11%)
Query: 326 KLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGC 384
LG+G ++++G K G + A+K R + E ++ ++H+N+++L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 385 --CSQGPELILVYEYMANSSLDKFLFGEKRGSLNW---KQRFDIILGTARGLAYLHEDFH 439
+ +L+ E+ SL L E+ + + ++ G+ +L E+
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 440 VRIIHRDIKPSNVLL----DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPE--- 492
I+HR+IKP N++ D K+ DFG AR L +++ GT Y P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYE 188
Query: 493 -----YAIHGQLSEKVDAYSFGVLVLEIISGT 519
+ VD +S GV +G+
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 40/231 (17%), Positives = 82/231 (35%), Gaps = 20/231 (8%)
Query: 304 QGPVNYRLKDLVSA---TRKFSEENKLGEG--GFGDIYKGT-LKNGKIVAVKKLAI-GIS 356
N + + S + +G+G + G+ V V+++ + S
Sbjct: 7 HHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS 66
Query: 357 RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLN 416
++ + E+ + +H N++ EL +V +MA S + +N
Sbjct: 67 NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN 126
Query: 417 WKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476
I+ G + L Y+H +HR +K S++L+ D + ++ + +
Sbjct: 127 ELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183
Query: 477 HLST------KFAGTLGYTAPEYAIHGQLS---EKVDAYSFGVLVLEIISG 518
L + +PE + L K D YS G+ E+ +G
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPE-VLQQNLQGYDAKSDIYSVGITACELANG 233
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVR-LISNVHHRNL 378
+ ++G G +G + K K +G+I+AVK++ + + ++ ++ + +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFD------IILGTARGLA 432
++ G + + + E M+ +S DKF K I L T + L
Sbjct: 84 VQFYGALFREGDCWICMELMS-TSFDKFY---KYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPE 492
+L E+ IIHRDIKPSN+LLD K+ DFG++ L S T+ AG Y APE
Sbjct: 140 HLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPE 195
Query: 493 YAIHGQLSE-----KVDAYSFGVLVLEIISG 518
I S + D +S G+ + E+ +G
Sbjct: 196 -RIDPSASRQGYDVRSDVWSLGITLYELATG 225
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVK---KLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
LG+GGF ++ + ++ A K K + + E+ + ++ H++++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLN-WKQRFDIILGTARGLAYLHEDFHVR 441
G + +V E SL + ++R +L + R+ + G YLH + R
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARY-YLRQIVLGCQYLHRN---R 161
Query: 442 IIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL-S 500
+IHRD+K N+ L++DL+ KI DFGLA + + GT Y APE + + S
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE-VLSKKGHS 219
Query: 501 EKVDAYSFGVLVLEIISGT 519
+VD +S G ++ ++ G
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVK---KLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
LG+GGF ++ + ++ A K K + + E+ + ++ H++++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
G + +V E SL + ++R +L + + G YLH + R+
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVLGCQYLHRN---RV 136
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL-SE 501
IHRD+K N+ L++DL+ KI DFGLA + + GT Y APE + + S
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE-VLSKKGHSF 194
Query: 502 KVDAYSFGVLVLEIISGT 519
+VD +S G ++ ++ G
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 54/208 (25%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 326 KLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSD-------FENEVRLISNVHHRN 377
LG GG +++ L++ + VAVK L R L+ F E + + ++H
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVL-----RADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 378 LIRLL--GCCSQGPELILVY---EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLA 432
++ + G ++ P L Y EY+ +L + G + K+ ++I + L
Sbjct: 74 IVAVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALN 130
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFA--GTLGYTA 490
+ H+ IIHRD+KP+N+++ K+ DFG+AR + ++ + ++ A GT Y +
Sbjct: 131 FSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 491 PEYAIHGQLSEKVDAYSFGVLVLEIISG 518
PE A + + D YS G ++ E+++G
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTG 215
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 52/216 (24%), Positives = 91/216 (42%), Gaps = 27/216 (12%)
Query: 321 FSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+ + +G G + + VA+K++ + + ++ + E++ +S HH N++
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFD------IILGTARGLAY 433
EL LV + ++ S+ + + D I+ GL Y
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK----FAGTLGYT 489
LH++ IHRD+K N+LL +D +IADFG++ L K F GT +
Sbjct: 137 LHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 490 APE-------YAIHGQLSEKVDAYSFGVLVLEIISG 518
APE Y K D +SFG+ +E+ +G
Sbjct: 194 APEVMEQVRGY------DFKADIWSFGITAIELATG 223
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVK---KLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
LG+G F +Y+ + G VA+K K A+ + +NEV++ + H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAM-YKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLN-WKQRFDIILGTARGLAYLHEDFHVR 441
+ LV E N ++++L + + + R + G+ YLH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEARH-FMHQIITGMLYLHSH---G 132
Query: 442 IIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSE 501
I+HRD+ SN+LL ++ KIADFGLA L T GT Y +PE A
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGL 191
Query: 502 KVDAYSFGVLVLEIISG 518
+ D +S G + ++ G
Sbjct: 192 ESDVWSLGCMFYTLLIG 208
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (324), Expect = 2e-31
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 326 KLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLL-- 382
+LG GGFG + + G+ VA+K+ +S + + E++++ ++H N++
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 383 ----GCCSQGPELILVYEYMANSSLDKFLFG-EKRGSLNWKQRFDIILGTARGLAYLHED 437
+ +L EY L K+L E L ++ + L YLHE+
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 438 FHVRIIHRDIKPSNVLLDDDLQP---KIADFGLARLLPENQSHLSTKFAGTLGYTAPEYA 494
RIIHRD+KP N++L Q KI D G A+ L + + L T+F GTL Y APE
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPE-L 194
Query: 495 IHGQL-SEKVDAYSFGVLVLEIISGT 519
+ + + VD +SFG L E I+G
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 47/212 (22%), Positives = 88/212 (41%), Gaps = 25/212 (11%)
Query: 326 KLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGC 384
LG+G ++++G K G + A+K R + E ++ ++H+N+++L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 385 --CSQGPELILVYEYMANSSLDKFLFGEKRGSLNW---KQRFDIILGTARGLAYLHEDFH 439
+ +L+ E+ SL L E+ + + ++ G+ +L E+
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 440 VRIIHRDIKPSNVLL----DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPE--- 492
I+HR+IKP N++ D K+ DFG AR L +++ GT Y P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYE 188
Query: 493 -----YAIHGQLSEKVDAYSFGVLVLEIISGT 519
+ VD +S GV +G+
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 62/198 (31%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 325 NKLGEGGFGDIYKGT-LKNGKIVAVK---KLAIGISRRTLSDFENEVRLISNVHHRNLIR 380
LG+G FG++Y ++ I+A+K K + EV + S++ H N++R
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-EKAGVEHQLRREVEIQSHLRHPNILR 73
Query: 381 LLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
L G + L+ EY ++ + L +K + ++ I A L+Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHSK--- 128
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLS 500
R+IHRDIKP N+LL + KIADFG + P ++ + GTL Y PE
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RTD-LCGTLDYLPPEMIEGRMHD 185
Query: 501 EKVDAYSFGVLVLEIISG 518
EKVD +S GVL E + G
Sbjct: 186 EKVDLWSLGVLCYEFLVG 203
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 49/225 (21%), Positives = 84/225 (37%), Gaps = 26/225 (11%)
Query: 319 RKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHR 376
+ L EGGF +Y+ + +G+ A+K+L EV + + H
Sbjct: 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHP 86
Query: 377 NLIRLLGCCSQGP--------ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTA 428
N+++ S G E +L+ E ++ E RG L+ I T
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 429 RGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFA----- 483
R + ++H IIHRD+K N+LL + K+ DFG A + + +
Sbjct: 147 RAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 484 ------GTLGYTAPE---YAIHGQLSEKVDAYSFGVLVLEIISGT 519
T Y PE + + EK D ++ G ++ +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 47/227 (20%), Positives = 83/227 (36%), Gaps = 35/227 (15%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGI-SRRTLSDFENEVRLISNV-H 374
T +F E K+G G FG ++K +G I A+K+ + + EV + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFL--FGEKRGSLNWKQRFDIILGTARGLA 432
H +++R ++ +++ EY SL + + D++L RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQP-------------------KIADFGLARLLPE 473
Y+H ++H DIKPSN+ + P KI D G +
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 474 NQSHLSTKFAGTLGYTAPEYAIHGQLS--EKVDAYSFGVLVLEIISG 518
Q G + A E + + K D ++ + V+
Sbjct: 187 PQV-----EEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGA 227
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 8e-31
Identities = 50/219 (22%), Positives = 85/219 (38%), Gaps = 30/219 (13%)
Query: 309 YRLKDLVSATRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSD----- 362
YRL+ L +G GG GD+Y+ +IVA+K + TLS
Sbjct: 36 YRLRRL------------VGRGGMGDVYEAEDTVRERIVALKLM-----SETLSSDPVFR 78
Query: 363 --FENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQR 420
+ E R + +++ + +L + + L L ++G L +
Sbjct: 79 TRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRA 136
Query: 421 FDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480
I+ L H HRD+KP N+L+ D + DFG+A + +
Sbjct: 137 VAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG 193
Query: 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGT 519
GTL Y APE + + D Y+ ++ E ++G+
Sbjct: 194 NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 45/205 (21%), Positives = 89/205 (43%), Gaps = 13/205 (6%)
Query: 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVR-LISNVHHRNL 378
++G G G ++K + G ++AVK++ ++ ++ ++ + +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
++ G ++ + E M + L +G + + + + + L YL E
Sbjct: 87 VQCFGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPE-----Y 493
+IHRD+KPSN+LLD+ Q K+ DFG++ L + AG Y APE
Sbjct: 145 G--VIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 494 AIHGQLSEKVDAYSFGVLVLEIISG 518
+ D +S G+ ++E+ +G
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATG 225
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 2e-30
Identities = 35/246 (14%), Positives = 69/246 (28%), Gaps = 53/246 (21%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIG--ISRRTLSDFENEVR------ 368
R LG+ + T + G+ V + + EV
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 369 -------------------LISNVHHRNLIRLLGCCSQG--PELILVYEYMANSSLDK-- 405
L+ + + +IR+ +Y M ++
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191
Query: 406 --FLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIA 463
SL R + L R LA LH H ++H ++P +++LD +
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLT 248
Query: 464 DFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH-----------GQLSEKVDAYSFGVLV 512
F + + + G+ PE ++ DA++ G+++
Sbjct: 249 GFEHLV-----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303
Query: 513 LEIISG 518
I
Sbjct: 304 YWIWCA 309
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-30
Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 324 ENKLGEGGFGDIYKGTLK-NGKIVAVKKLAI-GISRRTLSDFENEVRLISNVHHRNLIRL 381
KLG G +G++ K A+K + +S + S EV ++ + H N+++L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 382 LGCCSQGPELILVYEYMANSSL-DKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
LV E L D+ + R N II G+ YLH+
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKH--- 155
Query: 441 RIIHRDIKPSNVLL---DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG 497
I+HRD+KP N+LL + D KI DFGL+ + + + GT Y APE +
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPE-VLRK 212
Query: 498 QLSEKVDAYSFGVLVLEIISG 518
+ EK D +S GV++ +++G
Sbjct: 213 KYDEKCDVWSIGVILFILLAG 233
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-30
Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 324 ENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLS------DFENEVRLISNVHHR 376
+ LG+G FG++ K G+ AVK IS+R + EV+L+ + H
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKV----ISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSL-DKFLFGEKRGSLNWKQRFDIILGTARGLAYLH 435
N+++L LV E L D+ + R + II G+ Y+H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMH 143
Query: 436 EDFHVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPE 492
++ +I+HRD+KP N+LL D +I DFGL+ ++ GT Y APE
Sbjct: 144 KN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPE 198
Query: 493 YAIHGQLSEKVDAYSFGVLVLEIISG 518
+HG EK D +S GV++ ++SG
Sbjct: 199 -VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 57/195 (29%), Positives = 85/195 (43%), Gaps = 23/195 (11%)
Query: 326 KLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLS-----DFENEVRLISNVHHRNLI 379
LG+G FG++ K + + AVK I++ + EV L+ + H N++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKV----INKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 380 RLLGCCSQGPELILVYEYMANSSL-DKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
+L +V E L D+ + KR + II G+ Y+H+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKH- 140
Query: 439 HVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI 495
I+HRD+KP N+LL + D KI DFGL+ +N GT Y APE +
Sbjct: 141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VL 195
Query: 496 HGQLSEKVDAYSFGV 510
G EK D +S GV
Sbjct: 196 RGTYDEKCDVWSAGV 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 53/179 (29%), Positives = 85/179 (47%), Gaps = 16/179 (8%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAI-----GISRRTLSDFENEVRLISNV 373
K+ + K+GEG +G ++K G+IVA+KK I + L E+R++ +
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL----REIRMLKQL 59
Query: 374 HHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAY 433
H NL+ LL + L LV+EY + ++ L + + I T + + +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL-DRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPE 492
H+ H IHRD+KP N+L+ K+ DFG ARLL + + A T Y +PE
Sbjct: 118 CHK--H-NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPE 172
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-30
Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 324 ENKLGEGGFGDIYKGTLK-NGKIVAVKKLAI-GISRRTLSDFENEVRLISNVHHRNLIRL 381
LG+G FG++ K + + AVK + + S EV L+ + H N+++L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 382 LGCCSQGPELILVYEYMANSSL-DKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
+V E L D+ + KR + II G+ Y+H+
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKH--- 140
Query: 441 RIIHRDIKPSNVLL---DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG 497
I+HRD+KP N+LL + D KI DFGL+ +N GT Y APE + G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VLRG 197
Query: 498 QLSEKVDAYSFGVLVLEIISG 518
EK D +S GV++ ++SG
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 70/215 (32%), Positives = 107/215 (49%), Gaps = 34/215 (15%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAI-----GISRRTLSDFENEVRLISNVH 374
K+ + K+GEG +G +YK G+IVA+K++ + GI + E+ L+ +H
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI----REISLLKELH 77
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYL 434
H N++ L+ L LV+E+M L K L E + L Q + RG+A+
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL--LPENQ-SHLSTKFAGTLGYTAP 491
H+ RI+HRD+KP N+L++ D K+ADFGLAR +P +H TL Y AP
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAP 188
Query: 492 E-------YAIHGQLSEKVDAYSFGVLVLEIISGT 519
+ Y S VD +S G + E+I+G
Sbjct: 189 DVLMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 55/224 (24%), Positives = 89/224 (39%), Gaps = 28/224 (12%)
Query: 305 GPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKN-GKIVAVK----KLAIGISRRT 359
G + D V + +G+G F + + + G+ AVK +
Sbjct: 10 GGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS 69
Query: 360 LSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSL---------DKFLFGE 410
D + E + + H +++ LL S L +V+E+M + L F++ E
Sbjct: 70 TEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE 129
Query: 411 KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL---DDDLQPKIADFGL 467
S +Q IL L Y H++ IIHRD+KP VLL ++ K+ FG+
Sbjct: 130 AVASHYMRQ----ILE---ALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179
Query: 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVL 511
A L E+ GT + APE + VD + GV+
Sbjct: 180 AIQLGESGLVAGG-RVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 67/301 (22%), Positives = 111/301 (36%), Gaps = 58/301 (19%)
Query: 240 FFADNQTTDITPFLKNGSSNKEAIIGGVVGGGTGLILFALLIWLVISRKSKKIQRGN-IS 298
F ++++ S N + +VG G K + + + I+
Sbjct: 64 FREVGPKNSYIAYIEDHSGNGTFVNTELVGKG----------------KRRPLNNNSEIA 107
Query: 299 EATELQGPVNYR---LKDLVSATRKFSEE----NKLGEGGFGDIYKGTLKN-GKIVAVK- 349
+ + + D + +E LG G G++ + K VA++
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRI 167
Query: 350 ----KLAIGISRRT--LSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSL 403
K AIG +R + E E+ ++ ++H +I++ + +V E M
Sbjct: 168 ISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEG--- 223
Query: 404 DKFLFGE------KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL--- 454
GE L + YLHE IIHRD+KP NVLL
Sbjct: 224 -----GELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQ 275
Query: 455 DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPE---YAIHGQLSEKVDAYSFGVL 511
++D KI DFG +++L E + T GT Y APE + VD +S GV+
Sbjct: 276 EEDCLIKITDFGHSKILGETS-LMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333
Query: 512 V 512
+
Sbjct: 334 L 334
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
F + KLG G FGD++ + +G +K + S+ + E E+ ++ ++ H N+
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNI 82
Query: 379 IRLLGCCSQGPELILVYEYMANSSL-DKFL-FGEKRGSLNWKQRFDIILGTARGLAYLHE 436
I++ + +V E L ++ + + +L+ +++ LAY H
Sbjct: 83 IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142
Query: 437 DFHVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEY 493
++H+D+KP N+L KI DFGLA L ++ T AGT Y APE
Sbjct: 143 Q---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPE- 196
Query: 494 AIHGQLSEKVDAYSFGV 510
++ K D +S GV
Sbjct: 197 VFKRDVTFKCDIWSAGV 213
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 46/193 (23%), Positives = 77/193 (39%), Gaps = 21/193 (10%)
Query: 326 KLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFE---NEVRLISNVHHRNLIRL 381
+G G +G++ K A KK I + + D + E+ ++ ++ H N+IRL
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKK----IPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 382 LGCCSQGPELILVYEYMANSSL-DKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
++ LV E L ++ + + I+ +AY H+
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCHKL--- 125
Query: 441 RIIHRDIKPSNVLL---DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG 497
+ HRD+KP N L D K+ DFGLA + GT Y +P+ + G
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQ-VLEG 182
Query: 498 QLSEKVDAYSFGV 510
+ D +S GV
Sbjct: 183 LYGPECDEWSAGV 195
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 28/192 (14%)
Query: 315 VSATRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAI----GISRRTLSDFENEVRL 369
+S++ +F + KLG G + +YKG G VA+K++ + G + E+ L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI----REISL 56
Query: 370 ISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFD------I 423
+ + H N++RL +L LV+E+M ++ L K++ + R N + +
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYM--DSRTVGNTPRGLELNLVKYF 113
Query: 424 ILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL--LPENQ-SHLST 480
+GLA+ HE+ +I+HRD+KP N+L++ Q K+ DFGLAR +P N S
Sbjct: 114 QWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV 170
Query: 481 KFAGTLGYTAPE 492
TL Y AP+
Sbjct: 171 ----TLWYRAPD 178
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 2e-29
Identities = 33/241 (13%), Positives = 64/241 (26%), Gaps = 42/241 (17%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIG--ISRRTLSDFENEVR------ 368
R LG+ + T + G+ V + + EV
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 369 -------------------LISNVHHRNLIRLLGCCSQG--PELILVYEYMANSSLDKFL 407
L+ + + +IR+ +Y M ++
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196
Query: 408 F----GEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIA 463
SL R + L R LA LH H ++H ++P +++LD +
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLT 253
Query: 464 DFGLARLLPENQSHLSTKFAGTLGYTAPEYAI-----HGQLSEKVDAYSFGVLVLEIISG 518
F + + TA ++ D ++ G+ + I
Sbjct: 254 GFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 519 T 519
Sbjct: 314 D 314
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 28/204 (13%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSD---FENEVRLISNVHH 375
S+ LG G FG ++K G +A K I R + D +NE+ +++ + H
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKI----IKTRGMKDKEEVKNEISVMNQLDH 145
Query: 376 RNLIRLLGCCSQGPELILVYEYMANSSL------DKFLFGEKRGSLNWKQRFDIILGTAR 429
NLI+L +++LV EY+ L + + E L KQ I
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ----ICE--- 198
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLL--DDDLQPKIADFGLARLLPENQSHLSTKFAGTLG 487
G+ ++H+ I+H D+KP N+L D Q KI DFGLAR + L F GT
Sbjct: 199 GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNF-GTPE 253
Query: 488 YTAPEYAIHGQLSEKVDAYSFGVL 511
+ APE + +S D +S GV+
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVI 277
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 61/197 (30%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 327 LGEGGFGDIYKG-TLKNGKIVAVK---KLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
LG+G FG++Y +N I+A+K K + E+ + S++ H N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQL-EKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442
+ L+ E+ L K L R + + A L Y HE ++
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFD-EQRSAT-FMEELADALHYCHER---KV 135
Query: 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL-SE 501
IHRDIKP N+L+ + KIADFG + P + T GTL Y PE I G+ E
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPE-MIEGKTHDE 191
Query: 502 KVDAYSFGVLVLEIISG 518
KVD + GVL E + G
Sbjct: 192 KVDLWCAGVLCYEFLVG 208
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 31/218 (14%)
Query: 306 PVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSD-- 362
PV + + + +LG G FG +++ K G++ K I+ D
Sbjct: 41 PVEVKQGSV---YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF----INTPYPLDKY 93
Query: 363 -FENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSL------DKFLFGEKRGSL 415
+NE+ +++ +HH LI L E++L+ E+++ L + + E
Sbjct: 94 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 153
Query: 416 NWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL--DDDLQPKIADFGLARLLPE 473
+Q GL ++HE I+H DIKP N++ KI DFGLA L
Sbjct: 154 YMRQ----ACE---GLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203
Query: 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVL 511
++ + T + APE + D ++ GVL
Sbjct: 204 DEI-VKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVL 239
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 318 TRKFSEE----NKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLS-----DFENEV 367
+ KFS+ +LG+G F + + K G A K I+ + LS E E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI----INTKKLSARDFQKLEREA 56
Query: 368 RLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGE------KRGSLNWKQRF 421
R+ + H N++RL + LV++ + GE R +
Sbjct: 57 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG--------GELFEDIVAREFYSEADAS 108
Query: 422 DIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLLPENQSHL 478
I +AY H + I+HR++KP N+LL K+ADFGLA + ++++
Sbjct: 109 HCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW- 164
Query: 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGV 510
FAGT GY +PE S+ VD ++ GV
Sbjct: 165 -HGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 57/181 (31%), Positives = 93/181 (51%), Gaps = 21/181 (11%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAI-----GISRRTLSDFENEVRLISNVH 374
K+ K+GEG +G +YK G+ A+KK+ + GI T+ E+ ++ +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTI----REISILKELK 58
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYL 434
H N+++L L+LV+E++ + L K L G L +L G+AY
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL--LPENQ-SHLSTKFAGTLGYTAP 491
H+ R++HRD+KP N+L++ + + KIADFGLAR +P + +H TL Y AP
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAP 169
Query: 492 E 492
+
Sbjct: 170 D 170
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 16/179 (8%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAI-----GISRRTLSDFENEVRLISNV 373
K+ +GEG +G + K G+IVA+KK + + + E++L+ +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM----REIKLLKQL 81
Query: 374 HHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAY 433
H NL+ LL C + LV+E++ + ++ L L+++ + G+ +
Sbjct: 82 RHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDL-ELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPE 492
H H IIHRDIKP N+L+ K+ DFG AR L + A T Y APE
Sbjct: 140 CHS--H-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE 194
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 324 ENKLGEGGFGDIYKGTLK-NGKIVAVKKLA------------IGISRRTLSDFENEVRLI 370
KLG G +G++ K A+K + + + NE+ L+
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 371 SNVHHRNLIRLLGCCSQGPELILVYEYMANSSL-DKFLFGEKRGSLNWKQRFDIILGTAR 429
++ H N+I+L LV E+ L ++ + R + +I+
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILS 157
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLLPENQSHLSTKFAGTL 486
G+ YLH+ I+HRDIKP N+LL + L KI DFGL+ ++ GT
Sbjct: 158 GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTA 212
Query: 487 GYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
Y APE + + +EK D +S GV++ ++ G
Sbjct: 213 YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 17/194 (8%)
Query: 324 ENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRL 381
+ LGEG F K K + + AVK IS+R ++ + E+ + H N+++L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKI----ISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 382 LGCCSQGPELILVYEYMANSSL-DKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
LV E + L ++ K+ + + I+ ++++H+ V
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIK---KKKHFSETEASYIMRKLVSAVSHMHD---V 125
Query: 441 RIIHRDIKPSNVLL---DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG 497
++HRD+KP N+L +D+L+ KI DFG ARL P + L T TL Y APE
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPELLNQN 184
Query: 498 QLSEKVDAYSFGVL 511
E D +S GV+
Sbjct: 185 GYDESCDLWSLGVI 198
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 54/201 (26%), Positives = 83/201 (41%), Gaps = 27/201 (13%)
Query: 326 KLGEGGFGDIYKGTLK-NGKIVAVK-----KLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+LG G F + K K G A K + + + E EV ++ V H N+I
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 380 RLLGCCSQGPELILVYEYMANSSL-----DKFLFGEKRGSLNWKQRFDIILGTARGLAYL 434
L +++L+ E ++ L K E+ + KQ IL G+ YL
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ----ILD---GVNYL 131
Query: 435 HEDFHVRIIHRDIKPSNVLL----DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
H +I H D+KP N++L K+ DFGLA + + F GT + A
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF-GTPEFVA 186
Query: 491 PEYAIHGQLSEKVDAYSFGVL 511
PE + L + D +S GV+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVI 207
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 50/182 (27%), Positives = 91/182 (50%), Gaps = 22/182 (12%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAI-----GISRRTLSDFENEVRLISNV 373
K+ + K+GEG +G ++K + +IVA+K++ + G+ L E+ L+ +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKEL 58
Query: 374 HHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAY 433
H+N++RL +L LV+E+ + L K+ G L+ + + +GL +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL--LPENQ-SHLSTKFAGTLGYTA 490
H ++HRD+KP N+L++ + + K+A+FGLAR +P S TL Y
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV----TLWYRP 169
Query: 491 PE 492
P+
Sbjct: 170 PD 171
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 58/188 (30%), Positives = 94/188 (50%), Gaps = 17/188 (9%)
Query: 313 DLVSATRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFEN----EV 367
D+ S +++ + + LGEG F +YK +IVA+KK+ +G E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 368 RLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGT 427
+L+ + H N+I LL + LV+++M + L+ + + L +L T
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVII-KDNSLVLTPSHIKAYMLMT 121
Query: 428 ARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL--LPENQ-SHLSTKFAG 484
+GL YLH+ I+HRD+KP+N+LLD++ K+ADFGLA+ P +H
Sbjct: 122 LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV---- 174
Query: 485 TLGYTAPE 492
T Y APE
Sbjct: 175 TRWYRAPE 182
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 27/201 (13%)
Query: 326 KLGEGGFGDIYKGTLK-NGKIVAVK-----KLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+LG G F + K K GK A K +L+ + + E EV ++ + H N+I
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 380 RLLGCCSQGPELILVYEYMANSSL-----DKFLFGEKRGSLNWKQRFDIILGTARGLAYL 434
L +++L+ E ++ L +K E + KQ IL G+ YL
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ----ILD---GVHYL 124
Query: 435 HEDFHVRIIHRDIKPSNVLL----DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
H RI H D+KP N++L + + K+ DFG+A + F GT + A
Sbjct: 125 HS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF-GTPEFVA 179
Query: 491 PEYAIHGQLSEKVDAYSFGVL 511
PE + L + D +S GV+
Sbjct: 180 PEIVNYEPLGLEADMWSIGVI 200
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-28
Identities = 43/200 (21%), Positives = 77/200 (38%), Gaps = 21/200 (10%)
Query: 326 KLGEGGFGDIYKG--TLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLL- 382
+ GG G IY NG+ V +K L + E + ++ V H +++++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 383 ----GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
P +V EY+ SL + L + +L L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLHS-- 200
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ 498
+ +++ D+KP N++L ++ Q K+ D G + GT G+ APE
Sbjct: 201 -IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY-----GTPGFQAPEIV-RTG 252
Query: 499 LSEKVDAYSFGVLVLEIISG 518
+ D Y+ G + +
Sbjct: 253 PTVATDIYTVGRTLAALTLD 272
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 58/205 (28%), Positives = 85/205 (41%), Gaps = 34/205 (16%)
Query: 326 KLGEGGFGDIYKGTLKN-GKIVAVK-----KLAIGISRRT--LSDFENEVRLISNVHHRN 377
LG G G++ + K VA+K K AIG +R + E E+ ++ ++H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGE------KRGSLNWKQRFDIILGTARGL 431
+I++ + +V E M GE L +
Sbjct: 77 IIKIKNFF-DAEDYYIVLELMEG--------GELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 432 AYLHEDFHVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGY 488
YLHE+ IIHRD+KP NVLL ++D KI DFG +++L E + T GT Y
Sbjct: 128 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRT-LCGTPTY 182
Query: 489 TAPE---YAIHGQLSEKVDAYSFGV 510
APE + VD +S GV
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGV 207
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 42/225 (18%)
Query: 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR--RTLSDFENEVRLISNVH 374
+F E G+G FG + G K G VA+KK+ R L ++ ++ +H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ----IMQDLAVLH 77
Query: 375 HRNLIRLLGC-CSQGPE------LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILG- 426
H N+++L + G L +V EY+ +L + R + IL
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCC----RNYYRRQVAPPPILIK 132
Query: 427 -----TARGLAYLHEDFHVRIIHRDIKPSNVLLD-DDLQPKIADFGLARLLPENQSHLST 480
R + LH + HRDIKP NVL++ D K+ DFG A+ L ++ +
Sbjct: 133 VFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NV 189
Query: 481 KFAGTLGYTAPE-------YAIHGQLSEKVDAYSFGVLVLEIISG 518
+ + Y APE Y + VD +S G + E++ G
Sbjct: 190 AYICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLG 228
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 54/201 (26%), Positives = 82/201 (40%), Gaps = 27/201 (13%)
Query: 326 KLGEGGFGDIYKGTLK-NGKIVAVK-----KLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+LG G F + K K G A K + + E EV ++ V H N+I
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 380 RLLGCCSQGPELILVYEYMANSSL-----DKFLFGEKRGSLNWKQRFDIILGTARGLAYL 434
L +++L+ E ++ L K E+ + KQ IL G+ YL
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ----ILD---GVNYL 131
Query: 435 HEDFHVRIIHRDIKPSNVLL----DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
H +I H D+KP N++L K+ DFGLA + + F GT + A
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF-GTPEFVA 186
Query: 491 PEYAIHGQLSEKVDAYSFGVL 511
PE + L + D +S GV+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVI 207
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 54/226 (23%), Positives = 97/226 (42%), Gaps = 22/226 (9%)
Query: 295 GNISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAI 353
+++ ++ + + + + + +LG+G F + + K G A K
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI--- 61
Query: 354 GISRRTLS-----DFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSL-DKFL 407
I+ + LS E E R+ + H N++RL + LV++ + L + +
Sbjct: 62 -INTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 408 FGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL---DDDLQPKIAD 464
R + I +AY H + I+HR++KP N+LL K+AD
Sbjct: 121 ---AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLAD 174
Query: 465 FGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGV 510
FGLA + ++++ FAGT GY +PE S+ VD ++ GV
Sbjct: 175 FGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 46/203 (22%), Positives = 78/203 (38%), Gaps = 23/203 (11%)
Query: 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHR 376
K+ LG G FG +++ + K K + + + E+ +++ HR
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK--FVKVKGTDQVLVKKEISILNIARHR 61
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSL------DKFLFGEKRGSLNWKQRFDIILGTARG 430
N++ L EL++++E+++ + F E+ Q +
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ----VCE---A 114
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLL--DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGY 488
L +LH I H DI+P N++ KI +FG AR L + F Y
Sbjct: 115 LQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF-TAPEY 169
Query: 489 TAPEYAIHGQLSEKVDAYSFGVL 511
APE H +S D +S G L
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTL 192
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 5e-28
Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 31/219 (14%)
Query: 306 PVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFE 364
PV + + + +LG G FG +++ T + G A K + SD E
Sbjct: 147 PVEIKHDHV---LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKF----VMTPHESDKE 199
Query: 365 ---NEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSL------DKFLFGEKRGSL 415
E++ +S + H L+ L E++++YE+M+ L + E
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE 259
Query: 416 NWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL--DDDLQPKIADFGLARLLPE 473
+Q + GL ++HE +H D+KP N++ + K+ DFGL L
Sbjct: 260 YMRQ----VCK---GLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309
Query: 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLV 512
QS + GT + APE A + D +S GVL
Sbjct: 310 KQS-VKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 34/215 (15%)
Query: 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAI----GISRRTLSDFENEVRLISNVH 374
+ + +KLGEG + +YKG K +VA+K++ + G + EV L+ ++
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLK 58
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYL 434
H N++ L L LV+EY+ + L ++L + +N + RGLAY
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL--LPENQ-SHLSTKFAGTLGYTAP 491
H +++HRD+KP N+L+++ + K+ADFGLAR +P + TL Y P
Sbjct: 117 HRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV----TLWYRPP 169
Query: 492 E-------YAIHGQLSEKVDAYSFGVLVLEIISGT 519
+ Y S ++D + G + E+ +G
Sbjct: 170 DILLGSTDY------STQIDMWGVGCIFYEMATGR 198
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-28
Identities = 49/195 (25%), Positives = 82/195 (42%), Gaps = 21/195 (10%)
Query: 326 KLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLS-----DFENEVRLISNVHHRNLI 379
+LG+G F + + G+ A I+ + LS E E R+ + H N++
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMI----INTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 380 RLLGCCSQGPELILVYEYMANSSL-DKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
RL S+ L+++ + L + + R + I + + H+
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCHQM- 129
Query: 439 HVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI 495
++HR++KP N+LL K+ADFGLA + Q FAGT GY +PE
Sbjct: 130 --GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGTPGYLSPEVLR 186
Query: 496 HGQLSEKVDAYSFGV 510
+ VD ++ GV
Sbjct: 187 KDPYGKPVDLWACGV 201
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 56/203 (27%), Positives = 84/203 (41%), Gaps = 27/203 (13%)
Query: 324 ENKLGEGGFGDIYKGTLK-NGKIVAVK-----KLAIGISRRTLSDFENEVRLISNVHHRN 377
+LG G F + K K G A K + + D E EV ++ + H N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 378 LIRLLGCCSQGPELILVYEYMANSSL-----DKFLFGEKRGSLNWKQRFDIILGTARGLA 432
+I L ++IL+ E +A L +K E+ + KQ IL G+
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ----ILN---GVY 128
Query: 433 YLHEDFHVRIIHRDIKPSNVLL----DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGY 488
YLH ++I H D+KP N++L + KI DFGLA + GT +
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 183
Query: 489 TAPEYAIHGQLSEKVDAYSFGVL 511
APE + L + D +S GV+
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 32/217 (14%)
Query: 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHR 376
+++ +G G FG +Y+ L +G++VA+KK+ R E++++ + H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKN----RELQIMRKLDHC 107
Query: 377 NLIRLLGC-CSQGPE-----LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILG---- 426
N++RL S G + L LV +Y+ ++ + R KQ +I
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVA----RHYSRAKQTLPVIYVKLYM 162
Query: 427 --TARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP-KIADFGLARLLPENQSHLSTKFA 483
R LAY+H I HRDIKP N+LLD D K+ DFG A+ L + + +
Sbjct: 163 YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYI 217
Query: 484 GTLGYTAPEYAIHG--QLSEKVDAYSFGVLVLEIISG 518
+ Y APE I G + +D +S G ++ E++ G
Sbjct: 218 CSRYYRAPE-LIFGATDYTSSIDVWSAGCVLAELLLG 253
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFEN----EVRL---IS 371
++ ++G G +G +YK +G VA+K + + EV L +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 372 NVHHRNLIRLLGCC-----SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILG 426
H N++RL+ C + ++ LV+E++ + L +L L + D++
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 427 TARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL--LPENQSHLSTKFAG 484
RGL +LH + I+HRD+KP N+L+ K+ADFGLAR+ + +
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV---- 181
Query: 485 TLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
TL Y APE + + VD +S G + E+
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 31/200 (15%)
Query: 324 ENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLS---DFENEVRLISNVHHRNLI 379
LG G F +++ + GK+ A+K I + ENE+ ++ + H N++
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKC----IKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGE------KRGSLNWKQRFDIILGTARGLAY 433
L LV + ++ GE +RG K +I + Y
Sbjct: 70 TLEDIYESTTHYYLVMQLVSG--------GELFDRILERGVYTEKDASLVIQQVLSAVKY 121
Query: 434 LHEDFHVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
LHE+ I+HRD+KP N+L +++ + I DFGL+++ +ST GT GY A
Sbjct: 122 LHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MST-ACGTPGYVA 175
Query: 491 PEYAIHGQLSEKVDAYSFGV 510
PE S+ VD +S GV
Sbjct: 176 PEVLAQKPYSKAVDCWSIGV 195
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFEN-EVRLISNVHHRNL 378
++ +G G FG +++ L VA+KK+ F+N E++++ V H N+
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV------LQDKRFKNRELQIMRIVKHPNV 94
Query: 379 IRLLGC-CSQGPE-----LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILG------ 426
+ L S G + L LV EY+ ++ + R KQ ++L
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRAS----RHYAKLKQTMPMLLIKLYMYQ 149
Query: 427 TARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP-KIADFGLARLLPENQSHLSTKFAGT 485
R LAY+H + I HRDIKP N+LLD K+ DFG A++L + + + +
Sbjct: 150 LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSYICS 204
Query: 486 LGYTAPEYAIHG--QLSEKVDAYSFGVLVLEIISG 518
Y APE I G + +D +S G ++ E++ G
Sbjct: 205 RYYRAPE-LIFGATNYTTNIDIWSTGCVMAELMQG 238
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 41/221 (18%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAI-----GISRRTLSDFENEVRLISNV 373
++ KLGEG +G++YK + VA+K++ + G+ + EV L+ +
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI----REVSLLKEL 90
Query: 374 HHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAY 433
HRN+I L L L++EY + L K++ +K ++ + + G+ +
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYM--DKNPDVSMRVIKSFLYQLINGVNF 147
Query: 434 LHEDFHVRIIHRDIKPSNVLLDDDLQP-----KIADFGLARL--LPENQ-SHLSTKFAGT 485
H R +HRD+KP N+LL KI DFGLAR +P Q +H T
Sbjct: 148 CHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII----T 200
Query: 486 LGYTAPE-------YAIHGQLSEKVDAYSFGVLVLEIISGT 519
L Y PE Y S VD +S + E++ T
Sbjct: 201 LWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 37/220 (16%)
Query: 320 KFSEENKLGEGGFGDIYKG--TLKNGKIVAVKKLAIGISRRTLSDFENE------VRLIS 371
++ ++GEG +G ++K G+ VA+K++ + E +R ++
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV--------QTGEEGMPLSTIREVA 63
Query: 372 ------NVHHRNLIRLLGCC-----SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQR 420
H N++RL C + +L LV+E++ + L +L + +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETI 122
Query: 421 FDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL--LPENQSHL 478
D++ RGL +LH R++HRD+KP N+L+ Q K+ADFGLAR+ + +
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179
Query: 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
TL Y APE + + VD +S G + E+
Sbjct: 180 VV----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 56/250 (22%), Positives = 102/250 (40%), Gaps = 38/250 (15%)
Query: 286 SRKSKKIQRGNISEATELQGPVNYRLKDLVSATRKFSEE----NKLGEGGFGDIYKGTLK 341
K + +E Q +A ++F ++ + +G G + + +
Sbjct: 57 EAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR 116
Query: 342 -NGKIVAVK-------KLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQGPELI 392
G AVK +L+ E ++ V H ++I L+ +
Sbjct: 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176
Query: 393 LVYEYMANSSLDKFLFGE------KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRD 446
LV++ M GE ++ +L+ K+ I+ +++LH + I+HRD
Sbjct: 177 LVFDLMRK--------GELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRD 225
Query: 447 IKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPE------YAIHGQLS 500
+KP N+LLDD++Q +++DFG + L + L GT GY APE H
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRE-LCGTPGYLAPEILKCSMDETHPGYG 283
Query: 501 EKVDAYSFGV 510
++VD ++ GV
Sbjct: 284 KEVDLWACGV 293
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 56/209 (26%), Positives = 84/209 (40%), Gaps = 39/209 (18%)
Query: 326 KLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLS----------DFENEVRLISNV- 373
LG G + + K K AVK I ++ EV ++ V
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKI--IDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 374 HHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGE------KRGSLNWKQRFDIILGT 427
H N+I+L LV++ M GE ++ +L+ K+ I+
Sbjct: 82 GHPNIIQLKDTYETNTFFFLVFDLMKK--------GELFDYLTEKVTLSEKETRKIMRAL 133
Query: 428 ARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLG 487
+ LH+ I+HRD+KP N+LLDDD+ K+ DFG + L + L GT
Sbjct: 134 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LRE-VCGTPS 188
Query: 488 YTAPE------YAIHGQLSEKVDAYSFGV 510
Y APE H ++VD +S GV
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 59/235 (25%), Positives = 94/235 (40%), Gaps = 28/235 (11%)
Query: 286 SRKSKKIQRGNISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKN-GK 344
S S + + ++ +D +S + E LG G +Y+ K K
Sbjct: 22 SMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESE--LGRGATSIVYRCKQKGTQK 79
Query: 345 IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLD 404
A+K L E+ ++ + H N+I+L E+ LV E +
Sbjct: 80 PYALKVLK---KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT----- 131
Query: 405 KFLFGE------KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL---D 455
GE ++G + + D + +AYLHE+ I+HRD+KP N+L
Sbjct: 132 ---GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPA 185
Query: 456 DDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGV 510
D KIADFGL++++ GT GY APE +VD +S G+
Sbjct: 186 PDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 50/203 (24%), Positives = 82/203 (40%), Gaps = 33/203 (16%)
Query: 326 KLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLS-----DFENEVRLISNV-HHRNL 378
+LG G F + + K G+ A K + +R + +E+ ++ +
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKF----LKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 379 IRLLGCCSQGPELILVYEYMANSSL-------DKFLFGEKRGSLNWKQRFDIILGTARGL 431
I L E+IL+ EY A + + E KQ IL G+
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ----ILE---GV 144
Query: 432 AYLHEDFHVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGY 488
YLH++ I+H D+KP N+LL KI DFG++R + L GT Y
Sbjct: 145 YYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIM-GTPEY 199
Query: 489 TAPEYAIHGQLSEKVDAYSFGVL 511
APE + ++ D ++ G++
Sbjct: 200 LAPEILNYDPITTATDMWNIGII 222
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 35/212 (16%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVK-----KLAIGISRRTLSDFENEVRLISNVHHR--NL 378
LG GGFG +Y G + + VA+K +++ + EV L+ V +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTAR--------G 430
IRLL + +L+ E D F F +RG+L + AR
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEEL--------ARSFFWQVLEA 161
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLD-DDLQPKIADFGLARLLPENQSHLSTKFAGTLGYT 489
+ + H + ++HRDIK N+L+D + + K+ DFG LL + + + F GT Y+
Sbjct: 162 VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTD-FDGTRVYS 215
Query: 490 APEYAIHGQL--SEKVDAYSFGVLVLEIISGT 519
PE+ I +S G+L+ +++ G
Sbjct: 216 PPEW-IRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 49/193 (25%), Positives = 88/193 (45%), Gaps = 32/193 (16%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFEN-------EVRLIS 371
K+ + K+G+G FG+++K K G+ VA+KK+ ++ E E++++
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV------LMENEKEGFPITALREIKILQ 71
Query: 372 NVHHRNLIRLLGCC--------SQGPELILVYEYMANSSLD-KFLFGEKRGSLNWKQRFD 422
+ H N++ L+ C + LV+++ D L +
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFTLSEIKR 128
Query: 423 IILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKF 482
++ GL Y+H + +I+HRD+K +NVL+ D K+ADFGLAR ++ ++
Sbjct: 129 VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 483 AG---TLGYTAPE 492
TL Y PE
Sbjct: 186 TNRVVTLWYRPPE 198
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 21/216 (9%)
Query: 306 PVNYRLKDLVSATRKFSEE----NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTL 360
V+ ++ L + +F++ +G G + + K AVK I +
Sbjct: 5 GVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI----IDKSKR 60
Query: 361 SDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSL-DKFLFGEKRGSLNWKQ 419
E L+ H N+I L G + +V E M L DK L ++ + ++
Sbjct: 61 DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSERE 117
Query: 420 RFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL---DDDLQP-KIADFGLARLLPENQ 475
++ + + YLH ++HRD+KPSN+L + + +I DFG A+ L
Sbjct: 118 ASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVL 511
L T T + APE D +S GVL
Sbjct: 175 GLLMT-PCYTANFVAPEVLERQGYDAACDIWSLGVL 209
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 37/214 (17%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVK-----KLAIGISRRTLSDFENEVRLISNVH----HR 376
LG+GGFG ++ G L + VA+K ++ EV L+ V H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTAR------- 429
+IRLL +LV E + D F + ++G L +R
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGP--------SRCFFGQVV 149
Query: 430 -GLAYLHEDFHVRIIHRDIKPSNVLLD-DDLQPKIADFGLARLLPENQSHLSTKFAGTLG 487
+ + H ++HRDIK N+L+D K+ DFG LL + + F GT
Sbjct: 150 AAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTD-FDGTRV 203
Query: 488 YTAPEYAIHGQL--SEKVDAYSFGVLVLEIISGT 519
Y+ PE+ I + +S G+L+ +++ G
Sbjct: 204 YSPPEW-ISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 17/210 (8%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVK---KLAIG----ISRRTLSDFENEVRLIS 371
K+S + LG G FG ++ + K V VK K + I L E+ ++S
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 372 NVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGL 431
V H N+I++L LV E S LD F F ++ L+ I +
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEK-HGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 432 AYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAP 491
YL IIHRDIK N+++ +D K+ DFG A E T F GT+ Y AP
Sbjct: 144 GYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAA-YLERGKLFYT-FCGTIEYCAP 198
Query: 492 EYAIHGQLSE--KVDAYSFGVLVLEIISGT 519
E + G +++ +S GV + ++
Sbjct: 199 E-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 55/253 (21%), Positives = 88/253 (34%), Gaps = 57/253 (22%)
Query: 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVK----KLAIGISRRTLSDFENEVRLISN 372
+K+ + +G+G +G + I A+K I+ + + + EVRL+
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 373 VHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTAR--- 429
+HH N+ RL + LV E L + + ++ T
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHL--LDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 430 -------------------------------------GLAYLHEDFHVRIIHRDIKPSNV 452
L YLH I HRDIKP N
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENF 199
Query: 453 LL--DDDLQPKIADFGLARLLP---ENQSHLSTKFAGTLGYTAPE--YAIHGQLSEKVDA 505
L + + K+ DFGL++ + + T AGT + APE + K DA
Sbjct: 200 LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 506 YSFGVLVLEIISG 518
+S GVL+ ++ G
Sbjct: 260 WSAGVLLHLLLMG 272
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 46/250 (18%), Positives = 87/250 (34%), Gaps = 36/250 (14%)
Query: 356 SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGS- 414
S + ++R + +N + L S L + + +L ++
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 415 LNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL--- 471
I + A + +LH ++HRD+KPSN+ D K+ DFGL +
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 472 --------PENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSE 523
P T GT Y +PE S KVD +S G+++ E++
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF---S 274
Query: 524 TKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPT 583
T+ E + + + K E ++ + M + S RP
Sbjct: 275 TQMERVRIITD-------------VRNLKFPLLFTQKYPQEHMM-VQDMLSPSPTE-RPE 319
Query: 584 MSEVVALLKS 593
++ ++++
Sbjct: 320 ATD---IIEN 326
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 16/89 (17%), Positives = 33/89 (37%), Gaps = 1/89 (1%)
Query: 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN 377
F +G GGFG +++ K + A+K++ + EV+ ++ + H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKF 406
++R + P E D+
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDES 94
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 327 LGEGGFGDIYKGTLKN-GKIVAVKKL--AIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
LG+GGFG++ ++ GK+ A KKL R+ + NE +++ V+ R ++ L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 250
Query: 384 CCSQGPE-LILVYEYMANSSL-------DKFLFGEKRGSLNWKQRF---DIILGTARGLA 432
+ + L LV M L + F E R F +I G L
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA------VFYAAEICCG----LE 300
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPE 492
LH + RI++RD+KP N+LLDD +I+D GLA +PE Q+ GT+GY APE
Sbjct: 301 DLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPE 355
Query: 493 YAIHGQLSEKVDAYSFGVLVLEIISG 518
+ + + D ++ G L+ E+I+G
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAG 381
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLA-----IGISRRTLSDFENEVRLIS 371
+++ +G G G + + VA+KKL+ ++R E+ L+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----RELVLMK 116
Query: 372 NVHHRNLIRLL------GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL 425
V+H+N+I LL + ++ LV E M +++L + + + L+ ++ ++
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI----QMELDHERMSYLLY 171
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT 485
G+ +LH IIHRD+KPSN+++ D KI DFGLAR + + T + T
Sbjct: 172 QMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVT 226
Query: 486 LGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
Y APE + E VD +S G ++ E++
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 38/219 (17%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLA-----IGISRRTLSDFENEVRLIS 371
+++ +G G G + + VA+KKL+ ++R E+ L+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY----RELVLMK 79
Query: 372 NVHHRNLIRLL------GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFD--- 422
V+H+N+I LL + ++ +V E M +++L + + + D
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI----------QMELDHER 128
Query: 423 ---IILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS 479
++ G+ +LH IIHRD+KPSN+++ D KI DFGLAR + +
Sbjct: 129 MSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMM 183
Query: 480 TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
T + T Y APE + E VD +S G ++ E+I G
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 52/221 (23%), Positives = 81/221 (36%), Gaps = 35/221 (15%)
Query: 316 SATRKFSE-----ENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLS---DFENE 366
S + +F + E+ LGEG + + AVK I ++ E
Sbjct: 5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKI----IEKQPGHIRSRVFRE 60
Query: 367 VRLISNV-HHRNLIRLLGCCSQGPELILVYEYMANSSL-DKFLFGEKRGSLNWKQRFDII 424
V ++ HRN++ L+ + LV+E M S+ KR N + ++
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVV 117
Query: 425 LGTARGLAYLHEDFHVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLLPENQSHLS-- 479
A L +LH I HRD+KP N+L + KI DF L + N
Sbjct: 118 QDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 480 ----TKFAGTLGYTAPE-----YAIHGQLSEKVDAYSFGVL 511
G+ Y APE ++ D +S GV+
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 31/208 (14%)
Query: 327 LGEGGFGDIYKGTLKN-GKIVAVKKL--AIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
LG GGFG+++ +K GK+ A KKL R+ E ++++ VH R ++ L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 384 CCSQGPE-LILVYEYMA---------NSSLDKFLFGEKRGSLNWKQRF---DIILGTARG 430
+ L LV M N D F E R F I+ G
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA------IFYTAQIVSG---- 301
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
L +LH+ II+RD+KP NVLLDDD +I+D GLA L Q+ +AGT G+ A
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMA 357
Query: 491 PEYAIHGQLSEKVDAYSFGVLVLEIISG 518
PE + + VD ++ GV + E+I+
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAA 385
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 52/219 (23%), Positives = 95/219 (43%), Gaps = 27/219 (12%)
Query: 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSD-FEN---------EV 367
++ + + G +G + G G VA+K++ +S + + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 368 RLISNVHHRNLIRLL-----GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFD 422
RL+++ HH N++ L +L LV E M + L + + ++ ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 423 I--ILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480
+ IL GL LHE ++HRD+ P N+LL D+ I DF LAR + + T
Sbjct: 140 MYHIL---LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN--KT 191
Query: 481 KFAGTLGYTAPEYAI-HGQLSEKVDAYSFGVLVLEIISG 518
+ Y APE + ++ VD +S G ++ E+ +
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 48/186 (25%), Positives = 78/186 (41%), Gaps = 27/186 (14%)
Query: 326 KLGEGGFGDIYKGTLK---NGKIVAVKKLAI-GISRRTLSDFENEVRLISNVHHRNLIRL 381
K+G G +G +YK K + K A+K++ GIS E+ L+ + H N+I L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPNVISL 83
Query: 382 LGCCSQGPE--LILVYEYMANSSLDKFL-FGEKRGSLNWKQRFD------IILGTARGLA 432
+ + L+++Y L + F + + ++ G+
Sbjct: 84 QKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQP----KIADFGLARL--LPENQSHLSTKFAGTL 486
YLH + ++HRD+KP+N+L+ + KIAD G ARL P T
Sbjct: 143 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199
Query: 487 GYTAPE 492
Y APE
Sbjct: 200 WYRAPE 205
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 28/197 (14%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDF-----ENEVRLISNVHHRNLIR 380
+G+G F + + G+ VA+K I I + L+ EVR++ ++H N+++
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIK---I-IDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 381 LLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQ--RF--DIILGTARGLAYLHE 436
L L L+ EY + + F + G + K+ I+ + Y H+
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEV--FDYLVAHGRMKEKEARSKFRQIV----SAVQYCHQ 132
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH 496
RI+HRD+K N+LLD D+ KIADFG + L F G Y APE
Sbjct: 133 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDA-FCGAPPYAAPE-LFQ 186
Query: 497 GQLSE--KVDAYSFGVL 511
G+ + +VD +S GV+
Sbjct: 187 GKKYDGPEVDVWSLGVI 203
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 61/196 (31%), Positives = 91/196 (46%), Gaps = 26/196 (13%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFEN----EVRLISNVHHRNLIRL 381
LGEG +G++ + VAVK I + + D E+ + ++H N+++
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK---I-VDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 382 LGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQ--RF--DIILGTARGLAYLHED 437
G +G L EY + L F E + RF ++ G + YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAG----VVYLH-- 122
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL-PENQSHLSTKFAGTLGYTAPEYAIH 496
+ I HRDIKP N+LLD+ KI+DFGLA + N+ L K GTL Y APE +
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLK 180
Query: 497 GQL--SEKVDAYSFGV 510
+ +E VD +S G+
Sbjct: 181 RREFHAEPVDVWSCGI 196
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 50/222 (22%), Positives = 89/222 (40%), Gaps = 52/222 (23%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVK-------------------------KLAIGISRRTL 360
+G+G +G + + A+K R +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 361 SDFENEVRLISNVHHRNLIRL---LGCCSQGPELILVYEYMANSSL-DKFLFGEKRGSLN 416
E+ ++ + H N+++L L ++ L +V+E + + + L+
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEV----PTLKPLS 135
Query: 417 WKQ--RF--DIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472
Q + D+I G + YLH +IIHRDIKPSN+L+ +D KIADFG++
Sbjct: 136 EDQARFYFQDLIKG----IEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 473 ENQSHLSTKFAGTLGYTAPEYAIHGQLSE----KVDAYSFGV 510
+ + LS GT + APE ++ +D ++ GV
Sbjct: 189 GSDALLSN-TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGV 228
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 61/196 (31%), Positives = 91/196 (46%), Gaps = 26/196 (13%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFEN----EVRLISNVHHRNLIRL 381
LGEG +G++ + VAVK I + + D E+ + ++H N+++
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK---I-VDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 382 LGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQ--RF--DIILGTARGLAYLHED 437
G +G L EY + L F E + RF ++ G + YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAG----VVYLH-- 122
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL-LPENQSHLSTKFAGTLGYTAPEYAIH 496
+ I HRDIKP N+LLD+ KI+DFGLA + N+ L K GTL Y APE +
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLK 180
Query: 497 GQL--SEKVDAYSFGV 510
+ +E VD +S G+
Sbjct: 181 RREFHAEPVDVWSCGI 196
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLA-----IGISRRTLSDFENEVRLIS 371
+ + +G G +G + ++G+ VA+KKL+ ++R E+ L+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLK 78
Query: 372 NVHHRNLIRLL------GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFD--- 422
++ H N+I LL + LV +M + L K + +F
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM----------GLKFSEEK 127
Query: 423 ---IILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS 479
++ +GL Y+H ++HRD+KP N+ +++D + KI DFGLAR
Sbjct: 128 IQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM---- 180
Query: 480 TKFAGTLGYTAPEYAI-HGQLSEKVDAYSFGVLVLEIISG 518
T + T Y APE + ++ VD +S G ++ E+++G
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 59/240 (24%), Positives = 94/240 (39%), Gaps = 40/240 (16%)
Query: 295 GNISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVK---K 350
G++ A P R +D F LGEG F + + A+K K
Sbjct: 13 GSLQHAQPPPQPRKKRPED-------FKFGKILGEGSFSTVVLARELATSREYAIKILEK 65
Query: 351 LAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGE 410
I I + E ++S + H ++L +L Y N GE
Sbjct: 66 RHI-IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN--------GE 116
Query: 411 KRGSLNWKQRFD----------IILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP 460
+ FD I+ L YLH IIHRD+KP N+LL++D+
Sbjct: 117 LLKYIRKIGSFDETCTRFYTAEIVSA----LEYLHG---KGIIHRDLKPENILLNEDMHI 169
Query: 461 KIADFGLARLLPENQSHLSTK-FAGTLGYTAPEYAIHGQLSEK-VDAYSFGVLVLEIISG 518
+I DFG A++L F GT Y +PE + + + K D ++ G ++ ++++G
Sbjct: 170 QITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAG 228
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 54/223 (24%), Positives = 105/223 (47%), Gaps = 33/223 (14%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIG---ISRRTLSDFENEVRLISNV 373
++ + LG GG G ++ K VA+KK+ + + L E+++I +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL----REIKIIRRL 65
Query: 374 HHRNLIRLL--------------GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQ 419
H N++++ G ++ + +V EYM + L L ++G L +
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVL---EQGPLLEEH 121
Query: 420 RFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD-DDLQPKIADFGLARLLPENQSHL 478
+ RGL Y+H ++HRD+KP+N+ ++ +DL KI DFGLAR++ + SH
Sbjct: 122 ARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 479 S--TKFAGTLGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISG 518
++ T Y +P + ++ +D ++ G + E+++G
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 47/211 (22%), Positives = 91/211 (43%), Gaps = 32/211 (15%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRN 377
+ KLG G + ++++ + N + V VK L ++ E++++ N+ N
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK----REIKILENLRGGPN 92
Query: 378 LIRLLGCC--SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDI------ILGTAR 429
+I L LV+E++ N+ + +L +DI IL +
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLT---DYDIRFYMYEIL---K 141
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLLD-DDLQPKIADFGLARLLPENQSHLSTKFAGTLGY 488
L Y H + I+HRD+KP NV++D + + ++ D+GLA Q + + +
Sbjct: 142 ALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYF 196
Query: 489 TAPEYAIHGQL-SEKVDAYSFGVLVLEIISG 518
PE + Q+ +D +S G ++ +I
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 55/251 (21%), Positives = 99/251 (39%), Gaps = 68/251 (27%)
Query: 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHR 376
++K+S LG G FG + + +GK A+KK+ R E+ ++ + H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-DPRYKN----RELDIMKVLDHV 60
Query: 377 NLIRLLGC-------------------------------CSQGP-------ELILVYEYM 398
N+I+L+ L ++ EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 399 ANSSLDKFLFGEKRGSLNWKQRFDIILG------TARGLAYLHEDFHVRIIHRDIKPSNV 452
+L K L + + + + L R + ++H + I HRDIKP N+
Sbjct: 121 -PDTLHKVL----KSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNL 172
Query: 453 LLD---DDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG--QLSEKVDAYS 507
L++ + L K+ DFG A+ L ++ S + + Y APE + G + + +D +S
Sbjct: 173 LVNSKDNTL--KLCDFGSAKKLIPSEP--SVAYICSRFYRAPEL-MLGATEYTPSIDLWS 227
Query: 508 FGVLVLEIISG 518
G + E+I G
Sbjct: 228 IGCVFGELILG 238
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 46/208 (22%), Positives = 78/208 (37%), Gaps = 36/208 (17%)
Query: 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVR-LISNVHHRN 377
+ S++ LG G G + + + G+ A+K + EV +
Sbjct: 31 QLSKQ-VLGLGVNGKVLECFHRRTGQKCALKL----LYDS--PKARQEVDHHWQASGGPH 83
Query: 378 LIRLLGCC----SQGPELILVYEYMANSSL-DKFL------FGEKRGSLNWKQRFDIILG 426
++ +L L+++ E M L + F E+ + + I
Sbjct: 84 IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD----IGT 139
Query: 427 TARGLAYLHEDFHVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLLPENQSHLSTKFA 483
+ +LH I HRD+KP N+L + D K+ DFG A+ +N L T
Sbjct: 140 ---AIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTP-C 190
Query: 484 GTLGYTAPEYAIHGQLSEKVDAYSFGVL 511
T Y APE + + D +S GV+
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 52/228 (22%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFEN---------EV 367
+++ + +GEG +G + N VA+KK+ S FE+ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI---------SPFEHQTYCQRTLREI 76
Query: 368 RLISNVHHRNLIRLL-----GCCSQGPELILVYEYMANSSLDKFLFGEKRGSL-NWKQRF 421
+++ H N+I + Q ++ +V + M + L K L K L N +
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL---KTQHLSNDHICY 132
Query: 422 DI--ILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS 479
+ IL RGL Y+H ++HRD+KPSN+LL+ KI DFGLAR+ + H
Sbjct: 133 FLYQIL---RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 480 --TKFAGTLGYTAPE-------YAIHGQLSEKVDAYSFGVLVLEIISG 518
T++ T Y APE Y ++ +D +S G ++ E++S
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGY------TKSIDIWSVGCILAEMLSN 228
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFEN-------EVRLISNVHHRNL 378
LGEG +G + + + AVK I + ++ L N E++L+ + H+N+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVK---I-LKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 379 IRL---LGCCSQGPELILVYEYMANSSLDKFLFG---EKRGSLNWKQRF--DIILGTARG 430
I+L L + ++ +V EY + + EKR + + +I G
Sbjct: 69 IQLVDVLYNEEKQ-KMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDG---- 121
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ--SHLSTKFAGTLGY 488
L YLH I+H+DIKP N+LL KI+ G+A L T G+ +
Sbjct: 122 LEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAF 177
Query: 489 TAPEYAIHGQLS---EKVDAYSFGVLVLEIISG 518
PE +G + KVD +S GV + I +G
Sbjct: 178 QPPE-IANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 37/210 (17%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKL--AIGISRR----TLSDFENEV-RLISNVHHRNL 378
+G GGFG++Y GK+ A+K L ++ L+ E + L+S +
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN--ERIMLSLVSTGDCPFI 254
Query: 379 IRLLGCCSQGPE-LILVYEYMANSSLDKFL-----FGEKRGSLNWKQRF---DIILGTAR 429
+ + P+ L + + M L L F E RF +IILG
Sbjct: 255 VCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM------RFYAAEIILG--- 304
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYT 489
L ++H +++RD+KP+N+LLD+ +I+D GLA + + H GT GY
Sbjct: 305 -LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYM 357
Query: 490 APEYAIHGQLSEK-VDAYSFGVLVLEIISG 518
APE G + D +S G ++ +++ G
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRG 387
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 2e-22
Identities = 40/197 (20%), Positives = 82/197 (41%), Gaps = 23/197 (11%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLA-----IGISRRTLSDFENEVRLIS 371
++ + +G G +G + + ++VA+KK+ + +R L E+ +++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL----REIAILN 107
Query: 372 NVHHRNLIRLL-----GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDI-IL 425
++H +++++L + EL +V E +S K + + +L
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLL 166
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT 485
G+ Y+H I+HRD+KP+N L++ D K+ DFGLAR + ++ S
Sbjct: 167 ---VGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 486 LGYTAPEYAIHGQLSEK 502
+ K
Sbjct: 221 REDDMNLVTFPHTKNLK 237
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-22
Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 43/213 (20%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVK---KLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
+G+G FG + K+ A+K K + R + + E++++ + H L+ L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC-VERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 383 GCCSQGPE-LILVYEYMANSSLDKFLFGEKRGSLNWKQRFD----------IILGTARGL 431
Q E + +V + + L G+ R L F +++ L
Sbjct: 82 -YSFQDEEDMFMVVDLL--------LGGDLRYHLQQNVHFKEETVKLFICELVMA----L 128
Query: 432 AYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAP 491
YL RIIHRD+KP N+LLD+ I DF +A +LP + AGT Y AP
Sbjct: 129 DYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAP 183
Query: 492 E------YAIHGQLSEKVDAYSFGVLVLEIISG 518
E A + VD +S GV E++ G
Sbjct: 184 EMFSSRKGAGYSF---AVDWWSLGVTAYELLRG 213
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 28/214 (13%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLA-----IGISRRTLSDFENEVRLIS 371
+ + +G G +G + + G VA+KKL ++R E+RL+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLK 79
Query: 372 NVHHRNLIRLL------GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL 425
++ H N+I LL + LV +M + L K + K L + ++
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KHEKLGEDRIQFLVY 135
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT 485
+GL Y+H IIHRD+KP N+ +++D + KI DFGLAR T + T
Sbjct: 136 QMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----TGYVVT 188
Query: 486 LGYTAPEYAI-HGQLSEKVDAYSFGVLVLEIISG 518
Y APE + + ++ VD +S G ++ E+I+G
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVK---KLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382
LG G FG + G G VAVK + I S + + E++ + H ++I+L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 383 GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTAR--------GLAYL 434
S + +V EY++ L F + K G + + AR + Y
Sbjct: 78 QVISTPTDFFMVMEYVSGGEL--FDYICKHGRVEEME--------ARRLFQQILSAVDYC 127
Query: 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYA 494
H ++HRD+KP NVLLD + KIADFGL+ + + L T G+ Y APE
Sbjct: 128 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRT-SCGSPNYAAPE-V 181
Query: 495 IHGQLSE--KVDAYSFGVLVLEIISGT 519
I G+L +VD +S GV++ ++ GT
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 30/206 (14%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDF------ENEVRLISNVHHRNLI 379
LGEG FG + T K + VA+K ISR+ L E E+ + + H ++I
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALK---F-ISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQ--RF--DIILGTARGLAYLH 435
+L + ++++V EY D + ++ + + RF II + Y H
Sbjct: 73 KLYDVITTPTDIVMVIEYAGGELFDYIV---EKKRMTEDEGRRFFQQII----CAIEYCH 125
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI 495
+I+HRD+KP N+LLDD+L KIADFGL+ ++ + L T G+ Y APE I
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKT-SCGSPNYAAPE-VI 179
Query: 496 HGQLSE--KVDAYSFGVLVLEIISGT 519
+G+L +VD +S G+++ ++ G
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 62/241 (25%), Positives = 103/241 (42%), Gaps = 32/241 (13%)
Query: 296 NISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKL--A 352
NI E E P ++K + F +G G FG++ LK K+ A+K L
Sbjct: 51 NILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW 110
Query: 353 IGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPE-LILVYEYMAN----SSLDKF- 406
+ R + F E ++ N + + L Q L LV +Y + L KF
Sbjct: 111 EMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFE 169
Query: 407 -LFGEKRGSLNWKQRF---DIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKI 462
E+ RF ++++ + +H+ + +HRDIKP N+L+D + ++
Sbjct: 170 DRLPEEMA------RFYLAEMVIA----IDSVHQ---LHYVHRDIKPDNILMDMNGHIRL 216
Query: 463 ADFGLARLLPENQSHLSTKFAGTLGYTAPE-----YAIHGQLSEKVDAYSFGVLVLEIIS 517
ADFG L E+ + S+ GT Y +PE G+ + D +S GV + E++
Sbjct: 217 ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
Query: 518 G 518
G
Sbjct: 277 G 277
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLA-----IGISRRTLSDFENEVRLIS 371
++ + +G G +G + K G VAVKKL+ I ++RT E+RL+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLK 83
Query: 372 NVHHRNLIRLL------GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL 425
++ H N+I LL + ++ LV M + L+ + K L +I
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV---KCQKLTDDHVQFLIY 139
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT 485
RGL Y+H IIHRD+KPSN+ +++D + KI DFGLAR + + T + T
Sbjct: 140 QILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVAT 192
Query: 486 LGYTAPEYAI-HGQLSEKVDAYSFGVLVLEIISG 518
Y APE + ++ VD +S G ++ E+++G
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 3e-21
Identities = 48/204 (23%), Positives = 77/204 (37%), Gaps = 34/204 (16%)
Query: 324 ENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRL 381
LG G G + + K + A+K + EV L +++R+
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKM----LQDC--PKARREVELHWRASQCPHIVRI 120
Query: 382 LG----CCSQGPELILVYEYMANSSL-DKFL------FGEKRGSLNWKQRFDIILGTARG 430
+ + L++V E + L + F E+ S K I
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS----IGEA--- 173
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLLPENQSHLSTKFAGTLG 487
+ YLH + I HRD+KP N+L + K+ DFG A+ + S L+T T
Sbjct: 174 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTT-PCYTPY 228
Query: 488 YTAPEYAIHGQLSEKVDAYSFGVL 511
Y APE + + D +S GV+
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVI 252
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 5e-21
Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 41/214 (19%)
Query: 327 LGEGGFGDIY----KGTLKNGKIVAVKKL--AIGISRRTLSDFENEVRLISNVHHRNLIR 380
+G G FG++ K T K+ A+K L I R + F E +++ + +++
Sbjct: 77 IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 381 LLGCCSQGPE-LILVYEYMAN----SSLDKFLFGEKRGSLNWKQRF---DIILGTARGLA 432
L Q L +V EYM + + + EK RF +++L L
Sbjct: 134 LF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA------RFYTAEVVLA----LD 182
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPE 492
+H + IHRD+KP N+LLD K+ADFG + + GT Y +PE
Sbjct: 183 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239
Query: 493 -------YAIHGQLSEKVDAYSFGVLVLEIISGT 519
+G+ + D +S GV + E++ G
Sbjct: 240 VLKSQGGDGYYGR---ECDWWSVGVFLYEMLVGD 270
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-20
Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 29/206 (14%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFEN------EVRLISNVHHRNLI 379
LG G FG + G G VAVK I ++R+ + + E++ + H ++I
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVK---I-LNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQ--RF--DIILGTARGLAYLH 435
+L S ++ +V EY++ L F + K G L+ K+ R I+ G + Y H
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGEL--FDYICKNGRLDEKESRRLFQQILSG----VDYCH 133
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI 495
++HRD+KP NVLLD + KIADFGL+ + + L T G+ Y APE I
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRT-SCGSPNYAAPE-VI 187
Query: 496 HGQLSE--KVDAYSFGVLVLEIISGT 519
G+L +VD +S GV++ ++ GT
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 59/235 (25%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFEN---------EV 367
+ F ++ LGEG +G + T G+IVA+KK+ F+ E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP---------FDKPLFALRTLREI 60
Query: 368 RLISNVHHRNLIRLL-----GCCSQGPELILVYEYMANSSLDKFLFGEKRGSL-NWKQRF 421
+++ + H N+I + E+ ++ E M + L + + L + ++
Sbjct: 61 KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI---STQMLSDDHIQY 116
Query: 422 DI--ILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS 479
I L R + LH +IHRD+KPSN+L++ + K+ DFGLAR++ E+ + S
Sbjct: 117 FIYQTL---RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 480 TKFAGTLG---------YTAPE-------YAIHGQLSEKVDAYSFGVLVLEIISG 518
G Y APE Y S +D +S G ++ E+
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLR 219
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 60/246 (24%), Positives = 99/246 (40%), Gaps = 40/246 (16%)
Query: 296 NISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIY----KGTLKNGKIVAVKKL 351
+++ + P+ RLK++ F +G G F ++ K T G++ A+K +
Sbjct: 38 YVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIM 94
Query: 352 --AIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPE-LILVYEYMAN----SSLD 404
+ R +S F E ++ N R + +L Q L LV EY + L
Sbjct: 95 NKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS 153
Query: 405 KF--LFGEKRGSLNWKQRF---DIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ 459
KF + RF +I++ + +H + +HRDIKP N+LLD
Sbjct: 154 KFGERIPAEMA------RFYLAEIVMA----IDSVHR---LGYVHRDIKPDNILLDRCGH 200
Query: 460 PKIADFGLARLLPENQSHLSTKFAGTLGYTAPE-------YAIHGQLSEKVDAYSFGVLV 512
++ADFG L + + S GT Y +PE G + D ++ GV
Sbjct: 201 IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260
Query: 513 LEIISG 518
E+ G
Sbjct: 261 YEMFYG 266
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 5e-20
Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 26/200 (13%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLA-----IGISRRTLSDFENEVRLIS 371
+ ++ +G G +G +Y K VA+KK+ + +R L E+ +++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL----REITILN 80
Query: 372 NVHHRNLIRLL-----GCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDI--I 424
+ +IRL + EL +V E +S L K + + + +
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTI-LYNL 138
Query: 425 LGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL-PENQSHLSTKFA 483
L G ++HE IIHRD+KP+N LL+ D K+ DFGLAR + E +++
Sbjct: 139 L---LGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 484 GTLGYTAPEYAIHGQLSEKV 503
+ QL+ V
Sbjct: 193 ENEEPGPHNKNLKKQLTSHV 212
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 52/199 (26%), Positives = 78/199 (39%), Gaps = 35/199 (17%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSD--FENEVRLISNVHHRNLIRLLG 383
+G G FG ++VAVK I R D + E+ ++ H N++R
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVK---Y-IERGAAIDENVQREIINHRSLRHPNIVRFKE 83
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTAR--------GLAYLH 435
L ++ EY + L + G + + AR G++Y H
Sbjct: 84 VILTPTHLAIIMEYASGGEL--YERICNAGRFSEDE--------ARFFFQQLLSGVSYCH 133
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQP--KIADFGLARLLPENQSHLSTKFAGTLGYTAPEY 493
++I HRD+K N LLD P KI DFG ++ S + GT Y APE
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKS-TVGTPAYIAPE- 187
Query: 494 AIHGQL--SEKVDAYSFGV 510
+ Q + D +S GV
Sbjct: 188 VLLRQEYDGKIADVWSCGV 206
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 24/214 (11%), Positives = 51/214 (23%), Gaps = 50/214 (23%)
Query: 309 YRLKDLVSATRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKL--AIGISRRTLSDFEN 365
YRL G ++ + VA+ + + L + +
Sbjct: 33 YRLLIF------------HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLS 80
Query: 366 EVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL 425
+S + + R+L ++V E++ SL + S + +
Sbjct: 81 RTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQ 136
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT 485
A H + PS V + D +A
Sbjct: 137 SLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYP-------------------- 173
Query: 486 LGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGT 519
+ + D G + ++
Sbjct: 174 -ATMPDA-------NPQDDIRGIGASLYALLVNR 199
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 9e-19
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 327 LGEGGFGDIYKGTLKN-GKIVAVKKL--AIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
LG+G FG + K G+ A+K L + +++ ++ E R++ N H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 384 CCSQGPE-LILVYEYMANSSL-----DKFLFGEKRGSLNWKQRF---DIILGTARGLAYL 434
Q + L V EY L + +F E R RF +I+ L YL
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA------RFYGAEIVSA----LDYL 264
Query: 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYA 494
H + + +++RD+K N++LD D KI DFGL + ++ + + T F GT Y APE
Sbjct: 265 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVL 321
Query: 495 IHGQLSEKVDAYSFGVLVLEIISG 518
VD + GV++ E++ G
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCG 345
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 49/198 (24%), Positives = 93/198 (46%), Gaps = 26/198 (13%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLA-----IGISRRTLSDFENEVRLIS 371
RK+ KLG+G +G ++K + G++VAVKK+ ++RT E+ +++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF----REIMILT 63
Query: 372 NVH-HRNLIRLLGCC--SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQ-RFDI--IL 425
+ H N++ LL ++ LV++YM + L + + L ++ + ++
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVI---RANILEPVHKQYVVYQLI 119
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT 485
+ + YLH ++HRD+KPSN+LL+ + K+ADFGL+R + +
Sbjct: 120 ---KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 486 LGYTAPEYAIHGQLSEKV 503
T L++ V
Sbjct: 174 NENTENFDDDQPILTDYV 191
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKL--AIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
LG+G FG + K G+ A+K L + I++ ++ E R++ N H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 384 CCSQGPE-LILVYEYMANSSL-----DKFLFGEKRGSLNWKQRF---DIILGTARGLAYL 434
Q + L V EY L + +F E+R RF +I+ L YL
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA------RFYGAEIVSA----LEYL 121
Query: 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPE-- 492
H +++RDIK N++LD D KI DFGL + + + + T F GT Y APE
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVL 177
Query: 493 -YAIHGQLSEKVDAYSFGVLVLEIISG 518
+G+ VD + GV++ E++ G
Sbjct: 178 EDNDYGR---AVDWWGLGVVMYEMMCG 201
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 61/238 (25%), Positives = 96/238 (40%), Gaps = 37/238 (15%)
Query: 293 QRGNISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKL 351
+ + + E +L F LG G FG + K +G A+K L
Sbjct: 22 AKEDFLKKWETPSQNTAQLDQ-------FDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL 74
Query: 352 AIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFL-- 407
+ + + NE R++ V+ L++L L +V EY+A + L
Sbjct: 75 DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 134
Query: 408 ---FGEKRGSLNWKQRF---DIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPK 461
F E RF I+L YLH + +I+RD+KP N+L+D +
Sbjct: 135 IGRFSEPHA------RFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQ 181
Query: 462 IADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEK-VDAYSFGVLVLEIISG 518
+ DFG A+ + T GT APE I + K VD ++ GVL+ E+ +G
Sbjct: 182 VTDFGFAK---RVKGRTWT-LCGTPEALAPE-IILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 5e-18
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 32/205 (15%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKL--AIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
LG G FG ++ + NG+ A+K L I + + + +E ++S V H +IR+ G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 384 CCSQGPELILVYEYMANSSLDKFL-----FGEKRGSLNWKQRF---DIILGTARGLAYLH 435
++ ++ +Y+ L L F +F ++ L L YLH
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA------KFYAAEVCLA----LEYLH 123
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK-FAGTLGYTAPEYA 494
II+RD+KP N+LLD + KI DFG A+ +P+ T GT Y APE
Sbjct: 124 S---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPE-V 174
Query: 495 IHGQLSEK-VDAYSFGVLVLEIISG 518
+ + K +D +SFG+L+ E+++G
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 5e-18
Identities = 64/211 (30%), Positives = 91/211 (43%), Gaps = 40/211 (18%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKL--AIGISR----RTLSDFENEVRLISNVHHRNLI 379
LG+G FG + K ++ AVK L + I T+ E V L L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV--EKRV-LALPGKPPFLT 405
Query: 380 RLLGCCSQGPE-LILVYEYMANSSL-----DKFLFGEKRGSLNWKQRF---DIILGTARG 430
+L C Q + L V EY+ L F E F +I +G
Sbjct: 406 QLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA------VFYAAEIAIG---- 454
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
L +L II+RD+K NV+LD + KIADFG+ + + T F GT Y A
Sbjct: 455 LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIA 510
Query: 491 PE---YAIHGQLSEKVDAYSFGVLVLEIISG 518
PE Y +G+ VD ++FGVL+ E+++G
Sbjct: 511 PEIIAYQPYGK---SVDWWAFGVLLYEMLAG 538
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 65/208 (31%), Positives = 92/208 (44%), Gaps = 34/208 (16%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKL--AIGISR----RTLSDFENEVRLISNVHHRNLI 379
LG+G FG ++ K + A+K L + + T+ E V L H L
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMV--EKRV-LSLAWEHPFLT 81
Query: 380 RLLGCCSQGPE-LILVYEYMANSSL-----DKFLFGEKRGSLNWKQRF---DIILGTARG 430
+ C Q E L V EY+ L F R F +IILG
Sbjct: 82 HMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR------ATFYAAEIILG---- 130
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
L +LH I++RD+K N+LLD D KIADFG+ + + +T F GT Y A
Sbjct: 131 LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIA 186
Query: 491 PEYAIHGQLSEKVDAYSFGVLVLEIISG 518
PE + + + VD +SFGVL+ E++ G
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 36/209 (17%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKL--AIGISR----RTLSDFENEVRLISNVHHRNLI 379
+G G + + LK +I A+K + + + E V +H L+
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT--EKHV-FEQASNHPFLV 73
Query: 380 RLLGCCSQGPE-LILVYEYMANSSL-----DKFLFGEKRGSLNWKQRF---DIILGTARG 430
L C Q L V EY+ L + E+ RF +I L
Sbjct: 74 GLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA------RFYSAEISLA---- 122
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
L YLHE II+RD+K NVLLD + K+ D+G+ + ST F GT Y A
Sbjct: 123 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIA 178
Query: 491 PEYAIHGQLSEK-VDAYSFGVLVLEIISG 518
PE + G+ VD ++ GVL+ E+++G
Sbjct: 179 PE-ILRGEDYGFSVDWWALGVLMFEMMAG 206
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 64/211 (30%), Positives = 91/211 (43%), Gaps = 40/211 (18%)
Query: 327 LGEGGFGDIYKGTLKN-GKIVAVKKL--AIGISR----RTLSDFENEVRLISNVHHRNLI 379
LG+G FG + K ++ AVK L + I T+ E V L L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV--EKRV-LALPGKPPFLT 84
Query: 380 RLLGCCSQGPE-LILVYEYMANSSL-----DKFLFGEKRGSLNWKQRF---DIILGTARG 430
+L C Q + L V EY+ L F E F +I +G
Sbjct: 85 QLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA------VFYAAEIAIG---- 133
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
L +L II+RD+K NV+LD + KIADFG+ + + T F GT Y A
Sbjct: 134 LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIA 189
Query: 491 PE---YAIHGQLSEKVDAYSFGVLVLEIISG 518
PE Y +G+ VD ++FGVL+ E+++G
Sbjct: 190 PEIIAYQPYGK---SVDWWAFGVLLYEMLAG 217
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 43/213 (20%)
Query: 327 LGEGGFGDIY---KGTLKN-GKIVAVKKL--AIGISR---RTLSDFENEVRLISNVHHRN 377
LG+G FG ++ K + + ++ A+K L A R RT E ++ V+H
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM----ERDILVEVNHPF 87
Query: 378 LIRLLGCCSQGPE-LILVYEYMANSSL-----DKFLFGEKRGSLNWKQRF---DIILGTA 428
+++L Q L L+ +++ L + +F E+ +F ++ L
Sbjct: 88 IVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV------KFYLAELALA-- 138
Query: 429 RGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGY 488
L +LH + II+RD+KP N+LLD++ K+ DFGL++ +++ + F GT+ Y
Sbjct: 139 --LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEY 192
Query: 489 TAPE---YAIHGQLSEKVDAYSFGVLVLEIISG 518
APE H Q D +SFGVL+ E+++G
Sbjct: 193 MAPEVVNRRGHTQS---ADWWSFGVLMFEMLTG 222
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 36/209 (17%)
Query: 327 LGEGGFGDIYKGTLKN-GKIVAVKKL--AIGISR----RTLSDFENEVRLISNVHHRNLI 379
+G G + + LK +I A++ + + + E V +H L+
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT--EKHV-FEQASNHPFLV 116
Query: 380 RLLGCCSQGPE-LILVYEYMANSSL-----DKFLFGEKRGSLNWKQRF---DIILGTARG 430
L C Q L V EY+ L + E+ RF +I L
Sbjct: 117 GLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA------RFYSAEISLA---- 165
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
L YLHE II+RD+K NVLLD + K+ D+G+ + ST F GT Y A
Sbjct: 166 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIA 221
Query: 491 PEYAIHGQLSEK-VDAYSFGVLVLEIISG 518
PE + G+ VD ++ GVL+ E+++G
Sbjct: 222 PE-ILRGEDYGFSVDWWALGVLMFEMMAG 249
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 64/209 (30%), Positives = 94/209 (44%), Gaps = 36/209 (17%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKL--AIGISRR----TLSDFENEVRLISNVHHRNLI 379
+G+G FG + K AVK L + ++ +S E V L+ NV H L+
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMS--ERNV-LLKNVKHPFLV 102
Query: 380 RLLGCCSQGPE-LILVYEYMANSSL-----DKFLFGEKRGSLNWKQRF---DIILGTARG 430
L Q + L V +Y+ L + F E R RF +I
Sbjct: 103 GLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA------RFYAAEIASA---- 151
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
L YLH + I++RD+KP N+LLD + DFGL + E+ S ST F GT Y A
Sbjct: 152 LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLA 207
Query: 491 PEYAIHGQLSEK-VDAYSFGVLVLEIISG 518
PE +H Q ++ VD + G ++ E++ G
Sbjct: 208 PE-VLHKQPYDRTVDWWCLGAVLYEMLYG 235
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 67/211 (31%), Positives = 98/211 (46%), Gaps = 40/211 (18%)
Query: 327 LGEGGFGDIYKGTLK-NGKIVAVKKL--AIGISR----RTLSDFENEVRLISNVHHRNLI 379
LG+G FG + +K G + AVK L + + T++ E + L +H L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMT--EKRI-LSLARNHPFLT 87
Query: 380 RLLGCCSQGPE-LILVYEYMANSSL-----DKFLFGEKRGSLNWKQRF---DIILGTARG 430
+L CC Q P+ L V E++ L F E R RF +II
Sbjct: 88 QLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA------RFYAAEIISA---- 136
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
L +LH+ II+RD+K NVLLD + K+ADFG+ + N +T F GT Y A
Sbjct: 137 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIA 192
Query: 491 PE---YAIHGQLSEKVDAYSFGVLVLEIISG 518
PE ++G VD ++ GVL+ E++ G
Sbjct: 193 PEILQEMLYGP---AVDWWAMGVLLYEMLCG 220
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 81.9 bits (201), Expect = 6e-17
Identities = 39/196 (19%), Positives = 60/196 (30%), Gaps = 46/196 (23%)
Query: 317 ATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAI-------GISRRTLSDFENEV-- 367
T K K+GEG FG++++ VA+K +AI G ++T + E+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 368 -------RLISNVHHRNLIRLLGC-CSQG---PELILVYEYM------ANSSLDKF---- 406
I L C QG P L+ +++ AN D F
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 407 -------------LFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVL 453
L + + I+ LA HRD+ NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVL 194
Query: 454 LDDDLQPKIADFGLAR 469
L K+ +
Sbjct: 195 LKKTSLKKLHYTLNGK 210
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 45/217 (20%)
Query: 327 LGEGGFGDIY---KGTLKN-GKIVAVKKL--AIGISR-----RTLSDFENEVRLISNVHH 375
LG G +G ++ K + + GK+ A+K L A + + T + E +V L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT--ERQV-LEHIRQS 118
Query: 376 RNLIRLLGCCSQGPE-LILVYEYMANSSLDKFL-------FGEKRGSLNWKQRF---DII 424
L+ L Q L L+ +Y+ L F F E + +I+
Sbjct: 119 PFLVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEV------QIYVGEIV 169
Query: 425 LGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAG 484
L L +LH+ + II+RDIK N+LLD + + DFGL++ +++ + F G
Sbjct: 170 LA----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 485 TLGYTAPE---YAIHGQLSEKVDAYSFGVLVLEIISG 518
T+ Y AP+ G + VD +S GVL+ E+++G
Sbjct: 223 TIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTG 258
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 8e-17
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 37/211 (17%)
Query: 327 LGEGGFGDIY---KGTLKN-GKIVAVK---KLAIGISRRTLSDFENEVRLISNVHHRNLI 379
LG+GG+G ++ K T N GKI A+K K I + + + + E ++ V H ++
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 380 RLLGCCSQGPE-LILVYEYMANSSL-----DKFLFGEKRGSLNWKQRF---DIILGTARG 430
L+ Q L L+ EY++ L + +F E F +I +
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA------CFYLAEISMA---- 133
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
L +LH+ II+RD+KP N++L+ K+ DFGL + + + T F GT+ Y A
Sbjct: 134 LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMA 189
Query: 491 PE---YAIHGQLSEKVDAYSFGVLVLEIISG 518
PE + H + VD +S G L+ ++++G
Sbjct: 190 PEILMRSGHNRA---VDWWSLGALMYDMLTG 217
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 55/223 (24%), Positives = 88/223 (39%), Gaps = 24/223 (10%)
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYL 434
R L + S + + +++ ++ + L + A+G+ +L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT-LGYTAPEY 493
+ IHRD+ N+LL + KI DFGLAR + ++ ++ A L + APE
Sbjct: 210 AS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266
Query: 494 AIHGQLSEKVDAYSFGVLVLEIISGTKS---SETKGEEGEYLLKRAWRLYENGTHWELMD 550
+ + D +SFGVL+ EI S S EE LK R M
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR----------MR 316
Query: 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
P+ T E + + L C + RPT SE+V L +
Sbjct: 317 A---PDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLGN 352
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 27/127 (21%), Positives = 56/127 (44%), Gaps = 8/127 (6%)
Query: 324 ENKLGEGGFGDIYKGTLKN------GKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHR 376
LG G FG + + + VAVK L G + +E++++ ++ HH
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 377 NLIRLLGCCSQ-GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLH 435
N++ LLG C++ G L+++ E+ +L +L ++ + +K + + +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 436 EDFHVRI 442
D R+
Sbjct: 147 VDLKRRL 153
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 36/164 (21%), Positives = 58/164 (35%), Gaps = 35/164 (21%)
Query: 326 KLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVR-LISNVHHRNLIRLLG 383
LG G G + + K + A+K + EV +++R++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKM----LQDC--PKARREVELHWRASQCPHIVRIVD 78
Query: 384 CC----SQGPELILVYEYMANSSL-DKFL------FGEKRGSLNWKQRFDIILGTARGLA 432
+ L++V E + L + F E+ S K I +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS----IGEA---IQ 131
Query: 433 YLHEDFHVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLLPE 473
YLH + I HRD+KP N+L + K+ DFG A E
Sbjct: 132 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KE 169
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 50/241 (20%)
Query: 326 KLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFE---NEVRLISNVH------- 374
KLG G F ++ + N VA+K I R E +E++L+ V+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 375 ----HRNLIRLLGC----CSQGPELILVYEYMANSSLDKFL--FGEKRGSLNWKQRFDI- 423
++++LL G +++V+E + +L + + + L + ++
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 424 ILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP------KIADFGLARLLPENQS- 476
+L GL Y+H IIH DIKP NVL++ P KIAD G A E+ +
Sbjct: 140 LL---LGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 194
Query: 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG-----TKSSETKGEEGEY 531
+ T+ Y +PE + D +S L+ E+I+G + ++ ++
Sbjct: 195 SIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
Query: 532 L 532
+
Sbjct: 250 I 250
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 66/357 (18%), Positives = 112/357 (31%), Gaps = 104/357 (29%)
Query: 326 KLGEGGFGDIYKG-TLKNGKIVAVKKLAIGISRRTLSDF-ENEVRLISNVH--------H 375
KLG G F ++ ++ K VA+K + S ++ +E+RL+ +V
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 376 RNLIRLLGC-CSQGPE---LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGL 431
+++LL G + +V+E + L K++ L II +GL
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159
Query: 432 AYLHEDFHVRIIHRDIKPSNVLL------------------------------------- 454
YLH IIH DIKP N+LL
Sbjct: 160 DYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 455 ------------DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEK 502
+ L+ KIAD G A + ++ + T Y + E I +
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNTP 273
Query: 503 VDAYSFGVLVLEIISGTKSSETKGEEGEY-------------------LLKRA------- 536
D +S + E+ +G E E L+
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333
Query: 537 -----WRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVV 588
+ W L + ++ E ++E A + L + R T +E +
Sbjct: 334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 72.2 bits (176), Expect = 4e-13
Identities = 79/499 (15%), Positives = 156/499 (31%), Gaps = 123/499 (24%)
Query: 233 LRYSD------TPFFADNQTTDITPFLKNGSSNKEAIIGGVVGGGTGLILFALLIWLVIS 286
+Y D F + D+ K+ S +E I ++ + L W ++S
Sbjct: 16 YQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEE--IDHIIMSKDAVSGTLRLFWTLLS 73
Query: 287 RKSKKIQRGNISEATE-----LQGPVNYRLKDLVSATRKFSEE-NKLGEGG--------- 331
++ + +Q+ + E L P+ + TR + E+ ++L
Sbjct: 74 KQEEMVQKF-VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS 132
Query: 332 ----FGDIYKG--TLKNGKIVAV-------KK-LAIGISRRTLSDFENEVRLISNVHHRN 377
+ + + L+ K V + K +A+ ++ + ++ + N
Sbjct: 133 RLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVAL----DVCLSYKVQCKMDFKIFWLN 188
Query: 378 LIRLLGCCSQGPELILVYEYMAN--SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLH 435
L C+ PE +L E + +D S N K R I R L L
Sbjct: 189 ----LKNCNS-PETVL--EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL--LK 239
Query: 436 EDFHVR--IIHRDIKPSNVLLDDDLQPKI----ADFGLARLL-PENQSHLSTKFAGTLGY 488
+ ++ +++ + +L KI + L +H+S ++
Sbjct: 240 SKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHH-SMTL 298
Query: 489 TAPEYAIHGQLSEKVD---------AYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRL 539
T E L + +D + L II E L W
Sbjct: 299 TPDEVK--SLLLKYLDCRPQDLPREVLTTNPRRLSII---------AESIRDGLAT-WDN 346
Query: 540 YENGTHWELMD------ESLDPNECTKEAAEKV------VEI--ALMCTQSAANSRPTMS 585
+++ +L L+P E ++ +++ I L+ + +
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAE-YRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVM 405
Query: 586 EVVALLKSTSSSLLGNKPLLKPTFVETDYRKTPADTSTSTALLLLMLQPPS------HKS 639
VV L S L++ K P +++ S + L L+ H+S
Sbjct: 406 VVVNKLHKYS--------LVE---------KQPKESTISIPSIYLELKVKLENEYALHRS 448
Query: 640 QVDS---PFNFWPSDCMTN 655
VD P F D +
Sbjct: 449 IVDHYNIPKTFDSDDLIPP 467
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 7e-04
Identities = 79/584 (13%), Positives = 147/584 (25%), Gaps = 205/584 (35%)
Query: 9 WA----VAEPE--MELINSGCSQY--NVTNFSEFNSNLNATFKELREQLNGGKKFATAQR 60
W PE +E++ Q N T+ S+ +SN+ ++ +L + +
Sbjct: 186 WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR--RLLKSKPY 243
Query: 61 TRG---PDQVYTM-------VQCRRYVSTADCAACFTSAESLIRNCSAANGARVIYLACS 110
V + C+ ++T + + SAA + S
Sbjct: 244 ENCLLVLLNVQNAKAWNAFNLSCKILLTTRF--------KQVTDFLSAATTTHI-----S 290
Query: 111 LRYESSSFYDQSTQEGRFGFCGNRTALQADAFKTAAQELLENLEVATPKINGFFAAS-KN 169
L + S + + L Q+L + P+ A S ++
Sbjct: 291 LDHHSMTLTPDEVKS-----------LLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRD 339
Query: 170 NIIGSRAGANDDDDKNSTAVYGIAQCVETISETGCQNCLSGAFDNIQRCLGSAFGWAVDA 229
+ + + DK +T I + + ++
Sbjct: 340 GLATWDNWKHVNCDKLTTI---IESSLNVLEP-----------AEYRKM----------- 374
Query: 230 GCFLRYSDTPFFADNQTTDITPFLKNGSSNKEAIIGGVVGGGTGLILFALLIWLVISRKS 289
+ F + I IL +L+ W
Sbjct: 375 -----FDRLSVFPPS--AHIPT-----------------------ILLSLI-W------F 397
Query: 290 KKIQRGNISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVK 349
I+ + +L Y L + K +E+ + I
Sbjct: 398 DVIKSDVMVVVNKL---HKYSLVE------KQPKESTIS------IP------------- 429
Query: 350 KLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFG 409
I ENE L HR+++ Y + D
Sbjct: 430 ----SIYLELKVKLENEYAL-----HRSIVD---------------HYNIPKTFD----- 460
Query: 410 EKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII---HRDIKPSNVLLDDD-LQPKIADF 465
+ D+I Y H H++ I R V LD L+ KI
Sbjct: 461 ------SD----DLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHD 510
Query: 466 GLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETK 525
A + + + Y + V+A
Sbjct: 511 STAWNASGSILNTLQQLKFYKPYICDN---DPKYERLVNAI------------------- 548
Query: 526 GEEGEYLLKRAWRLYENGTHWELMDESL-DPNECTKEAAEKVVE 568
++L K L + +L+ +L +E E A K V+
Sbjct: 549 ---LDFLPKIEENLI-CSKYTDLLRIALMAEDEAIFEEAHKQVQ 588
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 40/183 (21%), Positives = 72/183 (39%), Gaps = 23/183 (12%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
+ ++GEG FG I++GT L N + VA+K L +E R +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL---RDEYRTYKLLAGCTG 67
Query: 379 I-RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
I + +G +LV + + S D ++ S+ + A+ + +
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVK------TVAMAAKQMLARVQS 121
Query: 438 FHVR-IIHRDIKPSNVLLDDDLQPK-----IADFGLAR--LLPENQSHL----STKFAGT 485
H + +++RDIKP N L+ + DFG+ + P + H+ +GT
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181
Query: 486 LGY 488
Y
Sbjct: 182 ARY 184
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 49/181 (27%), Positives = 76/181 (41%), Gaps = 21/181 (11%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
++ K+G G FGDIY GT + G+ VA+K + L E ++ +
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL---HIESKIYKMMQGGVG 66
Query: 379 I-RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
I + C ++G ++V E + S D F F ++ SL +L A + E
Sbjct: 67 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLK------TVLLLADQMISRIEY 120
Query: 438 FHVR-IIHRDIKPSNVLLDDDLQPK---IADFGLAR--LLPENQSHLSTK----FAGTLG 487
H + IHRD+KP N L+ + I DFGLA+ H+ + GT
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 488 Y 488
Y
Sbjct: 181 Y 181
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 46/183 (25%), Positives = 71/183 (38%), Gaps = 23/183 (12%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
F K+G G FG++ G L + VA+K + L E R + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQL---HLEYRFYKQLGSGDG 66
Query: 379 I-RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
I ++ G +V E + S D F ++ SL +L A L E
Sbjct: 67 IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLK------TVLMIAIQLISRMEY 120
Query: 438 FHVR-IIHRDIKPSNVLLDDDLQPK-----IADFGLAR--LLPENQSHLSTK----FAGT 485
H + +I+RD+KP N L+ I DF LA+ + PE + H+ + GT
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180
Query: 486 LGY 488
Y
Sbjct: 181 ARY 183
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 32/232 (13%), Positives = 77/232 (33%), Gaps = 34/232 (14%)
Query: 285 ISRKSKKIQRGNISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGT----- 339
+ ++ + +++ + E P L D R++ ++ G +Y+
Sbjct: 11 VDLGTENLYFQSMTTSLE-ALPTGTVLTDKSG--RQWKLKSFQTRDNQGILYEAAPTSTL 67
Query: 340 ----LKNGKIVAVK------KLAIGIS---RRTLSDFENEVRLISNVHHRNLIRLLGCCS 386
+ ++K +L + R N+ + + + + +G
Sbjct: 68 TCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGV 127
Query: 387 QGPEL-ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHR 445
+ LV + SL L + L+ + + L +LHE +H
Sbjct: 128 HQDKYRFLVLPSLG-RSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHG 183
Query: 446 DIKPSNVLLDDDLQPKI--ADFGLARLLPENQSHLSTK------FAGTLGYT 489
++ N+ +D + Q ++ A +G A + H++ G L +
Sbjct: 184 NVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 50/217 (23%), Positives = 92/217 (42%), Gaps = 51/217 (23%)
Query: 327 LGEGGFGDIYKGT-LKNGKIVAVK------------KLAIGISRRTLSDFENE-----VR 368
+G+G FG + K K + VA+K I I L + + +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEH-LRKQDKDNTMNVIH 163
Query: 369 LISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFL-FGEKRG-SLNWKQRFDIILG 426
++ N RN + + +E ++ +L + + + +G SL ++F +
Sbjct: 164 MLENFTFRN------------HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 427 TARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP--KIADFGLARLLPENQSH---LSTK 481
L LH+ RIIH D+KP N+LL + K+ DFG + E+Q + ++
Sbjct: 211 QC--LDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYTYIQSR 263
Query: 482 FAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
F Y APE + + +D +S G ++ E+++G
Sbjct: 264 F-----YRAPEVILGARYGMPIDMWSLGCILAELLTG 295
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 46/175 (26%), Positives = 72/175 (41%), Gaps = 21/175 (12%)
Query: 326 KLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI-RLLG 383
K+G G FG+IY GT ++ + VA+K + L E ++ + I +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL---LYESKIYRILQGGTGIPNVRW 70
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVR-I 442
+G +LV + + S D F F ++ SL +L A + E H +
Sbjct: 71 FGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLK------TVLMLADQMINRVEFVHSKSF 124
Query: 443 IHRDIKPSNVLLDDDLQPK---IADFGLARLL--PENQSHLSTK----FAGTLGY 488
+HRDIKP N L+ + I DFGLA+ H+ + GT Y
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 39/238 (16%), Positives = 75/238 (31%), Gaps = 49/238 (20%)
Query: 287 RKSKKIQRGNISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIV 346
+ ++ ++ + Q V + D+ + + +G+GGFG IY + + + V
Sbjct: 5 KAAQAGRQSSAKRHLAEQFAVGEIITDMAA--AAWKVGLPIGQGGFGCIYLADMNSSESV 62
Query: 347 AVK-KLAIGISRRTLSDFENEVRLISNVHHRNLI---------------RLLGCCSQGPE 390
+ + E++ I + G
Sbjct: 63 GSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKN 122
Query: 391 L----ILVYEYMANSSLDKFLFGEKRGSLNWK-------QRFDIILGTARGLAYLHEDFH 439
++ + + + KR S K + DI+ Y+HE
Sbjct: 123 GKSYRFMIMDRFGSDLQKIYEANAKRFSR--KTVLQLSLRILDIL-------EYIHE--- 170
Query: 440 VRIIHRDIKPSNVLLDDDLQPKI--ADFGLARLLPENQSHL------STKFAGTLGYT 489
+H DIK SN+LL+ ++ D+GLA H GT+ +T
Sbjct: 171 HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT 228
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 44/239 (18%), Positives = 75/239 (31%), Gaps = 55/239 (23%)
Query: 287 RKSKKIQRGNISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGT-LKNGKI 345
+ N+ + P L D+ ++ K+G GGFG IY +
Sbjct: 8 SSGVDLGTENLYFQSM-PFPEGKVLDDMEG--NQWVLGKKIGSGGFGLIYLAFPTNKPEK 64
Query: 346 VAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPEL-------------- 391
A + + + +E++ V ++ I+ Q L
Sbjct: 65 DARH--VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFK 122
Query: 392 -----ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLA--------YLHEDF 438
+V E + L K F T L Y+HE
Sbjct: 123 GRSYRFMVMERL-GIDLQKIS--------GQNGTFK--KSTVLQLGIRMLDVLEYIHE-- 169
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKI--ADFGLARLLPENQSHLSTK------FAGTLGYT 489
+H DIK +N+LL ++ AD+GL+ N +H + GT+ +T
Sbjct: 170 -NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT 227
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 49/219 (22%)
Query: 325 NKLGEGGFGDIYKGT-LKNGKIVAVK------------KLAIGISRRTLSDFENE----- 366
+ +G+G FG + K + VA+K ++ + + ++ + E
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLEL-MNKHDTEMKYYI 118
Query: 367 VRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFL--FGEKRGSLNWKQRFDII 424
V L + RN L LV+E ++ +L L + SLN ++F
Sbjct: 119 VHLKRHFMFRN------------HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 425 LGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP--KIADFGLARLLPENQSH---LS 479
+ TA L +L + IIH D+KP N+LL + + KI DFG + Q +
Sbjct: 166 MCTA--LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRIYQYIQ 220
Query: 480 TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISG 518
++F Y +PE + +D +S G +++E+ +G
Sbjct: 221 SRF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 49/248 (19%), Positives = 88/248 (35%), Gaps = 89/248 (35%)
Query: 326 KLGEGGFGDIYKGT-LKNGKIVAVK------------KLAIGISRRTLSDFENE----VR 368
K+G+G FG + + N K AVK K+ I + + + + V+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADI-LKKIQNDDINNNNIVK 100
Query: 369 LISNVHHRNLI----RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDII 424
+ + + LG +YE + ++ + F + + + I
Sbjct: 101 YHGKFMYYDHMCLIFEPLGPS--------LYEIITRNNYNGF-------HIEDIKLYCIE 145
Query: 425 LGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP------------------------ 460
+ A L YL + + + H D+KP N+LLDD
Sbjct: 146 ILKA--LNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 461 -KIADFGLARLLPENQSH---LSTKFAGTLGYTAPE------YAIHGQLSEKVDAYSFGV 510
K+ DFG A ++ H ++T+ Y APE + D +SFG
Sbjct: 201 IKLIDFGCA--TFKSDYHGSIINTRQ-----YRAPEVILNLGW------DVSSDMWSFGC 247
Query: 511 LVLEIISG 518
++ E+ +G
Sbjct: 248 VLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 45/244 (18%), Positives = 85/244 (34%), Gaps = 85/244 (34%)
Query: 326 KLGEGGFGDIYKG--TLKNGKIVAVK------------KLAIGISRRTLSDFENE----- 366
LGEG FG + + + VA+K +L I + + + + + E
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINV-LKKIKEKDKENKFLC 84
Query: 367 VRLISNVHHRNLI----RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFD 422
V + + + LLG +E++ ++ + L +
Sbjct: 85 VLMSDWFNFHGHMCIAFELLGKN--------TFEFLKENNFQPY-------PLPHVRHMA 129
Query: 423 IILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP-------------------KIA 463
L A L +LHE ++ H D+KP N+L + ++A
Sbjct: 130 YQLCHA--LRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 464 DFGLARLLPENQSH---LSTKFAGTLGYTAPE------YAIHGQLSEKVDAYSFGVLVLE 514
DFG A +++ H ++T+ Y PE + ++ D +S G ++ E
Sbjct: 185 DFGSA--TFDHEHHTTIVATRH-----YRPPEVILELGW------AQPCDVWSIGCILFE 231
Query: 515 IISG 518
G
Sbjct: 232 YYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 48/244 (19%), Positives = 85/244 (34%), Gaps = 85/244 (34%)
Query: 326 KLGEGGFGDIYKG--TLKNGKIVAVK------------KLAIGISRRTLSDFENE----- 366
LGEG FG + + G+ VAVK + I + L+ +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQV-LEHLNTTDPNSTFRC 79
Query: 367 VRLISNVHHRNLI----RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFD 422
V+++ H I LLG Y+++ + F L+ ++
Sbjct: 80 VQMLEWFEHHGHICIVFELLGLS--------TYDFIKENGFLPF-------RLDHIRKMA 124
Query: 423 IILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP-------------------KIA 463
+ + + +LH ++ H D+KP N+L K+
Sbjct: 125 YQICKS--VNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 464 DFGLARLLPENQSH---LSTKFAGTLGYTAPE------YAIHGQLSEKVDAYSFGVLVLE 514
DFG A +++ H +ST+ Y APE + S+ D +S G +++E
Sbjct: 180 DFGSATY--DDEHHSTLVSTRH-----YRAPEVILALGW------SQPCDVWSIGCILIE 226
Query: 515 IISG 518
G
Sbjct: 227 YYLG 230
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 658 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.93 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.75 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.73 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.08 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.48 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.39 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.32 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.21 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.92 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.91 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.91 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.8 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.56 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.21 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.2 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.15 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.14 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.13 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.1 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.95 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.8 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.75 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.5 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.02 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 95.29 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 95.01 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.91 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.98 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 87.43 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.07 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.69 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 84.22 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.85 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-54 Score=445.14 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=212.4
Q ss_pred CCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 321 FSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
+...++||+|+||+||+|++. +++.||||++.........++|.+|+.++++++|||||+++|+|.+.+.++||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 445678999999999999973 46789999997655556678999999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCe
Q 006168 395 YEYMANSSLDKFLFGEK--------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP 460 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~ 460 (658)
||||++|+|.++|.... ...++|.++++|+.|||+||.|||+. +||||||||+||||++++++
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCE
Confidence 99999999999996432 23599999999999999999999998 99999999999999999999
Q ss_pred EEeeccCccccCCCCc-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHH
Q 006168 461 KIADFGLARLLPENQS-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWR 538 (658)
Q Consensus 461 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~ 538 (658)
||+|||+++....... ...+...||+.|||||++.++.|+.|+|||||||+||||+| |+.||..... ..+..
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~~---- 258 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVVE---- 258 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHHH----
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHHH----
Confidence 9999999987644332 23446789999999999999999999999999999999999 8999875443 22222
Q ss_pred HhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 539 LYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 539 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
....+.... .+...+..+.+|+.+||+.||++||||.||++.|+..
T Consensus 259 ~i~~~~~~~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 MIRNRQVLP----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHcCCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 222222111 1223345699999999999999999999999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-54 Score=443.06 Aligned_cols=256 Identities=27% Similarity=0.479 Sum_probs=212.5
Q ss_pred cCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
++|...++||+|+||+||+|++. ++..||||++.. .+....++|.+|+++|++++|||||+++|+|.+.+..+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC-CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 46777899999999999999874 477899999975 34556788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeE
Q 006168 393 LVYEYMANSSLDKFLFGEK-----------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPK 461 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~k 461 (658)
||||||++|+|.++|+... ...++|.+++.|+.||++||.|||++ +|+||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 9999999999999996432 34699999999999999999999998 999999999999999999999
Q ss_pred EeeccCccccCCCCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHH
Q 006168 462 IADFGLARLLPENQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRL 539 (658)
Q Consensus 462 l~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~ 539 (658)
|+|||+++......... .....||+.|||||++.++.|+.|+|||||||++|||+| |+.||..... ..+...
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~---- 242 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIEC---- 242 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHH----
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH----
Confidence 99999998765443322 334679999999999999999999999999999999999 8999976433 222222
Q ss_pred hhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 540 YENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 540 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
...+...+ .+...+.++.+|+.+||+.||++|||++||++.|+++
T Consensus 243 i~~~~~~~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 243 ITQGRVLQ----------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCC----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22222111 1222345699999999999999999999999999887
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=444.73 Aligned_cols=257 Identities=27% Similarity=0.489 Sum_probs=206.6
Q ss_pred cCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
++|...++||+|+||+||+|+++ +++.||||++.. .+....++|.+|+++|++++|||||+++|+|.+.+.++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45667789999999999999875 478899999975 34556788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC
Q 006168 393 LVYEYMANSSLDKFLFGEK-------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ 459 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~ 459 (658)
||||||++|+|.++|+... ..+++|.+++.|+.|||+||.|||+. +|+||||||+||||+++++
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 9999999999999996532 24599999999999999999999998 9999999999999999999
Q ss_pred eEEeeccCccccCCCCc-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHH
Q 006168 460 PKIADFGLARLLPENQS-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAW 537 (658)
Q Consensus 460 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~ 537 (658)
+||+|||+++.+..... ...+...||+.|||||++.+..++.++|||||||+||||+| |+.||...... .+..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~--- 271 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAID--- 271 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHHH---
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHHH---
Confidence 99999999987654432 23346789999999999999999999999999999999999 89999754331 2222
Q ss_pred HHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 538 RLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 538 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
....+... ..+...+.++.+|+.+||+.||++||||.||++.|+.+.
T Consensus 272 -~i~~g~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 272 -CITQGREL----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp -HHHHTCCC----------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred -HHHcCCCC----------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 12222111 112223456899999999999999999999999999873
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=437.07 Aligned_cols=259 Identities=27% Similarity=0.453 Sum_probs=205.4
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+++...++||+|+||+||+|++++ .||||+++.. .+.+..+.|.+|++++++++|||||+++|++.+ +.++|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 567788999999999999999863 5999998643 334556789999999999999999999999865 568999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC-c
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ-S 476 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~-~ 476 (658)
|++|+|.++|+. ....++|.+++.|+.|||+||.|||+. +||||||||+||||++++++||+|||+++...... .
T Consensus 113 ~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 113 CEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 999999999953 345799999999999999999999998 99999999999999999999999999998765432 2
Q ss_pred cccccccCCccccccccccc---CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 477 HLSTKFAGTLGYTAPEYAIH---GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~---~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
...+...||+.|||||++.. +.|+.|+|||||||+||||+||+.||....... .+ ......+... +.+
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~----~~~~~~~~~~----p~~ 259 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QI----IFMVGRGYAS----PDL 259 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HH----HHHHHTTCCC----CCS
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HH----HHHHhcCCCC----CCc
Confidence 23446789999999999864 468999999999999999999999997544321 11 1111111111 111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...+...+..+.+|+.+||+.||++||||.||++.|+.+.
T Consensus 260 --~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 260 --SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp --TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred --ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1122234457999999999999999999999999998763
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=435.84 Aligned_cols=252 Identities=22% Similarity=0.381 Sum_probs=206.7
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
.++|++.++||+|+||+||+++.+ +|+.||||++... ......+.+.+|+++|++++|||||++++++.+.+.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999976 6999999999753 23345678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.++|...+...+++.+++.|+.||+.||.|||++ +|+||||||+||||++++++||+|||+++.+....
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999999999766666789999999999999999999998 99999999999999999999999999998764321
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
...+..+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .+.. +... +...
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~---~i~~-~~~~--------- 243 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK--NLVL---KIIS-GSFP--------- 243 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH---HHHH-TCCC---------
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHH---HHHc-CCCC---------
Confidence 2234578999999999999999999999999999999999999999754321 1211 1111 1111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 244 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 -PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223456899999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=436.30 Aligned_cols=269 Identities=26% Similarity=0.441 Sum_probs=221.1
Q ss_pred ccchHHHHHHhcCCCccCcccccCceEEEEEEecC------CcEEEEEEcccccccccHHHHHHHHHHHhccCC-Cccce
Q 006168 308 NYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKN------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHH-RNLIR 380 (658)
Q Consensus 308 ~~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~ 380 (658)
.+..++++...++|++.++||+|+||+||+|++.. ++.||||++.........+.|.+|+++|++++| ||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 35556666667899999999999999999998653 368999999875555567789999999999965 89999
Q ss_pred eeeEeec-CCeEEEEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeec
Q 006168 381 LLGCCSQ-GPELILVYEYMANSSLDKFLFGEK--------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHR 445 (658)
Q Consensus 381 l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 445 (658)
++|+|.+ ++.++||||||++|+|.++|+... ...++|.+++.++.|||+||.|||++ +||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence 9999966 467899999999999999996432 24589999999999999999999998 99999
Q ss_pred CcCCCcEEEcCCCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCC
Q 006168 446 DIKPSNVLLDDDLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSE 523 (658)
Q Consensus 446 Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~ 523 (658)
||||+|||+++++.+||+|||+++.+...... ..+...||+.|||||++.++.|+.++|||||||+||||+| |+.||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999977554433 3346789999999999999999999999999999999998 899997
Q ss_pred CCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 524 TKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 524 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
....... + .+...++..... +.. .+.++.+++..||+.||++|||+.||++.|+.+
T Consensus 290 ~~~~~~~-~----~~~i~~g~~~~~------p~~----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 290 GVKIDEE-F----CRRLKEGTRMRA------PDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp TCCCSHH-H----HHHHHHTCCCCC------CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCHHHH-H----HHHHHcCCCCCC------Ccc----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 6543221 1 122222221111 222 345689999999999999999999999999876
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=428.03 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=209.7
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+.|+..++||+|+||+||+|+++ +|+.||||++... .....+.+.+|+++|++++|||||++++++.+.+.+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGG-GCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecC-chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 56888999999999999999986 6999999999753 334456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++|+|.+++.. ..+++.++..++.||+.||.|||++ +|+||||||+||||+.++++||+|||+++.+.....
T Consensus 153 ~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 153 LEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp CTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 999999999953 4699999999999999999999999 999999999999999999999999999998754332
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
..+..+||+.|||||++.+..|+.++|||||||++|||++|+.||...... ..... ...+.. +.+ .
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~----i~~~~~-----~~~---~ 291 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKM----IRDNLP-----PRL---K 291 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH----HHHSSC-----CCC---S
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHH----HHcCCC-----CCC---C
Confidence 344678999999999999999999999999999999999999999754321 12111 111110 011 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.....+.++.+|+.+||+.||++|||+.|+++.
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 112334568999999999999999999998863
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=429.56 Aligned_cols=267 Identities=23% Similarity=0.317 Sum_probs=203.2
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCC----eEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP----ELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV 394 (658)
+++...++||+|+||+||+|++ +|+.||||++... ......++.|+..+.+++|||||+++|++.+.+ .++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~--~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc--chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 4567788999999999999998 5899999998642 222233455677778899999999999997653 68999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcC-----CCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF-----HVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
||||++|+|.++|+. ..++|+.+++++.|+++||+|||++. .++|+||||||+||||+.++++||+|||+++
T Consensus 80 ~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999953 46999999999999999999999762 4589999999999999999999999999998
Q ss_pred ccCCCCccc---cccccCCcccccccccccC------CCCCcccchhhhHHHHHHHhCCCCCCCCCcch---------hh
Q 006168 470 LLPENQSHL---STKFAGTLGYTAPEYAIHG------QLSEKVDAYSFGVLVLEIISGTKSSETKGEEG---------EY 531 (658)
Q Consensus 470 ~~~~~~~~~---~~~~~gt~~y~APE~~~~~------~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~---------~~ 531 (658)
......... .....||+.|||||++.+. .++.|+|||||||+||||+||+.|+....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 765443222 2346899999999998654 46789999999999999999988765332210 00
Q ss_pred HHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 532 LLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 532 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
......+....+. +++.++......+.+..+.+|+.+||+.||++||||.||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111222222111 22222111223356678999999999999999999999999998873
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=428.02 Aligned_cols=252 Identities=22% Similarity=0.300 Sum_probs=205.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+.|...++||+|+||.||+|+++ +|+.||||++..... ..+|+.++++++|||||++++++.+++.++|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45777889999999999999976 689999999975321 24799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC-CeEEeeccCccccCCCCc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL-QPKIADFGLARLLPENQS 476 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~-~~kl~DfGla~~~~~~~~ 476 (658)
+++|+|.++|.. .+.+++.++..++.||+.||.|||++ +|+||||||+||||+.++ ++||+|||+++.+.....
T Consensus 132 ~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999999953 45799999999999999999999998 999999999999999987 699999999998754322
Q ss_pred c----ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 477 H----LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 477 ~----~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||....... +... ........
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~---i~~~~~~~------ 275 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--LCLK---IASEPPPI------ 275 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--CHHH---HHHSCCGG------
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHH---HHcCCCCc------
Confidence 1 1224689999999999999999999999999999999999999997654321 1111 11111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...+...+..+.+++.+||+.||.+|||+.||++.|....
T Consensus 276 ---~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 276 ---REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp ---GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 1112233456899999999999999999999999887653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=420.51 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=210.0
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|++.+.||+|+||+||+++.+ +|+.||||++.+. ......+.+.+|+++|++++|||||++++++.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46889999999999999999976 6899999999753 23455678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.++|. +.+.+++.++..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++.+....
T Consensus 112 Ey~~gG~L~~~i~--~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999994 346799999999999999999999999 99999999999999999999999999999875433
Q ss_pred c-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 476 S-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 476 ~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
. ......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ..+...+. .+..
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~----~~~~--------- 251 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--GLIFAKII----KLEY--------- 251 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH----HTCC---------
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH----cCCC---------
Confidence 2 234567899999999999999999999999999999999999999975432 22222211 1111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVV 588 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 588 (658)
.++...+.++.+|+.+||+.||++|||+.|++
T Consensus 252 --~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11122345689999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-51 Score=414.62 Aligned_cols=247 Identities=25% Similarity=0.389 Sum_probs=199.0
Q ss_pred CccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeec----CCeEEEEE
Q 006168 322 SEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ----GPELILVY 395 (658)
Q Consensus 322 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 395 (658)
...++||+|+||+||+|+++ ++..||+|++... ......+.|.+|++++++++|||||++++++.. .+.++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999976 5889999998653 234446779999999999999999999999864 35689999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC-CCCeEEeeccCccccCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD-DLQPKIADFGLARLLPEN 474 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~-~~~~kl~DfGla~~~~~~ 474 (658)
|||++|+|.++|.. ...+++..+..|+.||+.||.|||++ +++|+||||||+||||+. ++.+||+|||+++.....
T Consensus 109 Ey~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 99999999999953 45799999999999999999999997 113999999999999984 799999999999864332
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
..+..+||+.|||||++. ++|+.++|||||||++|||+||+.||....... .+ .+....+.....++
T Consensus 186 ---~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~----~~~i~~~~~~~~~~---- 252 (290)
T 3fpq_A 186 ---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QI----YRRVTSGVKPASFD---- 252 (290)
T ss_dssp ---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HH----HHHHTTTCCCGGGG----
T ss_pred ---ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HH----HHHHHcCCCCCCCC----
Confidence 234678999999999875 579999999999999999999999996543321 11 22222222111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
...+.++.+|+.+||+.||++|||+.|+++
T Consensus 253 -----~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 -----KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112345899999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=405.97 Aligned_cols=246 Identities=24% Similarity=0.410 Sum_probs=192.5
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|++.+.||+|+||+||+++.+ +|+.||||++.... .......+.+|++++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999975 69999999997532 2344577999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+ +|+|.+++. +.+.+++.++..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+++......
T Consensus 93 Ey~-~g~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIV--QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHH--HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 679999984 346799999999999999999999999 99999999999999999999999999998764332
Q ss_pred ccccccccCCcccccccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
..+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... ..+... ...+..
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--~~~~~~----i~~~~~--------- 229 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--PVLFKN----ISNGVY--------- 229 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH----HHHTCC---------
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHH----HHcCCC---------
Confidence 2345789999999999988876 5799999999999999999999975432 122221 111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 230 --~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 --TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111223456899999999999999999999987
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=429.02 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=209.6
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+.|+..++||+|+||.||+|+.+ +|+.||||++... .....+.+.+|+++|++++|||||++++++.+.+.+||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEST-TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 57899999999999999999976 6999999999753 334456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
|++|+|.+++.. ..+++.++..|+.||+.||.|||++ +|+||||||+||||+.++++||+|||+++.+.....
T Consensus 230 ~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~- 302 (423)
T 4fie_A 230 LEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 302 (423)
T ss_dssp CTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred CCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence 999999999943 4699999999999999999999999 999999999999999999999999999998754332
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
..+..+||+.|||||++.+..|+.++|||||||++|||++|+.||...... ..... ...+.. ..+ .
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~----i~~~~~-----~~~---~ 368 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKM----IRDNLP-----PRL---K 368 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH----HHHSCC-----CCC---S
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHH----HHcCCC-----CCC---c
Confidence 344678999999999999999999999999999999999999999754321 11111 111111 111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111234568999999999999999999998863
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=412.25 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=197.6
Q ss_pred cCCCccCcccccCceEEEEEEec----CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK----NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
++|++.+.||+|+||+||+++.. .++.||||++.... .......+.+|+++|++++|||||++++++.+.+.++|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46889999999999999999863 47899999997532 22334568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+++|+|.++|. +.+.+++.++..++.||+.||.|||++ +|+||||||+|||+++++++||+|||+++....
T Consensus 104 vmEy~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999995 345799999999999999999999999 999999999999999999999999999986543
Q ss_pred CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
... ......||+.|||||++.+..|+.++|||||||++|||+||+.||...... .+...+ . .+..
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i---~-~~~~-------- 243 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--ETMTMI---L-KAKL-------- 243 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH---H-HCCC--------
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH--HHHHHH---H-cCCC--------
Confidence 322 234578999999999999999999999999999999999999999754331 222211 1 1110
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTM-----SEVVA 589 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~ 589 (658)
..+...+.++.+|+.+||+.||++|||+ +|+++
T Consensus 244 ---~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 ---GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ---CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1112234568999999999999999984 56553
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=406.78 Aligned_cols=250 Identities=21% Similarity=0.332 Sum_probs=190.2
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCC--------
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP-------- 389 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 389 (658)
++|++.+.||+|+||+||+|+.+ +|+.||||++.........+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45888999999999999999976 689999999976544455678999999999999999999999986543
Q ss_pred ----eEEEEEeccCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEee
Q 006168 390 ----ELILVYEYMANSSLDKFLFGEKR-GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIAD 464 (658)
Q Consensus 390 ----~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~D 464 (658)
.+++||||+++|+|.+++..... ...++..++.|+.||++||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 37999999999999999954332 2356777899999999999999999 999999999999999999999999
Q ss_pred ccCccccCCCCcc-----------ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHH
Q 006168 465 FGLARLLPENQSH-----------LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLL 533 (658)
Q Consensus 465 fGla~~~~~~~~~-----------~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~ 533 (658)
||+++.+...... ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||....+ ..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~----~~ 234 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----RV 234 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH----HH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH----HH
Confidence 9999877543221 1234679999999999999999999999999999999996 5542111 11
Q ss_pred HHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 534 KRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 534 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.. .......... .........+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~-~~~~~~~~~p----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 RT-LTDVRNLKFP----------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-HHHHHTTCCC----------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HHHHhcCCCC----------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 1111111111 111223345678999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=392.89 Aligned_cols=289 Identities=40% Similarity=0.700 Sum_probs=246.1
Q ss_pred CCcccchHHHHHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeE
Q 006168 305 GPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGC 384 (658)
Q Consensus 305 ~~~~~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 384 (658)
....|+++++..++++|...+.||+|+||.||+|++++++.||||++...........+.+|++++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 35678999999999999999999999999999999888999999999765444444578999999999999999999999
Q ss_pred eecCCeEEEEEeccCCCCHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEE
Q 006168 385 CSQGPELILVYEYMANSSLDKFLFGEKR--GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKI 462 (658)
Q Consensus 385 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl 462 (658)
+...+..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+...++|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 9999999999999999999999965433 34999999999999999999999986679999999999999999999999
Q ss_pred eeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCC---cchhhHHHHHHHH
Q 006168 463 ADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKG---EEGEYLLKRAWRL 539 (658)
Q Consensus 463 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~---~~~~~l~~~~~~~ 539 (658)
+|||++...............||+.|+|||++.+..++.++||||||+++|||++|+.||.... .....+..+....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999999876555555556779999999999999999999999999999999999999996321 1223344444444
Q ss_pred hhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 540 YENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 540 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..........+..+ ........+..+.+++.+||+.||.+|||+.||+++|+..
T Consensus 256 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 256 LKEKKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSSCCSTTSSCTTC-TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhchhhhhhcChhh-ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 45555556666555 3566788889999999999999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=385.46 Aligned_cols=282 Identities=38% Similarity=0.669 Sum_probs=239.3
Q ss_pred ccchHHHHHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeec
Q 006168 308 NYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ 387 (658)
Q Consensus 308 ~~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 387 (658)
.+.+.++..++++|...+.||+|+||.||+|++++++.||||++... .....+.+.+|++++++++||||+++++++.+
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC-CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 45556667788999999999999999999999988999999998753 44556789999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeec
Q 006168 388 GPELILVYEYMANSSLDKFLFGEKR--GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADF 465 (658)
Q Consensus 388 ~~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~Df 465 (658)
.+..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999965432 3599999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCCC-ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc-chhhHHHHHHHHhhcC
Q 006168 466 GLARLLPENQ-SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE-EGEYLLKRAWRLYENG 543 (658)
Q Consensus 466 Gla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~-~~~~l~~~~~~~~~~~ 543 (658)
|+++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||..... .......+.......+
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 9998754322 2223345689999999999999999999999999999999999999976544 3333444544555555
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 544 THWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 544 ~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.....+++.+ ......+.+..+.+++.+||+.||++|||+.||++.|+.+
T Consensus 264 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 264 QLEQIVDPNL-ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CCCSSSSSSC-TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHHhcChhh-ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 5666666655 3456778889999999999999999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=390.72 Aligned_cols=202 Identities=25% Similarity=0.432 Sum_probs=174.5
Q ss_pred HHhcCCCccCcccccCceEEEEEEec----CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCe
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK----NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 390 (658)
...++|++.++||+|+||+||+|+.+ .++.||||++... .....+.+|+++|+.+ +|||||++++++.+.+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 45688999999999999999999864 4678999998642 3456788999999998 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC-CCeEEeeccCcc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD-LQPKIADFGLAR 469 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~-~~~kl~DfGla~ 469 (658)
.++||||+++|+|.+++ ..+++.++..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+
T Consensus 95 ~~lvmE~~~g~~L~~~~-----~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL-----NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEEECCCCCCHHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEeCCCcccHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999998 3599999999999999999999999 99999999999999877 799999999998
Q ss_pred ccCCCCc---------------------------cccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCC
Q 006168 470 LLPENQS---------------------------HLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKS 521 (658)
Q Consensus 470 ~~~~~~~---------------------------~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p 521 (658)
....... ...+..+||+.|+|||++.+. .|+.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 6543221 112345799999999999876 589999999999999999999999
Q ss_pred CCCCCcc
Q 006168 522 SETKGEE 528 (658)
Q Consensus 522 ~~~~~~~ 528 (658)
|.....+
T Consensus 247 f~~~~~~ 253 (361)
T 4f9c_A 247 FYKASDD 253 (361)
T ss_dssp SSCCSSH
T ss_pred CCCCCCH
Confidence 9765543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=398.57 Aligned_cols=265 Identities=20% Similarity=0.319 Sum_probs=203.9
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeec------CC
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ------GP 389 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 389 (658)
.++|.+.+.||+|+||+||+|+.+ +|+.||||++.... .....+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999976 69999999997532 23345678899999999999999999999753 46
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
.+|||||||+ |+|.+++. ..+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 133 ~~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence 7899999996 68999994 456799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC---ccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCc-
Q 006168 470 LLPENQ---SHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGT- 544 (658)
Q Consensus 470 ~~~~~~---~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~- 544 (658)
.+.... ....+..+||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+..+........
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~--~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV--HQLQLIMMVLGTPSP 284 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--HHHHHHHHHHCCCCG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH--HHHHHHHHhcCCCCh
Confidence 764332 2234467899999999998875 5699999999999999999999999765432 12222221111000
Q ss_pred -ccc---------cccccCCCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 545 -HWE---------LMDESLDPNECTK-----EAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 545 -~~~---------~~d~~l~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+. .+.........+. ....++.+|+.+||+.||.+|||+.|+++.
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 0000000000111 123568899999999999999999998864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=405.23 Aligned_cols=248 Identities=21% Similarity=0.289 Sum_probs=201.6
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHH---HHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDF---ENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
++|++.+.||+|+||.||+++.+ +|+.||||++.+.. ........ ..++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57899999999999999999976 69999999996431 12223333 34467778889999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
|||||++||+|.++|. +.+.+++..+..++.||+.||.|||++ +||||||||+||||+.+|++||+|||+++.+.
T Consensus 269 lVmEy~~GGdL~~~l~--~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHH--HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999995 346799999999999999999999998 99999999999999999999999999998775
Q ss_pred CCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcch-hhHHHHHHHHhhcCccccccc
Q 006168 473 ENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEG-EYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 473 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d 550 (658)
... ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||....... ..+.... .. ..
T Consensus 344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---~~-~~------ 410 (689)
T 3v5w_A 344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LT-MA------ 410 (689)
T ss_dssp SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH---HH-CC------
T ss_pred CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh---cC-CC------
Confidence 432 335689999999999975 479999999999999999999999997543321 1111111 11 10
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPT-----MSEVVA 589 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 589 (658)
..++...+.++.+|+..||+.||.+|++ +.||++
T Consensus 411 -----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 -----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1122223456899999999999999998 677764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=403.31 Aligned_cols=253 Identities=21% Similarity=0.349 Sum_probs=209.4
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|.+.+.||+|+||.||+++.+ +|+.||+|++... .....+.+.+|+++|+.++|||||++++++.+.+.++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 468999999999999999999976 6999999998753 33445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC--CCeEEeeccCccccCCC
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD--LQPKIADFGLARLLPEN 474 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~--~~~kl~DfGla~~~~~~ 474 (658)
||++|+|.++|.. +...+++.++..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 235 ~~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 235 FMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred ecCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999999843 345699999999999999999999999 99999999999999854 89999999999987544
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...... ..... ...... ..
T Consensus 311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--~~~~~----i~~~~~-~~------ 375 (573)
T 3uto_A 311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRN----VKSCDW-NM------ 375 (573)
T ss_dssp S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHH----HHTTCC-CC------
T ss_pred C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHH----HHhCCC-CC------
Confidence 3 234568999999999999999999999999999999999999999764432 11111 111110 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+.......+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011111234568899999999999999999999873
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=361.31 Aligned_cols=282 Identities=37% Similarity=0.633 Sum_probs=230.6
Q ss_pred CcccchHHHHHHhcCCCcc------CcccccCceEEEEEEecCCcEEEEEEccccc---ccccHHHHHHHHHHHhccCCC
Q 006168 306 PVNYRLKDLVSATRKFSEE------NKLGEGGFGDIYKGTLKNGKIVAVKKLAIGI---SRRTLSDFENEVRLISNVHHR 376 (658)
Q Consensus 306 ~~~~~~~~l~~a~~~f~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~ 376 (658)
...|+++++..++++|... +.||+|+||.||+|.. +++.||||++.... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4579999999999999887 8999999999999997 57899999986532 233457899999999999999
Q ss_pred ccceeeeEeecCCeEEEEEeccCCCCHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc
Q 006168 377 NLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEK-RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD 455 (658)
Q Consensus 377 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~ 455 (658)
||+++++++.+.+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 99999999999999999999999999999986433 34699999999999999999999998 999999999999999
Q ss_pred CCCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHH
Q 006168 456 DDLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLK 534 (658)
Q Consensus 456 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~ 534 (658)
+++.+||+|||++......... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||....... .+..
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~ 245 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLD 245 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-BTTH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCCCcccCcchH-HHHH
Confidence 9999999999999876543322 233567999999999875 468999999999999999999999997654421 1111
Q ss_pred HHHHHhh-cCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 535 RAWRLYE-NGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 535 ~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
....... .....+.++..+ ...+...+..+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1111111 122233344433 3456677889999999999999999999999999999873
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=367.65 Aligned_cols=260 Identities=25% Similarity=0.443 Sum_probs=211.9
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|...+.||+|+||.||++.+. +++.||+|++.. ......+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 56788899999999999999976 589999998865 3455677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++|+|.+++... ...+++.+++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999542 45699999999999999999999998 9999999999999999999999999999876443321
Q ss_pred c-------------cccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCc
Q 006168 478 L-------------STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGT 544 (658)
Q Consensus 478 ~-------------~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 544 (658)
. .....||+.|+|||++.+..++.++||||||+++|||++|..|+.................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~----- 239 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF----- 239 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH-----
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc-----
Confidence 1 1146799999999999999999999999999999999999998865433211100000000
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 006168 545 HWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSS 597 (658)
Q Consensus 545 ~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 597 (658)
.+... +.. .+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 240 ----~~~~~-~~~----~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 240 ----LDRYC-PPN----CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ----HHHTC-CTT----CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----ccccC-CCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00111 111 223588999999999999999999999999987543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=374.14 Aligned_cols=258 Identities=29% Similarity=0.467 Sum_probs=214.0
Q ss_pred hcCCCccCcccccCceEEEEEEec--------CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecC
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK--------NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQG 388 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 388 (658)
.++|.+.+.||+|+||.||+|++. ++..||||++.........+.+.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 367888999999999999999863 35679999997655555677899999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE
Q 006168 389 PELILVYEYMANSSLDKFLFGEK--------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL 454 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll 454 (658)
+..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 99999999999999999996543 23589999999999999999999998 99999999999999
Q ss_pred cCCCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhH
Q 006168 455 DDDLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYL 532 (658)
Q Consensus 455 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l 532 (658)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~~ 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--EL 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HH
Confidence 99999999999999876543322 2334567889999999999999999999999999999999 99998754332 12
Q ss_pred HHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 533 LKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 533 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.. ....+... ..+...+..+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 315 ~~----~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 315 FK----LLKEGHRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HH----HHHTTCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----HHhcCCCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 11111111 11222345699999999999999999999999999886
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=359.83 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=209.6
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|...+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGG-GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecc-cccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 468999999999999999999964 6899999998753 34456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 98 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999954 3599999999999999999999998 999999999999999999999999999987654332
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ......+.. ..
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----~~~~~~~~~---------~~ 236 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-----YLIATNGTP---------EL 236 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHHHCSC---------CC
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhCCCC---------CC
Confidence 234567999999999999999999999999999999999999999754432111 111111110 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1122334568999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=367.04 Aligned_cols=264 Identities=27% Similarity=0.434 Sum_probs=205.3
Q ss_pred HHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 315 VSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 315 ~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
....++|.+.+.||+|+||.||++++ +++.||||++.... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 33456888999999999999999987 58899999986532 33445678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 394 VYEYMANSSLDKFLFGEKR-GSLNWKQRFDIILGTARGLAYLHEDFHVR--IIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
||||+++|+|.+++..... ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999999954321 2399999999999999999999998 7 99999999999999999999999999986
Q ss_pred cCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .... ......
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~---~~~~~~------ 256 (309)
T 3p86_A 189 KASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAA---VGFKCK------ 256 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHH---HHHSCC------
T ss_pred ccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH---HHhcCC------
Confidence 53322 22335679999999999999999999999999999999999999997544321 1111 111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSL 598 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~ 598 (658)
....+...+..+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus 257 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 257 ----RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ----CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 11122233456899999999999999999999999999885433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=367.05 Aligned_cols=257 Identities=29% Similarity=0.494 Sum_probs=210.3
Q ss_pred cCCCccCcccccCceEEEEEEec----CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK----NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
++|.+.+.||+|+||.||+|.+. .+..||||++.........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46777899999999999999985 35569999998655556677899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 129 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 129 TEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred eeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 999999999999943 345699999999999999999999998 9999999999999999999999999999877544
Q ss_pred Cccc--cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 475 QSHL--STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 475 ~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
.... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .+.. ....+..
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~----~~~~~~~------ 272 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVIS----SVEEGYR------ 272 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHH----HHHTTCC------
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHH----HHHcCCC------
Confidence 3222 223456788999999999999999999999999999999 99998654332 1111 1111110
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...+...+..+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus 273 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 273 ----LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1112223456999999999999999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=359.47 Aligned_cols=262 Identities=24% Similarity=0.356 Sum_probs=216.6
Q ss_pred cccchHHHHHHhcC----------CCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCC
Q 006168 307 VNYRLKDLVSATRK----------FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHH 375 (658)
Q Consensus 307 ~~~~~~~l~~a~~~----------f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h 375 (658)
..++++++..+++. |...+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT-TCCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc-chhHHHHHHHHHHHHHhCCC
Confidence 46888999888875 566779999999999999987 7999999998753 44566789999999999999
Q ss_pred CccceeeeEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc
Q 006168 376 RNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD 455 (658)
Q Consensus 376 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~ 455 (658)
|||+++++++...+..++||||+++++|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+|||++
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLT 175 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC
Confidence 999999999999999999999999999999983 35699999999999999999999998 999999999999999
Q ss_pred CCCCeEEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHH
Q 006168 456 DDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKR 535 (658)
Q Consensus 456 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~ 535 (658)
.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~~~~~ 252 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKR 252 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH
T ss_pred CCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 999999999999987654322 234568999999999999999999999999999999999999999754321 11111
Q ss_pred HHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 536 AWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 536 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...... +.+ ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 253 ----~~~~~~-----~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 253 ----LRDSPP-----PKL---KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ----HHHSSC-----CCC---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----HhcCCC-----CCc---CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 000 1111234568999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=353.11 Aligned_cols=256 Identities=26% Similarity=0.445 Sum_probs=214.1
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
.++|.+.+.||+|+||.||++.++++..||+|++... ....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG--SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT--TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC--CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4678889999999999999999998889999999753 33457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 85 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 85 ISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp CTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred cCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 9999999999542 34599999999999999999999998 9999999999999999999999999999877655444
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ... . ...+.. ...+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~---~-~~~~~~------~~~~~ 228 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--VVL---K-VSQGHR------LYRPH 228 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHH---H-HHTTCC------CCCCT
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--HHH---H-HHcCCC------CCCCC
Confidence 4445567788999999999999999999999999999999 999986544321 111 1 111110 00011
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
. .+..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus 229 ~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 229 L----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp T----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred c----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1 2346899999999999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=353.80 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=213.3
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
++|...+.||+|+||.||++.+.+++.||+|++... ....+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc--ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 567888999999999999999988999999999753 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..........
T Consensus 88 ~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 88 EHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp TTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 99999999953 345699999999999999999999998 99999999999999999999999999998765443333
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ....+.. ..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~----~~~~~~~----------~~ 227 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVE----DISTGFR----------LY 227 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH----HHHTTCC----------CC
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHH----HHhcCcc----------CC
Confidence 345567889999999999999999999999999999999 89998754332 1111 1111100 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
.+...+..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 11122456899999999999999999999999998763
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=363.47 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=205.7
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|.+.+.||+|+||.||+++.. +++.||||++.........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367889999999999999999977 7899999998654444445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++|+|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+.....
T Consensus 86 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999983 445699999999999999999999998 999999999999999999999999999986643322
Q ss_pred -cccccccCCcccccccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 477 -HLSTKFAGTLGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 477 -~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
.......||+.|+|||++.+..+ +.++||||||+++|||++|+.||............+ ......
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-----~~~~~~-------- 227 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKTY-------- 227 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH-----HTTCTT--------
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-----hccccc--------
Confidence 22345689999999999988775 779999999999999999999997655432222211 111000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..........+.+++.+||+.||.+|||+.|+++.
T Consensus 228 -~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 -LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00011234568899999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=371.96 Aligned_cols=257 Identities=28% Similarity=0.509 Sum_probs=200.7
Q ss_pred cCCCccCcccccCceEEEEEEec----CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK----NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
++|.+.+.||+|+||.||+|+++ ++..||||++.........+.|.+|++++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57889999999999999999975 57789999997655555667899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++|+|.+++.. ....+++.+++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 125 ~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 125 TEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 999999999999953 345699999999999999999999998 9999999999999999999999999999876543
Q ss_pred Ccccc--ccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 475 QSHLS--TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 475 ~~~~~--~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
..... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .+.. ....+..
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~~----~i~~~~~------ 268 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIK----AVDEGYR------ 268 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHHH----HHHTTEE------
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHcCCC------
Confidence 32221 12345778999999999999999999999999999998 99998654321 1111 1111110
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
. ..+...+..+.+++.+||+.||.+||++.+|+++|+.+.
T Consensus 269 -~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 269 -L---PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp -C---CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -C---CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 0 011123456999999999999999999999999998874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=380.22 Aligned_cols=260 Identities=27% Similarity=0.463 Sum_probs=215.0
Q ss_pred HHHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 314 LVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 314 l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
++...++|...+.||+|+||.||+|.++++..||||++... ....+.|.+|++++++++||||+++++++. .+..++
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC--CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 33445678889999999999999999998999999999753 345788999999999999999999999986 567899
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+++|+|.+++.......+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 99999999999999654444689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
..........++..|+|||++..+.++.++||||||+++|||++ |+.||...... .+... ...+..
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~----i~~~~~------- 403 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRA----LERGYR------- 403 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHH----HHHTCC-------
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HHcCCC-------
Confidence 33222334456789999999999999999999999999999999 99998754321 11111 111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...+...+..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 404 ---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 404 ---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0111223456999999999999999999999999999884
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=372.79 Aligned_cols=270 Identities=26% Similarity=0.433 Sum_probs=219.3
Q ss_pred cccchHHHHHHhcCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccc
Q 006168 307 VNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLI 379 (658)
Q Consensus 307 ~~~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 379 (658)
..+...++....++|.+.+.||+|+||.||+|++. +++.||||++.........+.+.+|++++.++ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 34566677777899999999999999999999842 46789999998655555567899999999999 899999
Q ss_pred eeeeEeecCC-eEEEEEeccCCCCHHHHhhcCCC----------------------------------------------
Q 006168 380 RLLGCCSQGP-ELILVYEYMANSSLDKFLFGEKR---------------------------------------------- 412 (658)
Q Consensus 380 ~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------- 412 (658)
++++++.+.+ ..++||||+++|+|.+++.....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 9999987754 48999999999999999965432
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 413 ------------------GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 413 ------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 1289999999999999999999998 9999999999999999999999999999876443
Q ss_pred Cc-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 475 QS-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 475 ~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
.. .......||+.|+|||++.+..++.++||||||+++|||++ |+.||......... ......+...
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-----~~~~~~~~~~------ 315 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-----CRRLKEGTRM------ 315 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH-----HHHHHHTCCC------
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH-----HHHHHcCCCC------
Confidence 32 22345678899999999999999999999999999999998 99999765433211 1111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+...+..+.+++..||+.||.+|||+.||++.|+.+
T Consensus 316 ----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 316 ----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11112335689999999999999999999999999876
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=380.73 Aligned_cols=267 Identities=22% Similarity=0.281 Sum_probs=215.5
Q ss_pred ccchHHHHHHhcCCCccCcccccCceEEEEEEecC-CcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeE
Q 006168 308 NYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGC 384 (658)
Q Consensus 308 ~~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 384 (658)
.+.++++....++|...++||+|+||.||++++++ ++.||+|++... ........+.+|..++..++||||++++++
T Consensus 63 ~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 142 (437)
T 4aw2_A 63 TSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA 142 (437)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred cchhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34566777778999999999999999999999874 789999998642 112223448899999999999999999999
Q ss_pred eecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEee
Q 006168 385 CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIAD 464 (658)
Q Consensus 385 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~D 464 (658)
+.+.+..++||||+++|+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 143 ~~~~~~~~lV~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 143 FQDDNNLYLVMDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred EeeCCEEEEEEecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 9999999999999999999999953 245699999999999999999999998 999999999999999999999999
Q ss_pred ccCccccCCCCccccccccCCcccccccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHH
Q 006168 465 FGLARLLPENQSHLSTKFAGTLGYTAPEYAI-----HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRL 539 (658)
Q Consensus 465 fGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~ 539 (658)
||+++..............||+.|+|||++. .+.++.++|||||||++|||++|+.||....... ....+...
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~--~~~~i~~~ 296 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--TYGKIMNH 296 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHTH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH--HHHhhhhc
Confidence 9999877655554455678999999999997 5679999999999999999999999997644321 11111110
Q ss_pred hhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 006168 540 YENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANS--RPTMSEVVAL 590 (658)
Q Consensus 540 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 590 (658)
...-. + + ......+..+.+|+.+||..+|++ ||+++|+++.
T Consensus 297 ~~~~~--------~-p-~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 297 KERFQ--------F-P-TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHCC--------C-C-SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccccc--------C-C-cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 00000 0 0 000112346899999999888888 9999999863
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=355.40 Aligned_cols=261 Identities=23% Similarity=0.350 Sum_probs=204.6
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhc--cCCCccceeeeEeec----CCeE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISN--VHHRNLIRLLGCCSQ----GPEL 391 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~ 391 (658)
.++|.+.+.||+|+||.||+|++ +++.||||++.. .....+..|.+++.. ++||||+++++++.. ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46889999999999999999998 689999999864 234556667776666 799999999998644 3568
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhH--------hcCCCCeeecCcCCCcEEEcCCCCeEEe
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLH--------EDFHVRIIHRDIKPSNVLLDDDLQPKIA 463 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dik~~NIll~~~~~~kl~ 463 (658)
++||||+++|+|.+++ +...+++..++.++.||+.||.||| +. +|+||||||+|||++.++.+||+
T Consensus 82 ~lv~e~~~~g~L~~~l---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEECCCTTCBHHHHH---TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred EEehhhccCCCHHHHH---hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999999 3457999999999999999999999 66 99999999999999999999999
Q ss_pred eccCccccCCCCccc---cccccCCcccccccccccC------CCCCcccchhhhHHHHHHHhC----------CCCCCC
Q 006168 464 DFGLARLLPENQSHL---STKFAGTLGYTAPEYAIHG------QLSEKVDAYSFGVLVLEIISG----------TKSSET 524 (658)
Q Consensus 464 DfGla~~~~~~~~~~---~~~~~gt~~y~APE~~~~~------~~s~ksDV~SfGvvl~elltG----------~~p~~~ 524 (658)
|||+++......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999998764433322 2245799999999999876 455799999999999999999 777765
Q ss_pred CCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 525 KGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 525 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.......... ......... ..+.+.........+..+.+++.+||+.||.+|||+.+|++.|+++
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFED-MRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHH-HHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhh-hhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 4332211111 111111111 1111111123345678899999999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=366.63 Aligned_cols=267 Identities=27% Similarity=0.374 Sum_probs=208.4
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCC----eEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP----ELIL 393 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 393 (658)
.++|.+.+.||+|+||.||+|++. ++.||||++... ......+..|+.++++++||||+++++++.... ..++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 467889999999999999999986 789999998642 333455677999999999999999999997743 4799
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcC-------CCCeeecCcCCCcEEEcCCCCeEEeecc
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF-------HVRIIHRDIKPSNVLLDDDLQPKIADFG 466 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------~~~ivH~Dik~~NIll~~~~~~kl~DfG 466 (658)
||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||
T Consensus 100 v~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 9999999999999954 45999999999999999999999851 2389999999999999999999999999
Q ss_pred CccccCCCCcc-ccccccCCcccccccccccC-----CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhH--------
Q 006168 467 LARLLPENQSH-LSTKFAGTLGYTAPEYAIHG-----QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYL-------- 532 (658)
Q Consensus 467 la~~~~~~~~~-~~~~~~gt~~y~APE~~~~~-----~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l-------- 532 (658)
+++.+...... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||..........
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 99876544332 23346799999999998763 55678999999999999999999997644311100
Q ss_pred --HHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 533 --LKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 533 --~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.............. +.+.........+..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 257 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKR----PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CCHHHHHHHHTTSCCC----CCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CchhhhhhhhhcccCC----CCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01111111111111 11111111234566799999999999999999999999999876
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=353.35 Aligned_cols=261 Identities=26% Similarity=0.417 Sum_probs=208.2
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
.++|.+.+.||+|+||.||+++.. +++.||+|++... ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357889999999999999999976 6899999998543 2233457789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 90 ~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 999999999999943 35799999999999999999999998 9999999999999999999999999999877554
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
.........||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..+..... .... ..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-----~~~~~~~~-~~~~-~~--- 234 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-----AIKHIQDS-VPNV-TT--- 234 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-----HHHHHSSC-CCCH-HH---
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHhhcc-CCCc-ch---
Confidence 43444456799999999999999999999999999999999999999976443211 11111111 1110 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcCc
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRP-TMSEVVALLKSTS 595 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~~~ 595 (658)
......+..+.+++.+||+.||.+|| ++.++.+.|+...
T Consensus 235 --~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 235 --DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp --HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred --hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 01112345699999999999999998 9999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=383.30 Aligned_cols=256 Identities=27% Similarity=0.463 Sum_probs=215.8
Q ss_pred hcCCCccCcccccCceEEEEEEecC-CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|...++||+|+||.||+|+++. +..||||++... ....++|.+|+++|++++||||+++++++...+..++|||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc--ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 4567888999999999999999875 889999999753 3457889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++|+|.+++.......+++..++.|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999999766667799999999999999999999998 999999999999999999999999999987754433
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.......++..|+|||++....++.++||||||+++|||++ |+.|+...... .+.. ....+..
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~----~~~~~~~---------- 437 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYE----LLEKDYR---------- 437 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHH----HHHTTCC----------
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHcCCC----------
Confidence 33334556789999999999999999999999999999999 88888754432 1111 1111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
...+...+..+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 111222345689999999999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=360.71 Aligned_cols=249 Identities=23% Similarity=0.384 Sum_probs=207.7
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
.++|.+.+.||+|+||.||+|++. +|+.||||++.... .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 457889999999999999999974 79999999986532 3344667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVA--HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CCCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred ECCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 99999999999843 35699999999999999999999998 99999999999999999999999999998764432
Q ss_pred ccccccccCCcccccccccccCCCC-CcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLS-EKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s-~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
......||+.|+|||++.+..+. .++||||||+++|||++|+.||...... .+... .. .+..
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~---i~-~~~~--------- 231 (328)
T 3fe3_A 169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--ELRER---VL-RGKY--------- 231 (328)
T ss_dssp --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH---HH-HCCC---------
T ss_pred --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HHHHH---HH-hCCC---------
Confidence 23456899999999999888775 7999999999999999999999764421 11111 11 1110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 232 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 --RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111234568899999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=375.13 Aligned_cols=257 Identities=26% Similarity=0.454 Sum_probs=210.8
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|...+.||+|+||.||+|+++ +++.||||.+...........|.+|++++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457788899999999999999987 6899999998764444445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHH-HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 9999999999953 234599999999999999999999998 999999999999999999999999999986543321
Q ss_pred ccc-ccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 477 HLS-TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 477 ~~~-~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
... ....+++.|+|||.+..+.++.++||||||+++|||++ |+.|+...... .. ......+...
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~----~~~~~~~~~~-------- 334 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QT----REFVEKGGRL-------- 334 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HH----HHHHHTTCCC--------
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HH----HHHHHcCCCC--------
Confidence 111 12235678999999999999999999999999999998 89888654331 11 1122221111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+...+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 335 --~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 335 --PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11122345689999999999999999999999999876
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=351.78 Aligned_cols=271 Identities=18% Similarity=0.260 Sum_probs=217.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCC--eEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP--ELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~ 395 (658)
++|.+.+.||+|+||.||+|+.. +++.||||++.........+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 57888999999999999999987 489999999976555566788899999999999999999999987654 789999
Q ss_pred eccCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE----cCCCCeEEeeccCccc
Q 006168 396 EYMANSSLDKFLFGEKR-GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL----DDDLQPKIADFGLARL 470 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll----~~~~~~kl~DfGla~~ 470 (658)
||+++++|.+++..... ..+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999965433 2399999999999999999999998 99999999999999 7788899999999987
Q ss_pred cCCCCccccccccCCcccccccccc--------cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcc--hhhHHHHHHHHh
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAI--------HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE--GEYLLKRAWRLY 540 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~--------~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~--~~~l~~~~~~~~ 540 (658)
...... .....||+.|+|||++. +..++.++||||||+++|||++|+.||...... ............
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 654432 23457999999999986 578899999999999999999999999754432 122222222111
Q ss_pred hcCcc----------cccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 541 ENGTH----------WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 541 ~~~~~----------~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..... ....................+.+++..||+.||++|||+.|+++.....
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 11100 0000011112345678888999999999999999999999999998766
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=352.87 Aligned_cols=255 Identities=26% Similarity=0.434 Sum_probs=210.0
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
.++|.+.+.||+|+||.||++.++++..||+|++... ....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC--CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 4678889999999999999999998889999999753 33457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 101 ~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 101 MANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp CTTCBHHHHHHC-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 999999999954 235699999999999999999999998 9999999999999999999999999999876544333
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ....+. . .
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~----~~~~~~-----~-----~ 240 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAE----HIAQGL-----R-----L 240 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHH----HHHTTC-----C-----C
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHH----HHhccc-----C-----C
Confidence 3334567888999999999999999999999999999998 99998754432 1111 111110 0 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 11112235689999999999999999999999999876
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=355.68 Aligned_cols=262 Identities=26% Similarity=0.488 Sum_probs=206.0
Q ss_pred cCCCccCcccccCceEEEEEEec-----CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeec--CCeE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-----NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ--GPEL 391 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 391 (658)
++|++.++||+|+||.||+++++ +++.||||++.. ......+.+.+|++++++++||||+++++++.. ....
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 67888999999999999999852 588999999875 344556789999999999999999999999854 3568
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++++||+|||++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 9999999999999999543 34599999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcc--ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcc----------hhhHHHHHHHH
Q 006168 472 PENQSH--LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE----------GEYLLKRAWRL 539 (658)
Q Consensus 472 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~----------~~~l~~~~~~~ 539 (658)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 543322 222455778899999999999999999999999999999999987643211 11111111122
Q ss_pred hhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 540 YENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 540 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...+.. ...+...+..+.+++..||+.||++|||+.||++.|+.+.
T Consensus 245 ~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 245 LKNNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHTTCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccCc----------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 211111 1112233457999999999999999999999999998874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=362.96 Aligned_cols=262 Identities=26% Similarity=0.469 Sum_probs=215.2
Q ss_pred HHHhcCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecC
Q 006168 315 VSATRKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG 388 (658)
Q Consensus 315 ~~a~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 388 (658)
....++|...+.||+|+||.||++++. +++.||||++.........+.+.+|++++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 344678999999999999999999975 34789999998655555567899999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecC
Q 006168 389 PELILVYEYMANSSLDKFLFGEK----------------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRD 446 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 446 (658)
+..++||||+++|+|.+++.... ...+++.+++.++.||++||.|||+. +|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 99999999999999999996532 15699999999999999999999998 999999
Q ss_pred cCCCcEEEcCCCCeEEeeccCccccCCCCc-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCC
Q 006168 447 IKPSNVLLDDDLQPKIADFGLARLLPENQS-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSET 524 (658)
Q Consensus 447 ik~~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~ 524 (658)
|||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999986643322 12234567899999999999999999999999999999999 9999865
Q ss_pred CCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 525 KGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 525 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
.... .+. .....+... ..+...+..+.+++.+||+.||.+|||+.+|++.|+++.
T Consensus 280 ~~~~--~~~----~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 280 MAHE--EVI----YYVRDGNIL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp SCHH--HHH----HHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CChH--HHH----HHHhCCCcC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 4321 111 112222111 111223456999999999999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=365.16 Aligned_cols=259 Identities=29% Similarity=0.461 Sum_probs=214.6
Q ss_pred hcCCCccCcccccCceEEEEEEec--------CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecC
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK--------NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQG 388 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 388 (658)
.++|.+.+.||+|+||.||+++.. ++..||||++...........+.+|+++++++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467888999999999999999863 24679999997655556668899999999999 999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE
Q 006168 389 PELILVYEYMANSSLDKFLFGEK--------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL 454 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll 454 (658)
+..++||||+++|+|.+++.... ...+++..++.|+.||+.||.|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 99999999999999999996543 24599999999999999999999998 99999999999999
Q ss_pred cCCCCeEEeeccCccccCCCCc-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhH
Q 006168 455 DDDLQPKIADFGLARLLPENQS-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYL 532 (658)
Q Consensus 455 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l 532 (658)
++++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .+
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--~~ 302 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL 302 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 9999999999999987654332 22334567889999999999999999999999999999999 99998654321 11
Q ss_pred HHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 533 LKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 533 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
.+....+.... .+...+..+.+++..||+.||++|||+.||++.|+.+.
T Consensus 303 ----~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 303 ----FKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp ----HHHHHTTCCCC----------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHcCCCCC----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 12222221111 11122356999999999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=375.43 Aligned_cols=257 Identities=31% Similarity=0.506 Sum_probs=207.1
Q ss_pred HhcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
..++|...++||+|+||.||+|.++++..||||++... ....+.|.+|++++++++||||+++++++.+ +..++|||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccC--CCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 44678889999999999999999998889999999753 2346789999999999999999999999976 67899999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++|+|.+++.......+++..++.++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 99999999999644445699999999999999999999998 999999999999999999999999999987654433
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.......++..|+|||.+..+.++.++||||||+++|||++ |+.|+...... .+. .....+..
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~----~~i~~~~~---------- 399 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVL----DQVERGYR---------- 399 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH----HHHHTTCC----------
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHH----HHHHcCCC----------
Confidence 33334567889999999999999999999999999999999 89998654321 111 11111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...+...+..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0112233456899999999999999999999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=357.25 Aligned_cols=258 Identities=29% Similarity=0.467 Sum_probs=214.4
Q ss_pred hcCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 391 (658)
.++|.+.+.||+|+||.||++... +++.||||++.........+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 467888999999999999999862 45789999998655556668899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCC
Q 006168 392 ILVYEYMANSSLDKFLFGEKR----------------------GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKP 449 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~ 449 (658)
++||||+++++|.+++..... ..+++..++.++.||++||.|||+. +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999965432 3489999999999999999999998 999999999
Q ss_pred CcEEEcCCCCeEEeeccCccccCCCCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCc
Q 006168 450 SNVLLDDDLQPKIADFGLARLLPENQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGE 527 (658)
Q Consensus 450 ~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~ 527 (658)
+|||++.++.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998765443322 234567889999999999999999999999999999999 9999875543
Q ss_pred chhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 528 EGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 528 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.. +. .....+... ..+...+..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 259 ~~--~~----~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 259 ER--LF----NLLKTGHRM----------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GG--HH----HHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH--HH----HHhhcCCcC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 21 11 112111111 11122345699999999999999999999999999876
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=360.69 Aligned_cols=256 Identities=26% Similarity=0.446 Sum_probs=203.1
Q ss_pred cCCCccCcccccCceEEEEEEec-CCc----EEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGK----IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
++|...+.||+|+||.||+|++. +++ +||+|.+.........+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56888999999999999999965 343 468998876555667789999999999999999999999998754 789
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
|+||+.+|+|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 99999999999999643 45699999999999999999999998 999999999999999999999999999987754
Q ss_pred CCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 474 NQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 474 ~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
..... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... +.. ....+..
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~----~~~~~~~------ 237 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS----ILEKGER------ 237 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH----HHHTTCC------
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHH----HHHcCCC------
Confidence 43322 234567889999999999999999999999999999999 999997654321 111 1111110
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...+...+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 238 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 238 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0111223456899999999999999999999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=356.92 Aligned_cols=249 Identities=24% Similarity=0.292 Sum_probs=207.9
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|...+.||+|+||.||+++.+ +|+.||+|++.... .......+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888999999999999999976 68999999986531 3455678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++......
T Consensus 85 E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 85 EYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999999843 45699999999999999999999998 99999999999999999999999999998643322
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+...+ .. +.
T Consensus 160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i---~~-~~----------- 221 (337)
T 1o6l_A 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELI---LM-EE----------- 221 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH---HH-CC-----------
T ss_pred -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--HHHHHH---Hc-CC-----------
Confidence 2234568999999999999999999999999999999999999999754321 111111 11 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRP-----TMSEVVAL 590 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 590 (658)
...+...+..+.+++.+||+.||.+|| ++.||++.
T Consensus 222 ~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 011122345689999999999999999 89999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=370.37 Aligned_cols=258 Identities=29% Similarity=0.431 Sum_probs=210.7
Q ss_pred cCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
++|.+.+.||+|+||.||+|++. +++.||||++...........+.+|+.++++++||||+++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 57888999999999999999953 467899999976555566678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC---CeEEee
Q 006168 393 LVYEYMANSSLDKFLFGEKR-----GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL---QPKIAD 464 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~---~~kl~D 464 (658)
+||||+++|+|.+++..... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 99999999999999965332 4599999999999999999999999 999999999999999554 599999
Q ss_pred ccCccccCCCC-ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhc
Q 006168 465 FGLARLLPENQ-SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYEN 542 (658)
Q Consensus 465 fGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 542 (658)
||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+.. ....
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~~~----~i~~ 301 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLE----FVTS 301 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHH----HHHT
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHc
Confidence 99998553221 122334568899999999999999999999999999999998 99998654331 1111 1111
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 543 GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 543 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
+... ..+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus 302 ~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 302 GGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1111 111223356899999999999999999999999998774
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=354.55 Aligned_cols=258 Identities=27% Similarity=0.452 Sum_probs=217.5
Q ss_pred HHhcCCCccCcccccCceEEEEEEecC-CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
...++|.+.+.||+|+||.||++.++. +..||+|.+.. .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS--CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 345778889999999999999999874 88999999874 334567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 9999999999999776667799999999999999999999999 9999999999999999999999999999877655
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
.........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... +... .....
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~~----~~~~~--------- 229 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYEL----LEKDY--------- 229 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHH----HHTTC---------
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----HhccC---------
Confidence 4444445667889999999999999999999999999999999 888886544321 1111 11110
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
....+...+..+.+++..||+.||.+|||+.++++.|+.+
T Consensus 230 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 230 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 0111122345699999999999999999999999999876
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=362.28 Aligned_cols=260 Identities=29% Similarity=0.465 Sum_probs=209.6
Q ss_pred CCccCcccccCceEEEEEEec-----CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeec--CCeEEE
Q 006168 321 FSEENKLGEGGFGDIYKGTLK-----NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ--GPELIL 393 (658)
Q Consensus 321 f~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 393 (658)
|...++||+|+||.||++.++ +++.||||++...........+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999998753 5889999999865555556789999999999999999999999977 467899
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 113 v~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 9999999999999943 3499999999999999999999998 999999999999999999999999999988755
Q ss_pred CCcc--ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchh---------hHHHHHHHHhhc
Q 006168 474 NQSH--LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE---------YLLKRAWRLYEN 542 (658)
Q Consensus 474 ~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~---------~l~~~~~~~~~~ 542 (658)
.... ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+........ .......+....
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 4322 23355688899999999999999999999999999999999999864321100 000111111111
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 006168 543 GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSS 596 (658)
Q Consensus 543 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 596 (658)
+. ....+...+..+.+|+.+||+.||.+|||+.|+++.|+.+..
T Consensus 267 ~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 267 GE----------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cc----------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11 111222334579999999999999999999999999998743
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=354.95 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=207.4
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccccc-----ccHHHHHHHHHHHhccCCCccceeeeEeecCCeE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR-----RTLSDFENEVRLISNVHHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 391 (658)
.++|.+.+.||+|+||.||+++.+ +|+.||+|.+...... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467889999999999999999976 6899999999754221 2357899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC----CeEEeeccC
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL----QPKIADFGL 467 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~----~~kl~DfGl 467 (658)
++||||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999993 456799999999999999999999998 999999999999998876 799999999
Q ss_pred ccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccc
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWE 547 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 547 (658)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... ...+.. .
T Consensus 166 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--~~~~~----i~~~~~-~ 236 (361)
T 2yab_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLAN----ITAVSY-D 236 (361)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHH----HHTTCC-C
T ss_pred ceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH----HHhcCC-C
Confidence 98765432 234567999999999999999999999999999999999999999764331 11111 111110 0
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 548 LMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 548 ~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
++.. .....+..+.+++..||+.||.+|||+.|+++
T Consensus 237 -~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 -FDEE-----FFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -CCHH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -CCch-----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 00112356899999999999999999999985
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=345.49 Aligned_cols=254 Identities=26% Similarity=0.508 Sum_probs=205.6
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccccccc------HHHHHHHHHHHhccCCCccceeeeEeecCCe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRT------LSDFENEVRLISNVHHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 390 (658)
.++|...+.||+|+||.||++++. +++.||+|++........ .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367888999999999999999975 689999999865432222 267899999999999999999999997665
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eeecCcCCCcEEEcCCCC-----eEEe
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVR--IIHRDIKPSNVLLDDDLQ-----PKIA 463 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dik~~NIll~~~~~-----~kl~ 463 (658)
++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. + |+||||||+|||++.++. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999988853 345799999999999999999999998 7 999999999999988776 9999
Q ss_pred eccCccccCCCCccccccccCCccccccccc--ccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh
Q 006168 464 DFGLARLLPENQSHLSTKFAGTLGYTAPEYA--IHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYE 541 (658)
Q Consensus 464 DfGla~~~~~~~~~~~~~~~gt~~y~APE~~--~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~ 541 (658)
|||+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||............... .
T Consensus 172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~ 244 (287)
T 4f0f_A 172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR---E 244 (287)
T ss_dssp CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH---H
T ss_pred CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh---c
Confidence 9999975433 23346799999999998 4556789999999999999999999999765543322222111 1
Q ss_pred cCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 542 NGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 542 ~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.+. ....+...+..+.+++..||+.||.+|||+.+|++.|+++
T Consensus 245 ~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 245 EGL----------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp SCC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cCC----------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111 1111223345699999999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=355.17 Aligned_cols=260 Identities=25% Similarity=0.433 Sum_probs=214.0
Q ss_pred hcCCCccCcccccCceEEEEEEe------cCCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTL------KNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 390 (658)
.++|...+.||+|+||.||++++ .+++.||||++.........+.+.+|+.+++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46788899999999999999985 246789999997654445567899999999999 99999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE
Q 006168 391 LILVYEYMANSSLDKFLFGEKR----------------GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL 454 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll 454 (658)
.++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 9999999999999999965432 2499999999999999999999998 99999999999999
Q ss_pred cCCCCeEEeeccCccccCCCCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhH
Q 006168 455 DDDLQPKIADFGLARLLPENQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYL 532 (658)
Q Consensus 455 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l 532 (658)
+.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-F 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-H
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-H
Confidence 999999999999998775543322 234567889999999999999999999999999999999 9999876543221 1
Q ss_pred HHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 533 LKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 533 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
. .....+. .. ..+...+..+.+++.+||+.||.+|||+.|+++.|++..
T Consensus 258 ~----~~~~~~~-----~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 258 Y----KMIKEGF-----RM-----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp H----HHHHHTC-----CC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----HHhccCC-----CC-----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1 1111110 00 111123456899999999999999999999999998763
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=351.65 Aligned_cols=258 Identities=29% Similarity=0.479 Sum_probs=212.5
Q ss_pred HhcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
..++|.+.+.||+|+||.||+|..++++.||+|.+... ....+.+.+|++++++++||||+++++++.. +..++|||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC--cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 34678889999999999999999988889999998753 3456789999999999999999999999864 56899999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999999999543333699999999999999999999998 999999999999999999999999999987755443
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.......++..|+|||.+.++.++.++||||||++++||++ |+.||...... .+.. ....+..
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~----~~~~~~~---------- 228 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQ----NLERGYR---------- 228 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH----HHHTTCC----------
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHH----HHhcccC----------
Confidence 33345567889999999999999999999999999999999 88888654321 1111 1111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSS 596 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 596 (658)
...+...+..+.+++..||+.||++|||+.++++.|+.+..
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 01111234569999999999999999999999999998743
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=351.03 Aligned_cols=256 Identities=24% Similarity=0.377 Sum_probs=198.7
Q ss_pred hcCCCccCcccccCceEEEEEEecC----CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
.++|.+.+.||+|+||.||+|.+.. +..||+|++.........+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4678889999999999999999753 45799999876444555678999999999999999999999984 467899
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCc
Confidence 99999999999999543 34699999999999999999999998 999999999999999999999999999987755
Q ss_pred CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
..........+++.|+|||.+....++.++||||||+++|||++ |+.||....... .... ...+...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~----i~~~~~~------ 236 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGR----IENGERL------ 236 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHH----HHTTCCC------
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHH----HHcCCCC------
Confidence 44333344567889999999999999999999999999999997 888987544321 1111 1111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+...+..+.+++..||+.||++|||+.+|++.|+.+
T Consensus 237 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 ----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11122345689999999999999999999999999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=360.61 Aligned_cols=262 Identities=24% Similarity=0.418 Sum_probs=211.6
Q ss_pred HHhcCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecC
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQG 388 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 388 (658)
...++|...+.||+|+||.||+|++. ++..||||++.........+.+.+|+.+++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 34578889999999999999999962 46689999997654455567899999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCc
Q 006168 389 PELILVYEYMANSSLDKFLFGEKR---------------------GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDI 447 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Di 447 (658)
+..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+. +|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 999999999999999999965432 2389999999999999999999998 9999999
Q ss_pred CCCcEEEcCCCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCC
Q 006168 448 KPSNVLLDDDLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETK 525 (658)
Q Consensus 448 k~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~ 525 (658)
||+|||++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999999866443322 2334567889999999999999999999999999999998 99998765
Q ss_pred CcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 526 GEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 526 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
..... + ......+.. ...+...+..+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus 279 ~~~~~-~----~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 279 PVDAN-F----YKLIQNGFK----------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp CCSHH-H----HHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CcHHH-H----HHHHhcCCC----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 43221 1 111221111 0111223456999999999999999999999999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=350.97 Aligned_cols=255 Identities=29% Similarity=0.475 Sum_probs=200.6
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
++|.+.+.||+|+||.||++++. ++.||||++.. ....+.+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS---TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC---hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 56778899999999999999985 78899999863 3345789999999999999999999999874 479999999
Q ss_pred CCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC-eEEeeccCccccCCCCc
Q 006168 399 ANSSLDKFLFGEKR-GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ-PKIADFGLARLLPENQS 476 (658)
Q Consensus 399 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~-~kl~DfGla~~~~~~~~ 476 (658)
++|+|.+++..... ..+++..++.++.|+++||.|||+....+|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999965433 24889999999999999999999943238999999999999998887 799999999765332
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||........... +... .+...
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~-~~~~~---------- 223 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVH-NGTRP---------- 223 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH---HHHH-TTCCC----------
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH---HHHh-cCCCC----------
Confidence 2234689999999999999999999999999999999999999976544322111 1111 11111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSS 597 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 597 (658)
......+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11112335689999999999999999999999999987533
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=346.59 Aligned_cols=254 Identities=29% Similarity=0.459 Sum_probs=196.8
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccc---cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGIS---RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|...+.||+|+||.||++.+. ++.||||++..... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57888999999999999999985 88999999865322 234578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC--------CCCeEEeeccC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD--------DLQPKIADFGL 467 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~--------~~~~kl~DfGl 467 (658)
||+++++|.+++. ...+++..++.++.|++.||.|||+....+|+||||||+|||++. ++.+||+|||+
T Consensus 86 e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 86 EFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp ECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 9999999999983 457999999999999999999999982223999999999999986 67899999999
Q ss_pred ccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccc
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWE 547 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 547 (658)
+....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..........
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~-- 232 (271)
T 3dtc_A 163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-----AYGVAMNKLA-- 232 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-----HHHHHTSCCC--
T ss_pred cccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHhhhcCCCC--
Confidence 98654332 2245789999999999999999999999999999999999999975443211 1111111110
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 548 LMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 548 ~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
...+...+..+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 233 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 233 --------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111222345699999999999999999999999999763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=353.71 Aligned_cols=259 Identities=17% Similarity=0.216 Sum_probs=209.4
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 395 (658)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+|+++++++ +||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC---SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 367889999999999999999964 78999999986532 234688999999999 9999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC-----eEEeeccCccc
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ-----PKIADFGLARL 470 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~-----~kl~DfGla~~ 470 (658)
||+ +++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 999 99999999643 45799999999999999999999998 9999999999999998887 99999999987
Q ss_pred cCCCCcc------ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcc-hhhHHHHHHHHhhcC
Q 006168 471 LPENQSH------LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE-GEYLLKRAWRLYENG 543 (658)
Q Consensus 471 ~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~-~~~l~~~~~~~~~~~ 543 (658)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 6443321 123568999999999999999999999999999999999999999865432 212222111111000
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 544 THWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 544 ~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
. .+ .+ ... .+ .+.+++..||+.||.+||++.+|++.|+.+.
T Consensus 240 ~-~~----~~-~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 240 P-IE----VL-CEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp C-HH----HH-TTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred C-HH----HH-hcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 0 00 00 011 12 6999999999999999999999999998763
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=371.21 Aligned_cols=251 Identities=28% Similarity=0.445 Sum_probs=207.6
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCC-eEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP-ELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E 396 (658)
.++|...+.||+|+||.||+|.++ ++.||||++... ...+.|.+|++++++++||||+++++++.+.+ ..++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSC---TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCc---hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 467788899999999999999986 789999999753 24578999999999999999999999987654 7999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++|+|.+++.......+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 99999999999765555589999999999999999999998 99999999999999999999999999998643221
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... +.. ....+...
T Consensus 344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~----~i~~~~~~--------- 405 (450)
T 1k9a_A 344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP----RVEKGYKM--------- 405 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHH----HHHTTCCC---------
T ss_pred ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcCCCC---------
Confidence 22367889999999999999999999999999999998 999987544321 111 11111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
..+...+..+.+|+..||+.||.+|||+.+|++.|+.+.
T Consensus 406 -~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 406 -DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 112223456999999999999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=350.96 Aligned_cols=264 Identities=26% Similarity=0.394 Sum_probs=204.2
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccc-cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGIS-RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|.+.++||+|+||.||+++..+++.||+|++..... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 468889999999999999999998899999999875422 2234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++ +|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 100 FMEK-DLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp CCSE-EHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred CCCC-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 9985 88887743 345699999999999999999999998 999999999999999999999999999987643322
Q ss_pred cccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccc--cccc---
Q 006168 477 HLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHW--ELMD--- 550 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~--~~~d--- 550 (658)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ............... ....
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD--QLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT--HHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHHCCCChHHhhhhhccc
Confidence 2334578999999999876 568999999999999999999999997654422 112222221111000 0000
Q ss_pred ----ccCC-CCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 551 ----ESLD-PNE-----CTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 551 ----~~l~-~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.... ... .......++.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 000 01112356889999999999999999999987
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=345.36 Aligned_cols=265 Identities=23% Similarity=0.399 Sum_probs=206.3
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
++|...++||+|+||+||+++.. +++.||+|++..... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57888999999999999999986 589999999975432 3334778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++ +|.+.+.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 9986 55555532 346799999999999999999999998 99999999999999999999999999998764332
Q ss_pred cccccccCCcccccccccccCC-CCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcC--cccccccc--
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQ-LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG--THWELMDE-- 551 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~-~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~~~~~~d~-- 551 (658)
.......||+.|+|||++.+.. ++.++||||||+++|||++|+.|+........ ......+..... ..+.....
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGGGST
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhhhhcccc
Confidence 2234567899999999998766 79999999999999999999988755443222 222222222111 00100000
Q ss_pred ----------cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 552 ----------SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 552 ----------~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..............+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000011122345678999999999999999999999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=344.76 Aligned_cols=251 Identities=22% Similarity=0.354 Sum_probs=207.1
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecC--CeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG--PELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 395 (658)
++|...+.||+|+||.||+|+++ ++.||||++.... .....+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57888999999999999999986 8899999987532 334457799999999999999999999999876 7889999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVR--IIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||+++|+|.+++.......+++..++.++.||+.||.|||+. + |+||||||+|||++.++.++|+|||+......
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999999999765555699999999999999999999997 7 99999999999999999999999998764322
Q ss_pred CCccccccccCCcccccccccccCCCCC---cccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSE---KVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~---ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
....||+.|+|||.+.+..++. ++||||||+++|||++|+.||....... . .......+...
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~---~~~~~~~~~~~---- 230 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME--I---GMKVALEGLRP---- 230 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH--H---HHHHHHSCCCC----
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH--H---HHHHHhcCCCC----
Confidence 2346899999999998766554 7999999999999999999997544321 1 11111111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+...+..+.+++..||+.||++|||+.++++.|+.+
T Consensus 231 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 231 ------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 11222345699999999999999999999999999886
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=368.30 Aligned_cols=262 Identities=21% Similarity=0.270 Sum_probs=212.3
Q ss_pred chHHHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEee
Q 006168 310 RLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCS 386 (658)
Q Consensus 310 ~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 386 (658)
.+.++....++|.+.+.||+|+||.||+++.+ +++.||+|++... ........+.+|+.+++.++||||+++++++.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34555666789999999999999999999987 5889999998642 12233445889999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeecc
Q 006168 387 QGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFG 466 (658)
Q Consensus 387 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG 466 (658)
+.+..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|||
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence 99999999999999999999853 4599999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCccccccccCCcccccccccccCC----CCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc
Q 006168 467 LARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ----LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN 542 (658)
Q Consensus 467 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~----~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 542 (658)
+++..............||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... .....+.....
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~~- 290 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMNHKN- 290 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTHHH-
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--hHHHHHHhccc-
Confidence 99887655443445678999999999998765 889999999999999999999999754432 11111111000
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 006168 543 GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANS--RPTMSEVVAL 590 (658)
Q Consensus 543 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~--RPt~~evl~~ 590 (658)
... . +. ....+..+.+|+..||+.+|.+ ||++.||++.
T Consensus 291 --~~~-----~-p~--~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 --SLT-----F-PD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --HCC-----C-CT--TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --ccc-----C-CC--cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000 0 00 0112356899999999999988 9999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=344.72 Aligned_cols=255 Identities=27% Similarity=0.454 Sum_probs=212.1
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
++|...+.||+|+||.||++.+.+++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--TBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEcccc--CCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 567888999999999999999988999999999753 334578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 86 ~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 86 EHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp TTCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHhh-CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 99999999954 335699999999999999999999998 99999999999999999999999999998765433223
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ....+.. ..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~----~i~~~~~----------~~ 225 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVE----DISTGFR----------LY 225 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH----HHHTTCC----------CC
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHHH----HHhcCCc----------CC
Confidence 334567889999999999999999999999999999999 88888654321 1111 1111110 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
.+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11122456899999999999999999999999998873
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=350.13 Aligned_cols=262 Identities=23% Similarity=0.463 Sum_probs=208.6
Q ss_pred cCCCccCcccccCceEEEEEEe-----cCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecC--CeE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTL-----KNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG--PEL 391 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 391 (658)
++|...+.||+|+||.||++++ .+++.||+|++...........+.+|++++++++||||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999984 368899999998655556678899999999999999999999999776 678
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 999999999999999953 335699999999999999999999998 9999999999999999999999999999877
Q ss_pred CCCCcc--ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc---------chhhHHHHHHHHh
Q 006168 472 PENQSH--LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE---------EGEYLLKRAWRLY 540 (658)
Q Consensus 472 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~---------~~~~l~~~~~~~~ 540 (658)
...... ......||..|+|||.+.+..++.++||||||+++|||++|+.|+..... .............
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 554332 23356788899999999999999999999999999999999988543210 0011111111111
Q ss_pred hcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 541 ENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 541 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+.. ...+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 257 ~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 257 KEGKR----------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred hccCC----------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 11111 112223345799999999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=360.20 Aligned_cols=264 Identities=25% Similarity=0.410 Sum_probs=213.7
Q ss_pred HHHHHhcCCCccCcccccCceEEEEEEecC------CcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEe
Q 006168 313 DLVSATRKFSEENKLGEGGFGDIYKGTLKN------GKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCC 385 (658)
Q Consensus 313 ~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 385 (658)
++....++|...+.||+|+||.||+|.... ...||+|.+.........+.+.+|+++++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344456789999999999999999999753 2479999997654445567899999999999 899999999999
Q ss_pred ecCCeEEEEEeccCCCCHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEE
Q 006168 386 SQGPELILVYEYMANSSLDKFLFGEK------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVL 453 (658)
Q Consensus 386 ~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIl 453 (658)
.+.+..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 99999999999999999999986432 34589999999999999999999998 9999999999999
Q ss_pred EcCCCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhh
Q 006168 454 LDDDLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEY 531 (658)
Q Consensus 454 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~ 531 (658)
++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~- 275 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK- 275 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence 999999999999999866433222 2234567889999999999999999999999999999999 8889876443221
Q ss_pred HHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 532 LLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 532 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
+ ......+.. . ..+...+..+.+++..||+.||.+|||+.+|++.|+..
T Consensus 276 ~----~~~~~~~~~-----~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 276 F----YKLVKDGYQ-----M-----AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp H----HHHHHHTCC-----C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHHhcCCC-----C-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1 111111110 0 01111235689999999999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=351.33 Aligned_cols=252 Identities=19% Similarity=0.317 Sum_probs=200.9
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCC-------
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP------- 389 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 389 (658)
.++|++.+.||+|+||.||+|+++ +++.||||++.........+.+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467889999999999999999987 799999999976544556688999999999999999999999985543
Q ss_pred --------------------------------------------------eEEEEEeccCCCCHHHHhhcCCC-CCCCHH
Q 006168 390 --------------------------------------------------ELILVYEYMANSSLDKFLFGEKR-GSLNWK 418 (658)
Q Consensus 390 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~ 418 (658)
..++||||+++++|.+++..... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 38999999999999999965432 236777
Q ss_pred HHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc-----------cccccccCCcc
Q 006168 419 QRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS-----------HLSTKFAGTLG 487 (658)
Q Consensus 419 ~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~~ 487 (658)
.++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8999999999999999998 999999999999999999999999999987755421 12234579999
Q ss_pred cccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHH
Q 006168 488 YTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVV 567 (658)
Q Consensus 488 y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~ 567 (658)
|+|||.+.+..++.++||||||+++|||++|..|+.. ... ......... ...........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----~~~----~~~~~~~~~----------~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----RVR----IITDVRNLK----------FPLLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----HHH----HHHHHHTTC----------CCHHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----HHH----HHHHhhccC----------CCcccccCChhHH
Confidence 9999999999999999999999999999998665311 001 111111111 1111223445678
Q ss_pred HHHHHccccCCCCCCCHHHHHHH
Q 006168 568 EIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 568 ~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+++.+||+.||.+|||+.|+++.
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999999874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=350.54 Aligned_cols=266 Identities=26% Similarity=0.429 Sum_probs=194.4
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|...+.||+|+||.||+|..+ +++.||+|++...........+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468899999999999999999976 5899999999765444555788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 397 YMANSSLDKFLFGEK----RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
|++ |+|.+++.... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999885432 24599999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc--Ccccccc
Q 006168 473 ENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN--GTHWELM 549 (658)
Q Consensus 473 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~~~~~~~ 549 (658)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .......+.... ...+..+
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE--EQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCTTTCGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChhHhhhh
Confidence 3322 2234578999999999876 46899999999999999999999999765432 122222221110 0011000
Q ss_pred cc------cCC---CCC--------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 550 DE------SLD---PNE--------CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 550 d~------~l~---~~~--------~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.. .+. ... ........+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00 000 000 001123568999999999999999999998863
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=357.38 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=206.3
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+.+.||+|+||.||+++.. +++.||+|++... ........+.+|++++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57888999999999999999976 5889999998653 23445678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+.+|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 95 e~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQ--QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp CCCTTEEHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 9999999999994 345699999999999999999999998 99999999999999999999999999998764432
Q ss_pred ccccccccCCccccccccccc---CCCCCcccchhhhHHHHHHHhCCCCCCCCCcc-hhhHHHHHHHHhhcCcccccccc
Q 006168 476 SHLSTKFAGTLGYTAPEYAIH---GQLSEKVDAYSFGVLVLEIISGTKSSETKGEE-GEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~---~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ...+.... ...
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~----~~~-------- 235 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF----ETT-------- 235 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH----HHC--------
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH----hhc--------
Confidence 2345789999999999864 45899999999999999999999999765442 22221111 100
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPT-MSEVVA 589 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~ 589 (658)
....+...+..+.+|+..||+.||.+||+ +.+|++
T Consensus 236 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 ---VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01122223456999999999999999998 777764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=353.17 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=207.0
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccccc-----ccHHHHHHHHHHHhccCCCccceeeeEeecCCeE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR-----RTLSDFENEVRLISNVHHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 391 (658)
.++|...+.||+|+||.||+++.. +++.||+|.+...... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356888999999999999999976 5899999998653221 2467899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC----CeEEeeccC
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL----QPKIADFGL 467 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~----~~kl~DfGl 467 (658)
++||||+++++|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999994 446799999999999999999999998 999999999999998887 899999999
Q ss_pred ccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccc
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWE 547 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 547 (658)
++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ........ ... .
T Consensus 165 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~----~~~-~ 235 (326)
T 2y0a_A 165 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANVSA----VNY-E 235 (326)
T ss_dssp CEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHH----TCC-C
T ss_pred CeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHHh----cCC-C
Confidence 98765332 223467999999999999999999999999999999999999999754331 11111111 000 0
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 548 LMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 548 ~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+. .....+..+.+++..||+.||.+|||+.|+++.
T Consensus 236 ~~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 FEDE------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCHH------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCcc------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 001123568899999999999999999999974
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=360.08 Aligned_cols=250 Identities=21% Similarity=0.313 Sum_probs=200.9
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 393 (658)
.++|...+.||+|+||.||+++.+ +++.||+|++.... .......+.+|..++.++ +||||+++++++...+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357889999999999999999987 57899999997532 223345678999999887 89999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 9999999999999853 35699999999999999999999998 999999999999999999999999999986432
Q ss_pred CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcc---hhhHHHHHHHHhhcCccccccc
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE---GEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~~d 550 (658)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .........+......
T Consensus 206 ~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------ 278 (396)
T 4dc2_A 206 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------ 278 (396)
T ss_dssp TT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC------
T ss_pred CC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc------
Confidence 22 2234578999999999999999999999999999999999999999754321 1111111112111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTM 584 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 584 (658)
...+...+..+.+|+..||+.||.+||++
T Consensus 279 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 -----IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11222234568999999999999999995
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=357.28 Aligned_cols=265 Identities=22% Similarity=0.393 Sum_probs=198.2
Q ss_pred HHHHHHhcCCCccCcccccCceEEEEEEecCC----cEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEee
Q 006168 312 KDLVSATRKFSEENKLGEGGFGDIYKGTLKNG----KIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCS 386 (658)
Q Consensus 312 ~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 386 (658)
+++....++|.+.+.||+|+||.||+|++... ..||||++.... .....+.+.+|++++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 33444567899999999999999999997643 279999987532 3445678999999999999999999999998
Q ss_pred cCCeE------EEEEeccCCCCHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC
Q 006168 387 QGPEL------ILVYEYMANSSLDKFLFGEK----RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD 456 (658)
Q Consensus 387 ~~~~~------~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~ 456 (658)
..+.. ++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||+++
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcC
Confidence 76654 99999999999999985432 22599999999999999999999998 9999999999999999
Q ss_pred CCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHH
Q 006168 457 DLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLK 534 (658)
Q Consensus 457 ~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~ 534 (658)
++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... +..
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~ 250 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--IYN 250 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--HHH
Confidence 999999999999876443322 2234567889999999999999999999999999999999 899987644321 111
Q ss_pred HHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 535 RAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 535 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
....+... ..+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 251 ----~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 251 ----YLIGGNRL----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp ----HHHTTCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHhcCCCC----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111111 111223456999999999999999999999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=358.72 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=205.4
Q ss_pred cCCCccCcccccCceEEEEEEec-CCc----EEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGK----IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
++|...+.||+|+||.||+|++. +++ +||+|.+...........+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56788899999999999999975 344 388888765444455567889999999999999999999986 566899
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+++|+|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999999532 45699999999999999999999998 999999999999999999999999999998755
Q ss_pred CCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 474 NQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 474 ~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
.... ......++..|+|||.+.++.++.++||||||+++|||++ |+.||....... +. .....+.....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~----~~~~~~~~~~~--- 238 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VP----DLLEKGERLAQ--- 238 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HH----HHHHTTCBCCC---
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HH----HHHHcCCCCCC---
Confidence 4332 2345677889999999999999999999999999999999 999997654321 11 11111111110
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
+. ..+..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus 239 ---~~----~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 239 ---PQ----ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ---CT----TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ---CC----cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 12235789999999999999999999999998874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.28 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=207.2
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|.+.+.||+|+||.||+++.. +++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 468889999999999999999976 5889999998642 3345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC--CCCeEEeeccCccccCCC
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD--DLQPKIADFGLARLLPEN 474 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~--~~~~kl~DfGla~~~~~~ 474 (658)
|+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++..+...
T Consensus 82 ~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 82 FISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred eCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999999943 334699999999999999999999998 9999999999999987 789999999999877543
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+ . .+... . +.
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i---~-~~~~~-~-~~--- 224 (321)
T 1tki_A 158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENI---M-NAEYT-F-DE--- 224 (321)
T ss_dssp C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHH---H-HTCCC-C-CH---
T ss_pred C--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHH---H-cCCCC-C-Ch---
Confidence 3 233467899999999999888999999999999999999999999764432 111111 1 11100 0 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
......+..+.+++.+||+.||.+|||+.|+++.
T Consensus 225 --~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 225 --EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0001124568999999999999999999999974
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=358.69 Aligned_cols=268 Identities=18% Similarity=0.228 Sum_probs=207.3
Q ss_pred HhcCCCccCcccccCceEEEEEEecC------CcEEEEEEccccccc----------ccHHHHHHHHHHHhccCCCccce
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLKN------GKIVAVKKLAIGISR----------RTLSDFENEVRLISNVHHRNLIR 380 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~ 380 (658)
..++|.+.+.||+|+||.||+|.+++ ++.||||++...... .....+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34688999999999999999999865 478999998653210 00112345666777888999999
Q ss_pred eeeEeecC----CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc-
Q 006168 381 LLGCCSQG----PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD- 455 (658)
Q Consensus 381 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~- 455 (658)
+++++... ...++||||+ +++|.+++.. ....+++..++.|+.||+.||.|||+. +|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 99998764 4589999999 9999999954 345699999999999999999999998 999999999999999
Q ss_pred -CCCCeEEeeccCccccCCCCccc------cccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcc
Q 006168 456 -DDLQPKIADFGLARLLPENQSHL------STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE 528 (658)
Q Consensus 456 -~~~~~kl~DfGla~~~~~~~~~~------~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~ 528 (658)
.++.+||+|||+++.+....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 88999999999998764332211 13456999999999999999999999999999999999999999854433
Q ss_pred hhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 529 GEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 529 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...... ..... .....++++..+.....+ ..+.+++..||+.||.+||++.+|++.|+.+.
T Consensus 268 ~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 268 PKYVRD-SKIRY-RENIASLMDKCFPAANAP----GEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp HHHHHH-HHHHH-HHCHHHHHHHHSCTTCCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHH-HHHHh-hhhHHHHHHHhcccccCH----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 222111 11111 112334444444323333 46899999999999999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=353.39 Aligned_cols=259 Identities=29% Similarity=0.464 Sum_probs=212.8
Q ss_pred hcCCCccCcccccCceEEEEEEec--------CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecC
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK--------NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQG 388 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 388 (658)
.++|.+.+.||+|+||.||++.+. ++..||||++...........+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468889999999999999999863 46789999997655555667899999999999 899999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE
Q 006168 389 PELILVYEYMANSSLDKFLFGEKR--------------GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL 454 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll 454 (658)
+..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999965432 2489999999999999999999998 99999999999999
Q ss_pred cCCCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhH
Q 006168 455 DDDLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYL 532 (658)
Q Consensus 455 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l 532 (658)
+.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .+
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~ 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--EL 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--HH
Confidence 99999999999999876544322 2234567889999999999999999999999999999999 99998654321 11
Q ss_pred HHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 533 LKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 533 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
.. ....+... ..+...+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 269 ~~----~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 269 FK----LLKEGHRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HH----HHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HHhcCCCC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 11111111 111223456899999999999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=354.85 Aligned_cols=270 Identities=26% Similarity=0.435 Sum_probs=218.4
Q ss_pred cccchHHHHHHhcCCCccCcccccCceEEEEEEe------cCCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccc
Q 006168 307 VNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTL------KNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLI 379 (658)
Q Consensus 307 ~~~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 379 (658)
..+...++....++|.+.+.||+|+||.||++++ .+++.||||++...........+.+|+++++++ +||||+
T Consensus 15 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv 94 (316)
T 2xir_A 15 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94 (316)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCee
Confidence 3455566666678999999999999999999985 246889999997655555567899999999999 799999
Q ss_pred eeeeEeecC-CeEEEEEeccCCCCHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeee
Q 006168 380 RLLGCCSQG-PELILVYEYMANSSLDKFLFGEKR--------------GSLNWKQRFDIILGTARGLAYLHEDFHVRIIH 444 (658)
Q Consensus 380 ~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 444 (658)
++++++... ...++||||+++++|.+++..... ..+++..++.++.||+.||.|||+. +|+|
T Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H 171 (316)
T 2xir_A 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH 171 (316)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 999998765 458999999999999999965432 1289999999999999999999998 9999
Q ss_pred cCcCCCcEEEcCCCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCC
Q 006168 445 RDIKPSNVLLDDDLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSS 522 (658)
Q Consensus 445 ~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~ 522 (658)
|||||+|||++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999876543322 2334567889999999999999999999999999999998 99998
Q ss_pred CCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 523 ETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 523 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
......... . .....+... ..+...+..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 252 ~~~~~~~~~-~----~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 252 PGVKIDEEF-C----RRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp TTCCCSHHH-H----HHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccchhHHH-H----HHhccCccC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 765433211 1 111111111 11112235689999999999999999999999999876
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=357.62 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=207.6
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
..++|.+.+.||+|+||.||++..+ +++.||+|++.... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4568999999999999999999976 68999999996532 334456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC---CCeEEeeccCcccc
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD---LQPKIADFGLARLL 471 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~---~~~kl~DfGla~~~ 471 (658)
|||+++|+|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++...
T Consensus 107 ~e~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 107 FDLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp ECCCCSCBHHHHHT--TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999984 445799999999999999999999998 99999999999999865 45999999999876
Q ss_pred CCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 472 PENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 472 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... ...+... .
T Consensus 182 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--~~~~~----i~~~~~~-~--- 249 (362)
T 2bdw_A 182 NDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQ----IKAGAYD-Y--- 249 (362)
T ss_dssp TTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HHHTCCC-C---
T ss_pred cCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHH----HHhCCCC-C---
Confidence 5432 233467999999999999999999999999999999999999999754321 11111 1111110 0
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+.......+..+.+++.+||+.||.+|||+.++++.
T Consensus 250 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 ---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ---CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000011234568999999999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=360.99 Aligned_cols=263 Identities=27% Similarity=0.432 Sum_probs=210.6
Q ss_pred cCCCccCcccccCceEEEEEEe-----cCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEee--cCCeE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTL-----KNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCS--QGPEL 391 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 391 (658)
++|...+.||+|+||.||++++ .+++.||||++... .....+.+.+|++++++++||||+++++++. +....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 5788899999999999999984 35889999998753 3445577999999999999999999999886 45678
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999999999542 34599999999999999999999998 9999999999999999999999999999877
Q ss_pred CCCCcc--ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchh---------hHHHHHHHHh
Q 006168 472 PENQSH--LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE---------YLLKRAWRLY 540 (658)
Q Consensus 472 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~---------~l~~~~~~~~ 540 (658)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+........ ..........
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 544322 22345688899999999999999999999999999999999999754322100 0001111111
Q ss_pred hcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 006168 541 ENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSS 596 (658)
Q Consensus 541 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 596 (658)
..+. ....+...+..+.+++..||+.||.+|||+.+|++.|+.+..
T Consensus 258 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 258 EEGQ----------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hccc----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111 111223344679999999999999999999999999998743
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=344.99 Aligned_cols=264 Identities=27% Similarity=0.424 Sum_probs=203.5
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|...+.||+|+||.||+++..+++.||+|++.... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788899999999999999999889999999986532 233347788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++ +|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CSE-EHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 986 99988853 345699999999999999999999998 999999999999999999999999999987643322
Q ss_pred ccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCc--ccc------c
Q 006168 478 LSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGT--HWE------L 548 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--~~~------~ 548 (658)
......||+.|+|||++.+. .++.++||||||+++|||++|+.||...... .......+...... .+. .
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHHCCCChhhchhhhcccc
Confidence 22345789999999998764 5899999999999999999999999765432 12222222211110 000 0
Q ss_pred ccccCC------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 549 MDESLD------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 549 ~d~~l~------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.++... ........+..+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 011100 001111234568999999999999999999999863
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=378.69 Aligned_cols=259 Identities=31% Similarity=0.500 Sum_probs=213.6
Q ss_pred HHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 315 VSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 315 ~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
+...++|.+.++||+|+||.||+|.++++..||||++... ....++|.+|+++|++++||||+++++++.+ +..++|
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCC--CCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 3345678889999999999999999998889999999753 2346789999999999999999999999976 678999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++|+|.++|.......+++.+++.|+.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 9999999999999644445699999999999999999999998 9999999999999999999999999999876543
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
.........++..|+|||.+..+.++.++||||||+++|||++ |+.||...... .+.. ....+...
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~----~i~~~~~~------- 483 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLD----QVERGYRM------- 483 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHH----HHHTTCCC-------
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHcCCCC-------
Confidence 2222234456789999999999999999999999999999999 89898654321 1111 11111110
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
..+...+..+.+|+.+||+.||++|||+.+|+++|+.+.
T Consensus 484 ---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 484 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111223456899999999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.40 Aligned_cols=260 Identities=18% Similarity=0.227 Sum_probs=211.0
Q ss_pred hcCCCccCcccccCceEEEEEEe-cCCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTL-KNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 395 (658)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+|+++++++ +|+|++++++++.+....++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 35788999999999999999996 478999999986432 234578899999999 8999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC-----eEEeeccCccc
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ-----PKIADFGLARL 470 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~-----~kl~DfGla~~ 470 (658)
||+ +++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||+|||+++.
T Consensus 86 e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp ECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 999 99999999543 34699999999999999999999998 9999999999999987766 99999999987
Q ss_pred cCCCCcc------ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc-chhhHHHHHHHHhhcC
Q 006168 471 LPENQSH------LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE-EGEYLLKRAWRLYENG 543 (658)
Q Consensus 471 ~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~-~~~~l~~~~~~~~~~~ 543 (658)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6543321 23456799999999999999999999999999999999999999987543 2222222221111111
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 544 THWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 544 ~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...+. .. ..+..+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus 241 ~~~~~------~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 241 PLREL------CA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp CHHHH------TT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cHHHH------Hh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 11111 11 12356999999999999999999999999999874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=358.47 Aligned_cols=249 Identities=25% Similarity=0.334 Sum_probs=202.3
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 393 (658)
.++|.+.+.||+|+||.||+++.+ +++.||||++... ........+.+|.++++.+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999976 5899999998753 1334567788999999988 79999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 9999999999999953 35699999999999999999999998 999999999999999999999999999986433
Q ss_pred CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+ . .+.
T Consensus 177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i---~-~~~--------- 240 (353)
T 3txo_A 177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAI---L-NDE--------- 240 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH---H-HCC---------
T ss_pred CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--HHHHHH---H-cCC---------
Confidence 22 2234568999999999999999999999999999999999999999765432 121111 1 111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTM------SEVVA 589 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~------~evl~ 589 (658)
..++......+.+++..||+.||.+||++ .|+++
T Consensus 241 --~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 --VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 01122234568999999999999999998 67764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=364.86 Aligned_cols=255 Identities=22% Similarity=0.312 Sum_probs=206.8
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
..++|.+.+.||+|+||.||++... +|+.+|+|++.... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999875 68999999986532 233456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc---CCCCeEEeeccCcccc
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD---DDLQPKIADFGLARLL 471 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~---~~~~~kl~DfGla~~~ 471 (658)
|||+++|+|.+.+.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||++...
T Consensus 89 ~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 999999999999853 45699999999999999999999998 999999999999998 4678999999999876
Q ss_pred CCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 472 PENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 472 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .+... ...+.. ..
T Consensus 164 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~--~~~~~----i~~~~~-~~--- 232 (444)
T 3soa_A 164 EGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH--RLYQQ----IKAGAY-DF--- 232 (444)
T ss_dssp CTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH----HHHTCC-CC---
T ss_pred cCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH--HHHHH----HHhCCC-CC---
Confidence 54332 234568999999999999999999999999999999999999999654321 11111 111111 00
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+.......+..+.+++..||+.||.+|||+.|+++.
T Consensus 233 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 ---PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ---CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000011224568999999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=355.87 Aligned_cols=267 Identities=26% Similarity=0.448 Sum_probs=217.9
Q ss_pred cchHHHHHHhcCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceee
Q 006168 309 YRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLL 382 (658)
Q Consensus 309 ~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 382 (658)
+..+++....++|.+.+.||+|+||.||+|++. +++.||||.+...........+.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 444556667789999999999999999999865 36789999997654555567799999999999999999999
Q ss_pred eEeecCCeEEEEEeccCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE
Q 006168 383 GCCSQGPELILVYEYMANSSLDKFLFGEK--------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL 454 (658)
Q Consensus 383 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll 454 (658)
+++.+.+..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 99999999999999999999999985422 24579999999999999999999998 99999999999999
Q ss_pred cCCCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhH
Q 006168 455 DDDLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYL 532 (658)
Q Consensus 455 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l 532 (658)
+.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~ 249 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QV 249 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH--HH
Confidence 99999999999999865433221 2234466889999999999999999999999999999999 78888654321 11
Q ss_pred HHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 533 LKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 533 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
. .....+.... .+...+..+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 250 ~----~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 250 L----RFVMEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp H----HHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred H----HHHHcCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 1 1122221111 1122345689999999999999999999999999887
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=348.51 Aligned_cols=245 Identities=24% Similarity=0.378 Sum_probs=206.0
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+.+.||+|+||.||+++.+ +|+.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57888999999999999999976 68999999986532 2345677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp CCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 99999999999953 45699999999999999999999998 9999999999999999999999999999876432
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .... +... +..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~---~i~~-~~~---------- 220 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTYE---KILN-AEL---------- 220 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH---HHHH-CCC----------
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHH---HHHh-CCC----------
Confidence 23467999999999999999999999999999999999999999754321 1111 1111 110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRP-----TMSEVVA 589 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 589 (658)
..+...+..+.+++.+||+.||.+|| +++++++
T Consensus 221 -~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 -RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11122345689999999999999999 8888884
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=357.74 Aligned_cols=270 Identities=17% Similarity=0.241 Sum_probs=207.6
Q ss_pred hcCCCccCccccc--CceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 318 TRKFSEENKLGEG--GFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 318 ~~~f~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
.++|++.++||+| +||.||+++.+ +++.||||++.... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4678899999999 99999999987 69999999997542 23345678889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+++|+|.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999766667799999999999999999999998 999999999999999999999999999865422
Q ss_pred CCc------cccccccCCccccccccccc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHH---hh-
Q 006168 474 NQS------HLSTKFAGTLGYTAPEYAIH--GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRL---YE- 541 (658)
Q Consensus 474 ~~~------~~~~~~~gt~~y~APE~~~~--~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~---~~- 541 (658)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||................. ..
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 211 11223578999999999987 6799999999999999999999999976543221110000000 00
Q ss_pred -----------------cCccccccc--------ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 542 -----------------NGTHWELMD--------ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 542 -----------------~~~~~~~~d--------~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.....+.+. ............+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000000000 0000011223345679999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=364.57 Aligned_cols=266 Identities=21% Similarity=0.242 Sum_probs=212.8
Q ss_pred ccchHHHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeE
Q 006168 308 NYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGC 384 (658)
Q Consensus 308 ~~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 384 (658)
.+.++++....++|...+.||+|+||.||+++.+ +|+.||||++.... .......+.+|..++.+++||||++++++
T Consensus 50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 3456666677889999999999999999999986 68999999986421 22234457899999999999999999999
Q ss_pred eecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEee
Q 006168 385 CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIAD 464 (658)
Q Consensus 385 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~D 464 (658)
+.+.+..++||||+++|+|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 99999999999999999999999532 34699999999999999999999998 999999999999999999999999
Q ss_pred ccCccccCCCCccccccccCCcccccccccc-------cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHH
Q 006168 465 FGLARLLPENQSHLSTKFAGTLGYTAPEYAI-------HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAW 537 (658)
Q Consensus 465 fGla~~~~~~~~~~~~~~~gt~~y~APE~~~-------~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~ 537 (658)
||+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||....... ....+.
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~i~ 283 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE--TYGKIV 283 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH--HHHHHH
Confidence 9999887655443344578999999999997 3578999999999999999999999997644321 111111
Q ss_pred HHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 006168 538 RLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSR---PTMSEVVAL 590 (658)
Q Consensus 538 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~R---Pt~~evl~~ 590 (658)
..... .. ........+..+.+++.+||. +|.+| |+++|+++.
T Consensus 284 ~~~~~---~~-------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 284 HYKEH---LS-------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp THHHH---CC-------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred hcccC---cC-------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 10000 00 000112234569999999999 99998 689998763
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=347.51 Aligned_cols=249 Identities=22% Similarity=0.357 Sum_probs=197.4
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-------------------------cccHHHHHHHHHHHhc
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-------------------------RRTLSDFENEVRLISN 372 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------------------~~~~~~~~~E~~~l~~ 372 (658)
++|.+.+.||+|+||.||+++.. +++.||||++..... ....+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 67889999999999999999975 688999999865321 1123568999999999
Q ss_pred cCCCccceeeeEeec--CCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCC
Q 006168 373 VHHRNLIRLLGCCSQ--GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPS 450 (658)
Q Consensus 373 l~h~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~ 450 (658)
++||||+++++++.+ .+..++||||+++++|.+++ ....+++..++.++.||+.||.|||+. +|+||||||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 166 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS 166 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence 999999999999976 67899999999999998865 345799999999999999999999998 9999999999
Q ss_pred cEEEcCCCCeEEeeccCccccCCCCccccccccCCcccccccccccCC---CCCcccchhhhHHHHHHHhCCCCCCCCCc
Q 006168 451 NVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ---LSEKVDAYSFGVLVLEIISGTKSSETKGE 527 (658)
Q Consensus 451 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~---~s~ksDV~SfGvvl~elltG~~p~~~~~~ 527 (658)
|||++.++.+||+|||++..+..... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999987654332 233567999999999997765 47789999999999999999999965432
Q ss_pred chhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 528 EGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 528 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
. .+.. . ...... .. ......+..+.+++.+||+.||++|||+.|+++
T Consensus 246 ~--~~~~---~-~~~~~~-~~--------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 M--CLHS---K-IKSQAL-EF--------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp H--HHHH---H-HHHCCC-CC--------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred H--HHHH---H-HhcccC-CC--------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 1111 1 111110 00 001122356899999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.26 Aligned_cols=272 Identities=21% Similarity=0.286 Sum_probs=214.1
Q ss_pred CcccchHHHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC-----CCccc
Q 006168 306 PVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-----HRNLI 379 (658)
Q Consensus 306 ~~~~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv 379 (658)
...+++++.....++|.+.++||+|+||.||+++.. +++.||||++.. .......+..|+++++.++ ||||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 345667777777899999999999999999999975 688999999863 2344567788999999986 99999
Q ss_pred eeeeEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC---
Q 006168 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD--- 456 (658)
Q Consensus 380 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~--- 456 (658)
++++++...+..++||||+ +++|.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence 9999999999999999999 89999999776666799999999999999999999998 9999999999999975
Q ss_pred ----------------------CCCeEEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHH
Q 006168 457 ----------------------DLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLE 514 (658)
Q Consensus 457 ----------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~e 514 (658)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 789999999999865432 234678999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCcchhhHHHHHHHHhhc-----------Ccccccccc-----cCCCCCCCH---------------HHH
Q 006168 515 IISGTKSSETKGEEGEYLLKRAWRLYEN-----------GTHWELMDE-----SLDPNECTK---------------EAA 563 (658)
Q Consensus 515 lltG~~p~~~~~~~~~~l~~~~~~~~~~-----------~~~~~~~d~-----~l~~~~~~~---------------~~~ 563 (658)
|++|+.||....... ........... ......++. ......... ...
T Consensus 252 ll~g~~pf~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 329 (360)
T 3llt_A 252 LYTGSLLFRTHEHME--HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329 (360)
T ss_dssp HHHSSCSCCCSSHHH--HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred HHHCCCCCCCCcHHH--HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence 999999997654321 11111111100 000000000 000000000 011
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 564 EKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 564 ~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
..+.+|+..||+.||.+|||+.|+++
T Consensus 330 ~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 330 ELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 56789999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=345.28 Aligned_cols=262 Identities=25% Similarity=0.390 Sum_probs=208.8
Q ss_pred CCCccCcccccCceEEEEEEecC----CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeE-EEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLKN----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPEL-ILV 394 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lV 394 (658)
.|...+.||+|+||.||+|.+.+ +..||+|.+.........+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 34456899999999999998642 2379999987655555667899999999999999999999999776655 999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+.+|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 999999999999954 345689999999999999999999998 9999999999999999999999999999866443
Q ss_pred Cc---cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 475 QS---HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 475 ~~---~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
.. .......+++.|+|||.+.+..++.++||||||+++|||++|+.|+........ +... ...+..
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~----~~~~~~------ 246 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHF----LAQGRR------ 246 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHH----HHTTCC------
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHH----hhcCCC------
Confidence 21 122345678999999999999999999999999999999997766544333221 1111 111110
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCC
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLG 600 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 600 (658)
...+...+..+.+++..||+.||.+|||+.++++.|+.+......
T Consensus 247 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 247 ----LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred ----CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 011122235699999999999999999999999999988554443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=345.44 Aligned_cols=260 Identities=27% Similarity=0.509 Sum_probs=197.8
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|.+.++||+|+||.||+|++.+ .||+|++.... .....+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4688999999999999999998753 59999986532 334457799999999999999999999965 4566899999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC-
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ- 475 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~- 475 (658)
|+++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 9999999999843 345699999999999999999999998 99999999999999999999999999998654322
Q ss_pred ccccccccCCcccccccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 476 SHLSTKFAGTLGYTAPEYAI---HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~---~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
........||+.|+|||.+. ...++.++||||||+++|||++|+.||....... .+.. ....+.....+
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~----~~~~~~~~~~~--- 247 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIE----MVGRGSLSPDL--- 247 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHH----HHHHTSCCCCT---
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHH----HhcccccCcch---
Confidence 22233567999999999986 5678889999999999999999999997654422 1111 11111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
.......+..+.+++..||+.||.+|||+.+++++|+.+.
T Consensus 248 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 248 ---SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp ---TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1112233457999999999999999999999999999873
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=344.40 Aligned_cols=256 Identities=22% Similarity=0.346 Sum_probs=206.1
Q ss_pred hcCCCccCcccccCceEEEEEEecC----CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
.++|...+.||+|+||.||+|++.+ +..||+|.+.........+.+.+|++++++++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4678889999999999999998653 3469999997654455667899999999999999999999998654 5689
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 90 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHH-HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 9999999999999954 335699999999999999999999998 999999999999999999999999999987655
Q ss_pred CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
..........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .... ...+...
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~----~~~~~~~------ 233 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGV----LEKGDRL------ 233 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHH----HHHTCCC------
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHH----HhcCCCC------
Confidence 44333345567889999999999999999999999999999998 999987544321 1111 1111100
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+...+..+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 234 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 ----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 01112235699999999999999999999999999876
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.39 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=201.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 394 (658)
++|...+.||+|+||.||+++.+ +++.||+|++.... .......+.+|..++.++ +||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57888999999999999999986 58899999997532 233456688999999988 899999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 999999999999853 35699999999999999999999998 9999999999999999999999999999864322
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcch---hhHHHHHHHHhhcCcccccccc
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEG---EYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~---~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+.......
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 236 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 236 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------
Confidence 2 22345689999999999999999999999999999999999999997533211 0111111121111110
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTM 584 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 584 (658)
..+...+..+.+++.+||+.||.+||++
T Consensus 237 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 -----RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -----CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1122234568999999999999999995
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=343.97 Aligned_cols=257 Identities=27% Similarity=0.458 Sum_probs=210.2
Q ss_pred cCCCccC-cccccCceEEEEEEec---CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 319 RKFSEEN-KLGEGGFGDIYKGTLK---NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 319 ~~f~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
++|.+.+ .||+|+||.||+|.+. ++..||||++.........+.+.+|++++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3454555 8999999999999864 57889999998654555677899999999999999999999999 55679999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 999999999999843 345699999999999999999999998 9999999999999999999999999999877544
Q ss_pred Cccc--cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 475 QSHL--STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 475 ~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
.... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+. .....+..
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~----~~i~~~~~------ 231 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVM----AFIEQGKR------ 231 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHH----HHHHTTCC------
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHH----HHHhcCCc------
Confidence 3322 223456889999999998999999999999999999998 99998764432 111 11111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSS 596 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 596 (658)
...+...+..+.+++..||+.||.+||++.+|++.|+.+..
T Consensus 232 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 232 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11122334579999999999999999999999999998743
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.18 Aligned_cols=254 Identities=22% Similarity=0.286 Sum_probs=205.4
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc----ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI----SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
.++|.+.+.||+|+||.||+++.+ +++.||||++.... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357889999999999999999976 68999999986421 1224678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC---eEEeeccC
Q 006168 393 LVYEYMANSSLDKFLFGE--KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ---PKIADFGL 467 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~---~kl~DfGl 467 (658)
+||||+++++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998887543 234589999999999999999999998 9999999999999987654 99999999
Q ss_pred ccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccc
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWE 547 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 547 (658)
+........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+... ...+....
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~----i~~~~~~~ 251 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---RLFEG----IIKGKYKM 251 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---HHHHH----HHHTCCCC
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---HHHHH----HHcCCCCC
Confidence 987754332 23456799999999999999999999999999999999999999975321 11111 11111000
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 548 LMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 548 ~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.... .. ..+..+.+++.+||+.||++|||+.|+++
T Consensus 252 --~~~~-~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 252 --NPRQ-WS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CHHH-HT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --Cccc-cc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 01 12356899999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=353.54 Aligned_cols=252 Identities=25% Similarity=0.338 Sum_probs=192.0
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
..++|.+.+.||+|+||.||+++.+ +++.||||++... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT---VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc---hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 4578899999999999999999987 5789999998753 23457889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC---CCCeEEeeccCccccC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD---DLQPKIADFGLARLLP 472 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~---~~~~kl~DfGla~~~~ 472 (658)
||+++|+|.+++. ....+++.+++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 128 e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 128 ELVTGGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCCSCBHHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EeCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999994 445699999999999999999999998 9999999999999975 8899999999998764
Q ss_pred CCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 473 ENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 473 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ +. +....... ..
T Consensus 203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~----~~i~~~~~-~~---- 270 (349)
T 2w4o_A 203 HQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-MF----RRILNCEY-YF---- 270 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-HH----HHHHTTCC-CC----
T ss_pred ccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-HH----HHHHhCCC-cc----
Confidence 322 23346789999999999999999999999999999999999999975443221 11 11111111 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
........+..+.+++.+||+.||++|||+.|+++.
T Consensus 271 --~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 --ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp --CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011112234568999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=353.52 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=194.9
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|...++||+|+||+||+|++. +++.||||++.... .......+..|+..+.++ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999987 79999999976432 223334455666666555 8999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+ +++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 66998888543 35699999999999999999999998 99999999999999999999999999998764432
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
......||+.|+|||++.+ .++.++||||||+++|||++|..++.... .+.....+.....
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---------~~~~~~~~~~~~~------- 272 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQLRQGYLPPE------- 272 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------HHHHHTTTCCCHH-------
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHHHHhccCCCcc-------
Confidence 2334579999999998775 79999999999999999999977654311 1122222111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 273 --~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 273 --FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp --HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111224569999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=351.30 Aligned_cols=247 Identities=21% Similarity=0.357 Sum_probs=203.5
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+.+.||+|+||.||+|... +++.||+|++.... .......+.+|+++++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57889999999999999999974 68999999986431 2233467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+ +|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 89 E~~-~g~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVE--KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CCC-CEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred ECC-CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 999 6899888843 35699999999999999999999999 99999999999999999999999999998764432
Q ss_pred ccccccccCCcccccccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... ..+.+...
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---------------~~~~i~~~-- 223 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---------------LFKKVNSC-- 223 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---------------CBCCCCSS--
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---------------HHHHHHcC--
Confidence 2345679999999999988776 789999999999999999999996543211 00111110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 224 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 224 VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 011222234568999999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=345.20 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=205.2
Q ss_pred cCCCccCcccccCceEEEEEEecC----CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEe-ecCCeEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCC-SQGPELIL 393 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l 393 (658)
.+|...+.||+|+||.||+|++.+ ...+|+|.+.........+.+.+|+.++++++||||+++++++ ..++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457788999999999999999653 2368999987655555667899999999999999999999986 45667899
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 9999999999999953 345689999999999999999999998 999999999999999999999999999987644
Q ss_pred CCcc---ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCC-CCCCCCcchhhHHHHHHHHhhcCcccccc
Q 006168 474 NQSH---LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTK-SSETKGEEGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 474 ~~~~---~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~-p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
.... ......+|+.|+|||.+.+..++.++||||||+++|||++|.. |+....... .... ...+..
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~----~~~~~~---- 250 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVY----LLQGRR---- 250 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHHH----HHTTCC----
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHHH----HhcCCC----
Confidence 3221 1234567889999999999999999999999999999999555 444332211 1111 111110
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSS 597 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 597 (658)
...+.. .+..+.+++..||+.||.+|||+.|+++.|+.+...
T Consensus 251 --~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 251 --LLQPEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp --CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 010122 234699999999999999999999999999987543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=355.72 Aligned_cols=253 Identities=21% Similarity=0.326 Sum_probs=207.0
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|.+.+.||+|+||.||+|..+ +++.||+|.+... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc-chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 467899999999999999999976 6889999998753 23345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC--CCCeEEeeccCccccCCC
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD--DLQPKIADFGLARLLPEN 474 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~--~~~~kl~DfGla~~~~~~ 474 (658)
|+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 129 ~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 129 FLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred cCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999999843 334699999999999999999999998 9999999999999974 578999999999877543
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...... .. ... . .+
T Consensus 205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~i---~~-~~~-~-~~---- 270 (387)
T 1kob_A 205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNV---KR-CDW-E-FD---- 270 (387)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHH---HH-CCC-C-CC----
T ss_pred cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--HHHHHH---Hh-CCC-C-CC----
Confidence 32 23457999999999999999999999999999999999999999764331 111111 11 110 0 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.......+..+.+++..||+.||.+|||+.|+++.
T Consensus 271 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 -EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11111234568999999999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=348.01 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=203.8
Q ss_pred cCCCccCcccccCceEEEEEEecC-C-------cEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN-G-------KIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 390 (658)
++|.+.+.||+|+||.||+|+... + ..||+|++.. ......+.+.+|++++++++||||+++++++.+.+.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK-AHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECG-GGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccc-ccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 578889999999999999998763 3 4799999865 344566889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC--------eEE
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ--------PKI 462 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~--------~kl 462 (658)
.++||||+++|+|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence 99999999999999999543 33499999999999999999999998 9999999999999998887 999
Q ss_pred eeccCccccCCCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh
Q 006168 463 ADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYE 541 (658)
Q Consensus 463 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~ 541 (658)
+|||++...... ....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+.......... ....
T Consensus 163 ~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-----~~~~ 232 (289)
T 4fvq_A 163 SDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-----QFYE 232 (289)
T ss_dssp CCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-----HHHH
T ss_pred ccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-----HHhh
Confidence 999998754322 23457889999999987 678999999999999999999766554433321111 1111
Q ss_pred cCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 006168 542 NGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSS 596 (658)
Q Consensus 542 ~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 596 (658)
... .+ +... +..+.+++..||+.||.+|||+.++++.|+.+..
T Consensus 233 ~~~-------~~-~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 DRH-------QL-PAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TTC-------CC-CCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ccC-------CC-CCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 100 00 1111 2358899999999999999999999999998843
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=352.48 Aligned_cols=245 Identities=22% Similarity=0.297 Sum_probs=206.2
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|...+.||+|+||.||+++.+ +|+.||+|++.... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999976 68999999986531 2345678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 99999999999953 35699999999999999999999998 9999999999999999999999999999876432
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+.. ....+..
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~----~i~~~~~---------- 255 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QIYE----KIVSGKV---------- 255 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----HHHHCCC----------
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH--HHHH----HHHcCCC----------
Confidence 23457999999999999999999999999999999999999999754321 1111 1111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPT-----MSEVVA 589 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 589 (658)
..+...+..+.+++.+||+.||.+||+ +.||++
T Consensus 256 -~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 -RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 111223456899999999999999998 888875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.16 Aligned_cols=257 Identities=28% Similarity=0.522 Sum_probs=203.5
Q ss_pred cCCCccCcccccCceEEEEEEecC-----CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN-----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
++|...+.||+|+||.||+|.++. +..||||++...........+.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456667899999999999998753 246999999765455556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 9999999999999954 345699999999999999999999998 999999999999999999999999999987654
Q ss_pred CCccc--cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 474 NQSHL--STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 474 ~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
..... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+. .....+...
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~~----~~~~~~~~~---- 269 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVM----KAINDGFRL---- 269 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH----HHHHTTCCC----
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HHH----HHHHCCCcC----
Confidence 33221 223456789999999999999999999999999999999 99998654321 111 111111100
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
..+...+..+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus 270 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 270 ------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp ------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111223456899999999999999999999999998863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=351.23 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=203.7
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCc----EEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGK----IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
.++|.+.+.||+|+||.||+|++. +++ +||+|.+.........+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 357889999999999999999965 344 468888866556667889999999999999999999999998764 88
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
+|+||+.+|+|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 999999999999999543 45699999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 473 ENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 473 ~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... +.. ....+..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~----~~~~~~~----- 237 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISS----ILEKGER----- 237 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH----HHHTTCC-----
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHH----HHHcCCC-----
Confidence 43322 2224556889999999999999999999999999999999 999997654322 111 1111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...+...+..+.+++..||+.||.+|||+.|+++.|+.+.
T Consensus 238 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 238 -----LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111223446899999999999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=369.16 Aligned_cols=252 Identities=26% Similarity=0.390 Sum_probs=210.5
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
.++|...+.||+|+||.||+++.+ +|+.||+|++... ........+.+|+++|++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 357888999999999999999986 6999999998653 1234567789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++|+|.+++.......+++..++.++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 9999999999999765556699999999999999999999998 9999999999999999999999999999877543
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcc--hhhHHHHHHHHhhcCccccccccc
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE--GEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+... ....
T Consensus 340 ~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~----i~~~--------- 404 (576)
T 2acx_A 340 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL----VKEV--------- 404 (576)
T ss_dssp CC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH----HHHC---------
T ss_pred cc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH----hhcc---------
Confidence 32 23458999999999999999999999999999999999999999765431 1222111 1111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRP-----TMSEVVA 589 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 589 (658)
+..++...+..+.+|+..||+.||.+|| ++.||++
T Consensus 405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1111222345699999999999999999 7888875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=354.05 Aligned_cols=253 Identities=21% Similarity=0.356 Sum_probs=199.0
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccc-cccccHHHHHHHHHHHhccCC--CccceeeeEeecCCeEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHH--RNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV 394 (658)
.++|.+.+.||+|+||.||++...+++.||||++... ......+.+.+|++++++++| |||+++++++...+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568899999999999999999988999999998653 233445778999999999976 9999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|| +.+++|.+++.. ...+++.++..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.+...
T Consensus 88 ~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EC-CCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred Ee-CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99 567899999954 45799999999999999999999998 999999999999997 578999999999876544
Q ss_pred Ccc-ccccccCCccccccccccc-----------CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc
Q 006168 475 QSH-LSTKFAGTLGYTAPEYAIH-----------GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN 542 (658)
Q Consensus 475 ~~~-~~~~~~gt~~y~APE~~~~-----------~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 542 (658)
... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.........+ ......
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----~~~~~~ 236 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL----HAIIDP 236 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH----HHHHCT
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH----HHHhcC
Confidence 322 2335679999999999865 678999999999999999999999997543321111 111111
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 006168 543 GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591 (658)
Q Consensus 543 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 591 (658)
.. ....+......+.+++..||+.||.+|||+.|+++..
T Consensus 237 ~~----------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 237 NH----------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp TS----------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred Cc----------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 11 0111111234689999999999999999999998753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.49 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=208.7
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|.+.+.||+|+||.||+++.. +++.||+|++.........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467889999999999999999986 6899999998754444556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++++|.+++. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..+.....
T Consensus 86 ~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999999983 345699999999999999999999998 999999999999999999999999999986543221
Q ss_pred -cccccccCCcccccccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 477 -HLSTKFAGTLGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 477 -~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
.......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||............+ ......
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~-------- 227 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKTY-------- 227 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH-----HTTCTT--------
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh-----hhcccc--------
Confidence 22335678999999999987765 779999999999999999999997655432222111 111100
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.......+..+.+++..||+.||.+|||+.|+++.
T Consensus 228 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 -LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 00011234568899999999999999999999863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=353.42 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=206.0
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeE
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 391 (658)
...++|...+.||+|+||.||+++.+ +++.||||++.... .......+..|.+++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 44578999999999999999999986 58999999997531 234567788999999887 999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999999953 35699999999999999999999998 9999999999999999999999999999864
Q ss_pred CCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 472 PENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 472 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+... ...+. .
T Consensus 169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~----i~~~~------~ 235 (345)
T 1xjd_A 169 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHS----IRMDN------P 235 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HHHCC------C
T ss_pred ccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHHH----HHhCC------C
Confidence 3322 2234578999999999999999999999999999999999999999754331 12111 11111 0
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMS-EVV 588 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-evl 588 (658)
..+...+..+.+++.+||+.||.+||++. +|+
T Consensus 236 -----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 -----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11122345689999999999999999997 665
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=348.96 Aligned_cols=259 Identities=20% Similarity=0.341 Sum_probs=197.6
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCC----e
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP----E 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 390 (658)
.++|.+.+.||+|+||.||+++.. +++.||||++.... .......+.+|++++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 468889999999999999999974 78999999997532 2233567899999999999999999999986543 3
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 4999999999999999953 35699999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCcc--ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccc
Q 006168 471 LPENQSH--LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWEL 548 (658)
Q Consensus 471 ~~~~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 548 (658)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..+...........
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~~~ 240 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-----VAYQHVREDPIPPS 240 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHCCCCCHH
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhcCCCCCcc
Confidence 6543322 2234678999999999999999999999999999999999999997544321 11122221111000
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH-HHHhcC
Q 006168 549 MDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVV-ALLKST 594 (658)
Q Consensus 549 ~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl-~~L~~~ 594 (658)
......+..+.+++.+||+.||.+||+..+++ ..|...
T Consensus 241 --------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 241 --------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp --------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 00111245689999999999999999665554 555544
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=356.66 Aligned_cols=272 Identities=18% Similarity=0.256 Sum_probs=217.0
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCC--eEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP--ELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~ 395 (658)
++|.+.+.||+|+||.||+|++. +++.||||++.........+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 57888999999999999999987 489999999976555566788899999999999999999999997654 789999
Q ss_pred eccCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE----cCCCCeEEeeccCccc
Q 006168 396 EYMANSSLDKFLFGEKR-GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL----DDDLQPKIADFGLARL 470 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll----~~~~~~kl~DfGla~~ 470 (658)
||+++|+|.+++..... ..+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999964332 2399999999999999999999998 99999999999999 7778899999999987
Q ss_pred cCCCCccccccccCCccccccccccc--------CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAIH--------GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN 542 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 542 (658)
..... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||......... .+...+....
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~-~~~~~~~~~~ 242 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-KEVMYKIITG 242 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC-HHHHHHHHHS
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch-HHHHHHHhcC
Confidence 64432 2334679999999999865 56788999999999999999999999754331111 1111122211
Q ss_pred Ccc-------------cccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 006168 543 GTH-------------WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSS 596 (658)
Q Consensus 543 ~~~-------------~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 596 (658)
... .+..................+.+++..||+.||++||++.++++.|+.+..
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 110 001111111234567788899999999999999999999999999987643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=375.64 Aligned_cols=249 Identities=27% Similarity=0.474 Sum_probs=202.4
Q ss_pred cccccCceEEEEEEec---CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCCC
Q 006168 326 KLGEGGFGDIYKGTLK---NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSS 402 (658)
Q Consensus 326 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 402 (658)
+||+|+||.||+|.++ ++..||||++.........+++.+|+++|++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 4667999999875555677899999999999999999999999976 56999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcccc--c
Q 006168 403 LDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS--T 480 (658)
Q Consensus 403 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~--~ 480 (658)
|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+........ .
T Consensus 422 L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 422 LHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp HHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 9999953 345699999999999999999999998 999999999999999999999999999987654332222 2
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCC
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECT 559 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 559 (658)
...+++.|+|||++.++.++.++|||||||++|||++ |+.||....... +. .....+... ..+
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~----~~i~~~~~~----------~~p 561 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VM----AFIEQGKRM----------ECP 561 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HH----HHHHTTCCC----------CCC
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HH----HHHHcCCCC----------CCC
Confidence 3345689999999999999999999999999999998 999997654321 11 122222111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 560 KEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 560 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...+..+.+|+..||+.||++||++.+|++.|+.+.
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 233456999999999999999999999999998763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.62 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=195.8
Q ss_pred hcCCCccCcccccCceEEEEEEe----cCCcEEEEEEccccc---ccccHHHHHHHHHHHhccCCCccceeeeEeecCCe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTL----KNGKIVAVKKLAIGI---SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 390 (658)
.++|.+.+.||+|+||.||+++. .+++.||+|++.... .......+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788999999999999999997 478999999987532 22344567899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 9999999999999999953 35689999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+ .. ..
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i---~~-~~------ 237 (327)
T 3a62_A 171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--KTIDKI---LK-CK------ 237 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHH---HH-TC------
T ss_pred cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--HHHHHH---Hh-CC------
Confidence 43322 2233567999999999999999999999999999999999999999754331 111111 11 10
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRP-----TMSEVVAL 590 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~ 590 (658)
...+...+..+.+++.+||+.||.+|| ++.|+++.
T Consensus 238 -----~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 -----LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -----CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 011122345689999999999999999 77788753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=365.55 Aligned_cols=249 Identities=23% Similarity=0.288 Sum_probs=196.7
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
.++|.+.+.||+|+||.||+++.. +++.||||++... ........+.+|++++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 367889999999999999999976 6899999998753 2334456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE-DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999843 3569999999999999999999998 6 899999999999999999999999999986433
Q ss_pred CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+...+ .. ..
T Consensus 302 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i---~~-~~--------- 365 (446)
T 4ejn_A 302 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELI---LM-EE--------- 365 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH---HH-CC---------
T ss_pred CC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHH---Hh-CC---------
Confidence 22 2234578999999999999999999999999999999999999999754332 111111 11 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRP-----TMSEVVA 589 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 589 (658)
...+...+..+.+|+..||+.||.+|| ++.|+++
T Consensus 366 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 --IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 011122345689999999999999999 9999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=353.00 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=204.8
Q ss_pred HHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc----cccccHHHHHHHHHHHhccCCCccceeeeEeec
Q 006168 313 DLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG----ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ 387 (658)
Q Consensus 313 ~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 387 (658)
++....++|.+.+.||+|+||.||+++.. +++.||+|++... ......+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 45677789999999999999999999975 6889999998643 134556789999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHhhcCC--------------------------------------CCCCCHHHHHHHHHHHHH
Q 006168 388 GPELILVYEYMANSSLDKFLFGEK--------------------------------------RGSLNWKQRFDIILGTAR 429 (658)
Q Consensus 388 ~~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~ia~ 429 (658)
.+..++||||+++|+|.+++.... ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999984210 112467788899999999
Q ss_pred HHHHhHhcCCCCeeecCcCCCcEEEcCCC--CeEEeeccCccccCCCC---ccccccccCCccccccccccc--CCCCCc
Q 006168 430 GLAYLHEDFHVRIIHRDIKPSNVLLDDDL--QPKIADFGLARLLPENQ---SHLSTKFAGTLGYTAPEYAIH--GQLSEK 502 (658)
Q Consensus 430 ~L~~LH~~~~~~ivH~Dik~~NIll~~~~--~~kl~DfGla~~~~~~~---~~~~~~~~gt~~y~APE~~~~--~~~s~k 502 (658)
||.|||+. +|+||||||+|||++.++ .+||+|||++..+.... ........||+.|+|||.+.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999998 999999999999998776 89999999998653322 112345679999999999875 678999
Q ss_pred ccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 006168 503 VDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRP 582 (658)
Q Consensus 503 sDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP 582 (658)
+||||||+++|||++|+.||....... .. .......... ........+..+.+++..||+.||.+||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~--~~---~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDAD--TI---SQVLNKKLCF--------ENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHH--HH---HHHHHCCCCT--------TSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHH--HH---HHHHhccccc--------CCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 999999999999999999997654321 11 1111111100 0011112345689999999999999999
Q ss_pred CHHHHHHH
Q 006168 583 TMSEVVAL 590 (658)
Q Consensus 583 t~~evl~~ 590 (658)
|+.++++.
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999873
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=349.80 Aligned_cols=249 Identities=26% Similarity=0.331 Sum_probs=205.7
Q ss_pred hcCCCccCcccccCceEEEEEEecC-CcEEEEEEccccc--ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGI--SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 393 (658)
.++|...+.||+|+||.||+++.+. ++.||||++.... .......+..|..++..+ +||||+++++++...+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4689999999999999999999874 7899999987532 334567788999999988 89999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+++|+|.+++.. .+.+++..++.++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 9999999999999953 35699999999999999999999998 999999999999999999999999999986432
Q ss_pred CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+...+ .. ..
T Consensus 174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i---~~-~~--------- 237 (353)
T 2i0e_A 174 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSI---ME-HN--------- 237 (353)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH---HH-CC---------
T ss_pred CC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--HHHHHH---Hh-CC---------
Confidence 22 2234568999999999999999999999999999999999999999754321 222111 11 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPT-----MSEVVA 589 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 589 (658)
..++...+..+.+++..||+.||.+||+ +.+|++
T Consensus 238 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 238 --VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0112223456999999999999999995 466664
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=355.62 Aligned_cols=262 Identities=15% Similarity=0.167 Sum_probs=209.3
Q ss_pred hcCCCccCcccccCceEEEEEEecC---------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccce--------
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN---------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIR-------- 380 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 380 (658)
.++|.+.+.||+|+||.||+|+... ++.||+|++... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 3678899999999999999999764 789999998642 36889999999999999998
Q ss_pred -------eeeEeec-CCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcE
Q 006168 381 -------LLGCCSQ-GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNV 452 (658)
Q Consensus 381 -------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NI 452 (658)
+++++.. ++..++||||+ +++|.+++.......+++..++.++.||+.||.|||+. +|+||||||+||
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI 190 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI 190 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence 5677765 78899999999 99999999765456799999999999999999999998 999999999999
Q ss_pred EEcCCC--CeEEeeccCccccCCCCcc------ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCC
Q 006168 453 LLDDDL--QPKIADFGLARLLPENQSH------LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSET 524 (658)
Q Consensus 453 ll~~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~ 524 (658)
|++.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999876433211 12345799999999999999999999999999999999999999976
Q ss_pred CCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 525 KGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 525 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
.......+.......... .....+....... .+..+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus 271 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDK--PGPFVGPCGHWIR----PSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp GTTCHHHHHHHHHHHHHS--CCCEECTTSCEEC----CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHhccCC--hhhhhhhccccCC----CcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 553333333322222111 1111111111111 2356999999999999999999999999998874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.29 Aligned_cols=263 Identities=24% Similarity=0.378 Sum_probs=201.6
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
.++|.+.+.||+|+||.||++... +++.||||++... ........+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 357889999999999999999975 7899999998642 2234457789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 395 YEYMANSSLDKFLFGE--KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
|||+++++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998542 345699999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 473 ENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 473 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.........+... ........
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~----- 257 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----IEQCDYPP----- 257 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH----HHTTCSCC-----
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH----hhcccCCC-----
Confidence 3322 2234578999999999999999999999999999999999999987544332222111 11111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSS 597 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~ 597 (658)
+... ..+..+.+++.+||+.||.+|||+.+|++.|+++...
T Consensus 258 ~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 258 LPSD----HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp CCTT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Cccc----ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1011 2235699999999999999999999999999988543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.88 Aligned_cols=259 Identities=19% Similarity=0.270 Sum_probs=200.8
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc--cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS--RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
.++|.+.+.||+|+||.||+++.. +++.||+|++..... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999976 688999999875322 22347789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 999999999999953 35699999999999999999999998 9999999999999999999999999999876554
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
.........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .+ ......... .
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~----~~~~~~~~~-~------- 253 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VM----GAHINQAIP-R------- 253 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HH----HHHHHSCCC-C-------
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HH----HHHhccCCC-C-------
Confidence 333344567899999999999999999999999999999999999998754321 11 111111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcCc
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRP-TMSEVVALLKSTS 595 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~~~ 595 (658)
........+..+.+++.+||+.||++|| ++.++++.|+...
T Consensus 254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 0011122234689999999999999999 9999999999873
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=344.21 Aligned_cols=270 Identities=22% Similarity=0.334 Sum_probs=205.0
Q ss_pred HHHHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhcc--CCCccceeeeEeecC--
Q 006168 313 DLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV--HHRNLIRLLGCCSQG-- 388 (658)
Q Consensus 313 ~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~-- 388 (658)
.-....++|.+.+.||+|+||.||+|+++ ++.||||++... ....+..|.+++..+ +||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 33445678999999999999999999986 899999998542 234455555555554 999999999999876
Q ss_pred --CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcC-----CCCeeecCcCCCcEEEcCCCCeE
Q 006168 389 --PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF-----HVRIIHRDIKPSNVLLDDDLQPK 461 (658)
Q Consensus 389 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dik~~NIll~~~~~~k 461 (658)
...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+|
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 789999999999999999943 46999999999999999999999752 33899999999999999999999
Q ss_pred EeeccCccccCCCCccc---cccccCCcccccccccccCCCCCc------ccchhhhHHHHHHHhC----------CCCC
Q 006168 462 IADFGLARLLPENQSHL---STKFAGTLGYTAPEYAIHGQLSEK------VDAYSFGVLVLEIISG----------TKSS 522 (658)
Q Consensus 462 l~DfGla~~~~~~~~~~---~~~~~gt~~y~APE~~~~~~~s~k------sDV~SfGvvl~elltG----------~~p~ 522 (658)
|+|||+++.+....... .....||+.|+|||++.+...+.+ +||||||+++|||++| +.|+
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999998764433221 124579999999999988777665 9999999999999999 5555
Q ss_pred CCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 523 ETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 523 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
............ ......... ..+.+.........+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 263 ~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 263 HDLVPSDPSYED-MREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp TTTSCSSCCHHH-HHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhcCCCCchhh-hHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 443321111111 111111111 11111111122366788999999999999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=356.26 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=197.6
Q ss_pred CCCccCcccccCceEEEEEEec--CC--cEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeec-CCeEEEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK--NG--KIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ-GPELILV 394 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV 394 (658)
.|...+.||+|+||.||+|++. ++ ..||+|.+.........+.+.+|+.++++++||||+++++++.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3556789999999999999864 22 36899998764455567889999999999999999999998754 5678999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++|+|.+++.. ....+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 999999999999953 345689999999999999999999998 9999999999999999999999999999866433
Q ss_pred Ccc---ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 475 QSH---LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 475 ~~~---~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||....... .... ...+...
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~----~~~~~~~---- 315 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVY----LLQGRRL---- 315 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHH----HHTTCCC----
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHH----HHcCCCC----
Confidence 211 1234567889999999999999999999999999999999 566665443321 1111 1111110
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCC
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLL 599 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 599 (658)
..+.. .+..+.+++.+||+.||++|||+.||++.|+.+.....
T Consensus 316 --~~p~~----~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 316 --LQPEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp --CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred --CCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 01122 23569999999999999999999999999998754333
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=338.62 Aligned_cols=248 Identities=29% Similarity=0.411 Sum_probs=202.6
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
.++|.+.+.||+|+||.||++... +++.||+|++.... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467889999999999999999976 57799999986431 223456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 999999999999853 35699999999999999999999998 9999999999999999999999999998654332
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... .....
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~~~~---------- 223 (279)
T 3fdn_A 163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKR----ISRVE---------- 223 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH----HHHTC----------
T ss_pred ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--HHHHH----HHhCC----------
Confidence 223467899999999999999999999999999999999999999754321 11111 11100
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+...+..+.+++..||+.||.+|||+.|+++.
T Consensus 224 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01112234568899999999999999999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=345.64 Aligned_cols=270 Identities=23% Similarity=0.308 Sum_probs=211.8
Q ss_pred chHHHHHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhc--cCCCccceeeeEeec
Q 006168 310 RLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISN--VHHRNLIRLLGCCSQ 387 (658)
Q Consensus 310 ~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~ 387 (658)
.+..-....++|.+.+.||+|+||.||+|++ +++.||||++.. .....+.+|++++.. ++||||+++++++..
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 3333445567999999999999999999998 489999999864 234677888888887 799999999999987
Q ss_pred CC----eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhH--------hcCCCCeeecCcCCCcEEEc
Q 006168 388 GP----ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLH--------EDFHVRIIHRDIKPSNVLLD 455 (658)
Q Consensus 388 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivH~Dik~~NIll~ 455 (658)
.+ ..++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +. +|+||||||+|||++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK 181 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence 65 79999999999999999953 46999999999999999999999 66 999999999999999
Q ss_pred CCCCeEEeeccCccccCCCCcc---ccccccCCcccccccccccC------CCCCcccchhhhHHHHHHHhC--------
Q 006168 456 DDLQPKIADFGLARLLPENQSH---LSTKFAGTLGYTAPEYAIHG------QLSEKVDAYSFGVLVLEIISG-------- 518 (658)
Q Consensus 456 ~~~~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~APE~~~~~------~~s~ksDV~SfGvvl~elltG-------- 518 (658)
.++++||+|||++......... ......||+.|+|||.+.+. .++.++||||||+++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999999876544322 22356799999999998765 334689999999999999999
Q ss_pred --CCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 519 --TKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 519 --~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
+.||............. .+....... .+.+.......+....+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 262 ~~~~p~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSVEEM-RKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCCCTTTTTSCSSCCHHHH-HHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCccccCcCcccHHHH-HHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 66775543321111111 122211111 1111111123356778999999999999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=351.12 Aligned_cols=264 Identities=18% Similarity=0.197 Sum_probs=201.2
Q ss_pred cCCCccCcccccCceEEEEEEec----CCcEEEEEEccccccc----------ccHHHHHHHHHHHhccCCCccceeeeE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK----NGKIVAVKKLAIGISR----------RTLSDFENEVRLISNVHHRNLIRLLGC 384 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~ 384 (658)
++|.+.+.||+|+||.||+|... ++..+|||++...... .....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57888999999999999999986 5778999998653211 012346678889999999999999999
Q ss_pred eec----CCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC--
Q 006168 385 CSQ----GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL-- 458 (658)
Q Consensus 385 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~-- 458 (658)
+.. ....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQ--NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBG--GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence 977 77899999999 9999999953 33799999999999999999999998 999999999999998887
Q ss_pred CeEEeeccCccccCCCCc------cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhH
Q 006168 459 QPKIADFGLARLLPENQS------HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYL 532 (658)
Q Consensus 459 ~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l 532 (658)
.+||+|||+++.+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 999999999987643221 11235679999999999999999999999999999999999999996533322222
Q ss_pred HHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 533 LKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 533 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
......... .....+........ .+..+.+++..||+.||++|||+.+|++.|+..
T Consensus 271 ~~~~~~~~~--~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 271 QTAKTNLLD--ELPQSVLKWAPSGS----SCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHH--TTTHHHHHHSCTTS----CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHhhcc--cccHHHHhhccccc----cHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 221111111 11111111111112 234699999999999999999999999999886
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=341.40 Aligned_cols=266 Identities=25% Similarity=0.374 Sum_probs=203.3
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc----ccccHHHHHHHHHHHhccC---CCccceeeeEeecC
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI----SRRTLSDFENEVRLISNVH---HRNLIRLLGCCSQG 388 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 388 (658)
..++|.+.++||+|+||.||+++.. +++.||||++.... .......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4679999999999999999999964 68999999986422 1122346677887777764 99999999999765
Q ss_pred C-----eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEe
Q 006168 389 P-----ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIA 463 (658)
Q Consensus 389 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~ 463 (658)
. ..++||||+. ++|.+++.......+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 4 5899999997 5999999766556699999999999999999999999 99999999999999999999999
Q ss_pred eccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcC
Q 006168 464 DFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG 543 (658)
Q Consensus 464 DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 543 (658)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .......+.....
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~ 238 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGKIFDLIGLP 238 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH--HHHHHHHHHHCCC
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCC
Confidence 999998764332 234567899999999999999999999999999999999999999765432 1222222221111
Q ss_pred ccccc------ccccCCCC-C-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 544 THWEL------MDESLDPN-E-----CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 544 ~~~~~------~d~~l~~~-~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..... ....+... . ...+....+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00000 00000000 0 011234568999999999999999999999863
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=354.37 Aligned_cols=255 Identities=23% Similarity=0.339 Sum_probs=205.8
Q ss_pred cCCCccCcccccCceEEEEEEe----cCCcEEEEEEccccc---ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTL----KNGKIVAVKKLAIGI---SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 390 (658)
++|.+.+.||+|+||.||+++. .+++.||||++.... .......+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788999999999999999997 368999999986532 223445678899999999 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ--RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEeecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 9999999999999999953 34699999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCccccccccCCccccccccccc--CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccc
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAIH--GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWEL 548 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 548 (658)
+............||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ...........
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~------ 281 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKS------ 281 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHC------
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhcc------
Confidence 65444444446789999999999985 3578999999999999999999999976543211 11111111111
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 006168 549 MDESLDPNECTKEAAEKVVEIALMCTQSAANSRP-----TMSEVVALL 591 (658)
Q Consensus 549 ~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~~L 591 (658)
....+...+..+.+|+.+||+.||.+|| |+.|+++..
T Consensus 282 ------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 ------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0111223345689999999999999999 999998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=337.61 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=201.5
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|.+.++||+|+||.||++... ++..+|+|++.........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 367888999999999999999976 6889999999876556667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE---cCCCCeEEeeccCcccc
Q 006168 397 YMANSSLDKFLFGE--KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLL 471 (658)
Q Consensus 397 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll---~~~~~~kl~DfGla~~~ 471 (658)
|+++|+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++..+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988543 235699999999999999999999998 99999999999999 45678999999999876
Q ss_pred CCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 472 PENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 472 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
.... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||....... .... ........
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--~~~~---~~~~~~~~----- 244 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--VQQK---ATYKEPNY----- 244 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH---HHHCCCCC-----
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--HHhh---hccCCccc-----
Confidence 4432 233567899999999875 578999999999999999999999997644321 1111 11111000
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
...... .+..+.+++.+||+.||.+|||+.||++
T Consensus 245 ~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 AVECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC--CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccccCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000111 2346889999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=337.81 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=206.5
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
.++|.+.+.||+|+||.||++..+ +++.||+|++.... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468899999999999999999976 58999999986532 3344577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC---eEEeeccCccccC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ---PKIADFGLARLLP 472 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~---~kl~DfGla~~~~ 472 (658)
||+++++|.+.+.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 99999999988843 35699999999999999999999998 9999999999999987655 9999999998765
Q ss_pred CCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 473 ENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 473 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ...+.. ..
T Consensus 160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~----~~~~~~-~~---- 226 (284)
T 3kk8_A 160 DSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQ----IKAGAY-DY---- 226 (284)
T ss_dssp SSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HHHTCC-CC----
T ss_pred cCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHH----HHhccc-cC----
Confidence 4322 23467999999999999999999999999999999999999999654332 11111 111110 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+.......+..+.+++..||+.||++|||+.|+++.
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 227 --PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp --CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 001111223568999999999999999999999873
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=356.65 Aligned_cols=251 Identities=21% Similarity=0.360 Sum_probs=199.1
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccc-cccccHHHHHHHHHHHhccC--CCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVH--HRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+.+.||+|+||.||++...+++.||||++... ........+.+|++++++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 468899999999999999999888999999998653 23345678999999999996 599999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
| +.+++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.+....
T Consensus 136 E-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 578899999954 34789999999999999999999998 999999999999996 5799999999998765433
Q ss_pred cc-ccccccCCccccccccccc-----------CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcC
Q 006168 476 SH-LSTKFAGTLGYTAPEYAIH-----------GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG 543 (658)
Q Consensus 476 ~~-~~~~~~gt~~y~APE~~~~-----------~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 543 (658)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........+ .......
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~----~~~~~~~ 284 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL----HAIIDPN 284 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH----HHHHCTT
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH----HHHhCcc
Confidence 22 2345679999999999865 468899999999999999999999997544321111 1111111
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 544 THWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 544 ~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.. ...+......+.+|+..||+.||.+|||+.||++.
T Consensus 285 ~~----------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 285 HE----------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp SC----------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cc----------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 00 01111113468999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=347.09 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=181.5
Q ss_pred cCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC-CCccceeeeEeecCCeEEEEEeccCCC
Q 006168 324 ENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQGPELILVYEYMANS 401 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~g 401 (658)
.+.||+|+||.||+++.+ +++.||||++.. .....+.+|+.+++.+. ||||+++++++.+....++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 478999999999999986 689999999864 34567889999999997 999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC---CeEEeeccCccccCCCCccc
Q 006168 402 SLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL---QPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 402 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~---~~kl~DfGla~~~~~~~~~~ 478 (658)
+|.+++.. ...+++.++..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++....... .
T Consensus 92 ~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~ 165 (325)
T 3kn6_A 92 ELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-P 165 (325)
T ss_dssp BHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-c
Confidence 99999954 45799999999999999999999998 999999999999997765 799999999987644322 2
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcch-hhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEG-EYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .............+... + ...
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~-~~~ 238 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------F-EGE 238 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------C-CSH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------C-Ccc
Confidence 335678999999999999999999999999999999999999997644311 00011111222221110 0 000
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.....+..+.+++..||+.||.+|||+.|+++.
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 011234579999999999999999999998753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=339.70 Aligned_cols=266 Identities=23% Similarity=0.357 Sum_probs=201.2
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
++|.+.+.||+|+||.||+++.. +++.||+|++..... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67889999999999999999986 589999999865322 2235668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 83 YCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 999999999884 345699999999999999999999998 999999999999999999999999999987653322
Q ss_pred cccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhH-HHH--------HHHHhhcCccc
Q 006168 477 HLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYL-LKR--------AWRLYENGTHW 546 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l-~~~--------~~~~~~~~~~~ 546 (658)
......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......... ... ....+......
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 2334578999999999876 678999999999999999999999997655422111 000 01111111111
Q ss_pred ccccccCCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 547 ELMDESLDPNECT-----KEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 547 ~~~d~~l~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
............+ ...+..+.+++..||+.||.+|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 1000000000000 1234568999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.88 Aligned_cols=244 Identities=24% Similarity=0.352 Sum_probs=203.6
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-------cccHHHHHHHHHHHhccCCCccceeeeEeecC
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-------RRTLSDFENEVRLISNVHHRNLIRLLGCCSQG 388 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 388 (658)
..++|.+.+.||+|+||.||+++.. +++.||||++..... ......+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3568999999999999999999965 688999999875321 12334678899999999999999999999999
Q ss_pred CeEEEEEeccCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccC
Q 006168 389 PELILVYEYMANS-SLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL 467 (658)
Q Consensus 389 ~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGl 467 (658)
+..++||||+.+| +|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999877 9999984 445699999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCcccccccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccc
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHW 546 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 546 (658)
+........ .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------ 236 (335)
T 3dls_A 177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------ 236 (335)
T ss_dssp CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------------
T ss_pred ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------------
Confidence 987654332 234679999999999988877 78999999999999999999998642110
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 547 ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 547 ~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..... ..+...+..+.+++..||+.||.+|||+.++++.
T Consensus 237 --~~~~~---~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 --VEAAI---HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --TTTCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --Hhhcc---CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111 0111123468999999999999999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=350.83 Aligned_cols=253 Identities=22% Similarity=0.314 Sum_probs=195.0
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|.+.+.||+|+||.||+++.. +++.||||++... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS--TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC--ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 468899999999999999999987 6899999999753 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC--eEEeeccCccccCCC
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ--PKIADFGLARLLPEN 474 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~--~kl~DfGla~~~~~~ 474 (658)
|+++|+|.+++.. .+.+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 97 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 97 YASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred eCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999999843 35699999999999999999999998 9999999999999987765 999999999753222
Q ss_pred CccccccccCCcccccccccccCCCCCc-ccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEK-VDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~k-sDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
. ......||+.|+|||++.+..++.+ +||||||+++|||++|+.||........ ............ . .+
T Consensus 172 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~~-~------~~ 241 (361)
T 3uc3_A 172 S--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSVK-Y------SI 241 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHTTC-C------CC
T ss_pred C--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhcCC-C------CC
Confidence 1 2234579999999999988888765 8999999999999999999976543211 111111111110 0 00
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+. ....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 242 -~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 242 -PD--DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -CT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -CC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00 00123468999999999999999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=345.71 Aligned_cols=265 Identities=20% Similarity=0.285 Sum_probs=210.9
Q ss_pred ccchHHHHHHhcCCCcc-CcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhcc-CCCccceeee
Q 006168 308 NYRLKDLVSATRKFSEE-NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNV-HHRNLIRLLG 383 (658)
Q Consensus 308 ~~~~~~l~~a~~~f~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 383 (658)
+..++......++|.+. +.||+|+||.||+++.. +++.||+|++... ........+.+|+.++.++ +||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 44455556666778777 88999999999999976 5899999998753 2334567899999999999 5699999999
Q ss_pred EeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC---CCCe
Q 006168 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD---DLQP 460 (658)
Q Consensus 384 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~---~~~~ 460 (658)
++.+.+..++||||+++|+|.+++.......+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCE
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcE
Confidence 999999999999999999999999655567799999999999999999999998 9999999999999988 7899
Q ss_pred EEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh
Q 006168 461 KIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLY 540 (658)
Q Consensus 461 kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~ 540 (658)
||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ........
T Consensus 174 kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~- 248 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--TYLNISQV- 248 (327)
T ss_dssp EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHT-
T ss_pred EEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHHHhc-
Confidence 999999998764332 2234679999999999999999999999999999999999999997644321 11111110
Q ss_pred hcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 541 ENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 541 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
. .. . ........+..+.+++..||+.||.+|||+.++++.
T Consensus 249 ~-~~--------~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 N-VD--------Y-SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp C-CC--------C-CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred c-cc--------c-CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 00 0 111112234568999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.09 Aligned_cols=262 Identities=21% Similarity=0.299 Sum_probs=204.2
Q ss_pred HHhcCCCccCcccccCceEEEEEEe-cCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEe-ecCCeEEE
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTL-KNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCC-SQGPELIL 393 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l 393 (658)
...++|...+.||+|+||.||+++. .+++.||||++..... ...+.+|+++++.++|++++..++.+ ...+..++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 3457899999999999999999997 4689999998754322 23578899999999988877776665 66788899
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE---cCCCCeEEeeccCccc
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL---DDDLQPKIADFGLARL 470 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll---~~~~~~kl~DfGla~~ 470 (658)
||||+ +++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEECC-CCBHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEcc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 99999 9999999853 245699999999999999999999999 99999999999999 7889999999999987
Q ss_pred cCCCCcc------ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc-chhhHHHHHHHHhhcC
Q 006168 471 LPENQSH------LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE-EGEYLLKRAWRLYENG 543 (658)
Q Consensus 471 ~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~-~~~~l~~~~~~~~~~~ 543 (658)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 6543321 22356799999999999999999999999999999999999999976543 2112222111111100
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 544 THWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 544 ~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
.. +.+ ... .+..+.+++..||+.||++|||+.+|++.|+.+.
T Consensus 238 ~~-~~~-----~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 238 PI-EVL-----CKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp CH-HHH-----TTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hh-hhh-----hcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 00 000 011 2356999999999999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=343.90 Aligned_cols=260 Identities=22% Similarity=0.324 Sum_probs=205.0
Q ss_pred HhcCCCccCcccccCceEEEEEEe-cCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEee----cCCeE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTL-KNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCS----QGPEL 391 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~ 391 (658)
..++|.+.+.||+|+||.||+++. .+++.||||++.. ......+.+.+|++++++++||||+++++++. .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE-SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec-CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 346889999999999999999997 4789999999865 34455678899999999999999999999986 34578
Q ss_pred EEEEeccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 392 ILVYEYMANSSLDKFLFGE--KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
++||||+++|+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 9999999999999998642 345699999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCcc--------ccccccCCcccccccccccCC---CCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHH
Q 006168 470 LLPENQSH--------LSTKFAGTLGYTAPEYAIHGQ---LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWR 538 (658)
Q Consensus 470 ~~~~~~~~--------~~~~~~gt~~y~APE~~~~~~---~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~ 538 (658)
........ ......||+.|+|||.+.... ++.++||||||+++|||++|+.||.........+...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--- 259 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA--- 259 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH---
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH---
Confidence 65321111 012346799999999987553 7899999999999999999999985321111111110
Q ss_pred HhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 539 LYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 539 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.... . ........+..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 260 -~~~~---------~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 260 -VQNQ---------L-SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp -HHCC------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -hhcc---------C-CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 1110 0 0001112345699999999999999999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=339.96 Aligned_cols=250 Identities=27% Similarity=0.458 Sum_probs=209.4
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.+.|...+.||+|+||.||+|+.. +++.||||++.........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888999999999999999975 6899999999765555667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++++|.+++. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 101 ~~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 101 YLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CCTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred eCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 999999999983 35799999999999999999999998 999999999999999999999999999987644322
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
......|++.|+|||.+.+..++.++||||||+++|||++|+.|+....... .... ...... ..+ ..
T Consensus 175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~----~~~~~~-----~~~-~~ 241 (303)
T 3a7i_A 175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFL----IPKNNP-----PTL-EG 241 (303)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHH----HHHSCC-----CCC-CS
T ss_pred -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHH----hhcCCC-----CCC-cc
Confidence 2234678999999999999999999999999999999999999986543211 1111 111111 111 12
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
. .+..+.+++..||+.||.+|||+.++++.
T Consensus 242 ~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 242 N----YSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp S----CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred c----cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 2 23468999999999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=344.99 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=207.4
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccccc-----ccHHHHHHHHHHHhccCCCccceeeeEeecCCeE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR-----RTLSDFENEVRLISNVHHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 391 (658)
.++|.+.+.||+|+||.||+++.. +|+.||+|.+...... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 467889999999999999999976 6899999998753222 2467899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC----CeEEeeccC
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL----QPKIADFGL 467 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~----~~kl~DfGl 467 (658)
++||||+++++|.+++. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHH--TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999994 345699999999999999999999998 999999999999999887 799999999
Q ss_pred ccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccc
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWE 547 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 547 (658)
+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ...... .
T Consensus 166 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~----i~~~~~-~ 236 (321)
T 2a2a_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLAN----ITSVSY-D 236 (321)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHH----HHTTCC-C
T ss_pred ceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--HHHHH----HHhccc-c
Confidence 98765432 223457999999999999999999999999999999999999999754331 11111 111100 0
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 548 LMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 548 ~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+.. .....+..+.+++..||+.||.+|||+.|+++.
T Consensus 237 -~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 237 -FDEE-----FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp -CCHH-----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred -cChh-----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 001123568999999999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=335.09 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=185.7
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
.++|.+.+.||+|+||.||+++.. +++.||||++.... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 357888999999999999999974 78999999986432 223457899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++++|.+++.. ....+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 999999999999853 335699999999999999999999998 9999999999999999999999999999876433
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ . ... ....
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~--------~~~~-- 228 (278)
T 3cok_A 166 HE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--L----NKV--------VLAD-- 228 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------C--------CSSC--
T ss_pred CC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--H----HHH--------hhcc--
Confidence 22 12345789999999999998999999999999999999999999875443210 0 000 0000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 229 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 229 -YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 01112234568999999999999999999999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=341.72 Aligned_cols=256 Identities=26% Similarity=0.425 Sum_probs=205.6
Q ss_pred hcCCCccC-cccccCceEEEEEEec---CCcEEEEEEcccccc-cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 318 TRKFSEEN-KLGEGGFGDIYKGTLK---NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 318 ~~~f~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
.++|.+.+ .||+|+||.||+|.+. +++.||||++..... ....+.+.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35666777 8999999999999653 468899999875322 23357899999999999999999999999 567789
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 94 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 99999999999999954 45699999999999999999999998 99999999999999999999999999998775
Q ss_pred CCCccc--cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccc
Q 006168 473 ENQSHL--STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 473 ~~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
...... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+ ......+...
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~----~~~~~~~~~~--- 239 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EV----TAMLEKGERM--- 239 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH----HHHHHTTCCC---
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HH----HHHHHcCCCC---
Confidence 443322 223456789999999999899999999999999999999 99998754432 11 1112222111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
..+...+..+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus 240 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 240 -------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 112233456999999999999999999999999998763
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=346.85 Aligned_cols=256 Identities=27% Similarity=0.439 Sum_probs=204.9
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcE--EEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKI--VAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 394 (658)
++|.+.+.||+|+||.||+++.. ++.. +|+|++.........+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888999999999999999976 4654 4999987644555667899999999999 999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCe
Q 006168 395 YEYMANSSLDKFLFGEK--------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP 460 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~ 460 (658)
|||+++++|.+++.... ...+++..++.++.||++||.|||+. +|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999996432 24699999999999999999999998 99999999999999999999
Q ss_pred EEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHH
Q 006168 461 KIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRL 539 (658)
Q Consensus 461 kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~ 539 (658)
||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+ ...
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~----~~~ 253 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--EL----YEK 253 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HH----HHH
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--HH----HHH
Confidence 99999999743221 11233467889999999999999999999999999999998 99998654321 11 111
Q ss_pred hhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 540 YENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 540 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...+.. ...+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 254 ~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 254 LPQGYR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp GGGTCC----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcCCC----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 211110 0111223456999999999999999999999999998874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.11 Aligned_cols=251 Identities=20% Similarity=0.322 Sum_probs=205.0
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
..++|.+.+.||+|+||.||++..+ ++..||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY-FVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGG-GCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhh-ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 3467889999999999999999977 4778999998763 3456788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE---cCCCCeEEeeccCccccC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLLP 472 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll---~~~~~~kl~DfGla~~~~ 472 (658)
||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++....
T Consensus 86 e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 86 ELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp ECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred eccCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999998853 35699999999999999999999998 99999999999999 788999999999998765
Q ss_pred CCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 473 ENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 473 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... ... . ...+... .....
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~---~-~~~~~~~-~~~~~ 230 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--VML---K-IREGTFT-FPEKD 230 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH---H-HHHCCCC-CCHHH
T ss_pred Ccc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH--HHH---H-HHhCCCC-CCchh
Confidence 433 2334579999999998765 59999999999999999999999997644321 111 1 1111100 00000
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
....+..+.+++..||+.||.+|||+.++++
T Consensus 231 ------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 ------WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ------hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0012456899999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.94 Aligned_cols=248 Identities=25% Similarity=0.467 Sum_probs=206.6
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeec--------
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ-------- 387 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 387 (658)
..++|...+.||+|+||.||++++. +++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 3467889999999999999999987 79999999986532 356789999999999999999998854
Q ss_pred --------CCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC
Q 006168 388 --------GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ 459 (658)
Q Consensus 388 --------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~ 459 (658)
....++||||+++++|.+++.......+++..++.++.||+.||.|||+. +|+||||||+|||+++++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence 45589999999999999999765556799999999999999999999998 9999999999999999999
Q ss_pred eEEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHH
Q 006168 460 PKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRL 539 (658)
Q Consensus 460 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~ 539 (658)
+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+... ...+..
T Consensus 161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~~ 230 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFTD 230 (284)
T ss_dssp EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHHH
T ss_pred EEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHHH
Confidence 99999999987654332 23457899999999999999999999999999999999998875311 011111
Q ss_pred hhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 540 YENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 540 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...+. + ...+ +..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 231 ~~~~~--------~-~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 231 LRDGI--------I-SDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHTTC--------C-CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred hhccc--------c-cccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 11111 1 1222 345889999999999999999999999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=354.11 Aligned_cols=247 Identities=26% Similarity=0.363 Sum_probs=197.0
Q ss_pred ccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCCC
Q 006168 323 EENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANS 401 (658)
Q Consensus 323 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 401 (658)
..+.||+|+||.||+++.. +|+.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTR-GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccc-ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3567999999999999975 6899999998753 3345678999999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE--cCCCCeEEeeccCccccCCCCcccc
Q 006168 402 SLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL--DDDLQPKIADFGLARLLPENQSHLS 479 (658)
Q Consensus 402 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll--~~~~~~kl~DfGla~~~~~~~~~~~ 479 (658)
+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 172 ~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 172 ELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp EEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred cHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 99998853 234699999999999999999999998 99999999999999 5678899999999987654332 2
Q ss_pred ccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCC
Q 006168 480 TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECT 559 (658)
Q Consensus 480 ~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 559 (658)
....||+.|+|||++....++.++||||||+++|||++|+.||...... ..... .... . +...... .
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~---i~~~-~-~~~~~~~------~ 312 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETLNN---ILAC-R-WDLEDEE------F 312 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH---HHHT-C-CCSCSGG------G
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH---HHhc-c-CCCChhh------h
Confidence 3457999999999999999999999999999999999999999765432 11111 1111 0 0000000 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 560 KEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 560 ~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
...+..+.+++.+||+.||.+|||+.|+++
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 122456899999999999999999999997
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=335.47 Aligned_cols=260 Identities=21% Similarity=0.300 Sum_probs=207.2
Q ss_pred hcCCCccCcccccCceEEEEEEe-cCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEe-ecCCeEEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTL-KNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCC-SQGPELILVY 395 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~ 395 (658)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+|+++++.++|++++..+.++ .+.+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 46889999999999999999997 478999999986532 234689999999999998877766655 6677889999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE---cCCCCeEEeeccCccccC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLLP 472 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll---~~~~~~kl~DfGla~~~~ 472 (658)
||+ +++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++....
T Consensus 85 e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 85 ELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Eec-CCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 999 8999999953 345699999999999999999999998 99999999999999 588999999999998765
Q ss_pred CCCcc------ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc-chhhHHHHHHHHhhcCcc
Q 006168 473 ENQSH------LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE-EGEYLLKRAWRLYENGTH 545 (658)
Q Consensus 473 ~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~-~~~~l~~~~~~~~~~~~~ 545 (658)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 44321 12356799999999999999999999999999999999999999976443 221222211111100000
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 546 WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 546 ~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
+ .+ ... .+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 240 -~----~~-~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 240 -E----VL-CKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp -H----HH-TTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred -H----HH-Hhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 0 00 111 2356999999999999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=362.72 Aligned_cols=247 Identities=28% Similarity=0.418 Sum_probs=205.6
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|...+.||+|+||.||+++.+ +|+.||+|++.... .......+.+|++++++++||||+++++++...+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 57888899999999999999986 69999999996532 2345678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 396 EYMANSSLDKFLFGEK--RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999986543 34699999999999999999999998 999999999999999999999999999987654
Q ss_pred CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc--chhhHHHHHHHHhhcCcccccccc
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE--EGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+...+ .. ..
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i---~~-~~------- 409 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV---LE-QA------- 409 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH---HH-CC-------
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH---hh-cc-------
Confidence 332 23346899999999999999999999999999999999999999976543 112222211 11 10
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTM 584 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 584 (658)
...+...+..+.+++..||+.||.+||++
T Consensus 410 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 410 ----VTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ----cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 11122334568999999999999999976
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=348.23 Aligned_cols=259 Identities=29% Similarity=0.433 Sum_probs=207.3
Q ss_pred hcCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 391 (658)
.++|.+.+.||+|+||.||+|++. +++.||||++..........++.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 468899999999999999999842 47789999997654555667899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC---CCCeEEe
Q 006168 392 ILVYEYMANSSLDKFLFGEKR-----GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD---DLQPKIA 463 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~---~~~~kl~ 463 (658)
++||||+++++|.+++..... ..+++..++.++.||+.||.|||+. +|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999975432 3499999999999999999999998 9999999999999984 4569999
Q ss_pred eccCccccCCCCc-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhh
Q 006168 464 DFGLARLLPENQS-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYE 541 (658)
Q Consensus 464 DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~ 541 (658)
|||++........ .......|++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+. ....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~----~~~~ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVL----EFVT 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH----HHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHH----HHHh
Confidence 9999986533222 22334567899999999999999999999999999999998 88888654321 111 1111
Q ss_pred cCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 542 NGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 542 ~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
.+... ..+...+..+.+++..||+.||.+|||+.+|++.|+.+.
T Consensus 260 ~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 260 SGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 11111 111223356899999999999999999999999998763
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=358.60 Aligned_cols=247 Identities=27% Similarity=0.444 Sum_probs=206.5
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999986 79999999986531 2234578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++. ..+.+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 96 E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999994 456799999999999999999999998 99999999999999999999999999998765432
Q ss_pred ccccccccCCcccccccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... .+.. ....+.. ..
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~----~i~~~~~------~~- 235 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLFK----KICDGIF------YT- 235 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHHH----HHHTTCC------CC-
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHHH----HHhcCCc------CC-
Confidence 2335679999999999988766 68999999999999999999999754432 1111 1111110 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
+.. .+..+.+++..||+.||.+|||+.|+++
T Consensus 236 p~~----~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 PQY----LNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Ccc----CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 112 2346899999999999999999999997
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=353.02 Aligned_cols=250 Identities=22% Similarity=0.282 Sum_probs=194.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHH-HhccCCCccceeeeEeecCCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRL-ISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
++|...+.||+|+||.||+++.+ +++.||||++.... .......+..|..+ ++.++||||+++++++...+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 57888999999999999999987 58899999997542 22334556777776 5778999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.....
T Consensus 118 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 999999999999853 35689999999999999999999998 9999999999999999999999999999864332
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+...+ .. +..
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~~i---~~-~~~--------- 256 (373)
T 2r5t_A 193 N-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNI---LN-KPL--------- 256 (373)
T ss_dssp C-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--HHHHHH---HH-SCC---------
T ss_pred C-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HHHHHH---Hh-ccc---------
Confidence 2 2234568999999999999999999999999999999999999999754321 111111 11 110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 591 (658)
..+...+..+.+++..||+.||.+||++.+.++.+
T Consensus 257 --~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 257 --QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp --CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 11112235689999999999999999986444333
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=344.45 Aligned_cols=262 Identities=25% Similarity=0.482 Sum_probs=208.7
Q ss_pred cCCCccCcccccCceEEEEEEe-----cCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCC--eE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTL-----KNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP--EL 391 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 391 (658)
++|.+.+.||+|+||.||++++ .+++.||||++.. ......+.+.+|++++++++||||+++++++...+ ..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS-CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 5678889999999999999984 3688999999875 34455678999999999999999999999986643 78
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 9999999999999999543 35699999999999999999999998 9999999999999999999999999999877
Q ss_pred CCCCccc--cccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc----------chhhHHHHHHHH
Q 006168 472 PENQSHL--STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE----------EGEYLLKRAWRL 539 (658)
Q Consensus 472 ~~~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~----------~~~~l~~~~~~~ 539 (658)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ............
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 5443221 2245677889999999999999999999999999999999988753211 001111111111
Q ss_pred hhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 540 YENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 540 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...+.. ...+...+..+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus 276 ~~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 276 LKNNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHTTCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcCCC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111110 0112223456999999999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=344.75 Aligned_cols=266 Identities=25% Similarity=0.416 Sum_probs=202.4
Q ss_pred hHHHHHHhcCCCccCcccccCceEEEEEEec----CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEe
Q 006168 311 LKDLVSATRKFSEENKLGEGGFGDIYKGTLK----NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCC 385 (658)
Q Consensus 311 ~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 385 (658)
++++....++|.+.+.||+|+||.||+|.+. .+..||+|++.... .....+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3444455678888999999999999999865 24589999987532 334457789999999999999999999999
Q ss_pred ecCC-----eEEEEEeccCCCCHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC
Q 006168 386 SQGP-----ELILVYEYMANSSLDKFLFGE----KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD 456 (658)
Q Consensus 386 ~~~~-----~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~ 456 (658)
.+.+ ..++||||+++++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC
Confidence 7654 359999999999999998532 335699999999999999999999998 9999999999999999
Q ss_pred CCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHH
Q 006168 457 DLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLK 534 (658)
Q Consensus 457 ~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~ 534 (658)
++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ...
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~ 260 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--MYD 260 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHH
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHH
Confidence 999999999999876443321 2234567889999999999999999999999999999999 888886544321 111
Q ss_pred HHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 535 RAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 535 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
. ...+... ..+...+..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus 261 ~----~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 261 Y----LLHGHRL----------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp H----HHTTCCC----------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----HHcCCCC----------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 1111111 111223456999999999999999999999999998863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=338.79 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=198.5
Q ss_pred cCCCc-cCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSE-ENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+ .+.||+|+||.||+++.. +++.||||++... .......+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ-PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC-SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC-cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 46666 478999999999999965 6899999999753 345577899999999985 7999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC---eEEeeccCccccC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ---PKIADFGLARLLP 472 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~---~kl~DfGla~~~~ 472 (658)
||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||+|||++....
T Consensus 91 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 91 EKMRGGSILSHIHK--RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp ECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999954 35699999999999999999999998 9999999999999988776 9999999998654
Q ss_pred CCCc------cccccccCCccccccccccc-----CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchh---------hH
Q 006168 473 ENQS------HLSTKFAGTLGYTAPEYAIH-----GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE---------YL 532 (658)
Q Consensus 473 ~~~~------~~~~~~~gt~~y~APE~~~~-----~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~---------~l 532 (658)
.... .......||+.|+|||++.. ..++.++||||||+++|||++|+.||........ ..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 11224569999999999875 5689999999999999999999999976543110 00
Q ss_pred HHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 533 LKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 533 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..........+.. ....... ...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 246 ~~~~~~~i~~~~~-~~~~~~~------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 246 QNMLFESIQEGKY-EFPDKDW------AHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHCCC-CCCHHHH------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhccCc-ccCchhc------ccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0111111111110 0000000 0123568999999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=349.79 Aligned_cols=248 Identities=29% Similarity=0.457 Sum_probs=202.2
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
+.|...+.||+|+||.||+|+.. +++.||||++.... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45888899999999999999964 78999999986532 2233467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+. |+|.+++.. ....+++..++.++.|+++||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp ECCS-EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCC-CCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 9997 688887743 345799999999999999999999998 9999999999999999999999999999865432
Q ss_pred ccccccccCCcccccccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 476 SHLSTKFAGTLGYTAPEYAI---HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~---~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
....||+.|+|||++. .+.++.++||||||+++|||++|+.||....... .......... +.
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-----~~~~~~~~~~------~~ 272 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQNES------PA 272 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCC------CC
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhcCC------CC
Confidence 2457999999999985 5688999999999999999999999986543311 1112221111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 591 (658)
+.... .+..+.+++..||+.||.+|||+.++++..
T Consensus 273 ~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 273 LQSGH----WSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CCCCC----CCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 11122 235689999999999999999999998653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=347.26 Aligned_cols=266 Identities=23% Similarity=0.356 Sum_probs=206.0
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|.+.+.||+|+||.||++... +++.||+|++.........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357888999999999999999987 6899999999765455556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 9999999999953 34699999999999999999999983 17999999999999999999999999999754221
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHH----------HHHHh------
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKR----------AWRLY------ 540 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~----------~~~~~------ 540 (658)
......||+.|+|||++.+..++.++||||||+++|||++|+.||............. .+...
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 2234578999999999999999999999999999999999999997644321110000 00000
Q ss_pred --------hcCcccccccc---cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 541 --------ENGTHWELMDE---SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 541 --------~~~~~~~~~d~---~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
......+.++. ...........+..+.+++..||+.||.+|||+.|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000000000 000011111234569999999999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=334.28 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=200.4
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
+|.....||+|+||.||+|... +++.||||.+... .....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 4555668999999999999975 6889999998753 3445678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC-CCCeEEeeccCccccCCCCc
Q 006168 399 ANSSLDKFLFGEKR-GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD-DLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 399 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~-~~~~kl~DfGla~~~~~~~~ 476 (658)
++++|.+++..... ..+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999965432 3478999999999999999999998 9999999999999987 89999999999987644321
Q ss_pred cccccccCCcccccccccccCC--CCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQ--LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~--~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||............. ... . ..
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~--~-----~~---- 244 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV--GMF--K-----VH---- 244 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH--HHH--C-----CC----
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh--ccc--c-----cc----
Confidence 223467899999999997654 8899999999999999999999986543322111111 000 0 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+...+..+.+++.+||+.||++|||+.++++.
T Consensus 245 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 245 -PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11122234568999999999999999999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=348.98 Aligned_cols=250 Identities=22% Similarity=0.276 Sum_probs=192.4
Q ss_pred cCCCcc-CcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhc-cCCCccceeeeEeec----CCeE
Q 006168 319 RKFSEE-NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISN-VHHRNLIRLLGCCSQ----GPEL 391 (658)
Q Consensus 319 ~~f~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 391 (658)
++|.+. +.||+|+||.||++..+ +++.||||++.. ...+.+|++++.+ .+||||+++++++.. .+..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 455555 68999999999999976 688999999853 1457788888754 489999999999865 5678
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC---CCCeEEeeccCc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD---DLQPKIADFGLA 468 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~---~~~~kl~DfGla 468 (658)
++||||+++|+|.+++.......+++..+..|+.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999999765555799999999999999999999998 9999999999999988 789999999999
Q ss_pred cccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcch--hhHHHHHHHHhhcCccc
Q 006168 469 RLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEG--EYLLKRAWRLYENGTHW 546 (658)
Q Consensus 469 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~~ 546 (658)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... ..+..
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~- 284 (400)
T 1nxk_A 212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQY- 284 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCC-
T ss_pred cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCcc-
Confidence 8764322 2345678999999999999999999999999999999999999997654311 1111111 11110
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 547 ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 547 ~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.. +.......+..+.+|+..||+.||.+|||+.|+++.
T Consensus 285 ~~------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 EF------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CC------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cC------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 000011234568999999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=340.86 Aligned_cols=264 Identities=23% Similarity=0.388 Sum_probs=188.9
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
..++|.+.+.||+|+||.||++... +++.||||++..........++.+|+.++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3578999999999999999999965 689999999876444455678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 396 EYMANSSLDKFLFG------EKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 396 E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
||+++++|.+++.. .....+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999853 1345699999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCc----cccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCc
Q 006168 470 LLPENQS----HLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGT 544 (658)
Q Consensus 470 ~~~~~~~----~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 544 (658)
....... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......... ..... .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~~~-~ 243 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM-----LTLQN-D 243 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-----HHHTS-S
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH-----HHhcc-C
Confidence 7643321 11234578999999999876 568999999999999999999999997654422111 11111 1
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 545 HWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 545 ~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.... .............+..+.+++.+||+.||.+|||+.++++.
T Consensus 244 ~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 244 PPSL-ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CCCT-TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCcc-ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1100 00000011111223568999999999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=338.68 Aligned_cols=251 Identities=28% Similarity=0.434 Sum_probs=199.8
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecC-CeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG-PELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~E 396 (658)
.++|...+.||+|+||.||++..+ |+.||||++... ...+.+.+|++++++++||||+++++++.+. +..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 467888999999999999999885 889999998642 3557899999999999999999999997554 57899999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999999999654333489999999999999999999998 99999999999999999999999999997653322
Q ss_pred cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.. ....+..
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~----~~~~~~~---------- 232 (278)
T 1byg_A 172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVP----RVEKGYK---------- 232 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHH----HHTTTCC----------
T ss_pred ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHhcCCC----------
Confidence 23457889999999999999999999999999999998 99998754332 1111 1111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...+...+..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 1111223456999999999999999999999999998874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.83 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=206.8
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
.++|.+.+.||+|+||.||+++.. +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357888999999999999999986 47899999986532 233456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++++|.+++.. ...+++.+++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 120 ~e~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 999999999999843 35699999999999999999999998 9999999999999999999999999999876433
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .. ........ .+
T Consensus 195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~----~~~~~~~~------~~- 260 (335)
T 2owb_A 195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TY----LRIKKNEY------SI- 260 (335)
T ss_dssp TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH----HHHHHTCC------CC-
T ss_pred cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH--HH----HHHhcCCC------CC-
Confidence 22 2334678999999999999999999999999999999999999997543321 11 11111110 11
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+. .....+.+++.+||+.||++|||+.|+++.
T Consensus 261 ~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 261 PK----HINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred Cc----cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 223468899999999999999999999873
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=345.04 Aligned_cols=252 Identities=22% Similarity=0.334 Sum_probs=202.5
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 394 (658)
..++|.+.+.||+|+||.||+++.+ +++.||||++..... ...+|++++.++ +||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 3567889999999999999999986 588999999875321 245788888888 799999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC----CCeEEeeccCccc
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD----LQPKIADFGLARL 470 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~----~~~kl~DfGla~~ 470 (658)
|||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||+.++ +.+||+|||+++.
T Consensus 95 ~E~~~gg~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 95 TELMKGGELLDKIL--RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp ECCCCSCBHHHHHH--TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999984 345699999999999999999999998 99999999999998543 3499999999987
Q ss_pred cCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc-chhhHHHHHHHHhhcCcccccc
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE-EGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~-~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....+... ...+...
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~----i~~~~~~--- 241 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR----IGSGKFS--- 241 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH----HHHCCCC---
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH----HccCCcc---
Confidence 644332 23356789999999999888899999999999999999999999976433 22222222 1111111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+ ........+..+.+++..||+.||.+|||+.++++.
T Consensus 242 ---~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 ---L-SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---C-CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---c-CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 111112234568999999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=345.06 Aligned_cols=267 Identities=23% Similarity=0.357 Sum_probs=195.9
Q ss_pred HHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 315 VSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 315 ~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
....++|.+.++||+|+||.||+++.. +++.||||++..... ......+.+|++++++++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 344578999999999999999999965 689999999975322 223456789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc-----CCCCeEEeeccC
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD-----DDLQPKIADFGL 467 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~-----~~~~~kl~DfGl 467 (658)
+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++ +++.+||+|||+
T Consensus 110 lv~e~~~~-~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEEECCSE-EHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEEecCCC-CHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 99999985 99999843 35699999999999999999999998 999999999999994 455699999999
Q ss_pred ccccCCCCccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc--Cc
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN--GT 544 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~~ 544 (658)
++.+..... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||....... ........... ..
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTT
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHHHhCCCchh
Confidence 987643322 23345789999999999875 58999999999999999999999997654321 11111111110 00
Q ss_pred cccccc---------ccCCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 545 HWELMD---------ESLDPNE----CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 545 ~~~~~d---------~~l~~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+.... +...... ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000000 0000000 001123568999999999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=352.91 Aligned_cols=265 Identities=24% Similarity=0.404 Sum_probs=194.1
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccC-CCccceeeeEeecC--Ce
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQG--PE 390 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~ 390 (658)
...++|.+.+.||+|+||.||+|... +++.||||++... ........+.+|+.+++++. ||||+++++++... ..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999975 6899999998643 23344567889999999997 99999999999754 47
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 899999998 589998843 4699999999999999999999998 999999999999999999999999999987
Q ss_pred cCCC--------------------CccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcch
Q 006168 471 LPEN--------------------QSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEG 529 (658)
Q Consensus 471 ~~~~--------------------~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~ 529 (658)
+... .....+...||+.|+|||++.+ ..++.++|||||||+++||++|+.||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5331 1112335689999999999976 678999999999999999999999997654311
Q ss_pred hhHHHHHHHHhhcCccccccc---------------------ccCCCCCC------------CHHHHHHHHHHHHHcccc
Q 006168 530 EYLLKRAWRLYENGTHWELMD---------------------ESLDPNEC------------TKEAAEKVVEIALMCTQS 576 (658)
Q Consensus 530 ~~l~~~~~~~~~~~~~~~~~d---------------------~~l~~~~~------------~~~~~~~l~~li~~cl~~ 576 (658)
.+..+........ .+.+. .......+ ....+..+.+|+.+||+.
T Consensus 239 --~~~~i~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 239 --QLERIIGVIDFPS-NEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp --HHHHHHHHHCCCC-HHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred --HHHHHHHhcCCCC-HHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 1111111110000 00000 00000000 001234689999999999
Q ss_pred CCCCCCCHHHHHHH
Q 006168 577 AANSRPTMSEVVAL 590 (658)
Q Consensus 577 dp~~RPt~~evl~~ 590 (658)
||.+|||+.|+++.
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=337.49 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=206.6
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEee--cCCeEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCS--QGPELIL 393 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 393 (658)
.++|.+.+.||+|+||.||++... +++.||+|++.... .....+.+.+|++++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467888999999999999999986 68999999987532 3344577899999999999999999999874 4678999
Q ss_pred EEeccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC-----eeecCcCCCcEEEcCCCCeEEeecc
Q 006168 394 VYEYMANSSLDKFLFGE--KRGSLNWKQRFDIILGTARGLAYLHEDFHVR-----IIHRDIKPSNVLLDDDLQPKIADFG 466 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivH~Dik~~NIll~~~~~~kl~DfG 466 (658)
||||+++++|.+++... ....+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999999643 234599999999999999999999998 7 9999999999999999999999999
Q ss_pred CccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccc
Q 006168 467 LARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHW 546 (658)
Q Consensus 467 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 546 (658)
++........ ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .+.. ....+...
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~----~i~~~~~~ 234 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAG----KIREGKFR 234 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----HHHHTCCC
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHH----HHhhcccc
Confidence 9987644322 223457899999999999999999999999999999999999998765321 1111 11112111
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 547 ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 547 ~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+...+..+.+++.+||+.||.+|||+.||++.+...
T Consensus 235 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 235 ----------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ----------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 11122345699999999999999999999999876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=346.19 Aligned_cols=264 Identities=23% Similarity=0.379 Sum_probs=197.0
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|.+.+.||+|+||.||+|+.. +++.||+|++...........+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57888999999999999999986 68999999986533322223456799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
++ |+|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 155 (324)
T ss_dssp CS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-c
Confidence 98 5898888543 45699999999999999999999998 99999999999999999999999999998654332 2
Q ss_pred ccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCc---ccccccc--
Q 006168 478 LSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGT---HWELMDE-- 551 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d~-- 551 (658)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .......+...... .......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHhchhhhcchh
Confidence 2334578999999999876 56899999999999999999999999765432 22222222211100 0000000
Q ss_pred -------cCCCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 552 -------SLDPN---ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 552 -------~l~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..... .........+.+|+.+||+.||.+|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 0001123568899999999999999999999873
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=336.41 Aligned_cols=250 Identities=23% Similarity=0.351 Sum_probs=207.0
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
.++|...+.||+|+||.||++... +++.||+|.+.... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888999999999999999987 58899999986532 233456789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++++|.+++.. ...+++.+++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKR--RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 999999999998843 35699999999999999999999998 9999999999999999999999999999876433
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .........
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~--------- 232 (294)
T 2rku_A 169 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKKNEY--------- 232 (294)
T ss_dssp TC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTTCC---------
T ss_pred cc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhhccC---------
Confidence 22 23346789999999999998999999999999999999999999975443211 111111110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+......+.+++.+||+.||++|||+.|+++.
T Consensus 233 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 --SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1111223468999999999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.84 Aligned_cols=267 Identities=27% Similarity=0.371 Sum_probs=198.0
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHH--HHHhccCCCccceeeeEee-----cCCe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEV--RLISNVHHRNLIRLLGCCS-----QGPE 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~--~~l~~l~h~niv~l~~~~~-----~~~~ 390 (658)
.++|.+.+.||+|+||.||+|+. +++.||||++... ....+..|. ..+..++||||+++++.+. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 36788899999999999999987 5899999998642 233444444 4455689999999998653 2346
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcC------CCCeeecCcCCCcEEEcCCCCeEEee
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF------HVRIIHRDIKPSNVLLDDDLQPKIAD 464 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~Dik~~NIll~~~~~~kl~D 464 (658)
.++||||+++|+|.+++.. ..+++..++.++.||+.||.|||+.. ..+|+||||||+|||++.++.+||+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 7999999999999999943 34589999999999999999999862 23899999999999999999999999
Q ss_pred ccCccccCCCCc-------cccccccCCccccccccccc-------CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchh
Q 006168 465 FGLARLLPENQS-------HLSTKFAGTLGYTAPEYAIH-------GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE 530 (658)
Q Consensus 465 fGla~~~~~~~~-------~~~~~~~gt~~y~APE~~~~-------~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~ 530 (658)
||+++.+..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999987653321 11224579999999999876 4567799999999999999999877644322110
Q ss_pred ---hH---------HHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 531 ---YL---------LKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 531 ---~l---------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
.+ ................+.... ......+..+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW---KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC---CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCccc---ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 00 001111111111111111111 112345678999999999999999999999999999873
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=373.16 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=199.8
Q ss_pred CcccccCceEEEEEEec---CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLK---NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
++||+|+||.||+|.+. .++.||||++.... .....+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999764 46789999997542 23446789999999999999999999999964 568999999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc--c
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH--L 478 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~--~ 478 (658)
|+|.+++. ....+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~--~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 99999994 345699999999999999999999998 9999999999999999999999999999877544322 2
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
.+...+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+ ......+... .
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~----~~~i~~~~~~----------~ 592 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EV----TAMLEKGERM----------G 592 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH----HHHHHTTCCC----------C
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HH----HHHHHcCCCC----------C
Confidence 234557889999999999999999999999999999998 99999765432 11 1122222111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.+...+..+.+|+..||+.||++|||+.+|++.|+.+
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1222345699999999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=344.29 Aligned_cols=251 Identities=16% Similarity=0.164 Sum_probs=204.5
Q ss_pred HHhcCCCccCcccccCceEEEEEE------ecCCcEEEEEEcccccccccHHHHHHHHHHHhccC---CCccceeeeEee
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGT------LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVH---HRNLIRLLGCCS 386 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 386 (658)
...++|.+.+.||+|+||.||+|+ ..+++.||||++... ...++..|++++..++ |+||+++++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 345788899999999999999994 346889999998642 3457778888887776 999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC-------
Q 006168 387 QGPELILVYEYMANSSLDKFLFGE---KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD------- 456 (658)
Q Consensus 387 ~~~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~------- 456 (658)
..+..++||||+++|+|.+++... ....+++..++.|+.||+.||.|||+. +|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence 999999999999999999999642 345699999999999999999999998 9999999999999998
Q ss_pred ----CCCeEEeeccCccccCC-CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhh
Q 006168 457 ----DLQPKIADFGLARLLPE-NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEY 531 (658)
Q Consensus 457 ----~~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~ 531 (658)
++.+||+|||+++.+.. ......+...||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-- 292 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-- 292 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence 89999999999976532 22233456789999999999999999999999999999999999999985322210
Q ss_pred HHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHhcC
Q 006168 532 LLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSR-PTMSEVVALLKST 594 (658)
Q Consensus 532 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~R-Pt~~evl~~L~~~ 594 (658)
..+...+.... ..+.+.+++..|++.+|.+| |++.++.+.|+..
T Consensus 293 ---------------~~~~~~~~~~~----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 ---------------CKPEGLFRRLP----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ---------------EEECSCCTTCS----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ---------------eeechhccccC----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 00111111111 24567889999999999999 6888888888775
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=333.48 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=199.9
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeec----CCeEEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ----GPELIL 393 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 393 (658)
.|...+.||+|+||.||+|... ++..||+|.+... ......+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4667788999999999999976 5789999998653 234456778999999999999999999999865 456899
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eeecCcCCCcEEEc-CCCCeEEeeccCccc
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVR--IIHRDIKPSNVLLD-DDLQPKIADFGLARL 470 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dik~~NIll~-~~~~~kl~DfGla~~ 470 (658)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+. + |+||||||+|||++ +++.+||+|||++..
T Consensus 107 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEecCCCCHHHHHHH--ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999943 35699999999999999999999998 7 99999999999997 789999999999976
Q ss_pred cCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
..... .....||+.|+|||.+. +.++.++||||||+++|||++|+.||......... ......+......
T Consensus 182 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~- 251 (290)
T 1t4h_A 182 KRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRRVTSGVKPASF- 251 (290)
T ss_dssp CCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----HHHHTTTCCCGGG-
T ss_pred ccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-----HHHHhccCCcccc-
Confidence 54332 33457999999999776 56999999999999999999999999764432211 1112221111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+...+..+.+++..||+.||.+|||+.|+++.
T Consensus 252 --------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 252 --------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --------CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11122468999999999999999999999863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=333.55 Aligned_cols=246 Identities=26% Similarity=0.370 Sum_probs=205.1
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+.+.||+|+||.||+++.. +++.||+|++.... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57888999999999999999976 57889999986431 2234577899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 94 EFAPRGELYKELQK--HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp CCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 99999999999853 34699999999999999999999998 99999999999999999999999999997654322
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .. ....... ..
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~----~~~~~~~------~~--- 230 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--TH----RRIVNVD------LK--- 230 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH----HHHHTTC------CC---
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--HH----HHHhccc------cC---
Confidence 234578999999999999999999999999999999999999997544311 11 1111111 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.+...+..+.+++..||+.||.+|||+.++++
T Consensus 231 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 --FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 11223456899999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=341.73 Aligned_cols=269 Identities=26% Similarity=0.387 Sum_probs=200.9
Q ss_pred HHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccc----cHHHHHHHHHHHhccCCCccceeeeEeecCC
Q 006168 315 VSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRR----TLSDFENEVRLISNVHHRNLIRLLGCCSQGP 389 (658)
Q Consensus 315 ~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 389 (658)
....++|...+.||+|+||.||+++.. +|+.||||++....... ....+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344578999999999999999999976 58999999987532111 1246789999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
..++||||+++ +|.+++.. ....+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred ceEEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 99999999986 88888843 335699999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCc--cc
Q 006168 470 LLPENQSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGT--HW 546 (658)
Q Consensus 470 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--~~ 546 (658)
.+.... .......||+.|+|||.+.+. .++.++||||||+++|||++|..||...... .............. .+
T Consensus 161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTS
T ss_pred eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHcCCCChhhh
Confidence 764432 223456789999999998764 5889999999999999999999988654432 22222222211110 00
Q ss_pred ccccc---cCCCC---CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 006168 547 ELMDE---SLDPN---ECT-----KEAAEKVVEIALMCTQSAANSRPTMSEVVALL 591 (658)
Q Consensus 547 ~~~d~---~l~~~---~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L 591 (658)
..... ..... ..+ ...+..+.+++..||+.||.+|||+.|+++.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00000 00000 001 12346799999999999999999999999753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=353.19 Aligned_cols=261 Identities=25% Similarity=0.327 Sum_probs=197.7
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecC------C
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG------P 389 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 389 (658)
.++|.+.+.||+|+||.||+++.. +++.||||++.... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999976 68999999997532 334467788999999999999999999999654 4
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
..++||||++++ |.+.+. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCC-HHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 679999999874 666652 2499999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh---------
Q 006168 470 LLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLY--------- 540 (658)
Q Consensus 470 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~--------- 540 (658)
..... ...+...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.+..
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~--~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 213 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp ----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHT
T ss_pred ecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHHH
Confidence 76432 22345689999999999999999999999999999999999999997654311 111111110
Q ss_pred ----------hcCc------ccccccccCCCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 541 ----------ENGT------HWELMDESLDPN--ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 541 ----------~~~~------~~~~~d~~l~~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.... ....+...+.+. .........+.+|+.+||+.||++|||+.|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000000100000 0112235679999999999999999999999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=355.03 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=194.1
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-------ccccHHHHHHHHHHHhccCCCccceeeeEeec
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-------SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ 387 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 387 (658)
...++|.+.+.||+|+||.||+|..+ +++.||||++.... .......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45678999999999999999999976 58999999986531 1122235789999999999999999999985
Q ss_pred CCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC---CCeEEee
Q 006168 388 GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD---LQPKIAD 464 (658)
Q Consensus 388 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~---~~~kl~D 464 (658)
.+..++||||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.+ ..+||+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred cCceEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 456899999999999999883 456799999999999999999999998 99999999999999654 4599999
Q ss_pred ccCccccCCCCccccccccCCccccccccccc---CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh
Q 006168 465 FGLARLLPENQSHLSTKFAGTLGYTAPEYAIH---GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYE 541 (658)
Q Consensus 465 fGla~~~~~~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~ 541 (658)
||+++..... .......||+.|+|||++.. ..++.++||||||+++|||++|+.||........ +.. ...
T Consensus 286 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~----~i~ 358 (419)
T 3i6u_A 286 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKD----QIT 358 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHH----HHH
T ss_pred cccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHH----HHh
Confidence 9999876432 22345679999999999853 6788899999999999999999999976443211 111 111
Q ss_pred cCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 542 NGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 542 ~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+... .... .....+..+.+++.+||+.||.+|||+.|+++.
T Consensus 359 ~~~~~-~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 359 SGKYN-FIPE------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp TTCCC-CCHH------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCCC-CCch------hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11110 0000 001124568999999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=334.98 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=202.7
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-----cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-----RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
++|.+.+.||+|+||.||+++.. +++.||+|.+..... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888999999999999999987 689999999865321 124678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC----CeEEeeccCc
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL----QPKIADFGLA 468 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~----~~kl~DfGla 468 (658)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 99999999999999953 35699999999999999999999998 999999999999998877 8999999999
Q ss_pred cccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccc
Q 006168 469 RLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWEL 548 (658)
Q Consensus 469 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 548 (658)
........ .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ... .........
T Consensus 160 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~----~~~~~~~~~-- 229 (283)
T 3bhy_A 160 HKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--ETL----TNISAVNYD-- 229 (283)
T ss_dssp EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH----HHHHTTCCC--
T ss_pred eeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--HHH----HHhHhcccC--
Confidence 87644322 23457899999999999999999999999999999999999998764331 111 111111100
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 549 MDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 549 ~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.... .....+..+.+++.+||+.||.+|||+.++++
T Consensus 230 ~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 FDEE-----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCHH-----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Ccch-----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0000 00112356899999999999999999999997
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=335.75 Aligned_cols=247 Identities=21% Similarity=0.337 Sum_probs=201.2
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 393 (658)
..++|.+.+.||+|+||.||+++.. +++.||+|++... ........+.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567889999999999999999987 7999999998753 2233456788999999999 99999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC---------------
Q 006168 394 VYEYMANSSLDKFLFGEK--RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD--------------- 456 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~--------------- 456 (658)
||||+++++|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999996432 25699999999999999999999998 9999999999999984
Q ss_pred ----CCCeEEeeccCccccCCCCccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhh
Q 006168 457 ----DLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEY 531 (658)
Q Consensus 457 ----~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~ 531 (658)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||++++||++|.+++.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 4479999999998765432 23589999999999776 667899999999999999999877542211
Q ss_pred HHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 532 LLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 532 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+.....+.... .+...+..+.+++..||+.||.+|||+.|+++.
T Consensus 237 -----~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 -----WHEIRQGRLPR----------IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -----HHHHHTTCCCC----------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -----HHHHHcCCCCC----------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11122221111 111233568999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=343.96 Aligned_cols=260 Identities=25% Similarity=0.399 Sum_probs=203.3
Q ss_pred cchHHHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEee
Q 006168 309 YRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCS 386 (658)
Q Consensus 309 ~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 386 (658)
+++.++....++|.+.+.||+|+||.||+|++. +++.||||++... ......+.+|+.+++++ +||||+++++++.
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC--cccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 445556667789999999999999999999975 6899999998642 33457889999999999 8999999999997
Q ss_pred c------CCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCe
Q 006168 387 Q------GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP 460 (658)
Q Consensus 387 ~------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~ 460 (658)
. .+..++||||+++++|.+++.......+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCE
Confidence 6 56899999999999999999766556799999999999999999999998 99999999999999999999
Q ss_pred EEeeccCccccCCCCccccccccCCcccccccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHH
Q 006168 461 KIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI-----HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKR 535 (658)
Q Consensus 461 kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~ 535 (658)
||+|||++........ ......||+.|+|||.+. +..++.++||||||+++|||++|+.||........
T Consensus 169 kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----- 242 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA----- 242 (326)
T ss_dssp EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----
T ss_pred EEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-----
Confidence 9999999987643221 223457899999999987 56789999999999999999999999865433111
Q ss_pred HHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 536 AWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 536 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
....... ... .+.... .+..+.+++.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~-~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 243 LFLIPRN-PAP-----RLKSKK----WSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHS-CCC-----CCSCSC----SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhhcC-ccc-----cCCccc----cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111111 111 111112 2346899999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=343.85 Aligned_cols=265 Identities=26% Similarity=0.443 Sum_probs=201.2
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
.++|...+.||+|+||.||+++.. +++.||||++..... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 367888999999999999999986 489999999865322 223456789999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++++|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 104 e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999998873 345699999999999999999999998 99999999999999999999999999998664432
Q ss_pred ccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHH----------HHHHhhcCc
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKR----------AWRLYENGT 544 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~----------~~~~~~~~~ 544 (658)
. ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||........ +... ....+....
T Consensus 179 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 179 E-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHHCG
T ss_pred c-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhHhhhcc
Confidence 2 23345789999999999775 789999999999999999999999976543211 1110 011111111
Q ss_pred ccc-cccccCCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 545 HWE-LMDESLDPNE----CTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 545 ~~~-~~d~~l~~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
... ...+.+.... .....+..+.+++.+||+.||.+|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 100 0000000000 00123467999999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=345.20 Aligned_cols=256 Identities=23% Similarity=0.320 Sum_probs=188.9
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC-CCccceeeeEee--------
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGCCS-------- 386 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-------- 386 (658)
...+|.+.+.||+|+||.||++++. +++.||||++.. ........+.+|+.+++++. ||||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE-SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC-CchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3457888999999999999999975 689999999865 33445677899999999996 999999999983
Q ss_pred cCCeEEEEEeccCCCCHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eeecCcCCCcEEEcCCCCeEEe
Q 006168 387 QGPELILVYEYMANSSLDKFLFGE-KRGSLNWKQRFDIILGTARGLAYLHEDFHVR--IIHRDIKPSNVLLDDDLQPKIA 463 (658)
Q Consensus 387 ~~~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dik~~NIll~~~~~~kl~ 463 (658)
.....++||||+. |+|.+++... ....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence 3456899999996 6998888542 345699999999999999999999998 7 9999999999999999999999
Q ss_pred eccCccccCCCCccc-----------cccccCCccccccccc---ccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcch
Q 006168 464 DFGLARLLPENQSHL-----------STKFAGTLGYTAPEYA---IHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEG 529 (658)
Q Consensus 464 DfGla~~~~~~~~~~-----------~~~~~gt~~y~APE~~---~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~ 529 (658)
|||++.......... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 999998765432211 1134689999999998 56678999999999999999999999986432210
Q ss_pred hhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 006168 530 EYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSS 596 (658)
Q Consensus 530 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 596 (658)
. .. +.. .... ... ....+.+|+..||+.||.+|||+.|+++.|+.+..
T Consensus 261 --~-------~~-~~~----~~~~-~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 261 --I-------VN-GKY----SIPP-HDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ---------------C----CCCT-TCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --h-------hc-Ccc----cCCc-ccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 00 000 0000 111 12348899999999999999999999999998743
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=353.60 Aligned_cols=195 Identities=25% Similarity=0.412 Sum_probs=155.4
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeec-----CCe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ-----GPE 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 390 (658)
.++|.+.+.||+|+||.||+++.. +++.||||++... ......+.+.+|+++|++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999976 6899999998653 223345778999999999999999999999843 357
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.++||||+. ++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeccc-cchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 999999985 69999984 445699999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCc--------------------------cccccccCCccccccccc-ccCCCCCcccchhhhHHHHHHHhC
Q 006168 471 LPENQS--------------------------HLSTKFAGTLGYTAPEYA-IHGQLSEKVDAYSFGVLVLEIISG 518 (658)
Q Consensus 471 ~~~~~~--------------------------~~~~~~~gt~~y~APE~~-~~~~~s~ksDV~SfGvvl~elltG 518 (658)
...... ...+..+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 643221 123356789999999986 456799999999999999999994
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=330.44 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=201.9
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc---ccccHHHHHHHHHHHhccCCCccceeeeEe--ecCCeE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI---SRRTLSDFENEVRLISNVHHRNLIRLLGCC--SQGPEL 391 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~ 391 (658)
.++|.+.+.||+|+||.||++... +++.||+|++.... .......+.+|++++++++||||+++++++ .+.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999975 68899999986531 123467899999999999999999999998 445689
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||++++ |.+++.......+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999986 77777666667799999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCC-ccccccccCCcccccccccccCC--CCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccc
Q 006168 472 PENQ-SHLSTKFAGTLGYTAPEYAIHGQ--LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWEL 548 (658)
Q Consensus 472 ~~~~-~~~~~~~~gt~~y~APE~~~~~~--~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 548 (658)
.... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... .+. .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~----~~i~~~~~--- 230 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KLF----ENIGKGSY--- 230 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH----HHHHHCCC---
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HHH----HHHhcCCC---
Confidence 4322 22233567899999999987644 377999999999999999999999754321 111 11111110
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 549 MDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 549 ~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+ +.. .+..+.+++.+||+.||.+|||+.|+++.
T Consensus 231 ---~~-~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ---AI-PGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---CC-CSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---CC-CCc----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 122 23468899999999999999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=330.09 Aligned_cols=248 Identities=25% Similarity=0.429 Sum_probs=197.5
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+.+.||+|+||.||++... +++.||||++.... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57888999999999999999987 68999999986432 2345678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 91 EYVSGGELFDYICK--HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp ECCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred eccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999953 34699999999999999999999999 99999999999999999999999999998764432
Q ss_pred ccccccccCCcccccccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...... .+.. ....+.. .+
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~----~~~~~~~------~~- 230 (276)
T 2h6d_A 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFK----KIRGGVF------YI- 230 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----HHHHCCC------CC-
T ss_pred --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHH----HhhcCcc------cC-
Confidence 2234578999999999987765 68999999999999999999998654321 1111 1111110 01
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+.. ....+.+++.+||+.||.+|||+.|+++.
T Consensus 231 ~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 PEY----LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred chh----cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 112 23468999999999999999999999974
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.73 Aligned_cols=251 Identities=25% Similarity=0.411 Sum_probs=203.6
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|...+.||+|+||.||+++.. +|+.||+|++... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS-PAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecc-cccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 467888999999999999999976 6899999998753 23344678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE---cCCCCeEEeeccCccccCC
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll---~~~~~~kl~DfGla~~~~~ 473 (658)
|+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||+ ++++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 87 LVSGGELFDRILE--RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCCSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred cCCCccHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999999843 35699999999999999999999998 99999999999999 7889999999999976432
Q ss_pred CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccC
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 553 (658)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .+... ...+.. ..
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~----i~~~~~-~~----- 226 (304)
T 2jam_A 162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--KLFEK----IKEGYY-EF----- 226 (304)
T ss_dssp B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH----HHHCCC-CC-----
T ss_pred C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHH----HHcCCC-CC-----
Confidence 2 223456899999999999999999999999999999999999998654321 11111 111110 00
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 554 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
........+..+.+++..||+.||.+|||+.|+++.
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 227 -ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011112234569999999999999999999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=337.70 Aligned_cols=265 Identities=22% Similarity=0.360 Sum_probs=202.0
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeec--------C
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ--------G 388 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 388 (658)
++|.+.+.||+|+||.||+++.. +|+.||||++.... .......+.+|++++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 67889999999999999999985 68999999986532 22334678899999999999999999999876 4
Q ss_pred CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCc
Q 006168 389 PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLA 468 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla 468 (658)
+..++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 568999999986 77777643 335699999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCc---cccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc--
Q 006168 469 RLLPENQS---HLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN-- 542 (658)
Q Consensus 469 ~~~~~~~~---~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~-- 542 (658)
+.+..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ...........
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH--QLALISQLCGSIT 249 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCC
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCC
Confidence 87653222 22335678999999999876 468999999999999999999999997654321 11222221111
Q ss_pred Cccccccc------c---cCCCCCCCHH------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 543 GTHWELMD------E---SLDPNECTKE------AAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 543 ~~~~~~~d------~---~l~~~~~~~~------~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+...+ . .........+ ....+.+|+.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000 0 0000000001 12458899999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=337.62 Aligned_cols=258 Identities=28% Similarity=0.460 Sum_probs=199.2
Q ss_pred hcCCCccCcccccCceEEEEEEec--CCc--EEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK--NGK--IVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 391 (658)
.++|.+.+.||+|+||.||+|++. +++ .||||++.... .....+.+.+|++++++++||||+++++++...+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357888999999999999999864 233 68999986532 2344678899999999999999999999998765 8
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence 9999999999999998542 35699999999999999999999998 9999999999999999999999999999877
Q ss_pred CCCCcc--ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCccccc
Q 006168 472 PENQSH--LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWEL 548 (658)
Q Consensus 472 ~~~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 548 (658)
...... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.. .........
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~---~~~~~~~~~-- 244 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILH---KIDKEGERL-- 244 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH---HHHTSCCCC--
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHH---HHHccCCCC--
Confidence 544332 1234567889999999999999999999999999999999 99998754332 1111 111111110
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 549 MDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 549 ~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
..+...+..+.+++.+||+.||.+|||+.++++.|++..
T Consensus 245 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 245 --------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 111223456999999999999999999999999999873
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=336.15 Aligned_cols=257 Identities=19% Similarity=0.285 Sum_probs=203.1
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC-CCccceeeeEeec--CCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQ--GPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV 394 (658)
++|.+.+.||+|+||.||+++.. +++.||||++.. ...+.+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 67888999999999999999864 689999999863 34578999999999997 9999999999987 6778999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC-CeEEeeccCccccCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL-QPKIADFGLARLLPE 473 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~-~~kl~DfGla~~~~~ 473 (658)
|||+++++|.+++. .+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++....
T Consensus 112 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 99999999999983 389999999999999999999998 999999999999999776 899999999987654
Q ss_pred CCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHH--------HHhhcCc
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAW--------RLYENGT 544 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~--------~~~~~~~ 544 (658)
... .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.........+..... .......
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 332 234578999999999877 67899999999999999999999999655443222221111 0000000
Q ss_pred --------------ccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 545 --------------HWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 545 --------------~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
......... ........+..+.+++..||+.||.+|||+.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFV-HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGC-CTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhccccchhhhc-cccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000 111122235679999999999999999999999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.35 Aligned_cols=261 Identities=22% Similarity=0.327 Sum_probs=207.5
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccc----------------cHHHHHHHHHHHhccCCCcccee
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRR----------------TLSDFENEVRLISNVHHRNLIRL 381 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~E~~~l~~l~h~niv~l 381 (658)
.++|.+.+.||+|+||.||++.. +++.||||++....... ....+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36888999999999999999999 89999999986532111 12789999999999999999999
Q ss_pred eeEeecCCeEEEEEeccCCCCHHHH------hhcCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeecCcCCCcEEE
Q 006168 382 LGCCSQGPELILVYEYMANSSLDKF------LFGEKRGSLNWKQRFDIILGTARGLAYLHE-DFHVRIIHRDIKPSNVLL 454 (658)
Q Consensus 382 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dik~~NIll 454 (658)
++++.+.+..++||||+++++|.++ +.......+++..++.++.||+.||.|||+ . +|+||||||+|||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999998 644336779999999999999999999999 7 99999999999999
Q ss_pred cCCCCeEEeeccCccccCCCCccccccccCCcccccccccccC-CCCC-cccchhhhHHHHHHHhCCCCCCCCCcchhhH
Q 006168 455 DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG-QLSE-KVDAYSFGVLVLEIISGTKSSETKGEEGEYL 532 (658)
Q Consensus 455 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~-ksDV~SfGvvl~elltG~~p~~~~~~~~~~l 532 (658)
+.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||........ +
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~ 261 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE-L 261 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH-H
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-H
Confidence 99999999999999876433 23456789999999999887 6666 99999999999999999999976544221 1
Q ss_pred HHHHHHHhhcCccccccc-----ccCCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 533 LKRAWRLYENGTHWELMD-----ESLDP---NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 533 ~~~~~~~~~~~~~~~~~d-----~~l~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
. .....+......+ ..+.. .......+..+.+++.+||+.||.+|||+.|+++.
T Consensus 262 ~----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 F----NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp H----HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred H----HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 1122211100000 00000 00112334578999999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.06 Aligned_cols=200 Identities=22% Similarity=0.362 Sum_probs=175.4
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhcc------CCCccceeeeEeecCCe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV------HHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~ 390 (658)
..+|.+.+.||+|+||.||+|... +++.||||++.. .......+.+|+++++.+ +|+||+++++++...+.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN--EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC--ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 457889999999999999999876 588999999864 233446677888888877 57799999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC--eEEeeccCc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ--PKIADFGLA 468 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~--~kl~DfGla 468 (658)
.++||||+. ++|.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999996 6999999776666799999999999999999999999 9999999999999999887 999999999
Q ss_pred cccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc
Q 006168 469 RLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE 527 (658)
Q Consensus 469 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~ 527 (658)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 250 CYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 765432 2345789999999999999999999999999999999999999976543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=332.79 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=189.3
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccH-HHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTL-SDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
.++|+..+.||+|+||.||+++.. +++.||+|++......... ..+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467889999999999999999975 6899999999754333333 33455555688889999999999999999999999
Q ss_pred eccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 396 EYMANSSLDKFLFG--EKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 396 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||+++ +|.+++.. .....+++..++.++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++.....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99984 88887743 2346799999999999999999999985 2899999999999999999999999999987644
Q ss_pred CCccccccccCCccccccccc----ccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccc
Q 006168 474 NQSHLSTKFAGTLGYTAPEYA----IHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~----~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||.........+.. ......
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~----- 231 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ----VVEEPS----- 231 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHH----HHHSCC-----
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHH----HhccCC-----
Confidence 322 2334789999999996 5667899999999999999999999999764443222211 111111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
...... ..+..+.+++.+||+.||++|||+.|+++
T Consensus 232 -~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -PQLPAD----KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -CCCCTT----TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCcccc----cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111111 22456899999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.91 Aligned_cols=258 Identities=22% Similarity=0.388 Sum_probs=207.0
Q ss_pred HHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccccc-------ccHHHHHHHHHHHhcc-CCCccceeee
Q 006168 313 DLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR-------RTLSDFENEVRLISNV-HHRNLIRLLG 383 (658)
Q Consensus 313 ~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l-~h~niv~l~~ 383 (658)
......++|.+.+.||+|+||.||++++. +|+.||||++...... ...+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34455678999999999999999999986 6999999998653211 1145678999999999 8999999999
Q ss_pred EeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEe
Q 006168 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIA 463 (658)
Q Consensus 384 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~ 463 (658)
++...+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999999953 35699999999999999999999998 99999999999999999999999
Q ss_pred eccCccccCCCCccccccccCCccccccccccc------CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHH
Q 006168 464 DFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH------GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAW 537 (658)
Q Consensus 464 DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~ 537 (658)
|||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .....
T Consensus 243 DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~-- 316 (365)
T 2y7j_A 243 DFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--LMLRM-- 316 (365)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH--
T ss_pred ecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--HHHHH--
Confidence 999998765432 2335689999999999863 36889999999999999999999999654321 11111
Q ss_pred HHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 538 RLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 538 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+... ...+.. . ..+..+.+++.+||+.||++|||+.++++.
T Consensus 317 --i~~~~~~-~~~~~~--~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 317 --IMEGQYQ-FSSPEW--D----DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp --HHHTCCC-CCHHHH--S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHhCCCC-CCCccc--c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111100 000000 0 123468999999999999999999999873
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=348.29 Aligned_cols=199 Identities=28% Similarity=0.408 Sum_probs=167.5
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecC-----Ce
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG-----PE 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 390 (658)
.++|.+.+.||+|+||.||+++.. +++.||||++.... .....+.+.+|++++++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999976 58899999996532 233457789999999999999999999999765 57
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.++||||+. ++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 999999987 59999994 345699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCc---------------------cccccccCCccccccccc-ccCCCCCcccchhhhHHHHHHHhCCCCC
Q 006168 471 LPENQS---------------------HLSTKFAGTLGYTAPEYA-IHGQLSEKVDAYSFGVLVLEIISGTKSS 522 (658)
Q Consensus 471 ~~~~~~---------------------~~~~~~~gt~~y~APE~~-~~~~~s~ksDV~SfGvvl~elltG~~p~ 522 (658)
...... ...+...||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 644321 123567899999999986 4567999999999999999999865444
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=347.73 Aligned_cols=259 Identities=20% Similarity=0.273 Sum_probs=206.4
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCC-CccceeeeEeecCCeEEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHH-RNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~ 395 (658)
.++|.+.++||+|+||.||+|++. +++.||||++..... ..++..|+++++.++| +++..+..++...+..+|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 468899999999999999999974 689999998764322 2357899999999977 55566666677888999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE---cCCCCeEEeeccCccccC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLLP 472 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll---~~~~~~kl~DfGla~~~~ 472 (658)
||+ +++|.+++.. ....+++..++.|+.||+.||.|||+. +|+||||||+|||| +.++.+||+|||+++.+.
T Consensus 83 e~~-g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 83 DLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp ECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ECC-CCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 999 9999999953 245699999999999999999999998 99999999999999 688999999999998775
Q ss_pred CCCcc------ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc-chhhHHHHHHHHhhcCcc
Q 006168 473 ENQSH------LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE-EGEYLLKRAWRLYENGTH 545 (658)
Q Consensus 473 ~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~-~~~~l~~~~~~~~~~~~~ 545 (658)
..... ......||+.|+|||++.+..++.++||||||++||||++|+.||..... ..................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 44321 12256899999999999999999999999999999999999999986544 222222221111111111
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 546 WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 546 ~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+ ...+ +.++.+|+..||+.+|++||++.+|+++|+.+
T Consensus 238 ~~l------~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 238 EAL------CRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHH------HTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHH------hcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 110 0112 35699999999999999999999999999876
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=368.30 Aligned_cols=250 Identities=26% Similarity=0.326 Sum_probs=206.9
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 392 (658)
..++|.+.+.||+|+||.||+++.+ +++.||||++... ......+.+..|..++..+ +||||+++++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3468899999999999999999976 5889999998753 1334556788999999988 7999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
|||||+++|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+||||+.++++||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999999953 35699999999999999999999998 99999999999999999999999999998643
Q ss_pred CCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 473 ENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 473 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... .....
T Consensus 494 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--~~~~~----i~~~~-------- 558 (674)
T 3pfq_A 494 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQS----IMEHN-------- 558 (674)
T ss_dssp CTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HHSSC--------
T ss_pred cCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--HHHHH----HHhCC--------
Confidence 322 2244678999999999999999999999999999999999999999764331 12111 11111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTM-----SEVVA 589 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~-----~evl~ 589 (658)
..++...+.++.+|+..||+.||.+||++ .||++
T Consensus 559 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 ---VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11222344579999999999999999997 66654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=334.07 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=202.0
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
..++|.+.+.||+|+||.||+|... +|+.||+|.+... .....+.+|++++++++||||+++++++...+..++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT---SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 4568899999999999999999986 5899999998652 34567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++++|.+++.. ....+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 104 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 104 EYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp ECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred ecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999852 345799999999999999999999998 99999999999999999999999999998764432
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ........ ...
T Consensus 180 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~-~~~-------- 244 (314)
T 3com_A 180 A-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-----IFMIPTNP-PPT-------- 244 (314)
T ss_dssp S-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSC-CCC--------
T ss_pred c-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHhcCC-Ccc--------
Confidence 2 23345789999999999999999999999999999999999999875433111 11111111 000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
...+...+..+.+++..||+.||.+|||+.++++
T Consensus 245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0111223456899999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=353.27 Aligned_cols=242 Identities=17% Similarity=0.193 Sum_probs=189.9
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHH---HHHhccCCCccceee-------eE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEV---RLISNVHHRNLIRLL-------GC 384 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 384 (658)
.++|.+.+.||+|+||.||+|++. +|+.||||++... ......+.+.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467888999999999999999964 6999999998743 2334567889999 556666899999998 66
Q ss_pred eecCC-----------------eEEEEEeccCCCCHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCe
Q 006168 385 CSQGP-----------------ELILVYEYMANSSLDKFLFGEK-----RGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442 (658)
Q Consensus 385 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 442 (658)
+...+ ..++||||+ +|+|.+++.... ...+++..++.|+.||+.||.|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 278999999 689999995421 11244688999999999999999998 99
Q ss_pred eecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccccccCCcccccccccccC-----------CCCCcccchhhhHH
Q 006168 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG-----------QLSEKVDAYSFGVL 511 (658)
Q Consensus 443 vH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-----------~~s~ksDV~SfGvv 511 (658)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2334567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 512 VLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 512 l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
+|||++|+.||....... ..+.+... .... +..+.+++.+||+.||.+|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~---------------~~~~~~~~--~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALG---------------GSEWIFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------C---------------CSGGGGSS--CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCccccccc---------------chhhhhhh--ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999986433210 00111111 1122 346899999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=340.12 Aligned_cols=260 Identities=27% Similarity=0.385 Sum_probs=197.1
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecC------C
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG------P 389 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 389 (658)
.++|...+.||+|+||.||+|... +|+.||||++.... .....+.+.+|++++++++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467889999999999999999975 68999999986432 233456789999999999999999999999765 3
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 7899999853 5699999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcC-----
Q 006168 470 LLPENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG----- 543 (658)
Q Consensus 470 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~----- 543 (658)
..... .+...+|+.|+|||++.+ ..++.++|||||||+++||++|+.||....... .+..+.+.....
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHH
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHHH
Confidence 76432 334678999999999887 689999999999999999999999997654311 111111110000
Q ss_pred ------ccccccc--ccCCC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 544 ------THWELMD--ESLDP---NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 544 ------~~~~~~d--~~l~~---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.....+. +.... .......+..+.+++.+||+.||.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000000 00000 01111234568999999999999999999999984
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=340.94 Aligned_cols=273 Identities=21% Similarity=0.300 Sum_probs=203.3
Q ss_pred cchHHHHHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEccccccc----------ccHHHHHHHHHHHhccCCCcc
Q 006168 309 YRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISR----------RTLSDFENEVRLISNVHHRNL 378 (658)
Q Consensus 309 ~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~h~ni 378 (658)
..++++....++|.+.+.||+|+||.||++...+|+.||||++...... ...+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 4467888899999999999999999999999988999999998653221 113788999999999999999
Q ss_pred ceeeeEeec-----CCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEE
Q 006168 379 IRLLGCCSQ-----GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVL 453 (658)
Q Consensus 379 v~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIl 453 (658)
+++++++.. ....++||||+. |+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 999999843 346899999998 588888753 345699999999999999999999998 9999999999999
Q ss_pred EcCCCCeEEeeccCccccCCCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhH
Q 006168 454 LDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYL 532 (658)
Q Consensus 454 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l 532 (658)
++.++.+||+|||++....... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~ 242 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN--Q 242 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--H
T ss_pred EcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH--H
Confidence 9999999999999997543322 2334678999999999877 678999999999999999999999997654311 1
Q ss_pred HHHHHHHhhcCcc-----------cccccccCC---CC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 533 LKRAWRLYENGTH-----------WELMDESLD---PN---ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 533 ~~~~~~~~~~~~~-----------~~~~d~~l~---~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
............. .+.+...+. .. .........+.+++..||+.||.+|||+.|+++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1111111110000 000000000 00 0011223568999999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=343.06 Aligned_cols=264 Identities=25% Similarity=0.337 Sum_probs=206.3
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC--------CCccceeeeEee--
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH--------HRNLIRLLGCCS-- 386 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~-- 386 (658)
.++|.+.++||+|+||.||+++.. +++.||||++.. .....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS--AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec--CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 468999999999999999999865 688999999864 2344577889999999995 888999999987
Q ss_pred --cCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC------
Q 006168 387 --QGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL------ 458 (658)
Q Consensus 387 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~------ 458 (658)
.....++||||+ +++|.+++.......+++..++.++.||+.||.|||+++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence 567899999999 567777765555567999999999999999999999852 799999999999998775
Q ss_pred -------------------------------------------CeEEeeccCccccCCCCccccccccCCcccccccccc
Q 006168 459 -------------------------------------------QPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI 495 (658)
Q Consensus 459 -------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~ 495 (658)
.+||+|||++...... .+...||+.|+|||++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence 8999999999876432 23457899999999999
Q ss_pred cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcc----hhhHHHHHHHHhhc--------Cc-cccccccc----------
Q 006168 496 HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE----GEYLLKRAWRLYEN--------GT-HWELMDES---------- 552 (658)
Q Consensus 496 ~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~----~~~l~~~~~~~~~~--------~~-~~~~~d~~---------- 552 (658)
+..++.++|||||||++|||++|+.||...... .........+.... +. ..+.+...
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 999999999999999999999999999765431 11111211111110 00 00000000
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 553 --------LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 553 --------l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
......+......+.+|+.+||+.||++|||+.|+++.
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00113456777889999999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=332.31 Aligned_cols=261 Identities=20% Similarity=0.304 Sum_probs=206.4
Q ss_pred hcCCCccCcccccCceEEEEEEe-c-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCc------cceeeeEeecCC
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTL-K-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN------LIRLLGCCSQGP 389 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~ 389 (658)
.++|.+.+.||+|+||.||++.. + +++.||||++.. .....+.+.+|+++++.++|++ ++++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN--VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS--SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec--CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 35888999999999999999987 3 688999999864 2344577889999999997765 999999999999
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC-------------
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD------------- 456 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~------------- 456 (658)
..++||||+ +++|.+++.......+++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999 88999999766656799999999999999999999998 9999999999999987
Q ss_pred ------CCCeEEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchh
Q 006168 457 ------DLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE 530 (658)
Q Consensus 457 ------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~ 530 (658)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE- 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-
Confidence 678999999999865432 234578999999999999999999999999999999999999997654321
Q ss_pred hHHHHHHHHhhc-----------Cccc------------------ccccccCCCCCCCHHHHHHHHHHHHHccccCCCCC
Q 006168 531 YLLKRAWRLYEN-----------GTHW------------------ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSR 581 (658)
Q Consensus 531 ~l~~~~~~~~~~-----------~~~~------------------~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~R 581 (658)
......+.... .... ...................+.+++.+||+.||.+|
T Consensus 242 -~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 242 -HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp -HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred -HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 11111111100 0000 00000000011233456789999999999999999
Q ss_pred CCHHHHHHH
Q 006168 582 PTMSEVVAL 590 (658)
Q Consensus 582 Pt~~evl~~ 590 (658)
||+.|+++.
T Consensus 321 pt~~ell~h 329 (339)
T 1z57_A 321 ITLREALKH 329 (339)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999853
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=334.73 Aligned_cols=253 Identities=22% Similarity=0.371 Sum_probs=200.4
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
..++|++.+.||+|+||.||+|++. +++.||+|++.. ......+.+.+|++++++++||||+++++++...+..++||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIET-KSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecC-CCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 3467889999999999999999987 588999999875 34556788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 96 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 96 EFCPGGAVDAIMLE-LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp ECCTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred EeCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999998853 235699999999999999999999998 9999999999999999999999999987543111
Q ss_pred ccccccccCCcccccccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 476 SHLSTKFAGTLGYTAPEYAI-----HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
........||+.|+|||++. ...++.++||||||+++|||++|+.|+....... .. ....... ...
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~---~~~~~~~-~~~--- 241 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VL---LKIAKSD-PPT--- 241 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH---HHHHHSC-CCC---
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HH---HHHhccC-Ccc---
Confidence 11122457899999999984 6678999999999999999999999987544321 11 1111111 100
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
...+...+..+.+++.+||+.||.+|||+.++++
T Consensus 242 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 -----LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0112223456899999999999999999999886
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=337.60 Aligned_cols=265 Identities=23% Similarity=0.345 Sum_probs=204.6
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecC-----Ce
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG-----PE 390 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 390 (658)
..++|.+.+.||+|+||.||+++.. +++.||||++...........+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999999999999976 68899999997544444557889999999999999999999998654 46
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.++||||+.+ +|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 105 ~~iv~e~~~~-~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEEECCSE-EHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcccCc-CHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 8999999984 99998843 4699999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCcc--ccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcc--
Q 006168 471 LPENQSH--LSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTH-- 545 (658)
Q Consensus 471 ~~~~~~~--~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-- 545 (658)
....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ..............
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGILGSPSQED 255 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG--HHHHHHHHHCSCCHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH--HHHHHHHHhCCCCHHH
Confidence 6543222 1245689999999998765 458999999999999999999999997654321 11111111100000
Q ss_pred ---------cccccccCCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 546 ---------WELMDESLDPNECT-----KEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 546 ---------~~~~d~~l~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.............+ ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000 1123568999999999999999999999964
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=355.15 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=204.8
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
..++|.+.++||+|+||.||+++.+ +++.||||++... ........+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3467899999999999999999976 6899999998643 2334567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc---CCCCeEEeeccCcccc
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD---DDLQPKIADFGLARLL 471 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~---~~~~~kl~DfGla~~~ 471 (658)
|||+.+|+|.+.+.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++.+
T Consensus 100 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 100 GELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999999998853 35699999999999999999999998 999999999999995 4567999999999876
Q ss_pred CCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 472 PENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 472 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... .+... ...+.....
T Consensus 175 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~----i~~~~~~~~--- 242 (486)
T 3mwu_A 175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILKR----VETGKYAFD--- 242 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HHHTCCCSC---
T ss_pred CCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH----HHhCCCCCC---
Confidence 4432 2334679999999998865 6999999999999999999999999764331 11111 111111100
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.......+..+.+++..||+.||.+|||+.++++.
T Consensus 243 ----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 ----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00111234568999999999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=368.48 Aligned_cols=258 Identities=24% Similarity=0.374 Sum_probs=206.7
Q ss_pred HHhcCCCccCcccccCceEEEEEEecC----CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeE
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLKN----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 391 (658)
...++|...+.||+|+||.||+|.+.. +..||||++.........+.+.+|+.++++++||||+++++++.+ +..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence 345678888999999999999999752 567999998764444556789999999999999999999999854 568
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 466 ~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEEECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999999954 334699999999999999999999998 9999999999999999999999999999877
Q ss_pred CCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 472 PENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 472 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
............+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... ..... ...+...
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~~----i~~~~~~---- 611 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR----IENGERL---- 611 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH----HHHTCCC----
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHH----HHcCCCC----
Confidence 5544433445567889999999999999999999999999999997 88898754332 11111 1111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+...+..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 612 ------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 612 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11122345689999999999999999999999999876
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=356.53 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=206.9
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
.++|...+.||+|+||.||+++.. +++.||||++.... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467889999999999999999986 68999999986532 244577899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE---cCCCCeEEeeccCcccc
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL---DDDLQPKIADFGLARLL 471 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll---~~~~~~kl~DfGla~~~ 471 (658)
|||+.+|+|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++..+
T Consensus 105 ~e~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEII--SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHH--TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999884 345699999999999999999999998 99999999999999 56789999999999876
Q ss_pred CCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 472 PENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 472 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... .+... ...+.....
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~----i~~~~~~~~--- 247 (484)
T 3nyv_A 180 EASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKK----VEKGKYTFE--- 247 (484)
T ss_dssp CCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HHHCCCCCC---
T ss_pred cccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--HHHHH----HHcCCCCCC---
Confidence 5433 2334579999999998865 7999999999999999999999999764431 11111 111111100
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.......+..+.+++.+||+.||.+|||+.|+++.
T Consensus 248 ----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 248 ----LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp ----SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00111234568999999999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=336.48 Aligned_cols=253 Identities=24% Similarity=0.351 Sum_probs=198.0
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-------ccccHHHHHHHHHHHhccCCCccceeeeEeecC
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-------SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG 388 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 388 (658)
..++|.+.+.||+|+||.||+++.. +++.||||++.... .......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467899999999999999999976 58899999986431 112234588999999999999999999998765
Q ss_pred CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC---eEEeec
Q 006168 389 PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ---PKIADF 465 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~---~kl~Df 465 (658)
+ .++||||+++++|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||+||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred c-eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 5 899999999999999984 456799999999999999999999998 9999999999999987654 999999
Q ss_pred cCccccCCCCccccccccCCcccccccccc---cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc
Q 006168 466 GLARLLPENQSHLSTKFAGTLGYTAPEYAI---HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN 542 (658)
Q Consensus 466 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~---~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 542 (658)
|++....... ......||+.|+|||++. ...++.++||||||+++|||++|+.||........ +.... ..
T Consensus 162 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~----~~ 234 (322)
T 2ycf_A 162 GHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQI----TS 234 (322)
T ss_dssp TTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHHH----HH
T ss_pred ccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHHH----Hh
Confidence 9998764332 223457899999999974 46789999999999999999999999975443211 11111 11
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 543 GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 543 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
+... .. +. .....+..+.+++.+||+.||.+|||+.++++
T Consensus 235 ~~~~-~~-~~-----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 GKYN-FI-PE-----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp TCCC-CC-HH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Cccc-cC-ch-----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1100 00 00 00112456899999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=356.68 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=202.9
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccccc------------ccHHHHHHHHHHHhccCCCccceeee
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR------------RTLSDFENEVRLISNVHHRNLIRLLG 383 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~l~~ 383 (658)
..++|.+.++||+|+||.||+++.+ +++.||+|++...... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999976 5789999998753211 34577899999999999999999999
Q ss_pred EeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC---Ce
Q 006168 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL---QP 460 (658)
Q Consensus 384 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~---~~ 460 (658)
++.+.+..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN--RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence 99999999999999999999998843 35699999999999999999999998 999999999999998775 69
Q ss_pred EEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh
Q 006168 461 KIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLY 540 (658)
Q Consensus 461 kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~ 540 (658)
||+|||++..+.... ......||+.|+|||++. +.++.++||||||+++|+|++|+.||...... .+... .
T Consensus 189 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~----i 259 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DIIKK----V 259 (504)
T ss_dssp EECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----H
T ss_pred EEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH----H
Confidence 999999998765432 234567999999999876 57999999999999999999999999764432 12111 1
Q ss_pred hcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 541 ENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 541 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+........ . ...+..+.+++..||+.||.+|||+.|+++.
T Consensus 260 ~~~~~~~~~~~---~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 260 EKGKYYFDFND---W----KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHCCCCCCHHH---H----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HcCCCCCCccc---c----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111000000 0 1123568999999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=355.45 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=200.1
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
..++|.+.+.||+|+||.||+++.+ ++..||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457889999999999999999986 68899999987532 234457889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC---CCeEEeeccCcccc
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD---LQPKIADFGLARLL 471 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~---~~~kl~DfGla~~~ 471 (658)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.. +.+||+|||++..+
T Consensus 115 ~e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 115 MECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp EECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999998843 35699999999999999999999998 99999999999999764 55999999999876
Q ss_pred CCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 472 PENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 472 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
.... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||...... .+... ...+... ...+
T Consensus 190 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~----i~~~~~~-~~~~ 259 (494)
T 3lij_A 190 ENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--EILRK----VEKGKYT-FDSP 259 (494)
T ss_dssp BTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HHHTCCC-CCSG
T ss_pred CCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH----HHhCCCC-CCch
Confidence 5432 234567999999999875 57999999999999999999999999764432 12111 1111110 0000
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
. ....+..+.+++..||+.||.+|||+.|+++
T Consensus 260 ~------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 E------WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp G------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred h------cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0 0122356899999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.00 Aligned_cols=262 Identities=23% Similarity=0.305 Sum_probs=197.0
Q ss_pred HHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeec------
Q 006168 315 VSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ------ 387 (658)
Q Consensus 315 ~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 387 (658)
....++|.+.+.||+|+||.||+++.. +|+.||||++..... ...+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 455678999999999999999999975 689999999865321 23479999999999999999999843
Q ss_pred --------------------------------CCeEEEEEeccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHH
Q 006168 388 --------------------------------GPELILVYEYMANSSLDKFLFG--EKRGSLNWKQRFDIILGTARGLAY 433 (658)
Q Consensus 388 --------------------------------~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~ 433 (658)
....++||||++ |+|.+.+.. .....+++..+..++.||++||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 334889999998 488777753 344679999999999999999999
Q ss_pred hHhcCCCCeeecCcCCCcEEEc-CCCCeEEeeccCccccCCCCccccccccCCcccccccccccC-CCCCcccchhhhHH
Q 006168 434 LHEDFHVRIIHRDIKPSNVLLD-DDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVL 511 (658)
Q Consensus 434 LH~~~~~~ivH~Dik~~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvv 511 (658)
||+. +|+||||||+|||++ .++.+||+|||+++.+..... .....||+.|+|||.+.+. .++.++||||||++
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9998 999999999999998 688999999999987644332 2345789999999998775 58999999999999
Q ss_pred HHHHHhCCCCCCCCCcchhhHHHHHHHHhhc----------CcccccccccCCCC----CCCHHHHHHHHHHHHHccccC
Q 006168 512 VLEIISGTKSSETKGEEGEYLLKRAWRLYEN----------GTHWELMDESLDPN----ECTKEAAEKVVEIALMCTQSA 577 (658)
Q Consensus 512 l~elltG~~p~~~~~~~~~~l~~~~~~~~~~----------~~~~~~~d~~l~~~----~~~~~~~~~l~~li~~cl~~d 577 (658)
+|||++|+.||....... .+....+.... ....+..-+.+... ..+...+..+.+|+.+||+.|
T Consensus 232 l~ell~g~~pf~~~~~~~--~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 232 FGELILGKPLFSGETSID--QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999997654321 11111111100 00000000000000 012223456899999999999
Q ss_pred CCCCCCHHHHHH
Q 006168 578 ANSRPTMSEVVA 589 (658)
Q Consensus 578 p~~RPt~~evl~ 589 (658)
|.+|||+.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=334.75 Aligned_cols=266 Identities=24% Similarity=0.392 Sum_probs=204.7
Q ss_pred HHhcCCCccCcccccCceEEEEEEec--CCcEEEEEEcccccc-cccHHHHHHHHHHHhcc---CCCccceeeeEee---
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK--NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNV---HHRNLIRLLGCCS--- 386 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~--- 386 (658)
.+.++|.+.+.||+|+||.||+++.. +++.||+|++..... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 35678999999999999999999983 688999999865322 12223566777777666 8999999999987
Q ss_pred --cCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEee
Q 006168 387 --QGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIAD 464 (658)
Q Consensus 387 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~D 464 (658)
.....++||||++ |+|.+++.......+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 5677899999998 6999999766666799999999999999999999998 999999999999999999999999
Q ss_pred ccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCc
Q 006168 465 FGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGT 544 (658)
Q Consensus 465 fGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 544 (658)
||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..............
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPG 239 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCCC
Confidence 99998654322 233567899999999999999999999999999999999999999765432 11222222111000
Q ss_pred cccc------ccccC------CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 545 HWEL------MDESL------DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 545 ~~~~------~d~~l------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.... ..... .........+..+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 00000 000111223456899999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.92 Aligned_cols=262 Identities=21% Similarity=0.356 Sum_probs=202.0
Q ss_pred ccchHHHHHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEcccc-cccccHHHHHHHHHHHhccC--CCccceeeeE
Q 006168 308 NYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVH--HRNLIRLLGC 384 (658)
Q Consensus 308 ~~~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~ 384 (658)
++.++.+....++|.+.+.||+|+||.||++..++++.||||++... ........+.+|++++++++ ||||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 34445555566789999999999999999999988999999998653 23345678899999999997 5999999999
Q ss_pred eecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEee
Q 006168 385 CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIAD 464 (658)
Q Consensus 385 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~D 464 (658)
+...+..++||| +.+++|.+++.. ...+++..++.++.||++||.|||+. +|+||||||+|||+++ +.+||+|
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECC
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEee
Confidence 999999999999 668899999953 35799999999999999999999998 9999999999999975 7999999
Q ss_pred ccCccccCCCCcc-ccccccCCccccccccccc-----------CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhH
Q 006168 465 FGLARLLPENQSH-LSTKFAGTLGYTAPEYAIH-----------GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYL 532 (658)
Q Consensus 465 fGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~-----------~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l 532 (658)
||++......... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.........+
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence 9999876443322 2234578999999999865 478889999999999999999999997544322111
Q ss_pred HHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 533 LKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 533 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.......... ..+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 250 ----~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 250 ----HAIIDPNHEI----------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ----HHHHCTTSCC----------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----HHHHhccccc----------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1111111100 1111123468999999999999999999999964
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=338.40 Aligned_cols=262 Identities=23% Similarity=0.406 Sum_probs=203.5
Q ss_pred HHHHHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCe
Q 006168 312 KDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 312 ~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 390 (658)
+++....++|.+.+.||+|+||.||+|.+++ .+|+|.+.... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3333445788899999999999999999864 49999986532 23334567899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||++..
T Consensus 104 ~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEEECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred eEEEeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 9999999999999999943 334699999999999999999999998 999999999999998 67999999999876
Q ss_pred cCCCC----ccccccccCCccccccccccc---------CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHH
Q 006168 471 LPENQ----SHLSTKFAGTLGYTAPEYAIH---------GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAW 537 (658)
Q Consensus 471 ~~~~~----~~~~~~~~gt~~y~APE~~~~---------~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~ 537 (658)
..... ........|++.|+|||.+.. ..++.++||||||+++|||++|+.||....... .. +
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~---~ 253 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--II---W 253 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH--HH---H
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH---H
Confidence 53221 112234568999999999864 457889999999999999999999987543321 11 1
Q ss_pred HHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 538 RLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 538 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
.. ..+.... +.... .+..+.+++..||+.||.+|||+.+|+++|+.+.
T Consensus 254 ~~-~~~~~~~-----~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 254 QM-GTGMKPN-----LSQIG----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp HH-HTTCCCC-----CCCSS----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred Hh-ccCCCCC-----CCcCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 11 1111111 11111 2235899999999999999999999999999884
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.98 Aligned_cols=255 Identities=12% Similarity=0.069 Sum_probs=182.9
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhcc--CCCccceee-------eEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNV--HHRNLIRLL-------GCC 385 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 385 (658)
..+|...+.||+|+||.||+|++. +++.||||++.... .....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345788999999999999999976 78999999997643 223456677885544444 699988755 444
Q ss_pred ecC-----------------CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHhHhcCCCCe
Q 006168 386 SQG-----------------PELILVYEYMANSSLDKFLFGEKRGSLNWKQR------FDIILGTARGLAYLHEDFHVRI 442 (658)
Q Consensus 386 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~i 442 (658)
... ...++||||++ |+|.+++... ...+.+..+ +.++.||+.||.|||+. +|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL-DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GL 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH-HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh-ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CC
Confidence 322 34899999999 8999999643 223566666 78889999999999998 99
Q ss_pred eecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccccccCCccccccccccc--CCCCCcccchhhhHHHHHHHhCCC
Q 006168 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH--GQLSEKVDAYSFGVLVLEIISGTK 520 (658)
Q Consensus 443 vH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--~~~s~ksDV~SfGvvl~elltG~~ 520 (658)
+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++||||||+++|||++|+.
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999998764321 14467799999999987 679999999999999999999999
Q ss_pred CCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 521 SSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 521 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
||.......... +............+. .......+..+.+|+.+||+.||++|||+.++++
T Consensus 292 Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 292 PFGLVTPGIKGS-------WKRPSLRVPGTDSLA-FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp STTBCCTTCTTC-------CCBCCTTSCCCCSCC-CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCcCcccccc-------hhhhhhhhccccccc-hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 997653311000 000000000001110 0111133457999999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=328.25 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=204.4
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc--------cccHHHHHHHHHHHhccC-CCccceeeeEeec
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS--------RRTLSDFENEVRLISNVH-HRNLIRLLGCCSQ 387 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 387 (658)
.++|.+.+.||+|+||.||++..+ +++.||||++..... ....+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468889999999999999999986 689999999864321 122456789999999995 9999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccC
Q 006168 388 GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGL 467 (658)
Q Consensus 388 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGl 467 (658)
.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEeccCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccc
Confidence 9999999999999999999953 35699999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCcccccccccc------cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAI------HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYE 541 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~------~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~ 541 (658)
+....... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||...... .... ...
T Consensus 171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~----~~~ 242 (298)
T 1phk_A 171 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--LMLR----MIM 242 (298)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----HHH
T ss_pred hhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH--HHHH----HHh
Confidence 98765432 233467899999999985 457889999999999999999999998654321 1111 111
Q ss_pred cCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 542 NGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 542 ~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.+... . ........+..+.+++.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~-~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 SGNYQ-F------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HTCCC-C------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCCcc-c------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11110 0 00111223456999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=329.81 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=195.0
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeec--------
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ-------- 387 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 387 (658)
..++|++.+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE--EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec--cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 3567889999999999999999975 789999999864 33456788999999999999999999998754
Q ss_pred -----CCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEE
Q 006168 388 -----GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKI 462 (658)
Q Consensus 388 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl 462 (658)
.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred cccccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 4578999999999999999954 334588899999999999999999998 9999999999999999999999
Q ss_pred eeccCccccCCCC-------------ccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcc
Q 006168 463 ADFGLARLLPENQ-------------SHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEE 528 (658)
Q Consensus 463 ~DfGla~~~~~~~-------------~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~ 528 (658)
+|||++....... ........||+.|+|||.+.+. .++.++||||||+++|||++ |+.... .
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-~ 233 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-E 233 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-H
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-h
Confidence 9999998764321 1122345789999999998764 78999999999999999998 332211 1
Q ss_pred hhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 529 GEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 529 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..... ....... ..+ +...+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 234 ~~~~~----~~~~~~~------~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 RVNIL----KKLRSVS------IEF-PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHH----HHHHSTT------CCC-CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHH----Hhccccc------ccc-CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11111 1111111 011 122333344568999999999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=338.92 Aligned_cols=264 Identities=24% Similarity=0.362 Sum_probs=202.4
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecC-----CeE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG-----PEL 391 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 391 (658)
.++|.+.+.||+|+||.||+|+.. +|+.||||++...........+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468889999999999999999976 68999999997544444566788999999999999999999998654 678
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
++||||+. ++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999998 599999853 4699999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcc---------ccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh
Q 006168 472 PENQSH---------LSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYE 541 (658)
Q Consensus 472 ~~~~~~---------~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~ 541 (658)
...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||........ .........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~ 240 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ--LLLIFGIIG 240 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhC
Confidence 533211 1123578999999998765 6789999999999999999999999976543211 111111111
Q ss_pred cCc---cccccc--------ccCC--C-C---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 542 NGT---HWELMD--------ESLD--P-N---ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 542 ~~~---~~~~~d--------~~l~--~-~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
... ....+. ..+. . . ......+..+.+++.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 000000 0000 0 0 0001234568899999999999999999999873
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=337.06 Aligned_cols=208 Identities=23% Similarity=0.337 Sum_probs=177.0
Q ss_pred HHHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC-CC-----ccceeeeE
Q 006168 312 KDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HR-----NLIRLLGC 384 (658)
Q Consensus 312 ~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~ 384 (658)
+......++|.+.+.||+|+||.||+|+.. +++.||||++.. ......++..|+++++.++ |+ +|++++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN--KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS--SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec--cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 333445689999999999999999999976 688999999864 2334567788998888884 44 49999999
Q ss_pred eecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc--CCCCeEE
Q 006168 385 CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD--DDLQPKI 462 (658)
Q Consensus 385 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~--~~~~~kl 462 (658)
+...+..++||||+. ++|.+++.......+++..+..++.||+.||.|||++ ..+|+||||||+|||++ .++.+||
T Consensus 125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEE
Confidence 999999999999996 5999999766656799999999999999999999952 23899999999999994 5788999
Q ss_pred eeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCc
Q 006168 463 ADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE 527 (658)
Q Consensus 463 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~ 527 (658)
+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 203 ~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 203 VDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999876432 2346789999999999999999999999999999999999999976543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=334.95 Aligned_cols=261 Identities=26% Similarity=0.335 Sum_probs=194.7
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCC------
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP------ 389 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 389 (658)
.++|.+.+.||+|+||.||++... +++.||||++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468899999999999999999976 68899999986532 2334567889999999999999999999997654
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
..++||||+++ +|.+++. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 78999999985 7888873 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHH-----------
Q 006168 470 LLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWR----------- 538 (658)
Q Consensus 470 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~----------- 538 (658)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......+
T Consensus 176 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 176 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHC-CCCCCHHHHT
T ss_pred cccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHH
Confidence 654322 2334678999999999999999999999999999999999999997654311 1111000
Q ss_pred --------HhhcCcc------cccccccCCCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 539 --------LYENGTH------WELMDESLDPN--ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 539 --------~~~~~~~------~~~~d~~l~~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....... .+.+.....+. .........+.+|+.+||+.||.+|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000000 00000000000 0112346679999999999999999999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=335.53 Aligned_cols=263 Identities=21% Similarity=0.349 Sum_probs=194.9
Q ss_pred hcCCCccCcccccCceEEEEEEecC-CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEee----------
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCS---------- 386 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---------- 386 (658)
.++|.+.+.||+|+||.||+|.... ++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3678899999999999999999874 899999998753 3455678899999999999999999999873
Q ss_pred ----cCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc-CCCCeE
Q 006168 387 ----QGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD-DDLQPK 461 (658)
Q Consensus 387 ----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~-~~~~~k 461 (658)
+.+..++||||++ |+|.+++. ...+++..++.++.||+.||.|||+. +|+||||||+|||++ +++.+|
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence 4467899999998 69999983 45699999999999999999999998 999999999999997 567999
Q ss_pred EeeccCccccCCCCc--cccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHH
Q 006168 462 IADFGLARLLPENQS--HLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWR 538 (658)
Q Consensus 462 l~DfGla~~~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~ 538 (658)
|+|||+++....... .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||....... .......
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~~~~ 239 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE--QMQLILE 239 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence 999999987643221 12234567899999998876 678999999999999999999999997654311 1111111
Q ss_pred Hhhc----------CcccccccccCCCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 539 LYEN----------GTHWELMDESLDPNE-----CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 539 ~~~~----------~~~~~~~d~~l~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.... ......+........ .....+..+.+++.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000 000000000000000 011234569999999999999999999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=337.72 Aligned_cols=260 Identities=27% Similarity=0.366 Sum_probs=185.4
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecC------C
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG------P 389 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 389 (658)
.++|...+.||+|+||.||+|... +|+.||||++... ......+.+.+|++++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468899999999999999999965 6899999998653 2233456788999999999999999999998653 5
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
..++|+||+ +++|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 689999999 689999883 35699999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCc----
Q 006168 470 LLPENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGT---- 544 (658)
Q Consensus 470 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~---- 544 (658)
..... .+...||+.|+|||++.+ ..++.++|||||||+++||++|+.||...... ..+..+.+......
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLILRLVGTPGAELL 254 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHHH
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence 65432 334678999999999887 68899999999999999999999999765431 11111111111000
Q ss_pred -------ccccccccCCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 545 -------HWELMDESLDPNECT-----KEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 545 -------~~~~~d~~l~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....+.......... ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000000000000 0123568999999999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=334.45 Aligned_cols=269 Identities=23% Similarity=0.318 Sum_probs=193.0
Q ss_pred HHHHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCe
Q 006168 312 KDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 312 ~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 390 (658)
++.....++|.+.+.||+|+||.||+|+.. +++.||||++... ......+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD--PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC--TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC--ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 456677889999999999999999999986 6899999998643 2333466788888999999999999999865333
Q ss_pred -------EEEEEeccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhH--hcCCCCeeecCcCCCcEEEcC-CC
Q 006168 391 -------LILVYEYMANSSLDKFLFG--EKRGSLNWKQRFDIILGTARGLAYLH--EDFHVRIIHRDIKPSNVLLDD-DL 458 (658)
Q Consensus 391 -------~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~ivH~Dik~~NIll~~-~~ 458 (658)
.++||||+++ +|.+.+.. .....+++..+..++.|++.||.||| +. +|+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 8899999987 55444322 34556999999999999999999999 77 9999999999999997 89
Q ss_pred CeEEeeccCccccCCCCccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHH
Q 006168 459 QPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAW 537 (658)
Q Consensus 459 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~ 537 (658)
.+||+|||+++....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||....... ......
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~~~ 245 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QLHEIV 245 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH
T ss_pred cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HHHHHH
Confidence 999999999987654332 2345789999999998765 48999999999999999999999997654321 111111
Q ss_pred HHhh-----------cC-ccccccccc-CC----CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 538 RLYE-----------NG-THWELMDES-LD----PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 538 ~~~~-----------~~-~~~~~~d~~-l~----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+... .. ......+.. .. ........+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1110 00 000000000 00 001111245679999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=342.86 Aligned_cols=259 Identities=23% Similarity=0.343 Sum_probs=194.5
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecC------CeE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG------PEL 391 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 391 (658)
.+|...+.||+|+||.||+|++. +++.||||++.... ..+.+|++++++++||||+++++++... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 35778899999999999999986 58999999986432 1234799999999999999999998432 236
Q ss_pred EEEEeccCCCCHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC-CCeEEeeccCc
Q 006168 392 ILVYEYMANSSLDKFLFG--EKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD-LQPKIADFGLA 468 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~-~~~kl~DfGla 468 (658)
++||||+++ +|.+.+.. .....+++..+..++.||++||.|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999986 66665532 2346799999999999999999999998 99999999999999965 56899999999
Q ss_pred cccCCCCccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh------
Q 006168 469 RLLPENQSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYE------ 541 (658)
Q Consensus 469 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~------ 541 (658)
+.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.. +.+...
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~-i~~~lg~p~~~~ 280 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVE-IIKVLGTPTREQ 280 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH-HHHHHCSCCHHH
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHH-HHHHhCCCCHHH
Confidence 87644322 2345789999999998765 7999999999999999999999999765432 11211 111110
Q ss_pred ----cCcccccccccCCCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 542 ----NGTHWELMDESLDPNE----CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 542 ----~~~~~~~~d~~l~~~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.....+...+.+.... +....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0000111001110000 111234579999999999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=338.73 Aligned_cols=265 Identities=22% Similarity=0.344 Sum_probs=184.8
Q ss_pred cCCCc-cCcccccCceEEEEEEec---CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEee--cCCeEE
Q 006168 319 RKFSE-ENKLGEGGFGDIYKGTLK---NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCS--QGPELI 392 (658)
Q Consensus 319 ~~f~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 392 (658)
+.|.+ .++||+|+||.||+++++ +++.||||++... .....+.+|+++|++++||||+++++++. .....+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS---SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC---CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 34544 568999999999999976 4788999999642 22357889999999999999999999994 477899
Q ss_pred EEEeccCCCCHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE----cCCCCeE
Q 006168 393 LVYEYMANSSLDKFLFGE-------KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL----DDDLQPK 461 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll----~~~~~~k 461 (658)
+||||+.+ +|.+++... ....+++..++.|+.||+.||.|||+. +|+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999975 787777421 123499999999999999999999998 99999999999999 6788999
Q ss_pred EeeccCccccCCCCc--cccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcc-------hhh
Q 006168 462 IADFGLARLLPENQS--HLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEE-------GEY 531 (658)
Q Consensus 462 l~DfGla~~~~~~~~--~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~-------~~~ 531 (658)
|+|||+++.+..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ...
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987654322 223356899999999999874 5899999999999999999999999754431 011
Q ss_pred HHHHHHHHhhc--CcccccccccC---------CC---CCCCH---------HHHHHHHHHHHHccccCCCCCCCHHHHH
Q 006168 532 LLKRAWRLYEN--GTHWELMDESL---------DP---NECTK---------EAAEKVVEIALMCTQSAANSRPTMSEVV 588 (658)
Q Consensus 532 l~~~~~~~~~~--~~~~~~~d~~l---------~~---~~~~~---------~~~~~l~~li~~cl~~dp~~RPt~~evl 588 (658)
.+......... ...++.+.... .. ..... .....+.+|+..||+.||.+|||+.|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 22222222110 01111110000 00 00000 0134688999999999999999999999
Q ss_pred HH
Q 006168 589 AL 590 (658)
Q Consensus 589 ~~ 590 (658)
+.
T Consensus 333 ~h 334 (405)
T 3rgf_A 333 QD 334 (405)
T ss_dssp TS
T ss_pred cC
Confidence 75
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.80 Aligned_cols=260 Identities=17% Similarity=0.249 Sum_probs=203.3
Q ss_pred hcCCCccCcccccCceEEEEEEec-CC-cEEEEEEcccccccccHHHHHHHHHHHhccCCCc------cceeeeEeecCC
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NG-KIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN------LIRLLGCCSQGP 389 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~ 389 (658)
.++|.+.+.||+|+||.||++... ++ +.||+|++.. .....+.+.+|++++++++|++ ++.+++++...+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN--VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc--cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 468899999999999999999975 34 6899999864 2344567889999999998776 899999999999
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE---------------
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL--------------- 454 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll--------------- 454 (658)
..++||||+ +++|.+++.......+++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence 999999999 66777777665556799999999999999999999998 99999999999999
Q ss_pred ----cCCCCeEEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchh
Q 006168 455 ----DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE 530 (658)
Q Consensus 455 ----~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~ 530 (658)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE- 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 66789999999999865332 234579999999999999999999999999999999999999997654321
Q ss_pred hHHHHHHHHhhcC--------c-cccccc--------------------ccCCCCCCCHHHHHHHHHHHHHccccCCCCC
Q 006168 531 YLLKRAWRLYENG--------T-HWELMD--------------------ESLDPNECTKEAAEKVVEIALMCTQSAANSR 581 (658)
Q Consensus 531 ~l~~~~~~~~~~~--------~-~~~~~d--------------------~~l~~~~~~~~~~~~l~~li~~cl~~dp~~R 581 (658)
......+....- . ...... ...............+.+|+.+||+.||.+|
T Consensus 247 -~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 247 -HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp -HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred -HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 111111111000 0 000000 0000001123445679999999999999999
Q ss_pred CCHHHHHH
Q 006168 582 PTMSEVVA 589 (658)
Q Consensus 582 Pt~~evl~ 589 (658)
||+.|+++
T Consensus 326 pt~~e~l~ 333 (355)
T 2eu9_A 326 ITLAEALL 333 (355)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=341.14 Aligned_cols=260 Identities=22% Similarity=0.302 Sum_probs=195.4
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCC------eEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP------ELI 392 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 392 (658)
.+|...+.||+|+||.||++++.++..+|+|++..... ...+|+++++.++||||+++++++...+ ..+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 46888999999999999999998777799998864321 1247999999999999999999985433 378
Q ss_pred EEEeccCCCCHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc-CCCCeEEeeccCccc
Q 006168 393 LVYEYMANSSLDKFLF-GEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD-DDLQPKIADFGLARL 470 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~-~~~~~kl~DfGla~~ 470 (658)
+||||++++.+..... ......+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999998755443332 12345799999999999999999999998 999999999999999 789999999999987
Q ss_pred cCCCCccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc-------
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN------- 542 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~------- 542 (658)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... . +..+.+....
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~-l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-Q-LVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H-HHHHHHHHCCCCHHHHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-H-HHHHHHHhCCCCHHHHH
Confidence 644332 2345789999999998765 58999999999999999999999997654321 1 1111111100
Q ss_pred ---CcccccccccCCCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 543 ---GTHWELMDESLDPN----ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 543 ---~~~~~~~d~~l~~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....+..-+..... .+....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000000000 0111234579999999999999999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=328.70 Aligned_cols=255 Identities=24% Similarity=0.391 Sum_probs=180.4
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHH-HHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVR-LISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
++|...+.||+|+||.||++..+ +++.||||++..........++..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 67888999999999999999986 689999999976444444455666666 7788899999999999999999999999
Q ss_pred ccCCCCHHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 397 YMANSSLDKFLFG---EKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 397 ~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
|+++ +|.+++.. .....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9986 88777642 2356799999999999999999999985 3899999999999999999999999999987643
Q ss_pred CCccccccccCCccccccccc----ccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccc
Q 006168 474 NQSHLSTKFAGTLGYTAPEYA----IHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~----~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||.........+ .....+..
T Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~~~~~~---- 247 (327)
T 3aln_A 179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL-----TQVVKGDP---- 247 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCCSCC----
T ss_pred ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH-----HHHhcCCC----
Confidence 321 2334789999999998 46678999999999999999999999987533211000 00000000
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
+.+ ........+..+.+++.+||+.||.+|||+.+|++
T Consensus 248 -~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 -PQL-SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CCC-CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCC-CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111 11111123456999999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=333.68 Aligned_cols=263 Identities=22% Similarity=0.301 Sum_probs=203.3
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC-----------CCccceeeeEee
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-----------HRNLIRLLGCCS 386 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 386 (658)
++|.+.+.||+|+||.||+++.. +++.||||++.. .......+.+|++++++++ ||||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC--CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 57889999999999999999975 689999999864 2334567889999999886 899999999987
Q ss_pred cCC----eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc------C
Q 006168 387 QGP----ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD------D 456 (658)
Q Consensus 387 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~------~ 456 (658)
..+ ..++||||+ +++|.+++.......+++..++.++.||+.||.|||+. .+|+||||||+|||++ .
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcC
Confidence 644 789999999 88999999766666799999999999999999999984 2799999999999994 4
Q ss_pred CCCeEEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcc----hhhH
Q 006168 457 DLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE----GEYL 532 (658)
Q Consensus 457 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~----~~~l 532 (658)
.+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ....
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 457999999999876432 23457899999999999999999999999999999999999999754421 1111
Q ss_pred HHHHHHHhhc------------------Ccccccccc---------cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 006168 533 LKRAWRLYEN------------------GTHWELMDE---------SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMS 585 (658)
Q Consensus 533 ~~~~~~~~~~------------------~~~~~~~d~---------~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 585 (658)
.......... ......+.. .......+......+.+|+..||+.||.+|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 1111111110 000000000 0001234567788999999999999999999999
Q ss_pred HHHHH
Q 006168 586 EVVAL 590 (658)
Q Consensus 586 evl~~ 590 (658)
|+++.
T Consensus 330 ell~h 334 (373)
T 1q8y_A 330 GLVNH 334 (373)
T ss_dssp HHHTC
T ss_pred HHhhC
Confidence 99874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=323.81 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=204.0
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
..++|.+.+.||+|+||.||+++.. +++.||+|++.... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3468999999999999999999986 68999999986532 334577899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC---CCeEEeeccCcccc
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD---LQPKIADFGLARLL 471 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~---~~~kl~DfGla~~~ 471 (658)
|||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+||+++.+ +.+||+|||++...
T Consensus 100 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 100 GELYTGGELFDEIIK--RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp ECCCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 999999999998853 34699999999999999999999998 99999999999999764 47999999999876
Q ss_pred CCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 472 PENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 472 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
..... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||...... .+.. ....+.......
T Consensus 175 ~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~----~~~~~~~~~~~~- 244 (287)
T 2wei_A 175 QQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DILK----RVETGKYAFDLP- 244 (287)
T ss_dssp CCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----HHHHCCCCCCSG-
T ss_pred cCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHHH----HHHcCCCCCCch-
Confidence 44322 223457899999998765 5899999999999999999999998764332 1111 111111110000
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.....+..+.+++.+||+.||.+|||+.|+++
T Consensus 245 ------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 245 ------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00122356899999999999999999999997
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.61 Aligned_cols=259 Identities=23% Similarity=0.368 Sum_probs=197.4
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeE----
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPEL---- 391 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 391 (658)
.++|...+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468888999999999999999976 68999999987532 233357788999999999999999999999876654
Q ss_pred --EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 392 --ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 392 --~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
++||||+. ++|.+++. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999998 58888872 3499999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCc--c-
Q 006168 470 LLPENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGT--H- 545 (658)
Q Consensus 470 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--~- 545 (658)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ......+...... .
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGTEFV 266 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCHHHH
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCcHHHH
Confidence 65432 234578999999999987 688999999999999999999999997654311 1111111110000 0
Q ss_pred --------cccccccCC--CCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 546 --------WELMDESLD--PNE---CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 546 --------~~~~d~~l~--~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
...+..... ... .....+..+.+|+..||+.||.+|||+.|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000000 000 011224578999999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=339.32 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=188.9
Q ss_pred CCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEEecc
Q 006168 320 KFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 34456789999999998776678999999998642 245678999999887 8999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCC-----CCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC-------------CCe
Q 006168 399 ANSSLDKFLFGEKRGS-----LNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD-------------LQP 460 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~-------------~~~ 460 (658)
. |+|.+++....... .++..++.++.||+.||.|||+. +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999996433221 24445678999999999999998 99999999999999754 479
Q ss_pred EEeeccCccccCCCCccc---cccccCCccccccccccc-------CCCCCcccchhhhHHHHHHHh-CCCCCCCCCcch
Q 006168 461 KIADFGLARLLPENQSHL---STKFAGTLGYTAPEYAIH-------GQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEG 529 (658)
Q Consensus 461 kl~DfGla~~~~~~~~~~---~~~~~gt~~y~APE~~~~-------~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~ 529 (658)
||+|||+++......... .....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999999875543221 234679999999999965 678999999999999999999 899986543322
Q ss_pred hhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 530 EYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 530 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
..+ ........ .+ ........+..+.+++.+||+.||.+|||+.+|++
T Consensus 248 ~~i-------~~~~~~~~----~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 SNI-------IRGIFSLD----EM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHH-------HHTCCCCC----CC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH-------hcCCCCcc----cc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111 11100000 00 11224566788999999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=330.93 Aligned_cols=259 Identities=23% Similarity=0.364 Sum_probs=197.5
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCe-----
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPE----- 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 390 (658)
.++|...+.||+|+||.||+|+.+ +|+.||||++.... .......+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 357888999999999999999976 68999999986532 22335678899999999999999999999977653
Q ss_pred -EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 391 -LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 391 -~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
.++||||+. ++|.+++. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 599999998 58888772 3499999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCc--c-
Q 006168 470 LLPENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGT--H- 545 (658)
Q Consensus 470 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--~- 545 (658)
..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .......+...... .
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH--HHHHHHHHHHCBCCHHHH
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence 65332 234578999999999877 67899999999999999999999999765431 11111111110000 0
Q ss_pred --------c---cccccc--CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 546 --------W---ELMDES--LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 546 --------~---~~~d~~--l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
. ..+... ..........+..+.+++.+||+.||.+|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 000000 00011112335679999999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.40 Aligned_cols=254 Identities=20% Similarity=0.258 Sum_probs=175.4
Q ss_pred HhcCCCccC-cccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeec----CCe
Q 006168 317 ATRKFSEEN-KLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ----GPE 390 (658)
Q Consensus 317 a~~~f~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~ 390 (658)
..++|.+.+ .||+|+||.||+++.+ +++.||||++... .....+....++.++||||+++++++.. +..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 356788854 6999999999999987 6899999998642 1222233344566799999999999865 455
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC---CCCeEEeeccC
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD---DLQPKIADFGL 467 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~---~~~~kl~DfGl 467 (658)
.++||||+++|+|.+++.......+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 89999999999999999765556799999999999999999999998 9999999999999976 45599999999
Q ss_pred ccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccc
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWE 547 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 547 (658)
+....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......... .........+.
T Consensus 178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~--- 249 (336)
T 3fhr_A 178 AKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--PGMKRRIRLGQ--- 249 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh--hhHHHhhhccc---
Confidence 98654322 23457899999999998889999999999999999999999999654432110 00000000000
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 548 LMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 548 ~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+ +.......+..+.+++..||+.||.+|||+.|+++.
T Consensus 250 ---~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 250 ---YGF-PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ----CC-CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---ccc-CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 111112234568999999999999999999999973
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=328.98 Aligned_cols=246 Identities=24% Similarity=0.373 Sum_probs=192.2
Q ss_pred HHHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccccc-----ccHHHHHHHHHHHhcc----CCCccceeee
Q 006168 314 LVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR-----RTLSDFENEVRLISNV----HHRNLIRLLG 383 (658)
Q Consensus 314 l~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l----~h~niv~l~~ 383 (658)
.....++|.+.+.||+|+||.||+|+.. +++.||||++...... .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445678999999999999999999875 6889999999653211 1223456799999988 8999999999
Q ss_pred EeecCCeEEEEEec-cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc-CCCCeE
Q 006168 384 CCSQGPELILVYEY-MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD-DDLQPK 461 (658)
Q Consensus 384 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~-~~~~~k 461 (658)
++...+..++|+|| +.+++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++ .++.+|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE--KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence 99999999999999 789999999954 35699999999999999999999999 999999999999999 889999
Q ss_pred EeeccCccccCCCCccccccccCCcccccccccccCCCC-CcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh
Q 006168 462 IADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLS-EKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLY 540 (658)
Q Consensus 462 l~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s-~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~ 540 (658)
|+|||++....... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||..... ..
T Consensus 181 l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~ 246 (312)
T 2iwi_A 181 LIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----------IL 246 (312)
T ss_dssp ECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------HH
T ss_pred EEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----------Hh
Confidence 99999998765432 2345789999999999877764 589999999999999999999863210 00
Q ss_pred hcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 541 ENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 541 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.. . ...+......+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~-~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 EA-E-----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HT-C-----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred hh-c-----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0 01112233568999999999999999999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=325.74 Aligned_cols=252 Identities=21% Similarity=0.371 Sum_probs=181.7
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccH-HHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTL-SDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
.++|...+.||+|+||.||++++. +++.||||++......... ..+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999986 6899999999754333333 33445556788889999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE-DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
||+ ++.+..+. ......+++..++.++.||++||.|||+ . +|+||||||+|||++.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLK-KRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 44555544 3335679999999999999999999998 5 8999999999999999999999999999765433
Q ss_pred CccccccccCCcccccccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccc
Q 006168 475 QSHLSTKFAGTLGYTAPEYAI-----HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
. ......||+.|+|||.+. ...++.++||||||+++|||++|+.||.........+ . ..... ...
T Consensus 179 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~---~~~~~-~~~--- 248 (318)
T 2dyl_A 179 K--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL-T---KVLQE-EPP--- 248 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH-H---HHHHS-CCC---
T ss_pred c--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHH-H---HHhcc-CCC---
Confidence 2 223457899999999984 5678899999999999999999999997644322211 1 11111 100
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.+ +. ....+..+.+++.+||+.||.+|||+.++++
T Consensus 249 --~~-~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 --LL-PG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --CC-CS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CC-Cc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 01 00 0112346899999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=333.60 Aligned_cols=245 Identities=24% Similarity=0.395 Sum_probs=200.3
Q ss_pred HHHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccccc-----ccHHHHHHHHHHHhccC--CCccceeeeEee
Q 006168 315 VSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR-----RTLSDFENEVRLISNVH--HRNLIRLLGCCS 386 (658)
Q Consensus 315 ~~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~ 386 (658)
....++|.+.+.||+|+||.||+|+.. +++.||||++...... .....+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 344578999999999999999999965 6899999998653211 12245678999999996 599999999999
Q ss_pred cCCeEEEEEeccCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc-CCCCeEEee
Q 006168 387 QGPELILVYEYMAN-SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD-DDLQPKIAD 464 (658)
Q Consensus 387 ~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~-~~~~~kl~D 464 (658)
..+..++|+|++.+ ++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++ +++.+||+|
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence 99999999999986 899999853 45699999999999999999999998 999999999999999 788999999
Q ss_pred ccCccccCCCCccccccccCCcccccccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcC
Q 006168 465 FGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG 543 (658)
Q Consensus 465 fGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~ 543 (658)
||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ... +
T Consensus 194 fg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----------~~~-~ 258 (320)
T 3a99_A 194 FGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------IIR-G 258 (320)
T ss_dssp CTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------HHH-C
T ss_pred Ccccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----------hhc-c
Confidence 99998765432 234579999999999987766 6789999999999999999999854210 011 0
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 544 THWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 544 ~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.. ..... .+..+.+++.+||+.||.+|||+.||++.
T Consensus 259 ~~-------~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 259 QV-------FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CC-------CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc-------ccccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00112 23468999999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=332.90 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=188.6
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 396 (658)
..+|...+.||+|+||+||.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 346788899999999997665566799999999865322 2356899999999 79999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC-----CCCeEEeeccCcccc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD-----DLQPKIADFGLARLL 471 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~-----~~~~kl~DfGla~~~ 471 (658)
|+. |+|.+++... ...+.+..++.++.||+.||.|||+. +|+||||||+|||++. ...+||+|||+++..
T Consensus 99 ~~~-g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 99 LCA-ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CCS-EEHHHHHHSS-SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CCC-CCHHHHHHhc-CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 997 5999999543 33456667789999999999999998 9999999999999943 346889999999876
Q ss_pred CCCCc--cccccccCCcccccccccc---cCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcc
Q 006168 472 PENQS--HLSTKFAGTLGYTAPEYAI---HGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTH 545 (658)
Q Consensus 472 ~~~~~--~~~~~~~gt~~y~APE~~~---~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~ 545 (658)
..... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||......... .......
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-------~~~~~~~ 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------ILLGACS 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-------HHTTCCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-------HHhccCC
Confidence 54322 2233567999999999997 4577889999999999999999 88888543322111 1111100
Q ss_pred cccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 546 WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 546 ~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.. ...........+.+|+.+||+.||.+|||+.+|++
T Consensus 247 ~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 LD-------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CT-------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc-------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 11112234556889999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=349.77 Aligned_cols=264 Identities=26% Similarity=0.364 Sum_probs=201.9
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeec------CCe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ------GPE 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 390 (658)
.++|.+.+.||+|+||.||++.+. +|+.||||++.........+.+.+|++++++++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999975 6899999998765555566789999999999999999999999765 677
Q ss_pred EEEEEeccCCCCHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCC---eEEeecc
Q 006168 391 LILVYEYMANSSLDKFLFGEKR-GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQ---PKIADFG 466 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~---~kl~DfG 466 (658)
.++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999965432 3599999999999999999999998 9999999999999997765 8999999
Q ss_pred CccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhh---HHHHHHHH-hhc
Q 006168 467 LARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEY---LLKRAWRL-YEN 542 (658)
Q Consensus 467 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~---l~~~~~~~-~~~ 542 (658)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... +....... ...
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 998765433 234568999999999999999999999999999999999999999754321100 00000000 000
Q ss_pred Cccc---ccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 006168 543 GTHW---ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSE 586 (658)
Q Consensus 543 ~~~~---~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e 586 (658)
.... ........+.......+..+.+++..||+.||++|||+.+
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000 0000001122345557788999999999999999999977
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=352.67 Aligned_cols=239 Identities=21% Similarity=0.310 Sum_probs=194.7
Q ss_pred cCCCccCcccccCceEEEEEEec--CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCe-----E
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK--NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPE-----L 391 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~ 391 (658)
++|.+.+.||+|+||.||++.+. +++.||||++...........+.+|++++++++||||+++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67889999999999999999976 5899999998754444556778999999999999999999999987655 7
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
+|||||+++++|.+++.. .+++.+++.|+.||+.||.|||+. +|+||||||+|||++.+ .+||+|||+++..
T Consensus 160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 999999999999987732 699999999999999999999998 99999999999999986 9999999999876
Q ss_pred CCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 472 PENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 472 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
... ....||+.|+|||++.++. +.++||||||++++||++|..|+......
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------------- 282 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD----------------------- 282 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------------
T ss_pred ccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-----------------------
Confidence 443 3457999999999987654 88999999999999999998876532110
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHhcC
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPT-MSEVVALLKST 594 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~evl~~L~~~ 594 (658)
.+............+.+|+.+||+.||.+||+ ++++.+.|...
T Consensus 283 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 283 GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00001111223456899999999999999995 66666666544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.94 Aligned_cols=230 Identities=12% Similarity=0.058 Sum_probs=183.7
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc--cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS--RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|.+.+.||+|+||.||+++.. +++.||||++..... ....+.+.+|+..+++++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57889999999999999999986 489999999976422 233578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++++|.+++.. + ....++.+|+.||+.||.|||+. +|+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 99999999999832 2 45667889999999999999998 99999999999999999999998443
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC-
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD- 554 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~- 554 (658)
|++ .++.++||||||+++|||++|+.||.......... .....+.....
T Consensus 175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-----------~~~~~~~~~~~~ 224 (286)
T 3uqc_A 175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-----------PAERDTAGQPIE 224 (286)
T ss_dssp ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-----------ECCBCTTSCBCC
T ss_pred ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-----------HHHHHhccCCCC
Confidence 333 36889999999999999999999997654311000 00000000000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
........+..+.+++.+||+.||.+| |+.|+++.|+...
T Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 000111234569999999999999999 9999999999874
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.88 Aligned_cols=227 Identities=20% Similarity=0.267 Sum_probs=179.9
Q ss_pred cCCCcc-CcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHH-hccCCCccceeeeEeec----CCeE
Q 006168 319 RKFSEE-NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLI-SNVHHRNLIRLLGCCSQ----GPEL 391 (658)
Q Consensus 319 ~~f~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 391 (658)
++|.+. +.||+|+||.||++... +++.||+|++.. ...+.+|++++ +.++||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 456665 77999999999999975 689999999853 24577888888 55699999999999876 6779
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC---CCCeEEeeccCc
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD---DLQPKIADFGLA 468 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~---~~~~kl~DfGla 468 (658)
++||||+++|+|.+++.......+++..++.++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999999776666799999999999999999999998 9999999999999998 788999999998
Q ss_pred cccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccc
Q 006168 469 RLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWEL 548 (658)
Q Consensus 469 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 548 (658)
.... +..++.++||||||+++|||++|+.||........ . ......
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----------~-~~~~~~ 213 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------S-PGMKTR 213 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCS
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----------h-HHHHHH
Confidence 6532 23567899999999999999999999965432110 0 000000
Q ss_pred ccccCCCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 549 MDESLDPNECT----KEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 549 ~d~~l~~~~~~----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+... ....+ ...+..+.+++..||+.||.+|||+.|+++.
T Consensus 214 ~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 214 IRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Hhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000 00111 1234579999999999999999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=323.83 Aligned_cols=241 Identities=16% Similarity=0.170 Sum_probs=180.1
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCC-Ccccee---------e--
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHH-RNLIRL---------L-- 382 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h-~niv~l---------~-- 382 (658)
++.|...+.||+|+||.||+|++. +|+.||||++.... .....+.+.+|+.+++.++| +|...+ .
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345667889999999999999965 69999999987422 22336789999999999977 221111 1
Q ss_pred ----------eEeec-----CCeEEEEEeccCCCCHHHHhh-----cCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCe
Q 006168 383 ----------GCCSQ-----GPELILVYEYMANSSLDKFLF-----GEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRI 442 (658)
Q Consensus 383 ----------~~~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 442 (658)
.++.. ....+++|+++ +++|.+++. ......+++..++.++.||++||.|||+. +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 11111 12356777765 579998884 22344588999999999999999999998 99
Q ss_pred eecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccccccCCccccccccc----------ccCCCCCcccchhhhHHH
Q 006168 443 IHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYA----------IHGQLSEKVDAYSFGVLV 512 (658)
Q Consensus 443 vH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~----------~~~~~s~ksDV~SfGvvl 512 (658)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999999865432 344567 999999999 555688899999999999
Q ss_pred HHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 006168 513 LEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVV 588 (658)
Q Consensus 513 ~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl 588 (658)
|||++|+.||........ ....+.. .... +..+.+|+..||+.||++|||+.+++
T Consensus 308 ~elltg~~Pf~~~~~~~~--------------~~~~~~~---~~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG--------------SEWIFRS---CKNI----PQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC--------------SGGGGSS---CCCC----CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHCCCCCCCcchhhh--------------HHHHHhh---cccC----CHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999975432110 0001110 1122 35699999999999999999987775
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.15 Aligned_cols=242 Identities=18% Similarity=0.182 Sum_probs=183.7
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEccccc-------ccccHHHHHHHHHHHhccC---------CCcccee
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGI-------SRRTLSDFENEVRLISNVH---------HRNLIRL 381 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~---------h~niv~l 381 (658)
.++|.+.+.||+|+||.||+|+. +|+.||||++.... .....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35678899999999999999998 68999999997542 2334578899999999886 5555555
Q ss_pred eeE-----------------eec-------------CCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 006168 382 LGC-----------------CSQ-------------GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGL 431 (658)
Q Consensus 382 ~~~-----------------~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L 431 (658)
.+. +.+ .+..++||||+++|++.+.+. +..+++..+..++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~---~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR---TKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT---TTCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH---hcCCCHHHHHHHHHHHHHHH
Confidence 554 433 678999999999997766662 25689999999999999999
Q ss_pred HHhH-hcCCCCeeecCcCCCcEEEcCCC--------------------CeEEeeccCccccCCCCccccccccCCccccc
Q 006168 432 AYLH-EDFHVRIIHRDIKPSNVLLDDDL--------------------QPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490 (658)
Q Consensus 432 ~~LH-~~~~~~ivH~Dik~~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~A 490 (658)
.||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|+|
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 9999 88 999999999999999887 8999999999876432 3479999999
Q ss_pred ccccccCCCCCcccchhhhHH-HHHHHhCCCCCCCCCcchhhHHHHHH-HHhhcCcccccccccCCCCCCCHHHHHHHHH
Q 006168 491 PEYAIHGQLSEKVDAYSFGVL-VLEIISGTKSSETKGEEGEYLLKRAW-RLYENGTHWELMDESLDPNECTKEAAEKVVE 568 (658)
Q Consensus 491 PE~~~~~~~s~ksDV~SfGvv-l~elltG~~p~~~~~~~~~~l~~~~~-~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~ 568 (658)
||++.+.. +.++||||||++ .+++++|..||... ....... ........ ............+.++.+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLKQMTF-----KTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHHTCCC-----SSCCCSHHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhhhhcc-----CcccchhhhhhcCHHHHH
Confidence 99988665 889999998777 77788898886311 0000011 11100000 000011223457788999
Q ss_pred HHHHccccCCCCCCCHHHHH
Q 006168 569 IALMCTQSAANSRPTMSEVV 588 (658)
Q Consensus 569 li~~cl~~dp~~RPt~~evl 588 (658)
|+.+||+.| |+.|++
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999976 899888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-29 Score=281.69 Aligned_cols=185 Identities=18% Similarity=0.154 Sum_probs=131.4
Q ss_pred cccccCceEEEEEEe-cCCcEEEEEEccccc---------ccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEE
Q 006168 326 KLGEGGFGDIYKGTL-KNGKIVAVKKLAIGI---------SRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 326 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 394 (658)
.++.|++|.+..++. -.|+.+++|.+.... .+...++|.+|+++|+++ +|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 356667776666553 358899999986531 223356799999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||++|++|.++|. ..++++.. +|+.||+.||.|||++ +||||||||+||||++++++||+|||+++.....
T Consensus 321 MEyv~G~~L~d~i~--~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLA--AGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHH--TTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHH--hCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999994 44567664 4889999999999999 9999999999999999999999999999877544
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTK 520 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~ 520 (658)
.. ..+..+||+.|+|||++.+ .+..++|+||+|++++++.++..
T Consensus 393 ~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 393 CS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred Cc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 32 2345789999999998864 56788999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=257.04 Aligned_cols=185 Identities=17% Similarity=0.163 Sum_probs=145.3
Q ss_pred CccCcccccCceEEEEEEecCCcEEEEEEccccccc-------ccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 322 SEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISR-------RTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 322 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
...+.||+|+||.||++.. .++.+++|+....... ...+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4567899999999999955 4678888886432111 1134589999999999999999766666677778999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++++|.+++.. +..++.|+++||.|||++ +|+||||||+|||++. ++||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999943 568999999999999998 9999999999999999 9999999999987553
Q ss_pred Cccc------cccccCCccccccccccc--CCCCCcccchhhhHHHHHHHhCCCCC
Q 006168 475 QSHL------STKFAGTLGYTAPEYAIH--GQLSEKVDAYSFGVLVLEIISGTKSS 522 (658)
Q Consensus 475 ~~~~------~~~~~gt~~y~APE~~~~--~~~s~ksDV~SfGvvl~elltG~~p~ 522 (658)
.... .....||+.|+|||++.. ..|+.++|+|+..+-.++-+.++.++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2221 235789999999999977 57888999999999888888776554
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=192.32 Aligned_cols=103 Identities=31% Similarity=0.607 Sum_probs=93.8
Q ss_pred ccccccCCCCCccCCchHHHHHHHHHHHHHHHHhcC-CCCceEEecc-CCCCcEEEEEeccCCCChhhhHHHHHHHHHhh
Q 006168 16 MELINSGCSQYNVTNFSEFNSNLNATFKELREQLNG-GKKFATAQRT-RGPDQVYTMVQCRRYVSTADCAACFTSAESLI 93 (658)
Q Consensus 16 ~~~~~~~c~~~~~~~~~~~~~~l~~ll~~l~~~~~~-~~~f~~~~~g-~~~~~vygl~qC~~d~~~~~C~~Cl~~a~~~~ 93 (658)
+++++..|++++|+++++|++||+.||+.|+++++. +.+|+++..+ .++++||||+|||||+++++|+.||+.|+..+
T Consensus 3 t~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~ 82 (108)
T 3a2e_A 3 TAFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRI 82 (108)
T ss_dssp CCEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTH
T ss_pred cceeeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHH
Confidence 567899999899999999999999999999998864 3467777766 46689999999999999999999999999999
Q ss_pred hh-cCCccCceEEccceEEEEecccc
Q 006168 94 RN-CSAANGARVIYLACSLRYESSSF 118 (658)
Q Consensus 94 ~~-c~~~~~~~v~~~~C~~ry~~~~f 118 (658)
.. |+++++|+||+++|+||||+++|
T Consensus 83 ~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 83 FSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHCCCCceEEEECCCEEEEEeCCcC
Confidence 88 99999999999999999999998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.8e-23 Score=210.18 Aligned_cols=166 Identities=16% Similarity=0.128 Sum_probs=130.0
Q ss_pred hHHHHHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEccccccc-----------------ccHHHHHHHHHHHhcc
Q 006168 311 LKDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISR-----------------RTLSDFENEVRLISNV 373 (658)
Q Consensus 311 ~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l 373 (658)
+..+......|.+.+.||+|+||.||+|.+.+|+.||||.+...... .....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 44555556677788999999999999999977999999998643211 1245689999999999
Q ss_pred CCCccceeeeEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEE
Q 006168 374 HHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVL 453 (658)
Q Consensus 374 ~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIl 453 (658)
+ | +++.+++.. +..++||||+++++|.+ +. ......++.|++.||.|||+. +|+||||||+|||
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL 225 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 225 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence 9 4 666665543 55699999999999988 41 123457999999999999998 9999999999999
Q ss_pred EcCCCCeEEeeccCccccCCCCccccccccCCccccccccccc----------CCCCCcccchh
Q 006168 454 LDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH----------GQLSEKVDAYS 507 (658)
Q Consensus 454 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~----------~~~s~ksDV~S 507 (658)
++ ++.+||+|||+++. +..+.|||++.. .++...+|+|.
T Consensus 226 l~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EE-TTEEEECCCTTCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EE-CCcEEEEECCCCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99 99999999999964 235689998743 34555566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.1e-19 Score=180.89 Aligned_cols=138 Identities=19% Similarity=0.203 Sum_probs=108.2
Q ss_pred CCCccCcccccCceEEEEEEe-cCCcE--EEEEEccccccc-----------------------ccHHHHHHHHHHHhcc
Q 006168 320 KFSEENKLGEGGFGDIYKGTL-KNGKI--VAVKKLAIGISR-----------------------RTLSDFENEVRLISNV 373 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l 373 (658)
-|.+.+.||+|+||.||+|.+ .+|+. ||||++...... .....+.+|++.+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999998 68989 999987542111 0113678999999999
Q ss_pred CCCcc--ceeeeEeecCCeEEEEEeccCC-C----CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhH-hcCCCCeeec
Q 006168 374 HHRNL--IRLLGCCSQGPELILVYEYMAN-S----SLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLH-EDFHVRIIHR 445 (658)
Q Consensus 374 ~h~ni--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~ 445 (658)
+|+++ +.++++ +..+|||||+.+ | +|.++... .++..+..++.|++.+|.||| +. +|+||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHr 195 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHA 195 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 88864 344432 356899999942 4 67766522 235677899999999999999 87 99999
Q ss_pred CcCCCcEEEcCCCCeEEeeccCcccc
Q 006168 446 DIKPSNVLLDDDLQPKIADFGLARLL 471 (658)
Q Consensus 446 Dik~~NIll~~~~~~kl~DfGla~~~ 471 (658)
||||+|||+++ .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999764
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.9e-19 Score=151.04 Aligned_cols=102 Identities=21% Similarity=0.388 Sum_probs=84.5
Q ss_pred cccccCCcccchhHHHHHHHHHHHHHHHHHCCCCccceeeeeccccccCCCCCCCCCCCCcceEEEeeeccCcccccccc
Q 006168 127 RFGFCGNRTALQADAFKTAAQELLENLEVATPKINGFFAASKNNIIGSRAGANDDDDKNSTAVYGIAQCVETISETGCQN 206 (658)
Q Consensus 127 ~~~~~~~~~~~~~~~f~~~~~~l~~~l~~~a~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~~vYglaQC~~Dls~~~C~~ 206 (658)
....|+..+.+....|+.++..||..|...++.+...|++..... ...++||||+||+|||++++|+.
T Consensus 6 v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~------------~~~~~vygl~qC~~Dls~~~C~~ 73 (108)
T 3a2e_A 6 VSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGS------------GGAPTAYGRATCKQSISQSDCTA 73 (108)
T ss_dssp EEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCS------------TTCCCEEEEEEECTTSCHHHHHH
T ss_pred eeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccC------------CCCceEEEEEEEcCCCCHHHHHH
Confidence 445688777777889999999999999877766666666543221 12368999999999999999999
Q ss_pred chhhhhhhcccccc-CCCceeeCCCCcccccCCCc
Q 006168 207 CLSGAFDNIQRCLG-SAFGWAVDAGCFLRYSDTPF 240 (658)
Q Consensus 207 CL~~~~~~~~~~~~-~~~g~~~~~~C~lry~~~~f 240 (658)
||..++.+++.||+ .++|+++..+|++||+.++|
T Consensus 74 Cl~~a~~~~~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 74 CLSNLVNRIFSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHHHHTTHHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHHHHHHHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence 99999999998774 78999999999999999887
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1e-16 Score=167.86 Aligned_cols=140 Identities=15% Similarity=0.180 Sum_probs=99.0
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccc-------------cccHHHH--------HHHHHHHhccCCCc
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGIS-------------RRTLSDF--------ENEVRLISNVHHRN 377 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------~~~~~~~--------~~E~~~l~~l~h~n 377 (658)
.-|.+.+.||+|++|.||+|...+|+.||||+++.... ....... .+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34889999999999999999999999999998753211 0011122 23555555554333
Q ss_pred cceeeeEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC
Q 006168 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD 457 (658)
Q Consensus 378 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~ 457 (658)
+.-..-+.. ...+|||||+++++|.++.. .+....++.||+.+|.+||+. +||||||||.|||++++
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE 241 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence 221111111 12379999999988876541 123456889999999999998 99999999999999877
Q ss_pred CC----------eEEeeccCcccc
Q 006168 458 LQ----------PKIADFGLARLL 471 (658)
Q Consensus 458 ~~----------~kl~DfGla~~~ 471 (658)
+. +.|+||+-+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 63 899999977643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=9.8e-12 Score=124.82 Aligned_cols=147 Identities=15% Similarity=0.067 Sum_probs=115.4
Q ss_pred HHHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccC-CCccceeeeEeecCCeEE
Q 006168 314 LVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 314 l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 392 (658)
+....+.|.....++.|+.+.||+.... ++.+++|+..... ......+.+|+++++.+. +.++.++++++...+..+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~-~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCccc-CCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 4445567888888888889999999864 6889999986421 122346889999999884 677889999998888999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhc-----------------------------------
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED----------------------------------- 437 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------------------------------- 437 (658)
+||||++|.+|.+.+. +......++.+++++|..||+.
T Consensus 87 lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 9999999999987641 1223457889999999999981
Q ss_pred ---------------------CCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 438 ---------------------FHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 438 ---------------------~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
....++|+|+++.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01369999999999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=5e-11 Score=119.19 Aligned_cols=137 Identities=13% Similarity=0.114 Sum_probs=101.0
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCc--cceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN--LIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~E 396 (658)
..+......+.|..+.||+....+|..+++|..... ....+..|+++++.+.+.+ +.+++++...++..++|||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 344433333355569999998877888999987542 2245788999999986544 4568888888888999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcC--------------------------------------
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF-------------------------------------- 438 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------- 438 (658)
|+++.+|. .. . .+ ...++.++++.|..||+..
T Consensus 96 ~i~G~~l~--~~-~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 96 EVPGQDLL--SS-H----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CCSSEETT--TS-C----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred ecCCcccC--cC-c----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 99998884 21 1 11 2367788888888888742
Q ss_pred -----------------CCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 439 -----------------HVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 439 -----------------~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
...++|+|++|.|||++++..+.|.||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.08 E-value=4e-10 Score=118.59 Aligned_cols=143 Identities=14% Similarity=0.181 Sum_probs=108.3
Q ss_pred ccCcccccCceEEEEEEecCCcEEEEEEcc--cccccccHHHHHHHHHHHhccC--CCccceeeeEeecC---CeEEEEE
Q 006168 323 EENKLGEGGFGDIYKGTLKNGKIVAVKKLA--IGISRRTLSDFENEVRLISNVH--HRNLIRLLGCCSQG---PELILVY 395 (658)
Q Consensus 323 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lV~ 395 (658)
..+.|+.|.++.||+....+ ..+++|+.. .+........+.+|+++++.+. +.++++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45678999999999998764 678888875 3322233457888999999996 45688899988766 4589999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcC-------------------------------------
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF------------------------------------- 438 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------- 438 (658)
||+++..+.+.. ...++..++..++.++++.|..||+..
T Consensus 121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999998874321 234788889999999999999999731
Q ss_pred ------------------CCCeeecCcCCCcEEEcCCCC--eEEeeccCccc
Q 006168 439 ------------------HVRIIHRDIKPSNVLLDDDLQ--PKIADFGLARL 470 (658)
Q Consensus 439 ------------------~~~ivH~Dik~~NIll~~~~~--~kl~DfGla~~ 470 (658)
...++|+|+++.|||+++++. +.|.||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=1.1e-09 Score=112.49 Aligned_cols=185 Identities=18% Similarity=0.149 Sum_probs=122.5
Q ss_pred cCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccC-CCc--cceeeeEeecCC---eEEEEEec
Q 006168 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRN--LIRLLGCCSQGP---ELILVYEY 397 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~E~ 397 (658)
.+.++.|....||+.. ..+++|+... ......+.+|+++++.+. +.. +.+++......+ ..++|||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~---~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH---SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS---HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC---cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4568999999999864 4688887542 234567899999998883 332 445555543333 34889999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcC---------------------------------------
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF--------------------------------------- 438 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------- 438 (658)
++|.+|.+... ..++..++..++.++++.|..||+..
T Consensus 98 i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 98 IKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99988875432 34778888889999999999999611
Q ss_pred ----------------CCCeeecCcCCCcEEEcC--CCCeEEeeccCccccCCCCccccccc--------------cCCc
Q 006168 439 ----------------HVRIIHRDIKPSNVLLDD--DLQPKIADFGLARLLPENQSHLSTKF--------------AGTL 486 (658)
Q Consensus 439 ----------------~~~ivH~Dik~~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~--------------~gt~ 486 (658)
.+.++|+|+++.||++++ +..+.|.||+.+....... ...... ....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHHHc
Confidence 145899999999999998 4567899999887542210 000000 0000
Q ss_pred cccc-ccccccCCCCCcccchhhhHHHHHHHhCCCCC
Q 006168 487 GYTA-PEYAIHGQLSEKVDAYSFGVLVLEIISGTKSS 522 (658)
Q Consensus 487 ~y~A-PE~~~~~~~s~ksDV~SfGvvl~elltG~~p~ 522 (658)
+... |+..... ....+.|++|.+++++.+|..++
T Consensus 253 ~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 1111 2221111 11258999999999999997653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=1.2e-06 Score=87.89 Aligned_cols=134 Identities=17% Similarity=0.085 Sum_probs=97.9
Q ss_pred cccccCce-EEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC-CCccceeeeEeecCCeEEEEEeccCCCC
Q 006168 326 KLGEGGFG-DIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQGPELILVYEYMANSS 402 (658)
Q Consensus 326 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gs 402 (658)
.+..|..| .||+.... ++..+++|+-.. ....++..|...|+.+. +-.+.++++++.+.+..++|||++++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 34445554 68988765 466789998643 23567889999998884 3346788999988899999999999988
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcC--------------------------------------------
Q 006168 403 LDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF-------------------------------------------- 438 (658)
Q Consensus 403 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------------- 438 (658)
+.+.... .......+..++++.|..||+..
T Consensus 107 ~~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 107 AFQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8765421 12334456667777777777421
Q ss_pred -----------CCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 439 -----------HVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 439 -----------~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
.+.++|+|+++.|||+++++.+-|.||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1238999999999999988777799998775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=3.6e-06 Score=86.16 Aligned_cols=136 Identities=18% Similarity=0.157 Sum_probs=97.2
Q ss_pred cCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCC---ccceeeeEee-cCCeEEEEEeccC
Q 006168 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHR---NLIRLLGCCS-QGPELILVYEYMA 399 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~E~~~ 399 (658)
.+.++.|....||+. +..+++|+-. .......+..|+++|+.+.+. .+.+.+.+.. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456788888899988 5678888742 223456789999999999652 3566677664 4556789999999
Q ss_pred CCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhc------------------------------------------
Q 006168 400 NSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED------------------------------------------ 437 (658)
Q Consensus 400 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------ 437 (658)
|..|.+... ..++..++..++.++++.|..||+.
T Consensus 97 G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 97 GQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp SEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred CeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 988876321 1245556666666666666666642
Q ss_pred ---------------CCCCeeecCcCCCcEEEcC---CCCe-EEeeccCccc
Q 006168 438 ---------------FHVRIIHRDIKPSNVLLDD---DLQP-KIADFGLARL 470 (658)
Q Consensus 438 ---------------~~~~ivH~Dik~~NIll~~---~~~~-kl~DfGla~~ 470 (658)
..+.++|+|+++.|||+++ ++.+ .|.||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 4564 8999997754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=2.4e-06 Score=89.33 Aligned_cols=81 Identities=10% Similarity=0.048 Sum_probs=56.4
Q ss_pred cCcc-cccCceEEEEEEec-------CCcEEEEEEcccccc--cccHHHHHHHHHHHhccC-C--CccceeeeEeecC--
Q 006168 324 ENKL-GEGGFGDIYKGTLK-------NGKIVAVKKLAIGIS--RRTLSDFENEVRLISNVH-H--RNLIRLLGCCSQG-- 388 (658)
Q Consensus 324 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 388 (658)
.+.| +.|....+|+.... +++.+++|+...... ......+..|+.+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78889999998765 267889998654220 101245788888888884 3 3567788887655
Q ss_pred -CeEEEEEeccCCCCHH
Q 006168 389 -PELILVYEYMANSSLD 404 (658)
Q Consensus 389 -~~~~lV~E~~~~gsL~ 404 (658)
+..++||||+++..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.92 E-value=4.6e-05 Score=78.77 Aligned_cols=139 Identities=15% Similarity=0.205 Sum_probs=80.4
Q ss_pred CcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCC--Cccceeee------EeecCCeEEEEEe
Q 006168 325 NKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHH--RNLIRLLG------CCSQGPELILVYE 396 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lV~E 396 (658)
+.|+.|..+.||+....+| .+++|+... ...++..|+++++.|.. -.+.+++. +....+..++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS-----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC-----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 4565567889999987655 588998764 12344455666655531 12333332 1234567899999
Q ss_pred ccCCCCHH--------------HHhhcCCC----C--------CCCHHHHH-----------------------------
Q 006168 397 YMANSSLD--------------KFLFGEKR----G--------SLNWKQRF----------------------------- 421 (658)
Q Consensus 397 ~~~~gsL~--------------~~l~~~~~----~--------~l~~~~~~----------------------------- 421 (658)
|++|..+. ..+|.... . .-.|...+
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 11111100 0 01232211
Q ss_pred --HHHHHHHHHHHHhHh----------cCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 422 --DIILGTARGLAYLHE----------DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 422 --~i~~~ia~~L~~LH~----------~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
.+...+..++.+|++ .....++|+|+++.|||++.++.+.|.||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445666663 124589999999999999888899999999774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=3.4e-05 Score=81.88 Aligned_cols=76 Identities=11% Similarity=0.124 Sum_probs=49.7
Q ss_pred cCcccccCceEEEEEEec-CCcEEEEEEcccccc------cccHHHHHHHHHHHhccCC--Cc-cceeeeEeecCCeEEE
Q 006168 324 ENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS------RRTLSDFENEVRLISNVHH--RN-LIRLLGCCSQGPELIL 393 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 393 (658)
.+.||.|..+.||++... +++.++||....... ......+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999865 468899997643111 1123456788888887742 33 4455544 3345689
Q ss_pred EEeccCCC
Q 006168 394 VYEYMANS 401 (658)
Q Consensus 394 V~E~~~~g 401 (658)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.91 E-value=3.9e-05 Score=77.57 Aligned_cols=79 Identities=15% Similarity=0.147 Sum_probs=57.7
Q ss_pred CCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCC---CccceeeeEeecCCeEEEEEe
Q 006168 320 KFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHH---RNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lV~E 396 (658)
.....+.+|.|..+.||+.++.||+.|.+|+-... .......|..|++.|+.|.- -.+.+++++. .-++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~-~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDD-APALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTT-CCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCC-CcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 45556789999999999999999999999986542 23334567889999988842 2345555542 2378999
Q ss_pred ccCCCCH
Q 006168 397 YMANSSL 403 (658)
Q Consensus 397 ~~~~gsL 403 (658)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00014 Score=74.16 Aligned_cols=139 Identities=18% Similarity=0.133 Sum_probs=93.5
Q ss_pred CccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccC---CCccceeeeEeecCCeEEEEEecc
Q 006168 322 SEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVH---HRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 322 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
...+.|+.|....+|+... ++..+++|+... .....+..|.+.|+.|. ...+++++.+....+..++||||+
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINER----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEG----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCc----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 3456789999999999986 467888998653 23567889999998884 357888999888888899999999
Q ss_pred CCCCHH--------H---HhhcCCC-C-------------------CCCHHHHH---HHH----------------HHHH
Q 006168 399 ANSSLD--------K---FLFGEKR-G-------------------SLNWKQRF---DII----------------LGTA 428 (658)
Q Consensus 399 ~~gsL~--------~---~l~~~~~-~-------------------~l~~~~~~---~i~----------------~~ia 428 (658)
++..+. + .||.... . .-+|.... ++. ..+.
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 987642 1 2222211 0 02454322 111 1111
Q ss_pred HHH-HHhHh-cCCCCeeecCcCCCcEEEcCCCCeEEeecc
Q 006168 429 RGL-AYLHE-DFHVRIIHRDIKPSNVLLDDDLQPKIADFG 466 (658)
Q Consensus 429 ~~L-~~LH~-~~~~~ivH~Dik~~NIll~~~~~~kl~DfG 466 (658)
+.+ ..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111 23321 2356899999999999999887 8888873
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00035 Score=74.66 Aligned_cols=77 Identities=14% Similarity=0.158 Sum_probs=46.8
Q ss_pred CCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccccccC--CcccccccccccCC---CCCcccchhhhHHHH
Q 006168 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAG--TLGYTAPEYAIHGQ---LSEKVDAYSFGVLVL 513 (658)
Q Consensus 439 ~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~APE~~~~~~---~s~ksDV~SfGvvl~ 513 (658)
...++|+|+++.|||+++++ ++|.||+.+..-.... .. ..... ...|.+|+...... -....++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 45899999999999998876 9999999887532110 00 00000 13456666543111 112345557777777
Q ss_pred HHHhC
Q 006168 514 EIISG 518 (658)
Q Consensus 514 elltG 518 (658)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00096 Score=68.66 Aligned_cols=142 Identities=13% Similarity=0.090 Sum_probs=74.2
Q ss_pred cCcccccCceE-EEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCC--CccceeeeEeecCCeEEEEEeccCC
Q 006168 324 ENKLGEGGFGD-IYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHH--RNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 324 ~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
.+.|+.|.... +|+....+++.+++|...... ..++..|+.+++.+.. -.+.+++.+....+ +++||++.+
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE----GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTT----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCC----CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 34565554444 667766446778887654321 0234556777766632 23556676644333 789999987
Q ss_pred CCHHHHhhcC---------------------CC---CCCCHHHHH-------H-------------HHHHHHHHHHHhHh
Q 006168 401 SSLDKFLFGE---------------------KR---GSLNWKQRF-------D-------------IILGTARGLAYLHE 436 (658)
Q Consensus 401 gsL~~~l~~~---------------------~~---~~l~~~~~~-------~-------------i~~~ia~~L~~LH~ 436 (658)
..+.+++... .. ..++..... . ....+...+..|.+
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 6665433211 00 111111100 0 00111122222211
Q ss_pred ---cCCCCeeecCcCCCcEEEcCC----CCeEEeeccCcccc
Q 006168 437 ---DFHVRIIHRDIKPSNVLLDDD----LQPKIADFGLARLL 471 (658)
Q Consensus 437 ---~~~~~ivH~Dik~~NIll~~~----~~~kl~DfGla~~~ 471 (658)
.....++|||+++.|||++.+ ..+.|.||+.+..-
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123579999999999999875 67899999988643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.004 Score=63.51 Aligned_cols=157 Identities=14% Similarity=0.136 Sum_probs=89.0
Q ss_pred cchHHHHHHhcCCCc-----cCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCc--ccee
Q 006168 309 YRLKDLVSATRKFSE-----ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN--LIRL 381 (658)
Q Consensus 309 ~~~~~l~~a~~~f~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l 381 (658)
++.+++.....+|.. .+.|+.|....+|+....+| .+++|...... ...++..|+.++..+.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 455666666666654 23466788889999987666 67889875421 1234566777777764222 2333
Q ss_pred eeE------eecCCeEEEEEeccCCCCHHH--------------HhhcCC-C---C---C---CCHHHHHH---------
Q 006168 382 LGC------CSQGPELILVYEYMANSSLDK--------------FLFGEK-R---G---S---LNWKQRFD--------- 422 (658)
Q Consensus 382 ~~~------~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~-~---~---~---l~~~~~~~--------- 422 (658)
+.. ....+..++++||+++..+.. .+|... . . . ..|...+.
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 122456789999999865321 111110 0 0 0 11322111
Q ss_pred ---HHHHHHHHHHHhHhc----CCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 423 ---IILGTARGLAYLHED----FHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 423 ---i~~~ia~~L~~LH~~----~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
+...+.+.+..+++. ....++|+|+++.|||++++..+.|.||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455566532 23479999999999999987656899998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0045 Score=63.28 Aligned_cols=158 Identities=15% Similarity=0.182 Sum_probs=90.3
Q ss_pred ccchHHHHHHhcCCCc-----cCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCc--cce
Q 006168 308 NYRLKDLVSATRKFSE-----ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN--LIR 380 (658)
Q Consensus 308 ~~~~~~l~~a~~~f~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 380 (658)
..+.+++..+.+.|.. ...|+ |....||+....+|+.+++|..... ......+..|..+++.+.... +++
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~--~~~~~~~~~E~~~~~~L~~~g~~vp~ 86 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPE--RWTADQILEEHQFALQLVNDEVPVAA 86 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTT--TSCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCC--CCCHHHHHHHHHHHHHHHHcCCeecc
Confidence 3445555555544432 23466 7788999988777878999987532 123456777888888774222 344
Q ss_pred eeeE-----eecCCeEEEEEeccCCCCHH-----H------H---hhc----C---CCCCCCHHHH----HHH-------
Q 006168 381 LLGC-----CSQGPELILVYEYMANSSLD-----K------F---LFG----E---KRGSLNWKQR----FDI------- 423 (658)
Q Consensus 381 l~~~-----~~~~~~~~lV~E~~~~gsL~-----~------~---l~~----~---~~~~l~~~~~----~~i------- 423 (658)
++.. ....+..++||||+++..+. . . +|. . ....+++... ..+
T Consensus 87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 166 (328)
T 1zyl_A 87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI 166 (328)
T ss_dssp CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence 4443 12245668899999875432 1 1 111 0 0111222211 000
Q ss_pred --------HHHHHHHHHHhHhc----CCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 424 --------ILGTARGLAYLHED----FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 424 --------~~~ia~~L~~LH~~----~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
...+...+..+.+. ....++|+|+++.|||++ + .+.|.||+.+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333321 234689999999999999 4 899999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0014 Score=69.99 Aligned_cols=73 Identities=19% Similarity=0.196 Sum_probs=50.3
Q ss_pred cCcccccCceEEEEEEecC--------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCcc-ceeeeEeecCCeEEEE
Q 006168 324 ENKLGEGGFGDIYKGTLKN--------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL-IRLLGCCSQGPELILV 394 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV 394 (658)
.+.|+.|....+|+....+ +..+++|+.... .....+..|..+++.+...++ .++++.+.+ .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 3567888889999998763 478888886321 122456689999988854444 567776643 389
Q ss_pred EeccCCCCH
Q 006168 395 YEYMANSSL 403 (658)
Q Consensus 395 ~E~~~~gsL 403 (658)
+||+++.+|
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0016 Score=68.23 Aligned_cols=140 Identities=14% Similarity=0.168 Sum_probs=84.3
Q ss_pred CcccccCceEEEEEEec--------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCc-cceeeeEeecCCeEEEEE
Q 006168 325 NKLGEGGFGDIYKGTLK--------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN-LIRLLGCCSQGPELILVY 395 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~ 395 (658)
+.|..|-...+|+.... +++.+.+|+... .........+|.++++.|.-.+ ..++++++.+ .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 45767778889998875 247899998532 2335667789999998884322 3567776654 2999
Q ss_pred eccCCCCHHHH-----------------hhcCC---CCCC--CHHHHHHHHHHHHH-------------------HHHHh
Q 006168 396 EYMANSSLDKF-----------------LFGEK---RGSL--NWKQRFDIILGTAR-------------------GLAYL 434 (658)
Q Consensus 396 E~~~~gsL~~~-----------------l~~~~---~~~l--~~~~~~~i~~~ia~-------------------~L~~L 434 (658)
||+++..|..- ||... .... -|.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998655310 11111 1112 23444445443321 23333
Q ss_pred Hh-----cCCCCeeecCcCCCcEEEcCC----CCeEEeeccCccc
Q 006168 435 HE-----DFHVRIIHRDIKPSNVLLDDD----LQPKIADFGLARL 470 (658)
Q Consensus 435 H~-----~~~~~ivH~Dik~~NIll~~~----~~~kl~DfGla~~ 470 (658)
.+ .....++|+|+.+.|||++++ +.+.|+||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 123479999999999999876 7899999987753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.001 Score=67.34 Aligned_cols=138 Identities=14% Similarity=0.109 Sum_probs=75.6
Q ss_pred ccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCcc-ceeeeEeecCCeEEEEEecc-CC
Q 006168 323 EENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL-IRLLGCCSQGPELILVYEYM-AN 400 (658)
Q Consensus 323 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~-~~ 400 (658)
..+.|+.|....+|+. +.+++|+..... .......+|+..++.+....+ .+++++.. +.-++|+||+ ++
T Consensus 22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~--~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g 92 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGT--EEYINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGA 92 (301)
T ss_dssp SCEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTC
T ss_pred ceeEcCCcccccccee-----eeEEEECCCCCc--cceeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCC
Confidence 3678888999999999 558888765421 111223568877777743333 45665543 3347899999 65
Q ss_pred CCHHH------------------HhhcCCCC---CCCH-HHHHHHHH--------------HHHHHHHH----hHh-cCC
Q 006168 401 SSLDK------------------FLFGEKRG---SLNW-KQRFDIIL--------------GTARGLAY----LHE-DFH 439 (658)
Q Consensus 401 gsL~~------------------~l~~~~~~---~l~~-~~~~~i~~--------------~ia~~L~~----LH~-~~~ 439 (658)
.+|.. .+|..... ..+. .....+.. .+.+.+.. |.. ...
T Consensus 93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~ 172 (301)
T 3dxq_A 93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP 172 (301)
T ss_dssp EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence 44421 01111100 0111 11111100 01111111 111 123
Q ss_pred CCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 440 ~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 46899999999999 6667889999987764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0016 Score=61.68 Aligned_cols=103 Identities=17% Similarity=0.095 Sum_probs=66.5
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccccc
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLST 480 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 480 (658)
-+|.++|. ....+++++++|.++.|.+..|.-+-... .-..+=+-|..|++..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~-~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILR-LYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHH-HcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 37888884 45678999999999999999987763210 111233457999999999988764 1110
Q ss_pred cccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCC
Q 006168 481 KFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKS 521 (658)
Q Consensus 481 ~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p 521 (658)
.....+.+||... ...+.+.-|||+|+++|.-+--..|
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122456888653 3456788999999999998864433
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.80 E-value=0.004 Score=66.92 Aligned_cols=74 Identities=11% Similarity=0.059 Sum_probs=48.2
Q ss_pred cCcccccCceEEEEEEecC-CcEEEEEEcccccccccHHHHHHHHHHHhccCCCcc-ceeeeEeecCCeEEEEEeccCCC
Q 006168 324 ENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL-IRLLGCCSQGPELILVYEYMANS 401 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~g 401 (658)
.+.|+.|-...+|+....+ +..+++|+..... ....+-..|..+++.|...++ .++++.+.. .+||||+++.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCc
Confidence 4568888889999999875 5778888764321 111123588888888865444 467777632 3599999875
Q ss_pred CH
Q 006168 402 SL 403 (658)
Q Consensus 402 sL 403 (658)
.|
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0026 Score=66.48 Aligned_cols=74 Identities=14% Similarity=0.106 Sum_probs=44.5
Q ss_pred cCcccccCceEEEEEEecC---------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCc-cceeeeEeecCCeEEE
Q 006168 324 ENKLGEGGFGDIYKGTLKN---------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN-LIRLLGCCSQGPELIL 393 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~l 393 (658)
.+.|+.|....+|+....+ +..+++|+.... .....+...|.++++.+...+ ..++++... -++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH--VDELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT--GGGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC--ccceecHHHHHHHHHHHHhcCCCCceEEecC----CcE
Confidence 3467778888999998764 267888876532 111223467888888875334 346665542 268
Q ss_pred EEeccCCCCH
Q 006168 394 VYEYMANSSL 403 (658)
Q Consensus 394 V~E~~~~gsL 403 (658)
||||+++..+
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.50 E-value=0.015 Score=59.98 Aligned_cols=31 Identities=29% Similarity=0.394 Sum_probs=27.7
Q ss_pred CCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 440 ~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
..++|+|+.+.||++++++.+.|.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 5799999999999999888899999987754
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.29 E-value=0.0039 Score=42.45 Aligned_cols=34 Identities=29% Similarity=0.304 Sum_probs=21.9
Q ss_pred CCcceeEeeeechhHHHHHHHHHhhheeeecccc
Q 006168 258 SNKEAIIGGVVGGGTGLILFALLIWLVISRKSKK 291 (658)
Q Consensus 258 ~~~~~ii~~vv~~~~~lv~l~~~~~~~~~~~~~~ 291 (658)
++...|++++++++++++++++++|++.|||+++
T Consensus 8 s~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 8 PKIPSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SCSSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCcceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 3456677888877777666666666665555443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.01 E-value=0.0032 Score=42.76 Aligned_cols=34 Identities=32% Similarity=0.433 Sum_probs=21.7
Q ss_pred CCcceeEeeeechhHHHHHHHHHhhheeeecccc
Q 006168 258 SNKEAIIGGVVGGGTGLILFALLIWLVISRKSKK 291 (658)
Q Consensus 258 ~~~~~ii~~vv~~~~~lv~l~~~~~~~~~~~~~~ 291 (658)
++...|++++++++++++++++++|+++|||+++
T Consensus 7 s~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 7 ARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp CSSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred CCcceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 3456677888877777666666666655555443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.91 E-value=0.098 Score=55.39 Aligned_cols=140 Identities=12% Similarity=0.169 Sum_probs=84.0
Q ss_pred cCcccccCceEEEEEEecC--------CcEEEEEEcccccccccHHHHHHHHHHHhccCCCc-cceeeeEeecCCeEEEE
Q 006168 324 ENKLGEGGFGDIYKGTLKN--------GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRN-LIRLLGCCSQGPELILV 394 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV 394 (658)
.+.|..|-...+|+....+ ++.+++|+.... .....+..+|..+++.+...+ ..++++.+. -++|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~--t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH--VGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC--C-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC--cchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence 3457677888999998763 578999886432 122223467888888885333 345665442 2789
Q ss_pred EeccCCCCHHH--------------H---hhc--C---------CCCCCCHHHHHHHHHHH-------------------
Q 006168 395 YEYMANSSLDK--------------F---LFG--E---------KRGSLNWKQRFDIILGT------------------- 427 (658)
Q Consensus 395 ~E~~~~gsL~~--------------~---l~~--~---------~~~~l~~~~~~~i~~~i------------------- 427 (658)
|||+++..|.. . ||. . ...+.-|.++.++..++
T Consensus 149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 228 (424)
T 3mes_A 149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI 228 (424)
T ss_dssp EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence 99999866421 0 010 0 11111244433333222
Q ss_pred HHHHHHhHh---------------------cCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 428 ARGLAYLHE---------------------DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 428 a~~L~~LH~---------------------~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
...+..|.+ .....++|+|+.+.||+ ++++.+.|+||..+..
T Consensus 229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 222333321 12347999999999999 8888999999988753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.98 E-value=0.42 Score=50.10 Aligned_cols=30 Identities=23% Similarity=0.421 Sum_probs=25.1
Q ss_pred CeeecCcCCCcEEE------cCCCCeEEeeccCccc
Q 006168 441 RIIHRDIKPSNVLL------DDDLQPKIADFGLARL 470 (658)
Q Consensus 441 ~ivH~Dik~~NIll------~~~~~~kl~DfGla~~ 470 (658)
.++|+|+.+.|||+ +++..++++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999988753
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=87.43 E-value=0.071 Score=36.09 Aligned_cols=27 Identities=26% Similarity=0.482 Sum_probs=13.1
Q ss_pred ceeEeeeechhHHHHHHHHHhhheeeec
Q 006168 261 EAIIGGVVGGGTGLILFALLIWLVISRK 288 (658)
Q Consensus 261 ~~ii~~vv~~~~~lv~l~~~~~~~~~~~ 288 (658)
..|++++++ +++++++++++.++.|||
T Consensus 12 ~~Ia~~vVG-vll~vi~~l~~~~~~RRR 38 (44)
T 2jwa_A 12 TSIISAVVG-ILLVVVLGVVFGILIKRR 38 (44)
T ss_dssp HHHHHHHHH-HHHHHHHHHHHHHHHHHH
T ss_pred cchHHHHHH-HHHHHHHHHHHHhheehh
Confidence 456666666 434444444444444443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.07 E-value=1.2 Score=41.94 Aligned_cols=115 Identities=16% Similarity=0.191 Sum_probs=78.5
Q ss_pred CCCccceeeeEeecCCeEEEEEeccCCC-CHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcE
Q 006168 374 HHRNLIRLLGCCSQGPELILVYEYMANS-SLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNV 452 (658)
Q Consensus 374 ~h~niv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NI 452 (658)
.||++++. .+-...+.+.+.|+.-+++ ++.. + ..++...+++++.+|+....+++. -+|--|+|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-----k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-----KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-----GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-----HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 68888876 4666667777777765422 2222 2 347889999999999988866653 47888999999
Q ss_pred EEcCCCCeEEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCC
Q 006168 453 LLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSE 523 (658)
Q Consensus 453 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~ 523 (658)
+++.++.+++.-.|+-..+ +|. .+++..=.-.+=+++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999877764332 121 01111112246678888998887763
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.69 E-value=1.8 Score=40.95 Aligned_cols=84 Identities=11% Similarity=0.065 Sum_probs=61.9
Q ss_pred CCCccceeeeEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH-HhHhcCCCCeeecCcCCCcE
Q 006168 374 HHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLA-YLHEDFHVRIIHRDIKPSNV 452 (658)
Q Consensus 374 ~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~ivH~Dik~~NI 452 (658)
.||++ -..+-.+.+.+.+.|+.-+++.=...+ ..++...+++++.+|+.... +++ .-+|--|+|+||
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL 115 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENL 115 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceE
Confidence 67877 334446677888888776443322233 34788999999999988776 555 457888999999
Q ss_pred EEcCCCCeEEeeccCcc
Q 006168 453 LLDDDLQPKIADFGLAR 469 (658)
Q Consensus 453 ll~~~~~~kl~DfGla~ 469 (658)
+++.++.+++.-.|+-.
T Consensus 116 ~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 116 MFNRALEPFFLHVGVKE 132 (219)
T ss_dssp EECTTCCEEESCCEETT
T ss_pred EEeCCCcEEEEEcCCcc
Confidence 99999999998877654
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=84.22 E-value=0.18 Score=33.19 Aligned_cols=27 Identities=19% Similarity=0.174 Sum_probs=14.9
Q ss_pred ceeEeeeechhHHHHHHHHHhhheeee
Q 006168 261 EAIIGGVVGGGTGLILFALLIWLVISR 287 (658)
Q Consensus 261 ~~ii~~vv~~~~~lv~l~~~~~~~~~~ 287 (658)
..|.++++++++.+++++.++|+++||
T Consensus 11 GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 11 GEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CceeeeehHHHHHHHHHHHHHHHHeec
Confidence 456666666666555555544444433
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.85 E-value=0.13 Score=55.13 Aligned_cols=62 Identities=10% Similarity=0.096 Sum_probs=18.3
Q ss_pred CccCcccccCceEEEEEEecC-CcEEEE------EEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEee
Q 006168 322 SEENKLGEGGFGDIYKGTLKN-GKIVAV------KKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCS 386 (658)
Q Consensus 322 ~~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 386 (658)
...++|| ||.||+|.+.. ..+||+ |....+ .+.+....|.+|..+++.++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456676 99999999864 357888 766542 23344567888999999999999999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 658 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-72 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-71 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-69 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-67 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-66 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-64 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-63 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-63 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-62 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-27 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 4e-72
Identities = 75/286 (26%), Positives = 135/286 (47%), Gaps = 27/286 (9%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAI-GISRRTLSDFENEVRLISNVHHRNL 378
+ + ++G G FG +YKG VAVK L + + + L F+NEV ++ H N+
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
+ +G + P+L +V ++ SSL L + DI TA+G+ YLH
Sbjct: 67 LLFMGYST-APQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQGMDYLH--- 121
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ-SHLSTKFAGTLGYTAPEYA--- 494
IIHRD+K +N+ L +DL KI DFGLA + SH + +G++ + APE
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 495 IHGQLSEKVDAYSFGVLVLEIISGTK--SSETKGEEGEYLLKRAWRLYENGTHWELMDES 552
S + D Y+FG+++ E+++G S+ ++ +++ R + S
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL-------------S 228
Query: 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSL 598
D ++ + + + C + + RP +++A ++ + SL
Sbjct: 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 1e-71
Identities = 78/280 (27%), Positives = 131/280 (46%), Gaps = 25/280 (8%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+LG G FG+++ G VAVK L + F E L+ + H+ L+
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
RL +Q P + ++ EYM N SL FL L + D+ A G+A++ E
Sbjct: 72 RLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER-- 128
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL 499
IHRD++ +N+L+ D L KIADFGLARL+ +N+ + +TAPE +G
Sbjct: 129 -NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 500 SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYL--LKRAWRLYENGTHWELMDESLDPNE 557
+ K D +SFG+L+ EI++ + E + L+R +R+ + P+
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------------VRPDN 234
Query: 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSS 597
C +E ++ +C + RPT + ++L+ ++
Sbjct: 235 CPEELY----QLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (573), Expect = 4e-69
Identities = 80/281 (28%), Positives = 134/281 (47%), Gaps = 25/281 (8%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
E KLG+G FG+++ GT VA+K L + F E +++ + H L+
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
+L S+ P + +V EYM+ SL FL GE L Q D+ A G+AY+
Sbjct: 76 QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 131
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL 499
+ +HRD++ +N+L+ ++L K+ADFGLARL+ +N+ + +TAPE A++G+
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 500 SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD--ESLDPNE 557
+ K D +SFG+L+ E+ + + Y + E++D E
Sbjct: 192 TIKSDVWSFGILLTELTTKGR-----------------VPYPGMVNREVLDQVERGYRMP 234
Query: 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSL 598
C E E + ++ C + RPT + A L+ +S
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 2e-67
Identities = 69/279 (24%), Positives = 119/279 (42%), Gaps = 25/279 (8%)
Query: 321 FSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIR 380
+ ++G G FG ++ G N VA+K + + DF E ++ + H L++
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 381 LLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHV 440
L G C + + LV+E+M + L + +RG + + L G+AYL E
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEEA--- 120
Query: 441 RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLS 500
+IHRD+ N L+ ++ K++DFG+ R + ++Q ST + + +PE + S
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 501 EKVDAYSFGVLVLEIISGTKSSETKGEEGEYL--LKRAWRLYENGTHWELMDESLDPNEC 558
K D +SFGVL+ E+ S K E + + +RLY P
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------------KPRLA 227
Query: 559 TKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSS 597
+ +I C + RP S ++ L + S
Sbjct: 228 STHVY----QIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 2e-67
Identities = 69/274 (25%), Positives = 125/274 (45%), Gaps = 21/274 (7%)
Query: 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
+ + +LG G FG + G + VA+K + + +F E +++ N+ H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKL 61
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
++L G C++ + ++ EYMAN L +L E R +Q ++ + YL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLE--- 117
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ 498
+ +HRD+ N L++D K++DFGL+R + +++ S + ++ PE ++ +
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 499 LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558
S K D ++FGVL+ EI S L K + + N E + + L
Sbjct: 178 FSSKSDIWAFGVLMWEIYS--------------LGKMPYERFTNSETAEHIAQGLRL-YR 222
Query: 559 TKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
A+EKV I C A+ RPT +++ +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 218 bits (556), Expect = 1e-66
Identities = 75/303 (24%), Positives = 138/303 (45%), Gaps = 40/303 (13%)
Query: 309 YRLKDLVSATRKFSEE---------NKLGEGGFGDIYKGTLK----NGKIVAVKKLAIGI 355
+ +D A R+F++E +G G FG++ G LK VA+K L G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 356 SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSL 415
+ + DF +E ++ H N+I L G ++ ++++ E+M N SLD FL + G
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQF 125
Query: 416 NWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475
Q ++ G A G+ YL + +HRD+ N+L++ +L K++DFGL+R L ++
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 476 SHLSTK----FAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEY 531
S + + +TAPE + + + D +S+G+++ E++S
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS-------------- 228
Query: 532 LLKRAWRLYENGTHWELMD--ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589
R Y + T+ ++++ E + + ++ L C Q N RP ++V
Sbjct: 229 ---YGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
Query: 590 LLK 592
L
Sbjct: 286 TLD 288
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 2e-66
Identities = 72/296 (24%), Positives = 121/296 (40%), Gaps = 30/296 (10%)
Query: 312 KDLVSATRKFS-EENKLGEGGFGDIYKGTLK---NGKIVAVKKLAIGISRRTLSDFENEV 367
K L + +LG G FG + +G + VA+K L G + + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 368 RLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGT 427
+++ + + ++RL+G C Q L+LV E L KFL G KR + +++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQV 118
Query: 428 ARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK--FAGT 485
+ G+ YL +HRD+ NVLL + KI+DFGL++ L + S+ + +
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 486 LGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTH 545
L + APE + S + D +S+GV + E +S + Y+
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALS-----------------YGQKPYKKMKG 218
Query: 546 WELMD--ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLL 599
E+M E EC E ++ + C RP V +++ SL
Sbjct: 219 PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 5e-66
Identities = 63/293 (21%), Positives = 113/293 (38%), Gaps = 29/293 (9%)
Query: 324 ENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
+ +G+G FG++++G + G+ VAVK + R E E+ + H N++ +
Sbjct: 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF--REAEIYQTVMLRHENILGFIA 64
Query: 384 CCSQG----PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
++ +L LV +Y + SL +L R ++ + + L TA GLA+LH +
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 440 V-----RIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLS---TKFAGTLGYTAP 491
I HRD+K N+L+ + IAD GLA + GT Y AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 492 EY------AIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGE-----EGEYLLKRAWRLY 540
E H + ++ D Y+ G++ EI + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 541 ENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
+ + ++ + EA + +I C + +R T + L
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (543), Expect = 8e-65
Identities = 69/275 (25%), Positives = 126/275 (45%), Gaps = 21/275 (7%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
+ ++KLG G +G++Y+G K VAVK L + +F E ++ + H NL
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNL 75
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
++LLG C++ P ++ E+M +L +L R ++ + + + YL +
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK- 134
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ 498
IHRD+ N L+ ++ K+ADFGL+RL+ + + +TAPE + +
Sbjct: 135 --NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 499 LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558
S K D ++FGVL+ EI + + + +EL+++ E
Sbjct: 193 FSIKSDVWAFGVLLWEIATYG--------------MSPYPGIDLSQVYELLEKDYRM-ER 237
Query: 559 TKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
+ EKV E+ C Q + RP+ +E+ ++
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 213 bits (543), Expect = 1e-64
Identities = 71/317 (22%), Positives = 129/317 (40%), Gaps = 51/317 (16%)
Query: 307 VNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTLKN------GKIVAVKKLAIGISRRTL 360
+N +L L +GEG FG +++ +VAVK L S
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 361 SDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGS------ 414
+DF+ E L++ + N+++LLG C+ G + L++EYMA L++FL +
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 415 ----------------LNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL 458
L+ ++ I A G+AYL + +HRD+ N L+ +++
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENM 177
Query: 459 QPKIADFGLARLLPENQ-SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS 517
KIADFGL+R + A + + PE + + + + D +++GV++ EI S
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 518 GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN--ECTKEAAEKVVEIALMCTQ 575
+ Y H E++ D N C + ++ + +C
Sbjct: 238 YGL-----------------QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWS 280
Query: 576 SAANSRPTMSEVVALLK 592
RP+ + +L+
Sbjct: 281 KLPADRPSFCSIHRILQ 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 4e-64
Identities = 73/275 (26%), Positives = 113/275 (41%), Gaps = 27/275 (9%)
Query: 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
++ +G+G FGD+ G + G VAVK + + T F E +++ + H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNL 62
Query: 379 IRLLGCCSQGPE-LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
++LLG + L +V EYMA SL +L R L L + YL +
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG 497
+HRD+ NVL+ +D K++DFGL + Q + +TAPE
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREK 175
Query: 498 QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557
+ S K D +SFG+L+ EI S + LK E G + P+
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGYKMDA------PDG 224
Query: 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
C E+ C A RP+ ++ L+
Sbjct: 225 CPPAVY----EVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 1e-63
Identities = 70/279 (25%), Positives = 123/279 (44%), Gaps = 31/279 (11%)
Query: 323 EENKLGEGGFGDIYKGTLKN---GKIVAVKKLAIGISRRTLSD-FENEVRLISNVHHRNL 378
E+ +LG G FG + KG + K VAVK L + L D E ++ + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
+R++G C + +LV E L+K+L + + K +++ + G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE--- 124
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK--FAGTLGYTAPEYAIH 496
+HRD+ NVLL KI+DFGL++ L ++++ + + + APE +
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 497 GQLSEKVDAYSFGVLVLEIISGTKS--SETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554
+ S K D +SFGVL+ E S + KG E +L++ R+
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG-------------C 231
Query: 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
P C +E ++ +C +RP + V L++
Sbjct: 232 PAGCPREMY----DLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 1e-63
Identities = 53/200 (26%), Positives = 102/200 (51%), Gaps = 8/200 (4%)
Query: 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
F + ++LG G G ++K + K +G ++A K + + I + E++++ + +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
+ G E+ + E+M SLD+ L +K G + + + + +GL YL E
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ 498
+I+HRD+KPSN+L++ + K+ DFG++ L ++ + F GT Y +PE
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTH 179
Query: 499 LSEKVDAYSFGVLVLEIISG 518
S + D +S G+ ++E+ G
Sbjct: 180 YSVQSDIWSMGLSLVEMAVG 199
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 3e-63
Identities = 72/280 (25%), Positives = 135/280 (48%), Gaps = 26/280 (9%)
Query: 321 FSEENKLGEGGFGDIYKGTLKNG-----KIVAVKKLAIGISRRTLSDFENEVRLISNVHH 375
+ + +G G FG++YKG LK VA+K L G + + DF E ++ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 376 RNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLH 435
N+IRL G S+ ++++ EYM N +LDKF EK G + Q ++ G A G+ YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTK--FAGTLGYTAPEY 493
++ +HRD+ N+L++ +L K++DFGL+R+L ++ T + +TAPE
Sbjct: 128 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 494 AIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553
+ + + D +SFG+++ E+++ +R + N + +++
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYG--------------ERPYWELSNHEVMKAINDGF 230
Query: 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
+ + ++ + C Q RP +++V++L
Sbjct: 231 RL-PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-62
Identities = 72/285 (25%), Positives = 118/285 (41%), Gaps = 27/285 (9%)
Query: 324 ENKLGEGGFGDIYKGTLKNGK----IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+G G FG +Y GTL + AVK L +S F E ++ + H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 380 RLLGCCSQGP-ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
LLG C + ++V YM + L F + + K L A+G+ +L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFLA--- 147
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ---SHLSTKFAGTLGYTAPEYAI 495
+ +HRD+ N +LD+ K+ADFGLAR + + + H T + + A E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 496 HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555
+ + K D +SFGVL+ E+++ L + L P
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPP----YPDVNTFDITVYLLQG-------RRLLQP 256
Query: 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLG 600
C + E+ L C A RP+ SE+V+ + + S+ +G
Sbjct: 257 EYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 205 bits (522), Expect = 2e-61
Identities = 71/277 (25%), Positives = 114/277 (41%), Gaps = 31/277 (11%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVH 374
+ FS+ ++G G FG +Y ++N ++VA+KK++ S D EVR + +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYL 434
H N I+ GC + LV EY S+ D + L + + G +GLAYL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYL 131
Query: 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYA 494
H +IHRD+K N+LL + K+ DFG A ++ S F GT + APE
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVI 183
Query: 495 I---HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551
+ GQ KVD +S G+ +E+ + + + +N
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL-----FNMNAMSALYHIAQNE------SP 232
Query: 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVV 588
+L ++ C Q RPT ++
Sbjct: 233 ALQSGHWSEYFR----NFVDSCLQKIPQDRPTSEVLL 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 5e-61
Identities = 61/277 (22%), Positives = 109/277 (39%), Gaps = 28/277 (10%)
Query: 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAI-GISRRTLSDFENEVRLISNVHHR 376
R + ++G G F +YKG VA +L +++ F+ E ++ + H
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 377 NLIRLLGCC----SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLA 432
N++R ++LV E M + +L +L + + K +GL
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQ 126
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDD-DLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAP 491
+LH IIHRD+K N+ + KI D GLA L ++ + GT + AP
Sbjct: 127 FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAP 182
Query: 492 EYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551
E + E VD Y+FG+ +LE+ + + + +
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--------------YRRVTS 227
Query: 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVV 588
+ P K A +V EI C + + R ++ +++
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 2e-60
Identities = 65/279 (23%), Positives = 109/279 (39%), Gaps = 29/279 (10%)
Query: 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRN 377
+ +G G +G K K +GKI+ K+L G ++ +EV L+ + H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 378 LIRLLGCCSQGPE--LILVYEYMANSSLDKFLF--GEKRGSLNWKQRFDIILGTARGLAY 433
++R L +V EY L + ++R L+ + ++ L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 434 LHE--DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAP 491
H D ++HRD+KP+NV LD K+ DFGLAR+L + S F GT Y +P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSP 183
Query: 492 EYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD- 550
E +EK D +S G L+ E+ + + + EL
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCAL------------------MPPFTAFSQKELAGK 225
Query: 551 -ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVV 588
++++ EI RP++ E++
Sbjct: 226 IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 5e-60
Identities = 65/303 (21%), Positives = 113/303 (37%), Gaps = 46/303 (15%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKN------GKIVAVKKLAIGISRRTLSDFENEVRLISNV 373
LG G FG + T VAVK L +E+++++ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 374 -HHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKR-------------------- 412
H N++ LLG C+ + L++EY L +L ++
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 413 -GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL 471
L ++ A+G+ +L +HRD+ NVL+ KI DFGLAR +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 472 PENQSHLS-TKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE 530
+ +++ + + APE G + K D +S+G+L+ EI S + G
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP----YPGI 270
Query: 531 YLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590
+ ++L +NG + P T+E I C + RP+ + +
Sbjct: 271 PVDANFYKLIQNGFKMDQ------PFYATEEIY----IIMQSCWAFDSRKRPSFPNLTSF 320
Query: 591 LKS 593
L
Sbjct: 321 LGC 323
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 9e-60
Identities = 64/298 (21%), Positives = 120/298 (40%), Gaps = 41/298 (13%)
Query: 320 KFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNV 373
+ S LG G FG + + T VAVK L +E++++S +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 374 -HHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEK----------------RGSLN 416
+H N++ LLG C+ G +++ EY L FL ++ +L+
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 417 WKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476
+ A+G+A+L IHRD+ N+LL KI DFGLAR + + +
Sbjct: 144 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 477 H-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKR 535
+ + + + APE + + + D +S+G+ + E+ S S
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY------------ 248
Query: 536 AWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
+ + ++++ E + A ++ +I C + RPT ++V L++
Sbjct: 249 -PGMPVDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 5e-59
Identities = 63/271 (23%), Positives = 114/271 (42%), Gaps = 22/271 (8%)
Query: 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
+ LGEG +G++ + + VAVK + + + + + E+ + ++H N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
++ G +G L EY + L + E + G+ YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH--- 120
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL-PENQSHLSTKFAGTLGYTAPEYAIHG 497
+ I HRDIKP N+LLD+ KI+DFGLA + N+ L K GTL Y APE
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 498 QL-SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556
+ +E VD +S G+++ +++G + + + W+ L+P
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-----------DWKEKKTYLNPW 229
Query: 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
+ A ++ ++R T+ ++
Sbjct: 230 KKIDSAPLALLH---KILVENPSARITIPDI 257
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-58
Identities = 71/290 (24%), Positives = 118/290 (40%), Gaps = 38/290 (13%)
Query: 321 FSEENKLGEGGFGDIYKGTLKNG---KIVAVKKLAIGISRRTLSDFENEVRLISNV-HHR 376
++ +GEG FG + K +K A+K++ S+ DF E+ ++ + HH
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSLDKFLFG--------------EKRGSLNWKQRFD 422
N+I LLG C L L EY + +L FL +L+ +Q
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 423 IILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKF 482
ARG+ YL + + IHRD+ N+L+ ++ KIADFGL+R T
Sbjct: 132 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMG 186
Query: 483 AGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN 542
+ + A E + + D +S+GVL+ EI+S + Y LYE
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--------YCGMTCAELYEK 238
Query: 543 GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
++ P C E ++ C + RP+ ++++ L
Sbjct: 239 LPQGYRLE---KPLNCDDEVY----DLMRQCWREKPYERPSFAQILVSLN 281
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-58
Identities = 78/288 (27%), Positives = 124/288 (43%), Gaps = 35/288 (12%)
Query: 319 RKFSEEN-----KLGEGGFGDIYKGTLK-NGKIVAVKKL--AIGISRRTLSDFENEVRLI 370
R+++ E+ LG+G FG++Y K + I+A+K L A EV +
Sbjct: 1 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 371 SNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARG 430
S++ H N++RL G + L+ EY ++ + L +K + ++ I A
Sbjct: 61 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANA 118
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
L+Y H R+IHRDIKP N+LL + KIADFG + P ++ GTL Y
Sbjct: 119 LSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLP 172
Query: 491 PEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550
PE EKVD +S GVL E + G E + Y+ + E
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---------ETYKRISRVEFT- 222
Query: 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA--LLKSTSS 596
P+ T+ A ++ + + RP + EV+ + + SS
Sbjct: 223 ---FPDFVTEGAR----DLISRLLKHNPSQRPMLREVLEHPWITANSS 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 7e-58
Identities = 70/316 (22%), Positives = 130/316 (41%), Gaps = 36/316 (11%)
Query: 321 FSEENKLGEGGFGDIYKGTLKN-----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHH 375
F + LG G FG +YKG VA+K+L S + + +E ++++V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 376 RNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLH 435
++ RLLG C ++ LD E + ++ + + + A+G+ YL
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS-HLSTKFAGTLGYTAPEYA 494
R++HRD+ NVL+ KI DFGLA+LL + + + + + A E
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 495 IHGQLSEKVDAYSFGVLVLEIISGTKS--SETKGEEGEYLLKRAWRLYENGTHWELMDES 552
+H + + D +S+GV V E+++ E +L++ RL
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL------------- 232
Query: 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK------STSSSLLGNKPLLK 606
P CT + I + C A+SRP E++ + G++ +
Sbjct: 233 PQPPICTIDVY----MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288
Query: 607 PTFVETDYRKTPADTS 622
P+ ++++ + D
Sbjct: 289 PSPTDSNFYRALMDEE 304
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 4e-57
Identities = 71/282 (25%), Positives = 107/282 (37%), Gaps = 27/282 (9%)
Query: 319 RKFSEENKLGEGGFGDIYKGTLK----NGKIVAVKKL--AIGISRRTLSDFENEVRLISN 372
+ KLG+G FG + +G VAVK L + + DF EV + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 373 VHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLA 432
+ HRNLIRL G P + +V E SL + +G + A G+
Sbjct: 68 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH--LSTKFAGTLGYTA 490
YL R IHRD+ N+LL KI DFGL R LP+N H + + A
Sbjct: 126 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 491 PEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550
PE S D + FGV + E+ + + + L ++ + G
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----HKIDKEGERLPR-- 236
Query: 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
P +C ++ + + + C RPT + L
Sbjct: 237 ----PEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 6e-57
Identities = 61/278 (21%), Positives = 109/278 (39%), Gaps = 24/278 (8%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKN----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHH 375
+ +GEG FGD+++G + VA+K S F E + H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 376 RNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLH 435
++++L+G ++ P + ++ E L F ++ SL+ + LAYL
Sbjct: 68 PHIVKLIGVITENP-VWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAI 495
R +HRDI NVL+ + K+ DFGL+R + ++ + ++K + + APE
Sbjct: 126 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 496 HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555
+ + D + FGV + EI+ + + ENG + P
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIENGERLPM------P 231
Query: 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
C + C + RP +E+ A L +
Sbjct: 232 PNCPPTLY----SLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 6e-57
Identities = 68/312 (21%), Positives = 132/312 (42%), Gaps = 47/312 (15%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKN------GKIVAVKKLAIGISRRTLSDFENEVRLISNV 373
K + +LG+G FG +Y+G K VA+K + S R +F NE ++
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 374 HHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKR--------GSLNWKQRFDIIL 425
+ +++RLLG SQG +++ E M L +L + + + +
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL-STKFAG 484
A G+AYL+ + + +HRD+ N ++ +D KI DFG+ R + E + K
Sbjct: 141 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 485 TLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGT 544
+ + +PE G + D +SFGV++ EI + + + Y+ +
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----------------QPYQGLS 240
Query: 545 HWELMDESLDPN--ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSSSLLGNK 602
+ +++ ++ + + + E+ MC Q RP+ E+++ +K
Sbjct: 241 NEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE--------- 291
Query: 603 PLLKPTFVETDY 614
++P F E +
Sbjct: 292 -EMEPGFREVSF 302
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 9e-57
Identities = 60/277 (21%), Positives = 108/277 (38%), Gaps = 42/277 (15%)
Query: 325 NKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLG 383
+LG+G FG +YK K + A K + S L D+ E+ ++++ H N+++LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLD 76
Query: 384 CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRII 443
L ++ E+ A ++D + E L Q + T L YLH+ +II
Sbjct: 77 AFYYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLHD---NKII 132
Query: 444 HRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL---- 499
HRD+K N+L D K+ADFG++ + F GT + APE +
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDRP 191
Query: 500 -SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL----- 553
K D +S G+ ++E+ + ++ +
Sbjct: 192 YDYKADVWSLGITLIEMAEIE------------------PPHHELNPMRVLLKIAKSEPP 233
Query: 554 ---DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
P+ + + C + ++R T S++
Sbjct: 234 TLAQPSRWSSNF----KDFLKKCLEKNVDARWTTSQL 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 4e-55
Identities = 70/282 (24%), Positives = 122/282 (43%), Gaps = 26/282 (9%)
Query: 310 RLKDLVSA---TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFEN 365
+L+ +VS +K++ K+G+G G +Y + G+ VA++++ + + N
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIIN 66
Query: 366 EVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL 425
E+ ++ + N++ L G EL +V EY+A SL + ++ Q +
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCR 123
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT 485
+ L +LH + ++IHRDIK N+LL D K+ DFG + QS ST GT
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGT 179
Query: 486 LGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTH 545
+ APE KVD +S G++ +E+I G E L+ + + NGT
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY-----LNENPLRALYLIATNGT- 233
Query: 546 WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
E +P + + + C R + E+
Sbjct: 234 ----PELQNPEKLSAIFR----DFLNRCLDMDVEKRGSAKEL 267
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 5e-54
Identities = 75/297 (25%), Positives = 122/297 (41%), Gaps = 40/297 (13%)
Query: 320 KFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVR-LISN 372
+ LG G FG + + + VAVK L G + +E++ LI
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 373 VHHRNLIRLLGCCSQ-GPELILVYEYMANSSLDKFLFGEK--------------RGSLNW 417
HH N++ LLG C++ G L+++ E+ +L +L ++ + L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 418 KQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477
+ A+G+ +L + IHRD+ N+LL + KI DFGLAR + ++ +
Sbjct: 134 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 478 L-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRA 536
+ L + APE + + D +SFGVL+ EI S S G + +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEEF 246
Query: 537 WRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
R + GT P+ T E + L C + RPT SE+V L +
Sbjct: 247 CRRLKEGTRMRA------PDYTTPEMY----QTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-52
Identities = 78/297 (26%), Positives = 121/297 (40%), Gaps = 42/297 (14%)
Query: 320 KFSEENKLGEGGFGDIYKGTLK--------NGKIVAVKKLAIGISRRTLSDFENEVRLIS 371
+ LGEG FG + VAVK L + + LSD +E+ ++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 372 NV-HHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLF--------------GEKRGSLN 416
+ H+N+I LLG C+Q L ++ EY + +L ++L L+
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 417 WKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476
K ARG+ YL + IHRD+ NVL+ +D KIADFGLAR +
Sbjct: 134 SKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 477 HLSTK-FAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKR 535
+ T + + APE + + D +SFGVL+ EI + S E
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 245
Query: 536 AWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592
++L + G + P+ CT E + C + + RPT ++V L
Sbjct: 246 LFKLLKEGHRMDK------PSNCTNELY----MMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (451), Expect = 7e-51
Identities = 54/271 (19%), Positives = 109/271 (40%), Gaps = 23/271 (8%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
+ +LG G FG +++ T G A K + E++ +S + H L
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTL 85
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
+ L E++++YE+M+ L + + ++ ++ + + + +GL ++HE+
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA-DEHNKMSEDEAVEYMRQVCKGLCHMHEN- 143
Query: 439 HVRIIHRDIKPSNVLL--DDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH 496
+H D+KP N++ + K+ DFGL L QS T GT + APE A
Sbjct: 144 --NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEG 199
Query: 497 GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556
+ D +S GVL ++SG + ++ N + + +
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---------ETLRNVKSCDWNMDDSAFS 250
Query: 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
+++ + + N+R T+ +
Sbjct: 251 GISEDG----KDFIRKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 1e-49
Identities = 61/277 (22%), Positives = 105/277 (37%), Gaps = 36/277 (12%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHR 376
F LGEG F + L + A+K L I + E ++S + H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE 436
++L +L Y N L K++ K GS + L YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL-PENQSHLSTKFAGTLGYTAPEYAI 495
IIHRD+KP N+LL++D+ +I DFG A++L PE++ + F GT Y +PE
Sbjct: 127 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 496 HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD- 554
+ D ++ G ++ ++++G + G + + + +
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGL------------------PPFRAGNEYLIFQKIIKL 225
Query: 555 ----PNECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
P + +A ++ A R E+
Sbjct: 226 EYDFPEKFFPKA----RDLVEKLLVLDATKRLGCEEM 258
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (429), Expect = 3e-48
Identities = 55/269 (20%), Positives = 106/269 (39%), Gaps = 18/269 (6%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
+ + LG G F ++ + K+VA+K +A ENE+ ++ + H N+
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 69
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
+ L G L L+ + ++ L + ++G + +I + YLH+
Sbjct: 70 VALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ 498
V + LD+D + I+DFGL+++ E+ + + GT GY APE
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQKP 185
Query: 499 LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558
S+ VD +S GV+ ++ G + + +L+E E +S ++
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPPFYDENDA---------KLFEQILKAEYEFDSPYWDDI 236
Query: 559 TKEAAEKVVEIALMCTQSAANSRPTMSEV 587
+ A + + R T +
Sbjct: 237 SDSA----KDFIRHLMEKDPEKRFTCEQA 261
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 169 bits (428), Expect = 1e-47
Identities = 61/326 (18%), Positives = 121/326 (37%), Gaps = 25/326 (7%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
+ +LG G FG +++ G++ K + +NE+ +++ +HH L
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKL 88
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
I L E++L+ E+++ L + + ++ + + + GL ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMHE-- 145
Query: 439 HVRIIHRDIKPSNVLLD--DDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH 496
I+H DIKP N++ + KI DFGLA L ++ T + APE
Sbjct: 146 -HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDR 202
Query: 497 GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556
+ D ++ GVL ++SG + + +N + + +
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---------ETLQNVKRCDWEFDEDAFS 253
Query: 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA--LLKSTSSSLLGNKPLLKPTFVETDY 614
+ EA + Q R T+ + + LK S+L P + +
Sbjct: 254 SVSPEA----KDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKI 309
Query: 615 RKTPADTSTSTALLLLMLQPPSHKSQ 640
++ AD + + S +
Sbjct: 310 KEKYADWPAPQPAIGRIANFSSLRKH 335
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 166 bits (422), Expect = 1e-47
Identities = 58/284 (20%), Positives = 107/284 (37%), Gaps = 36/284 (12%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIG--------ISRRTLSDFENEVRLI 370
+ + LG G + + K AVK + + + EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 371 SNVH-HRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTAR 429
V H N+I+L LV++ M L +L ++ +L+ K+ I+
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLE 121
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYT 489
+ LH+ + I+HRD+KP N+LLDDD+ K+ DFG + L + + GT Y
Sbjct: 122 VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYL 176
Query: 490 APEYA------IHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG 543
APE H ++VD +S GV++ +++G+ + + +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---------LMLRMI 227
Query: 544 THWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
S + ++ + ++ R T E
Sbjct: 228 MSGNYQFGSPEWDDYSDTVK----DLVSRFLVVQPQKRYTAEEA 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 167 bits (423), Expect = 1e-46
Identities = 57/276 (20%), Positives = 100/276 (36%), Gaps = 29/276 (10%)
Query: 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKL-----AIGISRRTLSDFENEVRLISNVH 374
FS +G GGFG++Y GK+ A+K L + + + L+S
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYL 434
++ + +L + + M L L + G + GL ++
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHM 123
Query: 435 HEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYA 494
H +++RD+KP+N+LLD+ +I+D GLA + + H GT GY APE
Sbjct: 124 HNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVL 177
Query: 495 IHGQ-LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESL 553
G D +S G ++ +++ G + ++ + R L
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----------LTMAVE 227
Query: 554 DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589
P+ + E + Q N R A
Sbjct: 228 LPDSFSPELR----SLLEGLLQRDVNRRLGCLGRGA 259
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-46
Identities = 59/271 (21%), Positives = 107/271 (39%), Gaps = 24/271 (8%)
Query: 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
K+ LG G FG +++ + K K + + + + L + E+ +++ HRN+
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIARHRNI 63
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
+ L EL++++E+++ + + + LN ++ + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLHS-- 120
Query: 439 HVRIIHRDIKPSNVLLD--DDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH 496
I H DI+P N++ KI +FG AR L + Y APE H
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQH 177
Query: 497 GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556
+S D +S G LV ++SG + + ++ EN + E +
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---------QIIENIMNAEYTFDEEAFK 228
Query: 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
E + EA ++ SR T SE
Sbjct: 229 EISIEA----MDFVDRLLVKERKSRMTASEA 255
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 162 bits (410), Expect = 7e-46
Identities = 62/281 (22%), Positives = 110/281 (39%), Gaps = 18/281 (6%)
Query: 320 KFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAI-GISRRTLSDFENEVRLISNVHHRNL 378
K+ K+GEG +G +YK G+ A+KK+ + S E+ ++ + H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 379 IRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF 438
++L L+LV+E++ G L +L G+AY H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHD-- 118
Query: 439 HVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ 498
R++HRD+KP N+L++ + + KIADFGLAR + + +
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 499 LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE------- 551
S +D +S G + E+++GT E + + N +W + E
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 552 -----SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
L K E +++ + N R T +
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 161 bits (407), Expect = 3e-45
Identities = 52/287 (18%), Positives = 99/287 (34%), Gaps = 30/287 (10%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
+ ++GEG FG I++GT L N + VA+K R +E R +
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP---RRSDAPQLRDEYRTYKLLAGCTG 62
Query: 379 I-RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
I + +G +LV + + S D L + K + +HE
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLED--LLDLCGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 438 FHVRIIHRDIKPSNVLLDDDLQP-----KIADFGLARLLPENQS------HLSTKFAGTL 486
+++RDIKP N L+ + DFG+ + + + +GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 487 GYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHW 546
Y + + + S + D + G + + + G+ +G + ++ R+ E
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL--PWQGLKAATNKQKYERIGE----- 230
Query: 547 ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
+S E E+ + A ++ P + L
Sbjct: 231 --KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (407), Expect = 3e-45
Identities = 57/285 (20%), Positives = 102/285 (35%), Gaps = 28/285 (9%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
++ K+G G FGDIY GT + G+ VA+K + E ++ +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP---QLHIESKIYKMMQGGVG 64
Query: 379 IRLLG-CCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
I + C ++G ++V E + S D F F ++ + K + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS- 121
Query: 438 FHVRIIHRDIKPSNVL---LDDDLQPKIADFGLARLLPENQSH------LSTKFAGTLGY 488
IHRD+KP N L I DFGLA+ + ++H + GT Y
Sbjct: 122 --KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 489 TAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWEL 548
+ + + S + D S G +++ G+ + +A +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSL---------PWQGLKAATKRQKYERISE 230
Query: 549 MDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKS 593
S K + C + +P S + L ++
Sbjct: 231 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 3e-45
Identities = 60/283 (21%), Positives = 111/283 (39%), Gaps = 20/283 (7%)
Query: 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRN 377
F + K+GEG +G +YK K G++VA+KK+ + + S E+ L+ ++H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
+++LL +L LV+E++ + L KF+ + + +GLA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG 497
++HRD+KP N+L++ + K+ADFGLAR + +
Sbjct: 122 R---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 498 QLSEKVDAYSFGVLVLEIISGT-------------KSSETKGEEGEYLLKRAWRLYENGT 544
S VD +S G + E+++ + T G E + + +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 545 HWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
+ D ++ E + N R +
Sbjct: 239 SFPKW-ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 159 bits (403), Expect = 6e-45
Identities = 60/282 (21%), Positives = 123/282 (43%), Gaps = 28/282 (9%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISR--RTLSDFENEVRLISNVHHR 376
++ LG GG +++ L+ + VAVK L ++R F E + + ++H
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 377 NLIRLLGCC----SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLA 432
++ + GP +V EY+ +L + G + K+ ++I + L
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALN 125
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL--STKFAGTLGYTA 490
+ H++ IIHRD+KP+N+++ K+ DFG+AR + ++ + + + GT Y +
Sbjct: 126 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 491 PEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550
PE A + + D YS G ++ E+++G G+ + + R +
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT--GDSPVSVAYQHVR-----------E 229
Query: 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRP-TMSEVVALL 591
+ + P+ + + + + L +R T +E+ A L
Sbjct: 230 DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 6e-45
Identities = 60/289 (20%), Positives = 113/289 (39%), Gaps = 22/289 (7%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHR 376
+++ + +GEG +G + N VA+KK++ + E++++ H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSLDKFLFGE-KRGSLNWKQRFDIILGTARGLAYLH 435
N+I + + Y+ + L+ K L+ + RGL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH--LSTKFAGTLGYTAPEY 493
++HRD+KPSN+LL+ KI DFGLAR+ + H T++ T Y APE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 494 AIHGQL-SEKVDAYSFGVLVLEIISGT-------------KSSETKGEEGEYLLKRAWRL 539
++ + ++ +D +S G ++ E++S G + L L
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 540 YENGTHWELMDESLDP-NECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
L ++ P N A K +++ + R + +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 158 bits (400), Expect = 5e-44
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 309 YRLKDLVSATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKL--AIGISRRTLSDFEN 365
Y L+D F LG G FG ++ + NG+ A+K L I + + + +
Sbjct: 1 YSLQD-------FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53
Query: 366 EVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL 425
E ++S V H +IR+ G ++ ++ +Y+ L L +R + + +
Sbjct: 54 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 113
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGT 485
L II+RD+KP N+LLD + KI DFG A+ +P+ GT
Sbjct: 114 -----CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGT 164
Query: 486 LGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTK 520
Y APE ++ +D +SFG+L+ E+++G
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 8e-44
Identities = 71/282 (25%), Positives = 119/282 (42%), Gaps = 27/282 (9%)
Query: 325 NKLGEGGFGDIYKGTLKN-GKIVAVKKLAIG----ISRRTLSDFENEVRLISNVHHRNLI 379
+ LGEG F +YK KN +IVA+KK+ +G E++L+ + H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 380 RLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFH 439
LL + LV+++M + + L +L T +GL YLH+ +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 440 VRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL 499
I+HRD+KP+N+LLD++ K+ADFGLA+ T T Y APE ++
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YTHQVVTRWYRAPELLFGARM 177
Query: 500 -SEKVDAYSFGVLVLEIISG-------------TKSSETKGEEGEYLLKRAWRLYENGTH 545
VD ++ G ++ E++ T+ ET G E L + T
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 546 WELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
L + A + ++++ +R T ++
Sbjct: 238 KSFPGIPL--HHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-43
Identities = 70/298 (23%), Positives = 117/298 (39%), Gaps = 33/298 (11%)
Query: 314 LVSATRKFSEENKLGEGGFGDIYKGTLK--NGKIVAVKKLAIGISRRTLS-DFENEV--- 367
L A +++ ++GEG +G ++K G+ VA+K++ + + EV
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 368 RLISNVHHRNLIRLLGCCSQGPE-----LILVYEYMANSSLDKFLFGEKRGSLNWKQRFD 422
R + H N++RL C+ L LV+E++ +L + + D
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKD 120
Query: 423 IILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKF 482
++ RGL +LH R++HRD+KP N+L+ Q K+ADFGLAR+ + T
Sbjct: 121 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSV 175
Query: 483 AGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGT-------------KSSETKGEEG 529
TL Y APE + + VD +S G + E+ K + G G
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 530 EYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
E R L H + + + E ++ L C R +
Sbjct: 236 EEDWPRDVALPRQAFH---SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-43
Identities = 75/309 (24%), Positives = 118/309 (38%), Gaps = 33/309 (10%)
Query: 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKL--AIGISRRTLSDFENEVRLIS-NVHHR 376
F LG+G FG ++ K + A+K L + + + E R++S H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE 436
L + L V EY+ L + + + + GL +LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH 496
I++RD+K N+LLD D KIADFG+ + + +T F GT Y APE +
Sbjct: 122 K---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLG 177
Query: 497 GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556
+ + VD +SFGVL+ E++ G + EE + H MD P
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-------------HSIRMDNPFYPR 224
Query: 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVV---ALLKSTSSSLLGNKPLLKPTFVETD 613
KEA ++ + R + + L + + L K + P F
Sbjct: 225 WLEKEA----KDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKE-IDPPFRPK- 278
Query: 614 YRKTPADTS 622
K+P D S
Sbjct: 279 -VKSPFDCS 286
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-43
Identities = 64/289 (22%), Positives = 114/289 (39%), Gaps = 32/289 (11%)
Query: 321 FSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLI 379
+++ +G G FG +Y+ L +G++VA+KK+ + E++++ + H N++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 380 RLLGCCSQGPE------LILVYEYMANSSLDKFL-FGEKRGSLNWKQRFDIILGTARGLA 432
RL E L LV +Y+ + + + +L + R LA
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 433 YLHEDFHVRIIHRDIKPSNVLLDDD-LQPKIADFGLARLLPENQSHLSTKFAGTLGYTAP 491
Y+H I HRDIKP N+LLD D K+ DFG A+ L + ++S + Y AP
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAP 191
Query: 492 EYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLL--------KRAWRLYEN 542
E + +D +S G ++ E++ G + + R N
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 543 GTHWELMDESLDPNECTKEAAEKVVEIAL----MCTQSAANSRPTMSEV 587
+ E + + TK + A+ + +R T E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 7e-42
Identities = 49/273 (17%), Positives = 100/273 (36%), Gaps = 29/273 (10%)
Query: 324 ENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRL 381
LG G G + + + + A+K L + EV L +++R+
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVRI 70
Query: 382 LGCC----SQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
+ + L++V E + L + + ++ +I+ + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 129
Query: 438 FHVRIIHRDIKPSNVLLDDDLQP---KIADFGLARLLPENQSHLSTKFAGTLGYTAPEYA 494
+ I HRD+KP N+L K+ DFG A+ + S + + T Y APE
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185
Query: 495 IHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554
+ + D +S GV++ ++ G + L + + + + +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPP-----FYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
+E ++E + ++ R T++E
Sbjct: 241 WSEVSEEV----KMLIRNLLKTEPTQRMTITEF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-41
Identities = 73/310 (23%), Positives = 116/310 (37%), Gaps = 41/310 (13%)
Query: 321 FSEEN---------KLGEGGFGDIYKGTLK-NGKIVAVKKL---AIGISRRTLS--DFEN 365
F +EN +LG G F + K K G A K + SRR +S D E
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 366 EVRLISNVHHRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIIL 425
EV ++ + H N+I L ++IL+ E +A L FL ++ SL ++ + +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLK 120
Query: 426 GTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD----LQPKIADFGLARLLPENQSHLSTK 481
G+ YLH I H D+KP N++L D + KI DFGLA +
Sbjct: 121 QILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KN 175
Query: 482 FAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYE 541
GT + APE + L + D +S GV+ ++SG +L
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---------ASPFLGDTKQETLA 226
Query: 542 NGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA--LLKSTSSSLL 599
N + E + + A + R T+ + + +K +
Sbjct: 227 NVSAVNYEFEDEYFSNTSALA----KDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282
Query: 600 GNKPLLKPTF 609
+ P F
Sbjct: 283 LSSAWSHPQF 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 7e-41
Identities = 57/278 (20%), Positives = 101/278 (36%), Gaps = 40/278 (14%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKL-----AIGISRRTLSDFENEVRLISNV 373
++ LG GGFG +Y G + + VA+K + + + EV L+ V
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 374 H--HRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGL 431
+IRLL + +L+ E +RG+L + +
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAV 123
Query: 432 AYLHEDFHVRIIHRDIKPSNVLLD-DDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
+ H ++HRDIK N+L+D + + K+ DFG LL + T F GT Y+
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 177
Query: 491 PEYAIHGQL-SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549
PE+ + + +S G+L+ +++ G + E ++
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCG---------------DIPFEHDEEIIRGQV- 221
Query: 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
+ E + C + RPT E+
Sbjct: 222 ---FFRQRVSSECQ----HLIRWCLALRPSDRPTFEEI 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (370), Expect = 3e-40
Identities = 58/284 (20%), Positives = 112/284 (39%), Gaps = 22/284 (7%)
Query: 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRN 377
K+ + K+GEG +G ++K + +IVA+K++ + S E+ L+ + H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 378 LIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHED 437
++RL +L LV+E+ F G L+ + + +GL + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLK--KYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-- 118
Query: 438 FHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHG 497
++HRD+KP N+L++ + + K+A+FGLAR S +
Sbjct: 119 -SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 498 QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN- 556
S +D +S G + E+ + + G + + LKR +RL T + + P+
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFP-GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 557 -------------ECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
+ ++ + R + E
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-38
Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAI-GISRRTLSDFENEVRLISNVHHRN 377
K+ + K+G+G FG+++K K G+ VA+KK+ + E++++ + H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 378 LIRLLGCCSQGPE--------LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTAR 429
++ L+ C + LV+++ + + +L+ +R +L
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML---- 126
Query: 430 GLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS---HLSTKFAGTL 486
L L+ +I+HRD+K +NVL+ D K+ADFGLAR ++ + T TL
Sbjct: 127 -LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 487 GYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISG 518
Y PE + + +D + G ++ E+ +
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 218
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 55/203 (27%), Positives = 83/203 (40%), Gaps = 9/203 (4%)
Query: 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKL--AIGISRRTLSDFENEVRLISNVHHR 376
F LG+G FG + K G+ A+K L + I++ ++ E R++ N H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE 436
L L L V EY L L + ++ L YLH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHS 123
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH 496
+++RDIK N++LD D KI DFGL + + + + F GT Y APE
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KTFCGTPEYLAPEVLED 179
Query: 497 GQLSEKVDAYSFGVLVLEIISGT 519
VD + GV++ E++ G
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (345), Expect = 3e-36
Identities = 50/202 (24%), Positives = 86/202 (42%), Gaps = 12/202 (5%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHR 376
+F LG G FG + ++G A+K L + + + NE R++ V+
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 377 NLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE 436
L++L L +V EY+A + L + G + YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 437 DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIH 496
+ +I+RD+KP N+L+D ++ DFG A+ + GT APE +
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----WTLCGTPEALAPEIILS 212
Query: 497 GQLSEKVDAYSFGVLVLEIISG 518
++ VD ++ GVL+ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 8e-36
Identities = 62/290 (21%), Positives = 106/290 (36%), Gaps = 32/290 (11%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRN 377
+ + +G G +G + + G VA+KKL S E+RL+ ++ H N
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHEN 78
Query: 378 LIRLLGCCSQGP------ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGL 431
+I LL + + LV +M K L + ++ +GL
Sbjct: 79 VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM----KHEKLGEDRIQFLVYQMLKGL 134
Query: 432 AYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAP 491
Y+H IHRD+KP N+ +++D + KI DFGLAR + S ++
Sbjct: 135 RYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRWYRAPE 188
Query: 492 EYAIHGQLSEKVDAYSFGVLVLEIISGT-------------KSSETKGEEGEYLLKRAWR 538
+ ++ VD +S G ++ E+I+G + + G ++R
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 539 LYENGTHWELMD-ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEV 587
L + E D A+ V + A R T E
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 9e-34
Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 319 RKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHR 376
+++ +G G G + + VA+KKL+ ++ E+ L+ V+H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 377 NLIRLLGCCS------QGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARG 430
N+I LL + + ++ LV E M + + L+ ++ ++ G
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-----QMELDHERMSYLLYQMLCG 131
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
+ +LH IHRD+KPSN+++ D KI DFGLAR S + T + T Y A
Sbjct: 132 IKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRA 186
Query: 491 PEYAIHGQLSEKVDAYSFGVLVLEIISGT 519
PE + E VD +S G ++ E++
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (321), Expect = 3e-33
Identities = 41/205 (20%), Positives = 85/205 (41%), Gaps = 20/205 (9%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRN 377
+ KLG G + ++++ + N + V VK + + E++++ N+ N
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKI----LKPVKKKKIKREIKILENLRGGPN 91
Query: 378 LIRLLGCCSQGPE--LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLH 435
+I L LV+E++ N+ + +L + + L Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH 146
Query: 436 EDFHVRIIHRDIKPSNVLLD-DDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYA 494
+ I+HRD+KP NV++D + + ++ D+GLA Q + + + PE
Sbjct: 147 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELL 201
Query: 495 I-HGQLSEKVDAYSFGVLVLEIISG 518
+ + +D +S G ++ +I
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFR 226
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 7e-33
Identities = 56/240 (23%), Positives = 102/240 (42%), Gaps = 27/240 (11%)
Query: 290 KKIQRGNISEATELQGPVNYRLKDLVSATRKFSEENKLGEGGFGDIYKGTL----KNGKI 345
+++ N++ E G N+ L LG G +G ++ GK+
Sbjct: 7 HELRTANLTGHAEKVGIENFELLK------------VLGTGAYGKVFLVRKISGHDTGKL 54
Query: 346 VAVKKL---AIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILVYEYMANS 401
A+K L I +T E +++ ++ L+ L +L L+ +Y+
Sbjct: 55 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 114
Query: 402 SLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPK 461
L L +R + + Q + + L + II+RDIK N+LLD +
Sbjct: 115 ELFTHLSQRERFTEHEVQIY-----VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 169
Query: 462 IADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQ--LSEKVDAYSFGVLVLEIISGT 519
+ DFGL++ +++ + F GT+ Y AP+ G + VD +S GVL+ E+++G
Sbjct: 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 4e-31
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 318 TRKFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHH 375
++ + +G G +G + K G VAVKKL+ S E+RL+ ++ H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 376 RNLIRLLGCCSQGPEL-----ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARG 430
N+I LL + L + + ++ + L+ K L +I RG
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRG 133
Query: 431 LAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHLSTKFAGTLGYTA 490
L Y+H IHRD+KPSN+ +++D + KI DFGLAR + T + T Y A
Sbjct: 134 LKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 186
Query: 491 PEYAIHGQ-LSEKVDAYSFGVLVLEIISG 518
PE ++ ++ VD +S G ++ E+++G
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (283), Expect = 6e-28
Identities = 48/221 (21%), Positives = 86/221 (38%), Gaps = 29/221 (13%)
Query: 320 KFSEENKLGEGGFGDIYKGT-LKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL 378
++ KLG G F ++ + N VA+K + + E+E++L+ V+ +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADN 71
Query: 379 IRLLGCCSQGP-ELILVYEYMANSSLDKFLFGE-------------KRGSLNWKQRFDII 424
+ + +L+ + + + + + E + + I
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 425 LGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD------LQPKIADFGLARLLPENQSHL 478
GL Y+H IIH DIKP NVL++ +Q KIAD G A E+ ++
Sbjct: 132 KQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN- 188
Query: 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGT 519
T Y +PE + D +S L+ E+I+G
Sbjct: 189 ---SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 107 bits (268), Expect = 2e-27
Identities = 31/201 (15%), Positives = 66/201 (32%), Gaps = 26/201 (12%)
Query: 325 NKLGEGGFGDIYKGTLKNGKIVAVKKLAIGIS---------RRTLSDFENEVRLISNVHH 375
+GEG ++ + VK +G + F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 376 RNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLH 435
R L +L G + VY + N+ L + + ++ + + +++ +A +
Sbjct: 66 RALQKLQGLA-----VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 436 EDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLL--PENQSHLSTKFAGTLGYTAPEY 493
I+H D+ NVL+ ++ I DF + + + L + Y + Y
Sbjct: 121 HRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY 176
Query: 494 AIHGQLSEKVDAYSFGVLVLE 514
+ D S +L+
Sbjct: 177 RT------EKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 658 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.54 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.09 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.55 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.93 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.67 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.22 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-52 Score=419.57 Aligned_cols=255 Identities=26% Similarity=0.441 Sum_probs=201.5
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
++|+..++||+|+||.||+|++.+++.||||++.. .....++|.+|++++++++|||||+++|++.+.+..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS--SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECC--CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 46778899999999999999999999999999975 3445678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++|+|.+++.. ....+++..++.|+.||++||.|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 83 ~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 83 EHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999999853 345699999999999999999999998 99999999999999999999999999998776554444
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 558 (658)
.....||+.|+|||++.+..++.|+|||||||++|||+|++.|+...... ..+...+ ..+.. ...
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i----~~~~~----------~~~ 223 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDI----STGFR----------LYK 223 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHH----HHTCC----------CCC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHHHHHH----HhcCC----------CCC
Confidence 44567999999999999999999999999999999999965554433222 2222221 11110 011
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 559 TKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 559 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
+...+.++.+|+.+||+.||++||||+||++.|+++
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 122235689999999999999999999999999876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-52 Score=420.86 Aligned_cols=256 Identities=29% Similarity=0.466 Sum_probs=213.5
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
.++|++.++||+|+||.||+|++++++.||||++.. .....+.|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECT--TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEcc--CcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 357788899999999999999999889999999975 33456789999999999999999999998865 567999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++|+|.+++.......++|..+++|+.||++||.|||+. +|+||||||+||||++++.+||+|||+++.+......
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999999988655555699999999999999999999998 9999999999999999999999999999988665555
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
..+...||+.|+|||++.++.++.++|||||||++|||+||+.|+....... .+. +....+... .
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~----~~i~~~~~~----------~ 230 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVI----QNLERGYRM----------V 230 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHH----HHHHTTCCC----------C
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHH----HHHHhcCCC----------C
Confidence 5556789999999999999999999999999999999999776654433322 121 122221111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.+...+..+.+|+.+||+.||++||||++|+++|+..
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 1122335689999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-52 Score=423.03 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=219.3
Q ss_pred HHhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 316 SATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 316 ~a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
...++|+..++||+|+||+||+|+++ +++.||||++.. .....++|.+|+++|++++|||||++++++.+++..++|
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCT--TCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECC--ccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 33467888999999999999999986 588999999875 344567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++|+|.+++.......+++..++.|+.||++||.|||++ +|+||||||+||||++++++||+|||+++.....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999999777777899999999999999999999998 9999999999999999999999999999987665
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
.....+...|++.|+|||++.++.++.|+|||||||++|||++|+.|+....... .+ .+....+..
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~----~~~i~~~~~--------- 234 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QV----YELLEKDYR--------- 234 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HH----HHHHHTTCC---------
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HH----HHHHhcCCC---------
Confidence 5444555678999999999999999999999999999999999877765433321 11 222222211
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
...+...+.++.+|+..||+.||++|||+.||++.|+.+
T Consensus 235 -~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 235 -MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111222345699999999999999999999999999876
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-51 Score=422.64 Aligned_cols=267 Identities=28% Similarity=0.497 Sum_probs=207.7
Q ss_pred ccchHHHHHHhcCC---------CccCcccccCceEEEEEEecC-C---cEEEEEEcccccccccHHHHHHHHHHHhccC
Q 006168 308 NYRLKDLVSATRKF---------SEENKLGEGGFGDIYKGTLKN-G---KIVAVKKLAIGISRRTLSDFENEVRLISNVH 374 (658)
Q Consensus 308 ~~~~~~l~~a~~~f---------~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 374 (658)
.++++++..++++| +..+.||+|+||+||+|+++. + ..||||++.........++|.+|+++|++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 35667777776554 445789999999999999763 3 3689999876556666788999999999999
Q ss_pred CCccceeeeEeecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE
Q 006168 375 HRNLIRLLGCCSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL 454 (658)
Q Consensus 375 h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll 454 (658)
|||||+++|++.+.+..++||||+++|+|.+++.. ..+.++|.+++.++.||++||.|||+. +|+||||||+||||
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV 161 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence 99999999999999999999999999999998853 345699999999999999999999998 99999999999999
Q ss_pred cCCCCeEEeeccCccccCCCCccc----cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcch
Q 006168 455 DDDLQPKIADFGLARLLPENQSHL----STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEG 529 (658)
Q Consensus 455 ~~~~~~kl~DfGla~~~~~~~~~~----~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~ 529 (658)
+.++++||+|||+++.+....... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||......
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~- 240 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ- 240 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-
Confidence 999999999999998775433221 123467899999999999999999999999999999998 89998654332
Q ss_pred hhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 530 EYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 530 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.+.. ....+.. ...+...+..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 241 -~~~~----~i~~~~~----------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 241 -DVIN----AIEQDYR----------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp -HHHH----HHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -HHHH----HHHcCCC----------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2221 1221111 111223345689999999999999999999999999876
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=415.18 Aligned_cols=260 Identities=27% Similarity=0.477 Sum_probs=205.5
Q ss_pred hcCCCccCcccccCceEEEEEEecCCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|.+.+.||+|+||+||+|+++ ..||||++... ......+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467889999999999999999875 35999998653 344557889999999999999999999999865 56899999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+++|+|.+++.. ....+++..++.|+.||++||+|||++ +|+||||||+||||+.++++||+|||+++.......
T Consensus 84 y~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999999953 345699999999999999999999998 999999999999999999999999999987654332
Q ss_pred -cccccccCCccccccccccc---CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 477 -HLSTKFAGTLGYTAPEYAIH---GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 477 -~~~~~~~gt~~y~APE~~~~---~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
...+...||+.|+|||++.. +.++.++|||||||++|||+||+.||........ +... ...+.....+
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~----~~~~~~~p~~--- 231 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFM----VGRGYLSPDL--- 231 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHH----HHHTSCCCCG---
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HHHH----HhcCCCCCcc---
Confidence 23446789999999999864 3589999999999999999999999976543221 1111 1111111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...+...+..+.+|+.+||+.||++|||++||++.|+.+.
T Consensus 232 ---~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 232 ---SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp ---GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1112223456999999999999999999999999998874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=414.86 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=205.7
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|++.+.||+|+||+||+|+++ +|+.||||++.........+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57889999999999999999986 68999999997644444556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC-c
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ-S 476 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~-~ 476 (658)
+++|+|.+++. ....+++.++..++.||++||.|||+. +|+||||||+|||+++++++||+|||+++.+.... .
T Consensus 85 ~~gg~L~~~l~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSB--TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999993 456799999999999999999999998 99999999999999999999999999999764433 2
Q ss_pred cccccccCCcccccccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
...+..+||+.|+|||++.+..+ +.++|||||||++|||++|+.||............. ......
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~-----~~~~~~--------- 225 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKTY--------- 225 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH-----HTTCTT---------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH-----hcCCCC---------
Confidence 23446789999999999988876 578999999999999999999997655432222111 111100
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.......+.++.+|+.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0011122356889999999999999999999865
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=404.32 Aligned_cols=254 Identities=26% Similarity=0.439 Sum_probs=215.7
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
++|+..++||+|+||+||+|++++++.||||+++.. ....++|.+|++++++++||||++++|++.+.+..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~--~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC--cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 578899999999999999999998999999999753 345678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++|+|.+++.. ....+++..+++++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++.+.......
T Consensus 82 ~~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 82 ANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TTEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99999999743 345699999999999999999999998 99999999999999999999999999998776655544
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
.....||+.|+|||.+.+..++.|+||||||+++|||+| |+.||...... .+.. ....+... .
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~----~i~~~~~~----------~ 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAE----HIAQGLRL----------Y 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHH----HHHTTCCC----------C
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHH----HHHhCCCC----------C
Confidence 556789999999999999999999999999999999998 78888755432 2221 12222110 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.+...+..+.+++.+||+.||++|||+++|++.|..+
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1122335699999999999999999999999998653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-51 Score=413.74 Aligned_cols=256 Identities=31% Similarity=0.511 Sum_probs=207.2
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEecc
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYM 398 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 398 (658)
++|++.+.||+|+||.||+|++++++.||||++... ....+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~--~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc--cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 578899999999999999999998889999999753 4456789999999999999999999999855 5689999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL 478 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 478 (658)
++|+|..++.......++|.+++.++.||++||+|||+. +|+||||||+||||+.++++||+|||+++.........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999999998665556799999999999999999999998 99999999999999999999999999998876555444
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNEC 558 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 558 (658)
.+...||+.|+|||++..+.++.++||||||+++|||++|+.|+.......+ +... ...+.. ...
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-~~~~----i~~~~~----------~~~ 235 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQ----VERGYR----------MPC 235 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHH----HHTTCC----------CCC
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH-HHHH----HHhcCC----------CCC
Confidence 5567899999999999999999999999999999999998777655443222 2221 111111 111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 559 TKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 559 ~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
+...++++.+++.+||+.||++||||++|+++|+...
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 2233456999999999999999999999999999863
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=408.51 Aligned_cols=249 Identities=25% Similarity=0.410 Sum_probs=209.3
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|+..++||+|+||+||+|+.. +|+.||||++... .....+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGG-GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecc-cChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 47999999999999999999975 6999999998753 344567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++|+|.+++.. ..+++.++..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++.+.....
T Consensus 99 ~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 99 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp CTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred cCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 999999998843 4699999999999999999999998 999999999999999999999999999998754332
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ......+.. ...
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~---~~~~~~~~~---------~~~ 237 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--AL---YLIATNGTP---------ELQ 237 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH---HHHHHHCSC---------CCS
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH--HH---HHHHhCCCC---------CCC
Confidence 3345689999999999999999999999999999999999999996543321 11 111111110 011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.+...+..+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12233457999999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=404.65 Aligned_cols=246 Identities=29% Similarity=0.423 Sum_probs=207.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|++.+.||+|+||.||+++.+ +++.||+|++... ......+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999986 6889999998643 22345678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++. ....+++..+..++.||++||.|||+. +|+||||||+|||++.++++||+|||+++......
T Consensus 86 Ey~~~g~L~~~l~--~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 86 EYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp ECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred eecCCCcHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 9999999999995 345699999999999999999999998 99999999999999999999999999998764432
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .......
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~----~i~~~~~---------- 221 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYK----RISRVEF---------- 221 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH----HHHTTCC----------
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--HHHH----HHHcCCC----------
Confidence 33568999999999999999999999999999999999999999654321 1211 1111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
..+...+.++.+++.+||+.||++|||++|+++
T Consensus 222 -~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111223456899999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=410.53 Aligned_cols=257 Identities=27% Similarity=0.501 Sum_probs=204.7
Q ss_pred cCCCccCcccccCceEEEEEEecCC-----cEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNG-----KIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
+.|+..+.||+|+||.||+|.+++. ..||||++..........+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999997642 37999999765555666789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+.+++|.+++.. ....++|.+++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 87 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 9999999999988743 345799999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcc--ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 474 NQSH--LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 474 ~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
.... ......||+.|+|||++.++.++.++|||||||++|||++|+.|+....... .+. +....+..
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~----~~i~~~~~------ 231 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVM----KAINDGFR------ 231 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHH----HHHHTTCC------
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HHH----HHHhccCC------
Confidence 3322 2234578999999999999999999999999999999999777665433322 222 22222211
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
...+...+..+.+|+.+||+.||++||||.||+++|+.+
T Consensus 232 ----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 232 ----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp ----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 111223345699999999999999999999999999876
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=407.43 Aligned_cols=255 Identities=26% Similarity=0.454 Sum_probs=210.0
Q ss_pred cCCCccC-cccccCceEEEEEEec---CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEE
Q 006168 319 RKFSEEN-KLGEGGFGDIYKGTLK---NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 319 ~~f~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 394 (658)
++|...+ +||+|+||+||+|.++ ++..||||++.........++|.+|+++|++++|||||+++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455555 4999999999999865 3557999999876556667889999999999999999999999865 568999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++|+|.+++. ..+..+++..++.++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 87 mE~~~~g~L~~~l~-~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHT-TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhh-ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999874 3345799999999999999999999998 9999999999999999999999999999987654
Q ss_pred Cccc--cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 475 QSHL--STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 475 ~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
.... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+. .....+...+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~----~~i~~~~~~~---- 232 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVM----AFIEQGKRME---- 232 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHH----HHHHTTCCCC----
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHH----HHHHcCCCCC----
Confidence 4322 234578999999999999999999999999999999998 89999765432 121 2222222111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.+...+.++.+|+.+||+.||++|||+.+|++.|+..
T Consensus 233 ------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 233 ------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1222345689999999999999999999999999865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-50 Score=405.35 Aligned_cols=254 Identities=25% Similarity=0.381 Sum_probs=196.3
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeec--CCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ--GPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 394 (658)
++|++.+.||+|+||+||+|+.+ +|+.||||++.... .....+.+.+|++++++++|||||++++++.+ .+.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57889999999999999999976 68999999987542 34445678999999999999999999999864 4568999
Q ss_pred EeccCCCCHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHhHhcC--CCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 395 YEYMANSSLDKFLFGE--KRGSLNWKQRFDIILGTARGLAYLHEDF--HVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998542 3457999999999999999999999872 12499999999999999999999999999998
Q ss_pred cCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccc
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD 550 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 550 (658)
+.... ...+...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+... ...+....
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~~----i~~~~~~~--- 233 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGK----IREGKFRR--- 233 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHH----HHHTCCCC---
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHHHH----HHcCCCCC---
Confidence 75433 233457899999999999999999999999999999999999999975432 222221 12222111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 551 ESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 551 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus 234 -------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 -------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11223456999999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=403.28 Aligned_cols=248 Identities=27% Similarity=0.436 Sum_probs=200.7
Q ss_pred CcccccCceEEEEEEecC---CcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEeccCC
Q 006168 325 NKLGEGGFGDIYKGTLKN---GKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEYMAN 400 (658)
Q Consensus 325 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 400 (658)
++||+|+||+||+|.+++ ++.||||++.... .....++|.+|+++|++++|||||+++|++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998753 4689999986532 23345679999999999999999999999965 467899999999
Q ss_pred CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCccc--
Q 006168 401 SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSHL-- 478 (658)
Q Consensus 401 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~~-- 478 (658)
|+|.+++. ....+++..++.|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~--~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHH--HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHh--hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 99999985 345699999999999999999999998 99999999999999999999999999999875544332
Q ss_pred cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCCC
Q 006168 479 STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNE 557 (658)
Q Consensus 479 ~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 557 (658)
.....||+.|+|||.+.++.++.++|||||||++|||+| |+.||...... .+. .....+... .
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~----~~i~~~~~~----------~ 230 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVT----AMLEKGERM----------G 230 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH----HHHHTTCCC----------C
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHH----HHHHcCCCC----------C
Confidence 235678999999999999999999999999999999998 89998754321 121 222222211 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 558 CTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 558 ~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.+...+.++.+|+.+||+.||++|||+++|+++|+..
T Consensus 231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1222345689999999999999999999999988754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=414.22 Aligned_cols=257 Identities=25% Similarity=0.437 Sum_probs=208.2
Q ss_pred hcCCCccCcccccCceEEEEEEecC------CcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN------GKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 390 (658)
.++|++.++||+|+||+||+|++.. ...||+|.+...........+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3678889999999999999999753 2369999987655555567899999999998 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCC
Q 006168 391 LILVYEYMANSSLDKFLFGEKR---------------------GSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKP 449 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~ 449 (658)
.++||||+++|+|.++|..... ..+++..++.++.||++||.|||++ +|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 9999999999999999965432 3489999999999999999999998 999999999
Q ss_pred CcEEEcCCCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCc
Q 006168 450 SNVLLDDDLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGE 527 (658)
Q Consensus 450 ~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~ 527 (658)
+|||++.++++||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876444332 2335678999999999999999999999999999999998 8999876443
Q ss_pred chhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 006168 528 EGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLK 592 (658)
Q Consensus 528 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~ 592 (658)
... + .+....+... ..+...+.++.+|+.+||+.||++|||++||+++|.
T Consensus 273 ~~~-~----~~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DAN-F----YKLIQNGFKM----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHH-H----HHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH-H----HHHHhcCCCC----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 221 1 1222222111 112223456999999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-50 Score=414.53 Aligned_cols=264 Identities=22% Similarity=0.361 Sum_probs=207.8
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|++.++||+|+||+||+|+.. +|+.||+|++...........+.+|+.+|++++|||||++++++.+.++.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 578999999999999999999975 6899999999765555556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE-DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
|+++|+|.+++.. .+.+++..+..++.||++||.|||+ + +|+||||||+|||++.++++||+|||+++.+...
T Consensus 85 y~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp CCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred cCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999999953 3569999999999999999999997 5 8999999999999999999999999999865322
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHH--HHhh------------
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAW--RLYE------------ 541 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~--~~~~------------ 541 (658)
..+..+||+.|+|||++.+.+|+.++|||||||++|||++|+.||............... ....
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 234568999999999999999999999999999999999999999765432111100000 0000
Q ss_pred ------c----Ccccccccc---cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 542 ------N----GTHWELMDE---SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 542 ------~----~~~~~~~d~---~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
. ....+..+. ...+.......+.++.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 000000000 00000001112356899999999999999999999987
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=404.62 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=206.6
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
+.|++.+.||+|+||+||+|+++ +++.||||++... .....+.+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 46788999999999999999976 6899999998753 445567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++|+|.+++.. ....+++.++..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++...... .
T Consensus 91 ~~~g~L~~~~~~-~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 91 CAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp CTTEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred CCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 999999998753 235699999999999999999999998 99999999999999999999999999997653221 1
Q ss_pred ccccccCCcccccccccc-----cCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 478 LSTKFAGTLGYTAPEYAI-----HGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~-----~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
......||+.|+|||++. ...|+.++|||||||++|||++|+.||....... .... .... ...
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~~~---i~~~-~~~------ 233 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VLLK---IAKS-EPP------ 233 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHH---HHHS-CCC------
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HHHH---HHcC-CCC------
Confidence 233568999999999984 4568999999999999999999999997654321 1111 1111 110
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 234 --~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 --TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112233457899999999999999999999876
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-49 Score=395.35 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=198.2
Q ss_pred CccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeec----CCeEEEEE
Q 006168 322 SEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ----GPELILVY 395 (658)
Q Consensus 322 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 395 (658)
...++||+|+||+||+|+++ +++.||+|++... ......+.|.+|+++|++++|||||++++++.. ...+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45568999999999999976 5889999998653 234446779999999999999999999999854 45689999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc-CCCCeEEeeccCccccCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD-DDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~-~~~~~kl~DfGla~~~~~~ 474 (658)
||+++|+|.+++.. ...+++..+..++.||++||.|||++ ..+|+||||||+|||++ +++.+||+|||+++.....
T Consensus 92 E~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp ECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 99999999999953 45799999999999999999999997 11399999999999996 5789999999999865332
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
......||+.|+|||++.+ +++.++|||||||++|||++|+.||....... .+ .+....+.....+
T Consensus 169 ---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-~~----~~~i~~~~~~~~~----- 234 (270)
T d1t4ha_ 169 ---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QI----YRRVTSGVKPASF----- 234 (270)
T ss_dssp ---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HH----HHHHTTTCCCGGG-----
T ss_pred ---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-HH----HHHHHcCCCCccc-----
Confidence 2345689999999998764 69999999999999999999999997544321 11 1222222111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 235 ----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 ----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1122345899999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-49 Score=406.90 Aligned_cols=263 Identities=25% Similarity=0.452 Sum_probs=214.5
Q ss_pred HHHHHhcCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEee
Q 006168 313 DLVSATRKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCS 386 (658)
Q Consensus 313 ~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 386 (658)
+++...++|++.+.||+|+||+||+|+++ +++.||||++.........++|.+|++++++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445678999999999999999999874 357899999986555556778999999999999999999999999
Q ss_pred cCCeEEEEEeccCCCCHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeee
Q 006168 387 QGPELILVYEYMANSSLDKFLFGEK----------------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIH 444 (658)
Q Consensus 387 ~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 444 (658)
..+..++||||+++|+|.+++.... ...+++..++.|+.||+.||+|||+. +|+|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence 9999999999999999999985422 12489999999999999999999998 9999
Q ss_pred cCcCCCcEEEcCCCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCC-CC
Q 006168 445 RDIKPSNVLLDDDLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTK-SS 522 (658)
Q Consensus 445 ~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~-p~ 522 (658)
|||||+|||++.++.+||+|||+++........ ..+...||+.|+|||.+.+..++.|+|||||||++|||++|.. |+
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999999999999999999876443322 2345678999999999999999999999999999999999965 55
Q ss_pred CCCCcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 523 ETKGEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 523 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
...... .+. ....++...+ .+...+.++.+|+.+||+.||++||||.||+++|+++
T Consensus 244 ~~~~~~--e~~----~~v~~~~~~~----------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 244 YGMAHE--EVI----YYVRDGNILA----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTSCHH--HHH----HHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCHH--HHH----HHHHcCCCCC----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 443221 121 1222222211 1222334689999999999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=402.38 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=206.1
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|++.+.||+|+||+||+|+.+ +|+.||||++... ......+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46889999999999999999975 6899999998643 23445678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++. ..+.+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 88 Ey~~gg~L~~~~~--~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhh--ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999884 346799999999999999999999998 99999999999999999999999999999875433
Q ss_pred c-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 476 S-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 476 ~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... ...+..
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~----i~~~~~--------- 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQK----IIKLEY--------- 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HHTTCC---------
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH--HHHHH----HHcCCC---------
Confidence 2 2334568999999999999999999999999999999999999999754321 12111 111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.++...+.++.+|+.+||+.||.+|||++|++..
T Consensus 228 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp --CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1112234568999999999999999999997543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-49 Score=404.32 Aligned_cols=254 Identities=22% Similarity=0.361 Sum_probs=193.2
Q ss_pred HhcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 317 ATRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 317 a~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
..+.|++.+.||+|+||+||+|+.+ +++.||||++...........+.+|+++|++++|||||++++++.+++..++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467899999999999999999976 689999999976544444567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc---CCCCeEEeeccCccccC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD---DDLQPKIADFGLARLLP 472 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~---~~~~~kl~DfGla~~~~ 472 (658)
||+++|+|.++|. ..+.+++.++..++.||+.||.|||+. +|+||||||+|||+. +++.+||+|||+++...
T Consensus 87 E~~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 87 QLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCCSCBHHHHHH--TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred eccCCCcHHHhhh--cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999994 456799999999999999999999998 999999999999994 57899999999998764
Q ss_pred CCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 473 ENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 473 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... ...+...
T Consensus 162 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~----i~~~~~~------ 227 (307)
T d1a06a_ 162 PGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KLFEQ----ILKAEYE------ 227 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH----HHTTCCC------
T ss_pred CCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HHHHH----HhccCCC------
Confidence 332 233568999999999999999999999999999999999999999754332 11111 1111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+ ........+..+.+|+..||+.||++|||+.|+++.
T Consensus 228 ~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 F-DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp C-CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C-CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 111122334569999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-49 Score=404.46 Aligned_cols=246 Identities=29% Similarity=0.462 Sum_probs=203.3
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
+.|+..++||+|+||+||+|+.. +++.||||++.... .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45888999999999999999975 68899999987532 2334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+.+|+|..++. ....+++.++..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++....
T Consensus 95 E~~~~g~l~~~~~--~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 9999999987763 346799999999999999999999998 999999999999999999999999999986533
Q ss_pred ccccccccCCccccccccccc---CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 476 SHLSTKFAGTLGYTAPEYAIH---GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~---~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
.....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||....... . ..+.... ... .
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--~---~~~i~~~-~~~-----~ 233 (309)
T d1u5ra_ 168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--A---LYHIAQN-ESP-----A 233 (309)
T ss_dssp ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--H---HHHHHHS-CCC-----C
T ss_pred ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--H---HHHHHhC-CCC-----C
Confidence 234679999999999863 568999999999999999999999997543311 1 1111111 111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
+... ..+..+.+|+.+||+.||.+|||+.|+++
T Consensus 234 ~~~~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 LQSG----HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CSCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC----CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1111 22456999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=394.32 Aligned_cols=256 Identities=24% Similarity=0.377 Sum_probs=199.9
Q ss_pred hcCCCccCcccccCceEEEEEEecC----CcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN----GKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
.++|+..+.||+|+||.||+|++.. +..||||.+.........+.|.+|++++++++|||||+++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578889999999999999998753 45699999876555555678999999999999999999999996 467899
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
||||+++|+|.+++.. ....+++..++.++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++.+..
T Consensus 85 v~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccC
Confidence 9999999999998753 445799999999999999999999998 999999999999999999999999999998765
Q ss_pred CCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCccccccccc
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDES 552 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 552 (658)
......+...||+.|+|||++.++.++.++|||||||++|||++ |+.|+...... .+... ...+...
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~----i~~~~~~------ 228 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR----IENGERL------ 228 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH----HHTTCCC------
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHH----HHcCCCC------
Confidence 55555556788999999999999999999999999999999998 78888655432 22221 2222211
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 553 LDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 553 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+...+..+.+|+.+||+.||++|||+.||++.|+.+
T Consensus 229 ----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 229 ----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11222345699999999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=399.78 Aligned_cols=267 Identities=25% Similarity=0.411 Sum_probs=204.4
Q ss_pred chHHHHHHhcCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceee
Q 006168 310 RLKDLVSATRKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLL 382 (658)
Q Consensus 310 ~~~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 382 (658)
..++++...++|++.++||+|+||.||+|++. +++.||||++.........+.+.+|...+.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 33444444568899999999999999999864 24689999998655556667888898888887 689999999
Q ss_pred eEeec-CCeEEEEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCc
Q 006168 383 GCCSQ-GPELILVYEYMANSSLDKFLFGEK--------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDI 447 (658)
Q Consensus 383 ~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Di 447 (658)
+++.+ ++..++||||+++|+|.++|.... ...+++.+++.++.||++||.|||++ +|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 99865 456899999999999999996432 23589999999999999999999998 9999999
Q ss_pred CCCcEEEcCCCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCC-CCCCC
Q 006168 448 KPSNVLLDDDLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTK-SSETK 525 (658)
Q Consensus 448 k~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~-p~~~~ 525 (658)
||+||||++++++||+|||+++........ ..+...||+.|+|||++.++.++.++|||||||++|||+||.. ||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544332 3345789999999999999999999999999999999999754 56543
Q ss_pred CcchhhHHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 526 GEEGEYLLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 526 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
.... .+. .....+...+ .+...+.++.+++.+||+.||++|||+.||+++|+++
T Consensus 241 ~~~~-~~~----~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 241 KIDE-EFC----RRLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CCSH-HHH----HHHHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHH-HHH----HHHhcCCCCC----------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 3322 221 1222221111 1122234689999999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=392.92 Aligned_cols=250 Identities=28% Similarity=0.443 Sum_probs=199.0
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeec-CCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ-GPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E~ 397 (658)
++|+..+.||+|+||.||+|+++ |+.||||+++. ....+.|.+|++++++++||||++++|++.+ .+.+++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC---CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECc---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 46777899999999999999995 78899999964 2345789999999999999999999999865 4568999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+++|+|.++|.......++|..+++|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999999655445699999999999999999999998 9999999999999999999999999999865432
Q ss_pred ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCCC
Q 006168 478 LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDPN 556 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 556 (658)
.....+|..|+|||++.++.++.++||||||+++|||+| |+.|+..... ..+... ..++...
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~----i~~~~~~---------- 219 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPR----VEKGYKM---------- 219 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHH----HTTTCCC----------
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHH----HHcCCCC----------
Confidence 223467899999999999999999999999999999998 5666654322 222222 1222111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 557 ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 557 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
+.+...+.++.+|+.+||+.||.+|||+.+|+++|+.+.
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 112223356899999999999999999999999998763
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=395.84 Aligned_cols=252 Identities=24% Similarity=0.312 Sum_probs=207.3
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-----ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-----SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 391 (658)
.++|++.+.||+|+||+||+|+.+ +|+.||||++.... .....+.+.+|+++|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999985 68999999986432 223467899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC----CeEEeeccC
Q 006168 392 ILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL----QPKIADFGL 467 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~----~~kl~DfGl 467 (658)
++||||+++|+|.+++.. .+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~--~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcc--ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 999999999999999953 35799999999999999999999998 999999999999998776 599999999
Q ss_pred ccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccc
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWE 547 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 547 (658)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ........
T Consensus 164 a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~----~i~~~~~~- 234 (293)
T d1jksa_ 164 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLA----NVSAVNYE- 234 (293)
T ss_dssp CEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----HHHTTCCC-
T ss_pred hhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH--HHHH----HHHhcCCC-
Confidence 98775433 234567899999999999999999999999999999999999999754432 1111 11111100
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 548 LMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 548 ~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
. +.......+..+.+|+.+||+.||++|||++|+++
T Consensus 235 -----~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 -----F-EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -----C-CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----C-CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00001112356889999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-47 Score=401.42 Aligned_cols=253 Identities=21% Similarity=0.356 Sum_probs=209.0
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|++.+.||+|+||.||+|+.+ +|+.||||++... .....+.+.+|+++|++++|||||++++++.+.+..++|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999999999975 6899999999753 33445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc--CCCCeEEeeccCccccCCC
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD--DDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~--~~~~~kl~DfGla~~~~~~ 474 (658)
|+++|+|.+++.. ..+.+++..+..|+.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.+...
T Consensus 104 ~~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 104 FMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred cCCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999999843 345699999999999999999999998 999999999999995 4678999999999987544
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+ ..... . +
T Consensus 180 ~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i----~~~~~-~-----~- 244 (350)
T d1koaa2 180 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNV----KSCDW-N-----M- 244 (350)
T ss_dssp SC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH----HHTCC-C-----S-
T ss_pred cc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHH----HhCCC-C-----C-
Confidence 32 3456899999999999999999999999999999999999999975432 1222211 11110 0 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+.......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011112234568999999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.7e-48 Score=404.11 Aligned_cols=253 Identities=21% Similarity=0.321 Sum_probs=208.8
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .......+.+|+++|++++|||||++++++.+++.+++|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc-chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 357999999999999999999975 6999999998753 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc--CCCCeEEeeccCccccCCC
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD--DDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~--~~~~~kl~DfGla~~~~~~ 474 (658)
|+++|+|.+++. .....+++.+++.|+.||+.||.|||+. +|+||||||+||||+ .++.+||+|||+++.+...
T Consensus 107 ~~~gg~L~~~~~-~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 107 FLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCCBHHHHTT-CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred cCCCChHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999998873 2345699999999999999999999998 999999999999997 5789999999999987554
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+ . .+.. ..
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i---~-~~~~------~~- 247 (352)
T d1koba_ 183 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQNV---K-RCDW------EF- 247 (352)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHH---H-HCCC------CC-
T ss_pred C--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH---H-hCCC------CC-
Confidence 3 234568999999999999999999999999999999999999999754332 121111 1 1110 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+.......+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111112234568999999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-48 Score=398.55 Aligned_cols=255 Identities=26% Similarity=0.447 Sum_probs=204.0
Q ss_pred cCCCccCcccccCceEEEEEEec-CCc----EEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGK----IVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 393 (658)
.+|++.++||+|+||+||+|++. +|+ +||+|++......+..++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 36888999999999999999975 343 68999987666667788999999999999999999999999865 5678
Q ss_pred EEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCC
Q 006168 394 VYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPE 473 (658)
Q Consensus 394 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~ 473 (658)
++||+.+|+|.+++.. ....+++..+++++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++.+..
T Consensus 88 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 8999999999998854 356799999999999999999999998 999999999999999999999999999998765
Q ss_pred CCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 474 NQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 474 ~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
..... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+.. ....+...
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~----~i~~~~~~----- 232 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISS----ILEKGERL----- 232 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHH----HHHHTCCC-----
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHH----HHHcCCCC-----
Confidence 44332 335678999999999999999999999999999999999 77787654332 1221 11111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..+...+..+.+|+.+||+.||.+|||+.||++.|+.+
T Consensus 233 -----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 233 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 11222345689999999999999999999999998876
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=392.03 Aligned_cols=254 Identities=27% Similarity=0.419 Sum_probs=206.0
Q ss_pred cCcccccCceEEEEEEecCC----cEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeec-CCeEEEEEecc
Q 006168 324 ENKLGEGGFGDIYKGTLKNG----KIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ-GPELILVYEYM 398 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E~~ 398 (658)
.++||+|+||+||+|++.++ ..||||++.........++|.+|+++|++++||||++++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46799999999999997542 35899999765566667889999999999999999999999865 56899999999
Q ss_pred CCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc-
Q 006168 399 ANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH- 477 (658)
Q Consensus 399 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~- 477 (658)
++|+|.+++.. ....+++..+++++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999999853 445688999999999999999999998 9999999999999999999999999999877544322
Q ss_pred --ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 478 --LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 478 --~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
......||+.|+|||.+.++.++.++||||||+++|||+||+.|+....... .+... ...+.... .+
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~----i~~g~~~~------~p 256 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVY----LLQGRRLL------QP 256 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHH----HHTTCCCC------CC
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHH----HHcCCCCC------Cc
Confidence 2234678999999999999999999999999999999999888876543221 11111 11221111 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTSS 596 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~~ 596 (658)
.. .+..+.+|+.+||+.||++||||.||++.|+++..
T Consensus 257 ~~----~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 257 EY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cc----CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 22 23568999999999999999999999999998853
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=394.37 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=204.6
Q ss_pred cCCCccCcccccCceEEEEEEecC-Cc--EEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN-GK--IVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 394 (658)
++|+..++||+|+||.||+|++++ |. .||||++.........++|.+|+++|+++ +|||||+++|++.+.+.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578888999999999999999864 44 47888886555555677899999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCe
Q 006168 395 YEYMANSSLDKFLFGE--------------KRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQP 460 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~ 460 (658)
|||+++|+|.++|+.. ....+++..++.++.||++||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999643 235699999999999999999999998 99999999999999999999
Q ss_pred EEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCC-CCCCCCcchhhHHHHHHHH
Q 006168 461 KIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTK-SSETKGEEGEYLLKRAWRL 539 (658)
Q Consensus 461 kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~-p~~~~~~~~~~l~~~~~~~ 539 (658)
||+|||+++....... .....||..|+|||.+.++.++.++|||||||++|||++|.. |+..... ..+. ..
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~--~~~~----~~ 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELY----EK 238 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH----HH
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH--HHHH----HH
Confidence 9999999986533221 224568999999999999999999999999999999999765 4543321 1121 22
Q ss_pred hhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 540 YENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 540 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...+.. ...+...+.++.+|+.+||+.||++||||+||++.|+++.
T Consensus 239 i~~~~~----------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 239 LPQGYR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp GGGTCC----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcCC----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 222211 1112223457999999999999999999999999998873
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=391.51 Aligned_cols=258 Identities=29% Similarity=0.470 Sum_probs=209.2
Q ss_pred hcCCCccCcccccCceEEEEEEecC--------CcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecC
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLKN--------GKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQG 388 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 388 (658)
.++|.+.+.||+|+||.||+|+... +..||||++..........++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3577888999999999999998642 3479999998766666678899999999998 799999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE
Q 006168 389 PELILVYEYMANSSLDKFLFGEK--------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL 454 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll 454 (658)
+..++||||+++|+|.++|.... ...+++.+++.++.||+.||.|||+. +||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 99999999999999999996443 24589999999999999999999999 99999999999999
Q ss_pred cCCCCeEEeeccCccccCCCCcc-ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhH
Q 006168 455 DDDLQPKIADFGLARLLPENQSH-LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYL 532 (658)
Q Consensus 455 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l 532 (658)
+.++.+||+|||+++........ ......||+.|+|||.+.++.|+.|+||||||+++|||++ |..||......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---- 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----
Confidence 99999999999999876543322 2345678999999999999999999999999999999998 57777543321
Q ss_pred HHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 533 LKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 533 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
..++.+..+...+. +. ..+..+.+|+.+||+.||.+|||+.||++.|+++
T Consensus 245 --~~~~~i~~~~~~~~------p~----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 --ELFKLLKEGHRMDK------PS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp --HHHHHHHTTCCCCC------CS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHHcCCCCCC------Cc----cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 12233333322111 12 2335699999999999999999999999999886
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-47 Score=393.10 Aligned_cols=248 Identities=24% Similarity=0.299 Sum_probs=208.9
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|++.+.||+|+||.||+++.+ +|+.||||++.+. ......+.+.+|+.+|++++||||+++++++.+.+.+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57899999999999999999975 6999999999753 23445778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|.+++. +...+++..+..++.||+.||.|||++ +|+||||||+|||+++++++||+|||+++......
T Consensus 85 ey~~gg~L~~~~~--~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eccCCCchhhhhh--cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999984 345799999999999999999999999 99999999999999999999999999998764432
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
. .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... .+... ...+.
T Consensus 160 ~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~~~~----i~~~~----------- 221 (337)
T d1o6la_ 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFEL----ILMEE----------- 221 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HHHCC-----------
T ss_pred c-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH--HHHHH----HhcCC-----------
Confidence 2 334578999999999999999999999999999999999999999765432 12211 11111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRPT-----MSEVVA 589 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 589 (658)
..++...+.++.+|+..||+.||.+||+ +.|+++
T Consensus 222 ~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1112223456899999999999999995 788875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=393.14 Aligned_cols=260 Identities=25% Similarity=0.410 Sum_probs=212.8
Q ss_pred hcCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeecCCe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQGPE 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 390 (658)
.++|+..++||+|+||.||+|++. +++.||||++..........+|.+|+.+++++ +|||||++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 367888999999999999999863 46789999998655555667899999999999 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEE
Q 006168 391 LILVYEYMANSSLDKFLFGEK----------------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLL 454 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll 454 (658)
.++||||+++|+|.+++.... ...+++..+..++.||++||+|||++ +|+||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999996543 23589999999999999999999999 99999999999999
Q ss_pred cCCCCeEEeeccCccccCCCCc-cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHH
Q 006168 455 DDDLQPKIADFGLARLLPENQS-HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLL 533 (658)
Q Consensus 455 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~ 533 (658)
+.++.+||+|||+++....... ...+...||+.|+|||++.++.++.++||||||+++|||+|++.|+.........+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999997755433 233467889999999999999999999999999999999995555443332222221
Q ss_pred HHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 534 KRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 534 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
+....+.. ...+...+..+.+|+.+||+.||++||||.+|+++|++.
T Consensus 259 ----~~i~~~~~----------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 259 ----KMIKEGFR----------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp ----HHHHHTCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHhcCCC----------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 12221111 111122345699999999999999999999999999865
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=391.37 Aligned_cols=258 Identities=26% Similarity=0.445 Sum_probs=212.4
Q ss_pred hcCCCccCcccccCceEEEEEEec------CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK------NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPEL 391 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 391 (658)
.++|...++||+|+||+||+|.++ +++.||||++......+....|.+|++++++++|||||++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 467888899999999999999874 35789999998655556667799999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEe
Q 006168 392 ILVYEYMANSSLDKFLFGEK--------RGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIA 463 (658)
Q Consensus 392 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~ 463 (658)
++||||+++|+|.+++...+ ...+++..+..++.|+++||.|||++ +|+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 99999999999999885421 23489999999999999999999998 99999999999999999999999
Q ss_pred eccCccccCCCCccc-cccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCC-CCCCCCCcchhhHHHHHHHHhh
Q 006168 464 DFGLARLLPENQSHL-STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGT-KSSETKGEEGEYLLKRAWRLYE 541 (658)
Q Consensus 464 DfGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~-~p~~~~~~~~~~l~~~~~~~~~ 541 (658)
|||+++.+....... .....||+.|+|||.+.++.++.++||||||+++|||+||+ .|+..... . ... ....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-~-~~~----~~i~ 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-E-QVL----RFVM 249 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-H-HHH----HHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-H-HHH----HHHH
Confidence 999998765443322 33557899999999999999999999999999999999986 45543222 1 111 1222
Q ss_pred cCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 542 NGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 542 ~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
++...+ .+...+..+.+|+.+||+.||++||||.+|+++|++.
T Consensus 250 ~~~~~~----------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 250 EGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp TTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred hCCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 222111 1122335699999999999999999999999999876
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.2e-47 Score=389.51 Aligned_cols=245 Identities=24% Similarity=0.382 Sum_probs=206.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|++.+.||+|+||+||+++.+ +|+.||||++... ......+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56889999999999999999975 6999999998653 23455678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+++|+|..++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHH--HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCcccccccc--ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999999884 445689999999999999999999998 9999999999999999999999999999876543
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.+...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. +... +..
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~---~i~~-~~~---------- 218 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTYE---KILN-AEL---------- 218 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH---HHHH-CCC----------
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--HHHH---HHHc-CCC----------
Confidence 23568999999999999999999999999999999999999999754331 1111 1111 110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRP-----TMSEVVA 589 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 589 (658)
..+...+..+.+++.+||+.||.+|| |++++++
T Consensus 219 -~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 -RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11122335689999999999999996 8999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=393.48 Aligned_cols=267 Identities=23% Similarity=0.312 Sum_probs=201.9
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCC----eEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP----ELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV 394 (658)
++|...+.||+|+||.||+|++ +|+.||||++... .......+.|+..+.+++|||||++++++.+.+ .+++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~--~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc--chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 4566788999999999999997 5889999998642 222223345666667889999999999997643 68999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcC-----CCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF-----HVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
|||+++|+|.++|.. ..++|..+++++.|++.||.|||+.. ..+|+||||||+||||++++.+||+|||+++
T Consensus 80 ~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999953 46999999999999999999999731 2489999999999999999999999999998
Q ss_pred ccCCCCcc---ccccccCCcccccccccccC------CCCCcccchhhhHHHHHHHhCCCCCCCCCcch---------hh
Q 006168 470 LLPENQSH---LSTKFAGTLGYTAPEYAIHG------QLSEKVDAYSFGVLVLEIISGTKSSETKGEEG---------EY 531 (658)
Q Consensus 470 ~~~~~~~~---~~~~~~gt~~y~APE~~~~~------~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~---------~~ 531 (658)
........ ......||+.|+|||++... .++.|+|||||||+||||+||..|+....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 77543322 23357899999999998654 35779999999999999999988775432210 01
Q ss_pred HHHHHHHHhhcCcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 006168 532 LLKRAWRLYENGTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKSTS 595 (658)
Q Consensus 532 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~~ 595 (658)
...........+. +++.+.....+.+....+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1122222222211 12222111123345677999999999999999999999999998773
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=388.76 Aligned_cols=256 Identities=28% Similarity=0.452 Sum_probs=198.4
Q ss_pred cCCCccCcccccCceEEEEEEecC--C--cEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKN--G--KIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
++|++.+.||+|+||.||+|+++. + ..||||++.... ..+..++|.+|+++|++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568889999999999999998642 2 368999987542 23445789999999999999999999999965 4678
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
+||||+++|+|.+++.. ....+++..+++++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 87 lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHH-HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhc-ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 99999999999988754 345699999999999999999999998 99999999999999999999999999999875
Q ss_pred CCCccc--cccccCCcccccccccccCCCCCcccchhhhHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcCcccccc
Q 006168 473 ENQSHL--STKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIIS-GTKSSETKGEEGEYLLKRAWRLYENGTHWELM 549 (658)
Q Consensus 473 ~~~~~~--~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 549 (658)
...... .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||...... ... ......+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~---~~i~~~~~~~--- 234 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QIL---HKIDKEGERL--- 234 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHH---HHHHTSCCCC---
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HHH---HHHHhCCCCC---
Confidence 544322 335568889999999999999999999999999999998 89998654332 111 2222222111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 550 DESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 550 d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
+.+...+..+.+|+.+||+.||++|||+.||++.|++.
T Consensus 235 -------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 -------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11122335699999999999999999999999999764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.3e-47 Score=384.54 Aligned_cols=259 Identities=21% Similarity=0.347 Sum_probs=203.8
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHhccCCCccceeeeEeecCC----e
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP----E 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 390 (658)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... .......+.+|++++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999975 79999999997542 2334567999999999999999999999986543 4
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.++||||+++++|.+++. ..+.+++.+++.++.||+.||.|||+. +|+||||||+|||++.++..+|+|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~--~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 899999999999999884 345799999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCc--cccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccc
Q 006168 471 LPENQS--HLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWEL 548 (658)
Q Consensus 471 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 548 (658)
...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +...+....+....
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~~~~~~~~~~- 234 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAYQHVREDPIPP- 234 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHCCCCCG-
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-----HHHHHHHhcCCCCC-
Confidence 543322 2334578999999999999999999999999999999999999999754331 11222222221111
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcC
Q 006168 549 MDESLDPNECTKEAAEKVVEIALMCTQSAANSRP-TMSEVVALLKST 594 (658)
Q Consensus 549 ~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-t~~evl~~L~~~ 594 (658)
.......+..+.+++.+||+.||.+|| |++++++.|.++
T Consensus 235 -------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 235 -------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 011112335699999999999999999 899999998765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-46 Score=389.98 Aligned_cols=245 Identities=22% Similarity=0.310 Sum_probs=206.9
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc--cccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG--ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 395 (658)
++|++.+.||+|+||.||+++++ +|+.||||++... ......+.+.+|+++|++++|||||++++++...+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999976 6999999998643 23355678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCC
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQ 475 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~ 475 (658)
||+.+|+|.+++.. .+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~~--~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR--IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 99999999999843 35799999999999999999999998 9999999999999999999999999999976533
Q ss_pred ccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCCC
Q 006168 476 SHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLDP 555 (658)
Q Consensus 476 ~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 555 (658)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+...+ .. +..
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~i---~~-~~~---------- 255 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKI---VS-GKV---------- 255 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH---HH-CCC----------
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--HHHHHHH---hc-CCC----------
Confidence 2346799999999999999999999999999999999999999975432 1222211 11 110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 006168 556 NECTKEAAEKVVEIALMCTQSAANSRP-----TMSEVVA 589 (658)
Q Consensus 556 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 589 (658)
..+...+.++.+++..||+.||.+|+ |++++++
T Consensus 256 -~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 -RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11122345689999999999999994 8999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.7e-46 Score=392.42 Aligned_cols=249 Identities=22% Similarity=0.274 Sum_probs=200.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHH---HHHHHHhccCCCccceeeeEeecCCeEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFE---NEVRLISNVHHRNLIRLLGCCSQGPELI 392 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~ 392 (658)
++|++.+.||+|+||.||+|+.. +|+.||||++.... .......+. .|+++++.++|||||++++++.+.+.++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67899999999999999999976 69999999986421 122233343 4577788889999999999999999999
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
+||||+++|+|.++|.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999999943 45689999999999999999999998 99999999999999999999999999999765
Q ss_pred CCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccc
Q 006168 473 ENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDE 551 (658)
Q Consensus 473 ~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 551 (658)
... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||.......... ..+.....
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~~~~~~~~-------- 224 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTLTM-------- 224 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH---HHHHSSSC--------
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhcccC--------
Confidence 432 335689999999999975 468999999999999999999999997654422111 11111100
Q ss_pred cCCCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 006168 552 SLDPNECTKEAAEKVVEIALMCTQSAANSRPT-----MSEVVA 589 (658)
Q Consensus 552 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-----~~evl~ 589 (658)
....+...+.++.+|+.+||+.||.+||| ++|+++
T Consensus 225 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 ---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ---CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ---CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 01111223456899999999999999999 688875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.1e-46 Score=377.28 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=206.0
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccccc--------ccHHHHHHHHHHHhccC-CCccceeeeEeecC
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR--------RTLSDFENEVRLISNVH-HRNLIRLLGCCSQG 388 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 388 (658)
++|++.+.||+|+||+||+++.. +|+.||||++...... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57889999999999999999975 6899999998653211 12345789999999997 99999999999999
Q ss_pred CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCc
Q 006168 389 PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLA 468 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla 468 (658)
+..+|||||+++|+|.++|.. .+.+++.++..++.||++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 999999999999999999953 45799999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCccccccccCCccccccccccc------CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc
Q 006168 469 RLLPENQSHLSTKFAGTLGYTAPEYAIH------GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN 542 (658)
Q Consensus 469 ~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~ 542 (658)
+.+.... ..+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ... +....
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~--~~~----~~i~~ 229 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--LML----RMIMS 229 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHHHH
T ss_pred eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH--HHH----HHHHh
Confidence 9875533 2345689999999999853 35788999999999999999999999765431 111 11111
Q ss_pred CcccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 543 GTHWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 543 ~~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
+... . +.......+.++.+++.+||+.||.+|||+.||++.
T Consensus 230 ~~~~-~------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 230 GNYQ-F------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TCCC-C------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCC-C------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1110 0 111112344579999999999999999999998753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=385.01 Aligned_cols=248 Identities=24% Similarity=0.353 Sum_probs=205.5
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc--ccccHHHHHHHHHHHh-ccCCCccceeeeEeecCCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI--SRRTLSDFENEVRLIS-NVHHRNLIRLLGCCSQGPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV 394 (658)
++|.+.+.||+|+||+||+|+.+ +++.||||++.... .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57889999999999999999986 68999999996532 3445667777877765 68999999999999999999999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPEN 474 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~ 474 (658)
|||+++|+|.+++. ....+++.++..++.||+.||.|||++ +|+||||||+|||+++++++||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~--~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHH--HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999995 345689999999999999999999999 9999999999999999999999999999866443
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
. ...+...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... ...+. .
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~----i~~~~------~--- 220 (320)
T d1xjda_ 157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHS----IRMDN------P--- 220 (320)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH----HHHCC------C---
T ss_pred c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHH----HHcCC------C---
Confidence 3 2344568999999999999999999999999999999999999999754432 22211 11111 1
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMS-EVVA 589 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-evl~ 589 (658)
..+...+.++.+|+.+||+.||.+|||+. ++++
T Consensus 221 --~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 --FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11222345689999999999999999995 6754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=379.39 Aligned_cols=251 Identities=23% Similarity=0.324 Sum_probs=205.7
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
.++|.+.+.||+|+||+||+|+++ +++.||||.+... ......+.+|+++|++++|||||++++++.+.+.+++|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 467899999999999999999986 6889999999753 2334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC--CCeEEeeccCccccCCC
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD--LQPKIADFGLARLLPEN 474 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~--~~~kl~DfGla~~~~~~ 474 (658)
|+++|+|.++|.. ....+++.++..++.||++||.|||+. +|+||||||+|||++.+ ..+||+|||+++.....
T Consensus 82 ~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 82 FISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred cCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999943 334699999999999999999999998 99999999999999854 58999999999876443
Q ss_pred CccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccccccccCC
Q 006168 475 QSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMDESLD 554 (658)
Q Consensus 475 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 554 (658)
. ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+...+ .. +.. .. +.
T Consensus 158 ~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~~~i---~~-~~~-~~-~~--- 224 (321)
T d1tkia_ 158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENI---MN-AEY-TF-DE--- 224 (321)
T ss_dssp C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHH---HH-TCC-CC-CH---
T ss_pred C--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHHHHH---Hh-CCC-CC-Ch---
Confidence 3 233467899999999999999999999999999999999999999765432 121111 11 110 00 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 555 PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 555 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
......+.++.+|+..||+.||++|||+.|+++
T Consensus 225 --~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 225 --EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000012356899999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=382.12 Aligned_cols=253 Identities=21% Similarity=0.256 Sum_probs=200.7
Q ss_pred hcCCCccC-cccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhcc-CCCccceeeeEeec----CCe
Q 006168 318 TRKFSEEN-KLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNV-HHRNLIRLLGCCSQ----GPE 390 (658)
Q Consensus 318 ~~~f~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 390 (658)
.++|.+.+ .||+|+||.||+|+.. +++.||||++.. ...+.+|++++.++ +|||||++++++.+ +..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 35787765 5999999999999975 689999999853 24678899987655 89999999999865 467
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC---CCCeEEeeccC
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD---DLQPKIADFGL 467 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~---~~~~kl~DfGl 467 (658)
+++||||+++|+|.++|.......+++.++..|+.||+.||.|||+. +|+||||||+|||++. .+.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 89999999999999999655456799999999999999999999998 9999999999999975 56799999999
Q ss_pred ccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcccc
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWE 547 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 547 (658)
++....... .....||+.|+|||++.+..|+.++|||||||++|||+||+.||........ ..........+.
T Consensus 161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~~~i~~~~--- 233 (335)
T d2ozaa1 161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKTRIRMGQ--- 233 (335)
T ss_dssp CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCS---
T ss_pred eeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHHHHHHhcCC---
Confidence 987654332 3456899999999999999999999999999999999999999965433110 000000000000
Q ss_pred cccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 548 LMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 548 ~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..+ +.......+.++.+|+.+||+.||++|||+.|+++.
T Consensus 234 ---~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 234 ---YEF-PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---SSC-CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---CCC-CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000 111122345679999999999999999999999873
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=376.83 Aligned_cols=260 Identities=25% Similarity=0.354 Sum_probs=198.5
Q ss_pred ccCcccccCceEEEEEEec-CCcEEEEEEcccccccc----cHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 323 EENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRR----TLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 323 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
..++||+|+||+||+|+.+ +|+.||||++....... ..+.+.+|++++++++|||||++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999975 68999999986532211 124688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+.++++..++ .....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 82 ~~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 82 METDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp CSEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred hcchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 9998877766 3456699999999999999999999998 9999999999999999999999999999876543322
Q ss_pred ccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccccc------
Q 006168 478 LSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWELMD------ 550 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~d------ 550 (658)
.....||+.|+|||++... .++.++|||||||++|||++|+.||...... ..+..+.+...........+
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH--HHHHHHHHhcCCCChhhccchhccch
Confidence 2346799999999998755 5799999999999999999999998755432 22222222211100000000
Q ss_pred c-cC-CCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 551 E-SL-DPNECT-----KEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 551 ~-~l-~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
. .. .....+ ......+.+|+.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0 00 000011 1224568999999999999999999999863
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-45 Score=372.87 Aligned_cols=265 Identities=27% Similarity=0.418 Sum_probs=203.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
++|++.++||+|+||+||+|+.. +|+.||||++.... .....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58899999999999999999975 68999999996532 22345788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
|+.+ ++.+++.......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 9976 455555445566799999999999999999999998 999999999999999999999999999987654332
Q ss_pred cccccccCCcccccccccccCC-CCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc--Ccccccccc--
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQ-LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN--GTHWELMDE-- 551 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~-~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~--~~~~~~~d~-- 551 (658)
......||+.|+|||.+.... ++.++|||||||++|||++|+.||....... ......+.... ...+.....
T Consensus 158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhcccccccc
Confidence 234568999999999887665 5789999999999999999999997554321 11111111111 000000000
Q ss_pred ----cCC---CCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 552 ----SLD---PNE---CTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 552 ----~l~---~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
... ... .....+.++.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 000 001123568999999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.9e-45 Score=370.89 Aligned_cols=263 Identities=27% Similarity=0.421 Sum_probs=204.2
Q ss_pred cCCCccCcccccCceEEEEEEecCCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEec
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYEY 397 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 397 (658)
++|...++||+|+||+||+|++++|+.||||++.... .....+.+.+|+.+|++++|||||++++++.+.+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6888999999999999999999999999999996532 334467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCcc
Q 006168 398 MANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQSH 477 (658)
Q Consensus 398 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~~ 477 (658)
+.++.+..+. ...+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHH--hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 9987777776 4456799999999999999999999998 999999999999999999999999999987654322
Q ss_pred ccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCc--cc----cc--
Q 006168 478 LSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGT--HW----EL-- 548 (658)
Q Consensus 478 ~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~--~~----~~-- 548 (658)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... .......+...... .+ +.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCChhhccchhhhhh
Confidence 23345689999999998754 5689999999999999999999999764432 11222222111100 00 00
Q ss_pred ccccCC------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 549 MDESLD------PNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 549 ~d~~l~------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.+.... ........+..+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 00111223456899999999999999999999984
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=373.71 Aligned_cols=242 Identities=24% Similarity=0.399 Sum_probs=197.3
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccccc-----ccHHHHHHHHHHHhccC--CCccceeeeEeecCC
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISR-----RTLSDFENEVRLISNVH--HRNLIRLLGCCSQGP 389 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 389 (658)
.++|.+.+.||+|+||+||+|+.. +|+.||||++...... .....+.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357899999999999999999975 6899999998653111 11234678999999996 899999999999999
Q ss_pred eEEEEEeccCC-CCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCC-CCeEEeeccC
Q 006168 390 ELILVYEYMAN-SSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDD-LQPKIADFGL 467 (658)
Q Consensus 390 ~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~-~~~kl~DfGl 467 (658)
..++||||+.+ +++.+++. ....+++.++..++.||++||.|||+. +|+||||||+|||++.+ +.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~--~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH--HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEEEEEeccCcchHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 99999999976 67778774 345799999999999999999999998 99999999999999854 7899999999
Q ss_pred ccccCCCCccccccccCCcccccccccccCCC-CCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccc
Q 006168 468 ARLLPENQSHLSTKFAGTLGYTAPEYAIHGQL-SEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHW 546 (658)
Q Consensus 468 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 546 (658)
++..... ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... . ... +..
T Consensus 158 a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~-------i~~-~~~- 221 (273)
T d1xwsa_ 158 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----E-------IIR-GQV- 221 (273)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----H-------HHH-CCC-
T ss_pred ceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----H-------Hhh-ccc-
Confidence 9875432 2345789999999999987765 567999999999999999999986421 0 111 100
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 547 ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 547 ~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.+ +.. .+.++.+++.+||+.||++|||++|+++.
T Consensus 222 -----~~-~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 -----FF-RQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -----CC-SSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----CC-CCC----CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01 112 23568999999999999999999999863
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=364.65 Aligned_cols=265 Identities=23% Similarity=0.362 Sum_probs=199.9
Q ss_pred hcCCCccCcccccCceEEEEEEec-C-CcEEEEEEcccccc-cccHHHHHHHHHHHhcc---CCCccceeeeEeec----
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-N-GKIVAVKKLAIGIS-RRTLSDFENEVRLISNV---HHRNLIRLLGCCSQ---- 387 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 387 (658)
.++|++.++||+|+||+||+|+.. + ++.||||++..... ......+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999974 4 67799999865322 22233466777777666 79999999999853
Q ss_pred -CCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeecc
Q 006168 388 -GPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFG 466 (658)
Q Consensus 388 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfG 466 (658)
....+++|||+.++++.... ......+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 35789999999987765444 34556799999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccc
Q 006168 467 LARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHW 546 (658)
Q Consensus 467 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 546 (658)
+++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||...... ..+.............
T Consensus 162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIGLPGEE 237 (305)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCGG
T ss_pred hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH--HHHHHHHHhhCCCchh
Confidence 99865332 2344678999999999999999999999999999999999999999765431 1222222211100000
Q ss_pred ---------c-cccccC--CCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 547 ---------E-LMDESL--DPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 547 ---------~-~~d~~l--~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
. ...... .........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 000000 0001112234568899999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-43 Score=362.40 Aligned_cols=265 Identities=21% Similarity=0.330 Sum_probs=199.0
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeec--------C
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ--------G 388 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 388 (658)
++|++.++||+|+||+||+|+++ +|+.||||++.... .......+.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 68889999999999999999975 79999999986532 33445778999999999999999999999854 3
Q ss_pred CeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCc
Q 006168 389 PELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLA 468 (658)
Q Consensus 389 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla 468 (658)
+..++||||+.++.+..+. .....+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence 4689999999988776655 4456799999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcc---ccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc--
Q 006168 469 RLLPENQSH---LSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN-- 542 (658)
Q Consensus 469 ~~~~~~~~~---~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~-- 542 (658)
+.+...... ......||+.|+|||++.+. .++.|+|||||||++|||++|+.||...... .......+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~ 242 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLCGSIT 242 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH--HHHHHHHHhcCCCC
Confidence 876543322 12245799999999998765 6899999999999999999999999754431 111111121110
Q ss_pred Ccccccc---------cccCCCCCCCH------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 543 GTHWELM---------DESLDPNECTK------EAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 543 ~~~~~~~---------d~~l~~~~~~~------~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
....... ........... .....+.+|+.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000000 00000000011 113356789999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=354.04 Aligned_cols=265 Identities=22% Similarity=0.376 Sum_probs=208.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccc-cccHHHHHHHHHHHhccCCCccceeeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGIS-RRTLSDFENEVRLISNVHHRNLIRLLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 396 (658)
++|++.++||+|+||+||+|+.. +++.||||++..... ......+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57899999999999999999975 688999999865432 3346788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccCCCCc
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLPENQS 476 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~~~~~ 476 (658)
++.+++|..++. ..+.+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999988873 456789999999999999999999998 999999999999999999999999999987754332
Q ss_pred cccccccCCcccccccccccCC-CCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcC--cccc------
Q 006168 477 HLSTKFAGTLGYTAPEYAIHGQ-LSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENG--THWE------ 547 (658)
Q Consensus 477 ~~~~~~~gt~~y~APE~~~~~~-~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--~~~~------ 547 (658)
......+++.|+|||.+.... ++.++|||||||++|||++|+.||.......+.+ ..+....... ..+.
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH-HHHHHHHCCCCTTTCTTGGGST
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH-HHHHhhcCCCChhhhhhhhhcc
Confidence 233456788999999987665 6899999999999999999999986544432222 2222221110 0000
Q ss_pred ------cccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 548 ------LMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 548 ------~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
..................+.+|+.+||+.||.+|||++||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000001112223344568899999999999999999999863
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=362.78 Aligned_cols=265 Identities=22% Similarity=0.328 Sum_probs=198.5
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeecCC----eEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP----ELI 392 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 392 (658)
+++|++.++||+|+||+||+|+.+ +|+.||||++.........+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 467999999999999999999965 799999999976444455678899999999999999999999986543 234
Q ss_pred EEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccccC
Q 006168 393 LVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARLLP 472 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~~~ 472 (658)
++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 87 ~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 55566779999999943 4699999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCcc--ccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcc----
Q 006168 473 ENQSH--LSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTH---- 545 (658)
Q Consensus 473 ~~~~~--~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~---- 545 (658)
..... ......||+.|+|||.+.. ..++.++||||+||+++||++|+.||......... ............
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL--NHILGILGSPSQEDLN 238 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCSCCHHHHH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH--HHHhhhccCCChhhhh
Confidence 43222 2345679999999999854 56789999999999999999999999765431111 111110000000
Q ss_pred -------cccccccCCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 546 -------WELMDESLDPNECT-----KEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 546 -------~~~~d~~l~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.............+ .....++.+++.+||+.||.+|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000000 0122468899999999999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-42 Score=354.58 Aligned_cols=258 Identities=21% Similarity=0.290 Sum_probs=198.2
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccce-eeeEeecCCeEEEEEe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIR-LLGCCSQGPELILVYE 396 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lV~E 396 (658)
++|++.+.||+|+||.||+|++. +|+.||||++..... ..++..|++++++++|+|++. +.++..+.+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 57999999999999999999975 689999999865322 235788999999998776555 5555677888999999
Q ss_pred ccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEc---CCCCeEEeeccCccccCC
Q 006168 397 YMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLD---DDLQPKIADFGLARLLPE 473 (658)
Q Consensus 397 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~---~~~~~kl~DfGla~~~~~ 473 (658)
|+. ++|.+.+. .....+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+++.+..
T Consensus 84 ~~~-~~l~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 84 LLG-PSLEDLFN-FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCC-CBHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EcC-Cchhhhhh-hccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 995 46666553 3445799999999999999999999998 999999999999985 356799999999998754
Q ss_pred CCcc------ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhh-HHHHHHHHhhcCccc
Q 006168 474 NQSH------LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEY-LLKRAWRLYENGTHW 546 (658)
Q Consensus 474 ~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~-l~~~~~~~~~~~~~~ 546 (658)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ...............
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 3321 233568999999999999999999999999999999999999999765542211 111111110000000
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 547 ELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 547 ~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
+ + ... .+.++.+++..||+.+|++||+++++.+.|+..
T Consensus 239 ~-----~-~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 239 V-----L-CKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp H-----H-TTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred H-----h-ccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0 0 112 235689999999999999999999999888765
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=364.40 Aligned_cols=258 Identities=27% Similarity=0.380 Sum_probs=195.0
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccc-cccccHHHHHHHHHHHhccCCCccceeeeEeecCC------
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIG-ISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQGP------ 389 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 389 (658)
.++|++.++||+|+||+||+|+.+ +|+.||||++... ......+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468889999999999999999975 6999999999753 23344567899999999999999999999997654
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
++++||||+ +.+|..++. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence 579999999 557887763 35699999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc------
Q 006168 470 LLPENQSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYEN------ 542 (658)
Q Consensus 470 ~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~------ 542 (658)
..... .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||........ ..........
T Consensus 170 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 170 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPAEFV 243 (346)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHH
T ss_pred ccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHHHHhccCCCcHHHH
Confidence 76443 2456799999999998764 568999999999999999999999976543111 1110000000
Q ss_pred --Cc----------ccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 543 --GT----------HWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 543 --~~----------~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.. ..+.....+ ..........+.+|+.+||+.||.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDF--ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCG--GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhcchhhhhhhccCCcccccch--HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 000000000 01111223468899999999999999999999974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-43 Score=361.60 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=204.5
Q ss_pred cCCCccCcccccCceEEEEEEec----CCcEEEEEEccccc---ccccHHHHHHHHHHHhccCC-CccceeeeEeecCCe
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK----NGKIVAVKKLAIGI---SRRTLSDFENEVRLISNVHH-RNLIRLLGCCSQGPE 390 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 390 (658)
++|.+.++||+|+||+||+|+.. +|+.||||.+.... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 48899999986532 22345678899999999976 899999999999999
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.++||||+.+|+|.+++. ....+.+.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~--~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHH--HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHH--hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999984 334678899999999999999999998 999999999999999999999999999988
Q ss_pred cCCCCccccccccCCcccccccccccC--CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCccccc
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAIHG--QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTHWEL 548 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 548 (658)
+............|++.|++||.+.+. .++.++|||||||+||||++|+.||......... ....+.....
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~i~~~~~~~----- 251 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS----- 251 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC-----
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcccC-----
Confidence 765555445567899999999999764 4688999999999999999999999765542111 1111111100
Q ss_pred ccccCCCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 006168 549 MDESLDPNECTKEAAEKVVEIALMCTQSAANSRP-----TMSEVVA 589 (658)
Q Consensus 549 ~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----t~~evl~ 589 (658)
....+...+.++.+++.+||+.||.+|| |++|+++
T Consensus 252 ------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1112223456799999999999999999 4788875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=363.41 Aligned_cols=258 Identities=23% Similarity=0.316 Sum_probs=193.8
Q ss_pred CCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCCCccceeeeEeec------CCeEE
Q 006168 320 KFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ------GPELI 392 (658)
Q Consensus 320 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~ 392 (658)
+|+..++||+|+||+||+|+.. +|+.||||++..... ...+|+++|++++||||+++++++.. ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 5777889999999999999986 699999999975321 23479999999999999999999853 23579
Q ss_pred EEEeccCCCCHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC-CeEEeeccCccc
Q 006168 393 LVYEYMANSSLDKFLFG-EKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL-QPKIADFGLARL 470 (658)
Q Consensus 393 lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~-~~kl~DfGla~~ 470 (658)
|||||++++.+..+... .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999987654444321 2445699999999999999999999998 999999999999999775 899999999987
Q ss_pred cCCCCccccccccCCccccccccccc-CCCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHH----------HHHH
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAIH-GQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKR----------AWRL 539 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~----------~~~~ 539 (658)
+..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+... .+..
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHH
T ss_pred ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCChHHhhhh
Confidence 754332 234679999999998875 478999999999999999999999997654321 11111 0111
Q ss_pred hhcCcccccccccCCC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 540 YENGTHWELMDESLDP----NECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 540 ~~~~~~~~~~d~~l~~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.........+ +.... .......+.++.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPNYTEFKF-PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC---CCCC-CCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhccc-cccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1100000000 00000 0111123456899999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.1e-42 Score=349.68 Aligned_cols=259 Identities=18% Similarity=0.233 Sum_probs=205.7
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccCC-CccceeeeEeecCCeEEEEE
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVHH-RNLIRLLGCCSQGPELILVY 395 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~ 395 (658)
.++|.+.++||+|+||+||+|++. +|+.||||++..... ...+.+|++.++.++| +|++.+++++.++...++||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 368899999999999999999976 689999999865332 2356788888888865 89999999999999999999
Q ss_pred eccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcC-----CCCeEEeeccCccc
Q 006168 396 EYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDD-----DLQPKIADFGLARL 470 (658)
Q Consensus 396 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~-----~~~~kl~DfGla~~ 470 (658)
||+ +++|.+++.. ....+++.++..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 81 e~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 81 DLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp ECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 999 6799998853 345699999999999999999999998 9999999999999964 57899999999997
Q ss_pred cCCCCcc------ccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcc-hhhHHHHHHHHhhcC
Q 006168 471 LPENQSH------LSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE-GEYLLKRAWRLYENG 543 (658)
Q Consensus 471 ~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~-~~~l~~~~~~~~~~~ 543 (658)
+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ...............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 6543221 233568999999999999999999999999999999999999999765442 211111111111111
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 006168 544 THWELMDESLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVALLKST 594 (658)
Q Consensus 544 ~~~~~~d~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~L~~~ 594 (658)
...++ ...+ +.++.+++..|+..+|++||+++.+.+.|+.+
T Consensus 236 ~~~~l------~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 236 PLREL------CAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp CHHHH------TTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ChHHh------cCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11111 1122 34689999999999999999999998888765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-41 Score=353.51 Aligned_cols=257 Identities=19% Similarity=0.290 Sum_probs=199.6
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC-CCccceeeeEeec--CCeEEEE
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQ--GPELILV 394 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV 394 (658)
++|++.++||+|+||+||+|+.. +|+.||||++.. ...+++.+|+++|++++ ||||+++++++.. ....++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 57999999999999999999975 689999999864 23567899999999995 9999999999874 4569999
Q ss_pred EeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCC-CeEEeeccCccccCC
Q 006168 395 YEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDL-QPKIADFGLARLLPE 473 (658)
Q Consensus 395 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~-~~kl~DfGla~~~~~ 473 (658)
|||+.+++|..+. +.+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++....
T Consensus 111 ~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 111 FEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999997764 4599999999999999999999999 999999999999998765 589999999987654
Q ss_pred CCccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHH--------HHHhhc--
Q 006168 474 NQSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRA--------WRLYEN-- 542 (658)
Q Consensus 474 ~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~--------~~~~~~-- 542 (658)
... .....+|+.|+|||.+.+. .++.++||||+|++++||++|+.||.............. ......
T Consensus 183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 332 3456789999999998765 479999999999999999999999976554322111100 000000
Q ss_pred Ccccccccc-----------cCCCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 543 GTHWELMDE-----------SLDPNECTKEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 543 ~~~~~~~d~-----------~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
......... ...........+.++.+|+.+||+.||.+|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000 00011112223456899999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-41 Score=353.67 Aligned_cols=263 Identities=24% Similarity=0.312 Sum_probs=193.0
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeec------CC
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQ------GP 389 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 389 (658)
.++|.+.++||+|+||+||+|++. +|+.||||++.... .......+.+|+.++++++|||||++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 468999999999999999999976 69999999997532 23445678999999999999999999999853 46
Q ss_pred eEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 390 ELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 390 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
..++||||+.++.+..+. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+|++|||+++
T Consensus 96 ~~~iv~Ey~~~~l~~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSEEHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eeEEEEeccchHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence 889999999775554432 4589999999999999999999999 99999999999999999999999999988
Q ss_pred ccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcchh--hHHH-------------
Q 006168 470 LLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEEGE--YLLK------------- 534 (658)
Q Consensus 470 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~--~l~~------------- 534 (658)
...... ..+...+|+.|+|||++.+..++.++||||+||+++||++|+.||........ .+..
T Consensus 168 ~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred cccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 654332 33456789999999999999999999999999999999999999975543110 0000
Q ss_pred --HHHHHhhcCc------ccccccccCCCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 006168 535 --RAWRLYENGT------HWELMDESLDPN--ECTKEAAEKVVEIALMCTQSAANSRPTMSEVVAL 590 (658)
Q Consensus 535 --~~~~~~~~~~------~~~~~d~~l~~~--~~~~~~~~~l~~li~~cl~~dp~~RPt~~evl~~ 590 (658)
.......... ............ ......+..+.+|+.+||+.||++|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000 000111111111 1123456778999999999999999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-41 Score=352.04 Aligned_cols=260 Identities=25% Similarity=0.348 Sum_probs=195.6
Q ss_pred hcCCCccCcccccCceEEEEEEec-CCcEEEEEEccccc-ccccHHHHHHHHHHHhccCCCccceeeeEeecC-----Ce
Q 006168 318 TRKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGI-SRRTLSDFENEVRLISNVHHRNLIRLLGCCSQG-----PE 390 (658)
Q Consensus 318 ~~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 390 (658)
.++|++.++||+|+||+||+|+.. +|+.||||++.... .....+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 468999999999999999999965 79999999997532 233456788999999999999999999998533 34
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
.++++||+.+|+|.+++. .+.+++.++..++.||+.||.|||++ +|+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~---~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcc---cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 566778888999999983 34699999999999999999999998 999999999999999999999999999975
Q ss_pred cCCCCccccccccCCcccccccccccC-CCCCcccchhhhHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcCcc----
Q 006168 471 LPENQSHLSTKFAGTLGYTAPEYAIHG-QLSEKVDAYSFGVLVLEIISGTKSSETKGEEGEYLLKRAWRLYENGTH---- 545 (658)
Q Consensus 471 ~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDV~SfGvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~---- 545 (658)
... ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||....... ....+.+.......
T Consensus 171 ~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~--~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 171 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCHHHHT
T ss_pred cCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCChHHhh
Confidence 432 23346789999999987765 46889999999999999999999997654311 11111111100000
Q ss_pred -------cccccccCCCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 006168 546 -------WELMDESLDPNECT-----KEAAEKVVEIALMCTQSAANSRPTMSEVVA 589 (658)
Q Consensus 546 -------~~~~d~~l~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~evl~ 589 (658)
.............. ......+.+|+.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00000000000000 112356889999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-36 Score=317.28 Aligned_cols=262 Identities=22% Similarity=0.256 Sum_probs=192.8
Q ss_pred cCCCccCcccccCceEEEEEEec-CCcEEEEEEcccccccccHHHHHHHHHHHhccC-----------CCccceeeeEee
Q 006168 319 RKFSEENKLGEGGFGDIYKGTLK-NGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-----------HRNLIRLLGCCS 386 (658)
Q Consensus 319 ~~f~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 386 (658)
++|.+.++||+|+||+||+|+.. +|+.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 35889999999999999999975 7999999999752 233467788999888875 578999999885
Q ss_pred c--CCeEEEEEeccCCCC-HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeecCcCCCcEEEcCCCC---
Q 006168 387 Q--GPELILVYEYMANSS-LDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHE-DFHVRIIHRDIKPSNVLLDDDLQ--- 459 (658)
Q Consensus 387 ~--~~~~~lV~E~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dik~~NIll~~~~~--- 459 (658)
. ....+++++++..+. ............+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence 4 345666776665544 3333434555679999999999999999999998 5 8999999999999986653
Q ss_pred ---eEEeeccCccccCCCCccccccccCCcccccccccccCCCCCcccchhhhHHHHHHHhCCCCCCCCCcc-----hhh
Q 006168 460 ---PKIADFGLARLLPENQSHLSTKFAGTLGYTAPEYAIHGQLSEKVDAYSFGVLVLEIISGTKSSETKGEE-----GEY 531 (658)
Q Consensus 460 ---~kl~DfGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDV~SfGvvl~elltG~~p~~~~~~~-----~~~ 531 (658)
++++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||...... ...
T Consensus 168 ~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 899999999865432 23467999999999999999999999999999999999999998754321 111
Q ss_pred HHHHHHHHhhc------------------Cccccccccc---------CCCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 006168 532 LLKRAWRLYEN------------------GTHWELMDES---------LDPNECTKEAAEKVVEIALMCTQSAANSRPTM 584 (658)
Q Consensus 532 l~~~~~~~~~~------------------~~~~~~~d~~---------l~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~ 584 (658)
+.... ..... ......+... .............+.+|+.+||+.||.+|||+
T Consensus 244 ~~~~~-~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 244 IAQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHH-HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 11111 11100 0000000000 00123446677889999999999999999999
Q ss_pred HHHHHH
Q 006168 585 SEVVAL 590 (658)
Q Consensus 585 ~evl~~ 590 (658)
+|+++.
T Consensus 323 ~e~L~H 328 (362)
T d1q8ya_ 323 GGLVNH 328 (362)
T ss_dssp HHHHTC
T ss_pred HHHhcC
Confidence 999863
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.9e-23 Score=198.24 Aligned_cols=165 Identities=15% Similarity=0.135 Sum_probs=123.2
Q ss_pred CccCcccccCceEEEEEEecCCcEEEEEEccccccc-----------------ccHHHHHHHHHHHhccCCCccceeeeE
Q 006168 322 SEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISR-----------------RTLSDFENEVRLISNVHHRNLIRLLGC 384 (658)
Q Consensus 322 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 384 (658)
.+.++||+|+||+||+|+..+|+.||||++..+... ........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457899999999999999989999999987532110 011334568889999999999988876
Q ss_pred eecCCeEEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeecCcCCCcEEEcCCCCeEEee
Q 006168 385 CSQGPELILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDFHVRIIHRDIKPSNVLLDDDLQPKIAD 464 (658)
Q Consensus 385 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dik~~NIll~~~~~~kl~D 464 (658)
.. .+++|||+++..+.+ +++.....++.|++++|.|||+. +|+||||||+|||++++ .++|+|
T Consensus 83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 42 379999999865533 44555678999999999999998 99999999999999976 489999
Q ss_pred ccCccccCCCCccccccccCCccccc------ccccccCCCCCcccchhhhHHHH
Q 006168 465 FGLARLLPENQSHLSTKFAGTLGYTA------PEYAIHGQLSEKVDAYSFGVLVL 513 (658)
Q Consensus 465 fGla~~~~~~~~~~~~~~~gt~~y~A------PE~~~~~~~s~ksDV~SfGvvl~ 513 (658)
||++......... .|.. .| ...++|+.++||||..--++
T Consensus 146 FG~a~~~~~~~~~---------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGWR---------EILERDVRNIIT-YFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTHH---------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred CCCcccCCCCCcH---------HHHHHHHHHHHH-HHcCCCCCcccHHHHHHHHh
Confidence 9999865433211 1111 11 12467889999999754443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.54 E-value=1.9e-07 Score=90.71 Aligned_cols=149 Identities=15% Similarity=0.061 Sum_probs=102.1
Q ss_pred HHHHHHhcCCCccCcccccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccC-CCccceeeeEeecCCe
Q 006168 312 KDLVSATRKFSEENKLGEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVH-HRNLIRLLGCCSQGPE 390 (658)
Q Consensus 312 ~~l~~a~~~f~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 390 (658)
+++...-+.|...+..+-+..+.||+... +++.+.+|+.... .......+.+|...+..+. +-.+.+++.+..+++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~-~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSR-YKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGG-GTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCC-cccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 45666666776665544444578999875 4566778887542 2333445778888887774 4446778888888889
Q ss_pred EEEEEeccCCCCHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhHhcC--------------------------------
Q 006168 391 LILVYEYMANSSLDKFLFGEKRGSLNWKQRFDIILGTARGLAYLHEDF-------------------------------- 438 (658)
Q Consensus 391 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------- 438 (658)
.++|||++++.++.+.... ......++.++++.|..||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred eEEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 9999999999888665411 1123334555666666666421
Q ss_pred ------------------------CCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 439 ------------------------HVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 439 ------------------------~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
...++|+|+.|.|||++++...-|.||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1238999999999999987667799998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.09 E-value=2.6e-06 Score=82.01 Aligned_cols=130 Identities=15% Similarity=0.156 Sum_probs=84.7
Q ss_pred cccccCc-eEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCC--CccceeeeEeecCCeEEEEEeccCCCC
Q 006168 326 KLGEGGF-GDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHH--RNLIRLLGCCSQGPELILVYEYMANSS 402 (658)
Q Consensus 326 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~gs 402 (658)
.+..|.. +.||+...+++..+.+|.-... ....+..|...++.+.. -.+.+++.+..+.+..++|||++++.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc----CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 3444443 6799999888888999976542 22346778888877743 346678888888888999999998866
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHhH-----------------------------------------------
Q 006168 403 LDKFLFGEKRGSLNWKQRFDIILGTARGLAYLH----------------------------------------------- 435 (658)
Q Consensus 403 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH----------------------------------------------- 435 (658)
+.+.. +.. ..++.++++.|.-||
T Consensus 93 ~~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 93 LLSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred ccccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 53210 010 111122222222222
Q ss_pred ----hcC----CCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 436 ----EDF----HVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 436 ----~~~----~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
... ...++|+|+.|.|||++++..+-|.||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 211 2348999999999999987667899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.55 E-value=9.4e-05 Score=75.74 Aligned_cols=77 Identities=12% Similarity=0.094 Sum_probs=48.6
Q ss_pred cCcccccCceEEEEEEecC-CcEEEEEEcccc-----c-ccccHHHHHHHHHHHhccC-C--CccceeeeEeecCCeEEE
Q 006168 324 ENKLGEGGFGDIYKGTLKN-GKIVAVKKLAIG-----I-SRRTLSDFENEVRLISNVH-H--RNLIRLLGCCSQGPELIL 393 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~-~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 393 (658)
.+.||.|....||+....+ ++.++||.-... . ..........|.+.|+.+. + ..+.+++.+. .+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 4568999999999998764 678999964321 0 1122344566888777662 2 3455566553 445688
Q ss_pred EEeccCCCC
Q 006168 394 VYEYMANSS 402 (658)
Q Consensus 394 V~E~~~~gs 402 (658)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.93 E-value=0.0019 Score=63.82 Aligned_cols=134 Identities=17% Similarity=0.240 Sum_probs=78.5
Q ss_pred eEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCCcc--ceeee-----EeecCCeEEEEEeccCCCCHH-
Q 006168 333 GDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL--IRLLG-----CCSQGPELILVYEYMANSSLD- 404 (658)
Q Consensus 333 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lV~E~~~~gsL~- 404 (658)
-.||++..++|+.+++|....+ ....+++..|...+..|....+ +..+. .....+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~--~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE--RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT--TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC--CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 4899999999999999987642 3345678889888888743222 11111 123456788999998764321
Q ss_pred ----H------Hh---hc----C---CCCCCCHH-------------------HHHHHHHHHHHHHHHhHh----cCCCC
Q 006168 405 ----K------FL---FG----E---KRGSLNWK-------------------QRFDIILGTARGLAYLHE----DFHVR 441 (658)
Q Consensus 405 ----~------~l---~~----~---~~~~l~~~-------------------~~~~i~~~ia~~L~~LH~----~~~~~ 441 (658)
. .+ +. . .+..+++. .+..+...+...+..+.. ....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 01 10 0 01112211 111122222233333322 22457
Q ss_pred eeecCcCCCcEEEcCCCCeEEeeccCccc
Q 006168 442 IIHRDIKPSNVLLDDDLQPKIADFGLARL 470 (658)
Q Consensus 442 ivH~Dik~~NIll~~~~~~kl~DfGla~~ 470 (658)
++|+|+.+.|||++++ ..+.||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 9999999999999754 45889987753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.67 E-value=0.0038 Score=63.37 Aligned_cols=73 Identities=19% Similarity=0.206 Sum_probs=50.3
Q ss_pred cCcccccCceEEEEEEecCC--------cEEEEEEcccccccccHHHHHHHHHHHhccCCCcc-ceeeeEeecCCeEEEE
Q 006168 324 ENKLGEGGFGDIYKGTLKNG--------KIVAVKKLAIGISRRTLSDFENEVRLISNVHHRNL-IRLLGCCSQGPELILV 394 (658)
Q Consensus 324 ~~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV 394 (658)
.+.|+.|-.-.+|+...+++ +.|.+++.. . .....+..+|..+++.+.-.++ .++++++.+ .+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 45788888899999987643 456665543 2 2344567789999988854444 467887754 689
Q ss_pred EeccCCCCH
Q 006168 395 YEYMANSSL 403 (658)
Q Consensus 395 ~E~~~~gsL 403 (658)
+||+++..|
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.22 E-value=0.036 Score=53.73 Aligned_cols=157 Identities=14% Similarity=0.058 Sum_probs=84.2
Q ss_pred cchHHHHHHhcCCCccCcc-----cccCceEEEEEEecCCcEEEEEEcccccccccHHHHHHHHHHHhccCCC-----cc
Q 006168 309 YRLKDLVSATRKFSEENKL-----GEGGFGDIYKGTLKNGKIVAVKKLAIGISRRTLSDFENEVRLISNVHHR-----NL 378 (658)
Q Consensus 309 ~~~~~l~~a~~~f~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~-----ni 378 (658)
.+.+|+....++|..++.. ..|---+.|+...++|+ +++|+.....+ .+++..|++++..|... ..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC---HHHHHHHHHHHHhhhhcccccccc
Confidence 4667888888888765443 35555788999887664 88998754222 23455567777776422 22
Q ss_pred ceee-e--EeecCCeEEEEEeccCCCCHHH--------------Hhhc---CCC-----CCC-----------------C
Q 006168 379 IRLL-G--CCSQGPELILVYEYMANSSLDK--------------FLFG---EKR-----GSL-----------------N 416 (658)
Q Consensus 379 v~l~-~--~~~~~~~~~lV~E~~~~gsL~~--------------~l~~---~~~-----~~l-----------------~ 416 (658)
+... | +.........++.++.+..... .++. ... ... .
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 2211 1 1122455667777766543210 0000 000 000 0
Q ss_pred HHHHHHHHHHHHHHHHHhHh-cCCCCeeecCcCCCcEEEcCCCCeEEeeccCcc
Q 006168 417 WKQRFDIILGTARGLAYLHE-DFHVRIIHRDIKPSNVLLDDDLQPKIADFGLAR 469 (658)
Q Consensus 417 ~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dik~~NIll~~~~~~kl~DfGla~ 469 (658)
.......+..+...+.-.+. ..+.++||+|+.+.||+++++...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 01111122222222222221 224579999999999999988777899999775
|